data_1vee_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vee _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.328 0.585 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.24 -117.6 0.61 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.348 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 m -122.2 148.4 45.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.523 1.529 . . . . 0.0 111.002 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.57 -42.87 75.32 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.315 1.046 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.36 -41.32 79.88 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.732 0.813 . . . . 0.0 111.482 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -61.45 -42.8 99.33 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.07 82.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.343 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.56 -40.17 90.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.036 1.289 . . . . 0.0 110.251 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.2 m -62.98 -54.02 44.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -57.17 -43.09 82.26 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.619 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.98 -20.5 58.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.966 1.257 . . . . 0.0 111.423 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.2 -9.33 62.11 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.219 1.866 . . . . 0.0 112.653 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -122.96 -18.18 6.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.064 1.432 . . . . 0.0 110.913 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -97.21 103.73 15.69 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.59 -24.48 67.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.904 0.881 . . . . 0.0 109.905 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -94.24 -0.19 55.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.164 1.785 . . . . 0.0 112.912 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.91 148.39 29.89 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.246 0.93 . . . . 0.0 111.646 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -148.11 154.68 40.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.02 1.728 . . . . 0.0 108.321 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.04 131.09 52.99 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.067 1.747 . . . . 0.0 108.022 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.0 tp -122.68 114.97 21.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.849 1.66 . . . . 0.0 109.284 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.6 m-20 -84.67 104.19 14.43 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 126.292 1.837 . . . . 0.0 109.445 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.66 2.96 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 122.224 -0.298 . . . . 0.0 110.71 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 26' ' ' ASP . 39.9 mtm180 -57.06 165.01 1.41 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.49 1.516 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.53 141.74 32.38 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.9 m -49.16 -33.66 12.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.351 1.46 . . . . 0.0 111.194 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.52 78.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.235 0.925 . . . . 0.0 110.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.69 -39.42 94.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -58.9 -20.72 54.15 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.276 -1.515 . . . . 0.0 114.574 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -96.03 -23.47 16.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.955 0.502 . . . . 0.0 111.586 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.35 -70.26 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.897 1.679 . . . . 0.0 110.941 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -77.36 -31.92 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.425 1.09 . . . . 0.0 111.708 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.3 -138.32 13.92 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -147.48 162.63 31.38 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 120.619 -1.518 . . . . 0.0 109.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 56.8 Cg_endo -68.55 163.28 37.44 Favored 'Trans proline' 0 N--CA 1.435 -1.937 0 CA-C-O 124.618 1.841 . . . . 0.0 110.141 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.549 ' C ' HD21 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -126.19 92.26 3.54 Favored 'General case' 0 N--CA 1.419 -2.003 1 C-N-CA 132.346 4.258 . . . . 0.0 105.295 -179.212 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 pt -115.43 -19.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.195 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -43.24 -26.54 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.567 -1.682 . . . . 0.0 115.475 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.4 37.36 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 119.991 1.269 . . . . 0.0 110.303 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.46 -71.5 0.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.32 32.2 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 CA-C-O 118.815 -0.992 . . . . 0.0 115.194 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -126.77 177.73 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.053 1.926 . . . . 0.0 110.39 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.86 133.7 43.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.413 1.085 . . . . 0.0 110.076 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.26 167.39 18.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.374 -0.828 . . . . 0.0 110.387 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.1 t -134.34 134.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -115.14 115.84 27.41 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.564 1.146 . . . . 0.0 109.355 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.5 107.86 4.41 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.73 111.44 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 119.776 1.171 . . . . 0.0 110.182 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -74.29 154.86 38.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.592 0.71 . . . . 0.0 109.34 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -165.3 134.78 3.5 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.91 -34.79 80.06 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -66.99 -24.87 66.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.414 1.107 . . . . 0.0 111.115 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -105.32 15.35 27.45 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.582 1.553 . . . . 0.0 114.169 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -39.43 -60.0 1.41 Allowed Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 121.459 1.936 . . . . 0.0 112.328 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.82 -47.64 6.6 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.554 2.836 . . . . 0.0 112.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.75 -22.85 68.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.847 0.737 . . . . 0.0 113.293 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -82.89 -50.17 8.89 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.097 1.759 . . . . 0.0 107.481 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.53 -47.58 66.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.495 1.518 . . . . 0.0 112.882 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -52.38 -43.44 64.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -58.16 -22.2 50.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.741 1.216 . . . . 0.0 113.794 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.41 -52.79 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.8 t -55.68 -30.0 60.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.951 0.9 . . . . 0.0 110.106 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.74 -4.58 59.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -36.67 4.54 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 119.497 1.044 . . . . 0.0 111.342 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.49 120.2 29.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.167 1.387 . . . . 0.0 107.503 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -58.79 -54.11 50.79 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.293 0.497 . . . . 0.0 111.124 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -116.87 83.78 14.91 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.526 1.13 . . . . 0.0 110.012 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.6 -40.75 82.25 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.163 1.909 . . . . 0.0 110.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.32 -0.78 1.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 -11.92 4.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.135 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 138.19 31.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.718 1.207 . . . . 0.0 110.979 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -100.82 123.46 45.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.64 97.16 6.76 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.018 1.327 . . . . 0.0 110.975 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -73.42 120.04 18.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.42 156.86 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.278 1.431 . . . . 0.0 109.992 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -156.35 110.57 2.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -123.76 169.21 11.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -54.89 -39.07 68.36 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.718 -1.238 . . . . 0.0 109.736 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -141.77 -140.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.658 1.983 . . . . 0.0 108.989 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -64.95 -62.29 1.65 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.643 1.577 . . . . 0.0 108.2 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.89 -86.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 127.739 2.59 . . . . 0.0 113.675 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.46 9.44 2.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -42.69 -53.6 4.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.829 1.652 . . . . 0.0 114.182 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -39.23 78.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.24 1.382 . . . . 0.0 112.249 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -50.59 72.81 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.9 -30.42 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 109.94 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.13 89.15 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -78.84 -35.62 43.67 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.04 -57.22 9.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 112.194 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.04 -41.07 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.63 77.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.038 0.935 . . . . 0.0 110.024 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.99 -38.5 91.4 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.211 1.004 . . . . 0.0 109.445 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.96 -49.35 76.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -8.07 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-O 118.132 -1.371 . . . . 0.0 113.269 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -61.1 156.33 18.36 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.123 1.961 . . . . 0.0 109.93 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -68.48 0.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 m -158.76 171.28 20.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.155 0.982 . . . . 0.0 109.068 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.72 164.24 36.61 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 125.45 26.59 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.87 109.58 20.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.36 92.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.02 133.5 14.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.98 2.112 . . . . 0.0 107.015 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 89.85 -5.07 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.636 3.174 . . . . 0.0 112.375 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 65.44 -164.54 37.51 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -88.89 -14.09 37.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.656 -1.164 . . . . 0.0 114.047 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.23 -2.63 14.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.362 0.983 . . . . 0.0 113.61 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.4 176.29 19.1 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.131 -0.981 . . . . 0.0 113.304 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.22 -25.48 56.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.316 3.344 . . . . 0.0 115.248 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -134.8 28.5 3.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.762 2.025 . . . . 0.0 110.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.19 -171.76 5.21 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.456 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 36.4 t-105 -47.2 -55.17 9.04 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.646 0.778 . . . . 0.0 112.613 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.14 -50.77 71.83 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.044 0.937 . . . . 0.0 110.29 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.11 24.96 0.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.802 1.241 . . . . 0.0 113.468 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.3 m -129.37 12.26 5.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.599 1.96 . . . . 0.0 110.823 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.46 18.29 11.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.398 1.479 . . . . 0.0 112.976 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.44 149.96 62.49 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.62 154.68 49.78 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.35 2.033 . . . . 0.0 109.856 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.425 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 50.6 t-105 -155.15 157.33 37.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.263 0.483 . . . . 0.0 110.385 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.83 88.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.184 1.394 . . . . 0.0 110.45 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.42 156.22 91.81 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.984 0.913 . . . . 0.0 109.365 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 C-N-CA 124.147 3.232 . . . . 0.0 109.124 178.506 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 C--O 1.241 0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.6 -120.77 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 118.64 -1.743 . . . . 0.0 115.438 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.02 146.05 52.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.018 1.327 . . . . 0.0 109.991 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.41 66.41 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.135 1.774 . . . . 0.0 107.864 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -55.71 -49.58 72.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.634 0.652 . . . . 0.0 111.823 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -55.49 -43.99 76.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.145 0.43 . . . . 0.0 111.086 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.06 -34.19 72.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.258 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.49 -49.13 67.61 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.762 1.619 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -54.43 -45.2 72.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.579 0.751 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -58.25 -36.26 72.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.604 -1.188 . . . . 0.0 112.275 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.08 -25.68 65.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.72 1.6 . . . . 0.0 111.736 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -40.18 6.36 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 t -78.67 -4.28 48.24 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.751 0.776 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -126.51 -168.72 1.9 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.565 0.746 . . . . 0.0 109.12 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -141.66 -43.23 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.882 2.473 . . . . 0.0 106.554 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.37 63.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.476 0.71 . . . . 0.0 111.44 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.85 124.03 27.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -134.33 138.02 44.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.5 133.5 34.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.413 1.085 . . . . 0.0 108.552 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.58 112.47 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.593 1.557 . . . . 0.0 109.407 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -89.09 117.96 28.46 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.585 2.354 . . . . 0.0 109.15 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.1 pt -108.98 14.2 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -76.55 164.87 25.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 135.15 55.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 m -51.6 -32.54 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.849 1.26 . . . . 0.0 111.724 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.3 77.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.637 1.108 . . . . 0.0 111.622 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -62.62 -28.99 70.28 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.74 0.7 . . . . 0.0 109.804 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -62.43 -13.67 32.42 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.873 -1.142 . . . . 0.0 111.313 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -107.78 -35.87 6.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.385 1.074 . . . . 0.0 110.467 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -85.61 -28.8 24.56 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.74 -22.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.424 1.011 . . . . 0.0 110.346 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.06 -159.6 17.2 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 121.64 -0.662 . . . . 0.0 112.722 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -140.01 161.39 56.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.611 0.764 . . . . 0.0 111.285 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.09 155.69 47.34 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.73 1.62 . . . . 0.0 110.51 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.602 HD22 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -127.39 86.86 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.494 1.918 . . . . 0.0 108.934 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 pt -85.18 6.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.962 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -51.92 -34.65 42.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.459 1.503 . . . . 0.0 112.257 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.57 -6.97 9.46 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.796 1.634 . . . . 0.0 114.173 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 mt -105.15 -23.33 12.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.571 1.548 . . . . 0.0 109.086 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.41 5.73 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 127.939 2.685 . . . . 0.0 109.883 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -124.37 168.5 12.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.849 0.824 . . . . 0.0 110.831 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 48' ' ' ALA . 6.7 tptt -135.84 120.16 17.93 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.613 1.165 . . . . 0.0 108.296 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . -66.75 174.77 2.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.84 0.829 . . . . 0.0 112.387 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.46 149.83 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.131 -2.914 . . . . 0.0 103.131 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -133.95 113.74 12.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.085 1.354 . . . . 0.0 111.315 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.9 m -158.26 113.75 2.68 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.78 121.32 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 112.773 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.89 156.4 32.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.1 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -166.88 161.27 15.12 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 129.33 3.052 . . . . 0.0 106.141 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.32 62.22 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.558 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.7 -42.57 77.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.352 1.061 . . . . 0.0 110.223 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.32 38.82 2.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.661 1.984 . . . . 0.0 112.841 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -46.83 -50.55 43.5 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 120.737 1.608 . . . . 0.0 109.882 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.9 -40.01 13.16 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.727 1.618 . . . . 0.0 111.959 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.88 -53.19 46.12 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 125.394 1.473 . . . . 0.0 109.644 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -55.93 -50.35 70.97 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.202 2.201 . . . . 0.0 108.307 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -56.85 -46.89 81.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.184 0.593 . . . . 0.0 109.902 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -58.21 -42.88 87.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.097 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -56.94 -24.08 50.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.466 1.03 . . . . 0.0 111.984 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mt -96.26 -46.9 6.24 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.57 1.148 . . . . 0.0 108.894 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -64.02 -11.9 33.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.51 0.595 . . . . 0.0 112.139 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.79 -3.86 51.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.251 0.478 . . . . 0.0 110.297 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 -32.68 5.88 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.5 1.92 . . . . 0.0 112.425 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.41 127.46 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.635 1.174 . . . . 0.0 111.503 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.29 -41.36 66.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -135.99 89.61 20.27 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 119.677 1.126 . . . . 0.0 111.027 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.58 -31.42 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.702 1.601 . . . . 0.0 112.414 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.1 -10.86 6.93 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.075 0.95 . . . . 0.0 112.706 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -130.84 23.61 4.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.434 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.8 m -134.06 120.93 20.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.84 1.2 . . . . 0.0 110.603 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -83.7 132.26 34.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.288 1.435 . . . . 0.0 110.605 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.7 mt -108.19 103.47 12.67 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.001 0.92 . . . . 0.0 112.154 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 65.7 m-85 -82.86 100.68 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.1 134.2 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.951 0.901 . . . . 0.0 110.127 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.79 135.94 38.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.063 0.945 . . . . 0.0 109.141 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -130.4 176.19 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 128.693 2.797 . . . . 0.0 108.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.69 -35.61 78.5 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.546 -1.347 . . . . 0.0 109.628 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.58 -151.64 0.39 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.598 1.959 . . . . 0.0 106.808 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.51 -45.68 89.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.61 -108.93 0.22 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 128.2 2.81 . . . . 0.0 114.66 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -118.6 2.15 11.72 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.596 1.159 . . . . 0.0 112.829 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 m -35.29 -57.14 0.6 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.978 2.111 . . . . 0.0 114.717 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.59 -38.07 89.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -31.44 63.19 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.601 0.715 . . . . 0.0 110.074 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.75 -31.29 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.15 93.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.386 0.674 . . . . 0.0 109.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.59 -44.61 73.98 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.91 0.484 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.57 -57.24 10.62 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.298 1.039 . . . . 0.0 112.648 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.21 -40.28 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.54 68.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.72 0.808 . . . . 0.0 109.902 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.36 -23.34 67.26 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.804 0.842 . . . . 0.0 112.623 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -82.01 -19.52 40.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.42 -4.18 5.88 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-O 117.406 -1.775 . . . . 0.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -65.38 140.75 58.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 120.61 2.205 . . . . 0.0 108.224 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.617 ' HG3' ' HG ' ' A' ' 101' ' ' SER . 20.3 tptt -47.77 -61.01 2.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.617 ' HG ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 p -157.29 166.57 32.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.28 151.39 31.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.408 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 24.8 m-85 -141.19 135.5 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 107.748 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.34 118.95 38.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.707 2.003 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.07 110.66 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -66.89 149.07 51.12 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 66.76 8.96 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.312 1.845 . . . . 0.0 113.833 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.71 -104.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.813 0 C-N-CA 127.057 2.265 . . . . 0.0 114.244 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.6 -45.5 0.67 Allowed 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.901 1.28 . . . . 0.0 111.948 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.0 -2.02 31.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.735 0.647 . . . . 0.0 112.089 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.33 174.53 53.46 Favored Glycine 0 CA--C 1.54 1.648 0 O-C-N 121.035 -1.04 . . . . 0.0 112.059 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.36 -23.69 75.36 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.559 3.506 . . . . 0.0 115.542 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -131.79 14.84 4.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.51 1.124 . . . . 0.0 110.57 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.4 165.91 30.99 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -27.7 -56.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.198 2.599 . . . . 0.0 114.697 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.71 -63.19 1.28 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.117 0.967 . . . . 0.0 109.159 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -69.07 7.21 0.75 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.741 1.616 . . . . 0.0 112.718 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 t -100.53 6.87 44.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.32 1.448 . . . . 0.0 109.877 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t 66.78 49.22 1.25 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.147 1.34 . . . . 0.0 108.657 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.7 mt -128.67 155.57 78.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 125.084 1.354 . . . . 0.0 109.123 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.62 168.72 23.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.645 2.23 . . . . 0.0 110.989 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.602 ' N ' HD22 ' A' ' 40' ' ' ASN . 34.0 t-105 -171.83 126.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.182 -1.574 . . . . 0.0 110.816 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.444 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.8 mt -68.66 88.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.324 1.85 . . . . 0.0 110.716 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.24 155.11 69.65 Favored Pre-proline 0 C--O 1.24 0.603 0 O-C-N 121.103 -0.998 . . . . 0.0 110.309 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 CA--C 1.535 0.525 0 C-N-CA 124.51 3.473 . . . . 0.0 110.72 179.111 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.239 0.501 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.4 -101.65 0.23 Allowed Glycine 0 C--N 1.338 0.67 0 O-C-N 121.491 -0.755 . . . . 0.0 111.941 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.3 m -160.11 164.94 32.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.054 2.542 . . . . 0.0 106.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.5 95.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.654 -0.654 . . . . 0.0 112.554 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -55.26 -48.81 73.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.006 0.821 . . . . 0.0 110.684 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -55.59 -50.1 71.01 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.379 0.671 . . . . 0.0 109.419 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.75 81.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.101 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.42 -43.37 93.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.777 1.171 . . . . 0.0 110.561 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.6 m -58.91 -45.02 91.3 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.235 -0.915 . . . . 0.0 109.425 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -65.04 -42.16 94.55 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.946 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -57.28 -41.88 80.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.108 0.867 . . . . 0.0 109.548 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.67 -14.31 77.92 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-O 118.186 -1.341 . . . . 0.0 115.32 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 t -115.25 -13.12 11.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.05 1.425 . . . . 0.0 112.02 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -113.3 99.78 8.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.84 -25.86 43.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.572 1.149 . . . . 0.0 112.9 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -89.37 -3.96 58.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.543 0.737 . . . . 0.0 112.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.05 149.84 24.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.528 1.058 . . . . 0.0 110.092 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -145.96 174.09 11.57 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.39 144.42 40.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.436 0.695 . . . . 0.0 110.144 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 tp -121.35 108.73 14.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.666 2.387 . . . . 0.0 112.541 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -86.5 109.82 19.34 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.476 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.07 2.25 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -42.19 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.72 130.02 3.68 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -44.59 -34.33 2.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.906 2.082 . . . . 0.0 114.726 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.78 -34.29 45.68 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 120.359 1.436 . . . . 0.0 110.781 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.08 -29.33 69.68 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.34 -20.69 65.73 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 119.628 -1.92 . . . . 0.0 112.168 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -91.92 -19.93 21.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.573 1.549 . . . . 0.0 109.474 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.5 -62.86 1.18 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.16 1.384 . . . . 0.0 112.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.02 -38.53 12.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 123.964 0.906 . . . . 0.0 111.136 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.69 -151.76 17.27 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 118.886 0.766 . . . . 0.0 113.618 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.56 154.6 60.04 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.801 1.64 . . . . 0.0 108.036 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.75 172.65 14.77 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 121.551 1.501 . . . . 0.0 109.774 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.19 113.15 12.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.624 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.4 pt -103.27 14.47 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.631 1.205 . . . . 0.0 110.933 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.02 -17.29 51.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.548 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.65 -6.82 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 120.276 1.398 . . . . 0.0 111.335 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -112.5 -22.72 10.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.703 2.801 . . . . 0.0 109.376 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.93 25.66 14.29 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.614 2.054 . . . . 0.0 109.667 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -116.63 178.92 4.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.512 1.925 . . . . 0.0 111.695 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.98 138.77 17.95 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.08 170.81 16.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.2 1.0 . . . . 0.0 112.421 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.0 133.75 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.956 2.102 . . . . 0.0 106.159 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -106.63 122.62 46.7 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.983 0.913 . . . . 0.0 111.611 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.488 ' CG2' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -152.13 102.96 2.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.866 1.266 . . . . 0.0 109.503 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.71 127.36 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 120.321 -1.487 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -81.37 151.81 27.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -157.84 131.29 7.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.475 1.11 . . . . 0.0 108.563 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.84 66.56 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -86.67 -0.5 56.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.801 1.3 . . . . 0.0 111.833 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.62 25.58 5.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.64 0.776 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -48.36 -57.14 11.44 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.676 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.28 -41.05 13.32 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.346 1.364 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -22.53 63.8 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.693 0.663 . . . . 0.0 113.78 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -83.29 -47.23 11.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.439 1.496 . . . . 0.0 107.585 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 mt -55.78 -46.83 77.85 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.214 1.405 . . . . 0.0 110.801 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -45.24 66.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.685 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HE3' ' CG2' ' A' ' 51' ' ' THR . 40.9 mtmt -62.32 -20.03 63.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.67 -46.24 6.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 t -60.74 -21.25 62.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.23 -2.79 56.28 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 -27.79 7.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.979 0.911 . . . . 0.0 112.308 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.8 114.18 25.8 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 108.268 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -66.21 -31.82 72.88 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.49 1.116 . . . . 0.0 111.287 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.49 77.48 34.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.15 -40.75 74.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.091 1.861 . . . . 0.0 112.919 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.97 -6.11 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -125.94 -4.04 6.98 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.782 0.719 . . . . 0.0 111.463 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.4 m -96.39 124.37 40.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 110.488 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.8 m -89.68 132.87 34.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.66 98.73 7.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 29.6 m-85 -78.33 113.99 16.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.127 -0.94 . . . . 0.0 108.478 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -81.93 134.55 26.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 120.228 1.376 . . . . 0.0 111.722 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 tp -129.88 113.29 14.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.35 1.46 . . . . 0.0 109.254 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -119.36 -177.27 3.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.691 1.596 . . . . 0.0 108.682 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -61.23 -54.48 43.67 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.356 -0.84 . . . . 0.0 110.121 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -139.1 -168.9 2.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.871 2.869 . . . . 0.0 106.34 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.68 -58.51 0.5 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.898 2.479 . . . . 0.0 112.689 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.02 -109.03 0.57 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.639 1.59 . . . . 0.0 114.835 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -134.55 10.04 3.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.194 2.198 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.7 m -44.13 -42.1 6.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.692 1.597 . . . . 0.0 113.157 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -64.01 -44.23 93.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.501 0.72 . . . . 0.0 111.284 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.61 -45.45 86.85 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.72 -28.6 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.094 0.958 . . . . 0.0 109.471 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.32 -44.8 82.37 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.916 0.78 . . . . 0.0 110.218 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.15 -39.35 60.45 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.1 -56.65 5.33 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.351 1.46 . . . . 0.0 111.798 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.56 -39.43 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.608 0.763 . . . . 0.0 111.19 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.57 -52.85 63.72 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.63 0.772 . . . . 0.0 109.093 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.84 -20.18 65.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.053 1.741 . . . . 0.0 111.656 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.58 -15.43 32.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.178 1.391 . . . . 0.0 114.025 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.14 -0.76 5.31 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.016 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -81.74 156.35 25.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.9 1.85 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -54.54 -69.45 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.077 0.951 . . . . 0.0 112.128 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.3 m -161.31 177.93 9.69 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.694 2.398 . . . . 0.0 107.008 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.15 163.93 39.01 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 126.103 1.761 . . . . 0.0 107.253 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 28.5 m-85 -136.21 145.45 45.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 107.891 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.15 118.43 35.33 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.846 1.259 . . . . 0.0 108.713 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.13 113.16 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -63.12 143.46 57.77 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 70.69 2.82 4.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.304 1.442 . . . . 0.0 112.983 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.69 -110.64 0.86 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 126.922 2.201 . . . . 0.0 114.639 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.44 -21.99 5.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.069 1.348 . . . . 0.0 114.36 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -110.01 -10.56 14.7 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.03 -173.47 47.62 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 119.579 1.081 . . . . 0.0 114.145 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.46 -36.32 93.92 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.116 3.211 . . . . 0.0 114.281 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.7 mmt-85 -111.32 11.1 21.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.491 1.116 . . . . 0.0 110.769 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.68 156.77 46.09 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -36.22 -54.54 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 114.538 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.29 -39.4 86.78 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -86.99 -8.56 57.08 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.013 0.925 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.8 t -82.63 6.59 17.29 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.264 1.026 . . . . 0.0 111.028 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m 54.72 57.08 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.993 1.717 . . . . 0.0 108.558 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 98.0 mt -121.67 154.58 60.2 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 126.844 2.058 . . . . 0.0 105.919 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.89 166.1 29.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.9 1.734 . . . . 0.0 110.159 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -159.94 143.09 13.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.847 1.203 . . . . 0.0 111.928 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 mt -95.2 98.07 7.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 0.0 110.173 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.33 141.13 42.33 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.544 0.993 0 C-N-CA 122.538 2.159 . . . . 0.0 106.584 176.845 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.238 0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.77 98.38 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -51.85 158.61 0.98 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.0 110.434 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.67 -49.77 46.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.684 0.674 . . . . 0.0 111.701 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG3' ' HG ' ' A' ' 118' ' ' SER . 33.4 mtmt -58.37 -48.36 80.85 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.759 -0.588 . . . . 0.0 110.785 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -52.73 63.86 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.24 64.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.53 1.132 . . . . 0.0 110.3 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.0 -41.86 93.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.209 0.603 . . . . 0.0 111.698 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -61.77 -51.63 67.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -62.93 -36.12 82.36 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.769 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.98 -30.59 69.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.088 1.313 . . . . 0.0 108.195 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.48 -24.84 74.09 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 125.266 1.413 . . . . 0.0 113.94 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -100.57 -24.16 14.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.301 1.551 . . . . 0.0 109.923 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.34 170.24 15.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.493 0.588 . . . . 0.0 110.329 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -119.36 -32.76 4.28 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.083 0.953 . . . . 0.0 111.475 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -101.83 -11.76 18.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.45 -0.781 . . . . 0.0 112.832 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.22 58.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.612 0.642 . . . . 0.0 112.466 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -140.02 166.55 24.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.93 125.16 42.7 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.628 1.571 . . . . 0.0 107.419 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.5 97.6 7.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.771 1.628 . . . . 0.0 108.574 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.87 106.2 8.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.1 1.41 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 122.953 0.501 . . . . 0.0 111.738 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -59.19 168.04 1.55 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 126.91 2.084 . . . . 0.0 112.393 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.35 135.97 35.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 m -41.71 -41.22 2.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.187 2.195 . . . . 0.0 114.249 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.34 92.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.621 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -58.86 -29.08 66.7 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.0 -19.27 51.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.091 0.859 . . . . 0.0 109.23 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -104.33 -33.69 8.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.779 2.432 . . . . 0.0 111.916 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -77.91 -44.01 28.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.232 1.013 . . . . 0.0 111.618 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.68 -25.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.492 1.117 . . . . 0.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.52 -163.27 13.55 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.199 0.909 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -143.06 162.97 40.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 122.958 0.503 . . . . 0.0 111.121 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.72 146.46 33.94 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.545 1.497 . . . . 0.0 112.94 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.493 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -108.69 76.25 1.01 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.812 2.445 . . . . 0.0 109.659 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 pt -85.57 5.23 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.651 0.739 . . . . 0.0 110.817 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -53.09 -34.51 56.93 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.889 1.676 . . . . 0.0 114.368 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.63 -30.65 69.22 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.061 1.3 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.62 -21.01 49.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.745 0.818 . . . . 0.0 110.129 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 38.18 5.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -126.56 171.03 11.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.822 1.249 . . . . 0.0 111.029 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -143.86 137.73 28.14 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.899 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.14 167.08 22.51 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.2 94.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -62.32 119.87 9.9 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 m -152.26 95.64 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.966 1.307 . . . . 0.0 108.884 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -61.78 122.76 13.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -75.64 154.23 36.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.693 0.397 . . . . 0.0 109.984 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -148.98 127.27 12.16 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.92 -13.3 82.64 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.57 -41.31 10.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.55 1.175 . . . . 0.0 108.15 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.71 29.03 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.744 1.618 . . . . 0.0 111.852 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -43.2 -53.84 10.3 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 120.971 -1.081 . . . . 0.0 111.137 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.09 -49.66 4.64 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.997 1.798 . . . . 0.0 112.136 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -29.47 71.92 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.763 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -69.56 -48.36 60.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.062 1.745 . . . . 0.0 108.657 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.4 -41.59 66.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.321 1.049 . . . . 0.0 111.854 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -59.12 -33.18 70.57 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.572 -0.705 . . . . 0.0 111.741 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -60.03 -16.46 31.15 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.663 0.785 . . . . 0.0 111.92 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.3 -37.58 8.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.349 1.46 . . . . 0.0 109.731 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -25.18 65.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.637 1.562 . . . . 0.0 111.498 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.67 -6.04 41.61 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.585 -0.697 . . . . 0.0 112.03 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 -49.69 2.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.209 1.003 . . . . 0.0 108.455 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -77.83 103.7 7.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 108.964 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.66 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.756 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -134.45 69.93 72.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.635 1.974 . . . . 0.0 112.861 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 -24.15 64.48 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.989 3.793 . . . . 0.0 111.919 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -53.87 -18.43 3.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 130.792 3.637 . . . . 0.0 113.057 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -134.31 -4.51 2.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.564 1.546 . . . . 0.0 111.689 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -76.03 121.79 23.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.607 1.094 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -89.58 122.77 33.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 72.2 m-85 -79.16 105.47 10.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 mt -83.56 129.15 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 119.235 0.925 . . . . 0.0 110.959 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -125.56 125.8 43.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.562 1.145 . . . . 0.0 108.319 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -128.17 177.36 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.961 2.105 . . . . 0.0 107.537 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -58.87 -52.59 65.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.692 -1.255 . . . . 0.0 109.378 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.31 178.77 7.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.691 3.196 . . . . 0.0 104.848 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -24.45 -57.33 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 130.399 3.48 . . . . 0.0 112.979 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.94 -104.33 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.906 2.193 . . . . 0.0 115.499 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -125.13 14.0 8.39 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.899 1.28 . . . . 0.0 112.82 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -51.96 -39.11 58.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.957 1.708 . . . . 0.0 112.068 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.55 -43.59 69.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.194 0.907 . . . . 0.0 110.362 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.27 -49.58 77.03 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.705 0.802 . . . . 0.0 109.733 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.97 -33.91 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.113 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.95 95.58 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.232 0.924 . . . . 0.0 109.34 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -69.02 -47.48 65.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.4 -62.05 1.69 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.941 1.696 . . . . 0.0 113.96 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 m -63.04 -39.02 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 122.584 0.354 . . . . 0.0 111.382 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.89 70.94 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.938 0.774 . . . . 0.0 110.196 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.26 -42.62 99.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.599 0.562 . . . . 0.0 109.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.86 -45.25 95.28 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 -14.97 0.06 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.313 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -71.93 156.04 39.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.217 1.509 . . . . 0.0 108.234 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -58.57 -66.86 0.42 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.879 0.871 . . . . 0.0 111.557 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -159.0 170.6 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.915 1.286 . . . . 0.0 107.584 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.33 163.75 35.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.416 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 42.9 m-85 -133.94 123.37 24.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.79 104.78 15.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.058 0.943 . . . . 0.0 108.856 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.52 109.44 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -59.99 146.45 42.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.43 2.44 1.57 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.503 1.521 . . . . 0.0 114.797 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.31 -111.71 2.21 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.733 1.159 . . . . 0.0 112.297 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.25 -28.52 2.34 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.53 -19.14 26.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.64 163.74 50.11 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 121.042 -1.036 . . . . 0.0 111.492 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.63 -24.96 47.85 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.575 3.517 . . . . 0.0 115.415 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 0.62 24.24 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.048 1.339 . . . . 0.0 110.815 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.92 163.56 54.91 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.663 1.125 . . . . 0.0 111.403 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -29.84 -66.59 0.09 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.57 2.348 . . . . 0.0 115.293 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.1 mt -50.64 -60.93 2.53 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.923 1.289 . . . . 0.0 110.735 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -69.12 -7.45 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.563 1.545 . . . . 0.0 113.806 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.486 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 11.0 t -88.75 8.14 30.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.551 -1.343 . . . . 0.0 111.203 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 t 69.13 47.32 0.74 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.19 157.28 58.73 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.088 1.355 . . . . 0.0 109.22 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' C ' HD22 ' A' ' 40' ' ' ASN . 30.0 Cg_endo -78.08 165.76 25.65 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.404 2.736 . . . . 0.0 109.479 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -168.37 133.75 1.78 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.804 -1.185 . . . . 0.0 112.463 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.463 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 2.3 mt -74.92 86.94 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.992 1.317 . . . . 0.0 110.439 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 150.52 75.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.679 -0.638 . . . . 0.0 110.535 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 CA--C 1.537 0.672 1 C-N-CA 125.313 4.009 . . . . 0.0 109.922 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.239 0.539 0 CA-C-O 121.307 0.575 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.55 -114.71 0.3 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -178.0 169.78 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 131.157 3.783 . . . . 0.0 106.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.69 -51.36 70.27 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.528 0.731 . . . . 0.0 112.451 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -52.31 -53.83 39.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.343 0.52 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -53.7 -51.07 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.935 0.494 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.88 94.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.047 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -56.94 -44.23 82.28 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.783 1.174 . . . . 0.0 110.293 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -63.28 -53.36 54.16 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -56.65 -43.06 79.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.481 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.85 -40.95 85.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.981 2.113 . . . . 0.0 107.937 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.9 -20.42 79.47 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.717 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -106.94 -10.36 16.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.606 1.703 . . . . 0.0 112.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.23 135.27 34.59 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -32.99 37.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -97.61 -13.43 21.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 149.43 26.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -150.0 164.45 35.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 108.309 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -106.04 133.4 50.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.593 1.557 . . . . 0.0 108.299 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.0 tp -122.26 104.8 9.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.903 1.681 . . . . 0.0 110.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.61 111.98 12.68 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.182 1.793 . . . . 0.0 106.978 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.89 3.33 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 118.698 0.681 . . . . 0.0 112.093 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -62.54 167.04 4.66 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.493 1.917 . . . . 0.0 112.58 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.34 133.71 37.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 108.519 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.03 -29.27 0.33 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.151 2.58 . . . . 0.0 115.609 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.95 63.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.596 -1.315 . . . . 0.0 110.528 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.52 -27.74 69.47 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.756 -1.215 . . . . 0.0 112.358 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -62.55 -21.07 65.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.886 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -91.75 -35.2 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.802 2.041 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.05 -58.15 3.44 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.935 1.694 . . . . 0.0 112.99 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.68 -19.3 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.99 -159.95 22.23 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.611 1.096 . . . . 0.0 111.808 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.0 p -142.03 161.6 50.2 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.88 -0.776 . . . . 0.0 112.088 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.67 158.15 54.09 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.03 1.153 . . . . 0.0 111.094 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -125.19 74.75 1.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.15 1.78 . . . . 0.0 109.583 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.2 pt -74.97 2.87 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 121.763 -0.585 . . . . 0.0 109.545 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.95 -31.61 65.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.467 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.28 75.81 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.0 -35.9 69.6 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.896 1.279 . . . . 0.0 110.669 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.0 21.62 1.88 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.775 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -123.01 178.57 5.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.383 1.591 . . . . 0.0 111.204 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -137.86 131.55 31.2 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.474 -0.766 . . . . 0.0 110.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.38 168.11 16.73 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.769 0.795 . . . . 0.0 111.125 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.7 138.03 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 127.645 2.378 . . . . 0.0 104.646 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.4 p -117.91 124.37 48.1 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -152.55 102.9 2.76 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -54.61 117.74 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.793 0.837 . . . . 0.0 111.859 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -79.63 134.67 36.45 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.52 119.78 6.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -51.46 -20.65 5.53 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -71.12 -16.65 62.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.538 1.169 . . . . 0.0 112.569 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -133.4 29.31 3.96 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 117.317 -1.325 . . . . 0.0 114.335 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -38.79 -56.14 2.47 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 121.482 1.946 . . . . 0.0 111.532 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.87 -40.82 33.12 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.421 2.747 . . . . 0.0 111.451 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.53 58.64 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.112 1.815 . . . . 0.0 109.844 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.62 -54.24 46.57 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.555 1.942 . . . . 0.0 106.633 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.28 -45.75 62.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.974 0.909 . . . . 0.0 110.112 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.92 -37.45 87.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.042 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -61.12 -31.54 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.052 1.296 . . . . 0.0 108.484 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -43.32 18.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.044 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.31 64.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.188 1.358 . . . . 0.0 112.443 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.24 -9.8 59.71 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.687 1.13 . . . . 0.0 110.968 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.04 -43.11 4.26 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.037 1.335 . . . . 0.0 110.363 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.72 102.95 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -57.72 -33.26 68.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.478 0.311 . . . . 0.0 111.395 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -131.93 86.41 47.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 123.719 0.808 . . . . 0.0 110.992 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -66.72 -33.43 34.88 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.395 2.063 . . . . 0.0 112.086 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.22 -23.52 14.96 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.4 1.48 . . . . 0.0 114.623 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -117.28 -6.42 11.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.087 1.312 . . . . 0.0 110.661 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.4 m -94.07 121.6 35.73 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 112.889 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -91.47 131.86 36.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.41 1.084 . . . . 0.0 108.681 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.35 97.35 5.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 111.153 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.91 119.4 19.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.715 0.806 . . . . 0.0 109.084 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mp -75.56 133.9 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 111.508 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.81 121.83 27.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.45 167.0 16.18 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 108.398 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -61.02 -39.55 90.18 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.988 -1.07 . . . . 0.0 109.411 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -131.92 -136.51 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.635 1.974 . . . . 0.0 106.919 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 106' ' ' LYS . 66.6 m-20 -83.93 -55.64 4.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.019 1.328 . . . . 0.0 108.723 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.66 -95.1 0.1 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.811 1.672 . . . . 0.0 113.203 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -145.82 10.79 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 128.097 2.559 . . . . 0.0 110.907 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.2 m -48.54 -40.56 27.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.248 1.419 . . . . 0.0 111.587 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.3 -30.49 71.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.702 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -83.47 -41.52 17.94 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.06 -34.75 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.9 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.983 1.313 . . . . 0.0 111.239 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -86.68 -44.28 11.95 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 108.979 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -48.79 -61.37 2.08 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 126.718 2.007 . . . . 0.0 112.771 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.14 -37.39 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.571 0.348 . . . . 0.0 111.744 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -53.47 54.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.853 0.721 . . . . 0.0 109.666 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.47 -20.47 65.61 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.483 1.113 . . . . 0.0 112.195 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -84.53 -35.34 22.93 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 111.58 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.42 -8.11 0.46 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.35 -1.805 . . . . 0.0 115.155 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.69 153.48 42.02 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 120.425 2.112 . . . . 0.0 109.484 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -56.62 -56.67 18.44 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 m -162.14 171.7 17.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -165.21 115.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.67 140.66 32.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.69 114.32 26.77 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.23 100.55 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 6.6 tmtm? -63.21 151.28 40.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 75.37 -1.58 3.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.945 2.098 . . . . 0.0 112.971 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.52 -140.24 48.06 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 119.703 1.138 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.62 -35.46 6.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.837 0.855 . . . . 0.0 111.188 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.2 -15.23 47.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.71 1.204 . . . . 0.0 113.358 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.7 166.32 27.25 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.64 -30.41 90.42 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.466 2.777 . . . . 0.0 113.454 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 20.8 tpt180 -110.63 14.26 22.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.354 1.862 . . . . 0.0 110.179 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.17 170.84 51.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -45.29 -58.68 3.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.6 mt -59.89 -38.22 81.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.557 0.343 . . . . 0.0 110.935 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -88.9 19.84 3.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 111.467 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.4 m -121.42 12.21 10.82 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.526 -1.359 . . . . 0.0 112.289 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.0 m 56.57 55.8 6.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.343 1.057 . . . . 0.0 108.503 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -121.74 150.93 56.55 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.469 ' C ' HD22 ' A' ' 40' ' ' ASN . 44.1 Cg_endo -70.31 158.9 54.81 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.634 1.556 . . . . 0.0 109.322 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.524 ' N ' HD22 ' A' ' 40' ' ' ASN . 37.8 t-105 -167.84 132.2 1.77 Allowed 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.388 -1.445 . . . . 0.0 110.749 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 8.8 mt -71.06 90.77 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.205 1.402 . . . . 0.0 108.443 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.63 151.01 60.92 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 CA--C 1.539 0.746 0 C-N-CA 124.605 3.536 . . . . 0.0 107.712 178.387 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.03 -90.05 0.08 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.591 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.7 t -166.63 167.56 15.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.024 0.929 . . . . 0.0 109.855 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.85 -34.18 75.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -71.19 -49.95 38.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.69 -50.88 62.44 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.169 0.588 . . . . 0.0 110.271 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.82 74.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.067 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.96 -39.68 78.72 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.253 1.388 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -68.79 -46.53 68.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.693 0.797 . . . . 0.0 109.102 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.01 -39.16 93.91 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.032 -1.668 . . . . 0.0 110.97 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.08 -23.53 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.954 1.702 . . . . 0.0 109.551 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.94 -22.92 36.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 -13.1 24.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.588 1.194 . . . . 0.0 110.458 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -114.74 112.35 22.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.911 1.232 . . . . 0.0 110.718 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.55 -36.08 82.6 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.722 1.209 . . . . 0.0 112.653 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -84.18 -17.21 40.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.575 -0.703 . . . . 0.0 112.349 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.0 153.81 32.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.309 0.959 . . . . 0.0 112.513 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -150.25 162.26 40.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.201 1.401 . . . . 0.0 109.388 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.42 154.22 19.0 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 tp -134.41 103.87 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.207 1.403 . . . . 0.0 109.837 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.41 96.63 5.4 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.036 1.334 . . . . 0.0 108.629 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -87.82 -1.33 8.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.6 mtm-85 -69.46 162.57 27.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.969 0.804 . . . . 0.0 109.978 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.73 133.97 51.26 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.34 -22.11 1.03 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.632 1.973 . . . . 0.0 112.38 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.92 88.9 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.285 -1.509 . . . . 0.0 110.16 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -55.15 -40.75 70.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.495 1.518 . . . . 0.0 111.267 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -53.66 -30.13 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.394 1.077 . . . . 0.0 112.066 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -97.3 -20.89 17.56 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 126.549 1.94 . . . . 0.0 112.726 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -101.11 -60.37 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.49 -31.61 4.23 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.758 1.623 . . . . 0.0 111.559 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.35 -163.34 12.26 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.78 158.55 49.29 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.79 157.8 54.49 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.141 1.894 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.496 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -122.39 83.68 2.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.897 2.479 . . . . 0.0 111.961 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -79.58 -0.68 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.394 -1.441 . . . . 0.0 109.747 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -46.12 -40.7 11.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.429 2.692 . . . . 0.0 113.188 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.05 77.07 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.422 -0.654 . . . . 0.0 113.044 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.4 mt -77.57 -40.85 40.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.56 1.03 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.909 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -126.02 -179.1 4.54 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.094 1.447 . . . . 0.0 111.927 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -133.23 144.11 49.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.177 1.391 . . . . 0.0 109.15 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 167.18 14.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 111.98 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -140.54 93.59 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -76.87 102.74 6.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.879 2.072 . . . . 0.0 112.393 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -141.54 98.82 3.43 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.53 125.89 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.221 0.919 . . . . 0.0 110.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -76.02 152.35 36.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.857 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -155.77 116.5 3.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.55 -24.11 61.44 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.539 -0.59 . . . . 0.0 112.192 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.89 -7.01 59.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.035 1.417 . . . . 0.0 110.159 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -126.22 28.95 5.92 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.333 1.453 . . . . 0.0 112.577 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -45.57 -52.38 23.67 Favored Pre-proline 0 N--CA 1.474 0.765 0 O-C-N 120.553 -1.342 . . . . 0.0 112.138 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.78 -44.61 16.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.446 2.097 . . . . 0.0 112.434 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.26 -44.07 96.76 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.71 -54.16 46.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.981 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.93 -43.72 66.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.991 1.716 . . . . 0.0 111.504 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -54.79 -50.56 68.21 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 109.544 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.29 -29.15 57.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -80.6 -51.79 8.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 t -56.36 -23.32 36.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.333 1.453 . . . . 0.0 110.624 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.84 -2.87 43.15 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 -42.52 3.13 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.39 114.4 21.86 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -30.37 71.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.35 70.14 82.22 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.092 1.757 . . . . 0.0 109.312 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.88 -43.11 52.01 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.381 2.054 . . . . 0.0 111.972 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -62.65 -3.53 1.55 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.301 1.441 . . . . 0.0 113.617 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -127.36 -18.04 4.56 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 111.586 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -90.93 104.76 17.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.401 1.48 . . . . 0.0 111.39 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.2 m -71.72 137.73 47.97 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.852 -1.155 . . . . 0.0 109.679 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -102.72 99.99 10.0 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.202 1.401 . . . . 0.0 113.839 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.98 99.78 8.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mt -79.41 133.58 29.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 123.922 0.889 . . . . 0.0 109.622 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.66 121.22 26.56 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.762 0.825 . . . . 0.0 112.391 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.77 172.3 7.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.069 2.548 . . . . 0.0 107.62 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.25 84.53 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 119.888 -1.757 . . . . 0.0 112.599 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -146.39 -173.22 4.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 130.094 3.358 . . . . 0.0 104.099 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.32 -55.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.641 2.776 . . . . 0.0 113.397 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.96 -101.51 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 128.288 2.851 . . . . 0.0 115.582 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -144.04 -0.21 1.03 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.17 1.388 . . . . 0.0 113.336 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 p -44.62 -44.71 9.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.741 1.155 . . . . 0.0 113.667 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -60.05 -40.34 89.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.782 0.719 . . . . 0.0 112.597 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -71.59 -49.69 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.939 1.696 . . . . 0.0 108.911 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.53 -33.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.231 1.013 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.9 70.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.408 0.549 . . . . 0.0 111.94 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.65 -42.76 13.17 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.363 0.983 . . . . 0.0 108.405 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.8 tp -49.95 -59.34 3.96 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.938 1.695 . . . . 0.0 112.332 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.3 -37.64 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.975 -0.453 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.68 68.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.384 0.674 . . . . 0.0 109.532 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.07 -28.93 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.55 0.74 . . . . 0.0 110.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.82 -33.63 70.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.541 0.61 . . . . 0.0 110.039 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.7 -13.52 0.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.242 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -60.24 146.48 43.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.219 1.509 . . . . 0.0 111.094 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -47.3 -60.19 2.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.701 2.001 . . . . 0.0 112.929 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -167.09 174.75 8.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 126.768 2.027 . . . . 0.0 105.686 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 152.98 36.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -135.62 111.22 9.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.415 0.686 . . . . 0.0 111.26 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.84 133.78 38.1 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 103.24 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -58.09 137.55 56.82 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 36.3 m-20 71.48 15.62 6.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.24 2.216 . . . . 0.0 112.933 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.72 -144.06 7.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.132 1.348 . . . . 0.0 114.913 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.67 -26.51 15.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.52 -1.45 12.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.98 -178.68 8.53 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.75 1.159 . . . . 0.0 114.078 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -29.92 43.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.333 3.355 . . . . 0.0 114.378 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -132.12 12.45 4.68 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.26 1.424 . . . . 0.0 110.296 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.85 174.35 3.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -31.56 -60.87 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.187 1.795 . . . . 0.0 114.327 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.18 -50.93 71.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.507 0.723 . . . . 0.0 111.049 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.92 3.3 5.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.067 1.747 . . . . 0.0 113.772 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.96 13.85 28.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 111.316 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 60.01 46.0 11.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.627 1.171 . . . . 0.0 110.306 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.09 151.18 45.39 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.496 ' C ' HD22 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -73.44 163.96 36.32 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.928 1.752 . . . . 0.0 110.221 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -161.65 128.13 3.81 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.66 -1.275 . . . . 0.0 111.792 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 1.8 mt -73.39 87.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.466 1.906 . . . . 0.0 111.489 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.46 146.0 46.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.864 0.865 . . . . 0.0 110.387 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 N--CA 1.45 -1.069 0 C-N-CA 122.649 2.233 . . . . 0.0 108.468 177.59 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 C--O 1.238 0.487 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.93 -112.56 0.43 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.454 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 m -152.35 150.33 29.6 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.574 1.55 . . . . 0.0 107.319 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.89 66.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.753 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG3' ' HG ' ' A' ' 118' ' ' SER . 22.7 mtmt -51.87 -43.71 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.068 -1.645 . . . . 0.0 113.182 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -53.28 54.76 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.27 71.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.444 0.465 . . . . 0.0 111.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.47 -51.57 42.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.805 1.242 . . . . 0.0 109.087 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -56.57 -40.84 75.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.521 0.601 . . . . 0.0 109.978 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -60.42 -44.18 96.02 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.36 -27.61 64.35 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.192 1.36 . . . . 0.0 109.576 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 -2.13 82.61 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.87 1.7 . . . . 0.0 114.171 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -0.21 6.59 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.832 2.053 . . . . 0.0 109.1 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -138.56 98.5 3.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.276 1.43 . . . . 0.0 110.064 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -62.46 -36.54 82.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.663 1.22 . . . . 0.0 110.297 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.76 -7.78 17.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.803 0.841 . . . . 0.0 111.62 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.32 150.17 21.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 120.364 1.438 . . . . 0.0 110.969 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -139.17 161.45 37.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.489 1.516 . . . . 0.0 109.691 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -106.01 128.82 54.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -118.36 102.3 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.221 1.809 . . . . 0.0 112.65 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.31 116.93 19.08 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.2 4.09 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -62.77 172.98 1.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.06 2.144 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.71 139.41 34.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -45.04 -35.99 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.308 1.843 . . . . 0.0 114.266 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.231 0.923 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.26 -35.33 64.89 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.343 1.057 . . . . 0.0 110.761 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.24 -23.69 64.27 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.378 -0.826 . . . . 0.0 112.253 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mtp85 -104.67 -15.79 15.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.936 1.294 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -89.88 -58.2 2.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.136 1.374 . . . . 0.0 111.007 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.87 -26.53 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.594 0.758 . . . . 0.0 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.03 -162.14 12.45 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 121.609 -0.682 . . . . 0.0 112.764 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -139.36 152.5 69.4 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 123.008 0.523 . . . . 0.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.6 139.63 25.65 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.186 1.924 . . . . 0.0 109.693 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.652 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -110.23 82.22 1.56 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.571 2.749 . . . . 0.0 106.982 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 pt -71.99 1.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 119.953 -1.717 . . . . 0.0 110.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -22.44 51.77 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.091 1.757 . . . . 0.0 112.099 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.79 -40.74 72.98 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.8 mt -75.92 -52.17 10.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.45 -9.37 1.24 Allowed Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.106 1.336 . . . . 0.0 115.519 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -91.5 -169.85 2.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.85 1.325 . . . . 0.0 113.073 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -144.42 139.15 28.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.525 1.13 . . . . 0.0 109.725 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.52 170.47 16.34 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.007 0.908 . . . . 0.0 112.265 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.3 138.42 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -120.3 132.01 55.13 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.748 0.419 . . . . 0.0 109.97 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.3 m -152.44 100.07 2.54 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.47 112.43 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.507 0.723 . . . . 0.0 110.262 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -83.56 148.97 26.88 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -156.54 131.27 8.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.46 2.704 . . . . 0.0 105.557 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.15 -23.27 52.07 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.321 0.962 . . . . 0.0 112.965 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.3 -22.57 63.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.756 1.223 . . . . 0.0 112.019 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -135.69 44.81 2.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -45.09 -56.05 9.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.538 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.18 -40.8 24.45 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.528 2.152 . . . . 0.0 111.317 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.78 61.01 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 124.2 0.905 . . . . 0.0 112.54 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.03 -53.7 4.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.84 -48.88 41.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.127 1.771 . . . . 0.0 111.899 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -54.52 -36.26 64.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 112.715 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.66 -22.49 66.5 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.276 1.03 . . . . 0.0 112.027 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.73 -44.99 8.25 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -52.19 -35.0 47.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.904 2.082 . . . . 0.0 111.459 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.67 -5.5 57.06 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.08 -32.85 4.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.969 0.804 . . . . 0.0 113.122 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.451 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 38.3 m-85 -91.02 121.07 32.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -51.89 42.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 110.485 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -113.66 81.91 5.97 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.877 0.871 . . . . 0.0 109.936 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 9.9 Cg_endo -53.54 -36.19 79.47 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.51 2.14 . . . . 0.0 111.391 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.63 -11.58 26.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.089 2.155 . . . . 0.0 111.361 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -130.14 26.9 5.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.872 2.069 . . . . 0.0 110.258 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -137.38 112.92 9.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.721 0.691 . . . . 0.0 109.934 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.9 m -83.34 141.32 31.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.266 0.627 . . . . 0.0 111.572 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -115.33 95.97 5.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.739 2.016 . . . . 0.0 114.843 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -78.63 102.5 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.06 136.72 23.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 123.717 0.807 . . . . 0.0 109.036 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.56 126.02 39.46 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.651 0.781 . . . . 0.0 111.107 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -127.89 166.91 17.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.255 2.622 . . . . 0.0 107.695 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -63.45 -41.67 98.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.563 -1.336 . . . . 0.0 113.733 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -144.97 179.27 7.45 Favored 'General case' 0 C--N 1.322 -0.626 1 C-N-CA 132.828 4.451 . . . . 0.0 103.545 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -34.35 -32.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.958 2.903 . . . . 0.0 117.097 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 24.3 -88.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 130.066 3.698 . . . . 0.0 116.631 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -144.35 0.56 1.03 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.892 1.277 . . . . 0.0 113.314 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.3 p -41.16 -48.6 3.45 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.31 -41.83 84.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.626 1.103 . . . . 0.0 112.105 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.06 -46.2 85.43 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.71 -35.86 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.27 71.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.734 -0.651 . . . . 0.0 110.052 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -46.62 15.97 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.496 1.044 . . . . 0.0 108.913 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.1 tp -46.52 -61.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.77 -42.49 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.168 -0.333 . . . . 0.0 110.3 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.74 88.02 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.608 0.763 . . . . 0.0 110.956 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.16 -43.37 91.97 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.336 0.654 . . . . 0.0 109.332 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -55.78 -39.05 70.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.167 0.44 . . . . 0.0 111.077 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.27 4.4 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.497 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 72' ' ' PRO . 41.4 m-85 -74.58 152.37 39.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.906 1.853 . . . . 0.0 109.558 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -50.82 -70.15 0.09 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.468 2.707 . . . . 0.0 112.95 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -155.8 164.2 38.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.515 1.526 . . . . 0.0 107.85 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.68 17.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -126.14 150.24 48.4 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.179 1.792 . . . . 0.0 108.024 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.68 118.92 36.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -72.1 109.87 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.29 151.43 46.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 63.05 19.33 11.58 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.131 1.373 . . . . 0.0 111.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 34.73 -114.75 0.15 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 129.004 3.192 . . . . 0.0 114.088 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.76 -12.67 4.79 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.874 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.26 -14.91 16.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.587 1.539 . . . . 0.0 110.727 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.78 35.22 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 118.95 0.795 . . . . 0.0 112.567 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.47 -16.89 48.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.647 2.898 . . . . 0.0 113.261 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -119.35 2.6 11.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.476 2.311 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.23 177.13 25.41 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.786 0.721 . . . . 0.0 112.454 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -41.38 -61.5 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.421 1.888 . . . . 0.0 113.029 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.0 mt -57.58 -36.63 71.95 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.005 1.322 . . . . 0.0 113.587 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -96.08 10.79 36.44 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.893 1.277 . . . . 0.0 111.726 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.509 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 29.2 t -113.73 24.41 12.16 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.499 -1.375 . . . . 0.0 111.614 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 m 63.06 22.87 13.67 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.367 1.867 . . . . 0.0 113.609 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.3 mt -92.37 160.19 35.5 Favored Pre-proline 0 C--N 1.334 -0.091 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.652 ' C ' HD22 ' A' ' 40' ' ' ASN . 71.6 Cg_endo -80.71 166.1 19.7 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.082 1.855 . . . . 0.0 108.922 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -167.49 134.27 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.528 -1.982 . . . . 0.0 112.653 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.447 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.1 mt -77.07 88.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.645 1.578 . . . . 0.0 108.809 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.85 144.55 48.31 Favored Pre-proline 0 C--O 1.245 0.863 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.669 2.913 . . . . 0.0 109.32 179.19 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 121.753 0.787 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.73 -125.84 1.32 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m -138.89 160.53 39.5 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.798 1.239 . . . . 0.0 111.641 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.62 -54.71 13.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.871 2.468 . . . . 0.0 114.339 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -60.36 -39.87 88.74 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.839 1.654 . . . . 0.0 112.837 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -47.92 84.21 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.22 96.6 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.191 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -61.85 -40.36 95.06 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.091 0.86 . . . . 0.0 109.95 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 m -61.97 -50.91 70.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -57.0 -47.65 80.34 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.26 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mt -52.29 -32.56 38.16 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.008 1.723 . . . . 0.0 113.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.14 -14.06 70.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.762 0.71 . . . . 0.0 112.934 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.3 -24.23 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 110.458 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -100.99 99.63 10.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.613 1.565 . . . . 0.0 108.371 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.48 -50.51 59.71 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.371 -0.831 . . . . 0.0 112.551 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -2.47 17.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.974 1.31 . . . . 0.0 113.856 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.18 128.39 33.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.932 0.787 . . . . 0.0 109.105 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -138.81 139.0 38.07 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -76.13 128.87 35.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 108.618 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.0 tp -117.23 109.63 17.11 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.687 1.595 . . . . 0.0 111.269 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 98.77 5.51 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.141 1.376 . . . . 0.0 108.412 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -86.63 -3.83 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 118.926 0.784 . . . . 0.0 111.235 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -63.52 163.68 10.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 125.902 1.681 . . . . 0.0 111.431 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.87 148.39 27.73 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.097 1.427 . . . . 0.0 108.984 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -42.41 -43.19 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 129.72 3.208 . . . . 0.0 111.529 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.69 -40.4 65.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.878 1.271 . . . . 0.0 112.914 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.16 -35.22 80.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 38' ' ' SER . 13.9 m-85 -61.06 -27.62 68.48 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.098 -1.626 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -89.1 -23.93 22.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.563 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.11 -35.71 7.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -117.9 -13.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.532 1.133 . . . . 0.0 112.948 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.4 -163.01 29.8 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . 2.5 p -135.74 157.17 76.7 Favored Pre-proline 0 CA--C 1.511 -0.528 0 O-C-N 122.354 -0.498 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.88 172.33 16.09 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.382 1.388 . . . . 0.0 109.454 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.435 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 6.4 p30 -146.36 167.56 23.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -145.0 20.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 127.475 2.31 . . . . 0.0 107.618 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.57 64.37 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.076 2.15 . . . . 0.0 114.142 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -33.73 78.92 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.66 -23.44 36.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 109.347 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 23.1 24.13 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 125.198 1.38 . . . . 0.0 111.327 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.04 173.08 6.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.356 1.862 . . . . 0.0 107.807 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -143.23 124.98 14.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.252 1.387 . . . . 0.0 109.625 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.03 171.02 7.36 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.09 136.15 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.753 1.621 . . . . 0.0 106.666 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 p -103.04 110.38 22.28 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.035 1.734 . . . . 0.0 110.884 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -149.97 98.32 2.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.69 117.74 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 122.229 -0.294 . . . . 0.0 110.847 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -81.29 142.91 32.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -154.2 140.7 18.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.45 -13.9 74.35 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.177 -1.346 . . . . 0.0 115.124 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -79.67 -15.95 56.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.509 1.654 . . . . 0.0 111.642 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -138.52 43.5 2.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.357 1.435 . . . . 0.0 111.189 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -45.05 -53.58 16.05 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.869 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.63 -39.28 36.03 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.844 1.696 . . . . 0.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.86 -14.67 73.26 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.273 -0.892 . . . . 0.0 112.671 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.9 -52.21 5.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -50.82 -48.38 59.76 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.794 1.638 . . . . 0.0 111.801 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.85 -36.15 69.68 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -58.74 -26.32 63.86 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.095 0.558 . . . . 0.0 110.648 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.51 -49.43 7.2 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.43 -30.63 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.07 0.85 . . . . 0.0 113.115 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.53 -23.39 62.63 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.819 -1.176 . . . . 0.0 110.249 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -41.34 8.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.635 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.44 ' CD1' HG22 ' A' ' 75' ' ' THR . 65.8 m-85 -85.68 99.42 11.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.464 1.106 . . . . 0.0 108.855 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -19.43 47.78 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.23 78.88 27.28 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.209 1.404 . . . . 0.0 107.548 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.55 -39.04 57.97 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.679 1.586 . . . . 0.0 111.05 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.53 -22.01 2.88 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 127.068 2.147 . . . . 0.0 114.981 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -120.94 -9.08 9.3 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.097 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.44 HG22 ' CD1' ' A' ' 69' ' ' PHE . 90.1 m -82.76 136.54 34.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.646 1.178 . . . . 0.0 109.156 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -111.1 125.37 53.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.9 mt -98.53 96.43 7.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.997 1.319 . . . . 0.0 112.526 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -80.07 106.76 12.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -67.36 145.37 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.33 1.052 . . . . 0.0 112.725 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.29 112.88 7.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -119.09 164.52 15.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.65 1.18 . . . . 0.0 108.511 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -53.5 -41.81 66.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.38 1.072 . . . . 0.0 109.736 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.98 -143.98 0.21 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.785 2.034 . . . . 0.0 106.943 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -75.57 -36.3 60.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.568 1.547 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.9 -103.67 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 130.432 3.872 . . . . 0.0 116.032 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.32 9.26 10.35 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.044 0.937 . . . . 0.0 113.352 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -46.71 -52.02 14.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.48 -33.26 75.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.033 0.933 . . . . 0.0 111.699 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.15 -52.0 13.84 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.631 0.772 . . . . 0.0 109.77 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.57 -31.07 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.494 1.117 . . . . 0.0 110.277 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.38 93.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.879 0.763 . . . . 0.0 108.951 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -73.2 -36.58 66.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.34 -59.0 5.13 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.9 0.88 . . . . 0.0 111.309 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.8 m -62.64 -39.26 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 121.909 -0.494 . . . . 0.0 111.072 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.55 -50.22 72.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.964 0.906 . . . . 0.0 111.436 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.29 -28.81 68.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.481 1.112 . . . . 0.0 110.623 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.78 -54.57 13.06 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.89 2.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 CA-C-O 118.196 -1.335 . . . . 0.0 115.67 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.54 157.16 34.3 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 120.04 1.92 . . . . 0.0 106.755 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -63.66 1.08 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.193 0.597 . . . . 0.0 110.235 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.7 t -161.53 -179.8 7.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.317 1.847 . . . . 0.0 106.09 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.47 20.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -118.16 123.8 46.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.5 101.66 14.32 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.32 116.89 13.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -72.46 156.52 38.96 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.82 8.91 5.54 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.114 1.766 . . . . 0.0 115.101 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.27 -127.46 21.45 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.61 -35.88 4.1 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.478 0.711 . . . . 0.0 109.565 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.28 -17.19 61.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.195 2.198 . . . . 0.0 114.28 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.1 172.46 46.98 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.18 0.9 . . . . 0.0 114.481 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.8 -30.71 58.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 125.172 3.915 . . . . 0.0 115.768 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.253 0.0 OUTLIER -131.49 20.7 4.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.025 1.33 . . . . 0.0 109.178 177.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.99 166.62 40.29 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -34.28 -50.94 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.65 -50.7 72.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.23 0.923 . . . . 0.0 110.058 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.79 -0.38 34.21 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.029 2.132 . . . . 0.0 113.403 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -91.77 6.53 45.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.666 1.986 . . . . 0.0 111.629 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t 60.7 46.09 9.48 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.34 145.26 46.04 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.016 0.926 . . . . 0.0 109.967 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.81 147.05 84.98 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.291 2.661 . . . . 0.0 110.211 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -148.49 139.57 23.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.596 1.559 . . . . 0.0 110.825 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.6 mt -78.9 91.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.486 1.114 . . . . 0.0 109.669 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.6 153.86 95.32 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.379 -0.826 . . . . 0.0 110.74 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 CA--C 1.537 0.649 1 C-N-CA 125.32 4.014 . . . . 0.0 110.198 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.01 -106.02 0.22 Allowed Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.375 -0.828 . . . . 0.0 115.079 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -153.67 154.11 33.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 118.298 1.049 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.62 91.75 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -65.47 -49.28 69.69 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.042 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.92 -44.96 91.35 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.03 -41.11 87.0 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.238 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.44 -41.93 96.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.815 0.734 . . . . 0.0 109.835 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -60.92 -46.47 90.55 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.33 -48.37 82.03 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.995 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.2 mt -56.75 -22.03 32.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.515 1.507 . . . . 0.0 113.115 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.61 -7.06 60.53 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.391 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t -126.08 -10.16 6.51 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.779 1.289 . . . . 0.0 110.223 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.07 95.23 5.45 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -12.85 12.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -106.4 -7.52 17.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.279 1.432 . . . . 0.0 111.129 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.16 148.86 41.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.24 152.32 36.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.043 1.737 . . . . 0.0 108.705 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -94.82 151.55 19.15 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 tp -140.13 101.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.368 1.467 . . . . 0.0 111.14 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.17 110.25 18.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.937 2.495 . . . . 0.0 107.378 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -103.68 3.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -61.83 167.32 3.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.22 141.12 43.6 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 m -46.81 -34.02 4.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.184 2.193 . . . . 0.0 112.478 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.61 76.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 119.259 0.936 . . . . 0.0 111.643 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.87 -36.48 84.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.56 -6.04 9.8 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.855 -1.153 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -112.93 -10.49 13.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.914 1.234 . . . . 0.0 111.643 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -115.6 -43.66 3.02 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.63 -16.81 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.904 1.281 . . . . 0.0 113.789 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.32 -153.81 20.3 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 121.219 -0.925 . . . . 0.0 112.297 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 p -143.48 158.09 58.03 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 111.129 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.85 172.17 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 N-CA-C 109.269 -1.089 . . . . 0.0 109.269 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 148.94 35.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.543 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.0 pt -140.85 15.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.287 1.835 . . . . 0.0 110.088 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -56.09 -31.05 62.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.573 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.35 -22.53 71.21 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 120.457 1.48 . . . . 0.0 110.735 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.31 -17.25 37.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.845 1.258 . . . . 0.0 110.274 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.25 33.65 7.12 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.166 1.365 . . . . 0.0 109.889 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -136.25 175.08 9.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.158 1.383 . . . . 0.0 109.578 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -140.81 160.15 40.67 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.82 0.736 . . . . 0.0 110.405 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.5 163.79 20.24 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' CG2' ' HZ2' ' A' ' 68' ' ' LYS . 19.6 t -139.82 88.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 p -58.02 108.71 0.62 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.51 0.724 . . . . 0.0 109.287 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -136.55 89.41 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.58 112.02 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 124.091 0.956 . . . . 0.0 108.493 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.53 149.1 30.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -159.73 145.63 15.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.347 2.259 . . . . 0.0 107.775 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.86 -26.73 61.91 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.22 -5.41 18.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.046 2.138 . . . . 0.0 113.965 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.44 31.97 0.73 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.527 0.731 . . . . 0.0 109.797 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -38.32 -57.01 1.94 Allowed Pre-proline 0 N--CA 1.475 0.824 0 CA-C-O 117.806 -1.092 . . . . 0.0 111.846 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.99 -48.16 9.05 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.493 2.795 . . . . 0.0 111.991 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.94 -50.15 62.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.3 -53.95 49.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.095 1.758 . . . . 0.0 108.427 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.44 -48.0 69.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.859 1.264 . . . . 0.0 111.672 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -55.95 -35.56 66.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.796 0.839 . . . . 0.0 110.007 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -60.72 -29.2 69.21 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.709 1.14 . . . . 0.0 111.226 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 -46.44 13.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -54.36 -34.05 60.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.956 1.302 . . . . 0.0 111.624 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.75 -8.03 58.35 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.065 -1.022 . . . . 0.0 113.222 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HZ2' ' CG2' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -113.91 -46.83 2.99 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.328 0.967 . . . . 0.0 112.417 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.78 120.84 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -29.44 64.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -129.0 68.65 80.12 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 126.842 2.057 . . . . 0.0 110.026 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.18 -41.34 79.52 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.2 -15.35 14.54 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.45 -14.09 10.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -86.72 124.21 32.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.226 1.376 . . . . 0.0 111.403 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.7 m -88.47 134.61 33.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.84 96.87 6.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.282 0.946 . . . . 0.0 109.239 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 42.2 m-85 -75.19 113.98 13.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.615 1.966 . . . . 0.0 109.006 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.66 144.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.185 1.357 . . . . 0.0 111.836 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.64 83.69 1.91 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.346 0.658 . . . . 0.0 110.639 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.98 176.5 7.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -53.29 -50.99 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.903 1.281 . . . . 0.0 110.342 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.58 -141.2 0.21 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.58 -40.54 88.99 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 40.94 -127.52 3.24 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.297 1.903 . . . . 0.0 113.741 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.23 3.8 35.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.271 1.028 . . . . 0.0 113.211 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.1 m -40.69 -61.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.103 2.261 . . . . 0.0 117.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -53.28 -37.73 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.167 0.987 . . . . 0.0 111.886 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.01 -46.99 61.27 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.85 -28.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.023 -1.048 . . . . 0.0 109.793 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.53 -36.03 78.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.972 0.805 . . . . 0.0 109.676 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.34 -41.36 28.08 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.449 -0.782 . . . . 0.0 109.665 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.6 tp -49.82 -60.82 2.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.056 2.143 . . . . 0.0 113.393 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.36 -40.96 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.037 0.535 . . . . 0.0 110.758 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -48.88 78.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.082 0.553 . . . . 0.0 109.85 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.17 -28.32 69.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -74.41 -43.32 56.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.292 0.496 . . . . 0.0 110.743 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.08 -5.74 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 CA-C-O 117.508 -1.718 . . . . 0.0 113.631 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.33 160.37 27.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 120.297 2.049 . . . . 0.0 110.396 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -59.04 -69.77 0.18 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.25 0.62 . . . . 0.0 112.038 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -155.0 -178.22 7.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.429 1.892 . . . . 0.0 108.809 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.9 154.37 27.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -142.77 111.99 6.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 128.387 2.675 . . . . 0.0 108.737 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.15 119.73 23.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.038 0.935 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.3 108.82 4.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.32 151.31 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 73.34 0.32 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.925 1.69 . . . . 0.0 111.86 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.59 -122.09 14.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.805 1.193 . . . . 0.0 110.997 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.67 -24.41 4.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.442 1.497 . . . . 0.0 111.465 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.11 -11.91 23.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.647 1.579 . . . . 0.0 114.38 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.53 174.3 39.0 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.818 0.736 . . . . 0.0 112.349 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.27 -28.14 86.26 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.543 2.829 . . . . 0.0 113.387 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -117.44 1.06 12.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 110.613 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.05 160.12 1.72 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.173 -0.954 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -25.94 -62.52 0.07 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.163 2.185 . . . . 0.0 115.622 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.18 -60.17 3.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.323 1.049 . . . . 0.0 109.265 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.05 -2.78 2.15 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.94 1.696 . . . . 0.0 113.022 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.35 12.82 31.78 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.249 -1.532 . . . . 0.0 109.555 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.1 t 66.38 12.55 8.72 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.327 1.851 . . . . 0.0 112.103 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.59 157.34 72.44 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.787 0.835 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.74 147.2 21.64 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.101 1.867 . . . . 0.0 110.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -144.25 144.14 31.37 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.97 87.13 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.205 1.002 . . . . 0.0 108.857 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.59 147.31 78.25 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.457 -0.626 0 C-N-CA 124.073 3.182 . . . . 0.0 112.505 -179.69 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.342 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.04 100.92 0.25 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.53 146.21 0.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.563 1.545 . . . . 0.0 110.821 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -38.78 -54.43 1.6 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -58.07 -49.78 75.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.021 1.282 . . . . 0.0 111.081 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -51.79 66.61 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.959 0.904 . . . . 0.0 109.176 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.99 73.11 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.868 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.66 -49.34 77.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.38 0.991 . . . . 0.0 109.39 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -62.3 -41.42 98.5 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.69 -0.631 . . . . 0.0 109.881 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.36 -41.51 97.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.209 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.39 -27.87 69.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 111.361 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 -21.99 45.03 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.901 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -98.35 -18.11 18.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.642 1.221 . . . . 0.0 110.903 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -101.6 110.37 22.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -38.41 -53.97 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.28 2.232 . . . . 0.0 114.98 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -101.37 13.61 34.51 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.67 23.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.936 -1.102 . . . . 0.0 111.507 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -128.84 144.55 51.2 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.064 0.945 . . . . 0.0 109.731 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.83 144.24 28.56 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.8 tp -127.08 107.2 9.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.658 1.583 . . . . 0.0 109.206 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -80.34 132.75 35.84 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.6 pt -119.67 13.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.827 0.74 . . . . 0.0 111.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -74.89 170.53 15.75 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.838 1.199 . . . . 0.0 110.08 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.5 142.23 44.83 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.62 -41.97 23.15 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.541 2.336 . . . . 0.0 112.68 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.13 73.81 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.53 -0.731 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -66.8 -27.42 67.56 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.572 0.749 . . . . 0.0 111.257 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -64.42 -16.62 62.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.159 -1.588 . . . . 0.0 110.452 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -104.89 -22.04 13.22 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.38 1.472 . . . . 0.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.75 -52.77 4.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.207 1.003 . . . . 0.0 112.22 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.8 -29.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.042 1.737 . . . . 0.0 112.259 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.84 -151.75 17.7 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.276 0.944 . . . . 0.0 112.12 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -147.49 156.16 45.61 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.903 0.881 . . . . 0.0 109.839 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.96 176.28 10.33 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.85 1.7 . . . . 0.0 109.75 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.2 142.96 37.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.923 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.95 12.16 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.734 2.014 . . . . 0.0 111.305 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -37.45 67.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 117.638 -1.172 . . . . 0.0 113.524 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.61 -35.33 85.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.61 -16.24 61.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.209 0.604 . . . . 0.0 110.57 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 45.66 5.89 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 106.606 -2.598 . . . . 0.0 106.606 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -135.47 168.1 19.84 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.608 0.763 . . . . 0.0 110.736 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -145.18 122.42 11.53 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.224 -0.922 . . . . 0.0 110.359 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.78 172.6 10.48 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.784 1.278 . . . . 0.0 112.265 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.89 146.64 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 m -129.13 117.81 21.43 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.926 -1.109 . . . . 0.0 111.38 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -147.73 115.77 6.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.399 1.08 . . . . 0.0 110.356 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.92 129.16 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 120.004 1.275 . . . . 0.0 109.221 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.03 166.83 22.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.23 125.63 0.91 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.78 -20.56 57.13 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.148 0.885 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -84.22 -11.7 56.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.579 1.189 . . . . 0.0 111.621 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -127.47 36.98 4.31 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.522 1.129 . . . . 0.0 111.375 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -48.12 -57.67 9.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.101 1.318 . . . . 0.0 111.847 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.46 -37.67 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.644 2.229 . . . . 0.0 110.623 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.5 -23.55 66.89 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.509 0.576 . . . . 0.0 112.958 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -87.4 -41.5 13.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.279 1.432 . . . . 0.0 107.28 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.74 -46.67 88.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.784 1.234 . . . . 0.0 112.067 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -54.68 -33.7 61.24 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.048 0.539 . . . . 0.0 111.257 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -60.04 -27.33 66.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.856 0.863 . . . . 0.0 110.99 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.12 -43.19 9.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -31.04 66.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.535 -0.728 . . . . 0.0 112.322 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 -7.23 52.14 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.063 -1.023 . . . . 0.0 112.405 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.76 -48.19 2.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.564 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.422 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 69.7 m-85 -77.79 107.56 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.733 1.213 . . . . 0.0 109.499 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -72.68 -17.49 61.63 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.483 0.713 . . . . 0.0 112.106 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -148.04 77.31 10.11 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 126.234 1.814 . . . . 0.0 109.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.25 -29.51 73.29 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.752 2.301 . . . . 0.0 110.645 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -53.85 -18.61 3.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.152 2.181 . . . . 0.0 113.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -125.93 3.98 7.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 0.0 112.39 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 m -109.38 121.77 45.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.382 1.473 . . . . 0.0 112.143 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.0 m -91.0 130.92 36.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.69 0.796 . . . . 0.0 110.169 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.53 105.99 15.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.67 110.53 19.36 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.37 134.38 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.012 1.325 . . . . 0.0 111.425 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.54 128.9 30.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.469 1.108 . . . . 0.0 109.337 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -130.7 174.78 9.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.908 1.683 . . . . 0.0 108.369 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -52.84 -52.15 58.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.746 1.218 . . . . 0.0 109.382 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -144.53 174.93 10.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.275 3.83 . . . . 0.0 105.164 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -17.81 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 128.85 2.86 . . . . 0.0 112.508 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.04 -103.22 0.12 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 126.204 1.859 . . . . 0.0 110.39 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -128.9 9.54 5.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.807 1.243 . . . . 0.0 112.38 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -39.01 -51.97 1.81 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.315 1.846 . . . . 0.0 113.791 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.63 -45.95 87.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -39.61 93.95 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.756 0.422 . . . . 0.0 110.938 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.33 -25.58 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.949 -0.469 . . . . 0.0 109.74 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.43 65.25 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.536 -0.727 . . . . 0.0 111.158 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.04 -36.59 61.85 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.007 -0.433 . . . . 0.0 110.87 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.41 -56.79 13.91 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.774 1.229 . . . . 0.0 112.227 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.25 -39.4 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.316 0.647 . . . . 0.0 111.425 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.55 73.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.01 -25.24 65.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.545 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -80.21 -23.79 40.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.43 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.11 1.84 3.15 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 119.956 1.253 . . . . 0.0 115.546 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -76.67 153.59 35.03 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.756 1.778 . . . . 0.0 110.099 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -51.21 -65.88 0.48 Allowed 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 126.785 2.034 . . . . 0.0 112.466 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 m -157.47 171.96 19.42 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.312 1.845 . . . . 0.0 108.29 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.51 140.16 14.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.45 142.85 49.63 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 108.618 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.7 113.56 26.91 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.2 108.12 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 0.0 110.036 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -71.17 141.77 50.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 72.82 22.46 3.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.746 2.818 . . . . 0.0 109.764 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 27.82 -113.02 0.03 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.002 2.239 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -119.18 -54.93 2.18 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.864 1.266 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.44 8.75 4.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.314 1.846 . . . . 0.0 114.045 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.06 173.52 55.34 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.066 -1.021 . . . . 0.0 112.475 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.42 -34.98 98.85 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.714 2.943 . . . . 0.0 111.674 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -129.88 22.14 5.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.114 0.966 . . . . 0.0 110.192 177.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.24 168.36 16.04 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -29.45 -53.61 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.27 -59.26 5.69 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.227 0.922 . . . . 0.0 109.302 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.03 3.53 4.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.195 1.798 . . . . 0.0 112.269 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 t -95.43 11.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.717 2.007 . . . . 0.0 111.539 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 27.86 15.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.352 1.061 . . . . 0.0 111.659 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.1 mt -107.99 153.77 41.52 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.119 0.968 . . . . 0.0 109.507 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.47 154.4 27.7 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.199 1.933 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -147.69 144.35 28.27 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 111.477 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.21 88.73 2.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 126.016 1.726 . . . . 0.0 108.83 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -77.25 153.54 82.11 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.423 0.689 . . . . 0.0 111.715 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 123.965 3.11 . . . . 0.0 108.501 177.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 122.289 1.042 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.34 -115.18 0.41 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -160.06 169.99 22.23 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.855 -1.38 . . . . 0.0 109.329 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.23 -46.03 92.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -49.74 -52.06 34.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 111.099 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -54.97 -59.78 4.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.222 1.009 . . . . 0.0 110.08 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.84 -41.13 67.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.084 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.19 -48.01 79.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.556 1.071 . . . . 0.0 112.91 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.0 m -68.2 -41.37 81.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -60.74 -31.69 70.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.969 0.804 . . . . 0.0 111.975 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.21 -17.01 60.44 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.391 1.876 . . . . 0.0 110.841 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.1 -52.49 2.21 Favored Glycine 0 CA--C 1.506 -0.494 0 C-N-CA 126.006 1.765 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -15.31 59.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.609 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -119.17 128.36 54.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 108.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.43 -39.69 38.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.633 0.651 . . . . 0.0 112.466 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.11 -14.08 60.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.95 1.3 . . . . 0.0 112.423 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 131.54 45.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.244 1.418 . . . . 0.0 110.388 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -138.86 142.69 38.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.413 0.625 . . . . 0.0 111.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.88 131.26 38.5 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.13 95.89 5.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.15 2.18 . . . . 0.0 107.552 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -75.63 109.48 9.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.95 0.38 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 46.8 mtm-85 -69.46 162.8 26.68 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.071 0.85 . . . . 0.0 110.485 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.09 136.66 56.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -52.34 -23.22 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 111.406 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.66 79.55 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.531 -1.356 . . . . 0.0 110.701 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.54 -33.84 76.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.006 1.722 . . . . 0.0 109.972 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.42 -18.9 53.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -95.59 -37.14 10.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.053 1.741 . . . . 0.0 109.984 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -81.29 -50.52 9.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.9 -23.33 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 113.85 -177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.13 -157.97 22.23 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 p -139.21 160.82 60.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.56 176.53 7.26 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.165 1.91 . . . . 0.0 109.009 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.412 ' HB3' ' CG1' ' A' ' 123' ' ' ILE 0.261 8.5 p30 -141.61 114.09 8.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 122.069 0.938 . . . . 0.0 111.973 177.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -85.57 8.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 122.188 0.994 . . . . 0.0 109.255 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -55.44 -28.07 52.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.817 1.647 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.42 -48.81 47.45 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.91 -46.65 62.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.646 1.178 . . . . 0.0 108.448 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.08 40.62 0.69 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.73 1.633 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.14 -176.38 3.11 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.1 0.96 . . . . 0.0 111.437 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.62 116.72 10.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.356 0.98 . . . . 0.0 110.992 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.65 152.25 39.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.592 0.757 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -108.85 91.15 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 110.314 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -57.96 102.43 0.1 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 127.171 2.188 . . . . 0.0 110.298 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -143.09 97.41 3.09 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.633 0.773 . . . . 0.0 109.757 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.15 119.82 3.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.348 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -74.94 154.52 38.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -156.09 118.7 4.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -22.93 68.06 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.115 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -82.5 -6.12 59.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.615 1.207 . . . . 0.0 110.952 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.37 39.61 2.67 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.032 0.833 . . . . 0.0 110.553 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -43.02 -60.83 2.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 120.762 -1.211 . . . . 0.0 113.622 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -67.2 -43.47 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.585 2.857 . . . . 0.0 111.42 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.03 -47.34 81.0 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.42 -50.62 72.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.533 1.533 . . . . 0.0 108.026 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.4 -39.59 70.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.465 0.706 . . . . 0.0 111.049 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -37.46 78.72 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.779 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.54 -24.17 44.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.432 1.093 . . . . 0.0 111.894 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.08 -44.09 7.47 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t -54.28 -33.01 57.73 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.654 1.182 . . . . 0.0 111.498 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.92 -2.92 39.18 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -121.32 -40.23 2.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.967 0.803 . . . . 0.0 112.564 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.41 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 64.1 m-85 -79.94 111.99 16.8 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -18.58 62.22 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.069 0.548 . . . . 0.0 111.315 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 78.26 11.06 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 125.815 1.646 . . . . 0.0 108.44 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.29 -32.97 97.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.47 2.113 . . . . 0.0 110.961 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -57.97 -18.75 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.354 3.062 . . . . 0.0 113.089 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.61 -4.71 9.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.918 . . . . 0.0 111.419 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -95.16 113.92 25.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 0.0 112.296 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.6 m -86.75 129.16 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.42 99.14 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.532 1.533 . . . . 0.0 111.768 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.34 98.6 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -68.0 157.58 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.559 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -152.47 112.06 3.93 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.773 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.79 173.3 6.44 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -31.05 70.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.93 -1.731 . . . . 0.0 111.409 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -138.6 -152.71 0.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.034 2.134 . . . . 0.0 106.48 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.11 -18.33 62.53 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.896 2.079 . . . . 0.0 113.58 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.96 -97.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.798 3.571 . . . . 0.0 115.913 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -129.62 6.89 5.22 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.363 1.865 . . . . 0.0 110.957 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -42.91 -47.4 5.64 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.26 1.824 . . . . 0.0 113.487 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.5 -43.64 84.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.424 1.09 . . . . 0.0 111.26 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.46 -49.05 58.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.342 1.057 . . . . 0.0 109.49 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.09 -31.56 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.563 0.745 . . . . 0.0 109.142 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.62 87.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.857 0.753 . . . . 0.0 110.162 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.87 74.26 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -50.39 -57.52 7.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.884 1.674 . . . . 0.0 112.557 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.91 -40.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.12 78.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.068 0.547 . . . . 0.0 109.808 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.15 -38.31 90.61 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.81 -23.38 67.22 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 117.66 -1.162 . . . . 0.0 113.265 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.98 1.32 4.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 117.871 -1.516 . . . . 0.0 113.46 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -76.11 157.67 32.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.15 1.475 . . . . 0.0 108.473 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -49.79 -71.07 0.07 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 127.445 2.298 . . . . 0.0 110.087 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 m -163.62 -178.86 6.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 126.674 1.99 . . . . 0.0 106.857 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.8 164.64 38.29 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -136.99 142.88 42.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.26 110.3 22.3 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 124.734 1.271 . . . . 0.0 107.784 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.95 106.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -68.63 144.01 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 82.24 -2.09 1.45 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.598 1.959 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.14 -102.61 0.07 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 126.449 1.976 . . . . 0.0 114.532 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.31 -43.52 2.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.674 1.59 . . . . 0.0 110.656 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.88 -28.79 39.87 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.0 171.82 41.58 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 121.151 1.796 . . . . 0.0 111.811 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.54 -15.37 35.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.798 3.665 . . . . 0.0 116.052 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 -115.78 5.64 14.2 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 111.112 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.45 163.23 54.78 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -46.52 -45.28 18.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -66.93 -39.89 87.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.247 0.476 . . . . 0.0 111.038 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -87.67 23.26 2.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.8 1.64 . . . . 0.0 111.433 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 t -120.51 6.56 10.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.445 1.098 . . . . 0.0 112.819 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 56.86 48.5 15.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.991 0.917 . . . . 0.0 109.363 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.1 mt -116.53 160.74 35.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.81 145.01 17.65 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.123 1.882 . . . . 0.0 110.149 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -144.0 132.2 21.86 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.987 -1.071 . . . . 0.0 110.833 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 6.6 mt -75.27 90.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.567 1.547 . . . . 0.0 110.082 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -83.49 143.9 45.19 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.809 -1.182 . . . . 0.0 110.94 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 125.03 3.82 . . . . 0.0 109.488 179.031 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.3 p . . . . . 0 C--O 1.239 0.545 0 CA-C-O 122.128 0.966 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.57 -116.82 0.5 Allowed Glycine 0 N--CA 1.445 -0.748 0 O-C-N 121.545 -0.722 . . . . 0.0 111.752 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -142.45 157.3 44.9 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.877 0.871 . . . . 0.0 112.439 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.45 90.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.374 1.469 . . . . 0.0 113.46 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.53 -52.66 64.7 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.841 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.82 -42.95 85.0 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.182 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.27 75.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.583 0.628 . . . . 0.0 111.283 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.23 -47.55 79.26 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -60.73 -40.67 93.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.308 0.243 . . . . 0.0 110.494 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -58.94 -43.77 91.26 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.446 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.26 -23.95 62.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.289 1.404 . . . . 0.0 111.121 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.06 4.38 62.75 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.435 1.493 . . . . 0.0 112.505 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.12 -4.72 3.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.121 1.768 . . . . 0.0 110.778 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -124.53 106.12 9.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.1 -18.19 2.0 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -122.57 5.48 9.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.397 0.999 . . . . 0.0 113.155 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.67 50.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.635 1.107 . . . . 0.0 108.442 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -140.27 152.86 46.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.338 1.055 . . . . 0.0 109.415 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.52 118.85 37.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.24 107.36 16.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.654 1.581 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.64 123.0 31.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.56 -0.85 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -33.78 -109.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.901 3.68 . . . . 0.0 115.39 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.64 134.27 5.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -45.74 -43.39 12.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.78 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.52 80.92 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.3 0.955 . . . . 0.0 109.809 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.98 -40.56 67.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.515 1.126 . . . . 0.0 110.635 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -60.99 -15.85 36.41 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.025 1.739 . . . . 0.0 112.913 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -107.91 -13.02 15.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.746 1.618 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -102.14 -47.06 4.65 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.717 1.207 . . . . 0.0 110.489 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 -24.93 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.808 1.243 . . . . 0.0 113.468 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.45 -148.16 18.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 119.145 0.884 . . . . 0.0 113.807 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -146.28 162.63 33.98 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.66 128.41 10.95 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.68 2.253 . . . . 0.0 110.044 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.532 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -86.29 73.89 10.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.494 -1.684 . . . . 0.0 109.64 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.4 pt -78.66 -4.37 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.556 -1.34 . . . . 0.0 110.597 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -50.03 -37.62 33.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.65 2.38 . . . . 0.0 112.474 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.95 -40.44 72.91 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 124.206 0.941 . . . . 0.0 111.465 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.87 -50.52 28.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.84 25.56 0.14 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.727 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -133.33 -175.12 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.12 1.46 . . . . 0.0 109.971 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -144.52 131.65 20.55 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.138 2.175 . . . . 0.0 105.879 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.23 164.89 14.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.679 0.672 . . . . 0.0 111.565 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.47 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.198 1.799 . . . . 0.0 107.252 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.7 p -63.84 108.7 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.062 1.345 . . . . 0.0 111.206 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -142.38 94.09 2.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.1 116.25 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -76.75 150.44 36.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -155.33 134.97 12.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 128.361 2.664 . . . . 0.0 104.516 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.17 -13.22 81.38 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 113.987 0.355 . . . . 0.0 113.987 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.33 -43.83 39.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.023 0.911 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.32 51.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 109.78 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -52.03 -54.8 37.01 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.27 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.55 -42.11 7.57 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.877 1.349 . . . . 0.0 109.802 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.03 -19.77 46.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.41 1.481 . . . . 0.0 113.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -89.76 -54.23 4.15 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.242 1.817 . . . . 0.0 106.664 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -54.09 -46.87 72.18 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.502 1.921 . . . . 0.0 111.082 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -41.34 66.07 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.597 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -60.61 -34.49 74.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.528 1.058 . . . . 0.0 110.948 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -48.01 25.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -61.21 -9.29 4.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.914 2.086 . . . . 0.0 115.323 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.11 -13.36 15.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.223 0.919 . . . . 0.0 109.337 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 -47.1 5.38 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.38 159.91 19.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.367 1.467 . . . . 0.0 109.529 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -2.38 1.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.274 2.63 . . . . 0.0 112.362 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -136.11 52.54 6.59 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 128.76 2.824 . . . . 0.0 112.384 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.95 -36.54 17.54 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.532 2.821 . . . . 0.0 112.7 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -55.64 -18.11 7.13 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.652 2.381 . . . . 0.0 113.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -125.02 -1.38 7.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.215 1.006 . . . . 0.0 112.736 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -100.69 136.22 40.9 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.166 1.387 . . . . 0.0 112.411 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.2 m -102.59 128.02 49.43 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.57 97.78 7.94 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.131 0.972 . . . . 0.0 111.708 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -74.87 126.78 31.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.01 126.7 57.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 121.002 1.728 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tt -120.94 114.58 21.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.97 1.708 . . . . 0.0 109.046 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -119.47 170.41 9.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.668 1.987 . . . . 0.0 107.22 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.211 -1.555 . . . . 0.0 111.648 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.83 -154.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.912 2.485 . . . . 0.0 106.996 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -59.42 -53.44 58.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.605 1.162 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.6 -112.86 0.62 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.521 2.486 . . . . 0.0 114.716 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -112.27 3.72 17.29 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.741 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.1 m -40.02 -51.33 2.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.791 1.636 . . . . 0.0 113.686 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.58 -38.5 91.23 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.311 0.96 . . . . 0.0 112.175 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.63 -48.21 70.16 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -60.59 -23.11 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.661 0.785 . . . . 0.0 110.043 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.31 -31.33 48.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.013 0.525 . . . . 0.0 109.928 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -85.59 -33.62 21.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.592 1.087 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.0 tp -50.79 -56.83 10.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.348 2.259 . . . . 0.0 111.325 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.96 -35.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 0.0 111.777 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.84 -17.67 62.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 111.935 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -91.34 -24.04 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.776 1.23 . . . . 0.0 113.851 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.28 -6.19 4.28 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.74 -1.033 . . . . 0.0 114.45 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -69.74 147.63 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.573 1.687 . . . . 0.0 109.021 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.01 -66.92 0.3 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 113.318 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -152.57 170.81 19.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 108.817 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.18 128.44 9.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.461 -0.774 . . . . 0.0 109.797 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -109.92 120.85 43.78 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.95 1.3 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.75 113.88 22.96 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.43 115.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -71.04 161.59 30.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.55 12.16 8.6 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 129.354 3.062 . . . . 0.0 113.822 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.22 -138.55 27.14 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.707 1.171 . . . . 0.0 112.701 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.68 5.49 14.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 110.529 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.91 -3.28 3.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.41 172.78 49.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.595 1.089 . . . . 0.0 112.465 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.62 -25.2 73.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.891 3.061 . . . . 0.0 114.392 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 13.08 15.88 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.354 1.862 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.31 176.51 26.99 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.953 -1.092 . . . . 0.0 111.619 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -47.05 -61.8 1.71 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 113.186 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.26 -53.31 59.76 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.54 -14.57 43.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.813 1.645 . . . . 0.0 112.79 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -91.62 13.79 16.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.568 1.547 . . . . 0.0 110.442 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.9 m 63.15 23.15 13.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.649 2.38 . . . . 0.0 113.498 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.75 153.2 64.17 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.532 ' C ' HD22 ' A' ' 40' ' ' ASN . 37.8 Cg_endo -74.24 160.9 41.61 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.805 1.67 . . . . 0.0 110.175 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -163.08 135.76 5.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.864 1.211 . . . . 0.0 112.12 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 4.0 mt -76.13 95.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.697 1.999 . . . . 0.0 109.973 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -96.69 139.89 21.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 120.962 -1.086 . . . . 0.0 108.352 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo . . . . . 0 CA--C 1.54 0.794 0 C-N-CA 123.798 2.998 . . . . 0.0 110.721 178.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 122.284 1.04 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.46 -103.51 0.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 m -156.29 163.92 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.414 1.086 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.51 44.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.618 1.967 . . . . 0.0 111.962 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -55.1 -50.55 68.91 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.216 0.916 . . . . 0.0 110.853 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -51.56 67.49 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.951 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.23 77.33 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -73.24 -41.76 63.34 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.102 -0.999 . . . . 0.0 108.999 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -57.92 -45.92 85.8 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -51.69 -51.62 54.57 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.039 1.735 . . . . 0.0 110.644 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.23 -21.16 13.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.97 1.259 . . . . 0.0 113.094 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.6 -5.97 57.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.891 1.223 . . . . 0.0 112.824 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -123.38 -1.13 8.66 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.656 1.582 . . . . 0.0 110.565 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -127.33 102.25 6.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.052 -1.03 . . . . 0.0 110.722 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -93.3 32.4 1.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.71 0.804 . . . . 0.0 110.077 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.11 137.47 47.82 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 123.63 0.772 . . . . 0.0 109.164 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -144.58 136.0 25.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.832 0.853 . . . . 0.0 109.772 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.68 133.95 34.37 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.6 tp -123.86 104.44 8.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.589 1.956 . . . . 0.0 109.264 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -80.95 122.95 27.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.7 pt -105.62 1.84 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -66.09 171.67 4.41 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.15 1.38 . . . . 0.0 111.294 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.5 146.85 28.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.61 1.195 . . . . 0.0 109.472 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -43.03 -45.15 5.07 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 129.831 3.253 . . . . 0.0 113.682 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -35.61 79.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -32.35 73.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -67.21 -14.01 62.51 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.067 -1.646 . . . . 0.0 111.034 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -100.74 -14.38 18.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.008 2.123 . . . . 0.0 109.266 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -103.19 -65.41 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.971 1.708 . . . . 0.0 110.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -86.65 -36.44 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.934 1.294 . . . . 0.0 111.636 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.42 -155.3 16.17 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 118.977 0.808 . . . . 0.0 113.395 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 p -133.96 148.95 70.26 Favored Pre-proline 0 CA--C 1.518 -0.266 0 C-N-CA 124.756 1.223 . . . . 0.0 110.1 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.56 169.2 22.3 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 129.96 45.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.148 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.8 pt -124.33 7.08 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 125.917 1.687 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -58.77 -31.02 67.98 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 125.066 1.346 . . . . 0.0 110.77 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.33 -51.09 32.76 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.89 -50.72 61.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.872 0.836 . . . . 0.0 110.074 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.2 39.01 0.14 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.664 1.126 . . . . 0.0 111.385 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.31 -179.56 5.43 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.566 1.183 . . . . 0.0 110.935 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -143.77 115.11 8.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.967 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 150.53 22.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 118.537 0.608 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.26 125.95 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 p -103.15 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.153 0.981 . . . . 0.0 109.752 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 m -138.05 98.85 3.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.6 114.4 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.355 1.062 . . . . 0.0 109.593 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -80.79 150.0 29.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.917 0.865 . . . . 0.0 110.131 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -157.57 119.77 3.79 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.751 2.42 . . . . 0.0 105.131 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -22.6 59.43 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.15 -11.9 52.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.165 1.386 . . . . 0.0 110.453 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -146.26 46.67 1.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.069 -1.019 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -46.0 -49.02 41.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.99 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.14 -49.7 3.52 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.674 1.583 . . . . 0.0 111.306 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.33 78.75 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.579 1.081 . . . . 0.0 110.825 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.12 -58.7 7.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.909 1.284 . . . . 0.0 107.871 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 mt -51.25 -47.34 62.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.657 1.583 . . . . 0.0 110.694 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -57.21 -37.64 72.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.227 1.411 . . . . 0.0 110.253 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -62.32 -26.38 68.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.541 1.519 . . . . 0.0 110.895 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -47.14 11.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -54.67 -37.96 66.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.709 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.51 -0.98 35.54 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 -38.69 3.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.098 0.863 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -89.92 113.56 25.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -25.35 67.97 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.954 -0.546 . . . . 0.0 111.822 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -138.11 78.82 33.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.924 1.29 . . . . 0.0 111.165 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.05 -37.25 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.521 2.814 . . . . 0.0 113.107 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -12.98 7.15 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.879 1.272 . . . . 0.0 112.892 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.12 28.04 5.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 109.596 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 70.6 m -125.75 120.82 31.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.4 m -100.79 122.03 42.7 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.476 1.11 . . . . 0.0 108.09 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.61 106.78 19.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -83.37 97.19 8.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mt -73.07 132.22 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 109.462 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.21 131.4 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.066 1.347 . . . . 0.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -134.48 175.43 9.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.797 2.439 . . . . 0.0 109.233 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -44.06 80.44 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.579 -1.326 . . . . 0.0 109.493 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -136.25 -148.82 0.3 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.64 -36.18 82.97 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.73 -1.231 . . . . 0.0 109.187 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.28 -99.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 127.247 2.356 . . . . 0.0 111.274 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -139.16 12.97 2.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 108.787 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -43.32 -57.07 3.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.049 1.74 . . . . 0.0 114.107 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -65.67 -30.67 71.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.252 0.933 . . . . 0.0 112.116 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -48.34 67.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.95 1.357 . . . . 0.0 108.966 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.58 -32.06 52.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.068 1.747 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.72 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.407 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -79.19 -48.8 13.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.703 1.138 . . . . 0.0 108.416 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.5 tp -42.21 -64.98 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.525 1.53 . . . . 0.0 114.056 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.8 m -62.92 -40.3 88.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.965 0.906 . . . . 0.0 112.018 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.62 45.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.848 0.718 . . . . 0.0 109.489 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 -27.11 68.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.07 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.59 -34.68 72.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.428 0.558 . . . . 0.0 111.839 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.52 -9.2 0.48 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.982 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.21 155.6 38.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.823 1.811 . . . . 0.0 110.806 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -66.59 0.36 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.518 0.727 . . . . 0.0 109.97 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -158.03 -179.46 8.15 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.505 1.922 . . . . 0.0 107.246 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.54 130.74 6.84 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -102.24 163.81 12.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.82 119.68 11.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.64 116.46 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.567 0.699 . . . . 0.0 111.26 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HE2' ' H ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -66.32 148.4 51.91 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.574 ' H ' ' HE2' ' A' ' 106' ' ' LYS . 4.2 m-20 68.09 -0.55 2.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.975 1.71 . . . . 0.0 111.426 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.75 -134.08 39.65 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.651 . . . . 0.0 111.723 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -94.07 -56.74 2.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.612 1.965 . . . . 0.0 111.827 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.39 -12.77 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.59 169.6 33.29 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 120.733 1.606 . . . . 0.0 113.048 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.6 -46.67 31.74 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.344 2.696 . . . . 0.0 113.306 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -98.76 21.41 11.47 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.542 1.519 . . . . 0.0 110.006 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.41 175.91 19.85 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.402 1.001 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -45.77 -67.29 0.3 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.431 1.892 . . . . 0.0 114.448 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.69 -45.55 63.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.921 0.888 . . . . 0.0 111.225 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -71.8 -8.14 52.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.245 1.418 . . . . 0.0 113.819 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -103.29 19.65 19.25 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.924 1.69 . . . . 0.0 112.745 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.8 t 61.53 32.03 18.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.858 0.863 . . . . 0.0 110.848 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.44 146.7 32.23 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.46 144.42 16.0 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.472 2.115 . . . . 0.0 111.196 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -142.27 156.35 45.28 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.355 -0.841 . . . . 0.0 110.441 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.3 90.3 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.491 1.117 . . . . 0.0 110.292 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -70.69 155.21 93.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.75 -0.594 . . . . 0.0 109.697 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.435 2.756 . . . . 0.0 110.164 178.491 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.267 0.556 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.07 -111.31 0.25 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.92 163.13 32.25 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.988 1.315 . . . . 0.0 112.135 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.17 79.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.646 1.578 . . . . 0.0 106.901 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.32 -50.65 72.79 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.194 -0.316 . . . . 0.0 111.351 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.3 -43.63 98.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.662 0.665 . . . . 0.0 111.04 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.5 66.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -72.71 -56.3 5.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.5 1.045 . . . . 0.0 109.054 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -51.16 -45.75 61.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.021 0.928 . . . . 0.0 110.983 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -57.15 -20.51 26.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.1 -29.27 31.83 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 119.598 1.09 . . . . 0.0 108.852 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.32 -35.04 12.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.062 1.315 . . . . 0.0 111.663 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -74.48 -14.53 60.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.02 0.91 . . . . 0.0 110.653 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.22 175.61 7.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.579 0.627 . . . . 0.0 111.793 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -112.72 -43.37 3.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.59 1.156 . . . . 0.0 111.372 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.99 -3.62 52.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.789 0.835 . . . . 0.0 111.781 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.63 119.58 21.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -132.39 145.74 51.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.259 0.481 . . . . 0.0 110.077 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.31 143.65 29.38 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.5 tp -122.42 109.39 14.32 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.734 1.614 . . . . 0.0 111.178 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.96 89.88 7.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.126 1.37 . . . . 0.0 109.221 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -83.12 -0.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 119.872 -1.768 . . . . 0.0 113.828 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -59.32 164.27 3.38 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 126.329 1.852 . . . . 0.0 111.818 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.32 147.97 32.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m -58.23 -20.72 44.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.704 1.602 . . . . 0.0 109.676 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -43.6 90.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.964 -1.085 . . . . 0.0 108.102 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -61.67 -28.64 69.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 110.777 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.73 -17.91 38.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.323 0.965 . . . . 0.0 110.805 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -110.12 -36.97 5.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.418 1.487 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.21 -27.64 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.86 -19.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.9 -152.61 17.76 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.311 -0.868 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 p -147.7 158.31 43.06 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 124.175 0.99 . . . . 0.0 111.527 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -78.66 155.42 27.48 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.696 1.597 . . . . 0.0 111.18 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.467 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 1.2 p30 -127.74 87.7 2.66 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.396 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 pt -72.95 5.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.589 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 40' ' ' ASN . 13.2 mptt -55.18 -34.72 64.09 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 110.543 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.16 -34.73 32.68 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.011 0.815 . . . . 0.0 111.729 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.58 -32.36 17.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.009 0.905 . . . . 0.0 111.034 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.57 29.2 1.09 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.897 1.237 . . . . 0.0 114.463 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -135.74 -178.79 5.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.234 1.017 . . . . 0.0 110.116 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.24 131.76 28.7 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.485 1.114 . . . . 0.0 109.636 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.2 163.07 27.42 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.69 130.19 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -96.77 94.72 7.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.039 2.135 . . . . 0.0 113.733 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -127.7 90.81 3.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.68 1.592 . . . . 0.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -49.97 116.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 121.476 -0.765 . . . . 0.0 110.966 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -82.52 153.57 25.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -156.33 130.1 8.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.01 -23.58 59.54 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.026 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -86.54 -8.88 57.17 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.674 1.19 . . . . 0.0 112.194 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -123.13 26.55 7.99 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.307 1.443 . . . . 0.0 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -42.7 -58.39 3.85 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.745 1.157 . . . . 0.0 111.913 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.65 -42.54 12.01 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.128 2.552 . . . . 0.0 112.101 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.28 -52.46 49.55 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -55.56 -49.03 73.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.491 1.517 . . . . 0.0 107.862 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -53.89 -50.21 66.84 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.769 0.828 . . . . 0.0 109.773 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -43.44 84.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.299 1.04 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -58.49 -23.99 59.29 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.133 1.333 . . . . 0.0 112.685 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mt -93.36 -50.55 5.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.709 1.604 . . . . 0.0 108.003 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.0 t -56.92 -23.25 43.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 109.398 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.2 -8.07 52.04 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -38.38 6.66 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.69 1.196 . . . . 0.0 109.663 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -83.07 177.44 8.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.072 1.349 . . . . 0.0 108.407 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -33.9 3.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.295 1.038 . . . . 0.0 112.334 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -144.57 86.3 8.11 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.99 0.916 . . . . 0.0 110.588 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.23 -32.61 81.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.948 2.432 . . . . 0.0 112.865 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.66 -8.0 1.8 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -123.22 -6.73 8.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.777 -1.106 . . . . 0.0 112.97 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -101.26 130.06 47.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -98.63 130.45 45.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.328 1.051 . . . . 0.0 109.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.36 103.16 12.64 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.646 1.178 . . . . 0.0 112.19 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.91 102.31 13.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.07 139.65 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.916 1.286 . . . . 0.0 113.414 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.43 123.65 21.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.935 1.694 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -130.58 170.65 13.99 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.576 2.351 . . . . 0.0 107.748 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -21.74 8.29 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 113.537 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -159.64 -162.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.916 3.287 . . . . 0.0 104.933 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.14 -55.09 16.48 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.861 2.065 . . . . 0.0 107.365 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.27 -96.95 0.02 OUTLIER Glycine 0 C--N 1.337 0.602 0 C-N-CA 128.251 2.834 . . . . 0.0 114.252 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -135.88 13.08 3.39 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.683 1.193 . . . . 0.0 110.859 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -52.03 -31.59 30.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.943 0.792 . . . . 0.0 110.961 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -72.19 -35.45 68.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.159 2.184 . . . . 0.0 111.745 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.43 -46.64 14.29 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.15 -30.84 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.02 94.91 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -71.65 -42.66 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.781 0.832 . . . . 0.0 109.203 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.2 tp -50.41 -62.15 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.133 1.373 . . . . 0.0 111.848 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.46 -38.62 80.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.115 0.566 . . . . 0.0 110.688 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.76 64.36 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.615 0.766 . . . . 0.0 109.727 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.05 -24.4 67.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.669 0.788 . . . . 0.0 111.589 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -77.2 -21.79 53.36 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.783 0.719 . . . . 0.0 110.844 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.56 6.52 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 117.154 -1.914 . . . . 0.0 114.086 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -70.01 152.1 44.8 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.616 2.208 . . . . 0.0 108.703 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -48.98 -65.81 0.5 Allowed 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.188 1.795 . . . . 0.0 113.184 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -155.74 174.75 14.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.911 1.284 . . . . 0.0 108.948 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.43 146.46 18.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -135.41 128.87 32.36 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.812 0.845 . . . . 0.0 110.394 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.81 118.39 30.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.36 115.74 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 121.286 -0.884 . . . . 0.0 109.029 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -68.23 150.1 48.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.8 11.59 8.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.625 1.57 . . . . 0.0 113.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.66 -136.84 2.71 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 124.964 1.269 . . . . 0.0 112.781 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.2 -26.61 13.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -100.12 -10.84 21.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.796 2.438 . . . . 0.0 115.281 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.9 170.39 8.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.999 1.272 . . . . 0.0 111.824 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.41 -29.33 23.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 124.022 3.148 . . . . 0.0 114.556 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.28 25.97 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.443 1.497 . . . . 0.0 110.616 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -173.59 3.88 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -41.66 -56.51 2.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.15 -52.81 64.01 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 123.492 0.717 . . . . 0.0 109.56 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.64 22.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.951 1.301 . . . . 0.0 112.791 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.3 m -120.13 10.26 11.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.055 1.742 . . . . 0.0 110.957 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.85 24.96 9.65 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.221 0.919 . . . . 0.0 110.397 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.2 mt -97.89 140.71 22.1 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.86 140.06 93.55 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 125.07 3.847 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -148.38 135.51 20.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.019 0.927 . . . . 0.0 112.204 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.2 mt -85.05 96.92 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.818 2.447 . . . . 0.0 108.108 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.73 155.93 68.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 O-C-N 121.484 -0.76 . . . . 0.0 112.719 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 C-N-CA 123.307 2.671 . . . . 0.0 107.083 177.348 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.237 0.416 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.9 -112.12 0.26 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 163.57 36.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.916 1.358 . . . . 0.0 112.076 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.95 98.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -53.22 -55.63 22.84 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.216 1.007 . . . . 0.0 110.202 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -62.06 -45.3 94.14 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.699 0.624 . . . . 0.0 111.832 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.47 -41.75 85.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.62 -48.18 82.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.867 0.758 . . . . 0.0 109.605 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -60.6 -43.37 97.49 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.199 0.6 . . . . 0.0 111.025 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -39.04 89.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.245 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.0 mt -64.74 -20.4 66.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.895 1.225 . . . . 0.0 110.663 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 -12.46 64.56 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.327 0.965 . . . . 0.0 112.212 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p -117.82 -2.45 11.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.628 1.571 . . . . 0.0 112.243 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -125.12 109.11 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.147 1.379 . . . . 0.0 107.567 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.16 -29.97 68.09 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -84.46 -26.86 27.9 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.717 -0.615 . . . . 0.0 111.977 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 137.98 58.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -141.02 121.98 14.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.857 1.263 . . . . 0.0 109.627 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -55.11 129.79 39.46 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.013 0.925 . . . . 0.0 109.192 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp -109.73 99.49 8.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.929 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.79 112.69 19.17 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.84 7.15 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -64.88 172.12 3.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 110.815 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 144.36 30.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -44.48 -39.87 5.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.027 2.131 . . . . 0.0 111.902 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.33 77.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.929 -0.557 . . . . 0.0 111.557 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.58 -37.2 75.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.393 0.997 . . . . 0.0 110.629 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -62.05 -7.69 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.935 -1.103 . . . . 0.0 112.887 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -123.41 -14.82 7.31 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.543 1.937 . . . . 0.0 111.115 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.93 -45.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.956 1.303 . . . . 0.0 110.814 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.19 -18.56 7.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 124.938 1.295 . . . . 0.0 110.472 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.25 -156.51 21.27 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.446 -0.784 . . . . 0.0 111.808 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.8 167.58 13.89 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 121.648 -0.913 . . . . 0.0 112.251 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 158.3 55.22 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.217 1.278 . . . . 0.0 110.309 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.47 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -125.0 56.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.946 1.698 . . . . 0.0 112.965 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.6 pt -71.67 10.54 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.415 1.086 . . . . 0.0 111.651 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -54.08 -42.63 69.55 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.133 1.373 . . . . 0.0 111.074 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -52.58 -46.05 59.17 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 mt -61.91 -23.71 66.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 112.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.32 38.87 3.63 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -136.45 168.54 19.27 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 117.773 0.786 . . . . 0.0 111.989 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -138.84 127.56 23.42 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 157.45 37.73 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -116.67 99.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 p -79.02 113.14 16.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.4 m -142.02 109.62 5.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.18 116.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.822 0.283 . . . . 0.0 110.67 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.95 138.95 36.1 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -150.64 127.69 11.15 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.65 -19.14 34.0 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.186 1.374 . . . . 0.0 113.96 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.18 -17.28 60.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.866 1.833 . . . . 0.0 110.938 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -133.12 59.91 1.72 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.686 0.794 . . . . 0.0 110.37 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.05 -54.6 53.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 120.699 -1.251 . . . . 0.0 108.533 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.82 -41.16 8.39 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 121.664 1.63 . . . . 0.0 109.468 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.91 59.17 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.287 0.946 . . . . 0.0 111.695 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -71.49 -60.18 2.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.9 mt -47.29 -46.58 25.01 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.335 1.854 . . . . 0.0 111.639 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -59.43 -33.3 71.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.485 0.714 . . . . 0.0 110.907 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -69.17 -23.99 64.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.064 1.302 . . . . 0.0 111.115 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.74 -34.73 30.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -57.79 -36.62 72.43 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.524 -0.735 . . . . 0.0 112.774 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.64 -5.76 44.87 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.11 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.987 0.812 . . . . 0.0 112.909 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -93.5 106.16 18.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.533 1.133 . . . . 0.0 111.139 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -56.82 -51.09 70.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.626 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.34 86.22 50.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.081 0.952 . . . . 0.0 109.048 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.08 -18.81 60.22 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.807 1.671 . . . . 0.0 113.808 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.4 -16.82 16.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -123.25 -1.84 8.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.603 1.561 . . . . 0.0 112.078 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -93.22 132.66 37.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 111.193 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -102.25 149.91 23.83 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.92 91.79 3.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.064 1.346 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 30.8 m-85 -74.34 101.52 4.09 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 102.961 -2.977 . . . . 0.0 102.961 177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.89 130.23 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.759 1.223 . . . . 0.0 112.671 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.23 107.88 11.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.513 1.525 . . . . 0.0 109.361 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.25 173.59 6.25 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.03 -58.73 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.615 -1.303 . . . . 0.0 109.311 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.78 -153.05 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.512 ' CG ' ' HZ3' ' A' ' 106' ' ' LYS . 71.5 m-20 -60.63 -36.68 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.247 0.476 . . . . 0.0 109.872 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.24 -118.67 0.19 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 128.572 2.987 . . . . 0.0 115.566 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -101.12 -3.1 29.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -41.55 -55.97 2.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.299 1.839 . . . . 0.0 115.102 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -26.79 66.32 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -49.81 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.24 -35.06 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.489 1.115 . . . . 0.0 109.222 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.3 66.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.392 1.077 . . . . 0.0 111.355 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -92.61 -35.38 13.57 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.775 0.716 . . . . 0.0 110.026 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.0 -59.22 4.61 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.649 0.738 . . . . 0.0 109.895 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.03 -38.81 78.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.14 0.976 . . . . 0.0 112.107 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.02 -53.75 51.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.129 1.372 . . . . 0.0 109.804 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.01 -28.62 67.87 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 110.54 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -76.97 -24.31 52.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.892 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.15 -0.8 2.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.906 -1.497 . . . . 0.0 115.695 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -73.1 150.62 42.11 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 120.198 1.999 . . . . 0.0 107.303 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.6 tpmt? -59.13 -52.83 64.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -165.49 176.41 8.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 107.903 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.9 163.39 40.12 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 43.9 m-85 -146.92 114.75 6.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.354 1.062 . . . . 0.0 109.144 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.11 113.89 15.34 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.497 1.119 . . . . 0.0 108.798 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.79 101.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.512 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 4.7 tmtm? -62.69 150.52 40.81 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 71.58 6.77 5.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.222 1.809 . . . . 0.0 110.934 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.35 -130.21 14.51 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.058 1.299 . . . . 0.0 110.51 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.66 -16.7 7.13 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.22 -25.57 21.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.504 1.047 . . . . 0.0 112.99 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.51 170.23 1.34 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 128.851 3.119 . . . . 0.0 116.598 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.82 -22.36 36.78 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 124.064 3.176 . . . . 0.0 112.774 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.255 12.7 tpt180 -124.85 14.13 8.57 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.741 2.017 . . . . 0.0 109.56 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.82 -177.94 20.62 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.45 -1.406 . . . . 0.0 111.382 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -48.88 -53.27 20.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 113.405 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.02 -51.12 70.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.848 0.459 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.6 32.14 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.737 2.015 . . . . 0.0 112.303 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.8 m -126.5 12.2 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.007 1.723 . . . . 0.0 109.836 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 t 62.0 28.51 17.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.867 0.758 . . . . 0.0 110.437 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.81 138.63 19.69 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HB2' HD22 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -70.75 157.23 59.05 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.031 1.821 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -158.39 151.29 22.5 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 108.772 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 40' ' ' ASN . 2.5 mt -98.08 88.57 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.73 153.94 85.27 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 C-N-CA 122.476 2.118 . . . . 0.0 108.509 178.083 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.28 109.38 0.41 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -37.47 149.89 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.446 2.298 . . . . 0.0 112.848 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.6 47.58 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.581 . . . . 0.0 111.623 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -60.71 -51.75 68.06 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 110.191 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -55.47 -46.57 76.83 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.758 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.85 87.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.267 0.627 . . . . 0.0 109.611 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.99 -51.34 70.49 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.656 0.782 . . . . 0.0 109.991 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.3 m -61.62 -41.86 98.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.888 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -56.97 -48.74 77.68 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.502 1.121 . . . . 0.0 109.978 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.86 -19.67 60.47 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.035 0.534 . . . . 0.0 111.656 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.03 -7.06 61.37 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.501 2.477 . . . . 0.0 114.418 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 t -121.3 -8.91 9.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.08 1.752 . . . . 0.0 109.351 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.81 178.43 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.884 0.874 . . . . 0.0 109.494 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 38.1 t70 -128.12 -49.16 1.33 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.333 0.969 . . . . 0.0 111.666 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -71.51 -2.84 18.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.695 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 121.83 23.67 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.555 2.342 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -136.38 149.22 48.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.49 132.08 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.663 1.185 . . . . 0.0 110.107 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 tp -113.38 111.12 21.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.026 1.33 . . . . 0.0 109.829 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.08 116.36 28.84 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.8 pt -99.4 9.06 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -65.36 163.65 15.19 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.728 1.611 . . . . 0.0 113.619 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.49 139.62 44.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -45.94 -41.84 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.792 1.237 . . . . 0.0 112.459 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.1 67.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.75 0.82 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -59.82 -43.69 94.41 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.435 0.562 . . . . 0.0 110.502 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -56.91 -21.94 33.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.004 0.82 . . . . 0.0 112.823 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -84.12 -26.83 28.61 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.024 0.929 . . . . 0.0 109.825 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -91.29 -59.3 2.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.457 1.503 . . . . 0.0 112.816 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.6 -34.71 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.836 1.254 . . . . 0.0 114.148 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -144.93 16.44 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.9 p -154.15 156.01 31.5 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 119.374 1.587 . . . . 0.0 112.889 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.51 135.93 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.936 2.424 . . . . 0.0 111.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.638 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -103.41 80.12 1.78 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.851 2.861 . . . . 0.0 107.893 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 pt -77.75 2.61 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.493 -1.379 . . . . 0.0 111.668 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -47.79 -31.84 5.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.495 2.718 . . . . 0.0 115.729 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.09 77.32 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt -85.05 -38.36 19.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.69 0.68 Allowed Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.696 1.141 . . . . 0.0 111.047 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 20' ' ' ASP . 41.6 mmtm -145.51 178.86 7.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.091 1.756 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -133.66 165.49 24.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.974 0.892 . . . . 0.0 110.839 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.49 163.74 15.62 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 108.843 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -138.79 128.37 31.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.153 1.381 . . . . 0.0 107.693 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -99.22 121.94 41.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.398 1.079 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.9 m -148.65 106.56 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.99 110.17 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -76.14 162.95 27.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -166.98 136.45 2.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.069 2.148 . . . . 0.0 105.277 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.2 66.7 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.472 0.558 . . . . 0.0 112.829 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.93 -50.28 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.15 24.48 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -43.76 -52.15 15.22 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 120.244 1.384 . . . . 0.0 110.09 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.41 -44.95 12.87 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.37 2.047 . . . . 0.0 111.786 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.95 83.69 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.722 1.153 . . . . 0.0 110.906 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.07 -53.06 51.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.527 1.931 . . . . 0.0 108.394 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.92 -47.47 64.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.228 1.011 . . . . 0.0 111.177 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -51.92 -47.42 64.66 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.95 -29.43 12.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.465 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -50.35 6.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m -55.93 -32.73 64.06 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.418 1.008 . . . . 0.0 112.198 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.25 -5.02 57.31 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.566 0.746 . . . . 0.0 112.961 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -41.48 3.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.524 1.13 . . . . 0.0 111.578 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.95 179.57 7.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.845 1.258 . . . . 0.0 108.716 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -127.6 -24.36 3.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.415 1.086 . . . . 0.0 113.153 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.75 83.09 8.31 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -56.19 -38.1 95.51 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.267 1.312 . . . . 0.0 110.229 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.45 -15.9 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.503 1.921 . . . . 0.0 114.425 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -124.03 -16.13 6.63 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.784 1.233 . . . . 0.0 111.55 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.1 m -77.98 137.2 38.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.049 0.84 . . . . 0.0 110.656 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -110.25 125.45 53.12 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.24 100.51 10.1 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.431 1.092 . . . . 0.0 112.408 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CE2' ' CD1' ' A' ' 103' ' ' TYR . 40.6 m-85 -82.54 96.7 8.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -73.99 124.49 31.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.095 1.358 . . . . 0.0 109.565 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -121.77 125.44 46.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 109.498 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 26.3 t0 -133.41 172.42 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.808 0.843 . . . . 0.0 112.572 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.42 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 52.3 mttm -46.52 -54.67 8.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.65 1.58 . . . . 0.0 108.926 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -136.82 -155.97 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.04 2.936 . . . . 0.0 104.716 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -52.85 -54.23 37.4 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.765 1.226 . . . . 0.0 109.722 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.36 -98.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.448 1.975 . . . . 0.0 111.459 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.66 16.47 2.71 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.293 2.237 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -45.04 -45.23 10.72 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.968 1.258 . . . . 0.0 113.41 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -73.38 -41.8 62.92 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.202 0.91 . . . . 0.0 111.24 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.42 -46.67 88.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.7 t -66.73 -34.51 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.13 82.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.036 0.835 . . . . 0.0 109.389 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -73.11 -48.17 37.93 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.9 tp -50.16 -58.97 4.42 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.122 1.769 . . . . 0.0 113.837 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.91 -38.39 81.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 122.15 -0.343 . . . . 0.0 110.126 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.4 77.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.36 -26.68 67.98 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.374 1.469 . . . . 0.0 111.349 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -84.55 -21.65 30.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.655 0.662 . . . . 0.0 111.968 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.66 1.98 2.04 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.046 -1.975 . . . . 0.0 115.978 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -73.34 150.27 41.98 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.78 2.29 . . . . 0.0 109.633 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -55.89 -58.41 8.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.582 0.753 . . . . 0.0 111.129 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.8 m -159.3 166.18 31.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 107.465 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.37 12.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CD1' ' CE2' ' A' ' 78' ' ' TYR . 55.3 m-85 -100.26 151.23 21.71 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.23 111.14 19.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.32 91.37 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 113.96 10.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.25 34.0 m-20 115.32 4.84 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 133.079 4.552 . . . . 0.0 110.553 179.994 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.39 -134.49 41.92 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.658 -1.276 . . . . 0.0 114.866 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.98 -44.77 5.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -87.72 -22.71 24.45 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -52.98 170.88 0.59 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.443 1.973 . . . . 0.0 115.012 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -57.0 -27.55 74.07 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 124.532 3.488 . . . . 0.0 115.619 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -120.64 9.67 10.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.002 2.121 . . . . 0.0 109.03 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 168.98 20.83 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -47.19 -62.62 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 113.632 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.37 -52.83 63.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.795 1.238 . . . . 0.0 110.459 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.36 13.98 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.172 2.189 . . . . 0.0 113.437 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.4 m -129.47 16.56 5.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.644 1.578 . . . . 0.0 112.0 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.7 m 63.59 18.97 11.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.084 1.754 . . . . 0.0 113.661 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.3 mt -76.7 154.74 83.45 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.638 ' C ' HD22 ' A' ' 40' ' ' ASN . 98.3 Cg_endo -72.61 162.62 40.82 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.165 1.243 . . . . 0.0 109.969 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -167.38 126.51 1.36 Allowed 'General case' 0 C--O 1.238 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 113.059 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -73.49 93.19 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.977 2.111 . . . . 0.0 109.565 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.55 151.69 50.91 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 CA--C 1.546 1.105 0 C-N-CA 123.14 2.56 . . . . 0.0 107.366 177.458 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.241 0.606 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.08 106.88 0.49 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -49.68 148.7 2.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.515 1.158 . . . . 0.0 109.023 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.86 48.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -67.8 -48.03 67.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.288 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -63.11 -45.14 93.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.856 0.753 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.12 81.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.47 -41.07 98.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.092 0.86 . . . . 0.0 111.581 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -60.35 -54.78 41.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -49.6 -53.01 26.36 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.327 1.051 . . . . 0.0 111.719 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.9 mt -57.55 -23.2 49.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 113.202 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.87 -5.79 60.93 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.951 1.262 . . . . 0.0 112.676 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -124.62 -1.86 7.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.495 1.148 . . . . 0.0 111.227 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -131.38 115.83 16.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.453 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -69.18 -47.48 64.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.842 1.257 . . . . 0.0 111.703 -178.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -72.56 -6.9 47.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.582 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.02 118.6 18.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.56 131.91 46.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.816 0.817 . . . . 0.0 110.944 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.28 127.52 32.09 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.465 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 tp -109.36 103.92 12.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.854 2.062 . . . . 0.0 109.525 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.96 108.3 16.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.245 1.018 . . . . 0.0 108.273 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -102.36 0.09 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -61.44 168.55 2.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.374 1.07 . . . . 0.0 113.632 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.45 136.81 37.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.413 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -38.25 -40.35 0.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.664 2.786 . . . . 0.0 114.322 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.02 76.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.869 0.759 . . . . 0.0 112.571 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.18 80.07 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.446 0.566 . . . . 0.0 111.024 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -65.67 -6.31 11.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.592 1.157 . . . . 0.0 111.824 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.68 -29.42 7.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.556 1.943 . . . . 0.0 109.486 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -94.67 -59.42 1.93 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.88 0.872 . . . . 0.0 112.824 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -26.33 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.696 1.599 . . . . 0.0 112.947 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.82 -153.38 19.17 Favored Glycine 0 C--N 1.335 0.487 0 O-C-N 121.42 -0.8 . . . . 0.0 112.836 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -143.3 162.0 44.84 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.49 178.39 6.23 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.072 1.181 . . . . 0.0 111.185 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.17 145.75 31.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.57 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.69 13.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.413 1.885 . . . . 0.0 110.619 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -59.06 -27.54 65.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.106 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.64 94.58 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.3 mt -70.16 -28.42 65.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 0.0 109.785 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.86 19.29 7.39 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 127.694 2.569 . . . . 0.0 110.817 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 20' ' ' ASP . 46.1 mmtm -130.24 -178.57 4.8 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 150.49 34.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.612 1.165 . . . . 0.0 108.855 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 179.96 7.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.745 0.818 . . . . 0.0 110.697 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.85 133.09 44.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -113.7 121.05 42.94 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.008 1.276 . . . . 0.0 111.273 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -146.69 108.1 4.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 t -57.98 119.91 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -75.92 124.45 27.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -131.12 116.72 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.04 1.736 . . . . 0.0 107.197 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.01 -27.43 67.12 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 118.464 0.575 . . . . 0.0 112.652 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -74.1 -15.42 61.05 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.625 0.712 . . . . 0.0 110.6 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.74 32.32 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.468 1.907 . . . . 0.0 113.584 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -43.06 -56.69 6.03 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 121.452 1.933 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -63.7 -37.05 48.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.724 2.282 . . . . 0.0 112.341 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.44 74.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.319 1.437 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -82.11 -56.7 3.77 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.09 -44.59 61.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.042 1.737 . . . . 0.0 112.769 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -57.36 -36.88 71.76 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.801 0.728 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -61.82 -20.62 63.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.921 0.889 . . . . 0.0 111.356 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.8 -43.28 8.3 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.6 t -52.43 -34.62 49.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.991 1.716 . . . . 0.0 111.541 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.99 -6.03 53.17 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -37.37 4.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.785 0.721 . . . . 0.0 110.899 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -91.88 103.88 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.901 0.881 . . . . 0.0 109.627 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -18.33 60.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.338 0.517 . . . . 0.0 111.68 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 68.24 79.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.642 1.177 . . . . 0.0 109.532 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -32.39 93.21 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.499 2.133 . . . . 0.0 111.63 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.11 -19.9 8.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.394 1.878 . . . . 0.0 115.934 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -124.87 8.48 8.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.841 1.256 . . . . 0.0 110.957 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -104.42 111.83 24.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.712 1.605 . . . . 0.0 111.323 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.5 m -83.67 129.32 34.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.85 102.61 14.43 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.478 0.711 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -84.43 92.56 8.09 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.18 127.17 31.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.68 1.592 . . . . 0.0 110.849 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -127.2 130.98 50.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.647 1.579 . . . . 0.0 109.128 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 49.1 t0 -137.09 -170.54 2.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.078 2.151 . . . . 0.0 107.703 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 17.9 ptmt -62.51 -48.5 79.28 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.03 -1.044 . . . . 0.0 108.676 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -140.97 -172.77 3.55 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.999 2.519 . . . . 0.0 108.886 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -48.89 -30.02 5.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.686 1.994 . . . . 0.0 113.121 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.33 -108.14 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 C-N-CA 130.208 3.766 . . . . 0.0 115.717 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -110.73 0.92 17.57 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 127.209 2.203 . . . . 0.0 108.816 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -51.48 -47.04 63.33 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 121.188 1.813 . . . . 0.0 109.755 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -64.47 -23.99 67.47 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 tp -87.32 -43.23 12.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.127 0.971 . . . . 0.0 110.97 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.98 -30.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.18 83.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.04 -43.24 71.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 125.794 1.637 . . . . 0.0 111.131 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.41 -56.16 21.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.915 0.886 . . . . 0.0 112.175 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.22 -35.32 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.14 95.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.058 0.543 . . . . 0.0 109.893 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.16 -37.97 84.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.579 0.752 . . . . 0.0 109.709 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -61.28 -50.58 72.44 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.18 -3.1 0.29 Allowed Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.976 -1.458 . . . . 0.0 115.377 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -58.79 153.2 17.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.632 1.716 . . . . 0.0 109.107 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -46.94 -70.13 0.11 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.489 1.116 . . . . 0.0 112.523 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 m -154.79 177.38 11.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.443 2.297 . . . . 0.0 105.826 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.06 136.55 8.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.15 -0.969 . . . . 0.0 108.651 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -113.33 154.52 26.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.703 1.201 . . . . 0.0 108.339 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.49 114.12 23.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.264 2.4 mp -66.15 106.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.73 128.02 34.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.22 9.88 4.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.885 2.874 . . . . 0.0 111.76 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.03 -111.8 0.51 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.196 1.855 . . . . 0.0 110.839 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.75 -9.12 3.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.516 1.126 . . . . 0.0 112.027 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.82 -1.54 27.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.2 41.64 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.31 -39.92 84.84 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.527 3.485 . . . . 0.0 114.746 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 21.55 9.63 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.862 0.865 . . . . 0.0 110.999 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.4 171.71 4.01 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -40.91 -46.3 2.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 113.52 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.8 mt -65.76 -57.2 8.55 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.374 0.988 . . . . 0.0 110.627 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -66.81 -4.49 9.33 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.712 2.005 . . . . 0.0 114.303 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 p -97.2 3.9 51.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 t 77.24 11.16 2.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.634 1.973 . . . . 0.0 111.859 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.1 152.88 79.72 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.012 0.824 . . . . 0.0 110.459 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.72 142.96 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.187 1.925 . . . . 0.0 110.981 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -145.06 142.2 29.52 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.502 -0.749 . . . . 0.0 110.313 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.0 mt -92.59 93.01 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.851 1.26 . . . . 0.0 109.121 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.85 148.64 72.73 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.639 0.775 . . . . 0.0 109.103 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 CA--C 1.545 1.035 0 C-N-CA 124.284 3.323 . . . . 0.0 107.118 177.483 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.9 -98.32 0.11 Allowed Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.6 m -157.26 160.08 38.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.104 1.452 . . . . 0.0 112.446 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.96 77.63 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.858 -1.068 . . . . 0.0 112.385 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -55.03 -51.5 66.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.911 1.232 . . . . 0.0 109.832 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -52.02 -54.36 30.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.598 0.759 . . . . 0.0 110.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.23 82.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 112.621 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.24 -45.72 75.89 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -59.89 -41.47 91.66 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -60.79 -44.2 97.12 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.631 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.81 -44.83 78.24 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.355 1.434 . . . . 0.0 107.708 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.0 -6.86 33.81 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.535 1.541 . . . . 0.0 115.952 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 t -129.59 -2.82 4.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.659 1.73 . . . . 0.0 111.655 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -113.97 94.09 4.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.805 1.642 . . . . 0.0 106.82 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.52 -27.03 1.59 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.523 1.929 . . . . 0.0 115.862 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -109.9 5.42 22.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.239 0.927 . . . . 0.0 113.11 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.27 148.56 39.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.008 0.822 . . . . 0.0 111.618 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' NE2' ' HZ1' ' A' ' 46' ' ' LYS . 36.1 mm-40 -142.9 158.88 43.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.235 0.614 . . . . 0.0 110.277 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -102.08 119.72 39.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.362 1.465 . . . . 0.0 108.006 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 109.33 20.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.492 1.917 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 121.16 27.43 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.148 2.179 . . . . 0.0 107.625 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.44 4.66 6.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -66.43 170.45 6.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 121.798 2.09 . . . . 0.0 108.968 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.73 150.11 48.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -52.42 -32.8 40.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 111.701 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.94 70.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.179 0.899 . . . . 0.0 113.222 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.82 -38.34 88.64 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -63.25 -10.4 15.63 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.573 -1.954 . . . . 0.0 114.803 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -21.05 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.337 1.855 . . . . 0.0 109.43 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.06 -79.32 0.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.853 2.061 . . . . 0.0 109.265 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.85 -30.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.267 1.427 . . . . 0.0 112.731 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.68 -134.22 11.9 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 p -151.11 158.17 34.83 Favored Pre-proline 0 N--CA 1.448 -0.573 0 O-C-N 122.654 -0.321 . . . . 0.0 111.175 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.74 173.81 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 N-CA-C 107.321 -1.838 . . . . 0.0 107.321 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.499 HD22 ' HB2' ' A' ' 121' ' ' PRO . 1.3 p30 -141.31 149.09 40.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.09 9.31 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.464 1.126 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -58.3 -32.72 68.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.392 1.477 . . . . 0.0 111.586 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -48.1 -42.79 24.28 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 124.804 1.315 . . . . 0.0 110.321 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 mt -77.1 -75.01 0.22 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.51 44.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HZ1' ' NE2' ' A' ' 23' ' ' GLN . 27.7 mmtp -141.09 -176.11 4.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.922 1.689 . . . . 0.0 109.014 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.23 136.93 25.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.862 2.065 . . . . 0.0 107.136 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -175.79 2.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.977 0.911 . . . . 0.0 111.732 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.14 133.95 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.4 p -120.05 108.47 14.32 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.982 0.913 . . . . 0.0 113.455 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -143.46 108.48 4.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -57.47 122.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 118.149 0.431 . . . . 0.0 110.226 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -74.18 151.09 40.07 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -156.45 116.16 3.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.17 -22.15 57.72 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 117.902 0.319 . . . . 0.0 112.726 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 58.1 mt-10 -76.66 -15.22 59.86 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.163 0.981 . . . . 0.0 111.591 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -128.13 33.75 4.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.073 1.349 . . . . 0.0 113.784 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.39 -54.37 7.99 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.765 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.92 -47.26 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.563 2.175 . . . . 0.0 112.362 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.42 -24.88 71.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.849 -0.417 . . . . 0.0 112.593 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.76 -39.82 17.99 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 118.159 0.979 . . . . 0.0 108.602 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.6 -47.97 79.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.89 0.876 . . . . 0.0 111.194 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -52.94 -37.74 61.3 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.034 0.534 . . . . 0.0 111.623 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.86 -29.39 68.26 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.474 -0.766 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.63 -50.61 6.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 t -55.0 -26.6 38.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.206 1.802 . . . . 0.0 112.631 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.67 -18.3 33.57 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.231 -0.918 . . . . 0.0 111.64 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -51.61 3.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.462 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.32 98.8 4.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -56.97 -33.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.176 0.99 . . . . 0.0 113.469 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -131.68 80.84 65.34 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.11 -26.42 42.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.814 2.343 . . . . 0.0 113.101 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -54.54 -18.62 4.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.161 1.785 . . . . 0.0 114.165 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -132.84 7.66 4.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 112.694 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -105.25 109.15 21.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.454 1.502 . . . . 0.0 109.895 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.7 m -80.84 137.98 36.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.519 0.728 . . . . 0.0 109.997 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.2 mt -113.54 99.62 7.88 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 112.22 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 52.7 m-85 -76.58 112.52 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.5 141.87 14.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.147 1.379 . . . . 0.0 110.478 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -137.42 133.48 34.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.33 175.58 9.38 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -58.28 -55.53 33.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.59 -1.319 . . . . 0.0 110.682 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -130.26 -152.52 0.52 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.258 3.423 . . . . 0.0 105.503 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.3 -6.09 2.92 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 10.38 -94.18 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 1 C-N-CA 131.872 4.558 . . . . 0.0 117.5 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.37 4.62 1.21 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.287 2.235 . . . . 0.0 112.161 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -29.31 -62.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.404 2.682 . . . . 0.0 114.463 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.04 -45.81 82.88 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.254 2.222 . . . . 0.0 112.916 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -48.24 79.23 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.695 1.198 . . . . 0.0 108.71 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.0 -34.6 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.72 87.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.983 0.81 . . . . 0.0 109.124 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.4 -42.38 87.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -53.13 -58.79 5.84 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.993 1.317 . . . . 0.0 111.685 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.11 -38.0 81.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 121.873 -0.517 . . . . 0.0 110.555 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.19 93.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.701 0.626 . . . . 0.0 111.057 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.59 -45.21 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.59 0.756 . . . . 0.0 110.236 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -55.26 -37.91 67.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.753 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -9.51 0.26 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.99 -0.895 . . . . 0.0 115.205 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.57 142.04 56.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.444 1.622 . . . . 0.0 108.923 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -41.14 -57.52 2.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.296 2.638 . . . . 0.0 112.79 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.0 t -166.99 173.59 9.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.44 149.61 27.94 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.466 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 44.9 m-85 -133.26 122.01 23.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.7 98.4 11.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 108.871 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -64.12 120.11 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -72.21 165.39 24.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.372 0.669 . . . . 0.0 109.82 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.3 16.07 10.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.244 1.818 . . . . 0.0 112.942 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.13 -123.97 32.85 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.36 -24.76 3.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.737 2.415 . . . . 0.0 109.472 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.43 -27.63 25.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.891 1.676 . . . . 0.0 113.524 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.48 178.9 41.14 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.214 0.911 . . . . 0.0 114.652 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.53 -51.12 11.2 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.411 3.408 . . . . 0.0 113.839 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.66 7.26 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.688 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.78 153.46 47.27 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -34.13 -64.06 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 129.512 3.125 . . . . 0.0 115.711 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -56.66 -53.94 51.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.03 0.377 . . . . 0.0 110.497 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.23 -15.33 62.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.91 2.084 . . . . 0.0 113.031 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 t -88.51 8.13 29.62 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.571 1.548 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.6 t 64.77 20.75 12.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.867 2.467 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.57 158.51 59.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 123.592 0.757 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.499 ' HB2' HD22 ' A' ' 40' ' ' ASN . 57.3 Cg_endo -77.62 152.88 29.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.305 2.003 . . . . 0.0 110.613 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -151.08 141.66 22.61 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 120.704 -1.247 . . . . 0.0 111.191 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.38 80.99 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.915 1.286 . . . . 0.0 109.908 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -78.98 122.36 84.44 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.0 110.002 179.208 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.0 p . . . . . 0 C--O 1.24 0.589 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.92 -110.93 0.28 Allowed Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.3 m -147.31 160.23 42.75 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.374 1.07 . . . . 0.0 111.064 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.48 33.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.462 1.905 . . . . 0.0 110.369 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -53.72 -49.87 67.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.398 0.544 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -57.03 -50.47 72.65 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.824 0.284 . . . . 0.0 111.493 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.81 77.09 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.927 0.491 . . . . 0.0 111.147 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -63.9 -48.3 77.15 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.8 m -58.16 -42.27 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.203 0.601 . . . . 0.0 109.954 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -62.31 -34.31 76.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.578 -1.201 . . . . 0.0 111.844 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.27 -43.0 99.59 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.09 -0.48 15.29 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.839 1.685 . . . . 0.0 113.142 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -19.88 7.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.99 2.516 . . . . 0.0 111.279 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -127.61 112.49 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.117 -1.614 . . . . 0.0 111.612 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -40.43 94.06 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.903 0.881 . . . . 0.0 110.812 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.65 -12.72 60.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.282 0.633 . . . . 0.0 110.788 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.83 143.03 38.18 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.61 155.6 47.35 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.321 1.048 . . . . 0.0 108.467 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.6 134.56 47.56 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -127.1 108.43 10.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.085 1.754 . . . . 0.0 111.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.33 116.89 21.39 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 pt -104.81 6.0 10.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -67.53 161.3 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.907 0.776 . . . . 0.0 110.053 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 144.5 55.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -54.15 -25.45 22.47 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.629 1.972 . . . . 0.0 110.951 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.98 92.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.07 -1.019 . . . . 0.0 109.93 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.03 -28.59 70.2 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.98 -17.18 61.82 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.759 -1.838 . . . . 0.0 111.604 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -105.49 -18.47 14.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.306 1.442 . . . . 0.0 110.332 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -100.71 -23.94 14.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.53 -26.33 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.758 1.163 . . . . 0.0 111.807 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.83 -137.79 13.47 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.72 158.0 31.64 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 118.553 1.176 . . . . 0.0 108.741 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.47 174.53 12.55 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.381 -1.815 . . . . 0.0 107.381 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.35 151.12 48.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.325 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -139.96 8.58 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.33 1.852 . . . . 0.0 110.472 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.92 -30.33 65.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.967 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.15 -37.33 94.33 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 mt -68.45 -33.96 75.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.4 19.42 4.62 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.254 1.883 . . . . 0.0 114.04 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -125.35 177.86 5.92 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.281 1.033 . . . . 0.0 111.661 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -131.15 159.18 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.752 1.621 . . . . 0.0 108.48 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.61 177.71 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.716 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.39 137.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.344 -2.835 . . . . 0.0 103.344 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -118.31 106.26 12.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.608 1.563 . . . . 0.0 107.883 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 m -143.96 98.31 3.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.01 122.26 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -77.38 145.02 37.51 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -146.74 114.15 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.82 1.248 . . . . 0.0 109.742 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.4 -21.82 9.49 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 121.11 -0.994 . . . . 0.0 114.104 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.88 -22.95 64.16 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.131 0.966 . . . . 0.0 111.62 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -144.53 62.79 1.32 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.42 1.105 . . . . 0.0 111.397 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.92 -56.4 23.79 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.605 1.162 . . . . 0.0 110.697 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.88 -38.76 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.897 1.731 . . . . 0.0 112.157 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.61 88.91 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -64.47 -47.03 80.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.329 1.052 . . . . 0.0 109.744 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mt -54.49 -42.23 70.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.101 0.96 . . . . 0.0 112.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -59.25 -32.42 69.97 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.842 -0.536 . . . . 0.0 111.743 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -62.85 -25.41 68.26 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -44.88 9.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -57.41 -28.01 62.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.698 1.199 . . . . 0.0 112.486 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.77 -12.23 59.96 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.766 -0.584 . . . . 0.0 111.627 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.84 -49.25 2.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.649 0.779 . . . . 0.0 109.699 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -80.87 99.14 8.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -57.77 -44.69 86.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 81.42 33.87 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -26.2 44.17 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.62 2.214 . . . . 0.0 113.789 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -59.42 -14.65 13.03 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -116.68 -16.47 10.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.655 1.582 . . . . 0.0 110.114 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -77.23 132.97 38.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.072 1.349 . . . . 0.0 111.507 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.9 m -103.67 138.15 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.09 101.93 8.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -78.87 103.42 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.63 123.89 38.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 tp -120.23 125.04 47.14 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.704 1.201 . . . . 0.0 109.061 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -127.94 172.92 10.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.856 1.662 . . . . 0.0 106.877 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -65.71 -36.44 83.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.561 -1.337 . . . . 0.0 111.986 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -138.76 -173.98 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.572 1.949 . . . . 0.0 107.017 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.64 -26.81 2.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.709 2.404 . . . . 0.0 114.548 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.55 -113.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 130.197 3.761 . . . . 0.0 116.552 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -116.54 0.49 12.71 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.057 1.743 . . . . 0.0 113.645 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -30.65 -54.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 130.085 3.354 . . . . 0.0 115.714 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.64 -42.28 82.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.724 0.81 . . . . 0.0 110.346 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -42.99 96.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.1 -37.45 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.349 1.46 . . . . 0.0 108.496 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.48 98.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.46 -43.6 76.65 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -52.43 -57.47 9.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.832 1.196 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.5 m -63.7 -39.28 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.135 -0.353 . . . . 0.0 111.033 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.48 -52.53 64.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.598 0.759 . . . . 0.0 110.161 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.8 -44.47 93.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.557 1.543 . . . . 0.0 108.572 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -57.07 -45.07 83.56 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.126 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.21 -13.55 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-O 117.269 -1.85 . . . . 0.0 114.943 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.51 146.5 40.22 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.861 2.33 . . . . 0.0 110.705 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -60.55 3.23 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.193 1.397 . . . . 0.0 113.367 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.5 t -149.7 169.89 19.98 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.11 141.25 15.03 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -128.19 143.94 51.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.936 1.694 . . . . 0.0 106.673 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.92 118.28 36.13 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.6 95.89 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.67 142.54 39.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 76.55 2.29 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.261 2.225 . . . . 0.0 111.673 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.92 -126.22 35.07 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.879 -1.138 . . . . 0.0 113.783 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.48 4.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.122 1.369 . . . . 0.0 112.211 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -93.99 -12.81 27.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.396 1.478 . . . . 0.0 114.533 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.01 169.28 13.29 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.878 1.217 . . . . 0.0 111.471 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 -25.46 24.97 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.951 3.101 . . . . 0.0 115.671 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -134.11 27.53 3.84 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.22 1.808 . . . . 0.0 110.053 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.65 174.16 39.66 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -40.43 -53.11 2.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -63.21 -51.2 67.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.34 0.518 . . . . 0.0 109.659 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -77.47 27.82 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.478 1.111 . . . . 0.0 111.453 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.0 m -128.38 7.4 5.87 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.063 1.745 . . . . 0.0 111.524 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.9 m 57.83 53.66 6.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.039 1.335 . . . . 0.0 110.08 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.5 mt -122.11 144.28 41.06 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.6 144.11 99.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.286 2.658 . . . . 0.0 112.285 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -147.2 156.05 42.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.87 0.868 . . . . 0.0 112.161 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.66 89.95 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 110.132 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -74.67 156.4 86.72 Favored Pre-proline 0 C--O 1.239 0.519 0 O-C-N 121.776 -0.577 . . . . 0.0 109.587 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 CA--C 1.54 0.809 0 C-N-CA 123.54 2.827 . . . . 0.0 109.042 178.18 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.441 -0.902 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 -86.43 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -178.03 167.32 2.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.642 1.977 . . . . 0.0 109.16 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.46 -52.69 60.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.929 0.892 . . . . 0.0 110.083 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -55.41 -52.04 64.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.901 0.48 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.55 -51.53 66.76 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.22 78.01 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.759 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -53.09 -52.23 59.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.606 0.763 . . . . 0.0 112.032 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 m -69.01 -36.06 77.36 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.557 -0.714 . . . . 0.0 111.441 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.39 -39.98 89.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.6 mt -63.9 -38.82 92.5 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.51 0.53 33.59 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 127.084 2.278 . . . . 0.0 114.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.48 -20.88 3.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.522 1.161 . . . . 0.0 111.043 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -117.16 102.98 9.75 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.562 -0.711 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.47 -26.24 60.94 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.42 -13.18 61.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.441 1.096 . . . . 0.0 111.252 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.74 146.63 23.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.914 -1.117 . . . . 0.0 111.524 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.56 30.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 tt -103.93 143.73 32.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.665 0.786 . . . . 0.0 108.903 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -131.37 98.44 4.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.917 1.687 . . . . 0.0 108.868 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -78.47 113.81 16.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.9 pt -103.79 13.38 7.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -73.74 166.33 23.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 134.36 50.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -54.63 -27.01 36.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.72 1.208 . . . . 0.0 112.39 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.26 88.35 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.997 -1.064 . . . . 0.0 110.128 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -71.41 -27.05 63.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.105 0.866 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -59.3 -28.5 66.84 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.593 0.633 . . . . 0.0 109.377 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -85.58 -38.9 17.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.862 0.865 . . . . 0.0 110.086 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -68.77 -50.11 53.14 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.81 -12.33 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.02 -152.18 20.01 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.141 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 p -143.71 161.36 46.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.562 1.181 . . . . 0.0 112.956 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.4 157.73 58.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.989 1.793 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.551 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -125.19 87.5 2.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.968 2.107 . . . . 0.0 112.493 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.3 5.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 119.313 -2.117 . . . . 0.0 111.043 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -24.53 61.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.234 1.814 . . . . 0.0 112.867 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.9 -27.08 61.53 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.61 -50.76 6.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 1.59 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.682 1.61 . . . . 0.0 112.668 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.25 -179.9 5.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.15 . . . . 0.0 109.55 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -141.28 133.88 28.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.68 1.592 . . . . 0.0 107.192 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.32 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.628 0.728 . . . . 0.0 111.754 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -127.95 138.3 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -115.72 110.33 18.96 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.439 1.096 . . . . 0.0 109.842 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.41 103.12 4.21 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.773 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.11 124.53 12.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 119.985 1.266 . . . . 0.0 109.417 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -79.75 122.49 26.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.68 121.58 25.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.21 -15.37 37.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.124 -0.82 . . . . 0.0 114.087 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.44 -17.8 60.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.68 1.24 . . . . 0.0 110.478 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -131.49 66.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.275 1.03 . . . . 0.0 109.976 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -57.54 -58.68 16.58 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 120.195 -1.566 . . . . 0.0 108.46 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -34.61 8.18 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.867 1.712 . . . . 0.0 110.241 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.82 -28.55 63.36 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -80.86 -55.93 4.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -48.74 -50.31 34.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.424 1.89 . . . . 0.0 112.824 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -32.99 63.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -63.35 -28.16 69.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.892 0.877 . . . . 0.0 110.189 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -45.91 10.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 t -53.93 -33.52 56.99 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.268 1.427 . . . . 0.0 112.095 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -6.18 52.11 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 -39.4 3.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.623 0.769 . . . . 0.0 112.851 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 75' ' ' THR . 47.7 m-85 -80.12 119.86 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -33.53 72.48 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.548 0.53 . . . . 0.0 112.097 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -145.67 96.24 4.8 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 124.467 1.107 . . . . 0.0 108.223 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.84 -34.53 91.22 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.699 1.6 . . . . 0.0 111.906 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.28 -12.81 32.09 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.25 6.9 p30 -122.5 25.5 8.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.941 1.296 . . . . 0.0 109.29 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.423 HG21 ' CD1' ' A' ' 69' ' ' PHE . 25.4 m -130.84 120.16 23.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.258 1.023 . . . . 0.0 110.696 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.6 m -93.18 137.05 32.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.6 mt -115.91 96.21 5.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.227 1.011 . . . . 0.0 112.148 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 13.9 m-85 -78.21 121.07 23.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.2 154.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.98 1.312 . . . . 0.0 112.668 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.4 tp -155.31 105.05 2.46 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.94 171.88 8.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.851 1.66 . . . . 0.0 106.823 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.66 -58.16 3.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.059 1.343 . . . . 0.0 112.304 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -137.74 -152.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.725 2.41 . . . . 0.0 105.544 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.76 -45.4 9.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.995 2.118 . . . . 0.0 112.253 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.17 -104.09 0.06 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.829 2.157 . . . . 0.0 113.834 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -143.74 11.81 1.65 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.055 1.742 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -39.77 -48.04 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.475 1.91 . . . . 0.0 114.601 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.93 -49.45 77.77 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.835 0.854 . . . . 0.0 110.518 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.18 89.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.24 -33.67 62.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.31 93.93 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.254 0.934 . . . . 0.0 109.66 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -74.28 -38.95 63.26 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.998 0.817 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.4 tp -51.55 -60.09 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.046 1.338 . . . . 0.0 111.808 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.58 -37.47 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 122.603 0.361 . . . . 0.0 111.388 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.6 70.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.15 -41.42 88.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -66.69 -25.68 66.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.03 -4.5 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 117.712 -1.605 . . . . 0.0 115.717 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.24 146.55 48.93 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 120.458 2.129 . . . . 0.0 108.137 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -45.36 -64.03 0.81 Allowed 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.726 1.211 . . . . 0.0 111.523 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.0 m -157.39 179.27 9.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.838 1.655 . . . . 0.0 107.599 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.59 142.31 12.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.494 1.518 . . . . 0.0 106.95 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.415 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -128.6 129.45 45.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.865 1.266 . . . . 0.0 108.78 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.64 139.88 30.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.65 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 126.417 1.887 . . . . 0.0 107.793 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -59.66 151.98 23.58 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.81 0.844 . . . . 0.0 109.445 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 66.83 10.17 7.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.42 1.488 . . . . 0.0 112.742 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.89 -116.54 3.39 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.925 2.202 . . . . 0.0 113.284 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 -43.57 3.26 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.653 0.781 . . . . 0.0 112.774 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.71 -10.74 41.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.74 176.01 9.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.028 1.286 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.44 -19.31 67.72 Favored 'Trans proline' 0 N--CA 1.471 0.147 0 C-N-CA 123.919 3.079 . . . . 0.0 112.982 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -119.54 -3.97 10.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.345 2.258 . . . . 0.0 109.327 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.45 159.26 25.81 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -25.9 -62.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.462 2.305 . . . . 0.0 114.164 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.51 -62.68 1.52 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.176 1.39 . . . . 0.0 110.77 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.66 -10.01 16.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.423 1.089 . . . . 0.0 113.263 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.82 15.31 7.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 0.0 109.113 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 m 68.85 15.56 8.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.349 2.66 . . . . 0.0 112.62 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.69 153.01 52.44 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 119.144 0.884 . . . . 0.0 110.252 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.551 ' C ' HD22 ' A' ' 40' ' ' ASN . 33.7 Cg_endo -74.64 169.75 21.85 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.2 1.934 . . . . 0.0 109.536 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -165.19 130.09 2.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 119.946 -1.721 . . . . 0.0 109.555 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -72.26 97.21 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.658 1.983 . . . . 0.0 109.439 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -93.91 149.52 37.1 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 121.058 -1.026 . . . . 0.0 112.388 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.453 -0.886 0 C-N-CA 124.046 3.164 . . . . 0.0 109.156 178.751 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.808 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -60.93 137.61 58.21 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.921 0.86 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 p -128.83 -70.32 0.68 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.678 1.191 . . . . 0.0 109.975 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.62 117.15 8.51 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.276 1.417 . . . . 0.0 110.21 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 m -57.5 115.24 2.63 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 p -147.01 178.45 8.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.693 -0.629 . . . . 0.0 111.536 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.24 -117.6 0.61 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.348 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 m -122.2 148.4 45.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.523 1.529 . . . . 0.0 111.002 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.57 -42.87 75.32 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.315 1.046 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.36 -41.32 79.88 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.732 0.813 . . . . 0.0 111.482 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -61.45 -42.8 99.33 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.07 82.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.343 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.56 -40.17 90.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.036 1.289 . . . . 0.0 110.251 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.2 m -62.98 -54.02 44.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -57.17 -43.09 82.26 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.619 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.98 -20.5 58.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.966 1.257 . . . . 0.0 111.423 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.2 -9.33 62.11 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.219 1.866 . . . . 0.0 112.653 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -122.96 -18.18 6.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.064 1.432 . . . . 0.0 110.913 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -97.21 103.73 15.69 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.59 -24.48 67.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.904 0.881 . . . . 0.0 109.905 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -94.24 -0.19 55.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.164 1.785 . . . . 0.0 112.912 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.91 148.39 29.89 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.246 0.93 . . . . 0.0 111.646 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -148.11 154.68 40.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.02 1.728 . . . . 0.0 108.321 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.04 131.09 52.99 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.067 1.747 . . . . 0.0 108.022 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.0 tp -122.68 114.97 21.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.849 1.66 . . . . 0.0 109.284 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.6 m-20 -84.67 104.19 14.43 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 126.292 1.837 . . . . 0.0 109.445 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.66 2.96 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 122.224 -0.298 . . . . 0.0 110.71 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 26' ' ' ASP . 39.9 mtm180 -57.06 165.01 1.41 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.49 1.516 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.53 141.74 32.38 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.9 m -49.16 -33.66 12.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.351 1.46 . . . . 0.0 111.194 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.52 78.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.235 0.925 . . . . 0.0 110.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.69 -39.42 94.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -58.9 -20.72 54.15 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.276 -1.515 . . . . 0.0 114.574 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -96.03 -23.47 16.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.955 0.502 . . . . 0.0 111.586 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.35 -70.26 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.897 1.679 . . . . 0.0 110.941 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -77.36 -31.92 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.425 1.09 . . . . 0.0 111.708 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.3 -138.32 13.92 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -147.48 162.63 31.38 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 120.619 -1.518 . . . . 0.0 109.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 56.8 Cg_endo -68.55 163.28 37.44 Favored 'Trans proline' 0 N--CA 1.435 -1.937 0 CA-C-O 124.618 1.841 . . . . 0.0 110.141 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.549 ' C ' HD21 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -126.19 92.26 3.54 Favored 'General case' 0 N--CA 1.419 -2.003 1 C-N-CA 132.346 4.258 . . . . 0.0 105.295 -179.212 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 pt -115.43 -19.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.195 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -43.24 -26.54 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.567 -1.682 . . . . 0.0 115.475 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.4 37.36 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 119.991 1.269 . . . . 0.0 110.303 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.46 -71.5 0.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.32 32.2 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 CA-C-O 118.815 -0.992 . . . . 0.0 115.194 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -126.77 177.73 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.053 1.926 . . . . 0.0 110.39 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.86 133.7 43.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.413 1.085 . . . . 0.0 110.076 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.26 167.39 18.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.374 -0.828 . . . . 0.0 110.387 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.1 t -134.34 134.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -115.14 115.84 27.41 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.564 1.146 . . . . 0.0 109.355 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.5 107.86 4.41 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.73 111.44 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 119.776 1.171 . . . . 0.0 110.182 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -74.29 154.86 38.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.592 0.71 . . . . 0.0 109.34 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -165.3 134.78 3.5 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.91 -34.79 80.06 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -66.99 -24.87 66.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.414 1.107 . . . . 0.0 111.115 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -105.32 15.35 27.45 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.582 1.553 . . . . 0.0 114.169 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -39.43 -60.0 1.41 Allowed Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 121.459 1.936 . . . . 0.0 112.328 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.82 -47.64 6.6 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.554 2.836 . . . . 0.0 112.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.75 -22.85 68.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.847 0.737 . . . . 0.0 113.293 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -82.89 -50.17 8.89 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.097 1.759 . . . . 0.0 107.481 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.53 -47.58 66.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.495 1.518 . . . . 0.0 112.882 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -52.38 -43.44 64.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -58.16 -22.2 50.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.741 1.216 . . . . 0.0 113.794 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.41 -52.79 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.8 t -55.68 -30.0 60.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.951 0.9 . . . . 0.0 110.106 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.74 -4.58 59.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -36.67 4.54 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 119.497 1.044 . . . . 0.0 111.342 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.49 120.2 29.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.167 1.387 . . . . 0.0 107.503 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -58.79 -54.11 50.79 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.293 0.497 . . . . 0.0 111.124 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -116.87 83.78 14.91 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.526 1.13 . . . . 0.0 110.012 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.6 -40.75 82.25 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.163 1.909 . . . . 0.0 110.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.32 -0.78 1.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 -11.92 4.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.135 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 138.19 31.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.718 1.207 . . . . 0.0 110.979 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -100.82 123.46 45.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.64 97.16 6.76 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.018 1.327 . . . . 0.0 110.975 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -73.42 120.04 18.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.42 156.86 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.278 1.431 . . . . 0.0 109.992 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -156.35 110.57 2.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -123.76 169.21 11.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -54.89 -39.07 68.36 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.718 -1.238 . . . . 0.0 109.736 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -141.77 -140.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.658 1.983 . . . . 0.0 108.989 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -64.95 -62.29 1.65 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.643 1.577 . . . . 0.0 108.2 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.89 -86.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 127.739 2.59 . . . . 0.0 113.675 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.46 9.44 2.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 m -42.69 -53.6 4.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.829 1.652 . . . . 0.0 114.182 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -39.23 78.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.24 1.382 . . . . 0.0 112.249 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -50.59 72.81 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.9 -30.42 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 109.94 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.13 89.15 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -78.84 -35.62 43.67 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.04 -57.22 9.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 112.194 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.04 -41.07 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.63 77.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.038 0.935 . . . . 0.0 110.024 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.99 -38.5 91.4 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.211 1.004 . . . . 0.0 109.445 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.96 -49.35 76.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -8.07 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-O 118.132 -1.371 . . . . 0.0 113.269 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -61.1 156.33 18.36 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.123 1.961 . . . . 0.0 109.93 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -68.48 0.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 m -158.76 171.28 20.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.155 0.982 . . . . 0.0 109.068 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.72 164.24 36.61 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 125.45 26.59 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.87 109.58 20.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.36 92.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.02 133.5 14.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.98 2.112 . . . . 0.0 107.015 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 89.85 -5.07 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.636 3.174 . . . . 0.0 112.375 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 65.44 -164.54 37.51 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -88.89 -14.09 37.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.656 -1.164 . . . . 0.0 114.047 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.23 -2.63 14.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.362 0.983 . . . . 0.0 113.61 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.4 176.29 19.1 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.131 -0.981 . . . . 0.0 113.304 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.22 -25.48 56.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.316 3.344 . . . . 0.0 115.248 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -134.8 28.5 3.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.762 2.025 . . . . 0.0 110.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.19 -171.76 5.21 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.456 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 36.4 t-105 -47.2 -55.17 9.04 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.646 0.778 . . . . 0.0 112.613 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.14 -50.77 71.83 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.044 0.937 . . . . 0.0 110.29 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.11 24.96 0.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.802 1.241 . . . . 0.0 113.468 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.3 m -129.37 12.26 5.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.599 1.96 . . . . 0.0 110.823 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.46 18.29 11.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.398 1.479 . . . . 0.0 112.976 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.44 149.96 62.49 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.62 154.68 49.78 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.35 2.033 . . . . 0.0 109.856 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.425 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 50.6 t-105 -155.15 157.33 37.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.263 0.483 . . . . 0.0 110.385 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.4 mt -107.83 88.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.184 1.394 . . . . 0.0 110.45 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.42 156.22 91.81 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.984 0.913 . . . . 0.0 109.365 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.75 -173.58 1.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.147 3.232 . . . . 0.0 109.124 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -68.82 103.53 1.8 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.768 0.794 . . . . 0.0 109.091 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -78.12 162.47 26.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.2 m -130.25 149.89 51.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -72.5 110.33 6.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.06 105.44 0.25 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.53 165.19 31.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.634 2.223 . . . . 0.0 109.622 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.8 p -147.35 -1.56 0.63 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.5 t -80.1 -173.47 3.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.077 1.418 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 1 C-N-CA 132.001 4.62 . . . . 0.0 104.544 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.698 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.41 31.16 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 108.68 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -67.14 -26.44 66.67 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.439 1.496 . . . . 0.0 111.716 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.1 170.58 53.15 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.2 t -117.63 100.53 7.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.9 p -133.35 166.01 23.5 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 109.617 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.6 -120.77 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 118.64 -1.743 . . . . 0.0 115.438 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.02 146.05 52.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.018 1.327 . . . . 0.0 109.991 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.9 -50.41 66.41 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.135 1.774 . . . . 0.0 107.864 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -55.71 -49.58 72.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.634 0.652 . . . . 0.0 111.823 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -55.49 -43.99 76.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.145 0.43 . . . . 0.0 111.086 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.06 -34.19 72.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.258 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.49 -49.13 67.61 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.762 1.619 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -54.43 -45.2 72.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.579 0.751 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -58.25 -36.26 72.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.604 -1.188 . . . . 0.0 112.275 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.08 -25.68 65.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.72 1.6 . . . . 0.0 111.736 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -40.18 6.36 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 t -78.67 -4.28 48.24 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.751 0.776 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -126.51 -168.72 1.9 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.565 0.746 . . . . 0.0 109.12 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -141.66 -43.23 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.882 2.473 . . . . 0.0 106.554 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.37 63.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.476 0.71 . . . . 0.0 111.44 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.85 124.03 27.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -134.33 138.02 44.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.5 133.5 34.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.413 1.085 . . . . 0.0 108.552 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.58 112.47 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.593 1.557 . . . . 0.0 109.407 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -89.09 117.96 28.46 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.585 2.354 . . . . 0.0 109.15 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.1 pt -108.98 14.2 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -76.55 164.87 25.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 135.15 55.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 m -51.6 -32.54 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.849 1.26 . . . . 0.0 111.724 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.3 77.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.637 1.108 . . . . 0.0 111.622 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -62.62 -28.99 70.28 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.74 0.7 . . . . 0.0 109.804 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -62.43 -13.67 32.42 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.873 -1.142 . . . . 0.0 111.313 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -107.78 -35.87 6.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.385 1.074 . . . . 0.0 110.467 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -85.61 -28.8 24.56 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.74 -22.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.424 1.011 . . . . 0.0 110.346 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.06 -159.6 17.2 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 121.64 -0.662 . . . . 0.0 112.722 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -140.01 161.39 56.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.611 0.764 . . . . 0.0 111.285 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.09 155.69 47.34 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.73 1.62 . . . . 0.0 110.51 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.602 HD22 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -127.39 86.86 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.494 1.918 . . . . 0.0 108.934 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 pt -85.18 6.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.962 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -51.92 -34.65 42.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.459 1.503 . . . . 0.0 112.257 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.57 -6.97 9.46 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.796 1.634 . . . . 0.0 114.173 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 mt -105.15 -23.33 12.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.571 1.548 . . . . 0.0 109.086 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.41 5.73 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 127.939 2.685 . . . . 0.0 109.883 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -124.37 168.5 12.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.849 0.824 . . . . 0.0 110.831 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 48' ' ' ALA . 6.7 tptt -135.84 120.16 17.93 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.613 1.165 . . . . 0.0 108.296 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . -66.75 174.77 2.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.84 0.829 . . . . 0.0 112.387 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.46 149.83 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.131 -2.914 . . . . 0.0 103.131 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -133.95 113.74 12.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.085 1.354 . . . . 0.0 111.315 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.9 m -158.26 113.75 2.68 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.78 121.32 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 112.773 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.89 156.4 32.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.1 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -166.88 161.27 15.12 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 129.33 3.052 . . . . 0.0 106.141 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.32 62.22 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.558 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.7 -42.57 77.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.352 1.061 . . . . 0.0 110.223 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.32 38.82 2.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.661 1.984 . . . . 0.0 112.841 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -46.83 -50.55 43.5 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 120.737 1.608 . . . . 0.0 109.882 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.9 -40.01 13.16 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.727 1.618 . . . . 0.0 111.959 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.88 -53.19 46.12 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 125.394 1.473 . . . . 0.0 109.644 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -55.93 -50.35 70.97 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.202 2.201 . . . . 0.0 108.307 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -56.85 -46.89 81.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.184 0.593 . . . . 0.0 109.902 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -58.21 -42.88 87.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.097 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -56.94 -24.08 50.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.466 1.03 . . . . 0.0 111.984 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mt -96.26 -46.9 6.24 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.57 1.148 . . . . 0.0 108.894 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -64.02 -11.9 33.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.51 0.595 . . . . 0.0 112.139 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.79 -3.86 51.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.251 0.478 . . . . 0.0 110.297 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 -32.68 5.88 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.5 1.92 . . . . 0.0 112.425 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.41 127.46 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.635 1.174 . . . . 0.0 111.503 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.29 -41.36 66.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -135.99 89.61 20.27 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 119.677 1.126 . . . . 0.0 111.027 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.58 -31.42 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.702 1.601 . . . . 0.0 112.414 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.1 -10.86 6.93 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.075 0.95 . . . . 0.0 112.706 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -130.84 23.61 4.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.434 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.8 m -134.06 120.93 20.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.84 1.2 . . . . 0.0 110.603 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -83.7 132.26 34.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.288 1.435 . . . . 0.0 110.605 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.7 mt -108.19 103.47 12.67 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.001 0.92 . . . . 0.0 112.154 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 65.7 m-85 -82.86 100.68 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.1 134.2 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.951 0.901 . . . . 0.0 110.127 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.79 135.94 38.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.063 0.945 . . . . 0.0 109.141 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -130.4 176.19 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 128.693 2.797 . . . . 0.0 108.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.69 -35.61 78.5 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.546 -1.347 . . . . 0.0 109.628 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.58 -151.64 0.39 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.598 1.959 . . . . 0.0 106.808 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.51 -45.68 89.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.61 -108.93 0.22 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 128.2 2.81 . . . . 0.0 114.66 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -118.6 2.15 11.72 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.596 1.159 . . . . 0.0 112.829 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 m -35.29 -57.14 0.6 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.978 2.111 . . . . 0.0 114.717 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.59 -38.07 89.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -31.44 63.19 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.601 0.715 . . . . 0.0 110.074 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.75 -31.29 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.15 93.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.386 0.674 . . . . 0.0 109.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.59 -44.61 73.98 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.91 0.484 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.57 -57.24 10.62 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.298 1.039 . . . . 0.0 112.648 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.21 -40.28 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.54 68.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.72 0.808 . . . . 0.0 109.902 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.36 -23.34 67.26 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.804 0.842 . . . . 0.0 112.623 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -82.01 -19.52 40.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.42 -4.18 5.88 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-O 117.406 -1.775 . . . . 0.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -65.38 140.75 58.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 120.61 2.205 . . . . 0.0 108.224 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.617 ' HG3' ' HG ' ' A' ' 101' ' ' SER . 20.3 tptt -47.77 -61.01 2.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.617 ' HG ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 p -157.29 166.57 32.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.28 151.39 31.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.408 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 24.8 m-85 -141.19 135.5 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 107.748 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.34 118.95 38.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.707 2.003 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.07 110.66 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -66.89 149.07 51.12 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 66.76 8.96 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.312 1.845 . . . . 0.0 113.833 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.71 -104.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.813 0 C-N-CA 127.057 2.265 . . . . 0.0 114.244 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.6 -45.5 0.67 Allowed 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.901 1.28 . . . . 0.0 111.948 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.0 -2.02 31.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.735 0.647 . . . . 0.0 112.089 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.33 174.53 53.46 Favored Glycine 0 CA--C 1.54 1.648 0 O-C-N 121.035 -1.04 . . . . 0.0 112.059 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.36 -23.69 75.36 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.559 3.506 . . . . 0.0 115.542 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -131.79 14.84 4.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.51 1.124 . . . . 0.0 110.57 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.4 165.91 30.99 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -27.7 -56.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.198 2.599 . . . . 0.0 114.697 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.71 -63.19 1.28 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.117 0.967 . . . . 0.0 109.159 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -69.07 7.21 0.75 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.741 1.616 . . . . 0.0 112.718 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.7 t -100.53 6.87 44.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.32 1.448 . . . . 0.0 109.877 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t 66.78 49.22 1.25 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.147 1.34 . . . . 0.0 108.657 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.7 mt -128.67 155.57 78.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 125.084 1.354 . . . . 0.0 109.123 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.62 168.72 23.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.645 2.23 . . . . 0.0 110.989 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.602 ' N ' HD22 ' A' ' 40' ' ' ASN . 34.0 t-105 -171.83 126.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.182 -1.574 . . . . 0.0 110.816 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.444 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.8 mt -68.66 88.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.324 1.85 . . . . 0.0 110.716 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.24 155.11 69.65 Favored Pre-proline 0 C--O 1.24 0.603 0 O-C-N 121.103 -0.998 . . . . 0.0 110.309 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.72 -175.2 2.34 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.51 3.473 . . . . 0.0 110.72 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -76.22 90.09 3.13 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -60.23 149.8 32.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.058 0.844 . . . . 0.0 109.131 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.6 t -127.42 177.5 6.7 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.517 1.127 . . . . 0.0 109.641 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -66.85 171.28 5.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.021 1.328 . . . . 0.0 109.563 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.13 73.29 1.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.58 177.84 6.36 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.449 2.099 . . . . 0.0 110.62 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.8 p -125.86 161.03 28.35 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 108.598 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.9 p -66.57 169.19 8.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.371 0.668 . . . . 0.0 111.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.745 -1.03 . . . . 0.0 111.296 179.524 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -122.1 -55.57 1.87 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.046 0.938 . . . . 0.0 109.218 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m 57.75 30.57 19.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.388 0.54 . . . . 0.0 111.544 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.91 73.89 0.02 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.656 1.598 . . . . 0.0 109.771 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -84.27 86.38 7.25 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.281 -1.129 . . . . 0.0 109.769 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -113.47 151.77 31.01 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.1 0.56 . . . . 0.0 111.533 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.4 -101.65 0.23 Allowed Glycine 0 C--N 1.338 0.67 0 O-C-N 121.491 -0.755 . . . . 0.0 111.941 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.3 m -160.11 164.94 32.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.054 2.542 . . . . 0.0 106.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.5 95.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.654 -0.654 . . . . 0.0 112.554 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -55.26 -48.81 73.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.006 0.821 . . . . 0.0 110.684 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -55.59 -50.1 71.01 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.379 0.671 . . . . 0.0 109.419 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.75 81.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.101 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -59.42 -43.37 93.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.777 1.171 . . . . 0.0 110.561 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.6 m -58.91 -45.02 91.3 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.235 -0.915 . . . . 0.0 109.425 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -65.04 -42.16 94.55 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.946 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.3 mt -57.28 -41.88 80.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.108 0.867 . . . . 0.0 109.548 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.67 -14.31 77.92 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-O 118.186 -1.341 . . . . 0.0 115.32 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 t -115.25 -13.12 11.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.05 1.425 . . . . 0.0 112.02 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -113.3 99.78 8.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.84 -25.86 43.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.572 1.149 . . . . 0.0 112.9 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -89.37 -3.96 58.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.543 0.737 . . . . 0.0 112.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.05 149.84 24.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.528 1.058 . . . . 0.0 110.092 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -145.96 174.09 11.57 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.39 144.42 40.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.436 0.695 . . . . 0.0 110.144 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 tp -121.35 108.73 14.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.666 2.387 . . . . 0.0 112.541 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -86.5 109.82 19.34 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.476 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.07 2.25 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -42.19 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.72 130.02 3.68 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -44.59 -34.33 2.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.906 2.082 . . . . 0.0 114.726 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.78 -34.29 45.68 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 120.359 1.436 . . . . 0.0 110.781 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.08 -29.33 69.68 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.34 -20.69 65.73 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 119.628 -1.92 . . . . 0.0 112.168 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -91.92 -19.93 21.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.573 1.549 . . . . 0.0 109.474 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.5 -62.86 1.18 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.16 1.384 . . . . 0.0 112.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.02 -38.53 12.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 123.964 0.906 . . . . 0.0 111.136 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.69 -151.76 17.27 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 118.886 0.766 . . . . 0.0 113.618 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.56 154.6 60.04 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.801 1.64 . . . . 0.0 108.036 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.75 172.65 14.77 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 121.551 1.501 . . . . 0.0 109.774 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.19 113.15 12.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.624 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.4 pt -103.27 14.47 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.631 1.205 . . . . 0.0 110.933 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.02 -17.29 51.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.548 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.65 -6.82 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 120.276 1.398 . . . . 0.0 111.335 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.3 mt -112.5 -22.72 10.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.703 2.801 . . . . 0.0 109.376 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.93 25.66 14.29 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.614 2.054 . . . . 0.0 109.667 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -116.63 178.92 4.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.512 1.925 . . . . 0.0 111.695 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.98 138.77 17.95 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.08 170.81 16.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.2 1.0 . . . . 0.0 112.421 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.0 133.75 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.956 2.102 . . . . 0.0 106.159 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -106.63 122.62 46.7 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.983 0.913 . . . . 0.0 111.611 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.488 ' CG2' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -152.13 102.96 2.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.866 1.266 . . . . 0.0 109.503 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.71 127.36 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 120.321 -1.487 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -81.37 151.81 27.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -157.84 131.29 7.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.475 1.11 . . . . 0.0 108.563 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.84 66.56 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -86.67 -0.5 56.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.801 1.3 . . . . 0.0 111.833 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.62 25.58 5.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.64 0.776 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -48.36 -57.14 11.44 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.676 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.28 -41.05 13.32 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.346 1.364 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -22.53 63.8 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.693 0.663 . . . . 0.0 113.78 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -83.29 -47.23 11.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.439 1.496 . . . . 0.0 107.585 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 mt -55.78 -46.83 77.85 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.214 1.405 . . . . 0.0 110.801 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -45.24 66.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.685 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HE3' ' CG2' ' A' ' 51' ' ' THR . 40.9 mtmt -62.32 -20.03 63.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.67 -46.24 6.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 t -60.74 -21.25 62.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.23 -2.79 56.28 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 -27.79 7.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.979 0.911 . . . . 0.0 112.308 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.8 114.18 25.8 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 108.268 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -66.21 -31.82 72.88 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.49 1.116 . . . . 0.0 111.287 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.49 77.48 34.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.15 -40.75 74.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.091 1.861 . . . . 0.0 112.919 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.97 -6.11 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -125.94 -4.04 6.98 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.782 0.719 . . . . 0.0 111.463 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.4 m -96.39 124.37 40.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 110.488 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.8 m -89.68 132.87 34.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.66 98.73 7.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 29.6 m-85 -78.33 113.99 16.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.127 -0.94 . . . . 0.0 108.478 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -81.93 134.55 26.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 120.228 1.376 . . . . 0.0 111.722 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 tp -129.88 113.29 14.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.35 1.46 . . . . 0.0 109.254 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -119.36 -177.27 3.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.691 1.596 . . . . 0.0 108.682 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -61.23 -54.48 43.67 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.356 -0.84 . . . . 0.0 110.121 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -139.1 -168.9 2.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.871 2.869 . . . . 0.0 106.34 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.68 -58.51 0.5 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.898 2.479 . . . . 0.0 112.689 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.02 -109.03 0.57 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.639 1.59 . . . . 0.0 114.835 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -134.55 10.04 3.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.194 2.198 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.7 m -44.13 -42.1 6.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.692 1.597 . . . . 0.0 113.157 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -64.01 -44.23 93.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.501 0.72 . . . . 0.0 111.284 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.61 -45.45 86.85 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.72 -28.6 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.094 0.958 . . . . 0.0 109.471 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.32 -44.8 82.37 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.916 0.78 . . . . 0.0 110.218 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.15 -39.35 60.45 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.1 -56.65 5.33 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.351 1.46 . . . . 0.0 111.798 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.56 -39.43 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.608 0.763 . . . . 0.0 111.19 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.57 -52.85 63.72 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.63 0.772 . . . . 0.0 109.093 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.84 -20.18 65.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.053 1.741 . . . . 0.0 111.656 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.58 -15.43 32.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.178 1.391 . . . . 0.0 114.025 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.14 -0.76 5.31 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.016 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -81.74 156.35 25.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.9 1.85 . . . . 0.0 109.196 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -54.54 -69.45 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.077 0.951 . . . . 0.0 112.128 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.3 m -161.31 177.93 9.69 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.694 2.398 . . . . 0.0 107.008 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.15 163.93 39.01 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 126.103 1.761 . . . . 0.0 107.253 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 28.5 m-85 -136.21 145.45 45.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 107.891 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.15 118.43 35.33 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.846 1.259 . . . . 0.0 108.713 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.13 113.16 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -63.12 143.46 57.77 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 70.69 2.82 4.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.304 1.442 . . . . 0.0 112.983 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.69 -110.64 0.86 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 126.922 2.201 . . . . 0.0 114.639 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.44 -21.99 5.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.069 1.348 . . . . 0.0 114.36 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -110.01 -10.56 14.7 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.03 -173.47 47.62 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 119.579 1.081 . . . . 0.0 114.145 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.46 -36.32 93.92 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.116 3.211 . . . . 0.0 114.281 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.7 mmt-85 -111.32 11.1 21.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.491 1.116 . . . . 0.0 110.769 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.68 156.77 46.09 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -36.22 -54.54 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 114.538 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.29 -39.4 86.78 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -86.99 -8.56 57.08 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.013 0.925 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.8 t -82.63 6.59 17.29 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.264 1.026 . . . . 0.0 111.028 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m 54.72 57.08 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.993 1.717 . . . . 0.0 108.558 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 98.0 mt -121.67 154.58 60.2 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 126.844 2.058 . . . . 0.0 105.919 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.89 166.1 29.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.9 1.734 . . . . 0.0 110.159 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -159.94 143.09 13.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.847 1.203 . . . . 0.0 111.928 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 mt -95.2 98.07 7.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 0.0 110.173 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.33 141.13 42.33 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.6 158.34 50.97 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.538 2.159 . . . . 0.0 106.584 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -75.15 35.44 0.11 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.462 -1.399 . . . . 0.0 113.065 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -15.25 50.46 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p -68.33 162.15 25.86 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 121.467 1.94 . . . . 0.0 110.168 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 m -148.9 117.82 6.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.843 2.057 . . . . 0.0 105.477 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.57 166.45 40.12 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.345 0.974 . . . . 0.0 111.61 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.29 -50.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.963 2.442 . . . . 0.0 113.059 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 m -53.94 113.61 1.28 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.854 2.062 . . . . 0.0 112.088 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 m -68.24 -14.91 63.33 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.529 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -67.53 172.21 5.32 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.306 0.553 . . . . 0.0 110.992 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -84.7 40.35 0.79 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.119 0.968 . . . . 0.0 108.827 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.64 -170.46 23.06 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.45 1.976 . . . . 0.0 112.657 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.0 m -63.13 93.35 0.06 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.802 2.441 . . . . 0.0 114.876 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -75.25 159.56 31.39 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 120.887 -1.133 . . . . 0.0 108.889 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.77 98.38 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -51.85 158.61 0.98 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.0 110.434 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.67 -49.77 46.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.684 0.674 . . . . 0.0 111.701 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG3' ' HG ' ' A' ' 118' ' ' SER . 33.4 mtmt -58.37 -48.36 80.85 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.759 -0.588 . . . . 0.0 110.785 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -52.73 63.86 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.24 64.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.53 1.132 . . . . 0.0 110.3 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.0 -41.86 93.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.209 0.603 . . . . 0.0 111.698 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -61.77 -51.63 67.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -62.93 -36.12 82.36 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.769 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.98 -30.59 69.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.088 1.313 . . . . 0.0 108.195 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.48 -24.84 74.09 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 125.266 1.413 . . . . 0.0 113.94 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -100.57 -24.16 14.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.301 1.551 . . . . 0.0 109.923 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.34 170.24 15.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.493 0.588 . . . . 0.0 110.329 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -119.36 -32.76 4.28 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.083 0.953 . . . . 0.0 111.475 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -101.83 -11.76 18.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.45 -0.781 . . . . 0.0 112.832 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.22 58.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.612 0.642 . . . . 0.0 112.466 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -140.02 166.55 24.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.93 125.16 42.7 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.628 1.571 . . . . 0.0 107.419 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.5 97.6 7.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.771 1.628 . . . . 0.0 108.574 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.87 106.2 8.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.1 1.41 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 122.953 0.501 . . . . 0.0 111.738 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -59.19 168.04 1.55 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 126.91 2.084 . . . . 0.0 112.393 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.35 135.97 35.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 m -41.71 -41.22 2.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.187 2.195 . . . . 0.0 114.249 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.34 92.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.621 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -58.86 -29.08 66.7 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.0 -19.27 51.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.091 0.859 . . . . 0.0 109.23 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -104.33 -33.69 8.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.779 2.432 . . . . 0.0 111.916 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -77.91 -44.01 28.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.232 1.013 . . . . 0.0 111.618 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.68 -25.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.492 1.117 . . . . 0.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.52 -163.27 13.55 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.199 0.909 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -143.06 162.97 40.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 122.958 0.503 . . . . 0.0 111.121 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.72 146.46 33.94 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.545 1.497 . . . . 0.0 112.94 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.493 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -108.69 76.25 1.01 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.812 2.445 . . . . 0.0 109.659 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 pt -85.57 5.23 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.651 0.739 . . . . 0.0 110.817 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -53.09 -34.51 56.93 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.889 1.676 . . . . 0.0 114.368 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.63 -30.65 69.22 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.061 1.3 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.62 -21.01 49.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.745 0.818 . . . . 0.0 110.129 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 38.18 5.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -126.56 171.03 11.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.822 1.249 . . . . 0.0 111.029 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -143.86 137.73 28.14 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.899 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.14 167.08 22.51 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.2 94.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -62.32 119.87 9.9 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 m -152.26 95.64 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.966 1.307 . . . . 0.0 108.884 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -61.78 122.76 13.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -75.64 154.23 36.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.693 0.397 . . . . 0.0 109.984 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -148.98 127.27 12.16 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.92 -13.3 82.64 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.57 -41.31 10.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.55 1.175 . . . . 0.0 108.15 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.71 29.03 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.744 1.618 . . . . 0.0 111.852 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -43.2 -53.84 10.3 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 120.971 -1.081 . . . . 0.0 111.137 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.09 -49.66 4.64 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.997 1.798 . . . . 0.0 112.136 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -29.47 71.92 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.763 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -69.56 -48.36 60.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.062 1.745 . . . . 0.0 108.657 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.4 -41.59 66.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.321 1.049 . . . . 0.0 111.854 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -59.12 -33.18 70.57 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.572 -0.705 . . . . 0.0 111.741 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -60.03 -16.46 31.15 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.663 0.785 . . . . 0.0 111.92 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.3 -37.58 8.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.349 1.46 . . . . 0.0 109.731 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -25.18 65.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.637 1.562 . . . . 0.0 111.498 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.67 -6.04 41.61 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.585 -0.697 . . . . 0.0 112.03 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 -49.69 2.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.209 1.003 . . . . 0.0 108.455 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -77.83 103.7 7.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 108.964 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.66 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.756 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -134.45 69.93 72.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.635 1.974 . . . . 0.0 112.861 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 -24.15 64.48 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.989 3.793 . . . . 0.0 111.919 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -53.87 -18.43 3.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 130.792 3.637 . . . . 0.0 113.057 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -134.31 -4.51 2.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.564 1.546 . . . . 0.0 111.689 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 m -76.03 121.79 23.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.607 1.094 . . . . 0.0 110.834 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -89.58 122.77 33.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 72.2 m-85 -79.16 105.47 10.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 mt -83.56 129.15 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 119.235 0.925 . . . . 0.0 110.959 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -125.56 125.8 43.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.562 1.145 . . . . 0.0 108.319 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -128.17 177.36 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.961 2.105 . . . . 0.0 107.537 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -58.87 -52.59 65.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.692 -1.255 . . . . 0.0 109.378 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.31 178.77 7.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.691 3.196 . . . . 0.0 104.848 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -24.45 -57.33 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 130.399 3.48 . . . . 0.0 112.979 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.94 -104.33 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.906 2.193 . . . . 0.0 115.499 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -125.13 14.0 8.39 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.899 1.28 . . . . 0.0 112.82 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -51.96 -39.11 58.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.957 1.708 . . . . 0.0 112.068 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.55 -43.59 69.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.194 0.907 . . . . 0.0 110.362 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.27 -49.58 77.03 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.705 0.802 . . . . 0.0 109.733 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.97 -33.91 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.113 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.95 95.58 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.232 0.924 . . . . 0.0 109.34 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -69.02 -47.48 65.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.4 -62.05 1.69 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.941 1.696 . . . . 0.0 113.96 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 m -63.04 -39.02 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 122.584 0.354 . . . . 0.0 111.382 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.89 70.94 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.938 0.774 . . . . 0.0 110.196 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.26 -42.62 99.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.599 0.562 . . . . 0.0 109.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.86 -45.25 95.28 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 -14.97 0.06 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.313 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -71.93 156.04 39.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.217 1.509 . . . . 0.0 108.234 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -58.57 -66.86 0.42 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.879 0.871 . . . . 0.0 111.557 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -159.0 170.6 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.915 1.286 . . . . 0.0 107.584 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.33 163.75 35.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.416 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 42.9 m-85 -133.94 123.37 24.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.79 104.78 15.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.058 0.943 . . . . 0.0 108.856 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.52 109.44 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -59.99 146.45 42.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.43 2.44 1.57 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.503 1.521 . . . . 0.0 114.797 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.31 -111.71 2.21 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.733 1.159 . . . . 0.0 112.297 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.25 -28.52 2.34 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.53 -19.14 26.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.64 163.74 50.11 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 121.042 -1.036 . . . . 0.0 111.492 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.63 -24.96 47.85 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.575 3.517 . . . . 0.0 115.415 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 0.62 24.24 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.048 1.339 . . . . 0.0 110.815 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.92 163.56 54.91 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.663 1.125 . . . . 0.0 111.403 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -29.84 -66.59 0.09 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.57 2.348 . . . . 0.0 115.293 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.1 mt -50.64 -60.93 2.53 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.923 1.289 . . . . 0.0 110.735 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -69.12 -7.45 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.563 1.545 . . . . 0.0 113.806 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.486 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 11.0 t -88.75 8.14 30.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.551 -1.343 . . . . 0.0 111.203 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 t 69.13 47.32 0.74 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.19 157.28 58.73 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.088 1.355 . . . . 0.0 109.22 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' C ' HD22 ' A' ' 40' ' ' ASN . 30.0 Cg_endo -78.08 165.76 25.65 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.404 2.736 . . . . 0.0 109.479 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -168.37 133.75 1.78 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.804 -1.185 . . . . 0.0 112.463 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.463 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 2.3 mt -74.92 86.94 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.992 1.317 . . . . 0.0 110.439 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 150.52 75.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.679 -0.638 . . . . 0.0 110.535 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -84.46 -172.89 1.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.313 4.009 . . . . 0.0 109.922 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.45 165.59 1.07 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.212 1.005 . . . . 0.0 111.048 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.63 161.69 24.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.54 1.136 . . . . 0.0 109.364 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.54 173.22 11.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.1 p -128.66 80.47 1.97 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.936 1.294 . . . . 0.0 110.076 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.42 -177.18 19.08 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 127.485 2.469 . . . . 0.0 107.657 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.71 154.85 44.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.197 1.932 . . . . 0.0 109.551 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.8 m -115.73 -35.45 4.51 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.389 1.076 . . . . 0.0 109.967 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.0 t -139.37 155.55 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.697 1.999 . . . . 0.0 108.834 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -179.243 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.987 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.1 m -142.97 148.38 36.73 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.645 1.578 . . . . 0.0 108.597 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 t -153.84 159.17 41.74 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.62 -102.19 0.13 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.379 1.466 . . . . 0.0 110.558 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.1 m -151.98 55.65 0.83 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.504 1.522 . . . . 0.0 108.381 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 p -65.55 158.16 27.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.142 0.977 . . . . 0.0 110.915 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.55 -114.71 0.3 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -178.0 169.78 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 131.157 3.783 . . . . 0.0 106.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.69 -51.36 70.27 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.528 0.731 . . . . 0.0 112.451 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -52.31 -53.83 39.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.343 0.52 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -53.7 -51.07 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.935 0.494 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.88 94.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.047 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -56.94 -44.23 82.28 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.783 1.174 . . . . 0.0 110.293 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -63.28 -53.36 54.16 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -56.65 -43.06 79.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.481 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.85 -40.95 85.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.981 2.113 . . . . 0.0 107.937 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.9 -20.42 79.47 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.717 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -106.94 -10.36 16.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.606 1.703 . . . . 0.0 112.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.23 135.27 34.59 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -32.99 37.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -97.61 -13.43 21.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 149.43 26.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -150.0 164.45 35.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 108.309 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -106.04 133.4 50.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.593 1.557 . . . . 0.0 108.299 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.0 tp -122.26 104.8 9.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.903 1.681 . . . . 0.0 110.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.61 111.98 12.68 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.182 1.793 . . . . 0.0 106.978 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.89 3.33 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 118.698 0.681 . . . . 0.0 112.093 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -62.54 167.04 4.66 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.493 1.917 . . . . 0.0 112.58 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.34 133.71 37.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 108.519 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.03 -29.27 0.33 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.151 2.58 . . . . 0.0 115.609 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.95 63.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.596 -1.315 . . . . 0.0 110.528 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.52 -27.74 69.47 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.756 -1.215 . . . . 0.0 112.358 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -62.55 -21.07 65.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.886 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -91.75 -35.2 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.802 2.041 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.05 -58.15 3.44 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.935 1.694 . . . . 0.0 112.99 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.68 -19.3 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.99 -159.95 22.23 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.611 1.096 . . . . 0.0 111.808 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 39.0 p -142.03 161.6 50.2 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.88 -0.776 . . . . 0.0 112.088 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.67 158.15 54.09 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.03 1.153 . . . . 0.0 111.094 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -125.19 74.75 1.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.15 1.78 . . . . 0.0 109.583 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.2 pt -74.97 2.87 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 121.763 -0.585 . . . . 0.0 109.545 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.95 -31.61 65.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.467 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.28 75.81 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.0 -35.9 69.6 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.896 1.279 . . . . 0.0 110.669 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.0 21.62 1.88 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.775 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -123.01 178.57 5.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.383 1.591 . . . . 0.0 111.204 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -137.86 131.55 31.2 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.474 -0.766 . . . . 0.0 110.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.38 168.11 16.73 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.769 0.795 . . . . 0.0 111.125 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.7 138.03 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 127.645 2.378 . . . . 0.0 104.646 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.4 p -117.91 124.37 48.1 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -152.55 102.9 2.76 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -54.61 117.74 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.793 0.837 . . . . 0.0 111.859 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -79.63 134.67 36.45 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.52 119.78 6.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -51.46 -20.65 5.53 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -71.12 -16.65 62.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.538 1.169 . . . . 0.0 112.569 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -133.4 29.31 3.96 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 117.317 -1.325 . . . . 0.0 114.335 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -38.79 -56.14 2.47 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 121.482 1.946 . . . . 0.0 111.532 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.87 -40.82 33.12 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.421 2.747 . . . . 0.0 111.451 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.53 58.64 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.112 1.815 . . . . 0.0 109.844 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.62 -54.24 46.57 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.555 1.942 . . . . 0.0 106.633 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.28 -45.75 62.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.974 0.909 . . . . 0.0 110.112 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.92 -37.45 87.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.042 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -61.12 -31.54 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.052 1.296 . . . . 0.0 108.484 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -43.32 18.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.044 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.31 64.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.188 1.358 . . . . 0.0 112.443 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.24 -9.8 59.71 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.687 1.13 . . . . 0.0 110.968 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.04 -43.11 4.26 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.037 1.335 . . . . 0.0 110.363 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -90.72 102.95 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -57.72 -33.26 68.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.478 0.311 . . . . 0.0 111.395 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -131.93 86.41 47.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 123.719 0.808 . . . . 0.0 110.992 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -66.72 -33.43 34.88 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.395 2.063 . . . . 0.0 112.086 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.22 -23.52 14.96 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.4 1.48 . . . . 0.0 114.623 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -117.28 -6.42 11.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.087 1.312 . . . . 0.0 110.661 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.4 m -94.07 121.6 35.73 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 112.889 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -91.47 131.86 36.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.41 1.084 . . . . 0.0 108.681 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.35 97.35 5.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 111.153 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.91 119.4 19.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.715 0.806 . . . . 0.0 109.084 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.1 mp -75.56 133.9 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 111.508 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.81 121.83 27.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.45 167.0 16.18 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 108.398 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -61.02 -39.55 90.18 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.988 -1.07 . . . . 0.0 109.411 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -131.92 -136.51 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.635 1.974 . . . . 0.0 106.919 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 106' ' ' LYS . 66.6 m-20 -83.93 -55.64 4.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.019 1.328 . . . . 0.0 108.723 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.66 -95.1 0.1 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.811 1.672 . . . . 0.0 113.203 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -145.82 10.79 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 128.097 2.559 . . . . 0.0 110.907 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.2 m -48.54 -40.56 27.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.248 1.419 . . . . 0.0 111.587 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.3 -30.49 71.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.702 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -83.47 -41.52 17.94 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.06 -34.75 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.9 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.983 1.313 . . . . 0.0 111.239 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -86.68 -44.28 11.95 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 108.979 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -48.79 -61.37 2.08 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 126.718 2.007 . . . . 0.0 112.771 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.14 -37.39 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.571 0.348 . . . . 0.0 111.744 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -53.47 54.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.853 0.721 . . . . 0.0 109.666 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.47 -20.47 65.61 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.483 1.113 . . . . 0.0 112.195 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -84.53 -35.34 22.93 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 111.58 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.42 -8.11 0.46 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.35 -1.805 . . . . 0.0 115.155 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -71.69 153.48 42.02 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 120.425 2.112 . . . . 0.0 109.484 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -56.62 -56.67 18.44 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 m -162.14 171.7 17.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -165.21 115.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.67 140.66 32.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.69 114.32 26.77 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.23 100.55 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 6.6 tmtm? -63.21 151.28 40.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 75.37 -1.58 3.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.945 2.098 . . . . 0.0 112.971 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.52 -140.24 48.06 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 119.703 1.138 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.62 -35.46 6.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.837 0.855 . . . . 0.0 111.188 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.2 -15.23 47.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.71 1.204 . . . . 0.0 113.358 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.7 166.32 27.25 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.64 -30.41 90.42 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.466 2.777 . . . . 0.0 113.454 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 20.8 tpt180 -110.63 14.26 22.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.354 1.862 . . . . 0.0 110.179 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.17 170.84 51.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -45.29 -58.68 3.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.6 mt -59.89 -38.22 81.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.557 0.343 . . . . 0.0 110.935 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -88.9 19.84 3.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 111.467 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.4 m -121.42 12.21 10.82 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.526 -1.359 . . . . 0.0 112.289 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.0 m 56.57 55.8 6.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.343 1.057 . . . . 0.0 108.503 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -121.74 150.93 56.55 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.469 ' C ' HD22 ' A' ' 40' ' ' ASN . 44.1 Cg_endo -70.31 158.9 54.81 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.634 1.556 . . . . 0.0 109.322 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.524 ' N ' HD22 ' A' ' 40' ' ' ASN . 37.8 t-105 -167.84 132.2 1.77 Allowed 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.388 -1.445 . . . . 0.0 110.749 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 8.8 mt -71.06 90.77 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.205 1.402 . . . . 0.0 108.443 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.63 151.01 60.92 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.18 -159.34 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.605 3.536 . . . . 0.0 107.712 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -124.04 97.97 5.58 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -130.72 156.77 44.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.105 2.162 . . . . 0.0 106.559 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 p -121.53 65.6 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.74 171.23 11.96 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.478 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.75 -157.04 7.39 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.589 1.09 . . . . 0.0 110.965 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.5 163.74 33.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.959 1.773 . . . . 0.0 111.808 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.3 m -122.8 178.85 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.414 1.885 . . . . 0.0 106.654 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.4 p -142.14 101.68 3.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.826 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 m -68.21 163.56 22.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.558 1.179 . . . . 0.0 108.614 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 t -151.78 152.96 33.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.4 158.59 37.88 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.01 147.78 30.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.144 1.472 . . . . 0.0 109.829 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.08 173.0 13.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.638 1.975 . . . . 0.0 107.16 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.03 -90.05 0.08 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.591 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.7 t -166.63 167.56 15.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.024 0.929 . . . . 0.0 109.855 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.85 -34.18 75.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -71.19 -49.95 38.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.69 -50.88 62.44 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.169 0.588 . . . . 0.0 110.271 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.82 74.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.067 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.96 -39.68 78.72 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.253 1.388 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -68.79 -46.53 68.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.693 0.797 . . . . 0.0 109.102 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.01 -39.16 93.91 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.032 -1.668 . . . . 0.0 110.97 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.08 -23.53 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.954 1.702 . . . . 0.0 109.551 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.94 -22.92 36.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 -13.1 24.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.588 1.194 . . . . 0.0 110.458 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -114.74 112.35 22.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.911 1.232 . . . . 0.0 110.718 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.55 -36.08 82.6 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.722 1.209 . . . . 0.0 112.653 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -84.18 -17.21 40.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.575 -0.703 . . . . 0.0 112.349 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.0 153.81 32.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.309 0.959 . . . . 0.0 112.513 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -150.25 162.26 40.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.201 1.401 . . . . 0.0 109.388 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.42 154.22 19.0 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 tp -134.41 103.87 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.207 1.403 . . . . 0.0 109.837 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.41 96.63 5.4 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.036 1.334 . . . . 0.0 108.629 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -87.82 -1.33 8.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.6 mtm-85 -69.46 162.57 27.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.969 0.804 . . . . 0.0 109.978 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.73 133.97 51.26 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.34 -22.11 1.03 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.632 1.973 . . . . 0.0 112.38 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.92 88.9 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.285 -1.509 . . . . 0.0 110.16 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -55.15 -40.75 70.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.495 1.518 . . . . 0.0 111.267 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -53.66 -30.13 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.394 1.077 . . . . 0.0 112.066 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -97.3 -20.89 17.56 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 126.549 1.94 . . . . 0.0 112.726 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -101.11 -60.37 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.49 -31.61 4.23 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.758 1.623 . . . . 0.0 111.559 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.35 -163.34 12.26 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.78 158.55 49.29 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.79 157.8 54.49 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.141 1.894 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.496 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -122.39 83.68 2.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.897 2.479 . . . . 0.0 111.961 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -79.58 -0.68 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.394 -1.441 . . . . 0.0 109.747 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -46.12 -40.7 11.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.429 2.692 . . . . 0.0 113.188 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.05 77.07 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.422 -0.654 . . . . 0.0 113.044 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.4 mt -77.57 -40.85 40.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.56 1.03 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.909 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -126.02 -179.1 4.54 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.094 1.447 . . . . 0.0 111.927 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -133.23 144.11 49.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.177 1.391 . . . . 0.0 109.15 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 167.18 14.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 111.98 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -140.54 93.59 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -76.87 102.74 6.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.879 2.072 . . . . 0.0 112.393 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -141.54 98.82 3.43 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.53 125.89 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.221 0.919 . . . . 0.0 110.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -76.02 152.35 36.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.857 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -155.77 116.5 3.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.55 -24.11 61.44 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.539 -0.59 . . . . 0.0 112.192 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.89 -7.01 59.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.035 1.417 . . . . 0.0 110.159 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -126.22 28.95 5.92 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.333 1.453 . . . . 0.0 112.577 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -45.57 -52.38 23.67 Favored Pre-proline 0 N--CA 1.474 0.765 0 O-C-N 120.553 -1.342 . . . . 0.0 112.138 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.78 -44.61 16.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.446 2.097 . . . . 0.0 112.434 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.26 -44.07 96.76 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.71 -54.16 46.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.981 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.93 -43.72 66.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.991 1.716 . . . . 0.0 111.504 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -54.79 -50.56 68.21 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 109.544 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.29 -29.15 57.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -80.6 -51.79 8.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 t -56.36 -23.32 36.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.333 1.453 . . . . 0.0 110.624 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.84 -2.87 43.15 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 -42.52 3.13 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.39 114.4 21.86 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -30.37 71.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.35 70.14 82.22 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.092 1.757 . . . . 0.0 109.312 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.88 -43.11 52.01 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.381 2.054 . . . . 0.0 111.972 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -62.65 -3.53 1.55 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.301 1.441 . . . . 0.0 113.617 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -127.36 -18.04 4.56 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 111.586 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -90.93 104.76 17.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.401 1.48 . . . . 0.0 111.39 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.2 m -71.72 137.73 47.97 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.852 -1.155 . . . . 0.0 109.679 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -102.72 99.99 10.0 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.202 1.401 . . . . 0.0 113.839 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.98 99.78 8.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mt -79.41 133.58 29.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 123.922 0.889 . . . . 0.0 109.622 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.66 121.22 26.56 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.762 0.825 . . . . 0.0 112.391 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.77 172.3 7.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.069 2.548 . . . . 0.0 107.62 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.25 84.53 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 119.888 -1.757 . . . . 0.0 112.599 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -146.39 -173.22 4.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 130.094 3.358 . . . . 0.0 104.099 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.32 -55.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.641 2.776 . . . . 0.0 113.397 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.96 -101.51 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 128.288 2.851 . . . . 0.0 115.582 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -144.04 -0.21 1.03 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.17 1.388 . . . . 0.0 113.336 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 p -44.62 -44.71 9.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.741 1.155 . . . . 0.0 113.667 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -60.05 -40.34 89.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.782 0.719 . . . . 0.0 112.597 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -71.59 -49.69 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.939 1.696 . . . . 0.0 108.911 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.53 -33.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.231 1.013 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.9 70.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.408 0.549 . . . . 0.0 111.94 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.65 -42.76 13.17 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.363 0.983 . . . . 0.0 108.405 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.8 tp -49.95 -59.34 3.96 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.938 1.695 . . . . 0.0 112.332 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.3 -37.64 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.975 -0.453 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.68 68.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.384 0.674 . . . . 0.0 109.532 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.07 -28.93 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.55 0.74 . . . . 0.0 110.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.82 -33.63 70.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.541 0.61 . . . . 0.0 110.039 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.7 -13.52 0.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.242 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -60.24 146.48 43.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.219 1.509 . . . . 0.0 111.094 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -47.3 -60.19 2.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.701 2.001 . . . . 0.0 112.929 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -167.09 174.75 8.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 126.768 2.027 . . . . 0.0 105.686 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 152.98 36.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -135.62 111.22 9.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.415 0.686 . . . . 0.0 111.26 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.84 133.78 38.1 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 103.24 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -58.09 137.55 56.82 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 36.3 m-20 71.48 15.62 6.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.24 2.216 . . . . 0.0 112.933 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.72 -144.06 7.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.132 1.348 . . . . 0.0 114.913 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.67 -26.51 15.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.52 -1.45 12.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.98 -178.68 8.53 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.75 1.159 . . . . 0.0 114.078 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -29.92 43.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.333 3.355 . . . . 0.0 114.378 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -132.12 12.45 4.68 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.26 1.424 . . . . 0.0 110.296 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.85 174.35 3.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -31.56 -60.87 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.187 1.795 . . . . 0.0 114.327 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.18 -50.93 71.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.507 0.723 . . . . 0.0 111.049 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.92 3.3 5.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.067 1.747 . . . . 0.0 113.772 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.96 13.85 28.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 111.316 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 60.01 46.0 11.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.627 1.171 . . . . 0.0 110.306 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.09 151.18 45.39 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.496 ' C ' HD22 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -73.44 163.96 36.32 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.928 1.752 . . . . 0.0 110.221 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -161.65 128.13 3.81 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.66 -1.275 . . . . 0.0 111.792 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 1.8 mt -73.39 87.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.466 1.906 . . . . 0.0 111.489 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.46 146.0 46.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.864 0.865 . . . . 0.0 110.387 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.27 163.32 27.7 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.649 2.233 . . . . 0.0 108.468 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.37 76.53 2.45 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.501 -0.75 . . . . 0.0 109.636 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -149.23 104.68 3.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -64.03 149.07 48.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.577 0.751 . . . . 0.0 110.332 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -125.77 166.7 16.33 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.19 78.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.87 174.36 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.123 2.549 . . . . 0.0 112.281 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.8 p -150.62 25.32 0.77 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.653 1.181 . . . . 0.0 111.334 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.4 p -109.16 83.63 1.79 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.481 1.913 . . . . 0.0 109.249 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.442 0 CA-C-O 117.335 -1.814 . . . . 0.0 109.002 -179.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.579 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 m -98.72 -0.72 42.21 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -154.76 1.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.616 1.553 . . . . 0.0 114.077 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.79 175.59 41.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -147.88 125.05 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -128.11 -173.68 3.01 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.93 -112.56 0.43 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.454 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 m -152.35 150.33 29.6 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.574 1.55 . . . . 0.0 107.319 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.89 66.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.753 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.509 ' HG3' ' HG ' ' A' ' 118' ' ' SER . 22.7 mtmt -51.87 -43.71 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.068 -1.645 . . . . 0.0 113.182 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -53.28 54.76 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.27 71.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.444 0.465 . . . . 0.0 111.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.47 -51.57 42.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.805 1.242 . . . . 0.0 109.087 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -56.57 -40.84 75.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.521 0.601 . . . . 0.0 109.978 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -60.42 -44.18 96.02 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.36 -27.61 64.35 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.192 1.36 . . . . 0.0 109.576 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 -2.13 82.61 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.87 1.7 . . . . 0.0 114.171 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -0.21 6.59 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.832 2.053 . . . . 0.0 109.1 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -138.56 98.5 3.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.276 1.43 . . . . 0.0 110.064 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -62.46 -36.54 82.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.663 1.22 . . . . 0.0 110.297 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.76 -7.78 17.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.803 0.841 . . . . 0.0 111.62 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.32 150.17 21.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 120.364 1.438 . . . . 0.0 110.969 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -139.17 161.45 37.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.489 1.516 . . . . 0.0 109.691 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -106.01 128.82 54.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -118.36 102.3 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.221 1.809 . . . . 0.0 112.65 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.31 116.93 19.08 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.2 4.09 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -62.77 172.98 1.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.06 2.144 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.71 139.41 34.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -45.04 -35.99 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.308 1.843 . . . . 0.0 114.266 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.231 0.923 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.26 -35.33 64.89 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.343 1.057 . . . . 0.0 110.761 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.24 -23.69 64.27 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.378 -0.826 . . . . 0.0 112.253 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mtp85 -104.67 -15.79 15.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.936 1.294 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -89.88 -58.2 2.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.136 1.374 . . . . 0.0 111.007 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.87 -26.53 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.594 0.758 . . . . 0.0 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.03 -162.14 12.45 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 121.609 -0.682 . . . . 0.0 112.764 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -139.36 152.5 69.4 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 123.008 0.523 . . . . 0.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.6 139.63 25.65 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.186 1.924 . . . . 0.0 109.693 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.652 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -110.23 82.22 1.56 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.571 2.749 . . . . 0.0 106.982 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 pt -71.99 1.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 119.953 -1.717 . . . . 0.0 110.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -22.44 51.77 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.091 1.757 . . . . 0.0 112.099 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.79 -40.74 72.98 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.8 mt -75.92 -52.17 10.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.45 -9.37 1.24 Allowed Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.106 1.336 . . . . 0.0 115.519 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -91.5 -169.85 2.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.85 1.325 . . . . 0.0 113.073 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -144.42 139.15 28.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.525 1.13 . . . . 0.0 109.725 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.52 170.47 16.34 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.007 0.908 . . . . 0.0 112.265 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.3 138.42 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -120.3 132.01 55.13 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.748 0.419 . . . . 0.0 109.97 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.3 m -152.44 100.07 2.54 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.47 112.43 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.507 0.723 . . . . 0.0 110.262 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -83.56 148.97 26.88 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -156.54 131.27 8.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.46 2.704 . . . . 0.0 105.557 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.15 -23.27 52.07 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.321 0.962 . . . . 0.0 112.965 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.3 -22.57 63.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.756 1.223 . . . . 0.0 112.019 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -135.69 44.81 2.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -45.09 -56.05 9.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.538 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.18 -40.8 24.45 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.528 2.152 . . . . 0.0 111.317 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.78 61.01 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 124.2 0.905 . . . . 0.0 112.54 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.03 -53.7 4.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.84 -48.88 41.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.127 1.771 . . . . 0.0 111.899 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -54.52 -36.26 64.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 112.715 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.66 -22.49 66.5 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.276 1.03 . . . . 0.0 112.027 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.73 -44.99 8.25 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -52.19 -35.0 47.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.904 2.082 . . . . 0.0 111.459 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.67 -5.5 57.06 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.08 -32.85 4.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.969 0.804 . . . . 0.0 113.122 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 38.3 m-85 -91.02 121.07 32.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -51.89 42.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 110.485 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -113.66 81.91 5.97 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.877 0.871 . . . . 0.0 109.936 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 9.9 Cg_endo -53.54 -36.19 79.47 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.51 2.14 . . . . 0.0 111.391 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.63 -11.58 26.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.089 2.155 . . . . 0.0 111.361 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -130.14 26.9 5.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.872 2.069 . . . . 0.0 110.258 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -137.38 112.92 9.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.721 0.691 . . . . 0.0 109.934 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.9 m -83.34 141.32 31.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.266 0.627 . . . . 0.0 111.572 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -115.33 95.97 5.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.739 2.016 . . . . 0.0 114.843 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -78.63 102.5 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.06 136.72 23.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 123.717 0.807 . . . . 0.0 109.036 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.56 126.02 39.46 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.651 0.781 . . . . 0.0 111.107 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -127.89 166.91 17.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.255 2.622 . . . . 0.0 107.695 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -63.45 -41.67 98.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.563 -1.336 . . . . 0.0 113.733 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -144.97 179.27 7.45 Favored 'General case' 0 C--N 1.322 -0.626 1 C-N-CA 132.828 4.451 . . . . 0.0 103.545 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -34.35 -32.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.958 2.903 . . . . 0.0 117.097 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 24.3 -88.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 130.066 3.698 . . . . 0.0 116.631 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -144.35 0.56 1.03 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.892 1.277 . . . . 0.0 113.314 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.3 p -41.16 -48.6 3.45 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.31 -41.83 84.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.626 1.103 . . . . 0.0 112.105 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.06 -46.2 85.43 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.71 -35.86 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.27 71.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.734 -0.651 . . . . 0.0 110.052 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -46.62 15.97 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.496 1.044 . . . . 0.0 108.913 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.1 tp -46.52 -61.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.77 -42.49 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.168 -0.333 . . . . 0.0 110.3 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.74 88.02 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.608 0.763 . . . . 0.0 110.956 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.16 -43.37 91.97 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.336 0.654 . . . . 0.0 109.332 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -55.78 -39.05 70.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.167 0.44 . . . . 0.0 111.077 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.27 4.4 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.497 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 72' ' ' PRO . 41.4 m-85 -74.58 152.37 39.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.906 1.853 . . . . 0.0 109.558 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -50.82 -70.15 0.09 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.468 2.707 . . . . 0.0 112.95 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -155.8 164.2 38.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.515 1.526 . . . . 0.0 107.85 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.68 17.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -126.14 150.24 48.4 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.179 1.792 . . . . 0.0 108.024 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.68 118.92 36.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -72.1 109.87 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.29 151.43 46.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 63.05 19.33 11.58 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.131 1.373 . . . . 0.0 111.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 34.73 -114.75 0.15 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 129.004 3.192 . . . . 0.0 114.088 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.76 -12.67 4.79 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.874 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.26 -14.91 16.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.587 1.539 . . . . 0.0 110.727 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.78 35.22 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 118.95 0.795 . . . . 0.0 112.567 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.47 -16.89 48.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.647 2.898 . . . . 0.0 113.261 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -119.35 2.6 11.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.476 2.311 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.23 177.13 25.41 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.786 0.721 . . . . 0.0 112.454 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -41.38 -61.5 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.421 1.888 . . . . 0.0 113.029 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.0 mt -57.58 -36.63 71.95 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.005 1.322 . . . . 0.0 113.587 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -96.08 10.79 36.44 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.893 1.277 . . . . 0.0 111.726 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.509 ' HG ' ' HG3' ' A' ' 10' ' ' LYS . 29.2 t -113.73 24.41 12.16 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.499 -1.375 . . . . 0.0 111.614 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 m 63.06 22.87 13.67 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.367 1.867 . . . . 0.0 113.609 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.3 mt -92.37 160.19 35.5 Favored Pre-proline 0 C--N 1.334 -0.091 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.652 ' C ' HD22 ' A' ' 40' ' ' ASN . 71.6 Cg_endo -80.71 166.1 19.7 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.082 1.855 . . . . 0.0 108.922 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -167.49 134.27 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.528 -1.982 . . . . 0.0 112.653 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.447 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.1 mt -77.07 88.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.645 1.578 . . . . 0.0 108.809 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.85 144.55 48.31 Favored Pre-proline 0 C--O 1.245 0.863 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.81 177.65 8.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.669 2.913 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -72.19 -8.74 56.4 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.09 -1.006 . . . . 0.0 111.787 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HE3' ' H ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -66.95 171.77 5.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.403 1.001 . . . . 0.0 110.065 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.478 ' H ' ' HE3' ' A' ' 127' ' ' LYS . 3.5 p -147.14 -77.57 0.17 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 128.391 2.676 . . . . 0.0 104.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 t -54.0 148.42 10.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.469 1.908 . . . . 0.0 110.534 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 138.22 -79.04 0.3 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.703 -2.959 . . . . 0.0 105.703 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 168.79 23.11 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.014 2.476 . . . . 0.0 111.274 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.3 p -148.66 -72.68 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.192 1.397 . . . . 0.0 109.203 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 m -143.21 142.58 31.46 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.38 1.072 . . . . 0.0 108.687 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.873 -2.071 . . . . 0.0 108.385 -179.308 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 114.16 13.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.741 0.77 . . . . 0.0 110.654 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -73.81 100.27 3.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.53 -174.5 50.42 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m -66.11 126.86 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.896 -0.767 . . . . 0.0 109.05 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -150.69 170.18 19.81 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 121.035 -1.04 . . . . 0.0 111.421 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.73 -125.84 1.32 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m -138.89 160.53 39.5 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.798 1.239 . . . . 0.0 111.641 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.62 -54.71 13.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.871 2.468 . . . . 0.0 114.339 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -60.36 -39.87 88.74 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.839 1.654 . . . . 0.0 112.837 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -47.92 84.21 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.22 96.6 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.191 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -61.85 -40.36 95.06 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.091 0.86 . . . . 0.0 109.95 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 m -61.97 -50.91 70.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -57.0 -47.65 80.34 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.26 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mt -52.29 -32.56 38.16 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.008 1.723 . . . . 0.0 113.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.14 -14.06 70.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.762 0.71 . . . . 0.0 112.934 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.3 -24.23 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 110.458 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -100.99 99.63 10.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.613 1.565 . . . . 0.0 108.371 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.48 -50.51 59.71 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.371 -0.831 . . . . 0.0 112.551 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -2.47 17.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.974 1.31 . . . . 0.0 113.856 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.18 128.39 33.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.932 0.787 . . . . 0.0 109.105 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -138.81 139.0 38.07 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -76.13 128.87 35.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 108.618 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.0 tp -117.23 109.63 17.11 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.687 1.595 . . . . 0.0 111.269 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 98.77 5.51 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.141 1.376 . . . . 0.0 108.412 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -86.63 -3.83 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 118.926 0.784 . . . . 0.0 111.235 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -63.52 163.68 10.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 125.902 1.681 . . . . 0.0 111.431 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.87 148.39 27.73 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.097 1.427 . . . . 0.0 108.984 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -42.41 -43.19 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 129.72 3.208 . . . . 0.0 111.529 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.69 -40.4 65.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.878 1.271 . . . . 0.0 112.914 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.16 -35.22 80.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.404 ' CD2' ' HB3' ' A' ' 38' ' ' SER . 13.9 m-85 -61.06 -27.62 68.48 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.098 -1.626 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -89.1 -23.93 22.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.563 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.11 -35.71 7.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.8 p -117.9 -13.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.532 1.133 . . . . 0.0 112.948 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.4 -163.01 29.8 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . 2.5 p -135.74 157.17 76.7 Favored Pre-proline 0 CA--C 1.511 -0.528 0 O-C-N 122.354 -0.498 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.88 172.33 16.09 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.382 1.388 . . . . 0.0 109.454 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.435 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 6.4 p30 -146.36 167.56 23.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -145.0 20.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 127.475 2.31 . . . . 0.0 107.618 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.57 64.37 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.076 2.15 . . . . 0.0 114.142 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -33.73 78.92 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.66 -23.44 36.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 109.347 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 23.1 24.13 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 125.198 1.38 . . . . 0.0 111.327 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -106.04 173.08 6.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.356 1.862 . . . . 0.0 107.807 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -143.23 124.98 14.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.252 1.387 . . . . 0.0 109.625 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.03 171.02 7.36 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.09 136.15 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.753 1.621 . . . . 0.0 106.666 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 p -103.04 110.38 22.28 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.035 1.734 . . . . 0.0 110.884 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -149.97 98.32 2.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.69 117.74 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 122.229 -0.294 . . . . 0.0 110.847 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -81.29 142.91 32.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -154.2 140.7 18.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.45 -13.9 74.35 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.177 -1.346 . . . . 0.0 115.124 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -79.67 -15.95 56.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.509 1.654 . . . . 0.0 111.642 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -138.52 43.5 2.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.357 1.435 . . . . 0.0 111.189 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -45.05 -53.58 16.05 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.869 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.63 -39.28 36.03 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.844 1.696 . . . . 0.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.86 -14.67 73.26 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.273 -0.892 . . . . 0.0 112.671 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.9 -52.21 5.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -50.82 -48.38 59.76 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.794 1.638 . . . . 0.0 111.801 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.85 -36.15 69.68 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -58.74 -26.32 63.86 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.095 0.558 . . . . 0.0 110.648 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.51 -49.43 7.2 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.43 -30.63 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.07 0.85 . . . . 0.0 113.115 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.53 -23.39 62.63 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.819 -1.176 . . . . 0.0 110.249 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -41.34 8.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.635 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.44 ' CD1' HG22 ' A' ' 75' ' ' THR . 65.8 m-85 -85.68 99.42 11.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.464 1.106 . . . . 0.0 108.855 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -19.43 47.78 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.23 78.88 27.28 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.209 1.404 . . . . 0.0 107.548 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.55 -39.04 57.97 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.679 1.586 . . . . 0.0 111.05 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.53 -22.01 2.88 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 127.068 2.147 . . . . 0.0 114.981 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -120.94 -9.08 9.3 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.097 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.44 HG22 ' CD1' ' A' ' 69' ' ' PHE . 90.1 m -82.76 136.54 34.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.646 1.178 . . . . 0.0 109.156 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -111.1 125.37 53.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.9 mt -98.53 96.43 7.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.997 1.319 . . . . 0.0 112.526 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -80.07 106.76 12.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -67.36 145.37 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.33 1.052 . . . . 0.0 112.725 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.29 112.88 7.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -119.09 164.52 15.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.65 1.18 . . . . 0.0 108.511 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -53.5 -41.81 66.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.38 1.072 . . . . 0.0 109.736 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.98 -143.98 0.21 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.785 2.034 . . . . 0.0 106.943 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -75.57 -36.3 60.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.568 1.547 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.9 -103.67 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 130.432 3.872 . . . . 0.0 116.032 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.32 9.26 10.35 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.044 0.937 . . . . 0.0 113.352 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.7 m -46.71 -52.02 14.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.48 -33.26 75.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.033 0.933 . . . . 0.0 111.699 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.15 -52.0 13.84 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.631 0.772 . . . . 0.0 109.77 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.57 -31.07 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.494 1.117 . . . . 0.0 110.277 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.38 93.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.879 0.763 . . . . 0.0 108.951 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -73.2 -36.58 66.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.34 -59.0 5.13 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.9 0.88 . . . . 0.0 111.309 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.8 m -62.64 -39.26 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 121.909 -0.494 . . . . 0.0 111.072 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.55 -50.22 72.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.964 0.906 . . . . 0.0 111.436 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.29 -28.81 68.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.481 1.112 . . . . 0.0 110.623 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.78 -54.57 13.06 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.89 2.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 CA-C-O 118.196 -1.335 . . . . 0.0 115.67 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.54 157.16 34.3 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 120.04 1.92 . . . . 0.0 106.755 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -63.66 1.08 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.193 0.597 . . . . 0.0 110.235 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.7 t -161.53 -179.8 7.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.317 1.847 . . . . 0.0 106.09 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.47 20.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -118.16 123.8 46.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.5 101.66 14.32 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.32 116.89 13.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -72.46 156.52 38.96 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.82 8.91 5.54 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.114 1.766 . . . . 0.0 115.101 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.27 -127.46 21.45 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.61 -35.88 4.1 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.478 0.711 . . . . 0.0 109.565 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.28 -17.19 61.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.195 2.198 . . . . 0.0 114.28 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.1 172.46 46.98 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.18 0.9 . . . . 0.0 114.481 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.8 -30.71 58.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 125.172 3.915 . . . . 0.0 115.768 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.253 0.0 OUTLIER -131.49 20.7 4.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.025 1.33 . . . . 0.0 109.178 177.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.99 166.62 40.29 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -34.28 -50.94 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.65 -50.7 72.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.23 0.923 . . . . 0.0 110.058 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.79 -0.38 34.21 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.029 2.132 . . . . 0.0 113.403 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -91.77 6.53 45.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.666 1.986 . . . . 0.0 111.629 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t 60.7 46.09 9.48 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.34 145.26 46.04 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.016 0.926 . . . . 0.0 109.967 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.81 147.05 84.98 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.291 2.661 . . . . 0.0 110.211 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -148.49 139.57 23.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.596 1.559 . . . . 0.0 110.825 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.435 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.6 mt -78.9 91.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.486 1.114 . . . . 0.0 109.669 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.6 153.86 95.32 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.379 -0.826 . . . . 0.0 110.74 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -86.81 -175.89 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.649 1 C-N-CA 125.32 4.014 . . . . 0.0 110.198 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -69.62 108.71 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -58.35 163.75 2.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.869 0.867 . . . . 0.0 111.209 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 178.69 7.9 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 0.0 108.766 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.8 p -71.7 -41.48 68.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.081 0.953 . . . . 0.0 109.744 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.45 167.56 43.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.247 1.403 . . . . 0.0 109.759 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.55 175.42 11.31 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.701 2.934 . . . . 0.0 110.166 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.5 p -71.65 107.33 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -42.82 117.59 1.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.997 1.719 . . . . 0.0 111.29 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.743 0 CA-C-O 118.697 -1.057 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.4 p -109.69 1.64 19.64 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 113.62 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -133.04 163.92 28.17 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.25 66.38 2.28 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 m -34.25 116.9 0.32 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.479 2.312 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 t -133.73 -175.27 3.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.076 1.35 . . . . 0.0 108.826 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.01 -106.02 0.22 Allowed Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.375 -0.828 . . . . 0.0 115.079 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -153.67 154.11 33.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 118.298 1.049 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.62 91.75 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -65.47 -49.28 69.69 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.042 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.92 -44.96 91.35 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.03 -41.11 87.0 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.238 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.44 -41.93 96.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.815 0.734 . . . . 0.0 109.835 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -60.92 -46.47 90.55 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.33 -48.37 82.03 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.995 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.2 mt -56.75 -22.03 32.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.515 1.507 . . . . 0.0 113.115 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.61 -7.06 60.53 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.391 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t -126.08 -10.16 6.51 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.779 1.289 . . . . 0.0 110.223 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.07 95.23 5.45 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -12.85 12.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -106.4 -7.52 17.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.279 1.432 . . . . 0.0 111.129 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.16 148.86 41.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.24 152.32 36.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.043 1.737 . . . . 0.0 108.705 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -94.82 151.55 19.15 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 tp -140.13 101.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.368 1.467 . . . . 0.0 111.14 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.17 110.25 18.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.937 2.495 . . . . 0.0 107.378 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -103.68 3.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -61.83 167.32 3.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.22 141.12 43.6 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 m -46.81 -34.02 4.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.184 2.193 . . . . 0.0 112.478 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.61 76.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 119.259 0.936 . . . . 0.0 111.643 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.87 -36.48 84.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -65.56 -6.04 9.8 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.855 -1.153 . . . . 0.0 111.997 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -112.93 -10.49 13.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.914 1.234 . . . . 0.0 111.643 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -115.6 -43.66 3.02 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.63 -16.81 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.904 1.281 . . . . 0.0 113.789 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.32 -153.81 20.3 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 121.219 -0.925 . . . . 0.0 112.297 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 p -143.48 158.09 58.03 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 111.129 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.85 172.17 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 N-CA-C 109.269 -1.089 . . . . 0.0 109.269 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 148.94 35.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.543 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.0 pt -140.85 15.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.287 1.835 . . . . 0.0 110.088 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -56.09 -31.05 62.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.573 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.35 -22.53 71.21 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 120.457 1.48 . . . . 0.0 110.735 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.31 -17.25 37.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.845 1.258 . . . . 0.0 110.274 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.25 33.65 7.12 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.166 1.365 . . . . 0.0 109.889 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -136.25 175.08 9.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.158 1.383 . . . . 0.0 109.578 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -140.81 160.15 40.67 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.82 0.736 . . . . 0.0 110.405 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.5 163.79 20.24 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' CG2' ' HZ2' ' A' ' 68' ' ' LYS . 19.6 t -139.82 88.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.7 p -58.02 108.71 0.62 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.51 0.724 . . . . 0.0 109.287 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -136.55 89.41 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.58 112.02 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 124.091 0.956 . . . . 0.0 108.493 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.53 149.1 30.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -159.73 145.63 15.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.347 2.259 . . . . 0.0 107.775 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.86 -26.73 61.91 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.22 -5.41 18.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.046 2.138 . . . . 0.0 113.965 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.44 31.97 0.73 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.527 0.731 . . . . 0.0 109.797 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -38.32 -57.01 1.94 Allowed Pre-proline 0 N--CA 1.475 0.824 0 CA-C-O 117.806 -1.092 . . . . 0.0 111.846 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.99 -48.16 9.05 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.493 2.795 . . . . 0.0 111.991 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.94 -50.15 62.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.3 -53.95 49.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.095 1.758 . . . . 0.0 108.427 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.44 -48.0 69.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.859 1.264 . . . . 0.0 111.672 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -55.95 -35.56 66.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.796 0.839 . . . . 0.0 110.007 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -60.72 -29.2 69.21 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.709 1.14 . . . . 0.0 111.226 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 -46.44 13.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -54.36 -34.05 60.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.956 1.302 . . . . 0.0 111.624 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.75 -8.03 58.35 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.065 -1.022 . . . . 0.0 113.222 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.429 ' HZ2' ' CG2' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -113.91 -46.83 2.99 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.328 0.967 . . . . 0.0 112.417 -178.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.78 120.84 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -29.44 64.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -129.0 68.65 80.12 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 126.842 2.057 . . . . 0.0 110.026 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.18 -41.34 79.52 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.2 -15.35 14.54 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.45 -14.09 10.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -86.72 124.21 32.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.226 1.376 . . . . 0.0 111.403 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.7 m -88.47 134.61 33.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.84 96.87 6.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.282 0.946 . . . . 0.0 109.239 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.441 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 42.2 m-85 -75.19 113.98 13.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.615 1.966 . . . . 0.0 109.006 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.66 144.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.185 1.357 . . . . 0.0 111.836 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.64 83.69 1.91 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.346 0.658 . . . . 0.0 110.639 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.98 176.5 7.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -53.29 -50.99 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.903 1.281 . . . . 0.0 110.342 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.58 -141.2 0.21 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.58 -40.54 88.99 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 40.94 -127.52 3.24 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.297 1.903 . . . . 0.0 113.741 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.23 3.8 35.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.271 1.028 . . . . 0.0 113.211 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.1 m -40.69 -61.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.103 2.261 . . . . 0.0 117.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -53.28 -37.73 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.167 0.987 . . . . 0.0 111.886 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.01 -46.99 61.27 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.85 -28.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.023 -1.048 . . . . 0.0 109.793 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.53 -36.03 78.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.972 0.805 . . . . 0.0 109.676 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.34 -41.36 28.08 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.449 -0.782 . . . . 0.0 109.665 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.6 tp -49.82 -60.82 2.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.056 2.143 . . . . 0.0 113.393 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.36 -40.96 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.037 0.535 . . . . 0.0 110.758 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -48.88 78.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.082 0.553 . . . . 0.0 109.85 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.17 -28.32 69.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -74.41 -43.32 56.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.292 0.496 . . . . 0.0 110.743 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.08 -5.74 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 CA-C-O 117.508 -1.718 . . . . 0.0 113.631 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.33 160.37 27.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 120.297 2.049 . . . . 0.0 110.396 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -59.04 -69.77 0.18 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.25 0.62 . . . . 0.0 112.038 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -155.0 -178.22 7.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.429 1.892 . . . . 0.0 108.809 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.9 154.37 27.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.441 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -142.77 111.99 6.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 128.387 2.675 . . . . 0.0 108.737 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.15 119.73 23.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.038 0.935 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.3 108.82 4.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.32 151.31 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 73.34 0.32 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.925 1.69 . . . . 0.0 111.86 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.59 -122.09 14.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.805 1.193 . . . . 0.0 110.997 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.67 -24.41 4.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.442 1.497 . . . . 0.0 111.465 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.11 -11.91 23.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.647 1.579 . . . . 0.0 114.38 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.53 174.3 39.0 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.818 0.736 . . . . 0.0 112.349 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.27 -28.14 86.26 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.543 2.829 . . . . 0.0 113.387 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -117.44 1.06 12.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 110.613 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.05 160.12 1.72 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.173 -0.954 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -25.94 -62.52 0.07 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.163 2.185 . . . . 0.0 115.622 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.18 -60.17 3.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.323 1.049 . . . . 0.0 109.265 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.05 -2.78 2.15 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.94 1.696 . . . . 0.0 113.022 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.35 12.82 31.78 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.249 -1.532 . . . . 0.0 109.555 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.1 t 66.38 12.55 8.72 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.327 1.851 . . . . 0.0 112.103 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.59 157.34 72.44 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.787 0.835 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.74 147.2 21.64 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.101 1.867 . . . . 0.0 110.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -144.25 144.14 31.37 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.97 87.13 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.205 1.002 . . . . 0.0 108.857 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.59 147.31 78.25 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.27 173.39 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.073 3.182 . . . . 0.0 112.505 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -64.68 -21.85 66.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.843 0.457 . . . . 0.0 109.801 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -53.74 155.0 3.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.965 1.306 . . . . 0.0 110.241 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 t -146.29 44.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.418 1.104 . . . . 0.0 109.585 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.48 70.12 1.43 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -173.69 91.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.15 -174.67 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.292 2.661 . . . . 0.0 110.266 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.5 m -80.2 66.32 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.2 m -59.23 146.34 39.58 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 110.256 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 179.56 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t 48.9 36.62 8.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.256 1.028 . . . . 0.0 112.899 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.27 -7.73 0.29 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.064 2.146 . . . . 0.0 114.439 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.06 152.02 47.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.691 1.132 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 m -80.65 91.91 5.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 130.35 42.12 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.04 100.92 0.25 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.53 146.21 0.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.563 1.545 . . . . 0.0 110.821 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -38.78 -54.43 1.6 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -58.07 -49.78 75.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.021 1.282 . . . . 0.0 111.081 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -51.79 66.61 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.959 0.904 . . . . 0.0 109.176 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.99 73.11 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.868 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.66 -49.34 77.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.38 0.991 . . . . 0.0 109.39 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -62.3 -41.42 98.5 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.69 -0.631 . . . . 0.0 109.881 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.36 -41.51 97.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.209 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.39 -27.87 69.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 111.361 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 -21.99 45.03 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.901 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -98.35 -18.11 18.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.642 1.221 . . . . 0.0 110.903 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -101.6 110.37 22.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -38.41 -53.97 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.28 2.232 . . . . 0.0 114.98 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -101.37 13.61 34.51 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.67 23.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.936 -1.102 . . . . 0.0 111.507 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -128.84 144.55 51.2 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.064 0.945 . . . . 0.0 109.731 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.83 144.24 28.56 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.8 tp -127.08 107.2 9.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.658 1.583 . . . . 0.0 109.206 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -80.34 132.75 35.84 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.6 pt -119.67 13.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.827 0.74 . . . . 0.0 111.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -74.89 170.53 15.75 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.838 1.199 . . . . 0.0 110.08 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.5 142.23 44.83 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.62 -41.97 23.15 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.541 2.336 . . . . 0.0 112.68 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.13 73.81 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.53 -0.731 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -66.8 -27.42 67.56 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.572 0.749 . . . . 0.0 111.257 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -64.42 -16.62 62.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.159 -1.588 . . . . 0.0 110.452 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -104.89 -22.04 13.22 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.38 1.472 . . . . 0.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.75 -52.77 4.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.207 1.003 . . . . 0.0 112.22 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.8 -29.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.042 1.737 . . . . 0.0 112.259 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.84 -151.75 17.7 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.276 0.944 . . . . 0.0 112.12 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -147.49 156.16 45.61 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.903 0.881 . . . . 0.0 109.839 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.96 176.28 10.33 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.85 1.7 . . . . 0.0 109.75 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.2 142.96 37.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.923 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.95 12.16 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.734 2.014 . . . . 0.0 111.305 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -37.45 67.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 117.638 -1.172 . . . . 0.0 113.524 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.61 -35.33 85.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.61 -16.24 61.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.209 0.604 . . . . 0.0 110.57 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 45.66 5.89 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 106.606 -2.598 . . . . 0.0 106.606 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -135.47 168.1 19.84 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.608 0.763 . . . . 0.0 110.736 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -145.18 122.42 11.53 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.224 -0.922 . . . . 0.0 110.359 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.78 172.6 10.48 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.784 1.278 . . . . 0.0 112.265 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.89 146.64 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 m -129.13 117.81 21.43 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.926 -1.109 . . . . 0.0 111.38 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -147.73 115.77 6.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.399 1.08 . . . . 0.0 110.356 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.92 129.16 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 120.004 1.275 . . . . 0.0 109.221 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.03 166.83 22.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.23 125.63 0.91 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.78 -20.56 57.13 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.148 0.885 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -84.22 -11.7 56.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.579 1.189 . . . . 0.0 111.621 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -127.47 36.98 4.31 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.522 1.129 . . . . 0.0 111.375 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -48.12 -57.67 9.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.101 1.318 . . . . 0.0 111.847 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.46 -37.67 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.644 2.229 . . . . 0.0 110.623 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.5 -23.55 66.89 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.509 0.576 . . . . 0.0 112.958 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -87.4 -41.5 13.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.279 1.432 . . . . 0.0 107.28 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.74 -46.67 88.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.784 1.234 . . . . 0.0 112.067 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -54.68 -33.7 61.24 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.048 0.539 . . . . 0.0 111.257 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -60.04 -27.33 66.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.856 0.863 . . . . 0.0 110.99 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.12 -43.19 9.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -31.04 66.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.535 -0.728 . . . . 0.0 112.322 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 -7.23 52.14 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.063 -1.023 . . . . 0.0 112.405 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.76 -48.19 2.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.564 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.422 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 69.7 m-85 -77.79 107.56 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.733 1.213 . . . . 0.0 109.499 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -72.68 -17.49 61.63 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.483 0.713 . . . . 0.0 112.106 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -148.04 77.31 10.11 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 126.234 1.814 . . . . 0.0 109.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.25 -29.51 73.29 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.752 2.301 . . . . 0.0 110.645 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -53.85 -18.61 3.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.152 2.181 . . . . 0.0 113.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -125.93 3.98 7.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 0.0 112.39 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 m -109.38 121.77 45.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.382 1.473 . . . . 0.0 112.143 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.0 m -91.0 130.92 36.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.69 0.796 . . . . 0.0 110.169 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.53 105.99 15.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -85.67 110.53 19.36 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.37 134.38 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.012 1.325 . . . . 0.0 111.425 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.54 128.9 30.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.469 1.108 . . . . 0.0 109.337 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -130.7 174.78 9.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.908 1.683 . . . . 0.0 108.369 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -52.84 -52.15 58.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.746 1.218 . . . . 0.0 109.382 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -144.53 174.93 10.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.275 3.83 . . . . 0.0 105.164 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -17.81 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 128.85 2.86 . . . . 0.0 112.508 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.04 -103.22 0.12 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 126.204 1.859 . . . . 0.0 110.39 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -128.9 9.54 5.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.807 1.243 . . . . 0.0 112.38 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -39.01 -51.97 1.81 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.315 1.846 . . . . 0.0 113.791 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.63 -45.95 87.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -39.61 93.95 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.756 0.422 . . . . 0.0 110.938 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.33 -25.58 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.949 -0.469 . . . . 0.0 109.74 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.43 65.25 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.536 -0.727 . . . . 0.0 111.158 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.04 -36.59 61.85 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.007 -0.433 . . . . 0.0 110.87 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.41 -56.79 13.91 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.774 1.229 . . . . 0.0 112.227 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.25 -39.4 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.316 0.647 . . . . 0.0 111.425 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.55 73.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.01 -25.24 65.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.545 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -80.21 -23.79 40.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.43 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.11 1.84 3.15 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 119.956 1.253 . . . . 0.0 115.546 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -76.67 153.59 35.03 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.756 1.778 . . . . 0.0 110.099 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -51.21 -65.88 0.48 Allowed 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 126.785 2.034 . . . . 0.0 112.466 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 m -157.47 171.96 19.42 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.312 1.845 . . . . 0.0 108.29 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.51 140.16 14.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.45 142.85 49.63 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 108.618 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.7 113.56 26.91 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.2 108.12 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 0.0 110.036 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -71.17 141.77 50.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 72.82 22.46 3.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.746 2.818 . . . . 0.0 109.764 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 27.82 -113.02 0.03 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.002 2.239 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -119.18 -54.93 2.18 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.864 1.266 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.44 8.75 4.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.314 1.846 . . . . 0.0 114.045 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.06 173.52 55.34 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.066 -1.021 . . . . 0.0 112.475 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.42 -34.98 98.85 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.714 2.943 . . . . 0.0 111.674 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -129.88 22.14 5.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.114 0.966 . . . . 0.0 110.192 177.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.24 168.36 16.04 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -29.45 -53.61 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.27 -59.26 5.69 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.227 0.922 . . . . 0.0 109.302 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.03 3.53 4.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.195 1.798 . . . . 0.0 112.269 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 t -95.43 11.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.717 2.007 . . . . 0.0 111.539 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 27.86 15.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.352 1.061 . . . . 0.0 111.659 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.1 mt -107.99 153.77 41.52 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.119 0.968 . . . . 0.0 109.507 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.47 154.4 27.7 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.199 1.933 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -147.69 144.35 28.27 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 111.477 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.21 88.73 2.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 126.016 1.726 . . . . 0.0 108.83 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -77.25 153.54 82.11 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.423 0.689 . . . . 0.0 111.715 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.29 -179.71 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.965 3.11 . . . . 0.0 108.501 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 110.89 6.38 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -34.86 119.82 0.48 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.826 2.05 . . . . 0.0 111.332 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 t -99.97 157.17 16.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 65.7 m -68.2 158.47 33.18 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.783 -0.573 . . . . 0.0 109.837 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.71 162.78 24.17 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.565 1.079 . . . . 0.0 111.904 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -87.77 162.0 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.356 3.371 . . . . 0.0 111.719 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.0 p -155.63 123.96 5.87 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.5 t -173.63 154.81 2.58 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.825 1.25 . . . . 0.0 109.511 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 CA-C-O 117.985 -1.453 . . . . 0.0 111.537 179.275 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m -58.55 117.45 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.691 1.196 . . . . 0.0 109.412 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 m -134.79 101.49 4.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.979 1.312 . . . . 0.0 108.269 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.63 163.57 20.59 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -81.21 44.35 0.77 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.988 1.315 . . . . 0.0 111.362 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m -74.15 161.43 30.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.289 1.042 . . . . 0.0 113.263 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.34 -115.18 0.41 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -160.06 169.99 22.23 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.855 -1.38 . . . . 0.0 109.329 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.23 -46.03 92.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -49.74 -52.06 34.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 111.099 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -54.97 -59.78 4.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.222 1.009 . . . . 0.0 110.08 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.84 -41.13 67.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.084 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.19 -48.01 79.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.556 1.071 . . . . 0.0 112.91 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.0 m -68.2 -41.37 81.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -60.74 -31.69 70.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.969 0.804 . . . . 0.0 111.975 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.21 -17.01 60.44 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.391 1.876 . . . . 0.0 110.841 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.1 -52.49 2.21 Favored Glycine 0 CA--C 1.506 -0.494 0 C-N-CA 126.006 1.765 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -15.31 59.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.609 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -119.17 128.36 54.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 108.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.43 -39.69 38.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.633 0.651 . . . . 0.0 112.466 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.11 -14.08 60.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.95 1.3 . . . . 0.0 112.423 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.86 131.54 45.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.244 1.418 . . . . 0.0 110.388 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -138.86 142.69 38.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.413 0.625 . . . . 0.0 111.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -76.88 131.26 38.5 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.13 95.89 5.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.15 2.18 . . . . 0.0 107.552 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -75.63 109.48 9.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.95 0.38 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 46.8 mtm-85 -69.46 162.8 26.68 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.071 0.85 . . . . 0.0 110.485 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.09 136.66 56.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -52.34 -23.22 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 111.406 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.66 79.55 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.531 -1.356 . . . . 0.0 110.701 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.422 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.54 -33.84 76.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.006 1.722 . . . . 0.0 109.972 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.42 -18.9 53.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -95.59 -37.14 10.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.053 1.741 . . . . 0.0 109.984 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -81.29 -50.52 9.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.9 -23.33 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 113.85 -177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.13 -157.97 22.23 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 p -139.21 160.82 60.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.56 176.53 7.26 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.165 1.91 . . . . 0.0 109.009 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.412 ' HB3' ' CG1' ' A' ' 123' ' ' ILE 0.261 8.5 p30 -141.61 114.09 8.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 122.069 0.938 . . . . 0.0 111.973 177.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -85.57 8.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 122.188 0.994 . . . . 0.0 109.255 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -55.44 -28.07 52.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.817 1.647 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.42 -48.81 47.45 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.91 -46.65 62.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.646 1.178 . . . . 0.0 108.448 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.08 40.62 0.69 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.73 1.633 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.14 -176.38 3.11 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.1 0.96 . . . . 0.0 111.437 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.62 116.72 10.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.356 0.98 . . . . 0.0 110.992 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.65 152.25 39.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.592 0.757 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -108.85 91.15 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 110.314 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -57.96 102.43 0.1 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 127.171 2.188 . . . . 0.0 110.298 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -143.09 97.41 3.09 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.633 0.773 . . . . 0.0 109.757 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.15 119.82 3.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.348 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -74.94 154.52 38.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -156.09 118.7 4.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -22.93 68.06 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.115 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -82.5 -6.12 59.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.615 1.207 . . . . 0.0 110.952 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.37 39.61 2.67 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.032 0.833 . . . . 0.0 110.553 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -43.02 -60.83 2.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 120.762 -1.211 . . . . 0.0 113.622 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -67.2 -43.47 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.585 2.857 . . . . 0.0 111.42 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.03 -47.34 81.0 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.42 -50.62 72.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.533 1.533 . . . . 0.0 108.026 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.4 -39.59 70.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.465 0.706 . . . . 0.0 111.049 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -37.46 78.72 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.779 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.54 -24.17 44.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.432 1.093 . . . . 0.0 111.894 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.08 -44.09 7.47 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t -54.28 -33.01 57.73 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.654 1.182 . . . . 0.0 111.498 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.92 -2.92 39.18 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.41 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -121.32 -40.23 2.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.967 0.803 . . . . 0.0 112.564 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.41 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 64.1 m-85 -79.94 111.99 16.8 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -18.58 62.22 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.069 0.548 . . . . 0.0 111.315 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 78.26 11.06 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 125.815 1.646 . . . . 0.0 108.44 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.29 -32.97 97.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.47 2.113 . . . . 0.0 110.961 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -57.97 -18.75 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.354 3.062 . . . . 0.0 113.089 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.61 -4.71 9.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.918 . . . . 0.0 111.419 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.2 m -95.16 113.92 25.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 0.0 112.296 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.6 m -86.75 129.16 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.42 99.14 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.532 1.533 . . . . 0.0 111.768 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -84.34 98.6 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -68.0 157.58 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.559 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 tt -152.47 112.06 3.93 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.773 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.79 173.3 6.44 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -31.05 70.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.93 -1.731 . . . . 0.0 111.409 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -138.6 -152.71 0.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.034 2.134 . . . . 0.0 106.48 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.11 -18.33 62.53 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.896 2.079 . . . . 0.0 113.58 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.96 -97.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.798 3.571 . . . . 0.0 115.913 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -129.62 6.89 5.22 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.363 1.865 . . . . 0.0 110.957 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -42.91 -47.4 5.64 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.26 1.824 . . . . 0.0 113.487 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.5 -43.64 84.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.424 1.09 . . . . 0.0 111.26 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.46 -49.05 58.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.342 1.057 . . . . 0.0 109.49 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.09 -31.56 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.563 0.745 . . . . 0.0 109.142 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.62 87.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.857 0.753 . . . . 0.0 110.162 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.87 74.26 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -50.39 -57.52 7.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.884 1.674 . . . . 0.0 112.557 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.91 -40.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.12 78.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.068 0.547 . . . . 0.0 109.808 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.15 -38.31 90.61 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.81 -23.38 67.22 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 117.66 -1.162 . . . . 0.0 113.265 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.98 1.32 4.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 117.871 -1.516 . . . . 0.0 113.46 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -76.11 157.67 32.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.15 1.475 . . . . 0.0 108.473 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -49.79 -71.07 0.07 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 127.445 2.298 . . . . 0.0 110.087 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 m -163.62 -178.86 6.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 126.674 1.99 . . . . 0.0 106.857 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.8 164.64 38.29 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -136.99 142.88 42.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.26 110.3 22.3 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 124.734 1.271 . . . . 0.0 107.784 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.95 106.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -68.63 144.01 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 82.24 -2.09 1.45 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.598 1.959 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.14 -102.61 0.07 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 126.449 1.976 . . . . 0.0 114.532 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.31 -43.52 2.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.674 1.59 . . . . 0.0 110.656 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.88 -28.79 39.87 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.0 171.82 41.58 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 121.151 1.796 . . . . 0.0 111.811 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.54 -15.37 35.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.798 3.665 . . . . 0.0 116.052 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.7 mmt-85 -115.78 5.64 14.2 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 111.112 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.45 163.23 54.78 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -46.52 -45.28 18.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -66.93 -39.89 87.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.247 0.476 . . . . 0.0 111.038 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -87.67 23.26 2.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.8 1.64 . . . . 0.0 111.433 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 t -120.51 6.56 10.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.445 1.098 . . . . 0.0 112.819 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 56.86 48.5 15.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.991 0.917 . . . . 0.0 109.363 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.1 mt -116.53 160.74 35.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.81 145.01 17.65 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.123 1.882 . . . . 0.0 110.149 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -144.0 132.2 21.86 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.987 -1.071 . . . . 0.0 110.833 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 6.6 mt -75.27 90.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.567 1.547 . . . . 0.0 110.082 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -83.49 143.9 45.19 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.809 -1.182 . . . . 0.0 110.94 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.3 -171.13 1.14 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 125.03 3.82 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.96 122.07 15.63 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.807 -1.183 . . . . 0.0 110.897 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -73.22 156.26 38.73 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -139.52 136.99 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 119.122 0.874 . . . . 0.0 109.009 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 m -69.56 114.14 7.5 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.8 52.9 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -81.08 -168.68 0.66 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.685 2.924 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 42.21 0.81 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.637 -1.29 . . . . 0.0 107.9 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 m 65.91 8.7 5.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.91 1.684 . . . . 0.0 110.842 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.443 2 C-N-CA 132.533 4.873 . . . . 0.0 102.785 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 p -144.32 94.4 2.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 106.529 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.7 t -128.25 -143.81 0.28 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.13 -167.93 39.0 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.2 m -126.42 21.75 7.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.545 1.172 . . . . 0.0 113.504 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.3 p -61.0 169.88 1.79 Allowed 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.404 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.57 -116.82 0.5 Allowed Glycine 0 N--CA 1.445 -0.748 0 O-C-N 121.545 -0.722 . . . . 0.0 111.752 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -142.45 157.3 44.9 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.877 0.871 . . . . 0.0 112.439 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.45 90.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.374 1.469 . . . . 0.0 113.46 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.53 -52.66 64.7 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.841 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.82 -42.95 85.0 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.182 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.27 75.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.583 0.628 . . . . 0.0 111.283 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.23 -47.55 79.26 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -60.73 -40.67 93.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.308 0.243 . . . . 0.0 110.494 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -58.94 -43.77 91.26 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.446 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.26 -23.95 62.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.289 1.404 . . . . 0.0 111.121 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.06 4.38 62.75 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.435 1.493 . . . . 0.0 112.505 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.12 -4.72 3.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.121 1.768 . . . . 0.0 110.778 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -124.53 106.12 9.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.1 -18.19 2.0 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -122.57 5.48 9.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.397 0.999 . . . . 0.0 113.155 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.67 50.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.635 1.107 . . . . 0.0 108.442 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -140.27 152.86 46.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.338 1.055 . . . . 0.0 109.415 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.52 118.85 37.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.24 107.36 16.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.654 1.581 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.64 123.0 31.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.56 -0.85 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -33.78 -109.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.901 3.68 . . . . 0.0 115.39 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.64 134.27 5.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -45.74 -43.39 12.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.78 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.52 80.92 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.3 0.955 . . . . 0.0 109.809 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.98 -40.56 67.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.515 1.126 . . . . 0.0 110.635 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -60.99 -15.85 36.41 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.025 1.739 . . . . 0.0 112.913 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -107.91 -13.02 15.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.746 1.618 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -102.14 -47.06 4.65 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.717 1.207 . . . . 0.0 110.489 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 -24.93 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.808 1.243 . . . . 0.0 113.468 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.45 -148.16 18.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 119.145 0.884 . . . . 0.0 113.807 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -146.28 162.63 33.98 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.66 128.41 10.95 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.68 2.253 . . . . 0.0 110.044 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.532 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -86.29 73.89 10.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.494 -1.684 . . . . 0.0 109.64 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.4 pt -78.66 -4.37 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.556 -1.34 . . . . 0.0 110.597 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -50.03 -37.62 33.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.65 2.38 . . . . 0.0 112.474 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.95 -40.44 72.91 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 124.206 0.941 . . . . 0.0 111.465 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.87 -50.52 28.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.84 25.56 0.14 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.727 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -133.33 -175.12 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.12 1.46 . . . . 0.0 109.971 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -144.52 131.65 20.55 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.138 2.175 . . . . 0.0 105.879 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.23 164.89 14.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.679 0.672 . . . . 0.0 111.565 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.47 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.198 1.799 . . . . 0.0 107.252 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.7 p -63.84 108.7 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.062 1.345 . . . . 0.0 111.206 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -142.38 94.09 2.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.1 116.25 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -76.75 150.44 36.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -155.33 134.97 12.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 128.361 2.664 . . . . 0.0 104.516 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.17 -13.22 81.38 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 113.987 0.355 . . . . 0.0 113.987 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.33 -43.83 39.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.023 0.911 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.32 51.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 109.78 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -52.03 -54.8 37.01 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.27 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.55 -42.11 7.57 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.877 1.349 . . . . 0.0 109.802 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.03 -19.77 46.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.41 1.481 . . . . 0.0 113.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -89.76 -54.23 4.15 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.242 1.817 . . . . 0.0 106.664 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -54.09 -46.87 72.18 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.502 1.921 . . . . 0.0 111.082 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -41.34 66.07 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.597 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -60.61 -34.49 74.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.528 1.058 . . . . 0.0 110.948 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -48.01 25.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -61.21 -9.29 4.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.914 2.086 . . . . 0.0 115.323 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.11 -13.36 15.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.223 0.919 . . . . 0.0 109.337 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 -47.1 5.38 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -86.38 159.91 19.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.367 1.467 . . . . 0.0 109.529 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -2.38 1.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.274 2.63 . . . . 0.0 112.362 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -136.11 52.54 6.59 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 128.76 2.824 . . . . 0.0 112.384 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.95 -36.54 17.54 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.532 2.821 . . . . 0.0 112.7 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -55.64 -18.11 7.13 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.652 2.381 . . . . 0.0 113.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -125.02 -1.38 7.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.215 1.006 . . . . 0.0 112.736 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -100.69 136.22 40.9 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.166 1.387 . . . . 0.0 112.411 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.2 m -102.59 128.02 49.43 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.57 97.78 7.94 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.131 0.972 . . . . 0.0 111.708 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -74.87 126.78 31.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.01 126.7 57.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 121.002 1.728 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tt -120.94 114.58 21.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.97 1.708 . . . . 0.0 109.046 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -119.47 170.41 9.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.668 1.987 . . . . 0.0 107.22 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.211 -1.555 . . . . 0.0 111.648 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.83 -154.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.912 2.485 . . . . 0.0 106.996 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -59.42 -53.44 58.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.605 1.162 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.6 -112.86 0.62 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.521 2.486 . . . . 0.0 114.716 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -112.27 3.72 17.29 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.741 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.1 m -40.02 -51.33 2.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.791 1.636 . . . . 0.0 113.686 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.58 -38.5 91.23 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.311 0.96 . . . . 0.0 112.175 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.63 -48.21 70.16 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -60.59 -23.11 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.661 0.785 . . . . 0.0 110.043 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.31 -31.33 48.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.013 0.525 . . . . 0.0 109.928 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -85.59 -33.62 21.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.592 1.087 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.0 tp -50.79 -56.83 10.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.348 2.259 . . . . 0.0 111.325 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.96 -35.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 0.0 111.777 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.84 -17.67 62.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 111.935 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -91.34 -24.04 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.776 1.23 . . . . 0.0 113.851 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.28 -6.19 4.28 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.74 -1.033 . . . . 0.0 114.45 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -69.74 147.63 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.573 1.687 . . . . 0.0 109.021 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.01 -66.92 0.3 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 113.318 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -152.57 170.81 19.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 108.817 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.18 128.44 9.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.461 -0.774 . . . . 0.0 109.797 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -109.92 120.85 43.78 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.95 1.3 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.75 113.88 22.96 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.43 115.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -71.04 161.59 30.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.55 12.16 8.6 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 129.354 3.062 . . . . 0.0 113.822 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.22 -138.55 27.14 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.707 1.171 . . . . 0.0 112.701 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -115.68 5.49 14.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 110.529 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.91 -3.28 3.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.41 172.78 49.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.595 1.089 . . . . 0.0 112.465 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.62 -25.2 73.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.891 3.061 . . . . 0.0 114.392 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 13.08 15.88 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.354 1.862 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.31 176.51 26.99 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.953 -1.092 . . . . 0.0 111.619 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -47.05 -61.8 1.71 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 113.186 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.26 -53.31 59.76 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.54 -14.57 43.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.813 1.645 . . . . 0.0 112.79 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -91.62 13.79 16.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.568 1.547 . . . . 0.0 110.442 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.9 m 63.15 23.15 13.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.649 2.38 . . . . 0.0 113.498 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.75 153.2 64.17 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' C ' HD22 ' A' ' 40' ' ' ASN . 37.8 Cg_endo -74.24 160.9 41.61 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.805 1.67 . . . . 0.0 110.175 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -163.08 135.76 5.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.864 1.211 . . . . 0.0 112.12 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 4.0 mt -76.13 95.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.697 1.999 . . . . 0.0 109.973 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -96.69 139.89 21.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 120.962 -1.086 . . . . 0.0 108.352 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.23 -172.05 1.06 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.798 2.998 . . . . 0.0 110.721 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.37 139.8 54.72 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.62 -178.58 3.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.551 1.54 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -112.99 157.23 21.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.516 1.126 . . . . 0.0 108.702 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 71.8 p -68.66 173.83 4.79 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.733 . . . . 0.0 110.141 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.24 154.75 28.31 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.5 168.24 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.167 1.911 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -127.46 -174.91 3.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.055 1.342 . . . . 0.0 107.962 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.6 m -154.62 178.01 10.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.204 1.401 . . . . 0.0 110.68 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.247 0 C-N-CA 127.116 2.293 . . . . 0.0 107.777 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.614 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.54 136.69 41.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.975 2.51 . . . . 0.0 105.051 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.49 -31.8 0.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.546 2.338 . . . . 0.0 114.722 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -168.02 22.84 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 125.573 1.559 . . . . 0.0 110.436 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 m -125.26 42.37 3.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.957 1.303 . . . . 0.0 110.654 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.3 p -69.58 173.43 6.05 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.364 -1.46 . . . . 0.0 111.205 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.46 -103.51 0.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 m -156.29 163.92 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.414 1.086 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.51 44.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.618 1.967 . . . . 0.0 111.962 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -55.1 -50.55 68.91 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.216 0.916 . . . . 0.0 110.853 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -51.56 67.49 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.951 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.23 77.33 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -73.24 -41.76 63.34 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.102 -0.999 . . . . 0.0 108.999 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -57.92 -45.92 85.8 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -51.69 -51.62 54.57 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.039 1.735 . . . . 0.0 110.644 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.23 -21.16 13.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.97 1.259 . . . . 0.0 113.094 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.6 -5.97 57.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.891 1.223 . . . . 0.0 112.824 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -123.38 -1.13 8.66 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.656 1.582 . . . . 0.0 110.565 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -127.33 102.25 6.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.052 -1.03 . . . . 0.0 110.722 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -93.3 32.4 1.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.71 0.804 . . . . 0.0 110.077 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.11 137.47 47.82 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 123.63 0.772 . . . . 0.0 109.164 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -144.58 136.0 25.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.832 0.853 . . . . 0.0 109.772 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -84.68 133.95 34.37 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.6 tp -123.86 104.44 8.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.589 1.956 . . . . 0.0 109.264 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -80.95 122.95 27.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.7 pt -105.62 1.84 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -66.09 171.67 4.41 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.15 1.38 . . . . 0.0 111.294 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.5 146.85 28.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.61 1.195 . . . . 0.0 109.472 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -43.03 -45.15 5.07 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 129.831 3.253 . . . . 0.0 113.682 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -35.61 79.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -32.35 73.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -67.21 -14.01 62.51 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.067 -1.646 . . . . 0.0 111.034 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -100.74 -14.38 18.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.008 2.123 . . . . 0.0 109.266 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -103.19 -65.41 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.971 1.708 . . . . 0.0 110.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -86.65 -36.44 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.934 1.294 . . . . 0.0 111.636 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.42 -155.3 16.17 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 118.977 0.808 . . . . 0.0 113.395 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 p -133.96 148.95 70.26 Favored Pre-proline 0 CA--C 1.518 -0.266 0 C-N-CA 124.756 1.223 . . . . 0.0 110.1 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.56 169.2 22.3 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 129.96 45.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.148 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.8 pt -124.33 7.08 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 125.917 1.687 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -58.77 -31.02 67.98 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 125.066 1.346 . . . . 0.0 110.77 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.33 -51.09 32.76 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.89 -50.72 61.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.872 0.836 . . . . 0.0 110.074 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.2 39.01 0.14 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.664 1.126 . . . . 0.0 111.385 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.31 -179.56 5.43 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.566 1.183 . . . . 0.0 110.935 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -143.77 115.11 8.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.967 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 150.53 22.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 118.537 0.608 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.26 125.95 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 p -103.15 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.153 0.981 . . . . 0.0 109.752 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 m -138.05 98.85 3.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.6 114.4 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.355 1.062 . . . . 0.0 109.593 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -80.79 150.0 29.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.917 0.865 . . . . 0.0 110.131 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -157.57 119.77 3.79 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.751 2.42 . . . . 0.0 105.131 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -22.6 59.43 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.15 -11.9 52.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.165 1.386 . . . . 0.0 110.453 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -146.26 46.67 1.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.069 -1.019 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -46.0 -49.02 41.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.99 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.14 -49.7 3.52 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.674 1.583 . . . . 0.0 111.306 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.33 78.75 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.579 1.081 . . . . 0.0 110.825 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.12 -58.7 7.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.909 1.284 . . . . 0.0 107.871 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 mt -51.25 -47.34 62.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.657 1.583 . . . . 0.0 110.694 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -57.21 -37.64 72.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.227 1.411 . . . . 0.0 110.253 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -62.32 -26.38 68.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.541 1.519 . . . . 0.0 110.895 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -47.14 11.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -54.67 -37.96 66.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.709 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.51 -0.98 35.54 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 -38.69 3.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.098 0.863 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -89.92 113.56 25.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -25.35 67.97 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.954 -0.546 . . . . 0.0 111.822 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -138.11 78.82 33.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.924 1.29 . . . . 0.0 111.165 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.05 -37.25 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.521 2.814 . . . . 0.0 113.107 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -12.98 7.15 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.879 1.272 . . . . 0.0 112.892 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.12 28.04 5.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 109.596 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 70.6 m -125.75 120.82 31.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.4 m -100.79 122.03 42.7 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.476 1.11 . . . . 0.0 108.09 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -97.61 106.78 19.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -83.37 97.19 8.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mt -73.07 132.22 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 109.462 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.2 tt -131.21 131.4 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.066 1.347 . . . . 0.0 109.223 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -134.48 175.43 9.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.797 2.439 . . . . 0.0 109.233 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -44.06 80.44 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.579 -1.326 . . . . 0.0 109.493 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -136.25 -148.82 0.3 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.64 -36.18 82.97 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.73 -1.231 . . . . 0.0 109.187 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.28 -99.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 127.247 2.356 . . . . 0.0 111.274 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -139.16 12.97 2.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 108.787 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -43.32 -57.07 3.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.049 1.74 . . . . 0.0 114.107 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -65.67 -30.67 71.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.252 0.933 . . . . 0.0 112.116 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -48.34 67.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.95 1.357 . . . . 0.0 108.966 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.58 -32.06 52.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.068 1.747 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.72 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.407 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -79.19 -48.8 13.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.703 1.138 . . . . 0.0 108.416 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.5 tp -42.21 -64.98 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.525 1.53 . . . . 0.0 114.056 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.8 m -62.92 -40.3 88.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.965 0.906 . . . . 0.0 112.018 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.62 45.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.848 0.718 . . . . 0.0 109.489 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 -27.11 68.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.07 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.59 -34.68 72.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.428 0.558 . . . . 0.0 111.839 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.52 -9.2 0.48 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.982 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.21 155.6 38.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.823 1.811 . . . . 0.0 110.806 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -66.59 0.36 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.518 0.727 . . . . 0.0 109.97 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -158.03 -179.46 8.15 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.505 1.922 . . . . 0.0 107.246 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.54 130.74 6.84 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -102.24 163.81 12.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.82 119.68 11.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.64 116.46 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.567 0.699 . . . . 0.0 111.26 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HE2' ' H ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -66.32 148.4 51.91 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.574 ' H ' ' HE2' ' A' ' 106' ' ' LYS . 4.2 m-20 68.09 -0.55 2.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.975 1.71 . . . . 0.0 111.426 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.75 -134.08 39.65 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.651 . . . . 0.0 111.723 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -94.07 -56.74 2.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.612 1.965 . . . . 0.0 111.827 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.39 -12.77 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.59 169.6 33.29 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 120.733 1.606 . . . . 0.0 113.048 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.6 -46.67 31.74 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.344 2.696 . . . . 0.0 113.306 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -98.76 21.41 11.47 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.542 1.519 . . . . 0.0 110.006 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.41 175.91 19.85 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.402 1.001 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -45.77 -67.29 0.3 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.431 1.892 . . . . 0.0 114.448 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.69 -45.55 63.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.921 0.888 . . . . 0.0 111.225 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -71.8 -8.14 52.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.245 1.418 . . . . 0.0 113.819 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -103.29 19.65 19.25 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.924 1.69 . . . . 0.0 112.745 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.8 t 61.53 32.03 18.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.858 0.863 . . . . 0.0 110.848 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.44 146.7 32.23 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.46 144.42 16.0 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.472 2.115 . . . . 0.0 111.196 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -142.27 156.35 45.28 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.355 -0.841 . . . . 0.0 110.441 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.3 90.3 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.491 1.117 . . . . 0.0 110.292 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -70.69 155.21 93.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.75 -0.594 . . . . 0.0 109.697 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.96 178.73 6.49 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.435 2.756 . . . . 0.0 110.164 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.18 -58.56 7.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.894 . . . . 0.0 109.26 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -73.84 156.71 37.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -137.03 161.31 36.42 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -178.78 2.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.159 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.64 73.08 0.03 OUTLIER Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.82 -178.73 4.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.206 2.604 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.3 t -132.15 157.36 44.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.43 1.492 . . . . 0.0 108.897 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -112.35 151.51 29.66 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 N-CA-C 104.099 -3.6 . . . . 0.0 104.099 -178.257 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -160.23 -169.77 2.6 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 t -56.65 -50.64 71.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.56 158.2 23.41 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 105.726 -2.95 . . . . 0.0 105.726 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 m -121.53 147.17 46.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.591 -0.946 . . . . 0.0 111.548 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.5 p -144.07 173.22 11.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.531 1.532 . . . . 0.0 110.351 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.07 -111.31 0.25 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.92 163.13 32.25 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.988 1.315 . . . . 0.0 112.135 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.17 79.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.646 1.578 . . . . 0.0 106.901 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.32 -50.65 72.79 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.194 -0.316 . . . . 0.0 111.351 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.3 -43.63 98.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.662 0.665 . . . . 0.0 111.04 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.5 66.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -72.71 -56.3 5.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.5 1.045 . . . . 0.0 109.054 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -51.16 -45.75 61.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.021 0.928 . . . . 0.0 110.983 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -57.15 -20.51 26.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.1 -29.27 31.83 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 119.598 1.09 . . . . 0.0 108.852 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.32 -35.04 12.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.062 1.315 . . . . 0.0 111.663 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -74.48 -14.53 60.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.02 0.91 . . . . 0.0 110.653 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.22 175.61 7.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.579 0.627 . . . . 0.0 111.793 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -112.72 -43.37 3.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.59 1.156 . . . . 0.0 111.372 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.99 -3.62 52.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.789 0.835 . . . . 0.0 111.781 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.63 119.58 21.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -132.39 145.74 51.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.259 0.481 . . . . 0.0 110.077 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.31 143.65 29.38 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.5 tp -122.42 109.39 14.32 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.734 1.614 . . . . 0.0 111.178 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.96 89.88 7.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.126 1.37 . . . . 0.0 109.221 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -83.12 -0.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 119.872 -1.768 . . . . 0.0 113.828 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -59.32 164.27 3.38 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 126.329 1.852 . . . . 0.0 111.818 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.32 147.97 32.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m -58.23 -20.72 44.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.704 1.602 . . . . 0.0 109.676 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -43.6 90.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.964 -1.085 . . . . 0.0 108.102 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -61.67 -28.64 69.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 110.777 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.73 -17.91 38.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.323 0.965 . . . . 0.0 110.805 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -110.12 -36.97 5.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.418 1.487 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.21 -27.64 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.86 -19.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.9 -152.61 17.76 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.311 -0.868 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 p -147.7 158.31 43.06 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 124.175 0.99 . . . . 0.0 111.527 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -78.66 155.42 27.48 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.696 1.597 . . . . 0.0 111.18 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.467 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 1.2 p30 -127.74 87.7 2.66 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.396 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 pt -72.95 5.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.589 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 40' ' ' ASN . 13.2 mptt -55.18 -34.72 64.09 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 110.543 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.16 -34.73 32.68 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.011 0.815 . . . . 0.0 111.729 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.58 -32.36 17.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.009 0.905 . . . . 0.0 111.034 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.57 29.2 1.09 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.897 1.237 . . . . 0.0 114.463 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -135.74 -178.79 5.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.234 1.017 . . . . 0.0 110.116 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.24 131.76 28.7 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.485 1.114 . . . . 0.0 109.636 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.2 163.07 27.42 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.69 130.19 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -96.77 94.72 7.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.039 2.135 . . . . 0.0 113.733 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -127.7 90.81 3.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.68 1.592 . . . . 0.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -49.97 116.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 121.476 -0.765 . . . . 0.0 110.966 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -82.52 153.57 25.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -156.33 130.1 8.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.01 -23.58 59.54 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.026 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -86.54 -8.88 57.17 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.674 1.19 . . . . 0.0 112.194 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -123.13 26.55 7.99 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.307 1.443 . . . . 0.0 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -42.7 -58.39 3.85 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.745 1.157 . . . . 0.0 111.913 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.65 -42.54 12.01 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.128 2.552 . . . . 0.0 112.101 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.28 -52.46 49.55 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -55.56 -49.03 73.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.491 1.517 . . . . 0.0 107.862 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -53.89 -50.21 66.84 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.769 0.828 . . . . 0.0 109.773 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -43.44 84.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.299 1.04 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -58.49 -23.99 59.29 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.133 1.333 . . . . 0.0 112.685 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mt -93.36 -50.55 5.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.709 1.604 . . . . 0.0 108.003 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.0 t -56.92 -23.25 43.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 109.398 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.2 -8.07 52.04 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -38.38 6.66 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.69 1.196 . . . . 0.0 109.663 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -83.07 177.44 8.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.072 1.349 . . . . 0.0 108.407 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -33.9 3.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.295 1.038 . . . . 0.0 112.334 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -144.57 86.3 8.11 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.99 0.916 . . . . 0.0 110.588 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -55.23 -32.61 81.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.948 2.432 . . . . 0.0 112.865 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.66 -8.0 1.8 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -123.22 -6.73 8.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.777 -1.106 . . . . 0.0 112.97 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -101.26 130.06 47.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -98.63 130.45 45.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.328 1.051 . . . . 0.0 109.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.36 103.16 12.64 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.646 1.178 . . . . 0.0 112.19 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.91 102.31 13.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.07 139.65 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.916 1.286 . . . . 0.0 113.414 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.43 123.65 21.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.935 1.694 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -130.58 170.65 13.99 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.576 2.351 . . . . 0.0 107.748 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -21.74 8.29 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 113.537 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -159.64 -162.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.916 3.287 . . . . 0.0 104.933 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.14 -55.09 16.48 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.861 2.065 . . . . 0.0 107.365 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.27 -96.95 0.02 OUTLIER Glycine 0 C--N 1.337 0.602 0 C-N-CA 128.251 2.834 . . . . 0.0 114.252 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -135.88 13.08 3.39 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.683 1.193 . . . . 0.0 110.859 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -52.03 -31.59 30.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.943 0.792 . . . . 0.0 110.961 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -72.19 -35.45 68.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.159 2.184 . . . . 0.0 111.745 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.43 -46.64 14.29 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.15 -30.84 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.02 94.91 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -71.65 -42.66 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.781 0.832 . . . . 0.0 109.203 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.2 tp -50.41 -62.15 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.133 1.373 . . . . 0.0 111.848 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.46 -38.62 80.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.115 0.566 . . . . 0.0 110.688 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.76 64.36 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.615 0.766 . . . . 0.0 109.727 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.05 -24.4 67.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.669 0.788 . . . . 0.0 111.589 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -77.2 -21.79 53.36 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.783 0.719 . . . . 0.0 110.844 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.56 6.52 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 117.154 -1.914 . . . . 0.0 114.086 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -70.01 152.1 44.8 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.616 2.208 . . . . 0.0 108.703 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -48.98 -65.81 0.5 Allowed 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.188 1.795 . . . . 0.0 113.184 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -155.74 174.75 14.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.911 1.284 . . . . 0.0 108.948 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.43 146.46 18.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -135.41 128.87 32.36 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.812 0.845 . . . . 0.0 110.394 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.81 118.39 30.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.36 115.74 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 121.286 -0.884 . . . . 0.0 109.029 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -68.23 150.1 48.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.8 11.59 8.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.625 1.57 . . . . 0.0 113.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.66 -136.84 2.71 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 124.964 1.269 . . . . 0.0 112.781 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.2 -26.61 13.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -100.12 -10.84 21.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.796 2.438 . . . . 0.0 115.281 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.9 170.39 8.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.999 1.272 . . . . 0.0 111.824 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.41 -29.33 23.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 124.022 3.148 . . . . 0.0 114.556 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.28 25.97 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.443 1.497 . . . . 0.0 110.616 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -173.59 3.88 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -41.66 -56.51 2.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.15 -52.81 64.01 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 123.492 0.717 . . . . 0.0 109.56 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.64 22.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.951 1.301 . . . . 0.0 112.791 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.3 m -120.13 10.26 11.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.055 1.742 . . . . 0.0 110.957 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.85 24.96 9.65 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.221 0.919 . . . . 0.0 110.397 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.2 mt -97.89 140.71 22.1 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.86 140.06 93.55 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 125.07 3.847 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -148.38 135.51 20.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.019 0.927 . . . . 0.0 112.204 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.467 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.2 mt -85.05 96.92 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.818 2.447 . . . . 0.0 108.108 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.73 155.93 68.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 O-C-N 121.484 -0.76 . . . . 0.0 112.719 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -80.13 165.16 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.307 2.671 . . . . 0.0 107.083 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -71.11 120.96 17.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -67.48 -2.71 6.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 p -66.19 -67.27 0.46 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.6 t -60.2 -16.93 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.51 119.27 5.09 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.94 160.05 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.296 2.048 . . . . 0.0 110.435 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 135.07 54.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 m -158.02 172.13 18.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.827 1.651 . . . . 0.0 108.566 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 125.82 1.676 . . . . 0.0 110.228 179.535 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -148.13 170.71 17.22 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.079 2.152 . . . . 0.0 107.892 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.51 118.9 3.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.949 0.795 . . . . 0.0 110.82 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.64 128.25 2.97 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 125.341 1.448 . . . . 0.0 109.891 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -64.47 108.45 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -136.05 162.8 31.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.65 0.78 . . . . 0.0 110.156 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.9 -112.12 0.26 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 163.57 36.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.916 1.358 . . . . 0.0 112.076 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.95 98.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -53.22 -55.63 22.84 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.216 1.007 . . . . 0.0 110.202 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -62.06 -45.3 94.14 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.699 0.624 . . . . 0.0 111.832 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.47 -41.75 85.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.62 -48.18 82.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.867 0.758 . . . . 0.0 109.605 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -60.6 -43.37 97.49 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.199 0.6 . . . . 0.0 111.025 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -39.04 89.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.245 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.0 mt -64.74 -20.4 66.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.895 1.225 . . . . 0.0 110.663 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 -12.46 64.56 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.327 0.965 . . . . 0.0 112.212 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p -117.82 -2.45 11.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.628 1.571 . . . . 0.0 112.243 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -125.12 109.11 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.147 1.379 . . . . 0.0 107.567 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.16 -29.97 68.09 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -84.46 -26.86 27.9 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.717 -0.615 . . . . 0.0 111.977 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 137.98 58.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -141.02 121.98 14.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.857 1.263 . . . . 0.0 109.627 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -55.11 129.79 39.46 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.013 0.925 . . . . 0.0 109.192 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp -109.73 99.49 8.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.929 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.79 112.69 19.17 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.84 7.15 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -64.88 172.12 3.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 110.815 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 144.36 30.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -44.48 -39.87 5.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.027 2.131 . . . . 0.0 111.902 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.33 77.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.929 -0.557 . . . . 0.0 111.557 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.58 -37.2 75.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.393 0.997 . . . . 0.0 110.629 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -62.05 -7.69 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.935 -1.103 . . . . 0.0 112.887 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -123.41 -14.82 7.31 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.543 1.937 . . . . 0.0 111.115 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.93 -45.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.956 1.303 . . . . 0.0 110.814 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.19 -18.56 7.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 124.938 1.295 . . . . 0.0 110.472 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.25 -156.51 21.27 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.446 -0.784 . . . . 0.0 111.808 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.8 167.58 13.89 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 121.648 -0.913 . . . . 0.0 112.251 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 158.3 55.22 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.217 1.278 . . . . 0.0 110.309 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.47 HD22 ' HB2' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -125.0 56.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.946 1.698 . . . . 0.0 112.965 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.6 pt -71.67 10.54 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.415 1.086 . . . . 0.0 111.651 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' H ' ' C ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -54.08 -42.63 69.55 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.133 1.373 . . . . 0.0 111.074 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -52.58 -46.05 59.17 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 mt -61.91 -23.71 66.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 112.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.32 38.87 3.63 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -136.45 168.54 19.27 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 117.773 0.786 . . . . 0.0 111.989 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -138.84 127.56 23.42 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 157.45 37.73 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -116.67 99.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 p -79.02 113.14 16.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.4 m -142.02 109.62 5.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.18 116.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.822 0.283 . . . . 0.0 110.67 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.95 138.95 36.1 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -150.64 127.69 11.15 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.65 -19.14 34.0 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.186 1.374 . . . . 0.0 113.96 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.18 -17.28 60.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.866 1.833 . . . . 0.0 110.938 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -133.12 59.91 1.72 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.686 0.794 . . . . 0.0 110.37 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.05 -54.6 53.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 120.699 -1.251 . . . . 0.0 108.533 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.82 -41.16 8.39 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 121.664 1.63 . . . . 0.0 109.468 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.91 59.17 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.287 0.946 . . . . 0.0 111.695 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -71.49 -60.18 2.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.9 mt -47.29 -46.58 25.01 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.335 1.854 . . . . 0.0 111.639 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -59.43 -33.3 71.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.485 0.714 . . . . 0.0 110.907 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -69.17 -23.99 64.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.064 1.302 . . . . 0.0 111.115 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.74 -34.73 30.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -57.79 -36.62 72.43 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.524 -0.735 . . . . 0.0 112.774 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.64 -5.76 44.87 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 -33.11 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.987 0.812 . . . . 0.0 112.909 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -93.5 106.16 18.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.533 1.133 . . . . 0.0 111.139 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -56.82 -51.09 70.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.626 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.34 86.22 50.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.081 0.952 . . . . 0.0 109.048 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.08 -18.81 60.22 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.807 1.671 . . . . 0.0 113.808 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.4 -16.82 16.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -123.25 -1.84 8.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.603 1.561 . . . . 0.0 112.078 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.1 m -93.22 132.66 37.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 111.193 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -102.25 149.91 23.83 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.92 91.79 3.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.064 1.346 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 30.8 m-85 -74.34 101.52 4.09 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 102.961 -2.977 . . . . 0.0 102.961 177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.89 130.23 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.759 1.223 . . . . 0.0 112.671 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.23 107.88 11.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.513 1.525 . . . . 0.0 109.361 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.25 173.59 6.25 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.03 -58.73 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.615 -1.303 . . . . 0.0 109.311 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.78 -153.05 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.512 ' CG ' ' HZ3' ' A' ' 106' ' ' LYS . 71.5 m-20 -60.63 -36.68 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.247 0.476 . . . . 0.0 109.872 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.24 -118.67 0.19 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 128.572 2.987 . . . . 0.0 115.566 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -101.12 -3.1 29.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -41.55 -55.97 2.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.299 1.839 . . . . 0.0 115.102 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -26.79 66.32 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -49.81 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.24 -35.06 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.489 1.115 . . . . 0.0 109.222 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.3 66.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.392 1.077 . . . . 0.0 111.355 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -92.61 -35.38 13.57 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.775 0.716 . . . . 0.0 110.026 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.0 -59.22 4.61 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.649 0.738 . . . . 0.0 109.895 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.03 -38.81 78.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.14 0.976 . . . . 0.0 112.107 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.02 -53.75 51.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.129 1.372 . . . . 0.0 109.804 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.01 -28.62 67.87 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 110.54 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -76.97 -24.31 52.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.892 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.15 -0.8 2.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.906 -1.497 . . . . 0.0 115.695 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -73.1 150.62 42.11 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 120.198 1.999 . . . . 0.0 107.303 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.6 tpmt? -59.13 -52.83 64.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -165.49 176.41 8.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 107.903 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.9 163.39 40.12 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 43.9 m-85 -146.92 114.75 6.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.354 1.062 . . . . 0.0 109.144 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.11 113.89 15.34 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.497 1.119 . . . . 0.0 108.798 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.79 101.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.512 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 4.7 tmtm? -62.69 150.52 40.81 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 71.58 6.77 5.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.222 1.809 . . . . 0.0 110.934 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.35 -130.21 14.51 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.058 1.299 . . . . 0.0 110.51 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.66 -16.7 7.13 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.22 -25.57 21.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.504 1.047 . . . . 0.0 112.99 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.51 170.23 1.34 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 128.851 3.119 . . . . 0.0 116.598 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.82 -22.36 36.78 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 124.064 3.176 . . . . 0.0 112.774 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.255 12.7 tpt180 -124.85 14.13 8.57 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.741 2.017 . . . . 0.0 109.56 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.82 -177.94 20.62 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.45 -1.406 . . . . 0.0 111.382 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -48.88 -53.27 20.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 113.405 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.02 -51.12 70.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.848 0.459 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.6 32.14 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.737 2.015 . . . . 0.0 112.303 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.8 m -126.5 12.2 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.007 1.723 . . . . 0.0 109.836 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 t 62.0 28.51 17.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.867 0.758 . . . . 0.0 110.437 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.81 138.63 19.69 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HB2' HD22 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -70.75 157.23 59.05 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.031 1.821 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -158.39 151.29 22.5 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 108.772 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 40' ' ' ASN . 2.5 mt -98.08 88.57 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.73 153.94 85.27 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.0 173.42 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.476 2.118 . . . . 0.0 108.509 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -59.25 -29.4 67.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -76.84 115.3 16.5 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.81 1.244 . . . . 0.0 111.135 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.52 133.54 34.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.8 t -165.62 141.58 5.2 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.709 1.203 . . . . 0.0 108.399 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.49 120.46 1.01 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.47 169.63 13.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.86 2.373 . . . . 0.0 112.209 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.9 m -76.98 96.36 4.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.94 144.14 29.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 106.331 -2.708 . . . . 0.0 106.331 -178.827 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.565 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -142.64 127.74 18.55 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 100.79 2.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.574 1.079 . . . . 0.0 109.564 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.74 -131.59 43.57 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -141.65 81.1 1.75 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p -59.94 128.65 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.026 -1.046 . . . . 0.0 108.502 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.28 109.38 0.41 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -37.47 149.89 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.446 2.298 . . . . 0.0 112.848 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.6 47.58 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.581 . . . . 0.0 111.623 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -60.71 -51.75 68.06 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 110.191 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -55.47 -46.57 76.83 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.758 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.85 87.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.267 0.627 . . . . 0.0 109.611 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.99 -51.34 70.49 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.656 0.782 . . . . 0.0 109.991 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.3 m -61.62 -41.86 98.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.888 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -56.97 -48.74 77.68 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.502 1.121 . . . . 0.0 109.978 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.86 -19.67 60.47 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.035 0.534 . . . . 0.0 111.656 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.03 -7.06 61.37 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.501 2.477 . . . . 0.0 114.418 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 t -121.3 -8.91 9.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.08 1.752 . . . . 0.0 109.351 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.81 178.43 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.884 0.874 . . . . 0.0 109.494 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 38.1 t70 -128.12 -49.16 1.33 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.333 0.969 . . . . 0.0 111.666 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -71.51 -2.84 18.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.695 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 121.83 23.67 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.555 2.342 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -136.38 149.22 48.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.49 132.08 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.663 1.185 . . . . 0.0 110.107 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 tp -113.38 111.12 21.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.026 1.33 . . . . 0.0 109.829 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.08 116.36 28.84 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.8 pt -99.4 9.06 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -65.36 163.65 15.19 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.728 1.611 . . . . 0.0 113.619 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.49 139.62 44.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -45.94 -41.84 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.792 1.237 . . . . 0.0 112.459 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.1 67.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.75 0.82 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -59.82 -43.69 94.41 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.435 0.562 . . . . 0.0 110.502 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -56.91 -21.94 33.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.004 0.82 . . . . 0.0 112.823 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -84.12 -26.83 28.61 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.024 0.929 . . . . 0.0 109.825 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -91.29 -59.3 2.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.457 1.503 . . . . 0.0 112.816 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.6 -34.71 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.836 1.254 . . . . 0.0 114.148 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -144.93 16.44 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.9 p -154.15 156.01 31.5 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 119.374 1.587 . . . . 0.0 112.889 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.51 135.93 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.936 2.424 . . . . 0.0 111.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.638 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -103.41 80.12 1.78 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.851 2.861 . . . . 0.0 107.893 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 pt -77.75 2.61 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.493 -1.379 . . . . 0.0 111.668 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -47.79 -31.84 5.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.495 2.718 . . . . 0.0 115.729 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.09 77.32 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt -85.05 -38.36 19.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.69 0.68 Allowed Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.696 1.141 . . . . 0.0 111.047 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 20' ' ' ASP . 41.6 mmtm -145.51 178.86 7.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.091 1.756 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -133.66 165.49 24.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.974 0.892 . . . . 0.0 110.839 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.49 163.74 15.62 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 108.843 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -138.79 128.37 31.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.153 1.381 . . . . 0.0 107.693 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -99.22 121.94 41.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.398 1.079 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.9 m -148.65 106.56 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.99 110.17 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -76.14 162.95 27.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -166.98 136.45 2.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.069 2.148 . . . . 0.0 105.277 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.2 66.7 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.472 0.558 . . . . 0.0 112.829 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.93 -50.28 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.15 24.48 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -43.76 -52.15 15.22 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 120.244 1.384 . . . . 0.0 110.09 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.41 -44.95 12.87 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.37 2.047 . . . . 0.0 111.786 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.95 83.69 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.722 1.153 . . . . 0.0 110.906 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.07 -53.06 51.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.527 1.931 . . . . 0.0 108.394 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.92 -47.47 64.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.228 1.011 . . . . 0.0 111.177 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -51.92 -47.42 64.66 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.95 -29.43 12.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.465 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -50.35 6.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m -55.93 -32.73 64.06 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.418 1.008 . . . . 0.0 112.198 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.25 -5.02 57.31 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.566 0.746 . . . . 0.0 112.961 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -41.48 3.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.524 1.13 . . . . 0.0 111.578 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.95 179.57 7.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.845 1.258 . . . . 0.0 108.716 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -127.6 -24.36 3.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.415 1.086 . . . . 0.0 113.153 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.75 83.09 8.31 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -56.19 -38.1 95.51 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.267 1.312 . . . . 0.0 110.229 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.45 -15.9 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.503 1.921 . . . . 0.0 114.425 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -124.03 -16.13 6.63 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.784 1.233 . . . . 0.0 111.55 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.1 m -77.98 137.2 38.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.049 0.84 . . . . 0.0 110.656 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -110.25 125.45 53.12 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.24 100.51 10.1 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.431 1.092 . . . . 0.0 112.408 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CE2' ' CD1' ' A' ' 103' ' ' TYR . 40.6 m-85 -82.54 96.7 8.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -73.99 124.49 31.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.095 1.358 . . . . 0.0 109.565 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -121.77 125.44 46.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 109.498 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 26.3 t0 -133.41 172.42 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.808 0.843 . . . . 0.0 112.572 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 52.3 mttm -46.52 -54.67 8.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.65 1.58 . . . . 0.0 108.926 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -136.82 -155.97 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.04 2.936 . . . . 0.0 104.716 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -52.85 -54.23 37.4 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.765 1.226 . . . . 0.0 109.722 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.36 -98.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.448 1.975 . . . . 0.0 111.459 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.66 16.47 2.71 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.293 2.237 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -45.04 -45.23 10.72 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.968 1.258 . . . . 0.0 113.41 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -73.38 -41.8 62.92 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.202 0.91 . . . . 0.0 111.24 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.42 -46.67 88.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.7 t -66.73 -34.51 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.13 82.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.036 0.835 . . . . 0.0 109.389 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -73.11 -48.17 37.93 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.9 tp -50.16 -58.97 4.42 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.122 1.769 . . . . 0.0 113.837 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.91 -38.39 81.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 122.15 -0.343 . . . . 0.0 110.126 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.4 77.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.36 -26.68 67.98 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.374 1.469 . . . . 0.0 111.349 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -84.55 -21.65 30.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.655 0.662 . . . . 0.0 111.968 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.66 1.98 2.04 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.046 -1.975 . . . . 0.0 115.978 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -73.34 150.27 41.98 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.78 2.29 . . . . 0.0 109.633 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -55.89 -58.41 8.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.582 0.753 . . . . 0.0 111.129 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.8 m -159.3 166.18 31.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 107.465 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.37 12.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CD1' ' CE2' ' A' ' 78' ' ' TYR . 55.3 m-85 -100.26 151.23 21.71 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.23 111.14 19.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.32 91.37 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 113.96 10.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.25 34.0 m-20 115.32 4.84 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 133.079 4.552 . . . . 0.0 110.553 179.994 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.39 -134.49 41.92 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.658 -1.276 . . . . 0.0 114.866 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.98 -44.77 5.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -87.72 -22.71 24.45 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -52.98 170.88 0.59 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.443 1.973 . . . . 0.0 115.012 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -57.0 -27.55 74.07 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 124.532 3.488 . . . . 0.0 115.619 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -120.64 9.67 10.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.002 2.121 . . . . 0.0 109.03 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 168.98 20.83 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -47.19 -62.62 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 113.632 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.37 -52.83 63.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.795 1.238 . . . . 0.0 110.459 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.36 13.98 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.172 2.189 . . . . 0.0 113.437 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.4 m -129.47 16.56 5.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.644 1.578 . . . . 0.0 112.0 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.7 m 63.59 18.97 11.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.084 1.754 . . . . 0.0 113.661 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.3 mt -76.7 154.74 83.45 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.638 ' C ' HD22 ' A' ' 40' ' ' ASN . 98.3 Cg_endo -72.61 162.62 40.82 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.165 1.243 . . . . 0.0 109.969 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -167.38 126.51 1.36 Allowed 'General case' 0 C--O 1.238 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 113.059 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -73.49 93.19 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.977 2.111 . . . . 0.0 109.565 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.55 151.69 50.91 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.56 -165.78 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.14 2.56 . . . . 0.0 107.366 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 135.23 29.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -43.88 103.33 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.602 1.561 . . . . 0.0 109.61 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.8 m -92.16 129.89 38.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.7 p -164.21 178.29 7.69 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.672 1.189 . . . . 0.0 109.299 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 163.61 -102.38 0.2 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-O 117.703 -1.61 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.98 -19.9 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.675 2.916 . . . . 0.0 115.836 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 p -133.06 157.51 45.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.853 1.66 . . . . 0.0 112.132 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.64 -162.5 1.53 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.955 2.102 . . . . 0.0 108.159 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 179.344 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -147.64 160.36 42.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.557 1.179 . . . . 0.0 111.231 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 p -169.88 115.35 0.53 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.63 1.972 . . . . 0.0 108.363 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.32 136.58 37.13 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 t -77.91 88.56 4.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.372 1.086 . . . . 0.0 109.196 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -61.0 136.1 57.99 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.08 106.88 0.49 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -49.68 148.7 2.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.515 1.158 . . . . 0.0 109.023 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.86 48.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -67.8 -48.03 67.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.288 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -63.11 -45.14 93.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.856 0.753 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.12 81.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.47 -41.07 98.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.092 0.86 . . . . 0.0 111.581 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -60.35 -54.78 41.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -49.6 -53.01 26.36 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.327 1.051 . . . . 0.0 111.719 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.9 mt -57.55 -23.2 49.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 113.202 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.87 -5.79 60.93 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.951 1.262 . . . . 0.0 112.676 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -124.62 -1.86 7.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.495 1.148 . . . . 0.0 111.227 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -131.38 115.83 16.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.453 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -69.18 -47.48 64.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.842 1.257 . . . . 0.0 111.703 -178.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -72.56 -6.9 47.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.582 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.02 118.6 18.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.56 131.91 46.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.816 0.817 . . . . 0.0 110.944 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.28 127.52 32.09 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.465 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.2 tp -109.36 103.92 12.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.854 2.062 . . . . 0.0 109.525 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.96 108.3 16.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.245 1.018 . . . . 0.0 108.273 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -102.36 0.09 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -61.44 168.55 2.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.374 1.07 . . . . 0.0 113.632 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.45 136.81 37.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.413 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -38.25 -40.35 0.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.664 2.786 . . . . 0.0 114.322 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.02 76.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.869 0.759 . . . . 0.0 112.571 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.18 80.07 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.446 0.566 . . . . 0.0 111.024 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -65.67 -6.31 11.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.592 1.157 . . . . 0.0 111.824 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.68 -29.42 7.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.556 1.943 . . . . 0.0 109.486 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -94.67 -59.42 1.93 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.88 0.872 . . . . 0.0 112.824 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -26.33 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.696 1.599 . . . . 0.0 112.947 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.82 -153.38 19.17 Favored Glycine 0 C--N 1.335 0.487 0 O-C-N 121.42 -0.8 . . . . 0.0 112.836 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -143.3 162.0 44.84 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.49 178.39 6.23 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.072 1.181 . . . . 0.0 111.185 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.17 145.75 31.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.57 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.69 13.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.413 1.885 . . . . 0.0 110.619 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -59.06 -27.54 65.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.106 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.64 94.58 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.3 mt -70.16 -28.42 65.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 0.0 109.785 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.86 19.29 7.39 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 127.694 2.569 . . . . 0.0 110.817 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 20' ' ' ASP . 46.1 mmtm -130.24 -178.57 4.8 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 150.49 34.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.612 1.165 . . . . 0.0 108.855 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 179.96 7.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.745 0.818 . . . . 0.0 110.697 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.85 133.09 44.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -113.7 121.05 42.94 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.008 1.276 . . . . 0.0 111.273 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -146.69 108.1 4.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 t -57.98 119.91 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -75.92 124.45 27.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -131.12 116.72 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.04 1.736 . . . . 0.0 107.197 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.01 -27.43 67.12 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 118.464 0.575 . . . . 0.0 112.652 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -74.1 -15.42 61.05 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.625 0.712 . . . . 0.0 110.6 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.74 32.32 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.468 1.907 . . . . 0.0 113.584 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -43.06 -56.69 6.03 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 121.452 1.933 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -63.7 -37.05 48.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.724 2.282 . . . . 0.0 112.341 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.44 74.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.319 1.437 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -82.11 -56.7 3.77 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.09 -44.59 61.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.042 1.737 . . . . 0.0 112.769 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -57.36 -36.88 71.76 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.801 0.728 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -61.82 -20.62 63.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.921 0.889 . . . . 0.0 111.356 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.8 -43.28 8.3 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.6 t -52.43 -34.62 49.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.991 1.716 . . . . 0.0 111.541 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.99 -6.03 53.17 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -37.37 4.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.785 0.721 . . . . 0.0 110.899 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -91.88 103.88 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.901 0.881 . . . . 0.0 109.627 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -18.33 60.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.338 0.517 . . . . 0.0 111.68 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 68.24 79.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.642 1.177 . . . . 0.0 109.532 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -32.39 93.21 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.499 2.133 . . . . 0.0 111.63 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.11 -19.9 8.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.394 1.878 . . . . 0.0 115.934 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -124.87 8.48 8.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.841 1.256 . . . . 0.0 110.957 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -104.42 111.83 24.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.712 1.605 . . . . 0.0 111.323 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.5 m -83.67 129.32 34.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.85 102.61 14.43 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.478 0.711 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -84.43 92.56 8.09 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.18 127.17 31.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.68 1.592 . . . . 0.0 110.849 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -127.2 130.98 50.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.647 1.579 . . . . 0.0 109.128 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 49.1 t0 -137.09 -170.54 2.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.078 2.151 . . . . 0.0 107.703 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 17.9 ptmt -62.51 -48.5 79.28 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.03 -1.044 . . . . 0.0 108.676 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -140.97 -172.77 3.55 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.999 2.519 . . . . 0.0 108.886 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -48.89 -30.02 5.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.686 1.994 . . . . 0.0 113.121 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.33 -108.14 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 C-N-CA 130.208 3.766 . . . . 0.0 115.717 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -110.73 0.92 17.57 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 127.209 2.203 . . . . 0.0 108.816 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -51.48 -47.04 63.33 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 121.188 1.813 . . . . 0.0 109.755 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -64.47 -23.99 67.47 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 tp -87.32 -43.23 12.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.127 0.971 . . . . 0.0 110.97 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.98 -30.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.18 83.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.04 -43.24 71.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 125.794 1.637 . . . . 0.0 111.131 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.41 -56.16 21.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.915 0.886 . . . . 0.0 112.175 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.22 -35.32 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.14 95.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.058 0.543 . . . . 0.0 109.893 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.16 -37.97 84.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.579 0.752 . . . . 0.0 109.709 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -61.28 -50.58 72.44 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.18 -3.1 0.29 Allowed Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.976 -1.458 . . . . 0.0 115.377 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -58.79 153.2 17.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.632 1.716 . . . . 0.0 109.107 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -46.94 -70.13 0.11 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.489 1.116 . . . . 0.0 112.523 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 m -154.79 177.38 11.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.443 2.297 . . . . 0.0 105.826 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.06 136.55 8.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.15 -0.969 . . . . 0.0 108.651 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -113.33 154.52 26.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.703 1.201 . . . . 0.0 108.339 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.49 114.12 23.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.264 2.4 mp -66.15 106.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.73 128.02 34.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.22 9.88 4.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.885 2.874 . . . . 0.0 111.76 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.03 -111.8 0.51 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.196 1.855 . . . . 0.0 110.839 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.75 -9.12 3.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.516 1.126 . . . . 0.0 112.027 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.82 -1.54 27.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.2 41.64 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.31 -39.92 84.84 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.527 3.485 . . . . 0.0 114.746 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 21.55 9.63 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.862 0.865 . . . . 0.0 110.999 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.4 171.71 4.01 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -40.91 -46.3 2.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 113.52 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.8 mt -65.76 -57.2 8.55 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.374 0.988 . . . . 0.0 110.627 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -66.81 -4.49 9.33 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.712 2.005 . . . . 0.0 114.303 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 p -97.2 3.9 51.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 t 77.24 11.16 2.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.634 1.973 . . . . 0.0 111.859 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.1 152.88 79.72 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.012 0.824 . . . . 0.0 110.459 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.72 142.96 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.187 1.925 . . . . 0.0 110.981 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -145.06 142.2 29.52 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.502 -0.749 . . . . 0.0 110.313 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.0 mt -92.59 93.01 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.851 1.26 . . . . 0.0 109.121 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.85 148.64 72.73 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.639 0.775 . . . . 0.0 109.103 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.91 -155.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.284 3.323 . . . . 0.0 107.118 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -118.43 56.05 0.89 Allowed 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.518 -1.364 . . . . 0.0 109.842 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -125.12 146.95 49.24 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.784 1.634 . . . . 0.0 109.726 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.8 m -156.82 121.53 4.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.05 145.29 10.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.559 1.544 . . . . 0.0 107.805 178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.22 149.5 45.82 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.63 176.44 9.88 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.875 3.05 . . . . 0.0 111.985 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.2 m -135.63 130.39 34.29 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.675 2.39 . . . . 0.0 107.132 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -61.26 141.43 57.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.843 1.257 . . . . 0.0 111.818 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.668 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -71.43 167.11 20.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.399 2.28 . . . . 0.0 111.171 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 2.46 26.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.727 0.811 . . . . 0.0 110.0 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.06 151.86 19.25 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.59 0.632 . . . . 0.0 113.593 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -84.02 100.15 10.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.197 2.199 . . . . 0.0 108.778 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 p -130.97 160.21 35.22 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.525 0.73 . . . . 0.0 111.416 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.9 -98.32 0.11 Allowed Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.6 m -157.26 160.08 38.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.104 1.452 . . . . 0.0 112.446 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.96 77.63 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.858 -1.068 . . . . 0.0 112.385 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -55.03 -51.5 66.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.911 1.232 . . . . 0.0 109.832 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -52.02 -54.36 30.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.598 0.759 . . . . 0.0 110.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.23 82.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 112.621 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.24 -45.72 75.89 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -59.89 -41.47 91.66 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -60.79 -44.2 97.12 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.631 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.81 -44.83 78.24 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.355 1.434 . . . . 0.0 107.708 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.0 -6.86 33.81 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.535 1.541 . . . . 0.0 115.952 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 t -129.59 -2.82 4.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.659 1.73 . . . . 0.0 111.655 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -113.97 94.09 4.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.805 1.642 . . . . 0.0 106.82 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.52 -27.03 1.59 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.523 1.929 . . . . 0.0 115.862 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -109.9 5.42 22.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.239 0.927 . . . . 0.0 113.11 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.27 148.56 39.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.008 0.822 . . . . 0.0 111.618 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' NE2' ' HZ1' ' A' ' 46' ' ' LYS . 36.1 mm-40 -142.9 158.88 43.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.235 0.614 . . . . 0.0 110.277 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -102.08 119.72 39.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.362 1.465 . . . . 0.0 108.006 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 109.33 20.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.492 1.917 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 121.16 27.43 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.148 2.179 . . . . 0.0 107.625 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.8 pt -120.44 4.66 6.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -66.43 170.45 6.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 121.798 2.09 . . . . 0.0 108.968 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.73 150.11 48.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -52.42 -32.8 40.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 111.701 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.94 70.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.179 0.899 . . . . 0.0 113.222 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.82 -38.34 88.64 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -63.25 -10.4 15.63 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.573 -1.954 . . . . 0.0 114.803 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -21.05 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.337 1.855 . . . . 0.0 109.43 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.06 -79.32 0.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.853 2.061 . . . . 0.0 109.265 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.85 -30.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.267 1.427 . . . . 0.0 112.731 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.68 -134.22 11.9 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 p -151.11 158.17 34.83 Favored Pre-proline 0 N--CA 1.448 -0.573 0 O-C-N 122.654 -0.321 . . . . 0.0 111.175 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.74 173.81 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 N-CA-C 107.321 -1.838 . . . . 0.0 107.321 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.499 HD22 ' HB2' ' A' ' 121' ' ' PRO . 1.3 p30 -141.31 149.09 40.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.09 9.31 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.464 1.126 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -58.3 -32.72 68.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.392 1.477 . . . . 0.0 111.586 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -48.1 -42.79 24.28 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 124.804 1.315 . . . . 0.0 110.321 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 mt -77.1 -75.01 0.22 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.51 44.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.548 ' HZ1' ' NE2' ' A' ' 23' ' ' GLN . 27.7 mmtp -141.09 -176.11 4.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.922 1.689 . . . . 0.0 109.014 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.23 136.93 25.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.862 2.065 . . . . 0.0 107.136 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -175.79 2.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.977 0.911 . . . . 0.0 111.732 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.14 133.95 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.4 p -120.05 108.47 14.32 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.982 0.913 . . . . 0.0 113.455 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -143.46 108.48 4.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -57.47 122.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 118.149 0.431 . . . . 0.0 110.226 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -74.18 151.09 40.07 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -156.45 116.16 3.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.17 -22.15 57.72 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 117.902 0.319 . . . . 0.0 112.726 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 58.1 mt-10 -76.66 -15.22 59.86 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.163 0.981 . . . . 0.0 111.591 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -128.13 33.75 4.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.073 1.349 . . . . 0.0 113.784 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.39 -54.37 7.99 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.765 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.92 -47.26 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.563 2.175 . . . . 0.0 112.362 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.42 -24.88 71.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.849 -0.417 . . . . 0.0 112.593 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.76 -39.82 17.99 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 118.159 0.979 . . . . 0.0 108.602 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.6 -47.97 79.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.89 0.876 . . . . 0.0 111.194 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -52.94 -37.74 61.3 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.034 0.534 . . . . 0.0 111.623 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.86 -29.39 68.26 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.474 -0.766 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.63 -50.61 6.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 t -55.0 -26.6 38.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.206 1.802 . . . . 0.0 112.631 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.67 -18.3 33.57 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.231 -0.918 . . . . 0.0 111.64 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -51.61 3.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.462 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.32 98.8 4.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -56.97 -33.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.176 0.99 . . . . 0.0 113.469 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -131.68 80.84 65.34 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.11 -26.42 42.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.814 2.343 . . . . 0.0 113.101 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -54.54 -18.62 4.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.161 1.785 . . . . 0.0 114.165 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -132.84 7.66 4.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 112.694 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -105.25 109.15 21.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.454 1.502 . . . . 0.0 109.895 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.7 m -80.84 137.98 36.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.519 0.728 . . . . 0.0 109.997 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.2 mt -113.54 99.62 7.88 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 112.22 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 52.7 m-85 -76.58 112.52 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.5 141.87 14.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.147 1.379 . . . . 0.0 110.478 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -137.42 133.48 34.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -134.33 175.58 9.38 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -58.28 -55.53 33.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.59 -1.319 . . . . 0.0 110.682 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -130.26 -152.52 0.52 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.258 3.423 . . . . 0.0 105.503 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.3 -6.09 2.92 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 10.38 -94.18 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 1 C-N-CA 131.872 4.558 . . . . 0.0 117.5 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.37 4.62 1.21 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.287 2.235 . . . . 0.0 112.161 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.7 m -29.31 -62.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.404 2.682 . . . . 0.0 114.463 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.04 -45.81 82.88 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.254 2.222 . . . . 0.0 112.916 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -48.24 79.23 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.695 1.198 . . . . 0.0 108.71 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.0 -34.6 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.72 87.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.983 0.81 . . . . 0.0 109.124 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.4 -42.38 87.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -53.13 -58.79 5.84 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.993 1.317 . . . . 0.0 111.685 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.11 -38.0 81.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 121.873 -0.517 . . . . 0.0 110.555 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.19 93.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.701 0.626 . . . . 0.0 111.057 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.59 -45.21 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.59 0.756 . . . . 0.0 110.236 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -55.26 -37.91 67.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.753 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -9.51 0.26 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.99 -0.895 . . . . 0.0 115.205 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -67.57 142.04 56.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.444 1.622 . . . . 0.0 108.923 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -41.14 -57.52 2.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.296 2.638 . . . . 0.0 112.79 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.0 t -166.99 173.59 9.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.44 149.61 27.94 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.466 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 44.9 m-85 -133.26 122.01 23.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.7 98.4 11.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 108.871 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -64.12 120.11 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -72.21 165.39 24.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.372 0.669 . . . . 0.0 109.82 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.3 16.07 10.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.244 1.818 . . . . 0.0 112.942 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.13 -123.97 32.85 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.36 -24.76 3.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.737 2.415 . . . . 0.0 109.472 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.43 -27.63 25.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.891 1.676 . . . . 0.0 113.524 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.48 178.9 41.14 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.214 0.911 . . . . 0.0 114.652 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.53 -51.12 11.2 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.411 3.408 . . . . 0.0 113.839 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -88.66 7.26 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.688 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.78 153.46 47.27 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -34.13 -64.06 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 129.512 3.125 . . . . 0.0 115.711 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -56.66 -53.94 51.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.03 0.377 . . . . 0.0 110.497 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.23 -15.33 62.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.91 2.084 . . . . 0.0 113.031 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 t -88.51 8.13 29.62 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.571 1.548 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.6 t 64.77 20.75 12.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.867 2.467 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.57 158.51 59.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 123.592 0.757 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.499 ' HB2' HD22 ' A' ' 40' ' ' ASN . 57.3 Cg_endo -77.62 152.88 29.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.305 2.003 . . . . 0.0 110.613 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -151.08 141.66 22.61 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 120.704 -1.247 . . . . 0.0 111.191 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 mt -81.38 80.99 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.915 1.286 . . . . 0.0 109.908 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -78.98 122.36 84.44 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.9 174.43 9.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.0 110.002 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -67.5 113.21 5.16 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -121.53 179.86 4.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.038 1.335 . . . . 0.0 109.468 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.7 t -87.86 179.78 6.4 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 p -128.1 168.41 15.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.726 -1.234 . . . . 0.0 109.59 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.95 142.99 11.29 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.29 165.66 25.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.496 2.13 . . . . 0.0 111.579 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.92 137.08 16.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -143.87 179.66 7.03 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.724 0.774 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.449 0 N-CA-C 106.981 -2.447 . . . . 0.0 106.981 179.421 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.405 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m -138.52 -42.24 0.5 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.049 0.94 . . . . 0.0 111.195 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -80.6 89.66 5.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.267 1.394 . . . . 0.0 108.335 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.02 130.96 3.38 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 106.462 -2.655 . . . . 0.0 106.462 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m -65.94 57.67 0.03 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.787 2.435 . . . . 0.0 115.631 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.0 p -75.58 162.39 28.32 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.92 -110.93 0.28 Allowed Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.3 m -147.31 160.23 42.75 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.374 1.07 . . . . 0.0 111.064 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.48 33.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.462 1.905 . . . . 0.0 110.369 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -53.72 -49.87 67.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.398 0.544 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -57.03 -50.47 72.65 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.824 0.284 . . . . 0.0 111.493 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.81 77.09 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.927 0.491 . . . . 0.0 111.147 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -63.9 -48.3 77.15 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.8 m -58.16 -42.27 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.203 0.601 . . . . 0.0 109.954 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -62.31 -34.31 76.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.578 -1.201 . . . . 0.0 111.844 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.27 -43.0 99.59 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.09 -0.48 15.29 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.839 1.685 . . . . 0.0 113.142 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -19.88 7.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.99 2.516 . . . . 0.0 111.279 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -127.61 112.49 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.117 -1.614 . . . . 0.0 111.612 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -40.43 94.06 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.903 0.881 . . . . 0.0 110.812 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.65 -12.72 60.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.282 0.633 . . . . 0.0 110.788 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.83 143.03 38.18 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.61 155.6 47.35 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.321 1.048 . . . . 0.0 108.467 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.6 134.56 47.56 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -127.1 108.43 10.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.085 1.754 . . . . 0.0 111.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.33 116.89 21.39 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 pt -104.81 6.0 10.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -67.53 161.3 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.907 0.776 . . . . 0.0 110.053 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 144.5 55.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -54.15 -25.45 22.47 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.629 1.972 . . . . 0.0 110.951 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.98 92.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.07 -1.019 . . . . 0.0 109.93 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.03 -28.59 70.2 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.98 -17.18 61.82 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.759 -1.838 . . . . 0.0 111.604 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -105.49 -18.47 14.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.306 1.442 . . . . 0.0 110.332 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -100.71 -23.94 14.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.53 -26.33 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.758 1.163 . . . . 0.0 111.807 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.83 -137.79 13.47 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.72 158.0 31.64 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 118.553 1.176 . . . . 0.0 108.741 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.47 174.53 12.55 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.381 -1.815 . . . . 0.0 107.381 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.35 151.12 48.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.325 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -139.96 8.58 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.33 1.852 . . . . 0.0 110.472 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.92 -30.33 65.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.967 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.15 -37.33 94.33 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 mt -68.45 -33.96 75.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.4 19.42 4.62 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.254 1.883 . . . . 0.0 114.04 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -125.35 177.86 5.92 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.281 1.033 . . . . 0.0 111.661 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -131.15 159.18 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.752 1.621 . . . . 0.0 108.48 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.61 177.71 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.716 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.39 137.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.344 -2.835 . . . . 0.0 103.344 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -118.31 106.26 12.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.608 1.563 . . . . 0.0 107.883 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 m -143.96 98.31 3.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.01 122.26 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -77.38 145.02 37.51 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -146.74 114.15 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.82 1.248 . . . . 0.0 109.742 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.4 -21.82 9.49 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 121.11 -0.994 . . . . 0.0 114.104 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.88 -22.95 64.16 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.131 0.966 . . . . 0.0 111.62 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -144.53 62.79 1.32 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.42 1.105 . . . . 0.0 111.397 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.92 -56.4 23.79 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.605 1.162 . . . . 0.0 110.697 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.88 -38.76 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.897 1.731 . . . . 0.0 112.157 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.61 88.91 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -64.47 -47.03 80.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.329 1.052 . . . . 0.0 109.744 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mt -54.49 -42.23 70.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.101 0.96 . . . . 0.0 112.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -59.25 -32.42 69.97 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.842 -0.536 . . . . 0.0 111.743 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -62.85 -25.41 68.26 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -44.88 9.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -57.41 -28.01 62.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.698 1.199 . . . . 0.0 112.486 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.77 -12.23 59.96 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.766 -0.584 . . . . 0.0 111.627 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.84 -49.25 2.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.649 0.779 . . . . 0.0 109.699 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -80.87 99.14 8.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -57.77 -44.69 86.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 81.42 33.87 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -26.2 44.17 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.62 2.214 . . . . 0.0 113.789 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -59.42 -14.65 13.03 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -116.68 -16.47 10.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.655 1.582 . . . . 0.0 110.114 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -77.23 132.97 38.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.072 1.349 . . . . 0.0 111.507 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.9 m -103.67 138.15 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.09 101.93 8.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -78.87 103.42 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.63 123.89 38.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 tp -120.23 125.04 47.14 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.704 1.201 . . . . 0.0 109.061 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -127.94 172.92 10.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.856 1.662 . . . . 0.0 106.877 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -65.71 -36.44 83.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.561 -1.337 . . . . 0.0 111.986 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -138.76 -173.98 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.572 1.949 . . . . 0.0 107.017 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.64 -26.81 2.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.709 2.404 . . . . 0.0 114.548 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.55 -113.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 130.197 3.761 . . . . 0.0 116.552 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -116.54 0.49 12.71 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.057 1.743 . . . . 0.0 113.645 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -30.65 -54.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 130.085 3.354 . . . . 0.0 115.714 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.64 -42.28 82.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.724 0.81 . . . . 0.0 110.346 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -42.99 96.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.1 -37.45 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.349 1.46 . . . . 0.0 108.496 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.48 98.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.46 -43.6 76.65 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -52.43 -57.47 9.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.832 1.196 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.5 m -63.7 -39.28 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.135 -0.353 . . . . 0.0 111.033 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.48 -52.53 64.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.598 0.759 . . . . 0.0 110.161 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.8 -44.47 93.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.557 1.543 . . . . 0.0 108.572 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -57.07 -45.07 83.56 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.126 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.21 -13.55 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-O 117.269 -1.85 . . . . 0.0 114.943 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.51 146.5 40.22 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.861 2.33 . . . . 0.0 110.705 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -60.55 3.23 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.193 1.397 . . . . 0.0 113.367 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.5 t -149.7 169.89 19.98 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.11 141.25 15.03 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -128.19 143.94 51.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.936 1.694 . . . . 0.0 106.673 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.92 118.28 36.13 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.6 95.89 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.67 142.54 39.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 76.55 2.29 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.261 2.225 . . . . 0.0 111.673 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.92 -126.22 35.07 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.879 -1.138 . . . . 0.0 113.783 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.48 4.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.122 1.369 . . . . 0.0 112.211 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -93.99 -12.81 27.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.396 1.478 . . . . 0.0 114.533 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.01 169.28 13.29 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.878 1.217 . . . . 0.0 111.471 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 -25.46 24.97 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.951 3.101 . . . . 0.0 115.671 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -134.11 27.53 3.84 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.22 1.808 . . . . 0.0 110.053 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.65 174.16 39.66 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -40.43 -53.11 2.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -63.21 -51.2 67.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.34 0.518 . . . . 0.0 109.659 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -77.47 27.82 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.478 1.111 . . . . 0.0 111.453 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.0 m -128.38 7.4 5.87 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.063 1.745 . . . . 0.0 111.524 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.9 m 57.83 53.66 6.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.039 1.335 . . . . 0.0 110.08 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.5 mt -122.11 144.28 41.06 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.6 144.11 99.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.286 2.658 . . . . 0.0 112.285 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -147.2 156.05 42.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.87 0.868 . . . . 0.0 112.161 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.5 mt -105.66 89.95 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 110.132 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -74.67 156.4 86.72 Favored Pre-proline 0 C--O 1.239 0.519 0 O-C-N 121.776 -0.577 . . . . 0.0 109.587 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.61 178.4 7.6 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.54 2.827 . . . . 0.0 109.042 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -66.91 -34.62 78.18 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 128.8 37.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.495 0.718 . . . . 0.0 109.41 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 t -151.46 173.74 14.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 p -161.5 142.29 11.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.037 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.69 -171.99 8.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 123.82 0.7 . . . . 0.0 111.628 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.15 59.85 7.56 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.803 3.002 . . . . 0.0 108.487 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -63.65 132.72 51.99 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.536 -0.727 . . . . 0.0 110.377 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 m -83.6 -178.81 7.15 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 110.885 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 179.344 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -137.12 150.02 47.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.13 1.372 . . . . 0.0 107.363 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -66.89 97.89 0.51 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.554 1.541 . . . . 0.0 108.309 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 41.07 -117.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.198 1.856 . . . . 0.0 108.598 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -157.61 142.3 16.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 p -149.71 179.24 8.16 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 123.933 0.893 . . . . 0.0 109.353 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 -86.43 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -178.03 167.32 2.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.642 1.977 . . . . 0.0 109.16 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.46 -52.69 60.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.929 0.892 . . . . 0.0 110.083 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -55.41 -52.04 64.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.901 0.48 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.55 -51.53 66.76 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.22 78.01 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.759 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -53.09 -52.23 59.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.606 0.763 . . . . 0.0 112.032 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 m -69.01 -36.06 77.36 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.557 -0.714 . . . . 0.0 111.441 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.39 -39.98 89.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.6 mt -63.9 -38.82 92.5 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.51 0.53 33.59 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 127.084 2.278 . . . . 0.0 114.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.48 -20.88 3.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.522 1.161 . . . . 0.0 111.043 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -117.16 102.98 9.75 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.562 -0.711 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.47 -26.24 60.94 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.42 -13.18 61.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.441 1.096 . . . . 0.0 111.252 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.74 146.63 23.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.914 -1.117 . . . . 0.0 111.524 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.56 30.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 tt -103.93 143.73 32.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.665 0.786 . . . . 0.0 108.903 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -131.37 98.44 4.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.917 1.687 . . . . 0.0 108.868 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -78.47 113.81 16.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.9 pt -103.79 13.38 7.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -73.74 166.33 23.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 134.36 50.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -54.63 -27.01 36.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.72 1.208 . . . . 0.0 112.39 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.26 88.35 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.997 -1.064 . . . . 0.0 110.128 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -71.41 -27.05 63.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.105 0.866 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -59.3 -28.5 66.84 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.593 0.633 . . . . 0.0 109.377 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -85.58 -38.9 17.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.862 0.865 . . . . 0.0 110.086 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -68.77 -50.11 53.14 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.81 -12.33 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.02 -152.18 20.01 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.141 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 p -143.71 161.36 46.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.562 1.181 . . . . 0.0 112.956 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.4 157.73 58.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.989 1.793 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.551 HD22 ' C ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -125.19 87.5 2.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.968 2.107 . . . . 0.0 112.493 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.3 5.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 119.313 -2.117 . . . . 0.0 111.043 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -24.53 61.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.234 1.814 . . . . 0.0 112.867 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.9 -27.08 61.53 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.61 -50.76 6.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 1.59 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.682 1.61 . . . . 0.0 112.668 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.25 -179.9 5.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.15 . . . . 0.0 109.55 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -141.28 133.88 28.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.68 1.592 . . . . 0.0 107.192 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.32 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.628 0.728 . . . . 0.0 111.754 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -127.95 138.3 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -115.72 110.33 18.96 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.439 1.096 . . . . 0.0 109.842 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.41 103.12 4.21 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.773 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.11 124.53 12.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 119.985 1.266 . . . . 0.0 109.417 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -79.75 122.49 26.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.68 121.58 25.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.21 -15.37 37.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.124 -0.82 . . . . 0.0 114.087 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.44 -17.8 60.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.68 1.24 . . . . 0.0 110.478 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -131.49 66.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.275 1.03 . . . . 0.0 109.976 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -57.54 -58.68 16.58 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 120.195 -1.566 . . . . 0.0 108.46 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -34.61 8.18 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.867 1.712 . . . . 0.0 110.241 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.82 -28.55 63.36 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -80.86 -55.93 4.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -48.74 -50.31 34.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.424 1.89 . . . . 0.0 112.824 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -32.99 63.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -63.35 -28.16 69.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.892 0.877 . . . . 0.0 110.189 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -45.91 10.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 t -53.93 -33.52 56.99 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.268 1.427 . . . . 0.0 112.095 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -6.18 52.11 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.66 -39.4 3.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.623 0.769 . . . . 0.0 112.851 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.423 ' CD1' HG21 ' A' ' 75' ' ' THR . 47.7 m-85 -80.12 119.86 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -33.53 72.48 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.548 0.53 . . . . 0.0 112.097 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -145.67 96.24 4.8 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 124.467 1.107 . . . . 0.0 108.223 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.84 -34.53 91.22 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.699 1.6 . . . . 0.0 111.906 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.28 -12.81 32.09 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.25 6.9 p30 -122.5 25.5 8.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.941 1.296 . . . . 0.0 109.29 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.423 HG21 ' CD1' ' A' ' 69' ' ' PHE . 25.4 m -130.84 120.16 23.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.258 1.023 . . . . 0.0 110.696 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.6 m -93.18 137.05 32.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.6 mt -115.91 96.21 5.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.227 1.011 . . . . 0.0 112.148 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 13.9 m-85 -78.21 121.07 23.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.2 154.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.98 1.312 . . . . 0.0 112.668 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.4 tp -155.31 105.05 2.46 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.94 171.88 8.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.851 1.66 . . . . 0.0 106.823 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.66 -58.16 3.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.059 1.343 . . . . 0.0 112.304 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -137.74 -152.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.725 2.41 . . . . 0.0 105.544 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.76 -45.4 9.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.995 2.118 . . . . 0.0 112.253 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.17 -104.09 0.06 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.829 2.157 . . . . 0.0 113.834 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -143.74 11.81 1.65 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.055 1.742 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -39.77 -48.04 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.475 1.91 . . . . 0.0 114.601 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.93 -49.45 77.77 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.835 0.854 . . . . 0.0 110.518 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.18 89.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.24 -33.67 62.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.31 93.93 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.254 0.934 . . . . 0.0 109.66 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -74.28 -38.95 63.26 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.998 0.817 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.4 tp -51.55 -60.09 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.046 1.338 . . . . 0.0 111.808 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.58 -37.47 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 122.603 0.361 . . . . 0.0 111.388 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.6 70.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.15 -41.42 88.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -66.69 -25.68 66.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.03 -4.5 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 117.712 -1.605 . . . . 0.0 115.717 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.24 146.55 48.93 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 120.458 2.129 . . . . 0.0 108.137 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -45.36 -64.03 0.81 Allowed 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.726 1.211 . . . . 0.0 111.523 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.0 m -157.39 179.27 9.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.838 1.655 . . . . 0.0 107.599 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.59 142.31 12.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.494 1.518 . . . . 0.0 106.95 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.415 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -128.6 129.45 45.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.865 1.266 . . . . 0.0 108.78 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.64 139.88 30.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.65 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 126.417 1.887 . . . . 0.0 107.793 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -59.66 151.98 23.58 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.81 0.844 . . . . 0.0 109.445 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 66.83 10.17 7.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.42 1.488 . . . . 0.0 112.742 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.89 -116.54 3.39 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.925 2.202 . . . . 0.0 113.284 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 -43.57 3.26 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.653 0.781 . . . . 0.0 112.774 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.71 -10.74 41.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.74 176.01 9.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.028 1.286 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.44 -19.31 67.72 Favored 'Trans proline' 0 N--CA 1.471 0.147 0 C-N-CA 123.919 3.079 . . . . 0.0 112.982 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -119.54 -3.97 10.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.345 2.258 . . . . 0.0 109.327 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.45 159.26 25.81 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -25.9 -62.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.462 2.305 . . . . 0.0 114.164 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.51 -62.68 1.52 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.176 1.39 . . . . 0.0 110.77 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.66 -10.01 16.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.423 1.089 . . . . 0.0 113.263 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.82 15.31 7.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 0.0 109.113 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 m 68.85 15.56 8.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.349 2.66 . . . . 0.0 112.62 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.69 153.01 52.44 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 119.144 0.884 . . . . 0.0 110.252 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.551 ' C ' HD22 ' A' ' 40' ' ' ASN . 33.7 Cg_endo -74.64 169.75 21.85 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.2 1.934 . . . . 0.0 109.536 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -165.19 130.09 2.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 119.946 -1.721 . . . . 0.0 109.555 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -72.26 97.21 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.658 1.983 . . . . 0.0 109.439 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -93.91 149.52 37.1 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 121.058 -1.026 . . . . 0.0 112.388 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.06 179.97 5.58 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.046 3.164 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.06 117.65 4.57 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.59 155.15 12.89 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.7 m -125.13 -68.77 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.4 p -75.25 -179.82 4.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.584 0.754 . . . . 0.0 110.94 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.66 167.31 15.03 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.68 1.61 . . . . 0.0 109.472 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.18 150.85 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.027 1.818 . . . . 0.0 109.883 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t 47.12 42.84 13.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.641 1.176 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.6 t -149.47 78.35 1.37 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 109.356 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 C-N-CA 125.232 1.396 . . . . 0.0 110.513 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.328 0.585 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.24 -117.6 0.61 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.348 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 m -122.2 148.4 45.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.523 1.529 . . . . 0.0 111.002 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.57 -42.87 75.32 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.315 1.046 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.36 -41.32 79.88 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.732 0.813 . . . . 0.0 111.482 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -61.45 -42.8 99.33 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.07 82.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.343 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.56 -40.17 90.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.036 1.289 . . . . 0.0 110.251 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.2 m -62.98 -54.02 44.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -57.17 -43.09 82.26 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.619 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.98 -20.5 58.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.966 1.257 . . . . 0.0 111.423 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.2 -9.33 62.11 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.219 1.866 . . . . 0.0 112.653 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -122.96 -18.18 6.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.064 1.432 . . . . 0.0 110.913 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -97.21 103.73 15.69 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.59 -24.48 67.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.904 0.881 . . . . 0.0 109.905 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -94.24 -0.19 55.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.164 1.785 . . . . 0.0 112.912 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.91 148.39 29.89 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.246 0.93 . . . . 0.0 111.646 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -148.11 154.68 40.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.02 1.728 . . . . 0.0 108.321 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.04 131.09 52.99 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.067 1.747 . . . . 0.0 108.022 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.0 tp -122.68 114.97 21.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.849 1.66 . . . . 0.0 109.284 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.6 m-20 -84.67 104.19 14.43 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 126.292 1.837 . . . . 0.0 109.445 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.66 2.96 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 122.224 -0.298 . . . . 0.0 110.71 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.473 HH21 ' CG ' ' A' ' 26' ' ' ASP . 39.9 mtm180 -57.06 165.01 1.41 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.49 1.516 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.53 141.74 32.38 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.9 m -49.16 -33.66 12.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.351 1.46 . . . . 0.0 111.194 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.52 78.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.235 0.925 . . . . 0.0 110.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 36' ' ' VAL . 66.3 m-20 -63.69 -39.42 94.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -58.9 -20.72 54.15 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.276 -1.515 . . . . 0.0 114.574 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -96.03 -23.47 16.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.955 0.502 . . . . 0.0 111.586 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.35 -70.26 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.897 1.679 . . . . 0.0 110.941 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 32' ' ' ASP . 9.6 p -77.36 -31.92 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.425 1.09 . . . . 0.0 111.708 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.3 -138.32 13.92 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -147.48 162.63 31.38 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 120.619 -1.518 . . . . 0.0 109.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.55 163.28 37.44 Favored 'Trans proline' 0 N--CA 1.435 -1.937 0 CA-C-O 124.618 1.841 . . . . 0.0 110.141 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.612 ' HB2' HG13 ' A' ' 123' ' ' ILE . 35.3 t-20 -126.19 92.26 3.54 Favored 'General case' 0 N--CA 1.419 -2.003 1 C-N-CA 132.346 4.258 . . . . 0.0 105.295 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 pt -115.43 -19.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.195 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -43.24 -26.54 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.567 -1.682 . . . . 0.0 115.475 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.4 37.36 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 119.991 1.269 . . . . 0.0 110.303 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.46 -71.5 0.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.32 32.2 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 CA-C-O 118.815 -0.992 . . . . 0.0 115.194 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -126.77 177.73 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.053 1.926 . . . . 0.0 110.39 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.86 133.7 43.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.413 1.085 . . . . 0.0 110.076 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.26 167.39 18.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.374 -0.828 . . . . 0.0 110.387 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.1 t -134.34 134.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -115.14 115.84 27.41 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.564 1.146 . . . . 0.0 109.355 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.5 107.86 4.41 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.73 111.44 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 119.776 1.171 . . . . 0.0 110.182 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -74.29 154.86 38.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.592 0.71 . . . . 0.0 109.34 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -165.3 134.78 3.5 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.91 -34.79 80.06 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -66.99 -24.87 66.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.414 1.107 . . . . 0.0 111.115 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -105.32 15.35 27.45 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.582 1.553 . . . . 0.0 114.169 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -39.43 -60.0 1.41 Allowed Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 121.459 1.936 . . . . 0.0 112.328 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.82 -47.64 6.6 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.554 2.836 . . . . 0.0 112.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.75 -22.85 68.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.847 0.737 . . . . 0.0 113.293 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -82.89 -50.17 8.89 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.097 1.759 . . . . 0.0 107.481 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.53 -47.58 66.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.495 1.518 . . . . 0.0 112.882 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -52.38 -43.44 64.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -58.16 -22.2 50.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.741 1.216 . . . . 0.0 113.794 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.41 -52.79 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.8 t -55.68 -30.0 60.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.951 0.9 . . . . 0.0 110.106 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.74 -4.58 59.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -36.67 4.54 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 119.497 1.044 . . . . 0.0 111.342 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.49 120.2 29.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.167 1.387 . . . . 0.0 107.503 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -58.79 -54.11 50.79 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.293 0.497 . . . . 0.0 111.124 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -116.87 83.78 14.91 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.526 1.13 . . . . 0.0 110.012 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 11.0 Cg_endo -56.6 -40.75 82.25 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.163 1.909 . . . . 0.0 110.253 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.32 -0.78 1.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 -11.92 4.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.135 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 138.19 31.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.718 1.207 . . . . 0.0 110.979 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -100.82 123.46 45.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.64 97.16 6.76 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.018 1.327 . . . . 0.0 110.975 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 41.8 m-85 -73.42 120.04 18.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.9 OUTLIER -76.42 156.86 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.278 1.431 . . . . 0.0 109.992 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.4 tt -156.35 110.57 2.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -123.76 169.21 11.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -54.89 -39.07 68.36 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.718 -1.238 . . . . 0.0 109.736 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -141.77 -140.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.658 1.983 . . . . 0.0 108.989 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -64.95 -62.29 1.65 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.643 1.577 . . . . 0.0 108.2 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.89 -86.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 127.739 2.59 . . . . 0.0 113.675 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.46 9.44 2.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.584 ' HA ' HG21 ' A' ' 79' ' ' ILE . 19.3 m -42.69 -53.6 4.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.829 1.652 . . . . 0.0 114.182 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -39.23 78.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.24 1.382 . . . . 0.0 112.249 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -50.59 72.81 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.9 -30.42 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 109.94 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.13 89.15 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -78.84 -35.62 43.67 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.04 -57.22 9.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 112.194 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.04 -41.07 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.63 77.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.038 0.935 . . . . 0.0 110.024 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.99 -38.5 91.4 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.211 1.004 . . . . 0.0 109.445 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.96 -49.35 76.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -8.07 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-O 118.132 -1.371 . . . . 0.0 113.269 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 31.9 m-85 -61.1 156.33 18.36 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.123 1.961 . . . . 0.0 109.93 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -59.22 -68.48 0.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 m -158.76 171.28 20.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.155 0.982 . . . . 0.0 109.068 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.72 164.24 36.61 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 32.9 m-85 -135.0 125.45 26.59 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.87 109.58 20.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.36 92.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.02 133.5 14.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.98 2.112 . . . . 0.0 107.015 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 89.85 -5.07 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.636 3.174 . . . . 0.0 112.375 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 65.44 -164.54 37.51 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -88.89 -14.09 37.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.656 -1.164 . . . . 0.0 114.047 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.23 -2.63 14.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.362 0.983 . . . . 0.0 113.61 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.4 176.29 19.1 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.131 -0.981 . . . . 0.0 113.304 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.22 -25.48 56.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.316 3.344 . . . . 0.0 115.248 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -134.8 28.5 3.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.762 2.025 . . . . 0.0 110.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.19 -171.76 5.21 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.483 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 36.4 t-105 -47.2 -55.17 9.04 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.646 0.778 . . . . 0.0 112.613 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.14 -50.77 71.83 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.044 0.937 . . . . 0.0 110.29 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.11 24.96 0.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.802 1.241 . . . . 0.0 113.468 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.3 m -129.37 12.26 5.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.599 1.96 . . . . 0.0 110.823 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.46 18.29 11.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.398 1.479 . . . . 0.0 112.976 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.44 149.96 62.49 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.62 154.68 49.78 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.35 2.033 . . . . 0.0 109.856 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -155.15 157.33 37.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.263 0.483 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' ' 40' ' ' ASN . 3.4 mt -107.83 88.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.184 1.394 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.42 156.22 91.81 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.984 0.913 . . . . 0.0 109.365 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 C-N-CA 124.147 3.232 . . . . 0.0 109.124 178.506 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 C--O 1.241 0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.6 -120.77 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 118.64 -1.743 . . . . 0.0 115.438 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.02 146.05 52.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.018 1.327 . . . . 0.0 109.991 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.43 ' HB3' ' OG ' ' A' ' 118' ' ' SER . . . -53.9 -50.41 66.41 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.135 1.774 . . . . 0.0 107.864 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -55.71 -49.58 72.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.634 0.652 . . . . 0.0 111.823 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -55.49 -43.99 76.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.145 0.43 . . . . 0.0 111.086 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.06 -34.19 72.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.258 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.49 -49.13 67.61 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.762 1.619 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -54.43 -45.2 72.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.579 0.751 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 18' ' ' THR . 51.4 mmtt -58.25 -36.26 72.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.604 -1.188 . . . . 0.0 112.275 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.08 -25.68 65.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.72 1.6 . . . . 0.0 111.736 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -40.18 6.36 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 15' ' ' LYS . 1.1 t -78.67 -4.28 48.24 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.751 0.776 . . . . 0.0 110.941 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -126.51 -168.72 1.9 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.565 0.746 . . . . 0.0 109.12 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -141.66 -43.23 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.882 2.473 . . . . 0.0 106.554 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.37 63.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.476 0.71 . . . . 0.0 111.44 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.85 124.03 27.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -134.33 138.02 44.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.6 tm? -84.5 133.5 34.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.413 1.085 . . . . 0.0 108.552 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 24' ' ' LEU . 21.3 tp -126.58 112.47 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.593 1.557 . . . . 0.0 109.407 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -89.09 117.96 28.46 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.585 2.354 . . . . 0.0 109.15 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.1 pt -108.98 14.2 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -76.55 164.87 25.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 135.15 55.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 m -51.6 -32.54 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.849 1.26 . . . . 0.0 111.724 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.3 77.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.637 1.108 . . . . 0.0 111.622 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -62.62 -28.99 70.28 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.74 0.7 . . . . 0.0 109.804 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -62.43 -13.67 32.42 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.873 -1.142 . . . . 0.0 111.313 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -107.78 -35.87 6.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.385 1.074 . . . . 0.0 110.467 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -85.61 -28.8 24.56 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.74 -22.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.424 1.011 . . . . 0.0 110.346 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.06 -159.6 17.2 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 121.64 -0.662 . . . . 0.0 112.722 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -140.01 161.39 56.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.611 0.764 . . . . 0.0 111.285 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.09 155.69 47.34 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.73 1.62 . . . . 0.0 110.51 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 3.0 p30 -127.39 86.86 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.494 1.918 . . . . 0.0 108.934 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 pt -85.18 6.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.962 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -51.92 -34.65 42.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.459 1.503 . . . . 0.0 112.257 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.57 -6.97 9.46 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.796 1.634 . . . . 0.0 114.173 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 mt -105.15 -23.33 12.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.571 1.548 . . . . 0.0 109.086 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.41 5.73 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 127.939 2.685 . . . . 0.0 109.883 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -124.37 168.5 12.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.849 0.824 . . . . 0.0 110.831 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 48' ' ' ALA . 6.7 tptt -135.84 120.16 17.93 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.613 1.165 . . . . 0.0 108.296 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . -66.75 174.77 2.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.84 0.829 . . . . 0.0 112.387 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.46 149.83 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.131 -2.914 . . . . 0.0 103.131 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -133.95 113.74 12.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.085 1.354 . . . . 0.0 111.315 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.9 m -158.26 113.75 2.68 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.78 121.32 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 112.773 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.89 156.4 32.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.1 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -166.88 161.27 15.12 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 129.33 3.052 . . . . 0.0 106.141 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.32 62.22 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.558 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.7 -42.57 77.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.352 1.061 . . . . 0.0 110.223 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.32 38.82 2.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.661 1.984 . . . . 0.0 112.841 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -46.83 -50.55 43.5 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 120.737 1.608 . . . . 0.0 109.882 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.9 -40.01 13.16 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.727 1.618 . . . . 0.0 111.959 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.88 -53.19 46.12 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 125.394 1.473 . . . . 0.0 109.644 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -55.93 -50.35 70.97 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.202 2.201 . . . . 0.0 108.307 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -56.85 -46.89 81.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.184 0.593 . . . . 0.0 109.902 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -58.21 -42.88 87.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.097 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -56.94 -24.08 50.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.466 1.03 . . . . 0.0 111.984 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mt -96.26 -46.9 6.24 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.57 1.148 . . . . 0.0 108.894 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -64.02 -11.9 33.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.51 0.595 . . . . 0.0 112.139 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.79 -3.86 51.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.251 0.478 . . . . 0.0 110.297 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 -32.68 5.88 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.5 1.92 . . . . 0.0 112.425 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.41 127.46 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.635 1.174 . . . . 0.0 111.503 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.29 -41.36 66.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -135.99 89.61 20.27 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 119.677 1.126 . . . . 0.0 111.027 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.58 -31.42 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.702 1.601 . . . . 0.0 112.414 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.1 -10.86 6.93 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.075 0.95 . . . . 0.0 112.706 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -130.84 23.61 4.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.434 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.8 m -134.06 120.93 20.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.84 1.2 . . . . 0.0 110.603 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -83.7 132.26 34.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.288 1.435 . . . . 0.0 110.605 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 99' ' ' PHE . 51.7 mt -108.19 103.47 12.67 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.001 0.92 . . . . 0.0 112.154 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 65.7 m-85 -82.86 100.68 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.1 134.2 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.951 0.901 . . . . 0.0 110.127 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.79 135.94 38.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.063 0.945 . . . . 0.0 109.141 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -130.4 176.19 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 128.693 2.797 . . . . 0.0 108.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.69 -35.61 78.5 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.546 -1.347 . . . . 0.0 109.628 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.58 -151.64 0.39 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.598 1.959 . . . . 0.0 106.808 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.51 -45.68 89.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.61 -108.93 0.22 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 128.2 2.81 . . . . 0.0 114.66 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -118.6 2.15 11.72 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.596 1.159 . . . . 0.0 112.829 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 m -35.29 -57.14 0.6 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.978 2.111 . . . . 0.0 114.717 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.59 -38.07 89.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -31.44 63.19 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.601 0.715 . . . . 0.0 110.074 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.75 -31.29 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.15 93.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.386 0.674 . . . . 0.0 109.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.59 -44.61 73.98 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.91 0.484 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.57 -57.24 10.62 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.298 1.039 . . . . 0.0 112.648 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.21 -40.28 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.54 68.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.72 0.808 . . . . 0.0 109.902 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.36 -23.34 67.26 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.804 0.842 . . . . 0.0 112.623 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -82.01 -19.52 40.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.42 -4.18 5.88 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-O 117.406 -1.775 . . . . 0.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 77' ' ' LEU . 35.2 m-85 -65.38 140.75 58.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 120.61 2.205 . . . . 0.0 108.224 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -47.77 -61.01 2.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -157.29 166.57 32.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.28 151.39 31.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.425 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 24.8 m-85 -141.19 135.5 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 107.748 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.34 118.95 38.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.707 2.003 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.07 110.66 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -66.89 149.07 51.12 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 66.76 8.96 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.312 1.845 . . . . 0.0 113.833 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.71 -104.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.813 0 C-N-CA 127.057 2.265 . . . . 0.0 114.244 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.6 -45.5 0.67 Allowed 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.901 1.28 . . . . 0.0 111.948 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.0 -2.02 31.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.735 0.647 . . . . 0.0 112.089 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.33 174.53 53.46 Favored Glycine 0 CA--C 1.54 1.648 0 O-C-N 121.035 -1.04 . . . . 0.0 112.059 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.36 -23.69 75.36 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.559 3.506 . . . . 0.0 115.542 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -131.79 14.84 4.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.51 1.124 . . . . 0.0 110.57 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.4 165.91 30.99 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -27.7 -56.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.198 2.599 . . . . 0.0 114.697 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.71 -63.19 1.28 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.117 0.967 . . . . 0.0 109.159 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -69.07 7.21 0.75 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.741 1.616 . . . . 0.0 112.718 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 22.7 t -100.53 6.87 44.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.32 1.448 . . . . 0.0 109.877 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t 66.78 49.22 1.25 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.147 1.34 . . . . 0.0 108.657 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.7 mt -128.67 155.57 78.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 125.084 1.354 . . . . 0.0 109.123 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.62 168.72 23.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.645 2.23 . . . . 0.0 110.989 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -171.83 126.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.182 -1.574 . . . . 0.0 110.816 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.426 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.8 mt -68.66 88.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.324 1.85 . . . . 0.0 110.716 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.24 155.11 69.65 Favored Pre-proline 0 C--O 1.24 0.603 0 O-C-N 121.103 -0.998 . . . . 0.0 110.309 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 CA--C 1.535 0.525 0 C-N-CA 124.51 3.473 . . . . 0.0 110.72 179.111 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.239 0.501 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.4 -101.65 0.23 Allowed Glycine 0 C--N 1.338 0.67 0 O-C-N 121.491 -0.755 . . . . 0.0 111.941 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.3 m -160.11 164.94 32.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.054 2.542 . . . . 0.0 106.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.5 95.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.654 -0.654 . . . . 0.0 112.554 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -55.26 -48.81 73.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.006 0.821 . . . . 0.0 110.684 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -55.59 -50.1 71.01 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.379 0.671 . . . . 0.0 109.419 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.75 81.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.101 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.4 t80 -59.42 -43.37 93.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.777 1.171 . . . . 0.0 110.561 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.6 m -58.91 -45.02 91.3 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.235 -0.915 . . . . 0.0 109.425 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -65.04 -42.16 94.55 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.946 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 13' ' ' TYR . 53.3 mt -57.28 -41.88 80.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.108 0.867 . . . . 0.0 109.548 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 44' ' ' LEU . . . -72.67 -14.31 77.92 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-O 118.186 -1.341 . . . . 0.0 115.32 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 t -115.25 -13.12 11.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.05 1.425 . . . . 0.0 112.02 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -113.3 99.78 8.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.84 -25.86 43.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.572 1.149 . . . . 0.0 112.9 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -89.37 -3.96 58.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.543 0.737 . . . . 0.0 112.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.05 149.84 24.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.528 1.058 . . . . 0.0 110.092 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -145.96 174.09 11.57 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.39 144.42 40.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.436 0.695 . . . . 0.0 110.144 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 tp -121.35 108.73 14.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.666 2.387 . . . . 0.0 112.541 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -86.5 109.82 19.34 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.476 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.07 2.25 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -42.19 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.72 130.02 3.68 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -44.59 -34.33 2.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.906 2.082 . . . . 0.0 114.726 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.78 -34.29 45.68 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 120.359 1.436 . . . . 0.0 110.781 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.08 -29.33 69.68 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.34 -20.69 65.73 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 119.628 -1.92 . . . . 0.0 112.168 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -91.92 -19.93 21.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.573 1.549 . . . . 0.0 109.474 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.5 -62.86 1.18 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.16 1.384 . . . . 0.0 112.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.02 -38.53 12.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 123.964 0.906 . . . . 0.0 111.136 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.69 -151.76 17.27 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 118.886 0.766 . . . . 0.0 113.618 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.56 154.6 60.04 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.801 1.64 . . . . 0.0 108.036 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.75 172.65 14.77 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 121.551 1.501 . . . . 0.0 109.774 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.19 113.15 12.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.624 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.4 pt -103.27 14.47 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.631 1.205 . . . . 0.0 110.933 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.02 -17.29 51.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.548 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.65 -6.82 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 120.276 1.398 . . . . 0.0 111.335 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 ' HA2' ' A' ' 17' ' ' GLY . 52.3 mt -112.5 -22.72 10.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.703 2.801 . . . . 0.0 109.376 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.93 25.66 14.29 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.614 2.054 . . . . 0.0 109.667 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -116.63 178.92 4.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.512 1.925 . . . . 0.0 111.695 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.98 138.77 17.95 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.08 170.81 16.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.2 1.0 . . . . 0.0 112.421 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.0 133.75 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.956 2.102 . . . . 0.0 106.159 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -106.63 122.62 46.7 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.983 0.913 . . . . 0.0 111.611 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.502 ' CG2' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -152.13 102.96 2.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.866 1.266 . . . . 0.0 109.503 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.71 127.36 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 120.321 -1.487 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -81.37 151.81 27.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -157.84 131.29 7.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.475 1.11 . . . . 0.0 108.563 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.84 66.56 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -86.67 -0.5 56.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.801 1.3 . . . . 0.0 111.833 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.62 25.58 5.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.64 0.776 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -48.36 -57.14 11.44 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.676 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.28 -41.05 13.32 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.346 1.364 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -22.53 63.8 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.693 0.663 . . . . 0.0 113.78 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -83.29 -47.23 11.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.439 1.496 . . . . 0.0 107.585 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 mt -55.78 -46.83 77.85 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.214 1.405 . . . . 0.0 110.801 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -45.24 66.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.685 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HE3' ' CG2' ' A' ' 51' ' ' THR . 40.9 mtmt -62.32 -20.03 63.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.67 -46.24 6.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 t -60.74 -21.25 62.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.23 -2.79 56.28 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 -27.79 7.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.979 0.911 . . . . 0.0 112.308 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.8 114.18 25.8 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 108.268 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -66.21 -31.82 72.88 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.49 1.116 . . . . 0.0 111.287 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.49 77.48 34.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 17.3 Cg_endo -58.15 -40.75 74.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.091 1.861 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.97 -6.11 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -125.94 -4.04 6.98 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.782 0.719 . . . . 0.0 111.463 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.4 m -96.39 124.37 40.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 110.488 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.8 m -89.68 132.87 34.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.66 98.73 7.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 29.6 m-85 -78.33 113.99 16.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.127 -0.94 . . . . 0.0 108.478 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -81.93 134.55 26.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 120.228 1.376 . . . . 0.0 111.722 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 tp -129.88 113.29 14.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.35 1.46 . . . . 0.0 109.254 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -119.36 -177.27 3.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.691 1.596 . . . . 0.0 108.682 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -61.23 -54.48 43.67 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.356 -0.84 . . . . 0.0 110.121 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -139.1 -168.9 2.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.871 2.869 . . . . 0.0 106.34 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.68 -58.51 0.5 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.898 2.479 . . . . 0.0 112.689 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.02 -109.03 0.57 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.639 1.59 . . . . 0.0 114.835 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -134.55 10.04 3.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.194 2.198 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.7 m -44.13 -42.1 6.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.692 1.597 . . . . 0.0 113.157 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -64.01 -44.23 93.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.501 0.72 . . . . 0.0 111.284 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.61 -45.45 86.85 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.72 -28.6 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.094 0.958 . . . . 0.0 109.471 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.32 -44.8 82.37 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.916 0.78 . . . . 0.0 110.218 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.15 -39.35 60.45 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.1 -56.65 5.33 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.351 1.46 . . . . 0.0 111.798 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.56 -39.43 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.608 0.763 . . . . 0.0 111.19 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.57 -52.85 63.72 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.63 0.772 . . . . 0.0 109.093 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.84 -20.18 65.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.053 1.741 . . . . 0.0 111.656 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.58 -15.43 32.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.178 1.391 . . . . 0.0 114.025 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.14 -0.76 5.31 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.016 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 36.2 m-85 -81.74 156.35 25.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.9 1.85 . . . . 0.0 109.196 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -54.54 -69.45 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.077 0.951 . . . . 0.0 112.128 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.3 m -161.31 177.93 9.69 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.694 2.398 . . . . 0.0 107.008 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.15 163.93 39.01 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 126.103 1.761 . . . . 0.0 107.253 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 28.5 m-85 -136.21 145.45 45.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 107.891 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.15 118.43 35.33 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.846 1.259 . . . . 0.0 108.713 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.13 113.16 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -63.12 143.46 57.77 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 70.69 2.82 4.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.304 1.442 . . . . 0.0 112.983 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.69 -110.64 0.86 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 126.922 2.201 . . . . 0.0 114.639 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -122.44 -21.99 5.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.069 1.348 . . . . 0.0 114.36 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -110.01 -10.56 14.7 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.03 -173.47 47.62 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 119.579 1.081 . . . . 0.0 114.145 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.46 -36.32 93.92 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.116 3.211 . . . . 0.0 114.281 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 78.7 mmt-85 -111.32 11.1 21.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.491 1.116 . . . . 0.0 110.769 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.68 156.77 46.09 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.4 t-105 -36.22 -54.54 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 114.538 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.29 -39.4 86.78 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -86.99 -8.56 57.08 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.013 0.925 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.8 t -82.63 6.59 17.29 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.264 1.026 . . . . 0.0 111.028 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m 54.72 57.08 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.993 1.717 . . . . 0.0 108.558 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 98.0 mt -121.67 154.58 60.2 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 126.844 2.058 . . . . 0.0 105.919 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.89 166.1 29.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.9 1.734 . . . . 0.0 110.159 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -159.94 143.09 13.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.847 1.203 . . . . 0.0 111.928 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 mt -95.2 98.07 7.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 0.0 110.173 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.33 141.13 42.33 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.544 0.993 0 C-N-CA 122.538 2.159 . . . . 0.0 106.584 176.845 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.238 0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.77 98.38 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -51.85 158.61 0.98 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.0 110.434 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.67 -49.77 46.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.684 0.674 . . . . 0.0 111.701 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -58.37 -48.36 80.85 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.759 -0.588 . . . . 0.0 110.785 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.73 -52.73 63.86 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 78' ' ' TYR . . . -53.77 -51.24 64.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.53 1.132 . . . . 0.0 110.3 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.0 -41.86 93.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.209 0.603 . . . . 0.0 111.698 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -61.77 -51.63 67.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -62.93 -36.12 82.36 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.769 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.98 -30.59 69.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.088 1.313 . . . . 0.0 108.195 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.48 -24.84 74.09 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 125.266 1.413 . . . . 0.0 113.94 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -100.57 -24.16 14.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.301 1.551 . . . . 0.0 109.923 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.34 170.24 15.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.493 0.588 . . . . 0.0 110.329 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -119.36 -32.76 4.28 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.083 0.953 . . . . 0.0 111.475 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -101.83 -11.76 18.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.45 -0.781 . . . . 0.0 112.832 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.22 58.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.612 0.642 . . . . 0.0 112.466 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -140.02 166.55 24.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.93 125.16 42.7 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.628 1.571 . . . . 0.0 107.419 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.5 97.6 7.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.771 1.628 . . . . 0.0 108.574 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.87 106.2 8.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.1 1.41 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 122.953 0.501 . . . . 0.0 111.738 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -59.19 168.04 1.55 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 126.91 2.084 . . . . 0.0 112.393 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.35 135.97 35.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 m -41.71 -41.22 2.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.187 2.195 . . . . 0.0 114.249 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.34 92.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.621 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -58.86 -29.08 66.7 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.0 -19.27 51.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.091 0.859 . . . . 0.0 109.23 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -104.33 -33.69 8.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.779 2.432 . . . . 0.0 111.916 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -77.91 -44.01 28.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.232 1.013 . . . . 0.0 111.618 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.68 -25.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.492 1.117 . . . . 0.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.52 -163.27 13.55 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.199 0.909 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -143.06 162.97 40.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 122.958 0.503 . . . . 0.0 111.121 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.72 146.46 33.94 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.545 1.497 . . . . 0.0 112.94 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 2.0 p30 -108.69 76.25 1.01 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.812 2.445 . . . . 0.0 109.659 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 pt -85.57 5.23 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.651 0.739 . . . . 0.0 110.817 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -53.09 -34.51 56.93 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.889 1.676 . . . . 0.0 114.368 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.63 -30.65 69.22 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.061 1.3 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.62 -21.01 49.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.745 0.818 . . . . 0.0 110.129 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 38.18 5.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -126.56 171.03 11.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.822 1.249 . . . . 0.0 111.029 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -143.86 137.73 28.14 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.899 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.14 167.08 22.51 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.2 94.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -62.32 119.87 9.9 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 m -152.26 95.64 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.966 1.307 . . . . 0.0 108.884 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -61.78 122.76 13.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -75.64 154.23 36.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.693 0.397 . . . . 0.0 109.984 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -148.98 127.27 12.16 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.92 -13.3 82.64 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.57 -41.31 10.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.55 1.175 . . . . 0.0 108.15 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.71 29.03 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.744 1.618 . . . . 0.0 111.852 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -43.2 -53.84 10.3 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 120.971 -1.081 . . . . 0.0 111.137 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.09 -49.66 4.64 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.997 1.798 . . . . 0.0 112.136 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -29.47 71.92 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.763 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -69.56 -48.36 60.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.062 1.745 . . . . 0.0 108.657 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.4 -41.59 66.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.321 1.049 . . . . 0.0 111.854 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -59.12 -33.18 70.57 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.572 -0.705 . . . . 0.0 111.741 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -60.03 -16.46 31.15 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.663 0.785 . . . . 0.0 111.92 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.3 -37.58 8.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.349 1.46 . . . . 0.0 109.731 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -25.18 65.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.637 1.562 . . . . 0.0 111.498 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.67 -6.04 41.61 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.585 -0.697 . . . . 0.0 112.03 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 -49.69 2.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.209 1.003 . . . . 0.0 108.455 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.9 m-85 -77.83 103.7 7.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 108.964 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.66 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.756 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -134.45 69.93 72.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.635 1.974 . . . . 0.0 112.861 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 -24.15 64.48 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.989 3.793 . . . . 0.0 111.919 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -53.87 -18.43 3.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 130.792 3.637 . . . . 0.0 113.057 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -134.31 -4.51 2.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.564 1.546 . . . . 0.0 111.689 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 69' ' ' PHE . 22.3 m -76.03 121.79 23.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.607 1.094 . . . . 0.0 110.834 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -89.58 122.77 33.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.433 ' CD1' ' HB1' ' A' ' 12' ' ' ALA . 72.2 m-85 -79.16 105.47 10.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 mt -83.56 129.15 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 119.235 0.925 . . . . 0.0 110.959 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -125.56 125.8 43.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.562 1.145 . . . . 0.0 108.319 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -128.17 177.36 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.961 2.105 . . . . 0.0 107.537 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -58.87 -52.59 65.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.692 -1.255 . . . . 0.0 109.378 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.31 178.77 7.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.691 3.196 . . . . 0.0 104.848 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -24.45 -57.33 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 130.399 3.48 . . . . 0.0 112.979 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.94 -104.33 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.906 2.193 . . . . 0.0 115.499 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -125.13 14.0 8.39 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.899 1.28 . . . . 0.0 112.82 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -51.96 -39.11 58.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.957 1.708 . . . . 0.0 112.068 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.55 -43.59 69.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.194 0.907 . . . . 0.0 110.362 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.27 -49.58 77.03 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.705 0.802 . . . . 0.0 109.733 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.97 -33.91 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.113 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.95 95.58 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.232 0.924 . . . . 0.0 109.34 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -69.02 -47.48 65.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.4 -62.05 1.69 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.941 1.696 . . . . 0.0 113.96 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 m -63.04 -39.02 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 122.584 0.354 . . . . 0.0 111.382 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.89 70.94 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.938 0.774 . . . . 0.0 110.196 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.26 -42.62 99.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.599 0.562 . . . . 0.0 109.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.86 -45.25 95.28 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 -14.97 0.06 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.313 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -71.93 156.04 39.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.217 1.509 . . . . 0.0 108.234 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -58.57 -66.86 0.42 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.879 0.871 . . . . 0.0 111.557 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -159.0 170.6 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.915 1.286 . . . . 0.0 107.584 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.33 163.75 35.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.432 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 42.9 m-85 -133.94 123.37 24.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.79 104.78 15.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.058 0.943 . . . . 0.0 108.856 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.52 109.44 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -59.99 146.45 42.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.43 2.44 1.57 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.503 1.521 . . . . 0.0 114.797 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.31 -111.71 2.21 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.733 1.159 . . . . 0.0 112.297 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.25 -28.52 2.34 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.53 -19.14 26.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.64 163.74 50.11 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 121.042 -1.036 . . . . 0.0 111.492 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.63 -24.96 47.85 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.575 3.517 . . . . 0.0 115.415 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 0.62 24.24 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.048 1.339 . . . . 0.0 110.815 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.92 163.56 54.91 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.663 1.125 . . . . 0.0 111.403 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -29.84 -66.59 0.09 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.57 2.348 . . . . 0.0 115.293 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.1 mt -50.64 -60.93 2.53 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.923 1.289 . . . . 0.0 110.735 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -69.12 -7.45 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.563 1.545 . . . . 0.0 113.806 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.0 t -88.75 8.14 30.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.551 -1.343 . . . . 0.0 111.203 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 t 69.13 47.32 0.74 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.19 157.28 58.73 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.088 1.355 . . . . 0.0 109.22 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -78.08 165.76 25.65 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.404 2.736 . . . . 0.0 109.479 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -168.37 133.75 1.78 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.804 -1.185 . . . . 0.0 112.463 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.501 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 2.3 mt -74.92 86.94 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.992 1.317 . . . . 0.0 110.439 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 150.52 75.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.679 -0.638 . . . . 0.0 110.535 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 CA--C 1.537 0.672 1 C-N-CA 125.313 4.009 . . . . 0.0 109.922 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.239 0.539 0 CA-C-O 121.307 0.575 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.55 -114.71 0.3 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -178.0 169.78 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 131.157 3.783 . . . . 0.0 106.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.69 -51.36 70.27 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.528 0.731 . . . . 0.0 112.451 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -52.31 -53.83 39.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.343 0.52 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -53.7 -51.07 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.935 0.494 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.88 94.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.047 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -56.94 -44.23 82.28 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.783 1.174 . . . . 0.0 110.293 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -63.28 -53.36 54.16 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -56.65 -43.06 79.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.481 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.85 -40.95 85.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.981 2.113 . . . . 0.0 107.937 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.9 -20.42 79.47 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.717 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -106.94 -10.36 16.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.606 1.703 . . . . 0.0 112.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.23 135.27 34.59 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -32.99 37.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -97.61 -13.43 21.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 149.43 26.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -150.0 164.45 35.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 108.309 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -106.04 133.4 50.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.593 1.557 . . . . 0.0 108.299 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.0 tp -122.26 104.8 9.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.903 1.681 . . . . 0.0 110.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.61 111.98 12.68 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.182 1.793 . . . . 0.0 106.978 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.89 3.33 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 118.698 0.681 . . . . 0.0 112.093 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -62.54 167.04 4.66 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.493 1.917 . . . . 0.0 112.58 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.34 133.71 37.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 108.519 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.437 ' HA ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -43.03 -29.27 0.33 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.151 2.58 . . . . 0.0 115.609 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.95 63.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.596 -1.315 . . . . 0.0 110.528 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.52 -27.74 69.47 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.756 -1.215 . . . . 0.0 112.358 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 81.2 m-85 -62.55 -21.07 65.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.886 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -91.75 -35.2 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.802 2.041 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.05 -58.15 3.44 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.935 1.694 . . . . 0.0 112.99 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.68 -19.3 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.99 -159.95 22.23 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.611 1.096 . . . . 0.0 111.808 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 39' ' ' PRO . 39.0 p -142.03 161.6 50.2 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.88 -0.776 . . . . 0.0 112.088 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 38' ' ' SER . 94.2 Cg_endo -71.67 158.15 54.09 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.03 1.153 . . . . 0.0 111.094 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 5.1 p30 -125.19 74.75 1.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.15 1.78 . . . . 0.0 109.583 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.2 pt -74.97 2.87 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 121.763 -0.585 . . . . 0.0 109.545 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.95 -31.61 65.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.467 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.28 75.81 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.0 -35.9 69.6 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.896 1.279 . . . . 0.0 110.669 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.0 21.62 1.88 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.775 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -123.01 178.57 5.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.383 1.591 . . . . 0.0 111.204 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -137.86 131.55 31.2 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.474 -0.766 . . . . 0.0 110.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.38 168.11 16.73 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.769 0.795 . . . . 0.0 111.125 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.7 138.03 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 127.645 2.378 . . . . 0.0 104.646 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.4 p -117.91 124.37 48.1 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -152.55 102.9 2.76 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -54.61 117.74 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.793 0.837 . . . . 0.0 111.859 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -79.63 134.67 36.45 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.52 119.78 6.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -51.46 -20.65 5.53 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -71.12 -16.65 62.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.538 1.169 . . . . 0.0 112.569 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -133.4 29.31 3.96 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 117.317 -1.325 . . . . 0.0 114.335 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -38.79 -56.14 2.47 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 121.482 1.946 . . . . 0.0 111.532 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.87 -40.82 33.12 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.421 2.747 . . . . 0.0 111.451 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.53 58.64 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.112 1.815 . . . . 0.0 109.844 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.62 -54.24 46.57 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.555 1.942 . . . . 0.0 106.633 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.28 -45.75 62.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.974 0.909 . . . . 0.0 110.112 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.92 -37.45 87.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.042 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -61.12 -31.54 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.052 1.296 . . . . 0.0 108.484 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -43.32 18.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.044 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.31 64.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.188 1.358 . . . . 0.0 112.443 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.24 -9.8 59.71 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.687 1.13 . . . . 0.0 110.968 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -109.04 -43.11 4.26 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.037 1.335 . . . . 0.0 110.363 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 66.6 m-85 -90.72 102.95 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -57.72 -33.26 68.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.478 0.311 . . . . 0.0 111.395 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -131.93 86.41 47.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 123.719 0.808 . . . . 0.0 110.992 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 26.3 Cg_endo -66.72 -33.43 34.88 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.395 2.063 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.22 -23.52 14.96 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.4 1.48 . . . . 0.0 114.623 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -117.28 -6.42 11.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.087 1.312 . . . . 0.0 110.661 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.4 m -94.07 121.6 35.73 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 112.889 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -91.47 131.86 36.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.41 1.084 . . . . 0.0 108.681 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.35 97.35 5.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 111.153 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.91 119.4 19.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.715 0.806 . . . . 0.0 109.084 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 79' ' ' ILE . 1.1 mp -75.56 133.9 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 111.508 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.81 121.83 27.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.45 167.0 16.18 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 108.398 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -61.02 -39.55 90.18 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.988 -1.07 . . . . 0.0 109.411 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -131.92 -136.51 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.635 1.974 . . . . 0.0 106.919 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.93 -55.64 4.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.019 1.328 . . . . 0.0 108.723 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.66 -95.1 0.1 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.811 1.672 . . . . 0.0 113.203 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -145.82 10.79 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 128.097 2.559 . . . . 0.0 110.907 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.2 m -48.54 -40.56 27.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.248 1.419 . . . . 0.0 111.587 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.3 -30.49 71.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.702 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 89' ' ' LEU . 2.5 tm? -83.47 -41.52 17.94 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.06 -34.75 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.9 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.983 1.313 . . . . 0.0 111.239 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -86.68 -44.28 11.95 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 108.979 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -48.79 -61.37 2.08 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 126.718 2.007 . . . . 0.0 112.771 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.14 -37.39 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.571 0.348 . . . . 0.0 111.744 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -53.47 54.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.853 0.721 . . . . 0.0 109.666 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.47 -20.47 65.61 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.483 1.113 . . . . 0.0 112.195 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -84.53 -35.34 22.93 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 111.58 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.42 -8.11 0.46 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.35 -1.805 . . . . 0.0 115.155 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 34.9 m-85 -71.69 153.48 42.02 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 120.425 2.112 . . . . 0.0 109.484 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -56.62 -56.67 18.44 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 m -162.14 171.7 17.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -165.21 115.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.67 140.66 32.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.69 114.32 26.77 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.23 100.55 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -63.21 151.28 40.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 75.37 -1.58 3.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.945 2.098 . . . . 0.0 112.971 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.52 -140.24 48.06 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 119.703 1.138 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.62 -35.46 6.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.837 0.855 . . . . 0.0 111.188 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.2 -15.23 47.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.71 1.204 . . . . 0.0 113.358 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.7 166.32 27.25 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.64 -30.41 90.42 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.466 2.777 . . . . 0.0 113.454 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 20.8 tpt180 -110.63 14.26 22.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.354 1.862 . . . . 0.0 110.179 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.17 170.84 51.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -45.29 -58.68 3.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.6 mt -59.89 -38.22 81.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.557 0.343 . . . . 0.0 110.935 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -88.9 19.84 3.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 111.467 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.4 m -121.42 12.21 10.82 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.526 -1.359 . . . . 0.0 112.289 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.0 m 56.57 55.8 6.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.343 1.057 . . . . 0.0 108.503 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -121.74 150.93 56.55 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.31 158.9 54.81 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.634 1.556 . . . . 0.0 109.322 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -167.84 132.2 1.77 Allowed 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.388 -1.445 . . . . 0.0 110.749 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.48 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 8.8 mt -71.06 90.77 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.205 1.402 . . . . 0.0 108.443 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.63 151.01 60.92 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 CA--C 1.539 0.746 0 C-N-CA 124.605 3.536 . . . . 0.0 107.712 178.387 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.03 -90.05 0.08 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.591 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.7 t -166.63 167.56 15.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.024 0.929 . . . . 0.0 109.855 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.85 -34.18 75.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -71.19 -49.95 38.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.69 -50.88 62.44 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.169 0.588 . . . . 0.0 110.271 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.82 74.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.067 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.96 -39.68 78.72 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.253 1.388 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -68.79 -46.53 68.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.693 0.797 . . . . 0.0 109.102 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.01 -39.16 93.91 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.032 -1.668 . . . . 0.0 110.97 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.08 -23.53 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.954 1.702 . . . . 0.0 109.551 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.94 -22.92 36.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 -13.1 24.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.588 1.194 . . . . 0.0 110.458 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -114.74 112.35 22.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.911 1.232 . . . . 0.0 110.718 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.55 -36.08 82.6 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.722 1.209 . . . . 0.0 112.653 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -84.18 -17.21 40.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.575 -0.703 . . . . 0.0 112.349 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.0 153.81 32.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.309 0.959 . . . . 0.0 112.513 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -150.25 162.26 40.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.201 1.401 . . . . 0.0 109.388 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.42 154.22 19.0 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 tp -134.41 103.87 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.207 1.403 . . . . 0.0 109.837 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.41 96.63 5.4 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.036 1.334 . . . . 0.0 108.629 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -87.82 -1.33 8.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.6 mtm-85 -69.46 162.57 27.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.969 0.804 . . . . 0.0 109.978 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.73 133.97 51.26 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.34 -22.11 1.03 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.632 1.973 . . . . 0.0 112.38 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.92 88.9 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.285 -1.509 . . . . 0.0 110.16 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -55.15 -40.75 70.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.495 1.518 . . . . 0.0 111.267 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -53.66 -30.13 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.394 1.077 . . . . 0.0 112.066 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -97.3 -20.89 17.56 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 126.549 1.94 . . . . 0.0 112.726 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -101.11 -60.37 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.49 -31.61 4.23 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.758 1.623 . . . . 0.0 111.559 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.35 -163.34 12.26 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.78 158.55 49.29 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.79 157.8 54.49 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.141 1.894 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.531 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -122.39 83.68 2.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.897 2.479 . . . . 0.0 111.961 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -79.58 -0.68 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.394 -1.441 . . . . 0.0 109.747 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -46.12 -40.7 11.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.429 2.692 . . . . 0.0 113.188 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.05 77.07 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.422 -0.654 . . . . 0.0 113.044 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.4 mt -77.57 -40.85 40.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.56 1.03 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.909 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -126.02 -179.1 4.54 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.094 1.447 . . . . 0.0 111.927 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -133.23 144.11 49.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.177 1.391 . . . . 0.0 109.15 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 167.18 14.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 111.98 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -140.54 93.59 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -76.87 102.74 6.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.879 2.072 . . . . 0.0 112.393 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -141.54 98.82 3.43 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.53 125.89 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.221 0.919 . . . . 0.0 110.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -76.02 152.35 36.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.857 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -155.77 116.5 3.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.55 -24.11 61.44 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.539 -0.59 . . . . 0.0 112.192 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.89 -7.01 59.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.035 1.417 . . . . 0.0 110.159 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -126.22 28.95 5.92 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.333 1.453 . . . . 0.0 112.577 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -45.57 -52.38 23.67 Favored Pre-proline 0 N--CA 1.474 0.765 0 O-C-N 120.553 -1.342 . . . . 0.0 112.138 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.78 -44.61 16.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.446 2.097 . . . . 0.0 112.434 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.26 -44.07 96.76 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.71 -54.16 46.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.981 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.93 -43.72 66.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.991 1.716 . . . . 0.0 111.504 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -54.79 -50.56 68.21 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 109.544 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.29 -29.15 57.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -80.6 -51.79 8.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 t -56.36 -23.32 36.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.333 1.453 . . . . 0.0 110.624 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.84 -2.87 43.15 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 -42.52 3.13 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.39 114.4 21.86 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -30.37 71.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.35 70.14 82.22 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.092 1.757 . . . . 0.0 109.312 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 18.8 Cg_endo -57.88 -43.11 52.01 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.381 2.054 . . . . 0.0 111.972 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -62.65 -3.53 1.55 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.301 1.441 . . . . 0.0 113.617 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -127.36 -18.04 4.56 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 111.586 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -90.93 104.76 17.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.401 1.48 . . . . 0.0 111.39 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.2 m -71.72 137.73 47.97 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.852 -1.155 . . . . 0.0 109.679 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -102.72 99.99 10.0 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.202 1.401 . . . . 0.0 113.839 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.98 99.78 8.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mt -79.41 133.58 29.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 123.922 0.889 . . . . 0.0 109.622 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.66 121.22 26.56 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.762 0.825 . . . . 0.0 112.391 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.77 172.3 7.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.069 2.548 . . . . 0.0 107.62 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.25 84.53 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 119.888 -1.757 . . . . 0.0 112.599 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -146.39 -173.22 4.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 130.094 3.358 . . . . 0.0 104.099 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.32 -55.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.641 2.776 . . . . 0.0 113.397 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.96 -101.51 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 128.288 2.851 . . . . 0.0 115.582 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -144.04 -0.21 1.03 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.17 1.388 . . . . 0.0 113.336 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 p -44.62 -44.71 9.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.741 1.155 . . . . 0.0 113.667 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -60.05 -40.34 89.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.782 0.719 . . . . 0.0 112.597 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -71.59 -49.69 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.939 1.696 . . . . 0.0 108.911 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.53 -33.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.231 1.013 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.9 70.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.408 0.549 . . . . 0.0 111.94 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.65 -42.76 13.17 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.363 0.983 . . . . 0.0 108.405 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.8 tp -49.95 -59.34 3.96 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.938 1.695 . . . . 0.0 112.332 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.3 -37.64 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.975 -0.453 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.68 68.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.384 0.674 . . . . 0.0 109.532 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.07 -28.93 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.55 0.74 . . . . 0.0 110.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.82 -33.63 70.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.541 0.61 . . . . 0.0 110.039 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.7 -13.52 0.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.242 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 66.6 m-85 -60.24 146.48 43.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.219 1.509 . . . . 0.0 111.094 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -47.3 -60.19 2.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.701 2.001 . . . . 0.0 112.929 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -167.09 174.75 8.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 126.768 2.027 . . . . 0.0 105.686 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 152.98 36.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -135.62 111.22 9.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.415 0.686 . . . . 0.0 111.26 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.84 133.78 38.1 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 103.24 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -58.09 137.55 56.82 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 36.3 m-20 71.48 15.62 6.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.24 2.216 . . . . 0.0 112.933 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.72 -144.06 7.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.132 1.348 . . . . 0.0 114.913 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.67 -26.51 15.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.52 -1.45 12.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.98 -178.68 8.53 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.75 1.159 . . . . 0.0 114.078 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -29.92 43.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.333 3.355 . . . . 0.0 114.378 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -132.12 12.45 4.68 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.26 1.424 . . . . 0.0 110.296 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.85 174.35 3.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -31.56 -60.87 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.187 1.795 . . . . 0.0 114.327 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.18 -50.93 71.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.507 0.723 . . . . 0.0 111.049 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.92 3.3 5.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.067 1.747 . . . . 0.0 113.772 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.96 13.85 28.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 111.316 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 60.01 46.0 11.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.627 1.171 . . . . 0.0 110.306 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.09 151.18 45.39 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.531 ' C ' HD21 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -73.44 163.96 36.32 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.928 1.752 . . . . 0.0 110.221 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -161.65 128.13 3.81 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.66 -1.275 . . . . 0.0 111.792 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 1.8 mt -73.39 87.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.466 1.906 . . . . 0.0 111.489 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.46 146.0 46.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.864 0.865 . . . . 0.0 110.387 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 N--CA 1.45 -1.069 0 C-N-CA 122.649 2.233 . . . . 0.0 108.468 177.59 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 C--O 1.238 0.487 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.93 -112.56 0.43 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.454 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 m -152.35 150.33 29.6 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.574 1.55 . . . . 0.0 107.319 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.89 66.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.753 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -51.87 -43.71 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.068 -1.645 . . . . 0.0 113.182 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -53.28 54.76 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -57.11 -37.27 71.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.444 0.465 . . . . 0.0 111.148 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.47 -51.57 42.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.805 1.242 . . . . 0.0 109.087 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -56.57 -40.84 75.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.521 0.601 . . . . 0.0 109.978 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -60.42 -44.18 96.02 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.36 -27.61 64.35 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.192 1.36 . . . . 0.0 109.576 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 -2.13 82.61 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.87 1.7 . . . . 0.0 114.171 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -0.21 6.59 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.832 2.053 . . . . 0.0 109.1 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -138.56 98.5 3.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.276 1.43 . . . . 0.0 110.064 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -62.46 -36.54 82.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.663 1.22 . . . . 0.0 110.297 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.76 -7.78 17.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.803 0.841 . . . . 0.0 111.62 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.32 150.17 21.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 120.364 1.438 . . . . 0.0 110.969 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -139.17 161.45 37.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.489 1.516 . . . . 0.0 109.691 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.9 tm? -106.01 128.82 54.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 24' ' ' LEU . 16.2 tp -118.36 102.3 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.221 1.809 . . . . 0.0 112.65 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.31 116.93 19.08 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.2 4.09 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -62.77 172.98 1.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.06 2.144 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.71 139.41 34.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -45.04 -35.99 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.308 1.843 . . . . 0.0 114.266 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.231 0.923 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.26 -35.33 64.89 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.343 1.057 . . . . 0.0 110.761 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.24 -23.69 64.27 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.378 -0.826 . . . . 0.0 112.253 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mtp85 -104.67 -15.79 15.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.936 1.294 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -89.88 -58.2 2.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.136 1.374 . . . . 0.0 111.007 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.87 -26.53 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.594 0.758 . . . . 0.0 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.03 -162.14 12.45 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 121.609 -0.682 . . . . 0.0 112.764 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -139.36 152.5 69.4 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 123.008 0.523 . . . . 0.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.6 139.63 25.65 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.186 1.924 . . . . 0.0 109.693 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.469 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 2.1 p30 -110.23 82.22 1.56 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.571 2.749 . . . . 0.0 106.982 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 pt -71.99 1.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 119.953 -1.717 . . . . 0.0 110.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -22.44 51.77 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.091 1.757 . . . . 0.0 112.099 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.79 -40.74 72.98 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.8 mt -75.92 -52.17 10.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.45 -9.37 1.24 Allowed Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.106 1.336 . . . . 0.0 115.519 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -91.5 -169.85 2.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.85 1.325 . . . . 0.0 113.073 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -144.42 139.15 28.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.525 1.13 . . . . 0.0 109.725 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.52 170.47 16.34 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.007 0.908 . . . . 0.0 112.265 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.3 138.42 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -120.3 132.01 55.13 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.748 0.419 . . . . 0.0 109.97 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.3 m -152.44 100.07 2.54 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.47 112.43 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.507 0.723 . . . . 0.0 110.262 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -83.56 148.97 26.88 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -156.54 131.27 8.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.46 2.704 . . . . 0.0 105.557 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.15 -23.27 52.07 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.321 0.962 . . . . 0.0 112.965 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.3 -22.57 63.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.756 1.223 . . . . 0.0 112.019 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -135.69 44.81 2.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -45.09 -56.05 9.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.538 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.18 -40.8 24.45 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.528 2.152 . . . . 0.0 111.317 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.78 61.01 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 124.2 0.905 . . . . 0.0 112.54 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.03 -53.7 4.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.84 -48.88 41.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.127 1.771 . . . . 0.0 111.899 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -54.52 -36.26 64.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 112.715 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.66 -22.49 66.5 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.276 1.03 . . . . 0.0 112.027 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.73 -44.99 8.25 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -52.19 -35.0 47.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.904 2.082 . . . . 0.0 111.459 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.67 -5.5 57.06 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.08 -32.85 4.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.969 0.804 . . . . 0.0 113.122 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 38.3 m-85 -91.02 121.07 32.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -51.89 42.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 110.485 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -113.66 81.91 5.97 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.877 0.871 . . . . 0.0 109.936 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 9.9 Cg_endo -53.54 -36.19 79.47 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.51 2.14 . . . . 0.0 111.391 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.63 -11.58 26.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.089 2.155 . . . . 0.0 111.361 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -130.14 26.9 5.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.872 2.069 . . . . 0.0 110.258 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -137.38 112.92 9.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.721 0.691 . . . . 0.0 109.934 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.9 m -83.34 141.32 31.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.266 0.627 . . . . 0.0 111.572 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -115.33 95.97 5.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.739 2.016 . . . . 0.0 114.843 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 39.8 m-85 -78.63 102.5 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.06 136.72 23.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 123.717 0.807 . . . . 0.0 109.036 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.56 126.02 39.46 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.651 0.781 . . . . 0.0 111.107 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -127.89 166.91 17.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.255 2.622 . . . . 0.0 107.695 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -63.45 -41.67 98.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.563 -1.336 . . . . 0.0 113.733 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -144.97 179.27 7.45 Favored 'General case' 0 C--N 1.322 -0.626 1 C-N-CA 132.828 4.451 . . . . 0.0 103.545 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -34.35 -32.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.958 2.903 . . . . 0.0 117.097 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 24.3 -88.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 130.066 3.698 . . . . 0.0 116.631 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -144.35 0.56 1.03 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.892 1.277 . . . . 0.0 113.314 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.3 p -41.16 -48.6 3.45 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.31 -41.83 84.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.626 1.103 . . . . 0.0 112.105 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.06 -46.2 85.43 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.71 -35.86 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.27 71.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.734 -0.651 . . . . 0.0 110.052 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -46.62 15.97 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.496 1.044 . . . . 0.0 108.913 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.1 tp -46.52 -61.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.77 -42.49 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.168 -0.333 . . . . 0.0 110.3 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.74 88.02 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.608 0.763 . . . . 0.0 110.956 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.16 -43.37 91.97 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.336 0.654 . . . . 0.0 109.332 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -55.78 -39.05 70.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.167 0.44 . . . . 0.0 111.077 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.27 4.4 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.497 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 72' ' ' PRO . 41.4 m-85 -74.58 152.37 39.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.906 1.853 . . . . 0.0 109.558 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -50.82 -70.15 0.09 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.468 2.707 . . . . 0.0 112.95 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -155.8 164.2 38.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.515 1.526 . . . . 0.0 107.85 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.68 17.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -126.14 150.24 48.4 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.179 1.792 . . . . 0.0 108.024 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.68 118.92 36.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -72.1 109.87 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.29 151.43 46.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 63.05 19.33 11.58 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.131 1.373 . . . . 0.0 111.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 34.73 -114.75 0.15 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 129.004 3.192 . . . . 0.0 114.088 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.76 -12.67 4.79 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.874 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.26 -14.91 16.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.587 1.539 . . . . 0.0 110.727 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.78 35.22 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 118.95 0.795 . . . . 0.0 112.567 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.47 -16.89 48.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.647 2.898 . . . . 0.0 113.261 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -119.35 2.6 11.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.476 2.311 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.23 177.13 25.41 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.786 0.721 . . . . 0.0 112.454 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -41.38 -61.5 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.421 1.888 . . . . 0.0 113.029 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.0 mt -57.58 -36.63 71.95 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.005 1.322 . . . . 0.0 113.587 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -96.08 10.79 36.44 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.893 1.277 . . . . 0.0 111.726 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.2 t -113.73 24.41 12.16 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.499 -1.375 . . . . 0.0 111.614 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 m 63.06 22.87 13.67 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.367 1.867 . . . . 0.0 113.609 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.3 mt -92.37 160.19 35.5 Favored Pre-proline 0 C--N 1.334 -0.091 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.71 166.1 19.7 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.082 1.855 . . . . 0.0 108.922 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -167.49 134.27 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.528 -1.982 . . . . 0.0 112.653 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.1 mt -77.07 88.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.645 1.578 . . . . 0.0 108.809 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.85 144.55 48.31 Favored Pre-proline 0 C--O 1.245 0.863 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.669 2.913 . . . . 0.0 109.32 179.19 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 121.753 0.787 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.73 -125.84 1.32 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m -138.89 160.53 39.5 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.798 1.239 . . . . 0.0 111.641 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.62 -54.71 13.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.871 2.468 . . . . 0.0 114.339 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -60.36 -39.87 88.74 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.839 1.654 . . . . 0.0 112.837 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.94 -47.92 84.21 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.22 96.6 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.191 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CG ' HD22 ' A' ' 120' ' ' LEU . 71.8 t80 -61.85 -40.36 95.06 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.091 0.86 . . . . 0.0 109.95 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 m -61.97 -50.91 70.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -57.0 -47.65 80.34 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.26 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mt -52.29 -32.56 38.16 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.008 1.723 . . . . 0.0 113.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.14 -14.06 70.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.762 0.71 . . . . 0.0 112.934 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.3 -24.23 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 110.458 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -100.99 99.63 10.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.613 1.565 . . . . 0.0 108.371 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.48 -50.51 59.71 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.371 -0.831 . . . . 0.0 112.551 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -2.47 17.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.974 1.31 . . . . 0.0 113.856 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -78.18 128.39 33.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.932 0.787 . . . . 0.0 109.105 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -138.81 139.0 38.07 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -76.13 128.87 35.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 108.618 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.0 tp -117.23 109.63 17.11 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.687 1.595 . . . . 0.0 111.269 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 98.77 5.51 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.141 1.376 . . . . 0.0 108.412 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -86.63 -3.83 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 118.926 0.784 . . . . 0.0 111.235 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -63.52 163.68 10.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 125.902 1.681 . . . . 0.0 111.431 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.87 148.39 27.73 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.097 1.427 . . . . 0.0 108.984 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -42.41 -43.19 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 129.72 3.208 . . . . 0.0 111.529 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.69 -40.4 65.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.878 1.271 . . . . 0.0 112.914 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.5 m-20 -64.16 -35.22 80.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 38' ' ' SER . 13.9 m-85 -61.06 -27.62 68.48 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.098 -1.626 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -89.1 -23.93 22.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.563 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.11 -35.71 7.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.8 p -117.9 -13.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.532 1.133 . . . . 0.0 112.948 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.4 -163.01 29.8 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . 2.5 p -135.74 157.17 76.7 Favored Pre-proline 0 CA--C 1.511 -0.528 0 O-C-N 122.354 -0.498 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.88 172.33 16.09 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.382 1.388 . . . . 0.0 109.454 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.53 ' HB3' HG13 ' A' ' 123' ' ' ILE . 6.4 p30 -146.36 167.56 23.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 46' ' ' LYS . 5.1 pt -145.0 20.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 127.475 2.31 . . . . 0.0 107.618 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.57 64.37 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.076 2.15 . . . . 0.0 114.142 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -33.73 78.92 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.66 -23.44 36.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 109.347 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 23.1 24.13 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 125.198 1.38 . . . . 0.0 111.327 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' HD12 ' A' ' 41' ' ' ILE . 32.0 mmtp -106.04 173.08 6.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.356 1.862 . . . . 0.0 107.807 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -143.23 124.98 14.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.252 1.387 . . . . 0.0 109.625 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.03 171.02 7.36 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.09 136.15 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.753 1.621 . . . . 0.0 106.666 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 p -103.04 110.38 22.28 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.035 1.734 . . . . 0.0 110.884 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -149.97 98.32 2.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.69 117.74 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 122.229 -0.294 . . . . 0.0 110.847 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -81.29 142.91 32.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -154.2 140.7 18.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.45 -13.9 74.35 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.177 -1.346 . . . . 0.0 115.124 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -79.67 -15.95 56.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.509 1.654 . . . . 0.0 111.642 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -138.52 43.5 2.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.357 1.435 . . . . 0.0 111.189 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -45.05 -53.58 16.05 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.869 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.63 -39.28 36.03 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.844 1.696 . . . . 0.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.86 -14.67 73.26 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.273 -0.892 . . . . 0.0 112.671 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.9 -52.21 5.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -50.82 -48.38 59.76 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.794 1.638 . . . . 0.0 111.801 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.85 -36.15 69.68 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -58.74 -26.32 63.86 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.095 0.558 . . . . 0.0 110.648 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.51 -49.43 7.2 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.43 -30.63 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.07 0.85 . . . . 0.0 113.115 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.53 -23.39 62.63 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.819 -1.176 . . . . 0.0 110.249 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -41.34 8.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.635 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD1' HG21 ' A' ' 75' ' ' THR . 65.8 m-85 -85.68 99.42 11.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.464 1.106 . . . . 0.0 108.855 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -19.43 47.78 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.23 78.88 27.28 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.209 1.404 . . . . 0.0 107.548 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.55 -39.04 57.97 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.679 1.586 . . . . 0.0 111.05 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.53 -22.01 2.88 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 127.068 2.147 . . . . 0.0 114.981 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -120.94 -9.08 9.3 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.097 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 69' ' ' PHE . 90.1 m -82.76 136.54 34.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.646 1.178 . . . . 0.0 109.156 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -111.1 125.37 53.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.9 mt -98.53 96.43 7.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.997 1.319 . . . . 0.0 112.526 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.44 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 13.8 m-85 -80.07 106.76 12.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.505 HG21 ' HA ' ' A' ' 87' ' ' SER . 1.2 mm -67.36 145.37 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.33 1.052 . . . . 0.0 112.725 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.29 112.88 7.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -119.09 164.52 15.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.65 1.18 . . . . 0.0 108.511 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -53.5 -41.81 66.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.38 1.072 . . . . 0.0 109.736 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.98 -143.98 0.21 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.785 2.034 . . . . 0.0 106.943 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -75.57 -36.3 60.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.568 1.547 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.9 -103.67 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 130.432 3.872 . . . . 0.0 116.032 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.32 9.26 10.35 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.044 0.937 . . . . 0.0 113.352 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 79' ' ' ILE . 13.7 m -46.71 -52.02 14.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.48 -33.26 75.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.033 0.933 . . . . 0.0 111.699 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.15 -52.0 13.84 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.631 0.772 . . . . 0.0 109.77 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.57 -31.07 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.494 1.117 . . . . 0.0 110.277 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.38 93.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.879 0.763 . . . . 0.0 108.951 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -73.2 -36.58 66.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.34 -59.0 5.13 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.9 0.88 . . . . 0.0 111.309 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.8 m -62.64 -39.26 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 121.909 -0.494 . . . . 0.0 111.072 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.55 -50.22 72.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.964 0.906 . . . . 0.0 111.436 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.29 -28.81 68.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.481 1.112 . . . . 0.0 110.623 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.78 -54.57 13.06 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.89 2.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 CA-C-O 118.196 -1.335 . . . . 0.0 115.67 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.54 157.16 34.3 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 120.04 1.92 . . . . 0.0 106.755 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -53.36 -63.66 1.08 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.193 0.597 . . . . 0.0 110.235 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.7 t -161.53 -179.8 7.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.317 1.847 . . . . 0.0 106.09 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.47 20.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -118.16 123.8 46.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.5 101.66 14.32 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.32 116.89 13.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -72.46 156.52 38.96 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.82 8.91 5.54 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.114 1.766 . . . . 0.0 115.101 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.27 -127.46 21.45 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.61 -35.88 4.1 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.478 0.711 . . . . 0.0 109.565 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.28 -17.19 61.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.195 2.198 . . . . 0.0 114.28 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.1 172.46 46.98 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.18 0.9 . . . . 0.0 114.481 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.8 -30.71 58.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 125.172 3.915 . . . . 0.0 115.768 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.253 0.0 OUTLIER -131.49 20.7 4.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.025 1.33 . . . . 0.0 109.178 177.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.99 166.62 40.29 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -34.28 -50.94 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.65 -50.7 72.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.23 0.923 . . . . 0.0 110.058 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.79 -0.38 34.21 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.029 2.132 . . . . 0.0 113.403 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -91.77 6.53 45.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.666 1.986 . . . . 0.0 111.629 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t 60.7 46.09 9.48 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 13' ' ' TYR . 88.3 mt -123.34 145.26 46.04 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.016 0.926 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.81 147.05 84.98 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.291 2.661 . . . . 0.0 110.211 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -148.49 139.57 23.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.596 1.559 . . . . 0.0 110.825 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 40' ' ' ASN . 3.6 mt -78.9 91.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.486 1.114 . . . . 0.0 109.669 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.6 153.86 95.32 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.379 -0.826 . . . . 0.0 110.74 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 CA--C 1.537 0.649 1 C-N-CA 125.32 4.014 . . . . 0.0 110.198 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.01 -106.02 0.22 Allowed Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.375 -0.828 . . . . 0.0 115.079 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -153.67 154.11 33.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 118.298 1.049 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.62 91.75 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -65.47 -49.28 69.69 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.042 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.92 -44.96 91.35 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -59.03 -41.11 87.0 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.238 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.44 -41.93 96.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.815 0.734 . . . . 0.0 109.835 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -60.92 -46.47 90.55 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.33 -48.37 82.03 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.995 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.2 mt -56.75 -22.03 32.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.515 1.507 . . . . 0.0 113.115 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.61 -7.06 60.53 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.391 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t -126.08 -10.16 6.51 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.779 1.289 . . . . 0.0 110.223 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.07 95.23 5.45 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -12.85 12.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -106.4 -7.52 17.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.279 1.432 . . . . 0.0 111.129 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.16 148.86 41.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.24 152.32 36.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.043 1.737 . . . . 0.0 108.705 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -94.82 151.55 19.15 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 tp -140.13 101.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.368 1.467 . . . . 0.0 111.14 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.17 110.25 18.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.937 2.495 . . . . 0.0 107.378 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -103.68 3.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -61.83 167.32 3.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.22 141.12 43.6 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 m -46.81 -34.02 4.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.184 2.193 . . . . 0.0 112.478 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.61 76.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 119.259 0.936 . . . . 0.0 111.643 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.87 -36.48 84.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 79.4 m-85 -65.56 -6.04 9.8 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.855 -1.153 . . . . 0.0 111.997 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -112.93 -10.49 13.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.914 1.234 . . . . 0.0 111.643 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -115.6 -43.66 3.02 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.63 -16.81 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.904 1.281 . . . . 0.0 113.789 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.32 -153.81 20.3 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 121.219 -0.925 . . . . 0.0 112.297 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 p -143.48 158.09 58.03 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 111.129 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.85 172.17 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 N-CA-C 109.269 -1.089 . . . . 0.0 109.269 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 148.94 35.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.543 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.0 pt -140.85 15.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.287 1.835 . . . . 0.0 110.088 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -56.09 -31.05 62.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.573 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.35 -22.53 71.21 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 120.457 1.48 . . . . 0.0 110.735 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.31 -17.25 37.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.845 1.258 . . . . 0.0 110.274 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.25 33.65 7.12 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.166 1.365 . . . . 0.0 109.889 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -136.25 175.08 9.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.158 1.383 . . . . 0.0 109.578 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -140.81 160.15 40.67 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.82 0.736 . . . . 0.0 110.405 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.5 163.79 20.24 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.82 88.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 7.7 p -58.02 108.71 0.62 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.51 0.724 . . . . 0.0 109.287 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -136.55 89.41 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.58 112.02 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 124.091 0.956 . . . . 0.0 108.493 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.53 149.1 30.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -159.73 145.63 15.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.347 2.259 . . . . 0.0 107.775 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.86 -26.73 61.91 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.22 -5.41 18.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.046 2.138 . . . . 0.0 113.965 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.44 31.97 0.73 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.527 0.731 . . . . 0.0 109.797 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -38.32 -57.01 1.94 Allowed Pre-proline 0 N--CA 1.475 0.824 0 CA-C-O 117.806 -1.092 . . . . 0.0 111.846 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.99 -48.16 9.05 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.493 2.795 . . . . 0.0 111.991 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.94 -50.15 62.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.3 -53.95 49.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.095 1.758 . . . . 0.0 108.427 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.44 -48.0 69.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.859 1.264 . . . . 0.0 111.672 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -55.95 -35.56 66.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.796 0.839 . . . . 0.0 110.007 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -60.72 -29.2 69.21 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.709 1.14 . . . . 0.0 111.226 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 -46.44 13.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -54.36 -34.05 60.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.956 1.302 . . . . 0.0 111.624 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.75 -8.03 58.35 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.065 -1.022 . . . . 0.0 113.222 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -46.83 2.99 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.328 0.967 . . . . 0.0 112.417 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.78 120.84 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -29.44 64.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -129.0 68.65 80.12 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 126.842 2.057 . . . . 0.0 110.026 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.18 -41.34 79.52 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.2 -15.35 14.54 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.45 -14.09 10.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -86.72 124.21 32.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.226 1.376 . . . . 0.0 111.403 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.7 m -88.47 134.61 33.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.84 96.87 6.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.282 0.946 . . . . 0.0 109.239 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.489 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 42.2 m-85 -75.19 113.98 13.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.615 1.966 . . . . 0.0 109.006 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.66 144.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.185 1.357 . . . . 0.0 111.836 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.64 83.69 1.91 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.346 0.658 . . . . 0.0 110.639 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.98 176.5 7.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -53.29 -50.99 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.903 1.281 . . . . 0.0 110.342 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.58 -141.2 0.21 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.58 -40.54 88.99 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 40.94 -127.52 3.24 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.297 1.903 . . . . 0.0 113.741 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.23 3.8 35.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.271 1.028 . . . . 0.0 113.211 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.1 m -40.69 -61.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.103 2.261 . . . . 0.0 117.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -53.28 -37.73 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.167 0.987 . . . . 0.0 111.886 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.01 -46.99 61.27 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.85 -28.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.023 -1.048 . . . . 0.0 109.793 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.53 -36.03 78.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.972 0.805 . . . . 0.0 109.676 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.34 -41.36 28.08 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.449 -0.782 . . . . 0.0 109.665 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.6 tp -49.82 -60.82 2.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.056 2.143 . . . . 0.0 113.393 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.36 -40.96 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.037 0.535 . . . . 0.0 110.758 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -48.88 78.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.082 0.553 . . . . 0.0 109.85 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.17 -28.32 69.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -74.41 -43.32 56.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.292 0.496 . . . . 0.0 110.743 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.08 -5.74 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 CA-C-O 117.508 -1.718 . . . . 0.0 113.631 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.33 160.37 27.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 120.297 2.049 . . . . 0.0 110.396 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.62 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -59.04 -69.77 0.18 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.25 0.62 . . . . 0.0 112.038 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -155.0 -178.22 7.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.429 1.892 . . . . 0.0 108.809 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.9 154.37 27.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.47 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -142.77 111.99 6.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 128.387 2.675 . . . . 0.0 108.737 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.15 119.73 23.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.038 0.935 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.3 108.82 4.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.32 151.31 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 73.34 0.32 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.925 1.69 . . . . 0.0 111.86 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.59 -122.09 14.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.805 1.193 . . . . 0.0 110.997 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.67 -24.41 4.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.442 1.497 . . . . 0.0 111.465 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.11 -11.91 23.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.647 1.579 . . . . 0.0 114.38 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.53 174.3 39.0 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.818 0.736 . . . . 0.0 112.349 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.27 -28.14 86.26 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.543 2.829 . . . . 0.0 113.387 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -117.44 1.06 12.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 110.613 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.05 160.12 1.72 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.173 -0.954 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -25.94 -62.52 0.07 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.163 2.185 . . . . 0.0 115.622 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.18 -60.17 3.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.323 1.049 . . . . 0.0 109.265 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.05 -2.78 2.15 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.94 1.696 . . . . 0.0 113.022 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.35 12.82 31.78 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.249 -1.532 . . . . 0.0 109.555 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.1 t 66.38 12.55 8.72 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.327 1.851 . . . . 0.0 112.103 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.59 157.34 72.44 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.787 0.835 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.74 147.2 21.64 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.101 1.867 . . . . 0.0 110.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -144.25 144.14 31.37 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.97 87.13 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.205 1.002 . . . . 0.0 108.857 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.59 147.31 78.25 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.457 -0.626 0 C-N-CA 124.073 3.182 . . . . 0.0 112.505 -179.69 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.342 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.04 100.92 0.25 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.53 146.21 0.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.563 1.545 . . . . 0.0 110.821 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -38.78 -54.43 1.6 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -58.07 -49.78 75.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.021 1.282 . . . . 0.0 111.081 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -56.09 -51.79 66.61 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.959 0.904 . . . . 0.0 109.176 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.99 73.11 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.868 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.66 -49.34 77.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.38 0.991 . . . . 0.0 109.39 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -62.3 -41.42 98.5 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.69 -0.631 . . . . 0.0 109.881 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.36 -41.51 97.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.209 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.39 -27.87 69.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 111.361 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 -21.99 45.03 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.901 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -98.35 -18.11 18.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.642 1.221 . . . . 0.0 110.903 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 11.2 t70 -101.6 110.37 22.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -38.41 -53.97 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.28 2.232 . . . . 0.0 114.98 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -101.37 13.61 34.51 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -67.88 124.67 23.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.936 -1.102 . . . . 0.0 111.507 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -128.84 144.55 51.2 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.064 0.945 . . . . 0.0 109.731 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.83 144.24 28.56 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.8 tp -127.08 107.2 9.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.658 1.583 . . . . 0.0 109.206 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -80.34 132.75 35.84 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.6 pt -119.67 13.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.827 0.74 . . . . 0.0 111.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -74.89 170.53 15.75 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.838 1.199 . . . . 0.0 110.08 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.5 142.23 44.83 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.62 -41.97 23.15 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.541 2.336 . . . . 0.0 112.68 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.13 73.81 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.53 -0.731 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -66.8 -27.42 67.56 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.572 0.749 . . . . 0.0 111.257 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -64.42 -16.62 62.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.159 -1.588 . . . . 0.0 110.452 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -104.89 -22.04 13.22 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.38 1.472 . . . . 0.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.75 -52.77 4.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.207 1.003 . . . . 0.0 112.22 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.8 -29.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.042 1.737 . . . . 0.0 112.259 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.84 -151.75 17.7 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.276 0.944 . . . . 0.0 112.12 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -147.49 156.16 45.61 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.903 0.881 . . . . 0.0 109.839 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.96 176.28 10.33 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.85 1.7 . . . . 0.0 109.75 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.2 142.96 37.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.923 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.95 12.16 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.734 2.014 . . . . 0.0 111.305 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -37.45 67.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 117.638 -1.172 . . . . 0.0 113.524 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.61 -35.33 85.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.61 -16.24 61.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.209 0.604 . . . . 0.0 110.57 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 45.66 5.89 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 106.606 -2.598 . . . . 0.0 106.606 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -135.47 168.1 19.84 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.608 0.763 . . . . 0.0 110.736 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -145.18 122.42 11.53 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.224 -0.922 . . . . 0.0 110.359 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.78 172.6 10.48 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.784 1.278 . . . . 0.0 112.265 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.89 146.64 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 m -129.13 117.81 21.43 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.926 -1.109 . . . . 0.0 111.38 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -147.73 115.77 6.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.399 1.08 . . . . 0.0 110.356 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.92 129.16 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 120.004 1.275 . . . . 0.0 109.221 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.03 166.83 22.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.23 125.63 0.91 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.78 -20.56 57.13 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.148 0.885 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -84.22 -11.7 56.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.579 1.189 . . . . 0.0 111.621 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -127.47 36.98 4.31 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.522 1.129 . . . . 0.0 111.375 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -48.12 -57.67 9.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.101 1.318 . . . . 0.0 111.847 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.46 -37.67 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.644 2.229 . . . . 0.0 110.623 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.5 -23.55 66.89 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.509 0.576 . . . . 0.0 112.958 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -87.4 -41.5 13.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.279 1.432 . . . . 0.0 107.28 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.74 -46.67 88.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.784 1.234 . . . . 0.0 112.067 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -54.68 -33.7 61.24 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.048 0.539 . . . . 0.0 111.257 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -60.04 -27.33 66.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.856 0.863 . . . . 0.0 110.99 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.12 -43.19 9.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -31.04 66.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.535 -0.728 . . . . 0.0 112.322 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 -7.23 52.14 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.063 -1.023 . . . . 0.0 112.405 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.76 -48.19 2.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.564 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 69.7 m-85 -77.79 107.56 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.733 1.213 . . . . 0.0 109.499 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -72.68 -17.49 61.63 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.483 0.713 . . . . 0.0 112.106 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -148.04 77.31 10.11 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 126.234 1.814 . . . . 0.0 109.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.25 -29.51 73.29 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.752 2.301 . . . . 0.0 110.645 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -53.85 -18.61 3.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.152 2.181 . . . . 0.0 113.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -125.93 3.98 7.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 0.0 112.39 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 m -109.38 121.77 45.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.382 1.473 . . . . 0.0 112.143 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.0 m -91.0 130.92 36.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.69 0.796 . . . . 0.0 110.169 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.53 105.99 15.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.62 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 23.7 m-85 -85.67 110.53 19.36 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.37 134.38 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.012 1.325 . . . . 0.0 111.425 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.54 128.9 30.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.469 1.108 . . . . 0.0 109.337 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -130.7 174.78 9.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.908 1.683 . . . . 0.0 108.369 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -52.84 -52.15 58.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.746 1.218 . . . . 0.0 109.382 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -144.53 174.93 10.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.275 3.83 . . . . 0.0 105.164 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -17.81 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 128.85 2.86 . . . . 0.0 112.508 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.04 -103.22 0.12 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 126.204 1.859 . . . . 0.0 110.39 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -128.9 9.54 5.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.807 1.243 . . . . 0.0 112.38 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -39.01 -51.97 1.81 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.315 1.846 . . . . 0.0 113.791 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.63 -45.95 87.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -39.61 93.95 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.756 0.422 . . . . 0.0 110.938 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.33 -25.58 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.949 -0.469 . . . . 0.0 109.74 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.43 65.25 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.536 -0.727 . . . . 0.0 111.158 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.04 -36.59 61.85 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.007 -0.433 . . . . 0.0 110.87 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.41 -56.79 13.91 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.774 1.229 . . . . 0.0 112.227 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.25 -39.4 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.316 0.647 . . . . 0.0 111.425 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.55 73.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.01 -25.24 65.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.545 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -80.21 -23.79 40.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.43 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.11 1.84 3.15 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 119.956 1.253 . . . . 0.0 115.546 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -76.67 153.59 35.03 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.756 1.778 . . . . 0.0 110.099 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -51.21 -65.88 0.48 Allowed 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 126.785 2.034 . . . . 0.0 112.466 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 m -157.47 171.96 19.42 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.312 1.845 . . . . 0.0 108.29 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.51 140.16 14.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.45 142.85 49.63 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 108.618 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.7 113.56 26.91 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.2 108.12 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 0.0 110.036 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -71.17 141.77 50.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 72.82 22.46 3.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.746 2.818 . . . . 0.0 109.764 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 27.82 -113.02 0.03 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.002 2.239 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -119.18 -54.93 2.18 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.864 1.266 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.44 8.75 4.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.314 1.846 . . . . 0.0 114.045 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.06 173.52 55.34 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.066 -1.021 . . . . 0.0 112.475 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.42 -34.98 98.85 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.714 2.943 . . . . 0.0 111.674 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -129.88 22.14 5.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.114 0.966 . . . . 0.0 110.192 177.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.24 168.36 16.04 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -29.45 -53.61 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.27 -59.26 5.69 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.227 0.922 . . . . 0.0 109.302 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.03 3.53 4.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.195 1.798 . . . . 0.0 112.269 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 t -95.43 11.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.717 2.007 . . . . 0.0 111.539 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 27.86 15.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.352 1.061 . . . . 0.0 111.659 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.1 mt -107.99 153.77 41.52 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.119 0.968 . . . . 0.0 109.507 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.47 154.4 27.7 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.199 1.933 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -147.69 144.35 28.27 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 111.477 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.21 88.73 2.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 126.016 1.726 . . . . 0.0 108.83 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -77.25 153.54 82.11 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.423 0.689 . . . . 0.0 111.715 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 123.965 3.11 . . . . 0.0 108.501 177.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 122.289 1.042 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.34 -115.18 0.41 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -160.06 169.99 22.23 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.855 -1.38 . . . . 0.0 109.329 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.23 -46.03 92.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -49.74 -52.06 34.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 111.099 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -54.97 -59.78 4.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.222 1.009 . . . . 0.0 110.08 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.84 -41.13 67.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.084 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.19 -48.01 79.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.556 1.071 . . . . 0.0 112.91 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.0 m -68.2 -41.37 81.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 18' ' ' THR . 20.5 mmtp -60.74 -31.69 70.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.969 0.804 . . . . 0.0 111.975 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.21 -17.01 60.44 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.391 1.876 . . . . 0.0 110.841 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.1 -52.49 2.21 Favored Glycine 0 CA--C 1.506 -0.494 0 C-N-CA 126.006 1.765 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -64.22 -15.31 59.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.609 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -119.17 128.36 54.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 108.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.43 -39.69 38.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.633 0.651 . . . . 0.0 112.466 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.11 -14.08 60.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.95 1.3 . . . . 0.0 112.423 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -68.86 131.54 45.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.244 1.418 . . . . 0.0 110.388 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -138.86 142.69 38.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.413 0.625 . . . . 0.0 111.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.3 tm? -76.88 131.26 38.5 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HD12 ' A' ' 77' ' ' LEU . 40.0 tp -112.13 95.89 5.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.15 2.18 . . . . 0.0 107.552 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -75.63 109.48 9.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.95 0.38 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 HD22 ' A' ' 80' ' ' LEU . 46.8 mtm-85 -69.46 162.8 26.68 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.071 0.85 . . . . 0.0 110.485 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.09 136.66 56.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -52.34 -23.22 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 111.406 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.66 79.55 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.531 -1.356 . . . . 0.0 110.701 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.54 -33.84 76.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.006 1.722 . . . . 0.0 109.972 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.42 -18.9 53.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -95.59 -37.14 10.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.053 1.741 . . . . 0.0 109.984 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -81.29 -50.52 9.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.9 -23.33 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 113.85 -177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.13 -157.97 22.23 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 p -139.21 160.82 60.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.56 176.53 7.26 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.165 1.91 . . . . 0.0 109.009 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.471 ' HB3' HG13 ' A' ' 123' ' ' ILE 0.261 8.5 p30 -141.61 114.09 8.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 122.069 0.938 . . . . 0.0 111.973 177.016 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -85.57 8.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 122.188 0.994 . . . . 0.0 109.255 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -55.44 -28.07 52.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.817 1.647 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.42 -48.81 47.45 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.91 -46.65 62.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.646 1.178 . . . . 0.0 108.448 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.08 40.62 0.69 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.73 1.633 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.14 -176.38 3.11 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.1 0.96 . . . . 0.0 111.437 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.62 116.72 10.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.356 0.98 . . . . 0.0 110.992 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.65 152.25 39.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.592 0.757 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -108.85 91.15 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 110.314 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -57.96 102.43 0.1 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 127.171 2.188 . . . . 0.0 110.298 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -143.09 97.41 3.09 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.633 0.773 . . . . 0.0 109.757 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.15 119.82 3.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.348 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -74.94 154.52 38.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -156.09 118.7 4.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -22.93 68.06 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.115 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -82.5 -6.12 59.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.615 1.207 . . . . 0.0 110.952 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.37 39.61 2.67 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.032 0.833 . . . . 0.0 110.553 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -43.02 -60.83 2.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 120.762 -1.211 . . . . 0.0 113.622 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -67.2 -43.47 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.585 2.857 . . . . 0.0 111.42 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.03 -47.34 81.0 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.42 -50.62 72.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.533 1.533 . . . . 0.0 108.026 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.4 -39.59 70.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.465 0.706 . . . . 0.0 111.049 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -37.46 78.72 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.779 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.54 -24.17 44.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.432 1.093 . . . . 0.0 111.894 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.08 -44.09 7.47 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t -54.28 -33.01 57.73 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.654 1.182 . . . . 0.0 111.498 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.92 -2.92 39.18 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -121.32 -40.23 2.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.967 0.803 . . . . 0.0 112.564 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CD1' HG21 ' A' ' 75' ' ' THR . 64.1 m-85 -79.94 111.99 16.8 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -18.58 62.22 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.069 0.548 . . . . 0.0 111.315 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 78.26 11.06 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 125.815 1.646 . . . . 0.0 108.44 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.29 -32.97 97.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.47 2.113 . . . . 0.0 110.961 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -57.97 -18.75 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.354 3.062 . . . . 0.0 113.089 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.61 -4.71 9.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.918 . . . . 0.0 111.419 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 69' ' ' PHE . 29.2 m -95.16 113.92 25.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 0.0 112.296 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.6 m -86.75 129.16 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -100.42 99.14 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.532 1.533 . . . . 0.0 111.768 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 37.5 m-85 -84.34 98.6 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -68.0 157.58 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.559 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.542 HD22 HH11 ' A' ' 28' ' ' ARG . 6.7 tt -152.47 112.06 3.93 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.773 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.79 173.3 6.44 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -31.05 70.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.93 -1.731 . . . . 0.0 111.409 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -138.6 -152.71 0.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.034 2.134 . . . . 0.0 106.48 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.11 -18.33 62.53 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.896 2.079 . . . . 0.0 113.58 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.96 -97.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.798 3.571 . . . . 0.0 115.913 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -129.62 6.89 5.22 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.363 1.865 . . . . 0.0 110.957 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -42.91 -47.4 5.64 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.26 1.824 . . . . 0.0 113.487 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.5 -43.64 84.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.424 1.09 . . . . 0.0 111.26 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.46 -49.05 58.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.342 1.057 . . . . 0.0 109.49 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.09 -31.56 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.563 0.745 . . . . 0.0 109.142 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.62 87.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.857 0.753 . . . . 0.0 110.162 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.87 74.26 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -50.39 -57.52 7.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.884 1.674 . . . . 0.0 112.557 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.91 -40.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.12 78.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.068 0.547 . . . . 0.0 109.808 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.15 -38.31 90.61 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.81 -23.38 67.22 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 117.66 -1.162 . . . . 0.0 113.265 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.98 1.32 4.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 117.871 -1.516 . . . . 0.0 113.46 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -76.11 157.67 32.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.15 1.475 . . . . 0.0 108.473 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -49.79 -71.07 0.07 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 127.445 2.298 . . . . 0.0 110.087 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 m -163.62 -178.86 6.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 126.674 1.99 . . . . 0.0 106.857 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.8 164.64 38.29 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -136.99 142.88 42.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.26 110.3 22.3 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 124.734 1.271 . . . . 0.0 107.784 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.95 106.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -68.63 144.01 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 82.24 -2.09 1.45 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.598 1.959 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.14 -102.61 0.07 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 126.449 1.976 . . . . 0.0 114.532 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.31 -43.52 2.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.674 1.59 . . . . 0.0 110.656 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.88 -28.79 39.87 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.0 171.82 41.58 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 121.151 1.796 . . . . 0.0 111.811 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.54 -15.37 35.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.798 3.665 . . . . 0.0 116.052 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 48.7 mmt-85 -115.78 5.64 14.2 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 111.112 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.45 163.23 54.78 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -46.52 -45.28 18.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -66.93 -39.89 87.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.247 0.476 . . . . 0.0 111.038 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -87.67 23.26 2.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.8 1.64 . . . . 0.0 111.433 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 t -120.51 6.56 10.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.445 1.098 . . . . 0.0 112.819 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 56.86 48.5 15.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.991 0.917 . . . . 0.0 109.363 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.1 mt -116.53 160.74 35.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.81 145.01 17.65 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.123 1.882 . . . . 0.0 110.149 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -144.0 132.2 21.86 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.987 -1.071 . . . . 0.0 110.833 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 40' ' ' ASN . 6.6 mt -75.27 90.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.567 1.547 . . . . 0.0 110.082 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -83.49 143.9 45.19 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.809 -1.182 . . . . 0.0 110.94 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 125.03 3.82 . . . . 0.0 109.488 179.031 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.3 p . . . . . 0 C--O 1.239 0.545 0 CA-C-O 122.128 0.966 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.57 -116.82 0.5 Allowed Glycine 0 N--CA 1.445 -0.748 0 O-C-N 121.545 -0.722 . . . . 0.0 111.752 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -142.45 157.3 44.9 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.877 0.871 . . . . 0.0 112.439 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.45 90.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.374 1.469 . . . . 0.0 113.46 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.53 -52.66 64.7 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.841 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.82 -42.95 85.0 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.182 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.27 75.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.583 0.628 . . . . 0.0 111.283 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.23 -47.55 79.26 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -60.73 -40.67 93.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.308 0.243 . . . . 0.0 110.494 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 9.5 mmpt? -58.94 -43.77 91.26 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.446 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.26 -23.95 62.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.289 1.404 . . . . 0.0 111.121 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.06 4.38 62.75 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.435 1.493 . . . . 0.0 112.505 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.12 -4.72 3.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.121 1.768 . . . . 0.0 110.778 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -124.53 106.12 9.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.1 -18.19 2.0 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -122.57 5.48 9.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.397 0.999 . . . . 0.0 113.155 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.67 50.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.635 1.107 . . . . 0.0 108.442 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -140.27 152.86 46.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.338 1.055 . . . . 0.0 109.415 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.52 118.85 37.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.24 107.36 16.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.654 1.581 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.64 123.0 31.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.56 -0.85 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -33.78 -109.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.901 3.68 . . . . 0.0 115.39 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.64 134.27 5.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -45.74 -43.39 12.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.78 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.52 80.92 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.3 0.955 . . . . 0.0 109.809 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.98 -40.56 67.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.515 1.126 . . . . 0.0 110.635 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -60.99 -15.85 36.41 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.025 1.739 . . . . 0.0 112.913 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -107.91 -13.02 15.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.746 1.618 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -102.14 -47.06 4.65 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.717 1.207 . . . . 0.0 110.489 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 -24.93 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.808 1.243 . . . . 0.0 113.468 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.45 -148.16 18.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 119.145 0.884 . . . . 0.0 113.807 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -146.28 162.63 33.98 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.66 128.41 10.95 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.68 2.253 . . . . 0.0 110.044 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.472 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 3.9 p30 -86.29 73.89 10.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.494 -1.684 . . . . 0.0 109.64 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.4 pt -78.66 -4.37 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.556 -1.34 . . . . 0.0 110.597 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -50.03 -37.62 33.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.65 2.38 . . . . 0.0 112.474 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.95 -40.44 72.91 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 124.206 0.941 . . . . 0.0 111.465 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.87 -50.52 28.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.84 25.56 0.14 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.727 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -133.33 -175.12 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.12 1.46 . . . . 0.0 109.971 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -144.52 131.65 20.55 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.138 2.175 . . . . 0.0 105.879 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.23 164.89 14.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.679 0.672 . . . . 0.0 111.565 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.47 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.198 1.799 . . . . 0.0 107.252 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.7 p -63.84 108.7 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.062 1.345 . . . . 0.0 111.206 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.434 HG23 ' HE3' ' A' ' 64' ' ' LYS . 2.1 m -142.38 94.09 2.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.1 116.25 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -76.75 150.44 36.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -155.33 134.97 12.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 128.361 2.664 . . . . 0.0 104.516 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.17 -13.22 81.38 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 113.987 0.355 . . . . 0.0 113.987 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.33 -43.83 39.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.023 0.911 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.32 51.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 109.78 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -52.03 -54.8 37.01 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.27 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.55 -42.11 7.57 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.877 1.349 . . . . 0.0 109.802 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.03 -19.77 46.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.41 1.481 . . . . 0.0 113.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -89.76 -54.23 4.15 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.242 1.817 . . . . 0.0 106.664 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -54.09 -46.87 72.18 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.502 1.921 . . . . 0.0 111.082 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -41.34 66.07 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.597 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 51' ' ' THR . 51.3 mtmt -60.61 -34.49 74.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.528 1.058 . . . . 0.0 110.948 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -48.01 25.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -61.21 -9.29 4.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.914 2.086 . . . . 0.0 115.323 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.11 -13.36 15.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.223 0.919 . . . . 0.0 109.337 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -98.97 -47.1 5.38 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 56.0 m-85 -86.38 159.91 19.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.367 1.467 . . . . 0.0 109.529 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -2.38 1.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.274 2.63 . . . . 0.0 112.362 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -136.11 52.54 6.59 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 128.76 2.824 . . . . 0.0 112.384 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.95 -36.54 17.54 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.532 2.821 . . . . 0.0 112.7 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -55.64 -18.11 7.13 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.652 2.381 . . . . 0.0 113.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -125.02 -1.38 7.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.215 1.006 . . . . 0.0 112.736 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -100.69 136.22 40.9 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.166 1.387 . . . . 0.0 112.411 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.2 m -102.59 128.02 49.43 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.57 97.78 7.94 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.131 0.972 . . . . 0.0 111.708 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 39.0 m-85 -74.87 126.78 31.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.01 126.7 57.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 121.002 1.728 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 80' ' ' LEU . 5.8 tt -120.94 114.58 21.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.97 1.708 . . . . 0.0 109.046 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -119.47 170.41 9.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.668 1.987 . . . . 0.0 107.22 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.211 -1.555 . . . . 0.0 111.648 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.83 -154.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.912 2.485 . . . . 0.0 106.996 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -59.42 -53.44 58.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.605 1.162 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.6 -112.86 0.62 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.521 2.486 . . . . 0.0 114.716 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -112.27 3.72 17.29 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.741 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.1 m -40.02 -51.33 2.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.791 1.636 . . . . 0.0 113.686 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.58 -38.5 91.23 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.311 0.96 . . . . 0.0 112.175 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.63 -48.21 70.16 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -60.59 -23.11 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.661 0.785 . . . . 0.0 110.043 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.31 -31.33 48.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.013 0.525 . . . . 0.0 109.928 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -85.59 -33.62 21.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.592 1.087 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.0 tp -50.79 -56.83 10.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.348 2.259 . . . . 0.0 111.325 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.96 -35.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 0.0 111.777 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.84 -17.67 62.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 111.935 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -91.34 -24.04 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.776 1.23 . . . . 0.0 113.851 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.28 -6.19 4.28 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.74 -1.033 . . . . 0.0 114.45 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -69.74 147.63 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.573 1.687 . . . . 0.0 109.021 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.01 -66.92 0.3 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 113.318 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -152.57 170.81 19.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 108.817 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.18 128.44 9.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.461 -0.774 . . . . 0.0 109.797 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.401 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 31.6 m-85 -109.92 120.85 43.78 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.95 1.3 . . . . 0.0 110.9 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.75 113.88 22.96 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.43 115.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -71.04 161.59 30.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.55 12.16 8.6 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 129.354 3.062 . . . . 0.0 113.822 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.22 -138.55 27.14 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.707 1.171 . . . . 0.0 112.701 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.446 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -115.68 5.49 14.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 110.529 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.91 -3.28 3.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.41 172.78 49.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.595 1.089 . . . . 0.0 112.465 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.62 -25.2 73.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.891 3.061 . . . . 0.0 114.392 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 13.08 15.88 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.354 1.862 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.31 176.51 26.99 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.953 -1.092 . . . . 0.0 111.619 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -47.05 -61.8 1.71 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 113.186 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.26 -53.31 59.76 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.54 -14.57 43.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.813 1.645 . . . . 0.0 112.79 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -91.62 13.79 16.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.568 1.547 . . . . 0.0 110.442 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.9 m 63.15 23.15 13.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.649 2.38 . . . . 0.0 113.498 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.75 153.2 64.17 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.24 160.9 41.61 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.805 1.67 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -163.08 135.76 5.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.864 1.211 . . . . 0.0 112.12 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.472 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 4.0 mt -76.13 95.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.697 1.999 . . . . 0.0 109.973 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -96.69 139.89 21.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 120.962 -1.086 . . . . 0.0 108.352 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo . . . . . 0 CA--C 1.54 0.794 0 C-N-CA 123.798 2.998 . . . . 0.0 110.721 178.834 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 122.284 1.04 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.46 -103.51 0.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 m -156.29 163.92 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.414 1.086 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.51 44.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.618 1.967 . . . . 0.0 111.962 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -55.1 -50.55 68.91 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.216 0.916 . . . . 0.0 110.853 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -51.56 67.49 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.951 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.23 77.33 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -73.24 -41.76 63.34 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.102 -0.999 . . . . 0.0 108.999 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -57.92 -45.92 85.8 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -51.69 -51.62 54.57 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.039 1.735 . . . . 0.0 110.644 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.23 -21.16 13.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.97 1.259 . . . . 0.0 113.094 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.6 -5.97 57.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.891 1.223 . . . . 0.0 112.824 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -123.38 -1.13 8.66 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.656 1.582 . . . . 0.0 110.565 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -127.33 102.25 6.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.052 -1.03 . . . . 0.0 110.722 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -93.3 32.4 1.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.71 0.804 . . . . 0.0 110.077 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -110.11 137.47 47.82 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 123.63 0.772 . . . . 0.0 109.164 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -144.58 136.0 25.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.832 0.853 . . . . 0.0 109.772 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.2 tm? -84.68 133.95 34.37 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 77' ' ' LEU . 15.6 tp -123.86 104.44 8.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.589 1.956 . . . . 0.0 109.264 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -80.95 122.95 27.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.7 pt -105.62 1.84 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -66.09 171.67 4.41 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.15 1.38 . . . . 0.0 111.294 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.5 146.85 28.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.61 1.195 . . . . 0.0 109.472 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -43.03 -45.15 5.07 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 129.831 3.253 . . . . 0.0 113.682 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -35.61 79.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -32.35 73.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -67.21 -14.01 62.51 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.067 -1.646 . . . . 0.0 111.034 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -100.74 -14.38 18.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.008 2.123 . . . . 0.0 109.266 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -103.19 -65.41 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.971 1.708 . . . . 0.0 110.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -86.65 -36.44 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.934 1.294 . . . . 0.0 111.636 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.42 -155.3 16.17 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 118.977 0.808 . . . . 0.0 113.395 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 p -133.96 148.95 70.26 Favored Pre-proline 0 CA--C 1.518 -0.266 0 C-N-CA 124.756 1.223 . . . . 0.0 110.1 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.56 169.2 22.3 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 129.96 45.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.148 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.8 pt -124.33 7.08 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 125.917 1.687 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -58.77 -31.02 67.98 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 125.066 1.346 . . . . 0.0 110.77 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.33 -51.09 32.76 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.89 -50.72 61.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.872 0.836 . . . . 0.0 110.074 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.2 39.01 0.14 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.664 1.126 . . . . 0.0 111.385 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.31 -179.56 5.43 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.566 1.183 . . . . 0.0 110.935 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -143.77 115.11 8.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.967 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 150.53 22.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 118.537 0.608 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.26 125.95 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 p -103.15 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.153 0.981 . . . . 0.0 109.752 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 m -138.05 98.85 3.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.6 114.4 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.355 1.062 . . . . 0.0 109.593 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -80.79 150.0 29.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.917 0.865 . . . . 0.0 110.131 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -157.57 119.77 3.79 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.751 2.42 . . . . 0.0 105.131 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -22.6 59.43 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.15 -11.9 52.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.165 1.386 . . . . 0.0 110.453 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -146.26 46.67 1.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.069 -1.019 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 48.5 mttp -46.0 -49.02 41.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.99 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 55.4 Cg_endo -64.14 -49.7 3.52 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.674 1.583 . . . . 0.0 111.306 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.33 78.75 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.579 1.081 . . . . 0.0 110.825 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.12 -58.7 7.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.909 1.284 . . . . 0.0 107.871 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 mt -51.25 -47.34 62.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.657 1.583 . . . . 0.0 110.694 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -57.21 -37.64 72.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.227 1.411 . . . . 0.0 110.253 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -62.32 -26.38 68.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.541 1.519 . . . . 0.0 110.895 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -47.14 11.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -54.67 -37.96 66.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.709 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.51 -0.98 35.54 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.83 -38.69 3.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.098 0.863 . . . . 0.0 111.288 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CD1' HG21 ' A' ' 75' ' ' THR . 62.8 m-85 -89.92 113.56 25.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -25.35 67.97 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.954 -0.546 . . . . 0.0 111.822 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -138.11 78.82 33.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.924 1.29 . . . . 0.0 111.165 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.05 -37.25 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.521 2.814 . . . . 0.0 113.107 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -12.98 7.15 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.879 1.272 . . . . 0.0 112.892 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.12 28.04 5.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 109.596 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 69' ' ' PHE . 70.6 m -125.75 120.82 31.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.4 m -100.79 122.03 42.7 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.476 1.11 . . . . 0.0 108.09 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 25' ' ' LEU . 1.3 mm? -97.61 106.78 19.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 21.4 m-85 -83.37 97.19 8.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mt -73.07 132.22 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 109.462 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.2 tt -131.21 131.4 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.066 1.347 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -134.48 175.43 9.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.797 2.439 . . . . 0.0 109.233 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -44.06 80.44 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.579 -1.326 . . . . 0.0 109.493 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -136.25 -148.82 0.3 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.64 -36.18 82.97 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.73 -1.231 . . . . 0.0 109.187 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.28 -99.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 127.247 2.356 . . . . 0.0 111.274 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -139.16 12.97 2.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 108.787 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -43.32 -57.07 3.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.049 1.74 . . . . 0.0 114.107 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -65.67 -30.67 71.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.252 0.933 . . . . 0.0 112.116 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -48.34 67.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.95 1.357 . . . . 0.0 108.966 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.58 -32.06 52.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.068 1.747 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.72 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.407 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -79.19 -48.8 13.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.703 1.138 . . . . 0.0 108.416 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.5 tp -42.21 -64.98 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.525 1.53 . . . . 0.0 114.056 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.8 m -62.92 -40.3 88.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.965 0.906 . . . . 0.0 112.018 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.62 45.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.848 0.718 . . . . 0.0 109.489 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 -27.11 68.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.07 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.59 -34.68 72.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.428 0.558 . . . . 0.0 111.839 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.52 -9.2 0.48 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.982 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.21 155.6 38.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.823 1.811 . . . . 0.0 110.806 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -66.59 0.36 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.518 0.727 . . . . 0.0 109.97 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -158.03 -179.46 8.15 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.505 1.922 . . . . 0.0 107.246 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.54 130.74 6.84 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -102.24 163.81 12.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.82 119.68 11.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.64 116.46 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.567 0.699 . . . . 0.0 111.26 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -66.32 148.4 51.91 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.621 ' H ' ' HE2' ' A' ' 106' ' ' LYS . 4.2 m-20 68.09 -0.55 2.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.975 1.71 . . . . 0.0 111.426 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.75 -134.08 39.65 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.651 . . . . 0.0 111.723 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -94.07 -56.74 2.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.612 1.965 . . . . 0.0 111.827 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.39 -12.77 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.59 169.6 33.29 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 120.733 1.606 . . . . 0.0 113.048 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.6 -46.67 31.74 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.344 2.696 . . . . 0.0 113.306 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -98.76 21.41 11.47 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.542 1.519 . . . . 0.0 110.006 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.41 175.91 19.85 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.402 1.001 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -45.77 -67.29 0.3 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.431 1.892 . . . . 0.0 114.448 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.69 -45.55 63.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.921 0.888 . . . . 0.0 111.225 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -71.8 -8.14 52.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.245 1.418 . . . . 0.0 113.819 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -103.29 19.65 19.25 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.924 1.69 . . . . 0.0 112.745 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.8 t 61.53 32.03 18.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.858 0.863 . . . . 0.0 110.848 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.44 146.7 32.23 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.46 144.42 16.0 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.472 2.115 . . . . 0.0 111.196 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -142.27 156.35 45.28 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.355 -0.841 . . . . 0.0 110.441 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.3 90.3 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.491 1.117 . . . . 0.0 110.292 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -70.69 155.21 93.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.75 -0.594 . . . . 0.0 109.697 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.435 2.756 . . . . 0.0 110.164 178.491 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.267 0.556 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.07 -111.31 0.25 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.92 163.13 32.25 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.988 1.315 . . . . 0.0 112.135 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.17 79.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.646 1.578 . . . . 0.0 106.901 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.32 -50.65 72.79 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.194 -0.316 . . . . 0.0 111.351 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.3 -43.63 98.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.662 0.665 . . . . 0.0 111.04 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.5 66.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -72.71 -56.3 5.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.5 1.045 . . . . 0.0 109.054 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -51.16 -45.75 61.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.021 0.928 . . . . 0.0 110.983 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -57.15 -20.51 26.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.1 -29.27 31.83 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 119.598 1.09 . . . . 0.0 108.852 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.32 -35.04 12.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.062 1.315 . . . . 0.0 111.663 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -74.48 -14.53 60.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.02 0.91 . . . . 0.0 110.653 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.22 175.61 7.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.579 0.627 . . . . 0.0 111.793 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -112.72 -43.37 3.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.59 1.156 . . . . 0.0 111.372 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.99 -3.62 52.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.789 0.835 . . . . 0.0 111.781 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.63 119.58 21.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -132.39 145.74 51.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.259 0.481 . . . . 0.0 110.077 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.31 143.65 29.38 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.5 tp -122.42 109.39 14.32 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.734 1.614 . . . . 0.0 111.178 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.96 89.88 7.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.126 1.37 . . . . 0.0 109.221 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -83.12 -0.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 119.872 -1.768 . . . . 0.0 113.828 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -59.32 164.27 3.38 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 126.329 1.852 . . . . 0.0 111.818 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.32 147.97 32.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m -58.23 -20.72 44.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.704 1.602 . . . . 0.0 109.676 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -43.6 90.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.964 -1.085 . . . . 0.0 108.102 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -61.67 -28.64 69.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 110.777 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.73 -17.91 38.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.323 0.965 . . . . 0.0 110.805 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -110.12 -36.97 5.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.418 1.487 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.21 -27.64 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.86 -19.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.9 -152.61 17.76 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.311 -0.868 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 p -147.7 158.31 43.06 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 124.175 0.99 . . . . 0.0 111.527 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -78.66 155.42 27.48 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.696 1.597 . . . . 0.0 111.18 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.553 ' HB3' HG13 ' A' ' 123' ' ' ILE . 1.2 p30 -127.74 87.7 2.66 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.396 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 pt -72.95 5.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.589 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -55.18 -34.72 64.09 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 110.543 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.16 -34.73 32.68 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.011 0.815 . . . . 0.0 111.729 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.58 -32.36 17.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.009 0.905 . . . . 0.0 111.034 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.57 29.2 1.09 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.897 1.237 . . . . 0.0 114.463 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -135.74 -178.79 5.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.234 1.017 . . . . 0.0 110.116 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.24 131.76 28.7 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.485 1.114 . . . . 0.0 109.636 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.2 163.07 27.42 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.69 130.19 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -96.77 94.72 7.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.039 2.135 . . . . 0.0 113.733 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -127.7 90.81 3.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.68 1.592 . . . . 0.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -49.97 116.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 121.476 -0.765 . . . . 0.0 110.966 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -82.52 153.57 25.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -156.33 130.1 8.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.01 -23.58 59.54 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.026 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -86.54 -8.88 57.17 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.674 1.19 . . . . 0.0 112.194 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -123.13 26.55 7.99 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.307 1.443 . . . . 0.0 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -42.7 -58.39 3.85 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.745 1.157 . . . . 0.0 111.913 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.65 -42.54 12.01 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.128 2.552 . . . . 0.0 112.101 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.28 -52.46 49.55 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -55.56 -49.03 73.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.491 1.517 . . . . 0.0 107.862 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.6 mt -53.89 -50.21 66.84 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.769 0.828 . . . . 0.0 109.773 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -43.44 84.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.299 1.04 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -58.49 -23.99 59.29 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.133 1.333 . . . . 0.0 112.685 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 62' ' ' LEU . 5.4 mt -93.36 -50.55 5.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.709 1.604 . . . . 0.0 108.003 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.0 t -56.92 -23.25 43.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 109.398 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.2 -8.07 52.04 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -38.38 6.66 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.69 1.196 . . . . 0.0 109.663 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -83.07 177.44 8.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.072 1.349 . . . . 0.0 108.407 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -33.9 3.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.295 1.038 . . . . 0.0 112.334 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -144.57 86.3 8.11 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.99 0.916 . . . . 0.0 110.588 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 10.7 Cg_endo -55.23 -32.61 81.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.948 2.432 . . . . 0.0 112.865 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.66 -8.0 1.8 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -123.22 -6.73 8.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.777 -1.106 . . . . 0.0 112.97 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -101.26 130.06 47.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -98.63 130.45 45.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.328 1.051 . . . . 0.0 109.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.36 103.16 12.64 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.646 1.178 . . . . 0.0 112.19 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.91 102.31 13.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.07 139.65 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.916 1.286 . . . . 0.0 113.414 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.43 123.65 21.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.935 1.694 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -130.58 170.65 13.99 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.576 2.351 . . . . 0.0 107.748 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -21.74 8.29 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 113.537 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -159.64 -162.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.916 3.287 . . . . 0.0 104.933 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.14 -55.09 16.48 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.861 2.065 . . . . 0.0 107.365 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.27 -96.95 0.02 OUTLIER Glycine 0 C--N 1.337 0.602 0 C-N-CA 128.251 2.834 . . . . 0.0 114.252 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -135.88 13.08 3.39 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.683 1.193 . . . . 0.0 110.859 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -52.03 -31.59 30.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.943 0.792 . . . . 0.0 110.961 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -72.19 -35.45 68.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.159 2.184 . . . . 0.0 111.745 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.43 -46.64 14.29 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.15 -30.84 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.02 94.91 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -71.65 -42.66 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.781 0.832 . . . . 0.0 109.203 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.2 tp -50.41 -62.15 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.133 1.373 . . . . 0.0 111.848 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.46 -38.62 80.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.115 0.566 . . . . 0.0 110.688 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.76 64.36 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.615 0.766 . . . . 0.0 109.727 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.05 -24.4 67.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.669 0.788 . . . . 0.0 111.589 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -77.2 -21.79 53.36 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.783 0.719 . . . . 0.0 110.844 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.56 6.52 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 117.154 -1.914 . . . . 0.0 114.086 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.7 m-85 -70.01 152.1 44.8 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.616 2.208 . . . . 0.0 108.703 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -48.98 -65.81 0.5 Allowed 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.188 1.795 . . . . 0.0 113.184 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -155.74 174.75 14.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.911 1.284 . . . . 0.0 108.948 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.43 146.46 18.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -135.41 128.87 32.36 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.812 0.845 . . . . 0.0 110.394 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.81 118.39 30.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.36 115.74 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 121.286 -0.884 . . . . 0.0 109.029 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -68.23 150.1 48.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.8 11.59 8.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.625 1.57 . . . . 0.0 113.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.66 -136.84 2.71 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 124.964 1.269 . . . . 0.0 112.781 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -101.2 -26.61 13.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -100.12 -10.84 21.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.796 2.438 . . . . 0.0 115.281 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.9 170.39 8.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.999 1.272 . . . . 0.0 111.824 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.41 -29.33 23.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 124.022 3.148 . . . . 0.0 114.556 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.28 25.97 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.443 1.497 . . . . 0.0 110.616 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -173.59 3.88 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.401 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 17.6 t-105 -41.66 -56.51 2.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.15 -52.81 64.01 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 123.492 0.717 . . . . 0.0 109.56 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.64 22.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.951 1.301 . . . . 0.0 112.791 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.3 m -120.13 10.26 11.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.055 1.742 . . . . 0.0 110.957 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.85 24.96 9.65 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.221 0.919 . . . . 0.0 110.397 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 57.2 mt -97.89 140.71 22.1 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 31.4 Cg_exo -58.86 140.06 93.55 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 125.07 3.847 . . . . 0.0 110.691 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -148.38 135.51 20.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.019 0.927 . . . . 0.0 112.204 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 40' ' ' ASN . 5.2 mt -85.05 96.92 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.818 2.447 . . . . 0.0 108.108 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.73 155.93 68.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 O-C-N 121.484 -0.76 . . . . 0.0 112.719 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 C-N-CA 123.307 2.671 . . . . 0.0 107.083 177.348 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.237 0.416 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.9 -112.12 0.26 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 163.57 36.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.916 1.358 . . . . 0.0 112.076 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.95 98.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -53.22 -55.63 22.84 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.216 1.007 . . . . 0.0 110.202 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -62.06 -45.3 94.14 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.699 0.624 . . . . 0.0 111.832 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.47 -41.75 85.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.62 -48.18 82.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.867 0.758 . . . . 0.0 109.605 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -60.6 -43.37 97.49 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.199 0.6 . . . . 0.0 111.025 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -39.04 89.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.245 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.0 mt -64.74 -20.4 66.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.895 1.225 . . . . 0.0 110.663 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 -12.46 64.56 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.327 0.965 . . . . 0.0 112.212 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p -117.82 -2.45 11.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.628 1.571 . . . . 0.0 112.243 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -125.12 109.11 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.147 1.379 . . . . 0.0 107.567 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.16 -29.97 68.09 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -84.46 -26.86 27.9 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.717 -0.615 . . . . 0.0 111.977 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 137.98 58.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -141.02 121.98 14.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.857 1.263 . . . . 0.0 109.627 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -55.11 129.79 39.46 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.013 0.925 . . . . 0.0 109.192 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp -109.73 99.49 8.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.929 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.79 112.69 19.17 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.84 7.15 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -64.88 172.12 3.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 110.815 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 144.36 30.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -44.48 -39.87 5.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.027 2.131 . . . . 0.0 111.902 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.33 77.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.929 -0.557 . . . . 0.0 111.557 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.58 -37.2 75.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.393 0.997 . . . . 0.0 110.629 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -62.05 -7.69 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.935 -1.103 . . . . 0.0 112.887 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -123.41 -14.82 7.31 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.543 1.937 . . . . 0.0 111.115 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.93 -45.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.956 1.303 . . . . 0.0 110.814 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.19 -18.56 7.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 124.938 1.295 . . . . 0.0 110.472 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.25 -156.51 21.27 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.446 -0.784 . . . . 0.0 111.808 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -145.8 167.58 13.89 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 121.648 -0.913 . . . . 0.0 112.251 -178.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 83.1 Cg_endo -71.16 158.3 55.22 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.217 1.278 . . . . 0.0 110.309 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB3' ' CD1' ' A' ' 123' ' ' ILE . 43.7 p-10 -125.0 56.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.946 1.698 . . . . 0.0 112.965 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.6 pt -71.67 10.54 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.415 1.086 . . . . 0.0 111.651 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -42.63 69.55 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.133 1.373 . . . . 0.0 111.074 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -52.58 -46.05 59.17 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 mt -61.91 -23.71 66.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 112.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.32 38.87 3.63 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -136.45 168.54 19.27 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 117.773 0.786 . . . . 0.0 111.989 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -138.84 127.56 23.42 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 157.45 37.73 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -116.67 99.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 p -79.02 113.14 16.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.4 m -142.02 109.62 5.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.18 116.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.822 0.283 . . . . 0.0 110.67 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.95 138.95 36.1 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -150.64 127.69 11.15 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.65 -19.14 34.0 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.186 1.374 . . . . 0.0 113.96 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.18 -17.28 60.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.866 1.833 . . . . 0.0 110.938 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -133.12 59.91 1.72 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.686 0.794 . . . . 0.0 110.37 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.05 -54.6 53.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 120.699 -1.251 . . . . 0.0 108.533 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.82 -41.16 8.39 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 121.664 1.63 . . . . 0.0 109.468 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.91 59.17 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.287 0.946 . . . . 0.0 111.695 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -71.49 -60.18 2.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.9 mt -47.29 -46.58 25.01 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.335 1.854 . . . . 0.0 111.639 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -59.43 -33.3 71.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.485 0.714 . . . . 0.0 110.907 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -69.17 -23.99 64.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.064 1.302 . . . . 0.0 111.115 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.74 -34.73 30.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -57.79 -36.62 72.43 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.524 -0.735 . . . . 0.0 112.774 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.64 -5.76 44.87 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -117.14 -33.11 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.987 0.812 . . . . 0.0 112.909 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.2 m-85 -93.5 106.16 18.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.533 1.133 . . . . 0.0 111.139 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -56.82 -51.09 70.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.626 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.34 86.22 50.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.081 0.952 . . . . 0.0 109.048 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.08 -18.81 60.22 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.807 1.671 . . . . 0.0 113.808 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.4 -16.82 16.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -123.25 -1.84 8.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.603 1.561 . . . . 0.0 112.078 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 69' ' ' PHE . 21.1 m -93.22 132.66 37.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 111.193 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -102.25 149.91 23.83 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.92 91.79 3.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.064 1.346 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 30.8 m-85 -74.34 101.52 4.09 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 102.961 -2.977 . . . . 0.0 102.961 177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.89 130.23 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.759 1.223 . . . . 0.0 112.671 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.23 107.88 11.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.513 1.525 . . . . 0.0 109.361 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.25 173.59 6.25 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.03 -58.73 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.615 -1.303 . . . . 0.0 109.311 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.78 -153.05 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.63 -36.68 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.247 0.476 . . . . 0.0 109.872 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.24 -118.67 0.19 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 128.572 2.987 . . . . 0.0 115.566 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -101.12 -3.1 29.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -41.55 -55.97 2.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.299 1.839 . . . . 0.0 115.102 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -26.79 66.32 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -49.81 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.24 -35.06 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.489 1.115 . . . . 0.0 109.222 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.3 66.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.392 1.077 . . . . 0.0 111.355 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -92.61 -35.38 13.57 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.775 0.716 . . . . 0.0 110.026 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.0 -59.22 4.61 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.649 0.738 . . . . 0.0 109.895 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.03 -38.81 78.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.14 0.976 . . . . 0.0 112.107 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.02 -53.75 51.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.129 1.372 . . . . 0.0 109.804 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.01 -28.62 67.87 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 110.54 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -76.97 -24.31 52.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.892 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.15 -0.8 2.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.906 -1.497 . . . . 0.0 115.695 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -73.1 150.62 42.11 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 120.198 1.999 . . . . 0.0 107.303 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 1.6 tpmt? -59.13 -52.83 64.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -165.49 176.41 8.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 107.903 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.9 163.39 40.12 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 43.9 m-85 -146.92 114.75 6.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.354 1.062 . . . . 0.0 109.144 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.11 113.89 15.34 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.497 1.119 . . . . 0.0 108.798 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.79 101.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -62.69 150.52 40.81 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 71.58 6.77 5.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.222 1.809 . . . . 0.0 110.934 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.35 -130.21 14.51 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.058 1.299 . . . . 0.0 110.51 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.66 -16.7 7.13 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.22 -25.57 21.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.504 1.047 . . . . 0.0 112.99 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.51 170.23 1.34 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 128.851 3.119 . . . . 0.0 116.598 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.82 -22.36 36.78 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 124.064 3.176 . . . . 0.0 112.774 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.255 12.7 tpt180 -124.85 14.13 8.57 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.741 2.017 . . . . 0.0 109.56 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.82 -177.94 20.62 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.45 -1.406 . . . . 0.0 111.382 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -48.88 -53.27 20.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 113.405 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.02 -51.12 70.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.848 0.459 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.6 32.14 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.737 2.015 . . . . 0.0 112.303 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.8 m -126.5 12.2 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.007 1.723 . . . . 0.0 109.836 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 t 62.0 28.51 17.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.867 0.758 . . . . 0.0 110.437 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.81 138.63 19.69 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HB2' HD22 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -70.75 157.23 59.05 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.031 1.821 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -158.39 151.29 22.5 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 108.772 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 40' ' ' ASN . 2.5 mt -98.08 88.57 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.73 153.94 85.27 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 C-N-CA 122.476 2.118 . . . . 0.0 108.509 178.083 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.28 109.38 0.41 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -37.47 149.89 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.446 2.298 . . . . 0.0 112.848 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.6 47.58 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.581 . . . . 0.0 111.623 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -60.71 -51.75 68.06 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 110.191 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -55.47 -46.57 76.83 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.758 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.85 87.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.267 0.627 . . . . 0.0 109.611 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.99 -51.34 70.49 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.656 0.782 . . . . 0.0 109.991 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.3 m -61.62 -41.86 98.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.888 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 18' ' ' THR . 27.7 mmtt -56.97 -48.74 77.68 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.502 1.121 . . . . 0.0 109.978 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.86 -19.67 60.47 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.035 0.534 . . . . 0.0 111.656 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.03 -7.06 61.37 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.501 2.477 . . . . 0.0 114.418 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 15' ' ' LYS . 11.2 t -121.3 -8.91 9.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.08 1.752 . . . . 0.0 109.351 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.81 178.43 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.884 0.874 . . . . 0.0 109.494 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 38.1 t70 -128.12 -49.16 1.33 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.333 0.969 . . . . 0.0 111.666 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -71.51 -2.84 18.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.695 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 121.83 23.67 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.555 2.342 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -136.38 149.22 48.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.49 132.08 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.663 1.185 . . . . 0.0 110.107 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 tp -113.38 111.12 21.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.026 1.33 . . . . 0.0 109.829 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.08 116.36 28.84 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.8 pt -99.4 9.06 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -65.36 163.65 15.19 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.728 1.611 . . . . 0.0 113.619 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.49 139.62 44.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -45.94 -41.84 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.792 1.237 . . . . 0.0 112.459 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.1 67.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.75 0.82 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -59.82 -43.69 94.41 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.435 0.562 . . . . 0.0 110.502 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -56.91 -21.94 33.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.004 0.82 . . . . 0.0 112.823 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -84.12 -26.83 28.61 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.024 0.929 . . . . 0.0 109.825 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -91.29 -59.3 2.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.457 1.503 . . . . 0.0 112.816 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.6 -34.71 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.836 1.254 . . . . 0.0 114.148 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -144.93 16.44 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.9 p -154.15 156.01 31.5 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 119.374 1.587 . . . . 0.0 112.889 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.51 135.93 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.936 2.424 . . . . 0.0 111.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.451 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 1.6 p30 -103.41 80.12 1.78 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.851 2.861 . . . . 0.0 107.893 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 pt -77.75 2.61 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.493 -1.379 . . . . 0.0 111.668 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -47.79 -31.84 5.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.495 2.718 . . . . 0.0 115.729 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.09 77.32 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt -85.05 -38.36 19.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.69 0.68 Allowed Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.696 1.141 . . . . 0.0 111.047 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 20' ' ' ASP . 41.6 mmtm -145.51 178.86 7.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.091 1.756 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -133.66 165.49 24.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.974 0.892 . . . . 0.0 110.839 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.49 163.74 15.62 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 108.843 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -138.79 128.37 31.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.153 1.381 . . . . 0.0 107.693 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -99.22 121.94 41.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.398 1.079 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.9 m -148.65 106.56 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.99 110.17 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -76.14 162.95 27.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -166.98 136.45 2.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.069 2.148 . . . . 0.0 105.277 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.2 66.7 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.472 0.558 . . . . 0.0 112.829 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.93 -50.28 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.15 24.48 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -43.76 -52.15 15.22 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 120.244 1.384 . . . . 0.0 110.09 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.41 -44.95 12.87 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.37 2.047 . . . . 0.0 111.786 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.95 83.69 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.722 1.153 . . . . 0.0 110.906 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.07 -53.06 51.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.527 1.931 . . . . 0.0 108.394 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.92 -47.47 64.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.228 1.011 . . . . 0.0 111.177 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -51.92 -47.42 64.66 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.95 -29.43 12.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.465 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -50.35 6.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m -55.93 -32.73 64.06 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.418 1.008 . . . . 0.0 112.198 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.25 -5.02 57.31 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.566 0.746 . . . . 0.0 112.961 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -41.48 3.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.524 1.13 . . . . 0.0 111.578 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.95 179.57 7.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.845 1.258 . . . . 0.0 108.716 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -127.6 -24.36 3.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.415 1.086 . . . . 0.0 113.153 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.75 83.09 8.31 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -56.19 -38.1 95.51 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.267 1.312 . . . . 0.0 110.229 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.45 -15.9 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.503 1.921 . . . . 0.0 114.425 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -124.03 -16.13 6.63 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.784 1.233 . . . . 0.0 111.55 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.1 m -77.98 137.2 38.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.049 0.84 . . . . 0.0 110.656 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -110.25 125.45 53.12 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.24 100.51 10.1 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.431 1.092 . . . . 0.0 112.408 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CE2' ' CD1' ' A' ' 103' ' ' TYR . 40.6 m-85 -82.54 96.7 8.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -73.99 124.49 31.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.095 1.358 . . . . 0.0 109.565 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -121.77 125.44 46.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 109.498 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -133.41 172.42 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.808 0.843 . . . . 0.0 112.572 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -46.52 -54.67 8.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.65 1.58 . . . . 0.0 108.926 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -136.82 -155.97 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.04 2.936 . . . . 0.0 104.716 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -52.85 -54.23 37.4 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.765 1.226 . . . . 0.0 109.722 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.36 -98.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.448 1.975 . . . . 0.0 111.459 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.66 16.47 2.71 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.293 2.237 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -45.04 -45.23 10.72 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.968 1.258 . . . . 0.0 113.41 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -73.38 -41.8 62.92 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.202 0.91 . . . . 0.0 111.24 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.42 -46.67 88.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.7 t -66.73 -34.51 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.13 82.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.036 0.835 . . . . 0.0 109.389 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -73.11 -48.17 37.93 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.9 tp -50.16 -58.97 4.42 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.122 1.769 . . . . 0.0 113.837 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.91 -38.39 81.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 122.15 -0.343 . . . . 0.0 110.126 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.4 77.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.36 -26.68 67.98 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.374 1.469 . . . . 0.0 111.349 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -84.55 -21.65 30.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.655 0.662 . . . . 0.0 111.968 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.66 1.98 2.04 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.046 -1.975 . . . . 0.0 115.978 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -73.34 150.27 41.98 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.78 2.29 . . . . 0.0 109.633 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -55.89 -58.41 8.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.582 0.753 . . . . 0.0 111.129 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.8 m -159.3 166.18 31.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 107.465 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.37 12.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CD1' ' CE2' ' A' ' 78' ' ' TYR . 55.3 m-85 -100.26 151.23 21.71 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.23 111.14 19.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.32 91.37 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 113.96 10.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.25 34.0 m-20 115.32 4.84 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 133.079 4.552 . . . . 0.0 110.553 179.994 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.39 -134.49 41.92 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.658 -1.276 . . . . 0.0 114.866 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.98 -44.77 5.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -87.72 -22.71 24.45 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -52.98 170.88 0.59 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.443 1.973 . . . . 0.0 115.012 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -57.0 -27.55 74.07 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 124.532 3.488 . . . . 0.0 115.619 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -120.64 9.67 10.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.002 2.121 . . . . 0.0 109.03 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 168.98 20.83 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -47.19 -62.62 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 113.632 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.37 -52.83 63.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.795 1.238 . . . . 0.0 110.459 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 13.98 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.172 2.189 . . . . 0.0 113.437 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.4 m -129.47 16.56 5.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.644 1.578 . . . . 0.0 112.0 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.7 m 63.59 18.97 11.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.084 1.754 . . . . 0.0 113.661 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.3 mt -76.7 154.74 83.45 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.61 162.62 40.82 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.165 1.243 . . . . 0.0 109.969 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -167.38 126.51 1.36 Allowed 'General case' 0 C--O 1.238 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 113.059 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -73.49 93.19 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.977 2.111 . . . . 0.0 109.565 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.55 151.69 50.91 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 CA--C 1.546 1.105 0 C-N-CA 123.14 2.56 . . . . 0.0 107.366 177.458 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.241 0.606 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.08 106.88 0.49 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -49.68 148.7 2.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.515 1.158 . . . . 0.0 109.023 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.86 48.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -67.8 -48.03 67.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.288 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -63.11 -45.14 93.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.856 0.753 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.12 81.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.47 -41.07 98.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.092 0.86 . . . . 0.0 111.581 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -60.35 -54.78 41.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -49.6 -53.01 26.36 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.327 1.051 . . . . 0.0 111.719 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.9 mt -57.55 -23.2 49.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 113.202 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.87 -5.79 60.93 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.951 1.262 . . . . 0.0 112.676 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -124.62 -1.86 7.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.495 1.148 . . . . 0.0 111.227 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -131.38 115.83 16.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -69.18 -47.48 64.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.842 1.257 . . . . 0.0 111.703 -178.488 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 75' ' ' THR . 22.1 m120 -72.56 -6.9 47.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.582 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -76.02 118.6 18.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.56 131.91 46.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.816 0.817 . . . . 0.0 110.944 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -65.28 127.52 32.09 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.465 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' LEU . 47.2 tp -109.36 103.92 12.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.854 2.062 . . . . 0.0 109.525 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.96 108.3 16.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.245 1.018 . . . . 0.0 108.273 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -102.36 0.09 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 70.6 mtm-85 -61.44 168.55 2.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.374 1.07 . . . . 0.0 113.632 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.45 136.81 37.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.413 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -38.25 -40.35 0.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.664 2.786 . . . . 0.0 114.322 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.02 76.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.869 0.759 . . . . 0.0 112.571 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.18 80.07 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.446 0.566 . . . . 0.0 111.024 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -65.67 -6.31 11.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.592 1.157 . . . . 0.0 111.824 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.68 -29.42 7.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.556 1.943 . . . . 0.0 109.486 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -94.67 -59.42 1.93 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.88 0.872 . . . . 0.0 112.824 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -26.33 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.696 1.599 . . . . 0.0 112.947 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.82 -153.38 19.17 Favored Glycine 0 C--N 1.335 0.487 0 O-C-N 121.42 -0.8 . . . . 0.0 112.836 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -143.3 162.0 44.84 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.49 178.39 6.23 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.072 1.181 . . . . 0.0 111.185 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -145.17 145.75 31.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.57 178.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.69 13.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.413 1.885 . . . . 0.0 110.619 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -59.06 -27.54 65.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.106 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.64 94.58 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.3 mt -70.16 -28.42 65.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 0.0 109.785 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.86 19.29 7.39 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 127.694 2.569 . . . . 0.0 110.817 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 20' ' ' ASP . 46.1 mmtm -130.24 -178.57 4.8 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 150.49 34.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.612 1.165 . . . . 0.0 108.855 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 179.96 7.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.745 0.818 . . . . 0.0 110.697 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.85 133.09 44.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -113.7 121.05 42.94 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.008 1.276 . . . . 0.0 111.273 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -146.69 108.1 4.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 t -57.98 119.91 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -75.92 124.45 27.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -131.12 116.72 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.04 1.736 . . . . 0.0 107.197 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.01 -27.43 67.12 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 118.464 0.575 . . . . 0.0 112.652 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -74.1 -15.42 61.05 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.625 0.712 . . . . 0.0 110.6 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.74 32.32 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.468 1.907 . . . . 0.0 113.584 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -43.06 -56.69 6.03 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 121.452 1.933 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -63.7 -37.05 48.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.724 2.282 . . . . 0.0 112.341 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.44 74.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.319 1.437 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -82.11 -56.7 3.77 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.09 -44.59 61.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.042 1.737 . . . . 0.0 112.769 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -57.36 -36.88 71.76 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.801 0.728 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -61.82 -20.62 63.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.921 0.889 . . . . 0.0 111.356 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.8 -43.28 8.3 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.6 t -52.43 -34.62 49.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.991 1.716 . . . . 0.0 111.541 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.99 -6.03 53.17 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.53 -37.37 4.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.785 0.721 . . . . 0.0 110.899 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 75' ' ' THR . 72.9 m-85 -91.88 103.88 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.901 0.881 . . . . 0.0 109.627 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -18.33 60.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.338 0.517 . . . . 0.0 111.68 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 68.24 79.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.642 1.177 . . . . 0.0 109.532 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -32.39 93.21 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.499 2.133 . . . . 0.0 111.63 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.11 -19.9 8.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.394 1.878 . . . . 0.0 115.934 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -124.87 8.48 8.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.841 1.256 . . . . 0.0 110.957 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.611 HG21 ' CD1' ' A' ' 69' ' ' PHE . 63.5 m -104.42 111.83 24.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.712 1.605 . . . . 0.0 111.323 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.5 m -83.67 129.32 34.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.85 102.61 14.43 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.478 0.711 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.499 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 49.4 m-85 -84.43 92.56 8.09 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.18 127.17 31.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.68 1.592 . . . . 0.0 110.849 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -127.2 130.98 50.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.647 1.579 . . . . 0.0 109.128 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 49.1 t0 -137.09 -170.54 2.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.078 2.151 . . . . 0.0 107.703 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -62.51 -48.5 79.28 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.03 -1.044 . . . . 0.0 108.676 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -140.97 -172.77 3.55 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.999 2.519 . . . . 0.0 108.886 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -48.89 -30.02 5.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.686 1.994 . . . . 0.0 113.121 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.33 -108.14 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 C-N-CA 130.208 3.766 . . . . 0.0 115.717 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -110.73 0.92 17.57 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 127.209 2.203 . . . . 0.0 108.816 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -51.48 -47.04 63.33 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 121.188 1.813 . . . . 0.0 109.755 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -64.47 -23.99 67.47 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 tp -87.32 -43.23 12.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.127 0.971 . . . . 0.0 110.97 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.98 -30.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.18 83.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.04 -43.24 71.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 125.794 1.637 . . . . 0.0 111.131 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.41 -56.16 21.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.915 0.886 . . . . 0.0 112.175 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.22 -35.32 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.14 95.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.058 0.543 . . . . 0.0 109.893 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.16 -37.97 84.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.579 0.752 . . . . 0.0 109.709 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -61.28 -50.58 72.44 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.18 -3.1 0.29 Allowed Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.976 -1.458 . . . . 0.0 115.377 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -58.79 153.2 17.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.632 1.716 . . . . 0.0 109.107 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -46.94 -70.13 0.11 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.489 1.116 . . . . 0.0 112.523 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 m -154.79 177.38 11.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.443 2.297 . . . . 0.0 105.826 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.06 136.55 8.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.15 -0.969 . . . . 0.0 108.651 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -113.33 154.52 26.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.703 1.201 . . . . 0.0 108.339 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.49 114.12 23.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.264 2.4 mp -66.15 106.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.73 128.02 34.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.22 9.88 4.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.885 2.874 . . . . 0.0 111.76 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.03 -111.8 0.51 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.196 1.855 . . . . 0.0 110.839 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.75 -9.12 3.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.516 1.126 . . . . 0.0 112.027 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.82 -1.54 27.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.2 41.64 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.31 -39.92 84.84 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.527 3.485 . . . . 0.0 114.746 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 21.55 9.63 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.862 0.865 . . . . 0.0 110.999 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.4 171.71 4.01 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -40.91 -46.3 2.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 113.52 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.8 mt -65.76 -57.2 8.55 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.374 0.988 . . . . 0.0 110.627 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -66.81 -4.49 9.33 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.712 2.005 . . . . 0.0 114.303 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 p -97.2 3.9 51.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 t 77.24 11.16 2.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.634 1.973 . . . . 0.0 111.859 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.1 152.88 79.72 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.012 0.824 . . . . 0.0 110.459 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.72 142.96 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.187 1.925 . . . . 0.0 110.981 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -145.06 142.2 29.52 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.502 -0.749 . . . . 0.0 110.313 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.0 mt -92.59 93.01 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.851 1.26 . . . . 0.0 109.121 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.85 148.64 72.73 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.639 0.775 . . . . 0.0 109.103 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 CA--C 1.545 1.035 0 C-N-CA 124.284 3.323 . . . . 0.0 107.118 177.483 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.9 -98.32 0.11 Allowed Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.6 m -157.26 160.08 38.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.104 1.452 . . . . 0.0 112.446 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.96 77.63 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.858 -1.068 . . . . 0.0 112.385 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -55.03 -51.5 66.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.911 1.232 . . . . 0.0 109.832 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -52.02 -54.36 30.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.598 0.759 . . . . 0.0 110.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.23 82.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 112.621 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.24 -45.72 75.89 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -59.89 -41.47 91.66 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -60.79 -44.2 97.12 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.631 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.81 -44.83 78.24 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.355 1.434 . . . . 0.0 107.708 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.0 -6.86 33.81 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.535 1.541 . . . . 0.0 115.952 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 t -129.59 -2.82 4.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.659 1.73 . . . . 0.0 111.655 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -113.97 94.09 4.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.805 1.642 . . . . 0.0 106.82 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.52 -27.03 1.59 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.523 1.929 . . . . 0.0 115.862 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -109.9 5.42 22.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.239 0.927 . . . . 0.0 113.11 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.27 148.56 39.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.008 0.822 . . . . 0.0 111.618 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -142.9 158.88 43.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.235 0.614 . . . . 0.0 110.277 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -102.08 119.72 39.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.362 1.465 . . . . 0.0 108.006 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 109.33 20.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.492 1.917 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 121.16 27.43 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.148 2.179 . . . . 0.0 107.625 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 81' ' ' ASP . 5.8 pt -120.44 4.66 6.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -66.43 170.45 6.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 121.798 2.09 . . . . 0.0 108.968 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.73 150.11 48.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -52.42 -32.8 40.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 111.701 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.94 70.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.179 0.899 . . . . 0.0 113.222 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.82 -38.34 88.64 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -63.25 -10.4 15.63 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.573 -1.954 . . . . 0.0 114.803 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -21.05 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.337 1.855 . . . . 0.0 109.43 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.06 -79.32 0.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.853 2.061 . . . . 0.0 109.265 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.85 -30.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.267 1.427 . . . . 0.0 112.731 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 125' ' ' PRO . . . 94.68 -134.22 11.9 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 p -151.11 158.17 34.83 Favored Pre-proline 0 N--CA 1.448 -0.573 0 O-C-N 122.654 -0.321 . . . . 0.0 111.175 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HG3' HD22 ' A' ' 80' ' ' LEU . 88.2 Cg_endo -71.74 173.81 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 N-CA-C 107.321 -1.838 . . . . 0.0 107.321 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.61 HD21 ' HB2' ' A' ' 121' ' ' PRO . 1.3 p30 -141.31 149.09 40.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.09 9.31 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.464 1.126 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -58.3 -32.72 68.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.392 1.477 . . . . 0.0 111.586 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -48.1 -42.79 24.28 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 124.804 1.315 . . . . 0.0 110.321 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 mt -77.1 -75.01 0.22 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.51 44.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -141.09 -176.11 4.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.922 1.689 . . . . 0.0 109.014 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.23 136.93 25.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.862 2.065 . . . . 0.0 107.136 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -175.79 2.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.977 0.911 . . . . 0.0 111.732 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.14 133.95 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.4 p -120.05 108.47 14.32 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.982 0.913 . . . . 0.0 113.455 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -143.46 108.48 4.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -57.47 122.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 118.149 0.431 . . . . 0.0 110.226 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -74.18 151.09 40.07 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -156.45 116.16 3.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.17 -22.15 57.72 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 117.902 0.319 . . . . 0.0 112.726 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 58.1 mt-10 -76.66 -15.22 59.86 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.163 0.981 . . . . 0.0 111.591 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -128.13 33.75 4.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.073 1.349 . . . . 0.0 113.784 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.39 -54.37 7.99 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.765 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.92 -47.26 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.563 2.175 . . . . 0.0 112.362 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.42 -24.88 71.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.849 -0.417 . . . . 0.0 112.593 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.76 -39.82 17.99 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 118.159 0.979 . . . . 0.0 108.602 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.6 -47.97 79.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.89 0.876 . . . . 0.0 111.194 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -52.94 -37.74 61.3 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.034 0.534 . . . . 0.0 111.623 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.86 -29.39 68.26 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.474 -0.766 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.63 -50.61 6.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 t -55.0 -26.6 38.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.206 1.802 . . . . 0.0 112.631 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.67 -18.3 33.57 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.231 -0.918 . . . . 0.0 111.64 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -51.61 3.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.462 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.32 98.8 4.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -56.97 -33.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.176 0.99 . . . . 0.0 113.469 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -131.68 80.84 65.34 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 39.5 Cg_endo -67.11 -26.42 42.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.814 2.343 . . . . 0.0 113.101 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -54.54 -18.62 4.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.161 1.785 . . . . 0.0 114.165 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -132.84 7.66 4.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 112.694 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -105.25 109.15 21.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.454 1.502 . . . . 0.0 109.895 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.7 m -80.84 137.98 36.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.519 0.728 . . . . 0.0 109.997 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.2 mt -113.54 99.62 7.88 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 112.22 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 52.7 m-85 -76.58 112.52 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.5 141.87 14.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.147 1.379 . . . . 0.0 110.478 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.421 HD22 ' HG3' ' A' ' 39' ' ' PRO . 12.7 tp -137.42 133.48 34.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.555 ' CG ' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -134.33 175.58 9.38 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -58.28 -55.53 33.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.59 -1.319 . . . . 0.0 110.682 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -130.26 -152.52 0.52 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.258 3.423 . . . . 0.0 105.503 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.3 -6.09 2.92 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 10.38 -94.18 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 1 C-N-CA 131.872 4.558 . . . . 0.0 117.5 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.37 4.62 1.21 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.287 2.235 . . . . 0.0 112.161 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' HG21 ' A' ' 79' ' ' ILE . 1.7 m -29.31 -62.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.404 2.682 . . . . 0.0 114.463 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.04 -45.81 82.88 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.254 2.222 . . . . 0.0 112.916 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -48.24 79.23 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.695 1.198 . . . . 0.0 108.71 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.0 -34.6 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -64.11 -45.72 87.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.983 0.81 . . . . 0.0 109.124 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.4 -42.38 87.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -53.13 -58.79 5.84 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.993 1.317 . . . . 0.0 111.685 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.11 -38.0 81.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 121.873 -0.517 . . . . 0.0 110.555 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.19 93.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.701 0.626 . . . . 0.0 111.057 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.59 -45.21 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.59 0.756 . . . . 0.0 110.236 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -55.26 -37.91 67.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.753 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -9.51 0.26 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.99 -0.895 . . . . 0.0 115.205 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 51.9 m-85 -67.57 142.04 56.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.444 1.622 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -41.14 -57.52 2.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.296 2.638 . . . . 0.0 112.79 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.0 t -166.99 173.59 9.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.44 149.61 27.94 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 44.9 m-85 -133.26 122.01 23.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.7 98.4 11.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 108.871 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -64.12 120.11 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -72.21 165.39 24.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.372 0.669 . . . . 0.0 109.82 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.3 16.07 10.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.244 1.818 . . . . 0.0 112.942 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.13 -123.97 32.85 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.36 -24.76 3.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.737 2.415 . . . . 0.0 109.472 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.43 -27.63 25.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.891 1.676 . . . . 0.0 113.524 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.48 178.9 41.14 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.214 0.911 . . . . 0.0 114.652 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.53 -51.12 11.2 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.411 3.408 . . . . 0.0 113.839 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 113' ' ' ARG . 34.0 mmt180 -88.66 7.26 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.688 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.78 153.46 47.27 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -34.13 -64.06 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 129.512 3.125 . . . . 0.0 115.711 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -56.66 -53.94 51.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.03 0.377 . . . . 0.0 110.497 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -15.33 62.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.91 2.084 . . . . 0.0 113.031 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 t -88.51 8.13 29.62 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.571 1.548 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.6 t 64.77 20.75 12.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.867 2.467 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.57 158.51 59.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 123.592 0.757 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.61 ' HB2' HD21 ' A' ' 40' ' ' ASN . 57.3 Cg_endo -77.62 152.88 29.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.305 2.003 . . . . 0.0 110.613 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -151.08 141.66 22.61 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 120.704 -1.247 . . . . 0.0 111.191 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 40' ' ' ASN . 2.9 mt -81.38 80.99 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.915 1.286 . . . . 0.0 109.908 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -78.98 122.36 84.44 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 37' ' ' GLY . 83.5 Cg_endo . . . . . 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.0 110.002 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.0 p . . . . . 0 C--O 1.24 0.589 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.92 -110.93 0.28 Allowed Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.3 m -147.31 160.23 42.75 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.374 1.07 . . . . 0.0 111.064 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.48 33.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.462 1.905 . . . . 0.0 110.369 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -53.72 -49.87 67.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.398 0.544 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -57.03 -50.47 72.65 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.824 0.284 . . . . 0.0 111.493 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.81 77.09 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.927 0.491 . . . . 0.0 111.147 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 120' ' ' LEU . 44.6 t80 -63.9 -48.3 77.15 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.8 m -58.16 -42.27 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.203 0.601 . . . . 0.0 109.954 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -62.31 -34.31 76.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.578 -1.201 . . . . 0.0 111.844 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.27 -43.0 99.59 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.09 -0.48 15.29 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.839 1.685 . . . . 0.0 113.142 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -19.88 7.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.99 2.516 . . . . 0.0 111.279 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -127.61 112.49 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.117 -1.614 . . . . 0.0 111.612 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -40.43 94.06 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.903 0.881 . . . . 0.0 110.812 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.65 -12.72 60.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.282 0.633 . . . . 0.0 110.788 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.407 ' HA ' ' HB ' ' A' ' 76' ' ' THR . . . -77.83 143.03 38.18 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.61 155.6 47.35 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.321 1.048 . . . . 0.0 108.467 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.6 134.56 47.56 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -127.1 108.43 10.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.085 1.754 . . . . 0.0 111.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.33 116.89 21.39 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 pt -104.81 6.0 10.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -67.53 161.3 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.907 0.776 . . . . 0.0 110.053 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 144.5 55.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -54.15 -25.45 22.47 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.629 1.972 . . . . 0.0 110.951 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.98 92.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.07 -1.019 . . . . 0.0 109.93 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.03 -28.59 70.2 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.98 -17.18 61.82 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.759 -1.838 . . . . 0.0 111.604 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -105.49 -18.47 14.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.306 1.442 . . . . 0.0 110.332 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -100.71 -23.94 14.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.53 -26.33 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.758 1.163 . . . . 0.0 111.807 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.83 -137.79 13.47 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.72 158.0 31.64 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 118.553 1.176 . . . . 0.0 108.741 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.47 174.53 12.55 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.381 -1.815 . . . . 0.0 107.381 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.35 151.12 48.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.325 177.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -139.96 8.58 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.33 1.852 . . . . 0.0 110.472 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.92 -30.33 65.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.967 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.15 -37.33 94.33 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 mt -68.45 -33.96 75.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.4 19.42 4.62 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.254 1.883 . . . . 0.0 114.04 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -125.35 177.86 5.92 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.281 1.033 . . . . 0.0 111.661 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -131.15 159.18 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.752 1.621 . . . . 0.0 108.48 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.61 177.71 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.716 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.39 137.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.344 -2.835 . . . . 0.0 103.344 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -118.31 106.26 12.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.608 1.563 . . . . 0.0 107.883 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 m -143.96 98.31 3.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.01 122.26 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -77.38 145.02 37.51 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -146.74 114.15 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.82 1.248 . . . . 0.0 109.742 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.4 -21.82 9.49 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 121.11 -0.994 . . . . 0.0 114.104 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.88 -22.95 64.16 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.131 0.966 . . . . 0.0 111.62 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -144.53 62.79 1.32 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.42 1.105 . . . . 0.0 111.397 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.92 -56.4 23.79 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.605 1.162 . . . . 0.0 110.697 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.88 -38.76 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.897 1.731 . . . . 0.0 112.157 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.61 88.91 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -64.47 -47.03 80.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.329 1.052 . . . . 0.0 109.744 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mt -54.49 -42.23 70.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.101 0.96 . . . . 0.0 112.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -59.25 -32.42 69.97 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.842 -0.536 . . . . 0.0 111.743 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -62.85 -25.41 68.26 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -44.88 9.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -57.41 -28.01 62.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.698 1.199 . . . . 0.0 112.486 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.77 -12.23 59.96 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.766 -0.584 . . . . 0.0 111.627 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -112.84 -49.25 2.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.649 0.779 . . . . 0.0 109.699 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 51.3 m-85 -80.87 99.14 8.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -57.77 -44.69 86.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 81.42 33.87 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -26.2 44.17 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.62 2.214 . . . . 0.0 113.789 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -59.42 -14.65 13.03 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -116.68 -16.47 10.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.655 1.582 . . . . 0.0 110.114 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -77.23 132.97 38.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.072 1.349 . . . . 0.0 111.507 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.407 ' HB ' ' HA ' ' A' ' 22' ' ' ALA . 25.9 m -103.67 138.15 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.09 101.93 8.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -78.87 103.42 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.63 123.89 38.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 tp -120.23 125.04 47.14 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.704 1.201 . . . . 0.0 109.061 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -127.94 172.92 10.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.856 1.662 . . . . 0.0 106.877 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -65.71 -36.44 83.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.561 -1.337 . . . . 0.0 111.986 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -138.76 -173.98 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.572 1.949 . . . . 0.0 107.017 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.64 -26.81 2.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.709 2.404 . . . . 0.0 114.548 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.55 -113.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 130.197 3.761 . . . . 0.0 116.552 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -116.54 0.49 12.71 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.057 1.743 . . . . 0.0 113.645 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -30.65 -54.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 130.085 3.354 . . . . 0.0 115.714 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.64 -42.28 82.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.724 0.81 . . . . 0.0 110.346 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -42.99 96.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.1 -37.45 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.349 1.46 . . . . 0.0 108.496 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.48 98.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.46 -43.6 76.65 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -52.43 -57.47 9.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.832 1.196 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.5 m -63.7 -39.28 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.135 -0.353 . . . . 0.0 111.033 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.48 -52.53 64.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.598 0.759 . . . . 0.0 110.161 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.8 -44.47 93.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.557 1.543 . . . . 0.0 108.572 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -57.07 -45.07 83.56 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.126 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.21 -13.55 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-O 117.269 -1.85 . . . . 0.0 114.943 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.51 146.5 40.22 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.861 2.33 . . . . 0.0 110.705 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -60.55 3.23 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.193 1.397 . . . . 0.0 113.367 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.5 t -149.7 169.89 19.98 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.11 141.25 15.03 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -128.19 143.94 51.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.936 1.694 . . . . 0.0 106.673 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.92 118.28 36.13 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.6 95.89 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.67 142.54 39.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 76.55 2.29 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.261 2.225 . . . . 0.0 111.673 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.92 -126.22 35.07 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.879 -1.138 . . . . 0.0 113.783 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.48 4.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.122 1.369 . . . . 0.0 112.211 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -93.99 -12.81 27.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.396 1.478 . . . . 0.0 114.533 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.01 169.28 13.29 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.878 1.217 . . . . 0.0 111.471 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 -25.46 24.97 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.951 3.101 . . . . 0.0 115.671 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -134.11 27.53 3.84 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.22 1.808 . . . . 0.0 110.053 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.65 174.16 39.66 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -40.43 -53.11 2.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -63.21 -51.2 67.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.34 0.518 . . . . 0.0 109.659 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -77.47 27.82 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.478 1.111 . . . . 0.0 111.453 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.0 m -128.38 7.4 5.87 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.063 1.745 . . . . 0.0 111.524 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.9 m 57.83 53.66 6.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.039 1.335 . . . . 0.0 110.08 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 13' ' ' TYR . 90.5 mt -122.11 144.28 41.06 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.6 144.11 99.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.286 2.658 . . . . 0.0 112.285 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -147.2 156.05 42.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.87 0.868 . . . . 0.0 112.161 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.5 mt -105.66 89.95 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 110.132 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -74.67 156.4 86.72 Favored Pre-proline 0 C--O 1.239 0.519 0 O-C-N 121.776 -0.577 . . . . 0.0 109.587 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 CA--C 1.54 0.809 0 C-N-CA 123.54 2.827 . . . . 0.0 109.042 178.18 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.441 -0.902 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 -86.43 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -178.03 167.32 2.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.642 1.977 . . . . 0.0 109.16 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.46 -52.69 60.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.929 0.892 . . . . 0.0 110.083 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -55.41 -52.04 64.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.901 0.48 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.55 -51.53 66.76 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -55.96 -47.22 78.01 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -53.09 -52.23 59.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.606 0.763 . . . . 0.0 112.032 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 m -69.01 -36.06 77.36 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.557 -0.714 . . . . 0.0 111.441 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.39 -39.98 89.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.5 HD23 ' HB1' ' A' ' 22' ' ' ALA . 73.6 mt -63.9 -38.82 92.5 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.51 0.53 33.59 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 127.084 2.278 . . . . 0.0 114.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.48 -20.88 3.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.522 1.161 . . . . 0.0 111.043 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -117.16 102.98 9.75 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.562 -0.711 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.47 -26.24 60.94 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.42 -13.18 61.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.441 1.096 . . . . 0.0 111.252 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -90.74 146.63 23.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.914 -1.117 . . . . 0.0 111.524 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.56 30.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 tt -103.93 143.73 32.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.665 0.786 . . . . 0.0 108.903 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -131.37 98.44 4.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.917 1.687 . . . . 0.0 108.868 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -78.47 113.81 16.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.9 pt -103.79 13.38 7.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -73.74 166.33 23.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 134.36 50.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -54.63 -27.01 36.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.72 1.208 . . . . 0.0 112.39 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.26 88.35 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.997 -1.064 . . . . 0.0 110.128 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -71.41 -27.05 63.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.105 0.866 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -59.3 -28.5 66.84 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.593 0.633 . . . . 0.0 109.377 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -85.58 -38.9 17.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.862 0.865 . . . . 0.0 110.086 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -68.77 -50.11 53.14 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.81 -12.33 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.02 -152.18 20.01 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.141 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 p -143.71 161.36 46.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.562 1.181 . . . . 0.0 112.956 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.4 157.73 58.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.989 1.793 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.453 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 4.7 p30 -125.19 87.5 2.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.968 2.107 . . . . 0.0 112.493 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.3 5.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 119.313 -2.117 . . . . 0.0 111.043 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -24.53 61.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.234 1.814 . . . . 0.0 112.867 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.9 -27.08 61.53 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.61 -50.76 6.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 1.59 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.682 1.61 . . . . 0.0 112.668 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.25 -179.9 5.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.15 . . . . 0.0 109.55 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -141.28 133.88 28.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.68 1.592 . . . . 0.0 107.192 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.32 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.628 0.728 . . . . 0.0 111.754 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -127.95 138.3 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -115.72 110.33 18.96 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.439 1.096 . . . . 0.0 109.842 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.41 103.12 4.21 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.773 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.11 124.53 12.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 119.985 1.266 . . . . 0.0 109.417 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -79.75 122.49 26.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.68 121.58 25.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.21 -15.37 37.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.124 -0.82 . . . . 0.0 114.087 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.44 -17.8 60.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.68 1.24 . . . . 0.0 110.478 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -131.49 66.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.275 1.03 . . . . 0.0 109.976 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -57.54 -58.68 16.58 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 120.195 -1.566 . . . . 0.0 108.46 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -34.61 8.18 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.867 1.712 . . . . 0.0 110.241 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.82 -28.55 63.36 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -80.86 -55.93 4.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -48.74 -50.31 34.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.424 1.89 . . . . 0.0 112.824 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -32.99 63.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -63.35 -28.16 69.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.892 0.877 . . . . 0.0 110.189 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -45.91 10.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 t -53.93 -33.52 56.99 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.268 1.427 . . . . 0.0 112.095 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -6.18 52.11 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.66 -39.4 3.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.623 0.769 . . . . 0.0 112.851 -178.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CD1' HG21 ' A' ' 75' ' ' THR . 47.7 m-85 -80.12 119.86 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -33.53 72.48 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.548 0.53 . . . . 0.0 112.097 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -145.67 96.24 4.8 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 124.467 1.107 . . . . 0.0 108.223 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.84 -34.53 91.22 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.699 1.6 . . . . 0.0 111.906 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.28 -12.81 32.09 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.25 6.9 p30 -122.5 25.5 8.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.941 1.296 . . . . 0.0 109.29 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' PHE . 25.4 m -130.84 120.16 23.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.258 1.023 . . . . 0.0 110.696 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.6 m -93.18 137.05 32.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.6 mt -115.91 96.21 5.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.227 1.011 . . . . 0.0 112.148 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 13.9 m-85 -78.21 121.07 23.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.434 HG12 ' H ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -74.2 154.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.98 1.312 . . . . 0.0 112.668 -179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 80' ' ' LEU . 12.4 tp -155.31 105.05 2.46 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 176.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.94 171.88 8.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.851 1.66 . . . . 0.0 106.823 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.66 -58.16 3.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.059 1.343 . . . . 0.0 112.304 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -137.74 -152.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.725 2.41 . . . . 0.0 105.544 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.76 -45.4 9.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.995 2.118 . . . . 0.0 112.253 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.17 -104.09 0.06 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.829 2.157 . . . . 0.0 113.834 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -143.74 11.81 1.65 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.055 1.742 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -39.77 -48.04 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.475 1.91 . . . . 0.0 114.601 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.93 -49.45 77.77 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.835 0.854 . . . . 0.0 110.518 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.18 89.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.24 -33.67 62.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.31 93.93 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.254 0.934 . . . . 0.0 109.66 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -74.28 -38.95 63.26 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.998 0.817 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.4 tp -51.55 -60.09 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.046 1.338 . . . . 0.0 111.808 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.58 -37.47 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 122.603 0.361 . . . . 0.0 111.388 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.6 70.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.15 -41.42 88.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -66.69 -25.68 66.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.03 -4.5 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 117.712 -1.605 . . . . 0.0 115.717 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.24 146.55 48.93 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 120.458 2.129 . . . . 0.0 108.137 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -45.36 -64.03 0.81 Allowed 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.726 1.211 . . . . 0.0 111.523 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.0 m -157.39 179.27 9.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.838 1.655 . . . . 0.0 107.599 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.59 142.31 12.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.494 1.518 . . . . 0.0 106.95 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.442 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -128.6 129.45 45.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.865 1.266 . . . . 0.0 108.78 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.64 139.88 30.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.65 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 126.417 1.887 . . . . 0.0 107.793 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -59.66 151.98 23.58 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.81 0.844 . . . . 0.0 109.445 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 66.83 10.17 7.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.42 1.488 . . . . 0.0 112.742 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.89 -116.54 3.39 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.925 2.202 . . . . 0.0 113.284 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 -43.57 3.26 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.653 0.781 . . . . 0.0 112.774 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.71 -10.74 41.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.74 176.01 9.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.028 1.286 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.44 -19.31 67.72 Favored 'Trans proline' 0 N--CA 1.471 0.147 0 C-N-CA 123.919 3.079 . . . . 0.0 112.982 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -119.54 -3.97 10.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.345 2.258 . . . . 0.0 109.327 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.45 159.26 25.81 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -25.9 -62.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.462 2.305 . . . . 0.0 114.164 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.51 -62.68 1.52 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.176 1.39 . . . . 0.0 110.77 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.66 -10.01 16.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.423 1.089 . . . . 0.0 113.263 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.82 15.31 7.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 0.0 109.113 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 m 68.85 15.56 8.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.349 2.66 . . . . 0.0 112.62 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.69 153.01 52.44 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 119.144 0.884 . . . . 0.0 110.252 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.64 169.75 21.85 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.2 1.934 . . . . 0.0 109.536 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -165.19 130.09 2.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 119.946 -1.721 . . . . 0.0 109.555 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -72.26 97.21 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.658 1.983 . . . . 0.0 109.439 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -93.91 149.52 37.1 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 121.058 -1.026 . . . . 0.0 112.388 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.453 -0.886 0 C-N-CA 124.046 3.164 . . . . 0.0 109.156 178.751 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.808 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -60.93 137.61 58.21 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.921 0.86 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 p -128.83 -70.32 0.68 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.678 1.191 . . . . 0.0 109.975 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.62 117.15 8.51 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.276 1.417 . . . . 0.0 110.21 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 m -57.5 115.24 2.63 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 p -147.01 178.45 8.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.693 -0.629 . . . . 0.0 111.536 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.24 -117.6 0.61 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.348 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 m -122.2 148.4 45.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.523 1.529 . . . . 0.0 111.002 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.57 -42.87 75.32 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.315 1.046 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.36 -41.32 79.88 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.732 0.813 . . . . 0.0 111.482 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -61.45 -42.8 99.33 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.07 82.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.343 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.56 -40.17 90.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.036 1.289 . . . . 0.0 110.251 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.2 m -62.98 -54.02 44.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -57.17 -43.09 82.26 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.619 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.98 -20.5 58.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.966 1.257 . . . . 0.0 111.423 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.2 -9.33 62.11 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.219 1.866 . . . . 0.0 112.653 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -122.96 -18.18 6.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.064 1.432 . . . . 0.0 110.913 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -97.21 103.73 15.69 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.59 -24.48 67.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.904 0.881 . . . . 0.0 109.905 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -94.24 -0.19 55.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.164 1.785 . . . . 0.0 112.912 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.91 148.39 29.89 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.246 0.93 . . . . 0.0 111.646 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -148.11 154.68 40.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.02 1.728 . . . . 0.0 108.321 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.04 131.09 52.99 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.067 1.747 . . . . 0.0 108.022 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.0 tp -122.68 114.97 21.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.849 1.66 . . . . 0.0 109.284 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.6 m-20 -84.67 104.19 14.43 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 126.292 1.837 . . . . 0.0 109.445 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.66 2.96 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 122.224 -0.298 . . . . 0.0 110.71 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 HH21 ' CG ' ' A' ' 26' ' ' ASP . 39.9 mtm180 -57.06 165.01 1.41 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.49 1.516 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.53 141.74 32.38 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.9 m -49.16 -33.66 12.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.351 1.46 . . . . 0.0 111.194 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.52 78.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.235 0.925 . . . . 0.0 110.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 36' ' ' VAL . 66.3 m-20 -63.69 -39.42 94.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -58.9 -20.72 54.15 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.276 -1.515 . . . . 0.0 114.574 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -96.03 -23.47 16.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.955 0.502 . . . . 0.0 111.586 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.35 -70.26 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.897 1.679 . . . . 0.0 110.941 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 32' ' ' ASP . 9.6 p -77.36 -31.92 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.425 1.09 . . . . 0.0 111.708 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.3 -138.32 13.92 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -147.48 162.63 31.38 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 120.619 -1.518 . . . . 0.0 109.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.55 163.28 37.44 Favored 'Trans proline' 0 N--CA 1.435 -1.937 0 CA-C-O 124.618 1.841 . . . . 0.0 110.141 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.612 ' HB2' HG13 ' A' ' 123' ' ' ILE . 35.3 t-20 -126.19 92.26 3.54 Favored 'General case' 0 N--CA 1.419 -2.003 1 C-N-CA 132.346 4.258 . . . . 0.0 105.295 -179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 pt -115.43 -19.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.195 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -43.24 -26.54 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.567 -1.682 . . . . 0.0 115.475 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.4 37.36 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 119.991 1.269 . . . . 0.0 110.303 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.46 -71.5 0.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.32 32.2 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 CA-C-O 118.815 -0.992 . . . . 0.0 115.194 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -126.77 177.73 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.053 1.926 . . . . 0.0 110.39 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.86 133.7 43.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.413 1.085 . . . . 0.0 110.076 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.26 167.39 18.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.374 -0.828 . . . . 0.0 110.387 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.1 t -134.34 134.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -115.14 115.84 27.41 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.564 1.146 . . . . 0.0 109.355 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.5 107.86 4.41 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.73 111.44 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 119.776 1.171 . . . . 0.0 110.182 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -74.29 154.86 38.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.592 0.71 . . . . 0.0 109.34 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -165.3 134.78 3.5 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.91 -34.79 80.06 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -66.99 -24.87 66.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.414 1.107 . . . . 0.0 111.115 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -105.32 15.35 27.45 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.582 1.553 . . . . 0.0 114.169 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -39.43 -60.0 1.41 Allowed Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 121.459 1.936 . . . . 0.0 112.328 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.82 -47.64 6.6 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.554 2.836 . . . . 0.0 112.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.75 -22.85 68.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.847 0.737 . . . . 0.0 113.293 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -82.89 -50.17 8.89 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.097 1.759 . . . . 0.0 107.481 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.53 -47.58 66.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.495 1.518 . . . . 0.0 112.882 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -52.38 -43.44 64.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -58.16 -22.2 50.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.741 1.216 . . . . 0.0 113.794 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.41 -52.79 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.8 t -55.68 -30.0 60.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.951 0.9 . . . . 0.0 110.106 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.74 -4.58 59.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -36.67 4.54 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 119.497 1.044 . . . . 0.0 111.342 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.49 120.2 29.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.167 1.387 . . . . 0.0 107.503 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -58.79 -54.11 50.79 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.293 0.497 . . . . 0.0 111.124 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -116.87 83.78 14.91 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.526 1.13 . . . . 0.0 110.012 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 11.0 Cg_endo -56.6 -40.75 82.25 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.163 1.909 . . . . 0.0 110.253 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.32 -0.78 1.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 -11.92 4.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.135 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 138.19 31.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.718 1.207 . . . . 0.0 110.979 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -100.82 123.46 45.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.64 97.16 6.76 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.018 1.327 . . . . 0.0 110.975 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 41.8 m-85 -73.42 120.04 18.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.9 OUTLIER -76.42 156.86 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.278 1.431 . . . . 0.0 109.992 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.4 tt -156.35 110.57 2.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -123.76 169.21 11.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -54.89 -39.07 68.36 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.718 -1.238 . . . . 0.0 109.736 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -141.77 -140.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.658 1.983 . . . . 0.0 108.989 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -64.95 -62.29 1.65 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.643 1.577 . . . . 0.0 108.2 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.89 -86.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 127.739 2.59 . . . . 0.0 113.675 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.46 9.44 2.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.584 ' HA ' HG21 ' A' ' 79' ' ' ILE . 19.3 m -42.69 -53.6 4.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.829 1.652 . . . . 0.0 114.182 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -39.23 78.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.24 1.382 . . . . 0.0 112.249 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -50.59 72.81 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.9 -30.42 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 109.94 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.13 89.15 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -78.84 -35.62 43.67 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.04 -57.22 9.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 112.194 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.04 -41.07 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.63 77.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.038 0.935 . . . . 0.0 110.024 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.99 -38.5 91.4 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.211 1.004 . . . . 0.0 109.445 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.96 -49.35 76.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -8.07 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-O 118.132 -1.371 . . . . 0.0 113.269 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 31.9 m-85 -61.1 156.33 18.36 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.123 1.961 . . . . 0.0 109.93 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -59.22 -68.48 0.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 m -158.76 171.28 20.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.155 0.982 . . . . 0.0 109.068 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.72 164.24 36.61 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 32.9 m-85 -135.0 125.45 26.59 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.87 109.58 20.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.36 92.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.02 133.5 14.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.98 2.112 . . . . 0.0 107.015 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 89.85 -5.07 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.636 3.174 . . . . 0.0 112.375 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 65.44 -164.54 37.51 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -88.89 -14.09 37.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.656 -1.164 . . . . 0.0 114.047 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.23 -2.63 14.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.362 0.983 . . . . 0.0 113.61 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.4 176.29 19.1 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.131 -0.981 . . . . 0.0 113.304 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.22 -25.48 56.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.316 3.344 . . . . 0.0 115.248 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -134.8 28.5 3.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.762 2.025 . . . . 0.0 110.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.19 -171.76 5.21 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.483 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 36.4 t-105 -47.2 -55.17 9.04 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.646 0.778 . . . . 0.0 112.613 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.14 -50.77 71.83 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.044 0.937 . . . . 0.0 110.29 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.11 24.96 0.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.802 1.241 . . . . 0.0 113.468 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.3 m -129.37 12.26 5.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.599 1.96 . . . . 0.0 110.823 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.46 18.29 11.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.398 1.479 . . . . 0.0 112.976 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.44 149.96 62.49 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.62 154.68 49.78 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.35 2.033 . . . . 0.0 109.856 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -155.15 157.33 37.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.263 0.483 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' ' 40' ' ' ASN . 3.4 mt -107.83 88.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.184 1.394 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.42 156.22 91.81 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.984 0.913 . . . . 0.0 109.365 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.75 -173.58 1.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.147 3.232 . . . . 0.0 109.124 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -68.82 103.53 1.8 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.768 0.794 . . . . 0.0 109.091 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -78.12 162.47 26.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.2 m -130.25 149.89 51.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -72.5 110.33 6.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.06 105.44 0.25 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.53 165.19 31.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.634 2.223 . . . . 0.0 109.622 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.8 p -147.35 -1.56 0.63 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.5 t -80.1 -173.47 3.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.077 1.418 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 1 C-N-CA 132.001 4.62 . . . . 0.0 104.544 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.698 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.41 31.16 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 108.68 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -67.14 -26.44 66.67 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.439 1.496 . . . . 0.0 111.716 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.1 170.58 53.15 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.2 t -117.63 100.53 7.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.9 p -133.35 166.01 23.5 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 109.617 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.6 -120.77 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 118.64 -1.743 . . . . 0.0 115.438 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.02 146.05 52.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.018 1.327 . . . . 0.0 109.991 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.43 ' HB3' ' OG ' ' A' ' 118' ' ' SER . . . -53.9 -50.41 66.41 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.135 1.774 . . . . 0.0 107.864 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -55.71 -49.58 72.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.634 0.652 . . . . 0.0 111.823 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -55.49 -43.99 76.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.145 0.43 . . . . 0.0 111.086 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.06 -34.19 72.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.258 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.49 -49.13 67.61 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.762 1.619 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -54.43 -45.2 72.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.579 0.751 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 18' ' ' THR . 51.4 mmtt -58.25 -36.26 72.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.604 -1.188 . . . . 0.0 112.275 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.08 -25.68 65.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.72 1.6 . . . . 0.0 111.736 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -40.18 6.36 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 15' ' ' LYS . 1.1 t -78.67 -4.28 48.24 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.751 0.776 . . . . 0.0 110.941 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -126.51 -168.72 1.9 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.565 0.746 . . . . 0.0 109.12 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -141.66 -43.23 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.882 2.473 . . . . 0.0 106.554 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.37 63.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.476 0.71 . . . . 0.0 111.44 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.85 124.03 27.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -134.33 138.02 44.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.6 tm? -84.5 133.5 34.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.413 1.085 . . . . 0.0 108.552 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 24' ' ' LEU . 21.3 tp -126.58 112.47 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.593 1.557 . . . . 0.0 109.407 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -89.09 117.96 28.46 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.585 2.354 . . . . 0.0 109.15 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.1 pt -108.98 14.2 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -76.55 164.87 25.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 135.15 55.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 m -51.6 -32.54 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.849 1.26 . . . . 0.0 111.724 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.3 77.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.637 1.108 . . . . 0.0 111.622 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -62.62 -28.99 70.28 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.74 0.7 . . . . 0.0 109.804 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -62.43 -13.67 32.42 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.873 -1.142 . . . . 0.0 111.313 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -107.78 -35.87 6.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.385 1.074 . . . . 0.0 110.467 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -85.61 -28.8 24.56 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.74 -22.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.424 1.011 . . . . 0.0 110.346 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.06 -159.6 17.2 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 121.64 -0.662 . . . . 0.0 112.722 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -140.01 161.39 56.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.611 0.764 . . . . 0.0 111.285 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.09 155.69 47.34 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.73 1.62 . . . . 0.0 110.51 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 3.0 p30 -127.39 86.86 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.494 1.918 . . . . 0.0 108.934 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 pt -85.18 6.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.962 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -51.92 -34.65 42.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.459 1.503 . . . . 0.0 112.257 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.57 -6.97 9.46 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.796 1.634 . . . . 0.0 114.173 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 mt -105.15 -23.33 12.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.571 1.548 . . . . 0.0 109.086 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.41 5.73 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 127.939 2.685 . . . . 0.0 109.883 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -124.37 168.5 12.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.849 0.824 . . . . 0.0 110.831 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 48' ' ' ALA . 6.7 tptt -135.84 120.16 17.93 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.613 1.165 . . . . 0.0 108.296 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . -66.75 174.77 2.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.84 0.829 . . . . 0.0 112.387 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.46 149.83 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.131 -2.914 . . . . 0.0 103.131 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -133.95 113.74 12.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.085 1.354 . . . . 0.0 111.315 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.9 m -158.26 113.75 2.68 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.78 121.32 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 112.773 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.89 156.4 32.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.1 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -166.88 161.27 15.12 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 129.33 3.052 . . . . 0.0 106.141 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.32 62.22 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.558 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.7 -42.57 77.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.352 1.061 . . . . 0.0 110.223 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.32 38.82 2.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.661 1.984 . . . . 0.0 112.841 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -46.83 -50.55 43.5 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 120.737 1.608 . . . . 0.0 109.882 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.9 -40.01 13.16 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.727 1.618 . . . . 0.0 111.959 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.88 -53.19 46.12 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 125.394 1.473 . . . . 0.0 109.644 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -55.93 -50.35 70.97 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.202 2.201 . . . . 0.0 108.307 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -56.85 -46.89 81.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.184 0.593 . . . . 0.0 109.902 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -58.21 -42.88 87.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.097 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -56.94 -24.08 50.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.466 1.03 . . . . 0.0 111.984 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mt -96.26 -46.9 6.24 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.57 1.148 . . . . 0.0 108.894 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -64.02 -11.9 33.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.51 0.595 . . . . 0.0 112.139 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.79 -3.86 51.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.251 0.478 . . . . 0.0 110.297 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 -32.68 5.88 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.5 1.92 . . . . 0.0 112.425 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.41 127.46 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.635 1.174 . . . . 0.0 111.503 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.29 -41.36 66.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -135.99 89.61 20.27 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 119.677 1.126 . . . . 0.0 111.027 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.58 -31.42 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.702 1.601 . . . . 0.0 112.414 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.1 -10.86 6.93 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.075 0.95 . . . . 0.0 112.706 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -130.84 23.61 4.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.434 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.8 m -134.06 120.93 20.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.84 1.2 . . . . 0.0 110.603 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -83.7 132.26 34.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.288 1.435 . . . . 0.0 110.605 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 99' ' ' PHE . 51.7 mt -108.19 103.47 12.67 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.001 0.92 . . . . 0.0 112.154 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 65.7 m-85 -82.86 100.68 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.1 134.2 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.951 0.901 . . . . 0.0 110.127 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.79 135.94 38.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.063 0.945 . . . . 0.0 109.141 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -130.4 176.19 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 128.693 2.797 . . . . 0.0 108.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.69 -35.61 78.5 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.546 -1.347 . . . . 0.0 109.628 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.58 -151.64 0.39 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.598 1.959 . . . . 0.0 106.808 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.51 -45.68 89.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.61 -108.93 0.22 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 128.2 2.81 . . . . 0.0 114.66 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -118.6 2.15 11.72 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.596 1.159 . . . . 0.0 112.829 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 m -35.29 -57.14 0.6 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.978 2.111 . . . . 0.0 114.717 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.59 -38.07 89.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -31.44 63.19 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.601 0.715 . . . . 0.0 110.074 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.75 -31.29 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.15 93.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.386 0.674 . . . . 0.0 109.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.59 -44.61 73.98 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.91 0.484 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.57 -57.24 10.62 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.298 1.039 . . . . 0.0 112.648 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.21 -40.28 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.54 68.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.72 0.808 . . . . 0.0 109.902 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.36 -23.34 67.26 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.804 0.842 . . . . 0.0 112.623 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -82.01 -19.52 40.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.42 -4.18 5.88 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-O 117.406 -1.775 . . . . 0.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 77' ' ' LEU . 35.2 m-85 -65.38 140.75 58.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 120.61 2.205 . . . . 0.0 108.224 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -47.77 -61.01 2.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -157.29 166.57 32.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.28 151.39 31.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.425 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 24.8 m-85 -141.19 135.5 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 107.748 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.34 118.95 38.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.707 2.003 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.07 110.66 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -66.89 149.07 51.12 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 66.76 8.96 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.312 1.845 . . . . 0.0 113.833 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.71 -104.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.813 0 C-N-CA 127.057 2.265 . . . . 0.0 114.244 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.6 -45.5 0.67 Allowed 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.901 1.28 . . . . 0.0 111.948 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.0 -2.02 31.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.735 0.647 . . . . 0.0 112.089 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.33 174.53 53.46 Favored Glycine 0 CA--C 1.54 1.648 0 O-C-N 121.035 -1.04 . . . . 0.0 112.059 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.36 -23.69 75.36 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.559 3.506 . . . . 0.0 115.542 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -131.79 14.84 4.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.51 1.124 . . . . 0.0 110.57 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.4 165.91 30.99 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -27.7 -56.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.198 2.599 . . . . 0.0 114.697 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.71 -63.19 1.28 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.117 0.967 . . . . 0.0 109.159 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -69.07 7.21 0.75 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.741 1.616 . . . . 0.0 112.718 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 22.7 t -100.53 6.87 44.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.32 1.448 . . . . 0.0 109.877 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t 66.78 49.22 1.25 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.147 1.34 . . . . 0.0 108.657 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.7 mt -128.67 155.57 78.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 125.084 1.354 . . . . 0.0 109.123 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.62 168.72 23.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.645 2.23 . . . . 0.0 110.989 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -171.83 126.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.182 -1.574 . . . . 0.0 110.816 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.426 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.8 mt -68.66 88.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.324 1.85 . . . . 0.0 110.716 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.24 155.11 69.65 Favored Pre-proline 0 C--O 1.24 0.603 0 O-C-N 121.103 -0.998 . . . . 0.0 110.309 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.72 -175.2 2.34 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.51 3.473 . . . . 0.0 110.72 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -76.22 90.09 3.13 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -60.23 149.8 32.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.058 0.844 . . . . 0.0 109.131 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.6 t -127.42 177.5 6.7 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.517 1.127 . . . . 0.0 109.641 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -66.85 171.28 5.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.021 1.328 . . . . 0.0 109.563 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.13 73.29 1.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.58 177.84 6.36 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.449 2.099 . . . . 0.0 110.62 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.8 p -125.86 161.03 28.35 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 108.598 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.9 p -66.57 169.19 8.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.371 0.668 . . . . 0.0 111.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.745 -1.03 . . . . 0.0 111.296 179.524 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -122.1 -55.57 1.87 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.046 0.938 . . . . 0.0 109.218 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m 57.75 30.57 19.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.388 0.54 . . . . 0.0 111.544 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.91 73.89 0.02 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.656 1.598 . . . . 0.0 109.771 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -84.27 86.38 7.25 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.281 -1.129 . . . . 0.0 109.769 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -113.47 151.77 31.01 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.1 0.56 . . . . 0.0 111.533 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.4 -101.65 0.23 Allowed Glycine 0 C--N 1.338 0.67 0 O-C-N 121.491 -0.755 . . . . 0.0 111.941 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.3 m -160.11 164.94 32.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.054 2.542 . . . . 0.0 106.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.5 95.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.654 -0.654 . . . . 0.0 112.554 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -55.26 -48.81 73.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.006 0.821 . . . . 0.0 110.684 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -55.59 -50.1 71.01 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.379 0.671 . . . . 0.0 109.419 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.75 81.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.101 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.4 t80 -59.42 -43.37 93.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.777 1.171 . . . . 0.0 110.561 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.6 m -58.91 -45.02 91.3 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.235 -0.915 . . . . 0.0 109.425 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -65.04 -42.16 94.55 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.946 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 13' ' ' TYR . 53.3 mt -57.28 -41.88 80.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.108 0.867 . . . . 0.0 109.548 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 44' ' ' LEU . . . -72.67 -14.31 77.92 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-O 118.186 -1.341 . . . . 0.0 115.32 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 t -115.25 -13.12 11.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.05 1.425 . . . . 0.0 112.02 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -113.3 99.78 8.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.84 -25.86 43.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.572 1.149 . . . . 0.0 112.9 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -89.37 -3.96 58.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.543 0.737 . . . . 0.0 112.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.05 149.84 24.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.528 1.058 . . . . 0.0 110.092 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -145.96 174.09 11.57 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.39 144.42 40.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.436 0.695 . . . . 0.0 110.144 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 tp -121.35 108.73 14.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.666 2.387 . . . . 0.0 112.541 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -86.5 109.82 19.34 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.476 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.07 2.25 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -42.19 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.72 130.02 3.68 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -44.59 -34.33 2.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.906 2.082 . . . . 0.0 114.726 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.78 -34.29 45.68 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 120.359 1.436 . . . . 0.0 110.781 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.08 -29.33 69.68 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.34 -20.69 65.73 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 119.628 -1.92 . . . . 0.0 112.168 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -91.92 -19.93 21.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.573 1.549 . . . . 0.0 109.474 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.5 -62.86 1.18 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.16 1.384 . . . . 0.0 112.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.02 -38.53 12.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 123.964 0.906 . . . . 0.0 111.136 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.69 -151.76 17.27 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 118.886 0.766 . . . . 0.0 113.618 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.56 154.6 60.04 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.801 1.64 . . . . 0.0 108.036 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.75 172.65 14.77 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 121.551 1.501 . . . . 0.0 109.774 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.19 113.15 12.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.624 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.4 pt -103.27 14.47 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.631 1.205 . . . . 0.0 110.933 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.02 -17.29 51.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.548 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.65 -6.82 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 120.276 1.398 . . . . 0.0 111.335 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 ' HA2' ' A' ' 17' ' ' GLY . 52.3 mt -112.5 -22.72 10.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.703 2.801 . . . . 0.0 109.376 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.93 25.66 14.29 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.614 2.054 . . . . 0.0 109.667 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -116.63 178.92 4.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.512 1.925 . . . . 0.0 111.695 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.98 138.77 17.95 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.08 170.81 16.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.2 1.0 . . . . 0.0 112.421 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.0 133.75 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.956 2.102 . . . . 0.0 106.159 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -106.63 122.62 46.7 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.983 0.913 . . . . 0.0 111.611 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.502 ' CG2' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -152.13 102.96 2.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.866 1.266 . . . . 0.0 109.503 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.71 127.36 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 120.321 -1.487 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -81.37 151.81 27.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -157.84 131.29 7.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.475 1.11 . . . . 0.0 108.563 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.84 66.56 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -86.67 -0.5 56.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.801 1.3 . . . . 0.0 111.833 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.62 25.58 5.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.64 0.776 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -48.36 -57.14 11.44 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.676 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.28 -41.05 13.32 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.346 1.364 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -22.53 63.8 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.693 0.663 . . . . 0.0 113.78 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -83.29 -47.23 11.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.439 1.496 . . . . 0.0 107.585 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 mt -55.78 -46.83 77.85 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.214 1.405 . . . . 0.0 110.801 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -45.24 66.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.685 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HE3' ' CG2' ' A' ' 51' ' ' THR . 40.9 mtmt -62.32 -20.03 63.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.67 -46.24 6.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 t -60.74 -21.25 62.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.23 -2.79 56.28 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 -27.79 7.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.979 0.911 . . . . 0.0 112.308 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.8 114.18 25.8 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 108.268 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -66.21 -31.82 72.88 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.49 1.116 . . . . 0.0 111.287 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.49 77.48 34.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 17.3 Cg_endo -58.15 -40.75 74.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.091 1.861 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.97 -6.11 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -125.94 -4.04 6.98 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.782 0.719 . . . . 0.0 111.463 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.4 m -96.39 124.37 40.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 110.488 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.8 m -89.68 132.87 34.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.66 98.73 7.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 29.6 m-85 -78.33 113.99 16.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.127 -0.94 . . . . 0.0 108.478 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -81.93 134.55 26.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 120.228 1.376 . . . . 0.0 111.722 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 tp -129.88 113.29 14.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.35 1.46 . . . . 0.0 109.254 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -119.36 -177.27 3.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.691 1.596 . . . . 0.0 108.682 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -61.23 -54.48 43.67 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.356 -0.84 . . . . 0.0 110.121 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -139.1 -168.9 2.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.871 2.869 . . . . 0.0 106.34 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.68 -58.51 0.5 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.898 2.479 . . . . 0.0 112.689 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.02 -109.03 0.57 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.639 1.59 . . . . 0.0 114.835 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -134.55 10.04 3.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.194 2.198 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.7 m -44.13 -42.1 6.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.692 1.597 . . . . 0.0 113.157 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -64.01 -44.23 93.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.501 0.72 . . . . 0.0 111.284 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.61 -45.45 86.85 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.72 -28.6 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.094 0.958 . . . . 0.0 109.471 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.32 -44.8 82.37 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.916 0.78 . . . . 0.0 110.218 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.15 -39.35 60.45 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.1 -56.65 5.33 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.351 1.46 . . . . 0.0 111.798 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.56 -39.43 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.608 0.763 . . . . 0.0 111.19 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.57 -52.85 63.72 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.63 0.772 . . . . 0.0 109.093 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.84 -20.18 65.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.053 1.741 . . . . 0.0 111.656 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.58 -15.43 32.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.178 1.391 . . . . 0.0 114.025 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.14 -0.76 5.31 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.016 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 36.2 m-85 -81.74 156.35 25.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.9 1.85 . . . . 0.0 109.196 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -54.54 -69.45 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.077 0.951 . . . . 0.0 112.128 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.3 m -161.31 177.93 9.69 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.694 2.398 . . . . 0.0 107.008 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.15 163.93 39.01 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 126.103 1.761 . . . . 0.0 107.253 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 28.5 m-85 -136.21 145.45 45.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 107.891 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.15 118.43 35.33 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.846 1.259 . . . . 0.0 108.713 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.13 113.16 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -63.12 143.46 57.77 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 70.69 2.82 4.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.304 1.442 . . . . 0.0 112.983 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.69 -110.64 0.86 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 126.922 2.201 . . . . 0.0 114.639 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -122.44 -21.99 5.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.069 1.348 . . . . 0.0 114.36 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -110.01 -10.56 14.7 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.03 -173.47 47.62 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 119.579 1.081 . . . . 0.0 114.145 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.46 -36.32 93.92 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.116 3.211 . . . . 0.0 114.281 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 78.7 mmt-85 -111.32 11.1 21.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.491 1.116 . . . . 0.0 110.769 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.68 156.77 46.09 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.4 t-105 -36.22 -54.54 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 114.538 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.29 -39.4 86.78 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -86.99 -8.56 57.08 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.013 0.925 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.8 t -82.63 6.59 17.29 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.264 1.026 . . . . 0.0 111.028 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m 54.72 57.08 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.993 1.717 . . . . 0.0 108.558 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 98.0 mt -121.67 154.58 60.2 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 126.844 2.058 . . . . 0.0 105.919 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.89 166.1 29.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.9 1.734 . . . . 0.0 110.159 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -159.94 143.09 13.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.847 1.203 . . . . 0.0 111.928 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 mt -95.2 98.07 7.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 0.0 110.173 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.33 141.13 42.33 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.6 158.34 50.97 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.538 2.159 . . . . 0.0 106.584 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -75.15 35.44 0.11 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.462 -1.399 . . . . 0.0 113.065 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -15.25 50.46 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p -68.33 162.15 25.86 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 121.467 1.94 . . . . 0.0 110.168 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 m -148.9 117.82 6.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.843 2.057 . . . . 0.0 105.477 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.57 166.45 40.12 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.345 0.974 . . . . 0.0 111.61 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.29 -50.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.963 2.442 . . . . 0.0 113.059 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 m -53.94 113.61 1.28 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.854 2.062 . . . . 0.0 112.088 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 m -68.24 -14.91 63.33 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.529 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -67.53 172.21 5.32 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.306 0.553 . . . . 0.0 110.992 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -84.7 40.35 0.79 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.119 0.968 . . . . 0.0 108.827 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.64 -170.46 23.06 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.45 1.976 . . . . 0.0 112.657 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.0 m -63.13 93.35 0.06 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.802 2.441 . . . . 0.0 114.876 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -75.25 159.56 31.39 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 120.887 -1.133 . . . . 0.0 108.889 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.77 98.38 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -51.85 158.61 0.98 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.0 110.434 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.67 -49.77 46.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.684 0.674 . . . . 0.0 111.701 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -58.37 -48.36 80.85 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.759 -0.588 . . . . 0.0 110.785 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -56.73 -52.73 63.86 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 78' ' ' TYR . . . -53.77 -51.24 64.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.53 1.132 . . . . 0.0 110.3 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.0 -41.86 93.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.209 0.603 . . . . 0.0 111.698 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -61.77 -51.63 67.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -62.93 -36.12 82.36 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.769 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.98 -30.59 69.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.088 1.313 . . . . 0.0 108.195 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.48 -24.84 74.09 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 125.266 1.413 . . . . 0.0 113.94 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -100.57 -24.16 14.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.301 1.551 . . . . 0.0 109.923 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.34 170.24 15.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.493 0.588 . . . . 0.0 110.329 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -119.36 -32.76 4.28 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.083 0.953 . . . . 0.0 111.475 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -101.83 -11.76 18.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.45 -0.781 . . . . 0.0 112.832 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.22 58.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.612 0.642 . . . . 0.0 112.466 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -140.02 166.55 24.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.93 125.16 42.7 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.628 1.571 . . . . 0.0 107.419 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.5 97.6 7.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.771 1.628 . . . . 0.0 108.574 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.87 106.2 8.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.1 1.41 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 122.953 0.501 . . . . 0.0 111.738 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -59.19 168.04 1.55 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 126.91 2.084 . . . . 0.0 112.393 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.35 135.97 35.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 m -41.71 -41.22 2.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.187 2.195 . . . . 0.0 114.249 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.34 92.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.621 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -58.86 -29.08 66.7 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.0 -19.27 51.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.091 0.859 . . . . 0.0 109.23 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -104.33 -33.69 8.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.779 2.432 . . . . 0.0 111.916 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -77.91 -44.01 28.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.232 1.013 . . . . 0.0 111.618 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.68 -25.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.492 1.117 . . . . 0.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.52 -163.27 13.55 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.199 0.909 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -143.06 162.97 40.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 122.958 0.503 . . . . 0.0 111.121 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.72 146.46 33.94 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.545 1.497 . . . . 0.0 112.94 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 2.0 p30 -108.69 76.25 1.01 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.812 2.445 . . . . 0.0 109.659 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 pt -85.57 5.23 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.651 0.739 . . . . 0.0 110.817 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -53.09 -34.51 56.93 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.889 1.676 . . . . 0.0 114.368 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.63 -30.65 69.22 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.061 1.3 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.62 -21.01 49.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.745 0.818 . . . . 0.0 110.129 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 38.18 5.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -126.56 171.03 11.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.822 1.249 . . . . 0.0 111.029 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -143.86 137.73 28.14 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.899 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.14 167.08 22.51 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.2 94.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -62.32 119.87 9.9 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 m -152.26 95.64 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.966 1.307 . . . . 0.0 108.884 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -61.78 122.76 13.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -75.64 154.23 36.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.693 0.397 . . . . 0.0 109.984 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -148.98 127.27 12.16 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.92 -13.3 82.64 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.57 -41.31 10.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.55 1.175 . . . . 0.0 108.15 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.71 29.03 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.744 1.618 . . . . 0.0 111.852 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -43.2 -53.84 10.3 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 120.971 -1.081 . . . . 0.0 111.137 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.09 -49.66 4.64 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.997 1.798 . . . . 0.0 112.136 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -29.47 71.92 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.763 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -69.56 -48.36 60.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.062 1.745 . . . . 0.0 108.657 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.4 -41.59 66.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.321 1.049 . . . . 0.0 111.854 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -59.12 -33.18 70.57 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.572 -0.705 . . . . 0.0 111.741 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -60.03 -16.46 31.15 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.663 0.785 . . . . 0.0 111.92 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.3 -37.58 8.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.349 1.46 . . . . 0.0 109.731 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -25.18 65.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.637 1.562 . . . . 0.0 111.498 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.67 -6.04 41.61 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.585 -0.697 . . . . 0.0 112.03 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 -49.69 2.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.209 1.003 . . . . 0.0 108.455 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.9 m-85 -77.83 103.7 7.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 108.964 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.66 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.756 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -134.45 69.93 72.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.635 1.974 . . . . 0.0 112.861 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 -24.15 64.48 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.989 3.793 . . . . 0.0 111.919 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -53.87 -18.43 3.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 130.792 3.637 . . . . 0.0 113.057 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -134.31 -4.51 2.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.564 1.546 . . . . 0.0 111.689 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 69' ' ' PHE . 22.3 m -76.03 121.79 23.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.607 1.094 . . . . 0.0 110.834 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -89.58 122.77 33.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.433 ' CD1' ' HB1' ' A' ' 12' ' ' ALA . 72.2 m-85 -79.16 105.47 10.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 mt -83.56 129.15 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 119.235 0.925 . . . . 0.0 110.959 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -125.56 125.8 43.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.562 1.145 . . . . 0.0 108.319 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -128.17 177.36 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.961 2.105 . . . . 0.0 107.537 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -58.87 -52.59 65.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.692 -1.255 . . . . 0.0 109.378 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.31 178.77 7.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.691 3.196 . . . . 0.0 104.848 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -24.45 -57.33 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 130.399 3.48 . . . . 0.0 112.979 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.94 -104.33 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.906 2.193 . . . . 0.0 115.499 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -125.13 14.0 8.39 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.899 1.28 . . . . 0.0 112.82 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -51.96 -39.11 58.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.957 1.708 . . . . 0.0 112.068 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.55 -43.59 69.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.194 0.907 . . . . 0.0 110.362 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.27 -49.58 77.03 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.705 0.802 . . . . 0.0 109.733 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.97 -33.91 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.113 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.95 95.58 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.232 0.924 . . . . 0.0 109.34 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -69.02 -47.48 65.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.4 -62.05 1.69 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.941 1.696 . . . . 0.0 113.96 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 m -63.04 -39.02 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 122.584 0.354 . . . . 0.0 111.382 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.89 70.94 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.938 0.774 . . . . 0.0 110.196 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.26 -42.62 99.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.599 0.562 . . . . 0.0 109.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.86 -45.25 95.28 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 -14.97 0.06 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.313 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -71.93 156.04 39.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.217 1.509 . . . . 0.0 108.234 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -58.57 -66.86 0.42 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.879 0.871 . . . . 0.0 111.557 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -159.0 170.6 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.915 1.286 . . . . 0.0 107.584 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.33 163.75 35.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.432 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 42.9 m-85 -133.94 123.37 24.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.79 104.78 15.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.058 0.943 . . . . 0.0 108.856 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.52 109.44 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -59.99 146.45 42.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.43 2.44 1.57 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.503 1.521 . . . . 0.0 114.797 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.31 -111.71 2.21 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.733 1.159 . . . . 0.0 112.297 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.25 -28.52 2.34 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.53 -19.14 26.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.64 163.74 50.11 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 121.042 -1.036 . . . . 0.0 111.492 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.63 -24.96 47.85 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.575 3.517 . . . . 0.0 115.415 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 0.62 24.24 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.048 1.339 . . . . 0.0 110.815 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.92 163.56 54.91 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.663 1.125 . . . . 0.0 111.403 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -29.84 -66.59 0.09 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.57 2.348 . . . . 0.0 115.293 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.1 mt -50.64 -60.93 2.53 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.923 1.289 . . . . 0.0 110.735 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -69.12 -7.45 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.563 1.545 . . . . 0.0 113.806 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.0 t -88.75 8.14 30.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.551 -1.343 . . . . 0.0 111.203 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 t 69.13 47.32 0.74 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.19 157.28 58.73 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.088 1.355 . . . . 0.0 109.22 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -78.08 165.76 25.65 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.404 2.736 . . . . 0.0 109.479 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -168.37 133.75 1.78 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.804 -1.185 . . . . 0.0 112.463 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.501 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 2.3 mt -74.92 86.94 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.992 1.317 . . . . 0.0 110.439 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 150.52 75.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.679 -0.638 . . . . 0.0 110.535 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -84.46 -172.89 1.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.313 4.009 . . . . 0.0 109.922 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.45 165.59 1.07 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.212 1.005 . . . . 0.0 111.048 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.63 161.69 24.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.54 1.136 . . . . 0.0 109.364 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.54 173.22 11.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.1 p -128.66 80.47 1.97 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.936 1.294 . . . . 0.0 110.076 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.42 -177.18 19.08 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 127.485 2.469 . . . . 0.0 107.657 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.71 154.85 44.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.197 1.932 . . . . 0.0 109.551 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.8 m -115.73 -35.45 4.51 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.389 1.076 . . . . 0.0 109.967 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.0 t -139.37 155.55 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.697 1.999 . . . . 0.0 108.834 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -179.243 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.987 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.1 m -142.97 148.38 36.73 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.645 1.578 . . . . 0.0 108.597 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 t -153.84 159.17 41.74 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.62 -102.19 0.13 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.379 1.466 . . . . 0.0 110.558 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.1 m -151.98 55.65 0.83 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.504 1.522 . . . . 0.0 108.381 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 p -65.55 158.16 27.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.142 0.977 . . . . 0.0 110.915 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.55 -114.71 0.3 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -178.0 169.78 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 131.157 3.783 . . . . 0.0 106.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.69 -51.36 70.27 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.528 0.731 . . . . 0.0 112.451 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -52.31 -53.83 39.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.343 0.52 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -53.7 -51.07 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.935 0.494 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.88 94.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.047 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -56.94 -44.23 82.28 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.783 1.174 . . . . 0.0 110.293 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -63.28 -53.36 54.16 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -56.65 -43.06 79.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.481 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.85 -40.95 85.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.981 2.113 . . . . 0.0 107.937 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.9 -20.42 79.47 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.717 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -106.94 -10.36 16.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.606 1.703 . . . . 0.0 112.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.23 135.27 34.59 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -32.99 37.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -97.61 -13.43 21.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 149.43 26.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -150.0 164.45 35.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 108.309 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -106.04 133.4 50.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.593 1.557 . . . . 0.0 108.299 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.0 tp -122.26 104.8 9.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.903 1.681 . . . . 0.0 110.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.61 111.98 12.68 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.182 1.793 . . . . 0.0 106.978 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.89 3.33 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 118.698 0.681 . . . . 0.0 112.093 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -62.54 167.04 4.66 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.493 1.917 . . . . 0.0 112.58 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.34 133.71 37.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 108.519 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.437 ' HA ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -43.03 -29.27 0.33 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.151 2.58 . . . . 0.0 115.609 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.95 63.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.596 -1.315 . . . . 0.0 110.528 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.52 -27.74 69.47 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.756 -1.215 . . . . 0.0 112.358 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 81.2 m-85 -62.55 -21.07 65.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.886 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -91.75 -35.2 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.802 2.041 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.05 -58.15 3.44 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.935 1.694 . . . . 0.0 112.99 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.68 -19.3 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.99 -159.95 22.23 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.611 1.096 . . . . 0.0 111.808 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 39' ' ' PRO . 39.0 p -142.03 161.6 50.2 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.88 -0.776 . . . . 0.0 112.088 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 38' ' ' SER . 94.2 Cg_endo -71.67 158.15 54.09 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.03 1.153 . . . . 0.0 111.094 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 5.1 p30 -125.19 74.75 1.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.15 1.78 . . . . 0.0 109.583 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.2 pt -74.97 2.87 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 121.763 -0.585 . . . . 0.0 109.545 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.95 -31.61 65.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.467 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.28 75.81 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.0 -35.9 69.6 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.896 1.279 . . . . 0.0 110.669 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.0 21.62 1.88 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.775 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -123.01 178.57 5.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.383 1.591 . . . . 0.0 111.204 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -137.86 131.55 31.2 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.474 -0.766 . . . . 0.0 110.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.38 168.11 16.73 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.769 0.795 . . . . 0.0 111.125 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.7 138.03 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 127.645 2.378 . . . . 0.0 104.646 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.4 p -117.91 124.37 48.1 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -152.55 102.9 2.76 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -54.61 117.74 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.793 0.837 . . . . 0.0 111.859 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -79.63 134.67 36.45 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.52 119.78 6.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -51.46 -20.65 5.53 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -71.12 -16.65 62.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.538 1.169 . . . . 0.0 112.569 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -133.4 29.31 3.96 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 117.317 -1.325 . . . . 0.0 114.335 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -38.79 -56.14 2.47 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 121.482 1.946 . . . . 0.0 111.532 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.87 -40.82 33.12 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.421 2.747 . . . . 0.0 111.451 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.53 58.64 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.112 1.815 . . . . 0.0 109.844 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.62 -54.24 46.57 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.555 1.942 . . . . 0.0 106.633 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.28 -45.75 62.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.974 0.909 . . . . 0.0 110.112 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.92 -37.45 87.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.042 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -61.12 -31.54 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.052 1.296 . . . . 0.0 108.484 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -43.32 18.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.044 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.31 64.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.188 1.358 . . . . 0.0 112.443 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.24 -9.8 59.71 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.687 1.13 . . . . 0.0 110.968 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -109.04 -43.11 4.26 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.037 1.335 . . . . 0.0 110.363 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 66.6 m-85 -90.72 102.95 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -57.72 -33.26 68.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.478 0.311 . . . . 0.0 111.395 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -131.93 86.41 47.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 123.719 0.808 . . . . 0.0 110.992 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 26.3 Cg_endo -66.72 -33.43 34.88 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.395 2.063 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.22 -23.52 14.96 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.4 1.48 . . . . 0.0 114.623 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -117.28 -6.42 11.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.087 1.312 . . . . 0.0 110.661 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.4 m -94.07 121.6 35.73 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 112.889 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -91.47 131.86 36.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.41 1.084 . . . . 0.0 108.681 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.35 97.35 5.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 111.153 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.91 119.4 19.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.715 0.806 . . . . 0.0 109.084 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 79' ' ' ILE . 1.1 mp -75.56 133.9 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 111.508 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.81 121.83 27.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.45 167.0 16.18 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 108.398 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -61.02 -39.55 90.18 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.988 -1.07 . . . . 0.0 109.411 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -131.92 -136.51 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.635 1.974 . . . . 0.0 106.919 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.93 -55.64 4.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.019 1.328 . . . . 0.0 108.723 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.66 -95.1 0.1 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.811 1.672 . . . . 0.0 113.203 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -145.82 10.79 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 128.097 2.559 . . . . 0.0 110.907 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.2 m -48.54 -40.56 27.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.248 1.419 . . . . 0.0 111.587 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.3 -30.49 71.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.702 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 89' ' ' LEU . 2.5 tm? -83.47 -41.52 17.94 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.06 -34.75 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.9 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.983 1.313 . . . . 0.0 111.239 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -86.68 -44.28 11.95 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 108.979 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -48.79 -61.37 2.08 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 126.718 2.007 . . . . 0.0 112.771 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.14 -37.39 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.571 0.348 . . . . 0.0 111.744 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -53.47 54.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.853 0.721 . . . . 0.0 109.666 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.47 -20.47 65.61 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.483 1.113 . . . . 0.0 112.195 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -84.53 -35.34 22.93 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 111.58 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.42 -8.11 0.46 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.35 -1.805 . . . . 0.0 115.155 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 34.9 m-85 -71.69 153.48 42.02 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 120.425 2.112 . . . . 0.0 109.484 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -56.62 -56.67 18.44 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 m -162.14 171.7 17.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -165.21 115.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.67 140.66 32.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.69 114.32 26.77 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.23 100.55 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -63.21 151.28 40.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 75.37 -1.58 3.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.945 2.098 . . . . 0.0 112.971 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.52 -140.24 48.06 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 119.703 1.138 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.62 -35.46 6.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.837 0.855 . . . . 0.0 111.188 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.2 -15.23 47.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.71 1.204 . . . . 0.0 113.358 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.7 166.32 27.25 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.64 -30.41 90.42 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.466 2.777 . . . . 0.0 113.454 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 20.8 tpt180 -110.63 14.26 22.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.354 1.862 . . . . 0.0 110.179 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.17 170.84 51.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -45.29 -58.68 3.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.6 mt -59.89 -38.22 81.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.557 0.343 . . . . 0.0 110.935 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -88.9 19.84 3.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 111.467 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.4 m -121.42 12.21 10.82 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.526 -1.359 . . . . 0.0 112.289 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.0 m 56.57 55.8 6.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.343 1.057 . . . . 0.0 108.503 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -121.74 150.93 56.55 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.31 158.9 54.81 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.634 1.556 . . . . 0.0 109.322 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -167.84 132.2 1.77 Allowed 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.388 -1.445 . . . . 0.0 110.749 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.48 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 8.8 mt -71.06 90.77 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.205 1.402 . . . . 0.0 108.443 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.63 151.01 60.92 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.18 -159.34 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.605 3.536 . . . . 0.0 107.712 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -124.04 97.97 5.58 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -130.72 156.77 44.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.105 2.162 . . . . 0.0 106.559 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 p -121.53 65.6 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.74 171.23 11.96 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.478 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.75 -157.04 7.39 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.589 1.09 . . . . 0.0 110.965 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.5 163.74 33.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.959 1.773 . . . . 0.0 111.808 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.3 m -122.8 178.85 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.414 1.885 . . . . 0.0 106.654 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.4 p -142.14 101.68 3.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.826 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.611 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 m -68.21 163.56 22.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.558 1.179 . . . . 0.0 108.614 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 t -151.78 152.96 33.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.4 158.59 37.88 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.01 147.78 30.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.144 1.472 . . . . 0.0 109.829 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.08 173.0 13.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.638 1.975 . . . . 0.0 107.16 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.03 -90.05 0.08 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.591 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.7 t -166.63 167.56 15.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.024 0.929 . . . . 0.0 109.855 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.85 -34.18 75.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -71.19 -49.95 38.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.69 -50.88 62.44 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.169 0.588 . . . . 0.0 110.271 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.82 74.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.067 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.96 -39.68 78.72 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.253 1.388 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -68.79 -46.53 68.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.693 0.797 . . . . 0.0 109.102 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.01 -39.16 93.91 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.032 -1.668 . . . . 0.0 110.97 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.08 -23.53 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.954 1.702 . . . . 0.0 109.551 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.94 -22.92 36.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 -13.1 24.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.588 1.194 . . . . 0.0 110.458 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -114.74 112.35 22.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.911 1.232 . . . . 0.0 110.718 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.55 -36.08 82.6 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.722 1.209 . . . . 0.0 112.653 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -84.18 -17.21 40.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.575 -0.703 . . . . 0.0 112.349 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.0 153.81 32.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.309 0.959 . . . . 0.0 112.513 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -150.25 162.26 40.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.201 1.401 . . . . 0.0 109.388 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.42 154.22 19.0 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 tp -134.41 103.87 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.207 1.403 . . . . 0.0 109.837 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.41 96.63 5.4 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.036 1.334 . . . . 0.0 108.629 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -87.82 -1.33 8.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.6 mtm-85 -69.46 162.57 27.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.969 0.804 . . . . 0.0 109.978 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.73 133.97 51.26 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.34 -22.11 1.03 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.632 1.973 . . . . 0.0 112.38 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.92 88.9 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.285 -1.509 . . . . 0.0 110.16 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -55.15 -40.75 70.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.495 1.518 . . . . 0.0 111.267 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -53.66 -30.13 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.394 1.077 . . . . 0.0 112.066 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -97.3 -20.89 17.56 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 126.549 1.94 . . . . 0.0 112.726 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -101.11 -60.37 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.49 -31.61 4.23 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.758 1.623 . . . . 0.0 111.559 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.35 -163.34 12.26 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.78 158.55 49.29 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.79 157.8 54.49 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.141 1.894 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.531 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -122.39 83.68 2.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.897 2.479 . . . . 0.0 111.961 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -79.58 -0.68 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.394 -1.441 . . . . 0.0 109.747 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -46.12 -40.7 11.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.429 2.692 . . . . 0.0 113.188 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.05 77.07 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.422 -0.654 . . . . 0.0 113.044 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.4 mt -77.57 -40.85 40.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.56 1.03 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.909 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -126.02 -179.1 4.54 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.094 1.447 . . . . 0.0 111.927 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -133.23 144.11 49.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.177 1.391 . . . . 0.0 109.15 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 167.18 14.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 111.98 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -140.54 93.59 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -76.87 102.74 6.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.879 2.072 . . . . 0.0 112.393 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -141.54 98.82 3.43 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.53 125.89 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.221 0.919 . . . . 0.0 110.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -76.02 152.35 36.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.857 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -155.77 116.5 3.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.55 -24.11 61.44 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.539 -0.59 . . . . 0.0 112.192 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.89 -7.01 59.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.035 1.417 . . . . 0.0 110.159 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -126.22 28.95 5.92 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.333 1.453 . . . . 0.0 112.577 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -45.57 -52.38 23.67 Favored Pre-proline 0 N--CA 1.474 0.765 0 O-C-N 120.553 -1.342 . . . . 0.0 112.138 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.78 -44.61 16.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.446 2.097 . . . . 0.0 112.434 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.26 -44.07 96.76 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.71 -54.16 46.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.981 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.93 -43.72 66.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.991 1.716 . . . . 0.0 111.504 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -54.79 -50.56 68.21 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 109.544 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.29 -29.15 57.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -80.6 -51.79 8.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 t -56.36 -23.32 36.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.333 1.453 . . . . 0.0 110.624 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.84 -2.87 43.15 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 -42.52 3.13 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.39 114.4 21.86 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -30.37 71.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.35 70.14 82.22 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.092 1.757 . . . . 0.0 109.312 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 18.8 Cg_endo -57.88 -43.11 52.01 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.381 2.054 . . . . 0.0 111.972 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -62.65 -3.53 1.55 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.301 1.441 . . . . 0.0 113.617 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -127.36 -18.04 4.56 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 111.586 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -90.93 104.76 17.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.401 1.48 . . . . 0.0 111.39 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.2 m -71.72 137.73 47.97 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.852 -1.155 . . . . 0.0 109.679 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -102.72 99.99 10.0 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.202 1.401 . . . . 0.0 113.839 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.98 99.78 8.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mt -79.41 133.58 29.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 123.922 0.889 . . . . 0.0 109.622 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.66 121.22 26.56 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.762 0.825 . . . . 0.0 112.391 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.77 172.3 7.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.069 2.548 . . . . 0.0 107.62 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.25 84.53 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 119.888 -1.757 . . . . 0.0 112.599 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -146.39 -173.22 4.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 130.094 3.358 . . . . 0.0 104.099 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.32 -55.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.641 2.776 . . . . 0.0 113.397 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.96 -101.51 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 128.288 2.851 . . . . 0.0 115.582 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -144.04 -0.21 1.03 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.17 1.388 . . . . 0.0 113.336 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 p -44.62 -44.71 9.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.741 1.155 . . . . 0.0 113.667 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -60.05 -40.34 89.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.782 0.719 . . . . 0.0 112.597 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -71.59 -49.69 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.939 1.696 . . . . 0.0 108.911 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.53 -33.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.231 1.013 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.9 70.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.408 0.549 . . . . 0.0 111.94 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.65 -42.76 13.17 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.363 0.983 . . . . 0.0 108.405 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.8 tp -49.95 -59.34 3.96 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.938 1.695 . . . . 0.0 112.332 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.3 -37.64 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.975 -0.453 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.68 68.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.384 0.674 . . . . 0.0 109.532 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.07 -28.93 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.55 0.74 . . . . 0.0 110.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.82 -33.63 70.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.541 0.61 . . . . 0.0 110.039 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.7 -13.52 0.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.242 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 66.6 m-85 -60.24 146.48 43.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.219 1.509 . . . . 0.0 111.094 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -47.3 -60.19 2.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.701 2.001 . . . . 0.0 112.929 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -167.09 174.75 8.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 126.768 2.027 . . . . 0.0 105.686 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 152.98 36.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -135.62 111.22 9.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.415 0.686 . . . . 0.0 111.26 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.84 133.78 38.1 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 103.24 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -58.09 137.55 56.82 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 36.3 m-20 71.48 15.62 6.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.24 2.216 . . . . 0.0 112.933 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.72 -144.06 7.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.132 1.348 . . . . 0.0 114.913 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.67 -26.51 15.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.52 -1.45 12.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.98 -178.68 8.53 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.75 1.159 . . . . 0.0 114.078 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -29.92 43.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.333 3.355 . . . . 0.0 114.378 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -132.12 12.45 4.68 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.26 1.424 . . . . 0.0 110.296 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.85 174.35 3.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -31.56 -60.87 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.187 1.795 . . . . 0.0 114.327 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.18 -50.93 71.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.507 0.723 . . . . 0.0 111.049 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.92 3.3 5.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.067 1.747 . . . . 0.0 113.772 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.96 13.85 28.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 111.316 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 60.01 46.0 11.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.627 1.171 . . . . 0.0 110.306 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.09 151.18 45.39 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.531 ' C ' HD21 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -73.44 163.96 36.32 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.928 1.752 . . . . 0.0 110.221 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -161.65 128.13 3.81 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.66 -1.275 . . . . 0.0 111.792 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 1.8 mt -73.39 87.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.466 1.906 . . . . 0.0 111.489 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.46 146.0 46.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.864 0.865 . . . . 0.0 110.387 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.27 163.32 27.7 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.649 2.233 . . . . 0.0 108.468 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.37 76.53 2.45 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.501 -0.75 . . . . 0.0 109.636 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -149.23 104.68 3.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -64.03 149.07 48.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.577 0.751 . . . . 0.0 110.332 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -125.77 166.7 16.33 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.19 78.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.87 174.36 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.123 2.549 . . . . 0.0 112.281 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.8 p -150.62 25.32 0.77 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.653 1.181 . . . . 0.0 111.334 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.4 p -109.16 83.63 1.79 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.481 1.913 . . . . 0.0 109.249 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.442 0 CA-C-O 117.335 -1.814 . . . . 0.0 109.002 -179.726 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.579 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 m -98.72 -0.72 42.21 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -154.76 1.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.616 1.553 . . . . 0.0 114.077 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.79 175.59 41.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -147.88 125.05 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -128.11 -173.68 3.01 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.93 -112.56 0.43 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.454 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 m -152.35 150.33 29.6 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.574 1.55 . . . . 0.0 107.319 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.89 66.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.753 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -51.87 -43.71 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.068 -1.645 . . . . 0.0 113.182 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -53.28 54.76 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -57.11 -37.27 71.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.444 0.465 . . . . 0.0 111.148 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.47 -51.57 42.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.805 1.242 . . . . 0.0 109.087 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -56.57 -40.84 75.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.521 0.601 . . . . 0.0 109.978 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -60.42 -44.18 96.02 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.36 -27.61 64.35 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.192 1.36 . . . . 0.0 109.576 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 -2.13 82.61 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.87 1.7 . . . . 0.0 114.171 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -0.21 6.59 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.832 2.053 . . . . 0.0 109.1 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -138.56 98.5 3.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.276 1.43 . . . . 0.0 110.064 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -62.46 -36.54 82.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.663 1.22 . . . . 0.0 110.297 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.76 -7.78 17.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.803 0.841 . . . . 0.0 111.62 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.32 150.17 21.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 120.364 1.438 . . . . 0.0 110.969 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -139.17 161.45 37.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.489 1.516 . . . . 0.0 109.691 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.9 tm? -106.01 128.82 54.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 24' ' ' LEU . 16.2 tp -118.36 102.3 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.221 1.809 . . . . 0.0 112.65 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.31 116.93 19.08 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.2 4.09 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -62.77 172.98 1.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.06 2.144 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.71 139.41 34.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -45.04 -35.99 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.308 1.843 . . . . 0.0 114.266 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.231 0.923 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.26 -35.33 64.89 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.343 1.057 . . . . 0.0 110.761 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.24 -23.69 64.27 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.378 -0.826 . . . . 0.0 112.253 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mtp85 -104.67 -15.79 15.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.936 1.294 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -89.88 -58.2 2.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.136 1.374 . . . . 0.0 111.007 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.87 -26.53 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.594 0.758 . . . . 0.0 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.03 -162.14 12.45 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 121.609 -0.682 . . . . 0.0 112.764 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -139.36 152.5 69.4 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 123.008 0.523 . . . . 0.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.6 139.63 25.65 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.186 1.924 . . . . 0.0 109.693 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.469 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 2.1 p30 -110.23 82.22 1.56 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.571 2.749 . . . . 0.0 106.982 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 pt -71.99 1.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 119.953 -1.717 . . . . 0.0 110.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -22.44 51.77 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.091 1.757 . . . . 0.0 112.099 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.79 -40.74 72.98 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.8 mt -75.92 -52.17 10.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.45 -9.37 1.24 Allowed Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.106 1.336 . . . . 0.0 115.519 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -91.5 -169.85 2.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.85 1.325 . . . . 0.0 113.073 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -144.42 139.15 28.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.525 1.13 . . . . 0.0 109.725 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.52 170.47 16.34 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.007 0.908 . . . . 0.0 112.265 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.3 138.42 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -120.3 132.01 55.13 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.748 0.419 . . . . 0.0 109.97 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.3 m -152.44 100.07 2.54 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.47 112.43 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.507 0.723 . . . . 0.0 110.262 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -83.56 148.97 26.88 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -156.54 131.27 8.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.46 2.704 . . . . 0.0 105.557 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.15 -23.27 52.07 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.321 0.962 . . . . 0.0 112.965 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.3 -22.57 63.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.756 1.223 . . . . 0.0 112.019 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -135.69 44.81 2.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -45.09 -56.05 9.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.538 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.18 -40.8 24.45 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.528 2.152 . . . . 0.0 111.317 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.78 61.01 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 124.2 0.905 . . . . 0.0 112.54 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.03 -53.7 4.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.84 -48.88 41.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.127 1.771 . . . . 0.0 111.899 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -54.52 -36.26 64.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 112.715 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.66 -22.49 66.5 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.276 1.03 . . . . 0.0 112.027 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.73 -44.99 8.25 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -52.19 -35.0 47.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.904 2.082 . . . . 0.0 111.459 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.67 -5.5 57.06 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.08 -32.85 4.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.969 0.804 . . . . 0.0 113.122 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 38.3 m-85 -91.02 121.07 32.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -51.89 42.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 110.485 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -113.66 81.91 5.97 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.877 0.871 . . . . 0.0 109.936 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 9.9 Cg_endo -53.54 -36.19 79.47 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.51 2.14 . . . . 0.0 111.391 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.63 -11.58 26.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.089 2.155 . . . . 0.0 111.361 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -130.14 26.9 5.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.872 2.069 . . . . 0.0 110.258 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -137.38 112.92 9.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.721 0.691 . . . . 0.0 109.934 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.9 m -83.34 141.32 31.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.266 0.627 . . . . 0.0 111.572 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -115.33 95.97 5.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.739 2.016 . . . . 0.0 114.843 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 39.8 m-85 -78.63 102.5 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.06 136.72 23.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 123.717 0.807 . . . . 0.0 109.036 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.56 126.02 39.46 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.651 0.781 . . . . 0.0 111.107 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -127.89 166.91 17.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.255 2.622 . . . . 0.0 107.695 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -63.45 -41.67 98.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.563 -1.336 . . . . 0.0 113.733 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -144.97 179.27 7.45 Favored 'General case' 0 C--N 1.322 -0.626 1 C-N-CA 132.828 4.451 . . . . 0.0 103.545 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -34.35 -32.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.958 2.903 . . . . 0.0 117.097 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 24.3 -88.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 130.066 3.698 . . . . 0.0 116.631 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -144.35 0.56 1.03 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.892 1.277 . . . . 0.0 113.314 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.3 p -41.16 -48.6 3.45 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.31 -41.83 84.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.626 1.103 . . . . 0.0 112.105 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.06 -46.2 85.43 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.71 -35.86 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.27 71.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.734 -0.651 . . . . 0.0 110.052 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -46.62 15.97 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.496 1.044 . . . . 0.0 108.913 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.1 tp -46.52 -61.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.77 -42.49 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.168 -0.333 . . . . 0.0 110.3 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.74 88.02 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.608 0.763 . . . . 0.0 110.956 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.16 -43.37 91.97 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.336 0.654 . . . . 0.0 109.332 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -55.78 -39.05 70.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.167 0.44 . . . . 0.0 111.077 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.27 4.4 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.497 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 72' ' ' PRO . 41.4 m-85 -74.58 152.37 39.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.906 1.853 . . . . 0.0 109.558 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -50.82 -70.15 0.09 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.468 2.707 . . . . 0.0 112.95 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -155.8 164.2 38.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.515 1.526 . . . . 0.0 107.85 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.68 17.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -126.14 150.24 48.4 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.179 1.792 . . . . 0.0 108.024 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.68 118.92 36.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -72.1 109.87 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.29 151.43 46.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 63.05 19.33 11.58 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.131 1.373 . . . . 0.0 111.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 34.73 -114.75 0.15 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 129.004 3.192 . . . . 0.0 114.088 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.76 -12.67 4.79 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.874 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.26 -14.91 16.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.587 1.539 . . . . 0.0 110.727 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.78 35.22 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 118.95 0.795 . . . . 0.0 112.567 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.47 -16.89 48.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.647 2.898 . . . . 0.0 113.261 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -119.35 2.6 11.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.476 2.311 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.23 177.13 25.41 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.786 0.721 . . . . 0.0 112.454 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -41.38 -61.5 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.421 1.888 . . . . 0.0 113.029 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.0 mt -57.58 -36.63 71.95 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.005 1.322 . . . . 0.0 113.587 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -96.08 10.79 36.44 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.893 1.277 . . . . 0.0 111.726 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.2 t -113.73 24.41 12.16 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.499 -1.375 . . . . 0.0 111.614 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 m 63.06 22.87 13.67 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.367 1.867 . . . . 0.0 113.609 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.3 mt -92.37 160.19 35.5 Favored Pre-proline 0 C--N 1.334 -0.091 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.71 166.1 19.7 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.082 1.855 . . . . 0.0 108.922 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -167.49 134.27 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.528 -1.982 . . . . 0.0 112.653 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.1 mt -77.07 88.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.645 1.578 . . . . 0.0 108.809 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.85 144.55 48.31 Favored Pre-proline 0 C--O 1.245 0.863 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.81 177.65 8.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.669 2.913 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -72.19 -8.74 56.4 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.09 -1.006 . . . . 0.0 111.787 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE3' ' H ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -66.95 171.77 5.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.403 1.001 . . . . 0.0 110.065 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.539 ' H ' ' HE3' ' A' ' 127' ' ' LYS . 3.5 p -147.14 -77.57 0.17 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 128.391 2.676 . . . . 0.0 104.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 t -54.0 148.42 10.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.469 1.908 . . . . 0.0 110.534 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 138.22 -79.04 0.3 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.703 -2.959 . . . . 0.0 105.703 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 168.79 23.11 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.014 2.476 . . . . 0.0 111.274 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.3 p -148.66 -72.68 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.192 1.397 . . . . 0.0 109.203 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 m -143.21 142.58 31.46 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.38 1.072 . . . . 0.0 108.687 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.873 -2.071 . . . . 0.0 108.385 -179.308 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 114.16 13.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.741 0.77 . . . . 0.0 110.654 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -73.81 100.27 3.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.53 -174.5 50.42 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.412 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 4.8 m -66.11 126.86 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.896 -0.767 . . . . 0.0 109.05 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -150.69 170.18 19.81 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 121.035 -1.04 . . . . 0.0 111.421 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.73 -125.84 1.32 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m -138.89 160.53 39.5 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.798 1.239 . . . . 0.0 111.641 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.62 -54.71 13.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.871 2.468 . . . . 0.0 114.339 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -60.36 -39.87 88.74 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.839 1.654 . . . . 0.0 112.837 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.94 -47.92 84.21 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.22 96.6 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.191 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CG ' HD22 ' A' ' 120' ' ' LEU . 71.8 t80 -61.85 -40.36 95.06 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.091 0.86 . . . . 0.0 109.95 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 m -61.97 -50.91 70.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -57.0 -47.65 80.34 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.26 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mt -52.29 -32.56 38.16 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.008 1.723 . . . . 0.0 113.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.14 -14.06 70.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.762 0.71 . . . . 0.0 112.934 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.3 -24.23 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 110.458 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -100.99 99.63 10.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.613 1.565 . . . . 0.0 108.371 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.48 -50.51 59.71 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.371 -0.831 . . . . 0.0 112.551 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -2.47 17.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.974 1.31 . . . . 0.0 113.856 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -78.18 128.39 33.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.932 0.787 . . . . 0.0 109.105 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -138.81 139.0 38.07 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -76.13 128.87 35.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 108.618 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.0 tp -117.23 109.63 17.11 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.687 1.595 . . . . 0.0 111.269 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 98.77 5.51 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.141 1.376 . . . . 0.0 108.412 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -86.63 -3.83 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 118.926 0.784 . . . . 0.0 111.235 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -63.52 163.68 10.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 125.902 1.681 . . . . 0.0 111.431 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.87 148.39 27.73 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.097 1.427 . . . . 0.0 108.984 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -42.41 -43.19 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 129.72 3.208 . . . . 0.0 111.529 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.69 -40.4 65.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.878 1.271 . . . . 0.0 112.914 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.5 m-20 -64.16 -35.22 80.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 38' ' ' SER . 13.9 m-85 -61.06 -27.62 68.48 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.098 -1.626 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -89.1 -23.93 22.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.563 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.11 -35.71 7.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.8 p -117.9 -13.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.532 1.133 . . . . 0.0 112.948 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.4 -163.01 29.8 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . 2.5 p -135.74 157.17 76.7 Favored Pre-proline 0 CA--C 1.511 -0.528 0 O-C-N 122.354 -0.498 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.88 172.33 16.09 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.382 1.388 . . . . 0.0 109.454 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.53 ' HB3' HG13 ' A' ' 123' ' ' ILE . 6.4 p30 -146.36 167.56 23.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 46' ' ' LYS . 5.1 pt -145.0 20.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 127.475 2.31 . . . . 0.0 107.618 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.57 64.37 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.076 2.15 . . . . 0.0 114.142 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -33.73 78.92 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.66 -23.44 36.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 109.347 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 23.1 24.13 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 125.198 1.38 . . . . 0.0 111.327 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' HD12 ' A' ' 41' ' ' ILE . 32.0 mmtp -106.04 173.08 6.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.356 1.862 . . . . 0.0 107.807 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -143.23 124.98 14.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.252 1.387 . . . . 0.0 109.625 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.03 171.02 7.36 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.09 136.15 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.753 1.621 . . . . 0.0 106.666 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 p -103.04 110.38 22.28 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.035 1.734 . . . . 0.0 110.884 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -149.97 98.32 2.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.69 117.74 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 122.229 -0.294 . . . . 0.0 110.847 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -81.29 142.91 32.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -154.2 140.7 18.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.45 -13.9 74.35 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.177 -1.346 . . . . 0.0 115.124 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -79.67 -15.95 56.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.509 1.654 . . . . 0.0 111.642 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -138.52 43.5 2.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.357 1.435 . . . . 0.0 111.189 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -45.05 -53.58 16.05 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.869 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.63 -39.28 36.03 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.844 1.696 . . . . 0.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.86 -14.67 73.26 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.273 -0.892 . . . . 0.0 112.671 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.9 -52.21 5.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -50.82 -48.38 59.76 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.794 1.638 . . . . 0.0 111.801 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.85 -36.15 69.68 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -58.74 -26.32 63.86 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.095 0.558 . . . . 0.0 110.648 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.51 -49.43 7.2 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.43 -30.63 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.07 0.85 . . . . 0.0 113.115 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.53 -23.39 62.63 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.819 -1.176 . . . . 0.0 110.249 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -41.34 8.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.635 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD1' HG21 ' A' ' 75' ' ' THR . 65.8 m-85 -85.68 99.42 11.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.464 1.106 . . . . 0.0 108.855 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -19.43 47.78 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.23 78.88 27.28 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.209 1.404 . . . . 0.0 107.548 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.55 -39.04 57.97 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.679 1.586 . . . . 0.0 111.05 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.53 -22.01 2.88 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 127.068 2.147 . . . . 0.0 114.981 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -120.94 -9.08 9.3 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.097 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 69' ' ' PHE . 90.1 m -82.76 136.54 34.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.646 1.178 . . . . 0.0 109.156 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -111.1 125.37 53.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.9 mt -98.53 96.43 7.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.997 1.319 . . . . 0.0 112.526 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.44 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 13.8 m-85 -80.07 106.76 12.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.505 HG21 ' HA ' ' A' ' 87' ' ' SER . 1.2 mm -67.36 145.37 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.33 1.052 . . . . 0.0 112.725 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.29 112.88 7.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -119.09 164.52 15.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.65 1.18 . . . . 0.0 108.511 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -53.5 -41.81 66.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.38 1.072 . . . . 0.0 109.736 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.98 -143.98 0.21 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.785 2.034 . . . . 0.0 106.943 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -75.57 -36.3 60.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.568 1.547 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.9 -103.67 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 130.432 3.872 . . . . 0.0 116.032 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.32 9.26 10.35 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.044 0.937 . . . . 0.0 113.352 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 79' ' ' ILE . 13.7 m -46.71 -52.02 14.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.48 -33.26 75.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.033 0.933 . . . . 0.0 111.699 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.15 -52.0 13.84 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.631 0.772 . . . . 0.0 109.77 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.57 -31.07 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.494 1.117 . . . . 0.0 110.277 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.38 93.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.879 0.763 . . . . 0.0 108.951 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -73.2 -36.58 66.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.34 -59.0 5.13 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.9 0.88 . . . . 0.0 111.309 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.8 m -62.64 -39.26 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 121.909 -0.494 . . . . 0.0 111.072 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.55 -50.22 72.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.964 0.906 . . . . 0.0 111.436 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.29 -28.81 68.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.481 1.112 . . . . 0.0 110.623 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.78 -54.57 13.06 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.89 2.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 CA-C-O 118.196 -1.335 . . . . 0.0 115.67 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.54 157.16 34.3 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 120.04 1.92 . . . . 0.0 106.755 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -53.36 -63.66 1.08 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.193 0.597 . . . . 0.0 110.235 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.7 t -161.53 -179.8 7.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.317 1.847 . . . . 0.0 106.09 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.47 20.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 5' ' ' SER . 27.7 m-85 -118.16 123.8 46.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.5 101.66 14.32 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.32 116.89 13.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -72.46 156.52 38.96 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.82 8.91 5.54 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.114 1.766 . . . . 0.0 115.101 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.27 -127.46 21.45 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.61 -35.88 4.1 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.478 0.711 . . . . 0.0 109.565 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.28 -17.19 61.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.195 2.198 . . . . 0.0 114.28 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.1 172.46 46.98 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.18 0.9 . . . . 0.0 114.481 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.8 -30.71 58.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 125.172 3.915 . . . . 0.0 115.768 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.253 0.0 OUTLIER -131.49 20.7 4.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.025 1.33 . . . . 0.0 109.178 177.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.99 166.62 40.29 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -34.28 -50.94 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.65 -50.7 72.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.23 0.923 . . . . 0.0 110.058 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.79 -0.38 34.21 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.029 2.132 . . . . 0.0 113.403 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -91.77 6.53 45.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.666 1.986 . . . . 0.0 111.629 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t 60.7 46.09 9.48 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 13' ' ' TYR . 88.3 mt -123.34 145.26 46.04 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.016 0.926 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.81 147.05 84.98 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.291 2.661 . . . . 0.0 110.211 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -148.49 139.57 23.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.596 1.559 . . . . 0.0 110.825 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 40' ' ' ASN . 3.6 mt -78.9 91.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.486 1.114 . . . . 0.0 109.669 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.6 153.86 95.32 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.379 -0.826 . . . . 0.0 110.74 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -86.81 -175.89 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.649 1 C-N-CA 125.32 4.014 . . . . 0.0 110.198 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -69.62 108.71 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -58.35 163.75 2.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.869 0.867 . . . . 0.0 111.209 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 178.69 7.9 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 0.0 108.766 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.8 p -71.7 -41.48 68.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.081 0.953 . . . . 0.0 109.744 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.45 167.56 43.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.247 1.403 . . . . 0.0 109.759 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.55 175.42 11.31 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.701 2.934 . . . . 0.0 110.166 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.5 p -71.65 107.33 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -42.82 117.59 1.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.997 1.719 . . . . 0.0 111.29 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.743 0 CA-C-O 118.697 -1.057 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.4 p -109.69 1.64 19.64 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 113.62 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -133.04 163.92 28.17 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.25 66.38 2.28 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 m -34.25 116.9 0.32 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.479 2.312 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 t -133.73 -175.27 3.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.076 1.35 . . . . 0.0 108.826 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.01 -106.02 0.22 Allowed Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.375 -0.828 . . . . 0.0 115.079 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -153.67 154.11 33.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 118.298 1.049 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.62 91.75 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -65.47 -49.28 69.69 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.042 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.92 -44.96 91.35 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -59.03 -41.11 87.0 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.238 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.44 -41.93 96.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.815 0.734 . . . . 0.0 109.835 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -60.92 -46.47 90.55 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.33 -48.37 82.03 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.995 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.2 mt -56.75 -22.03 32.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.515 1.507 . . . . 0.0 113.115 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.61 -7.06 60.53 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.391 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t -126.08 -10.16 6.51 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.779 1.289 . . . . 0.0 110.223 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.07 95.23 5.45 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -12.85 12.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -106.4 -7.52 17.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.279 1.432 . . . . 0.0 111.129 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.16 148.86 41.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.24 152.32 36.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.043 1.737 . . . . 0.0 108.705 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -94.82 151.55 19.15 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 tp -140.13 101.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.368 1.467 . . . . 0.0 111.14 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.17 110.25 18.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.937 2.495 . . . . 0.0 107.378 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -103.68 3.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -61.83 167.32 3.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.22 141.12 43.6 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 m -46.81 -34.02 4.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.184 2.193 . . . . 0.0 112.478 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.61 76.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 119.259 0.936 . . . . 0.0 111.643 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.87 -36.48 84.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 79.4 m-85 -65.56 -6.04 9.8 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.855 -1.153 . . . . 0.0 111.997 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -112.93 -10.49 13.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.914 1.234 . . . . 0.0 111.643 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -115.6 -43.66 3.02 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.63 -16.81 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.904 1.281 . . . . 0.0 113.789 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.32 -153.81 20.3 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 121.219 -0.925 . . . . 0.0 112.297 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 p -143.48 158.09 58.03 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 111.129 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.85 172.17 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 N-CA-C 109.269 -1.089 . . . . 0.0 109.269 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 148.94 35.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.543 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.0 pt -140.85 15.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.287 1.835 . . . . 0.0 110.088 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -56.09 -31.05 62.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.573 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.35 -22.53 71.21 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 120.457 1.48 . . . . 0.0 110.735 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.31 -17.25 37.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.845 1.258 . . . . 0.0 110.274 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.25 33.65 7.12 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.166 1.365 . . . . 0.0 109.889 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -136.25 175.08 9.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.158 1.383 . . . . 0.0 109.578 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -140.81 160.15 40.67 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.82 0.736 . . . . 0.0 110.405 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.5 163.79 20.24 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.82 88.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 7.7 p -58.02 108.71 0.62 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.51 0.724 . . . . 0.0 109.287 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -136.55 89.41 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.58 112.02 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 124.091 0.956 . . . . 0.0 108.493 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.53 149.1 30.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -159.73 145.63 15.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.347 2.259 . . . . 0.0 107.775 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.86 -26.73 61.91 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.22 -5.41 18.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.046 2.138 . . . . 0.0 113.965 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.44 31.97 0.73 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.527 0.731 . . . . 0.0 109.797 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -38.32 -57.01 1.94 Allowed Pre-proline 0 N--CA 1.475 0.824 0 CA-C-O 117.806 -1.092 . . . . 0.0 111.846 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.99 -48.16 9.05 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.493 2.795 . . . . 0.0 111.991 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.94 -50.15 62.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.3 -53.95 49.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.095 1.758 . . . . 0.0 108.427 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.44 -48.0 69.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.859 1.264 . . . . 0.0 111.672 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -55.95 -35.56 66.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.796 0.839 . . . . 0.0 110.007 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -60.72 -29.2 69.21 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.709 1.14 . . . . 0.0 111.226 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 -46.44 13.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -54.36 -34.05 60.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.956 1.302 . . . . 0.0 111.624 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.75 -8.03 58.35 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.065 -1.022 . . . . 0.0 113.222 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -46.83 2.99 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.328 0.967 . . . . 0.0 112.417 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.78 120.84 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -29.44 64.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -129.0 68.65 80.12 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 126.842 2.057 . . . . 0.0 110.026 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.18 -41.34 79.52 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.2 -15.35 14.54 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.45 -14.09 10.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -86.72 124.21 32.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.226 1.376 . . . . 0.0 111.403 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.7 m -88.47 134.61 33.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.84 96.87 6.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.282 0.946 . . . . 0.0 109.239 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.489 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 42.2 m-85 -75.19 113.98 13.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.615 1.966 . . . . 0.0 109.006 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.66 144.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.185 1.357 . . . . 0.0 111.836 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.64 83.69 1.91 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.346 0.658 . . . . 0.0 110.639 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.98 176.5 7.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -53.29 -50.99 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.903 1.281 . . . . 0.0 110.342 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.58 -141.2 0.21 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.58 -40.54 88.99 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 40.94 -127.52 3.24 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.297 1.903 . . . . 0.0 113.741 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.23 3.8 35.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.271 1.028 . . . . 0.0 113.211 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.1 m -40.69 -61.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.103 2.261 . . . . 0.0 117.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -53.28 -37.73 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.167 0.987 . . . . 0.0 111.886 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.01 -46.99 61.27 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.85 -28.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.023 -1.048 . . . . 0.0 109.793 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.53 -36.03 78.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.972 0.805 . . . . 0.0 109.676 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.34 -41.36 28.08 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.449 -0.782 . . . . 0.0 109.665 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.6 tp -49.82 -60.82 2.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.056 2.143 . . . . 0.0 113.393 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.36 -40.96 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.037 0.535 . . . . 0.0 110.758 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -48.88 78.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.082 0.553 . . . . 0.0 109.85 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.17 -28.32 69.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -74.41 -43.32 56.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.292 0.496 . . . . 0.0 110.743 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.08 -5.74 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 CA-C-O 117.508 -1.718 . . . . 0.0 113.631 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.33 160.37 27.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 120.297 2.049 . . . . 0.0 110.396 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.62 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -59.04 -69.77 0.18 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.25 0.62 . . . . 0.0 112.038 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -155.0 -178.22 7.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.429 1.892 . . . . 0.0 108.809 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.9 154.37 27.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.47 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -142.77 111.99 6.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 128.387 2.675 . . . . 0.0 108.737 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.15 119.73 23.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.038 0.935 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.3 108.82 4.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.32 151.31 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 73.34 0.32 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.925 1.69 . . . . 0.0 111.86 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.59 -122.09 14.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.805 1.193 . . . . 0.0 110.997 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.67 -24.41 4.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.442 1.497 . . . . 0.0 111.465 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.11 -11.91 23.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.647 1.579 . . . . 0.0 114.38 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.53 174.3 39.0 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.818 0.736 . . . . 0.0 112.349 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.27 -28.14 86.26 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.543 2.829 . . . . 0.0 113.387 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -117.44 1.06 12.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 110.613 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.05 160.12 1.72 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.173 -0.954 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -25.94 -62.52 0.07 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.163 2.185 . . . . 0.0 115.622 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.18 -60.17 3.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.323 1.049 . . . . 0.0 109.265 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.05 -2.78 2.15 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.94 1.696 . . . . 0.0 113.022 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.35 12.82 31.78 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.249 -1.532 . . . . 0.0 109.555 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.1 t 66.38 12.55 8.72 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.327 1.851 . . . . 0.0 112.103 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.59 157.34 72.44 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.787 0.835 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.74 147.2 21.64 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.101 1.867 . . . . 0.0 110.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -144.25 144.14 31.37 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.97 87.13 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.205 1.002 . . . . 0.0 108.857 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.59 147.31 78.25 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.27 173.39 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.073 3.182 . . . . 0.0 112.505 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -64.68 -21.85 66.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.843 0.457 . . . . 0.0 109.801 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -53.74 155.0 3.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.965 1.306 . . . . 0.0 110.241 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 t -146.29 44.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.418 1.104 . . . . 0.0 109.585 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.48 70.12 1.43 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -173.69 91.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.15 -174.67 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.292 2.661 . . . . 0.0 110.266 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.5 m -80.2 66.32 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.2 m -59.23 146.34 39.58 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 110.256 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 179.56 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t 48.9 36.62 8.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.256 1.028 . . . . 0.0 112.899 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.27 -7.73 0.29 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.064 2.146 . . . . 0.0 114.439 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.06 152.02 47.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.691 1.132 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 m -80.65 91.91 5.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 130.35 42.12 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.04 100.92 0.25 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.53 146.21 0.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.563 1.545 . . . . 0.0 110.821 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -38.78 -54.43 1.6 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -58.07 -49.78 75.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.021 1.282 . . . . 0.0 111.081 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -56.09 -51.79 66.61 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.959 0.904 . . . . 0.0 109.176 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.99 73.11 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.868 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.66 -49.34 77.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.38 0.991 . . . . 0.0 109.39 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -62.3 -41.42 98.5 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.69 -0.631 . . . . 0.0 109.881 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.36 -41.51 97.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.209 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.39 -27.87 69.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 111.361 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 -21.99 45.03 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.901 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -98.35 -18.11 18.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.642 1.221 . . . . 0.0 110.903 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 11.2 t70 -101.6 110.37 22.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -38.41 -53.97 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.28 2.232 . . . . 0.0 114.98 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -101.37 13.61 34.51 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -67.88 124.67 23.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.936 -1.102 . . . . 0.0 111.507 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -128.84 144.55 51.2 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.064 0.945 . . . . 0.0 109.731 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.83 144.24 28.56 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.8 tp -127.08 107.2 9.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.658 1.583 . . . . 0.0 109.206 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -80.34 132.75 35.84 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.6 pt -119.67 13.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.827 0.74 . . . . 0.0 111.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -74.89 170.53 15.75 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.838 1.199 . . . . 0.0 110.08 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.5 142.23 44.83 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.62 -41.97 23.15 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.541 2.336 . . . . 0.0 112.68 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.13 73.81 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.53 -0.731 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -66.8 -27.42 67.56 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.572 0.749 . . . . 0.0 111.257 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -64.42 -16.62 62.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.159 -1.588 . . . . 0.0 110.452 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -104.89 -22.04 13.22 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.38 1.472 . . . . 0.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.75 -52.77 4.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.207 1.003 . . . . 0.0 112.22 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.8 -29.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.042 1.737 . . . . 0.0 112.259 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.84 -151.75 17.7 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.276 0.944 . . . . 0.0 112.12 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -147.49 156.16 45.61 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.903 0.881 . . . . 0.0 109.839 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.96 176.28 10.33 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.85 1.7 . . . . 0.0 109.75 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.2 142.96 37.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.923 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.95 12.16 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.734 2.014 . . . . 0.0 111.305 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -37.45 67.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 117.638 -1.172 . . . . 0.0 113.524 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.61 -35.33 85.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.61 -16.24 61.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.209 0.604 . . . . 0.0 110.57 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 45.66 5.89 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 106.606 -2.598 . . . . 0.0 106.606 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -135.47 168.1 19.84 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.608 0.763 . . . . 0.0 110.736 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -145.18 122.42 11.53 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.224 -0.922 . . . . 0.0 110.359 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.78 172.6 10.48 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.784 1.278 . . . . 0.0 112.265 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.89 146.64 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 m -129.13 117.81 21.43 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.926 -1.109 . . . . 0.0 111.38 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -147.73 115.77 6.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.399 1.08 . . . . 0.0 110.356 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.92 129.16 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 120.004 1.275 . . . . 0.0 109.221 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.03 166.83 22.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.23 125.63 0.91 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.78 -20.56 57.13 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.148 0.885 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -84.22 -11.7 56.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.579 1.189 . . . . 0.0 111.621 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -127.47 36.98 4.31 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.522 1.129 . . . . 0.0 111.375 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -48.12 -57.67 9.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.101 1.318 . . . . 0.0 111.847 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.46 -37.67 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.644 2.229 . . . . 0.0 110.623 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.5 -23.55 66.89 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.509 0.576 . . . . 0.0 112.958 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -87.4 -41.5 13.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.279 1.432 . . . . 0.0 107.28 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.74 -46.67 88.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.784 1.234 . . . . 0.0 112.067 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -54.68 -33.7 61.24 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.048 0.539 . . . . 0.0 111.257 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -60.04 -27.33 66.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.856 0.863 . . . . 0.0 110.99 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.12 -43.19 9.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -31.04 66.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.535 -0.728 . . . . 0.0 112.322 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 -7.23 52.14 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.063 -1.023 . . . . 0.0 112.405 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.76 -48.19 2.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.564 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 69.7 m-85 -77.79 107.56 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.733 1.213 . . . . 0.0 109.499 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -72.68 -17.49 61.63 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.483 0.713 . . . . 0.0 112.106 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -148.04 77.31 10.11 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 126.234 1.814 . . . . 0.0 109.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.25 -29.51 73.29 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.752 2.301 . . . . 0.0 110.645 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -53.85 -18.61 3.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.152 2.181 . . . . 0.0 113.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -125.93 3.98 7.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 0.0 112.39 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 m -109.38 121.77 45.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.382 1.473 . . . . 0.0 112.143 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.0 m -91.0 130.92 36.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.69 0.796 . . . . 0.0 110.169 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.53 105.99 15.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.62 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 23.7 m-85 -85.67 110.53 19.36 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.37 134.38 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.012 1.325 . . . . 0.0 111.425 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.54 128.9 30.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.469 1.108 . . . . 0.0 109.337 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -130.7 174.78 9.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.908 1.683 . . . . 0.0 108.369 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -52.84 -52.15 58.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.746 1.218 . . . . 0.0 109.382 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -144.53 174.93 10.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.275 3.83 . . . . 0.0 105.164 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -17.81 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 128.85 2.86 . . . . 0.0 112.508 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.04 -103.22 0.12 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 126.204 1.859 . . . . 0.0 110.39 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -128.9 9.54 5.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.807 1.243 . . . . 0.0 112.38 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -39.01 -51.97 1.81 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.315 1.846 . . . . 0.0 113.791 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.63 -45.95 87.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -39.61 93.95 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.756 0.422 . . . . 0.0 110.938 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.33 -25.58 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.949 -0.469 . . . . 0.0 109.74 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.43 65.25 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.536 -0.727 . . . . 0.0 111.158 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.04 -36.59 61.85 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.007 -0.433 . . . . 0.0 110.87 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.41 -56.79 13.91 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.774 1.229 . . . . 0.0 112.227 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.25 -39.4 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.316 0.647 . . . . 0.0 111.425 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.55 73.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.01 -25.24 65.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.545 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -80.21 -23.79 40.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.43 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.11 1.84 3.15 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 119.956 1.253 . . . . 0.0 115.546 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -76.67 153.59 35.03 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.756 1.778 . . . . 0.0 110.099 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -51.21 -65.88 0.48 Allowed 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 126.785 2.034 . . . . 0.0 112.466 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 m -157.47 171.96 19.42 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.312 1.845 . . . . 0.0 108.29 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.51 140.16 14.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.45 142.85 49.63 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 108.618 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.7 113.56 26.91 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.2 108.12 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 0.0 110.036 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -71.17 141.77 50.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 72.82 22.46 3.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.746 2.818 . . . . 0.0 109.764 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 27.82 -113.02 0.03 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.002 2.239 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -119.18 -54.93 2.18 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.864 1.266 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.44 8.75 4.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.314 1.846 . . . . 0.0 114.045 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.06 173.52 55.34 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.066 -1.021 . . . . 0.0 112.475 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.42 -34.98 98.85 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.714 2.943 . . . . 0.0 111.674 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -129.88 22.14 5.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.114 0.966 . . . . 0.0 110.192 177.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.24 168.36 16.04 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -29.45 -53.61 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.27 -59.26 5.69 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.227 0.922 . . . . 0.0 109.302 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.03 3.53 4.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.195 1.798 . . . . 0.0 112.269 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 t -95.43 11.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.717 2.007 . . . . 0.0 111.539 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 27.86 15.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.352 1.061 . . . . 0.0 111.659 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.1 mt -107.99 153.77 41.52 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.119 0.968 . . . . 0.0 109.507 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.47 154.4 27.7 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.199 1.933 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -147.69 144.35 28.27 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 111.477 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.21 88.73 2.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 126.016 1.726 . . . . 0.0 108.83 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -77.25 153.54 82.11 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.423 0.689 . . . . 0.0 111.715 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.29 -179.71 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.965 3.11 . . . . 0.0 108.501 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 110.89 6.38 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -34.86 119.82 0.48 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.826 2.05 . . . . 0.0 111.332 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 t -99.97 157.17 16.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 65.7 m -68.2 158.47 33.18 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.783 -0.573 . . . . 0.0 109.837 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.71 162.78 24.17 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.565 1.079 . . . . 0.0 111.904 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -87.77 162.0 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.356 3.371 . . . . 0.0 111.719 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.0 p -155.63 123.96 5.87 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.5 t -173.63 154.81 2.58 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.825 1.25 . . . . 0.0 109.511 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 CA-C-O 117.985 -1.453 . . . . 0.0 111.537 179.275 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m -58.55 117.45 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.691 1.196 . . . . 0.0 109.412 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 m -134.79 101.49 4.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.979 1.312 . . . . 0.0 108.269 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.63 163.57 20.59 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -81.21 44.35 0.77 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.988 1.315 . . . . 0.0 111.362 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m -74.15 161.43 30.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.289 1.042 . . . . 0.0 113.263 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.34 -115.18 0.41 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -160.06 169.99 22.23 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.855 -1.38 . . . . 0.0 109.329 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.23 -46.03 92.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -49.74 -52.06 34.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 111.099 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -54.97 -59.78 4.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.222 1.009 . . . . 0.0 110.08 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.84 -41.13 67.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.084 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.19 -48.01 79.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.556 1.071 . . . . 0.0 112.91 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.0 m -68.2 -41.37 81.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 18' ' ' THR . 20.5 mmtp -60.74 -31.69 70.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.969 0.804 . . . . 0.0 111.975 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.21 -17.01 60.44 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.391 1.876 . . . . 0.0 110.841 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.1 -52.49 2.21 Favored Glycine 0 CA--C 1.506 -0.494 0 C-N-CA 126.006 1.765 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -64.22 -15.31 59.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.609 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -119.17 128.36 54.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 108.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.43 -39.69 38.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.633 0.651 . . . . 0.0 112.466 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.11 -14.08 60.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.95 1.3 . . . . 0.0 112.423 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -68.86 131.54 45.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.244 1.418 . . . . 0.0 110.388 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -138.86 142.69 38.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.413 0.625 . . . . 0.0 111.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.3 tm? -76.88 131.26 38.5 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HD12 ' A' ' 77' ' ' LEU . 40.0 tp -112.13 95.89 5.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.15 2.18 . . . . 0.0 107.552 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -75.63 109.48 9.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.95 0.38 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 HD22 ' A' ' 80' ' ' LEU . 46.8 mtm-85 -69.46 162.8 26.68 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.071 0.85 . . . . 0.0 110.485 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.09 136.66 56.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -52.34 -23.22 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 111.406 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.66 79.55 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.531 -1.356 . . . . 0.0 110.701 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.54 -33.84 76.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.006 1.722 . . . . 0.0 109.972 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.42 -18.9 53.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -95.59 -37.14 10.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.053 1.741 . . . . 0.0 109.984 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -81.29 -50.52 9.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.9 -23.33 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 113.85 -177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.13 -157.97 22.23 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 p -139.21 160.82 60.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.56 176.53 7.26 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.165 1.91 . . . . 0.0 109.009 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' HB3' HG13 ' A' ' 123' ' ' ILE 0.261 8.5 p30 -141.61 114.09 8.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 122.069 0.938 . . . . 0.0 111.973 177.016 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -85.57 8.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 122.188 0.994 . . . . 0.0 109.255 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -55.44 -28.07 52.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.817 1.647 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.42 -48.81 47.45 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.91 -46.65 62.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.646 1.178 . . . . 0.0 108.448 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.08 40.62 0.69 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.73 1.633 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.14 -176.38 3.11 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.1 0.96 . . . . 0.0 111.437 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.62 116.72 10.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.356 0.98 . . . . 0.0 110.992 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.65 152.25 39.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.592 0.757 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -108.85 91.15 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 110.314 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -57.96 102.43 0.1 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 127.171 2.188 . . . . 0.0 110.298 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -143.09 97.41 3.09 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.633 0.773 . . . . 0.0 109.757 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.15 119.82 3.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.348 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -74.94 154.52 38.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -156.09 118.7 4.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -22.93 68.06 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.115 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -82.5 -6.12 59.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.615 1.207 . . . . 0.0 110.952 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.37 39.61 2.67 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.032 0.833 . . . . 0.0 110.553 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -43.02 -60.83 2.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 120.762 -1.211 . . . . 0.0 113.622 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -67.2 -43.47 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.585 2.857 . . . . 0.0 111.42 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.03 -47.34 81.0 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.42 -50.62 72.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.533 1.533 . . . . 0.0 108.026 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.4 -39.59 70.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.465 0.706 . . . . 0.0 111.049 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -37.46 78.72 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.779 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.54 -24.17 44.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.432 1.093 . . . . 0.0 111.894 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.08 -44.09 7.47 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t -54.28 -33.01 57.73 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.654 1.182 . . . . 0.0 111.498 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.92 -2.92 39.18 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -121.32 -40.23 2.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.967 0.803 . . . . 0.0 112.564 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CD1' HG21 ' A' ' 75' ' ' THR . 64.1 m-85 -79.94 111.99 16.8 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -18.58 62.22 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.069 0.548 . . . . 0.0 111.315 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 78.26 11.06 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 125.815 1.646 . . . . 0.0 108.44 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.29 -32.97 97.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.47 2.113 . . . . 0.0 110.961 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -57.97 -18.75 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.354 3.062 . . . . 0.0 113.089 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.61 -4.71 9.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.918 . . . . 0.0 111.419 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 69' ' ' PHE . 29.2 m -95.16 113.92 25.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 0.0 112.296 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.6 m -86.75 129.16 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -100.42 99.14 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.532 1.533 . . . . 0.0 111.768 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 37.5 m-85 -84.34 98.6 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -68.0 157.58 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.559 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD22 HH11 ' A' ' 28' ' ' ARG . 6.7 tt -152.47 112.06 3.93 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.773 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.79 173.3 6.44 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -31.05 70.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.93 -1.731 . . . . 0.0 111.409 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -138.6 -152.71 0.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.034 2.134 . . . . 0.0 106.48 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.11 -18.33 62.53 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.896 2.079 . . . . 0.0 113.58 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.96 -97.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.798 3.571 . . . . 0.0 115.913 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -129.62 6.89 5.22 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.363 1.865 . . . . 0.0 110.957 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -42.91 -47.4 5.64 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.26 1.824 . . . . 0.0 113.487 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.5 -43.64 84.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.424 1.09 . . . . 0.0 111.26 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.46 -49.05 58.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.342 1.057 . . . . 0.0 109.49 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.09 -31.56 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.563 0.745 . . . . 0.0 109.142 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.62 87.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.857 0.753 . . . . 0.0 110.162 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.87 74.26 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -50.39 -57.52 7.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.884 1.674 . . . . 0.0 112.557 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.91 -40.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.12 78.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.068 0.547 . . . . 0.0 109.808 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.15 -38.31 90.61 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.81 -23.38 67.22 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 117.66 -1.162 . . . . 0.0 113.265 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.98 1.32 4.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 117.871 -1.516 . . . . 0.0 113.46 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -76.11 157.67 32.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.15 1.475 . . . . 0.0 108.473 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -49.79 -71.07 0.07 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 127.445 2.298 . . . . 0.0 110.087 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 m -163.62 -178.86 6.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 126.674 1.99 . . . . 0.0 106.857 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.8 164.64 38.29 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -136.99 142.88 42.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.26 110.3 22.3 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 124.734 1.271 . . . . 0.0 107.784 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.95 106.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -68.63 144.01 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 82.24 -2.09 1.45 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.598 1.959 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.14 -102.61 0.07 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 126.449 1.976 . . . . 0.0 114.532 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.31 -43.52 2.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.674 1.59 . . . . 0.0 110.656 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.88 -28.79 39.87 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.0 171.82 41.58 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 121.151 1.796 . . . . 0.0 111.811 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.54 -15.37 35.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.798 3.665 . . . . 0.0 116.052 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 48.7 mmt-85 -115.78 5.64 14.2 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 111.112 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.45 163.23 54.78 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -46.52 -45.28 18.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -66.93 -39.89 87.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.247 0.476 . . . . 0.0 111.038 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -87.67 23.26 2.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.8 1.64 . . . . 0.0 111.433 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 t -120.51 6.56 10.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.445 1.098 . . . . 0.0 112.819 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 56.86 48.5 15.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.991 0.917 . . . . 0.0 109.363 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.1 mt -116.53 160.74 35.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.81 145.01 17.65 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.123 1.882 . . . . 0.0 110.149 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -144.0 132.2 21.86 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.987 -1.071 . . . . 0.0 110.833 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 40' ' ' ASN . 6.6 mt -75.27 90.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.567 1.547 . . . . 0.0 110.082 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -83.49 143.9 45.19 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.809 -1.182 . . . . 0.0 110.94 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.3 -171.13 1.14 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 125.03 3.82 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.96 122.07 15.63 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.807 -1.183 . . . . 0.0 110.897 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -73.22 156.26 38.73 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -139.52 136.99 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 119.122 0.874 . . . . 0.0 109.009 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 m -69.56 114.14 7.5 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.8 52.9 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -81.08 -168.68 0.66 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.685 2.924 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 42.21 0.81 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.637 -1.29 . . . . 0.0 107.9 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 m 65.91 8.7 5.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.91 1.684 . . . . 0.0 110.842 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.443 2 C-N-CA 132.533 4.873 . . . . 0.0 102.785 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 p -144.32 94.4 2.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 106.529 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.7 t -128.25 -143.81 0.28 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.13 -167.93 39.0 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.2 m -126.42 21.75 7.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.545 1.172 . . . . 0.0 113.504 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.3 p -61.0 169.88 1.79 Allowed 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.404 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.57 -116.82 0.5 Allowed Glycine 0 N--CA 1.445 -0.748 0 O-C-N 121.545 -0.722 . . . . 0.0 111.752 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -142.45 157.3 44.9 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.877 0.871 . . . . 0.0 112.439 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.45 90.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.374 1.469 . . . . 0.0 113.46 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.53 -52.66 64.7 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.841 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.82 -42.95 85.0 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.182 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.27 75.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.583 0.628 . . . . 0.0 111.283 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.23 -47.55 79.26 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -60.73 -40.67 93.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.308 0.243 . . . . 0.0 110.494 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 9.5 mmpt? -58.94 -43.77 91.26 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.446 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.26 -23.95 62.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.289 1.404 . . . . 0.0 111.121 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.06 4.38 62.75 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.435 1.493 . . . . 0.0 112.505 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.12 -4.72 3.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.121 1.768 . . . . 0.0 110.778 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -124.53 106.12 9.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.1 -18.19 2.0 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -122.57 5.48 9.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.397 0.999 . . . . 0.0 113.155 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.67 50.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.635 1.107 . . . . 0.0 108.442 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -140.27 152.86 46.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.338 1.055 . . . . 0.0 109.415 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.52 118.85 37.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.24 107.36 16.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.654 1.581 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.64 123.0 31.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.56 -0.85 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -33.78 -109.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.901 3.68 . . . . 0.0 115.39 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.64 134.27 5.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -45.74 -43.39 12.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.78 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.52 80.92 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.3 0.955 . . . . 0.0 109.809 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.98 -40.56 67.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.515 1.126 . . . . 0.0 110.635 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -60.99 -15.85 36.41 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.025 1.739 . . . . 0.0 112.913 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -107.91 -13.02 15.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.746 1.618 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -102.14 -47.06 4.65 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.717 1.207 . . . . 0.0 110.489 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 -24.93 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.808 1.243 . . . . 0.0 113.468 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.45 -148.16 18.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 119.145 0.884 . . . . 0.0 113.807 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -146.28 162.63 33.98 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.66 128.41 10.95 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.68 2.253 . . . . 0.0 110.044 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.472 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 3.9 p30 -86.29 73.89 10.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.494 -1.684 . . . . 0.0 109.64 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.4 pt -78.66 -4.37 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.556 -1.34 . . . . 0.0 110.597 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -50.03 -37.62 33.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.65 2.38 . . . . 0.0 112.474 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.95 -40.44 72.91 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 124.206 0.941 . . . . 0.0 111.465 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.87 -50.52 28.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.84 25.56 0.14 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.727 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -133.33 -175.12 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.12 1.46 . . . . 0.0 109.971 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -144.52 131.65 20.55 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.138 2.175 . . . . 0.0 105.879 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.23 164.89 14.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.679 0.672 . . . . 0.0 111.565 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.47 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.198 1.799 . . . . 0.0 107.252 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.7 p -63.84 108.7 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.062 1.345 . . . . 0.0 111.206 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.434 HG23 ' HE3' ' A' ' 64' ' ' LYS . 2.1 m -142.38 94.09 2.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.1 116.25 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -76.75 150.44 36.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -155.33 134.97 12.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 128.361 2.664 . . . . 0.0 104.516 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.17 -13.22 81.38 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 113.987 0.355 . . . . 0.0 113.987 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.33 -43.83 39.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.023 0.911 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.32 51.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 109.78 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -52.03 -54.8 37.01 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.27 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.55 -42.11 7.57 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.877 1.349 . . . . 0.0 109.802 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.03 -19.77 46.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.41 1.481 . . . . 0.0 113.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -89.76 -54.23 4.15 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.242 1.817 . . . . 0.0 106.664 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -54.09 -46.87 72.18 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.502 1.921 . . . . 0.0 111.082 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -41.34 66.07 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.597 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 51' ' ' THR . 51.3 mtmt -60.61 -34.49 74.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.528 1.058 . . . . 0.0 110.948 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -48.01 25.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -61.21 -9.29 4.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.914 2.086 . . . . 0.0 115.323 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.11 -13.36 15.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.223 0.919 . . . . 0.0 109.337 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -98.97 -47.1 5.38 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 56.0 m-85 -86.38 159.91 19.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.367 1.467 . . . . 0.0 109.529 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -2.38 1.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.274 2.63 . . . . 0.0 112.362 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -136.11 52.54 6.59 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 128.76 2.824 . . . . 0.0 112.384 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.95 -36.54 17.54 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.532 2.821 . . . . 0.0 112.7 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -55.64 -18.11 7.13 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.652 2.381 . . . . 0.0 113.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -125.02 -1.38 7.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.215 1.006 . . . . 0.0 112.736 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -100.69 136.22 40.9 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.166 1.387 . . . . 0.0 112.411 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.2 m -102.59 128.02 49.43 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.57 97.78 7.94 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.131 0.972 . . . . 0.0 111.708 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 39.0 m-85 -74.87 126.78 31.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.01 126.7 57.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 121.002 1.728 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 80' ' ' LEU . 5.8 tt -120.94 114.58 21.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.97 1.708 . . . . 0.0 109.046 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -119.47 170.41 9.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.668 1.987 . . . . 0.0 107.22 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.211 -1.555 . . . . 0.0 111.648 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.83 -154.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.912 2.485 . . . . 0.0 106.996 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -59.42 -53.44 58.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.605 1.162 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.6 -112.86 0.62 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.521 2.486 . . . . 0.0 114.716 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -112.27 3.72 17.29 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.741 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.1 m -40.02 -51.33 2.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.791 1.636 . . . . 0.0 113.686 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.58 -38.5 91.23 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.311 0.96 . . . . 0.0 112.175 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.63 -48.21 70.16 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -60.59 -23.11 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.661 0.785 . . . . 0.0 110.043 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.31 -31.33 48.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.013 0.525 . . . . 0.0 109.928 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -85.59 -33.62 21.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.592 1.087 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.0 tp -50.79 -56.83 10.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.348 2.259 . . . . 0.0 111.325 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.96 -35.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 0.0 111.777 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.84 -17.67 62.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 111.935 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -91.34 -24.04 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.776 1.23 . . . . 0.0 113.851 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.28 -6.19 4.28 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.74 -1.033 . . . . 0.0 114.45 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -69.74 147.63 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.573 1.687 . . . . 0.0 109.021 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.01 -66.92 0.3 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 113.318 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -152.57 170.81 19.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 108.817 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.18 128.44 9.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.461 -0.774 . . . . 0.0 109.797 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.401 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 31.6 m-85 -109.92 120.85 43.78 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.95 1.3 . . . . 0.0 110.9 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.75 113.88 22.96 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.43 115.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -71.04 161.59 30.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.55 12.16 8.6 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 129.354 3.062 . . . . 0.0 113.822 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.22 -138.55 27.14 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.707 1.171 . . . . 0.0 112.701 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.446 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -115.68 5.49 14.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 110.529 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.91 -3.28 3.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.41 172.78 49.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.595 1.089 . . . . 0.0 112.465 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.62 -25.2 73.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.891 3.061 . . . . 0.0 114.392 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 13.08 15.88 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.354 1.862 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.31 176.51 26.99 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.953 -1.092 . . . . 0.0 111.619 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -47.05 -61.8 1.71 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 113.186 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.26 -53.31 59.76 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.54 -14.57 43.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.813 1.645 . . . . 0.0 112.79 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -91.62 13.79 16.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.568 1.547 . . . . 0.0 110.442 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.9 m 63.15 23.15 13.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.649 2.38 . . . . 0.0 113.498 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.75 153.2 64.17 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -74.24 160.9 41.61 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.805 1.67 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -163.08 135.76 5.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.864 1.211 . . . . 0.0 112.12 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.472 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 4.0 mt -76.13 95.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.697 1.999 . . . . 0.0 109.973 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -96.69 139.89 21.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 120.962 -1.086 . . . . 0.0 108.352 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.23 -172.05 1.06 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.798 2.998 . . . . 0.0 110.721 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.37 139.8 54.72 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.62 -178.58 3.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.551 1.54 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -112.99 157.23 21.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.516 1.126 . . . . 0.0 108.702 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 71.8 p -68.66 173.83 4.79 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.733 . . . . 0.0 110.141 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.24 154.75 28.31 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.5 168.24 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.167 1.911 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -127.46 -174.91 3.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.055 1.342 . . . . 0.0 107.962 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.6 m -154.62 178.01 10.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.204 1.401 . . . . 0.0 110.68 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.247 0 C-N-CA 127.116 2.293 . . . . 0.0 107.777 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.614 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.54 136.69 41.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.975 2.51 . . . . 0.0 105.051 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.49 -31.8 0.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.546 2.338 . . . . 0.0 114.722 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -168.02 22.84 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 125.573 1.559 . . . . 0.0 110.436 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 m -125.26 42.37 3.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.957 1.303 . . . . 0.0 110.654 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.3 p -69.58 173.43 6.05 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.364 -1.46 . . . . 0.0 111.205 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.46 -103.51 0.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 m -156.29 163.92 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.414 1.086 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.51 44.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.618 1.967 . . . . 0.0 111.962 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -55.1 -50.55 68.91 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.216 0.916 . . . . 0.0 110.853 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -51.56 67.49 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.951 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.23 77.33 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -73.24 -41.76 63.34 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.102 -0.999 . . . . 0.0 108.999 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -57.92 -45.92 85.8 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -51.69 -51.62 54.57 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.039 1.735 . . . . 0.0 110.644 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.23 -21.16 13.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.97 1.259 . . . . 0.0 113.094 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.6 -5.97 57.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.891 1.223 . . . . 0.0 112.824 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -123.38 -1.13 8.66 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.656 1.582 . . . . 0.0 110.565 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -127.33 102.25 6.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.052 -1.03 . . . . 0.0 110.722 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -93.3 32.4 1.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.71 0.804 . . . . 0.0 110.077 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -110.11 137.47 47.82 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 123.63 0.772 . . . . 0.0 109.164 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -144.58 136.0 25.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.832 0.853 . . . . 0.0 109.772 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.2 tm? -84.68 133.95 34.37 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 77' ' ' LEU . 15.6 tp -123.86 104.44 8.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.589 1.956 . . . . 0.0 109.264 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -80.95 122.95 27.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.7 pt -105.62 1.84 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -66.09 171.67 4.41 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.15 1.38 . . . . 0.0 111.294 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.5 146.85 28.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.61 1.195 . . . . 0.0 109.472 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -43.03 -45.15 5.07 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 129.831 3.253 . . . . 0.0 113.682 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -35.61 79.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -32.35 73.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -67.21 -14.01 62.51 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.067 -1.646 . . . . 0.0 111.034 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -100.74 -14.38 18.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.008 2.123 . . . . 0.0 109.266 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -103.19 -65.41 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.971 1.708 . . . . 0.0 110.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -86.65 -36.44 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.934 1.294 . . . . 0.0 111.636 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.42 -155.3 16.17 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 118.977 0.808 . . . . 0.0 113.395 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 p -133.96 148.95 70.26 Favored Pre-proline 0 CA--C 1.518 -0.266 0 C-N-CA 124.756 1.223 . . . . 0.0 110.1 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.56 169.2 22.3 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 129.96 45.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.148 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.8 pt -124.33 7.08 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 125.917 1.687 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -58.77 -31.02 67.98 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 125.066 1.346 . . . . 0.0 110.77 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.33 -51.09 32.76 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.89 -50.72 61.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.872 0.836 . . . . 0.0 110.074 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.2 39.01 0.14 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.664 1.126 . . . . 0.0 111.385 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.31 -179.56 5.43 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.566 1.183 . . . . 0.0 110.935 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -143.77 115.11 8.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.967 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 150.53 22.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 118.537 0.608 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.26 125.95 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 p -103.15 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.153 0.981 . . . . 0.0 109.752 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 m -138.05 98.85 3.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.6 114.4 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.355 1.062 . . . . 0.0 109.593 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -80.79 150.0 29.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.917 0.865 . . . . 0.0 110.131 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -157.57 119.77 3.79 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.751 2.42 . . . . 0.0 105.131 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -22.6 59.43 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.15 -11.9 52.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.165 1.386 . . . . 0.0 110.453 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -146.26 46.67 1.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.069 -1.019 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 48.5 mttp -46.0 -49.02 41.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.99 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 55.4 Cg_endo -64.14 -49.7 3.52 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.674 1.583 . . . . 0.0 111.306 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.33 78.75 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.579 1.081 . . . . 0.0 110.825 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.12 -58.7 7.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.909 1.284 . . . . 0.0 107.871 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 mt -51.25 -47.34 62.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.657 1.583 . . . . 0.0 110.694 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -57.21 -37.64 72.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.227 1.411 . . . . 0.0 110.253 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -62.32 -26.38 68.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.541 1.519 . . . . 0.0 110.895 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -47.14 11.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -54.67 -37.96 66.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.709 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.51 -0.98 35.54 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.83 -38.69 3.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.098 0.863 . . . . 0.0 111.288 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CD1' HG21 ' A' ' 75' ' ' THR . 62.8 m-85 -89.92 113.56 25.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -25.35 67.97 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.954 -0.546 . . . . 0.0 111.822 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -138.11 78.82 33.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.924 1.29 . . . . 0.0 111.165 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.05 -37.25 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.521 2.814 . . . . 0.0 113.107 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -12.98 7.15 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.879 1.272 . . . . 0.0 112.892 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.12 28.04 5.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 109.596 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 69' ' ' PHE . 70.6 m -125.75 120.82 31.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.4 m -100.79 122.03 42.7 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.476 1.11 . . . . 0.0 108.09 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 25' ' ' LEU . 1.3 mm? -97.61 106.78 19.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 21.4 m-85 -83.37 97.19 8.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mt -73.07 132.22 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 109.462 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.2 tt -131.21 131.4 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.066 1.347 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -134.48 175.43 9.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.797 2.439 . . . . 0.0 109.233 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -44.06 80.44 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.579 -1.326 . . . . 0.0 109.493 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -136.25 -148.82 0.3 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.64 -36.18 82.97 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.73 -1.231 . . . . 0.0 109.187 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.28 -99.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 127.247 2.356 . . . . 0.0 111.274 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -139.16 12.97 2.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 108.787 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -43.32 -57.07 3.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.049 1.74 . . . . 0.0 114.107 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -65.67 -30.67 71.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.252 0.933 . . . . 0.0 112.116 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -48.34 67.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.95 1.357 . . . . 0.0 108.966 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.58 -32.06 52.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.068 1.747 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.72 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.407 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -79.19 -48.8 13.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.703 1.138 . . . . 0.0 108.416 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.5 tp -42.21 -64.98 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.525 1.53 . . . . 0.0 114.056 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.8 m -62.92 -40.3 88.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.965 0.906 . . . . 0.0 112.018 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.62 45.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.848 0.718 . . . . 0.0 109.489 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 -27.11 68.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.07 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.59 -34.68 72.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.428 0.558 . . . . 0.0 111.839 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.52 -9.2 0.48 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.982 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.21 155.6 38.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.823 1.811 . . . . 0.0 110.806 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -66.59 0.36 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.518 0.727 . . . . 0.0 109.97 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -158.03 -179.46 8.15 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.505 1.922 . . . . 0.0 107.246 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.54 130.74 6.84 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -102.24 163.81 12.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.82 119.68 11.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.64 116.46 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.567 0.699 . . . . 0.0 111.26 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -66.32 148.4 51.91 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.621 ' H ' ' HE2' ' A' ' 106' ' ' LYS . 4.2 m-20 68.09 -0.55 2.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.975 1.71 . . . . 0.0 111.426 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.75 -134.08 39.65 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.651 . . . . 0.0 111.723 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -94.07 -56.74 2.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.612 1.965 . . . . 0.0 111.827 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.39 -12.77 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.59 169.6 33.29 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 120.733 1.606 . . . . 0.0 113.048 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.6 -46.67 31.74 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.344 2.696 . . . . 0.0 113.306 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -98.76 21.41 11.47 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.542 1.519 . . . . 0.0 110.006 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.41 175.91 19.85 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.402 1.001 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -45.77 -67.29 0.3 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.431 1.892 . . . . 0.0 114.448 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.69 -45.55 63.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.921 0.888 . . . . 0.0 111.225 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -71.8 -8.14 52.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.245 1.418 . . . . 0.0 113.819 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -103.29 19.65 19.25 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.924 1.69 . . . . 0.0 112.745 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.8 t 61.53 32.03 18.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.858 0.863 . . . . 0.0 110.848 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.44 146.7 32.23 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.46 144.42 16.0 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.472 2.115 . . . . 0.0 111.196 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -142.27 156.35 45.28 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.355 -0.841 . . . . 0.0 110.441 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.3 90.3 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.491 1.117 . . . . 0.0 110.292 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -70.69 155.21 93.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.75 -0.594 . . . . 0.0 109.697 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.96 178.73 6.49 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.435 2.756 . . . . 0.0 110.164 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.18 -58.56 7.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.894 . . . . 0.0 109.26 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -73.84 156.71 37.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -137.03 161.31 36.42 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -178.78 2.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.159 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.64 73.08 0.03 OUTLIER Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.82 -178.73 4.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.206 2.604 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.3 t -132.15 157.36 44.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.43 1.492 . . . . 0.0 108.897 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -112.35 151.51 29.66 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 N-CA-C 104.099 -3.6 . . . . 0.0 104.099 -178.257 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -160.23 -169.77 2.6 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 t -56.65 -50.64 71.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.56 158.2 23.41 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 105.726 -2.95 . . . . 0.0 105.726 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 m -121.53 147.17 46.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.591 -0.946 . . . . 0.0 111.548 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.5 p -144.07 173.22 11.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.531 1.532 . . . . 0.0 110.351 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.07 -111.31 0.25 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.92 163.13 32.25 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.988 1.315 . . . . 0.0 112.135 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.17 79.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.646 1.578 . . . . 0.0 106.901 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.32 -50.65 72.79 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.194 -0.316 . . . . 0.0 111.351 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.3 -43.63 98.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.662 0.665 . . . . 0.0 111.04 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.5 66.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -72.71 -56.3 5.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.5 1.045 . . . . 0.0 109.054 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -51.16 -45.75 61.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.021 0.928 . . . . 0.0 110.983 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -57.15 -20.51 26.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.1 -29.27 31.83 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 119.598 1.09 . . . . 0.0 108.852 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.32 -35.04 12.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.062 1.315 . . . . 0.0 111.663 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -74.48 -14.53 60.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.02 0.91 . . . . 0.0 110.653 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.22 175.61 7.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.579 0.627 . . . . 0.0 111.793 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -112.72 -43.37 3.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.59 1.156 . . . . 0.0 111.372 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.99 -3.62 52.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.789 0.835 . . . . 0.0 111.781 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.63 119.58 21.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -132.39 145.74 51.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.259 0.481 . . . . 0.0 110.077 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.31 143.65 29.38 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.5 tp -122.42 109.39 14.32 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.734 1.614 . . . . 0.0 111.178 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.96 89.88 7.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.126 1.37 . . . . 0.0 109.221 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -83.12 -0.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 119.872 -1.768 . . . . 0.0 113.828 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -59.32 164.27 3.38 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 126.329 1.852 . . . . 0.0 111.818 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.32 147.97 32.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m -58.23 -20.72 44.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.704 1.602 . . . . 0.0 109.676 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -43.6 90.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.964 -1.085 . . . . 0.0 108.102 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -61.67 -28.64 69.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 110.777 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.73 -17.91 38.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.323 0.965 . . . . 0.0 110.805 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -110.12 -36.97 5.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.418 1.487 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.21 -27.64 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.86 -19.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.9 -152.61 17.76 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.311 -0.868 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 p -147.7 158.31 43.06 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 124.175 0.99 . . . . 0.0 111.527 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -78.66 155.42 27.48 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.696 1.597 . . . . 0.0 111.18 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.553 ' HB3' HG13 ' A' ' 123' ' ' ILE . 1.2 p30 -127.74 87.7 2.66 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.396 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 pt -72.95 5.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.589 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -55.18 -34.72 64.09 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 110.543 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.16 -34.73 32.68 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.011 0.815 . . . . 0.0 111.729 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.58 -32.36 17.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.009 0.905 . . . . 0.0 111.034 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.57 29.2 1.09 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.897 1.237 . . . . 0.0 114.463 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -135.74 -178.79 5.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.234 1.017 . . . . 0.0 110.116 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.24 131.76 28.7 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.485 1.114 . . . . 0.0 109.636 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.2 163.07 27.42 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.69 130.19 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -96.77 94.72 7.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.039 2.135 . . . . 0.0 113.733 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -127.7 90.81 3.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.68 1.592 . . . . 0.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -49.97 116.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 121.476 -0.765 . . . . 0.0 110.966 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -82.52 153.57 25.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -156.33 130.1 8.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.01 -23.58 59.54 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.026 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -86.54 -8.88 57.17 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.674 1.19 . . . . 0.0 112.194 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -123.13 26.55 7.99 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.307 1.443 . . . . 0.0 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -42.7 -58.39 3.85 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.745 1.157 . . . . 0.0 111.913 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.65 -42.54 12.01 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.128 2.552 . . . . 0.0 112.101 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.28 -52.46 49.55 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -55.56 -49.03 73.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.491 1.517 . . . . 0.0 107.862 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.6 mt -53.89 -50.21 66.84 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.769 0.828 . . . . 0.0 109.773 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -43.44 84.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.299 1.04 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -58.49 -23.99 59.29 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.133 1.333 . . . . 0.0 112.685 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 62' ' ' LEU . 5.4 mt -93.36 -50.55 5.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.709 1.604 . . . . 0.0 108.003 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.0 t -56.92 -23.25 43.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 109.398 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.2 -8.07 52.04 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -38.38 6.66 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.69 1.196 . . . . 0.0 109.663 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -83.07 177.44 8.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.072 1.349 . . . . 0.0 108.407 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -33.9 3.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.295 1.038 . . . . 0.0 112.334 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -144.57 86.3 8.11 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.99 0.916 . . . . 0.0 110.588 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 10.7 Cg_endo -55.23 -32.61 81.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.948 2.432 . . . . 0.0 112.865 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.66 -8.0 1.8 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -123.22 -6.73 8.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.777 -1.106 . . . . 0.0 112.97 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -101.26 130.06 47.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -98.63 130.45 45.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.328 1.051 . . . . 0.0 109.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.36 103.16 12.64 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.646 1.178 . . . . 0.0 112.19 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.91 102.31 13.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.07 139.65 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.916 1.286 . . . . 0.0 113.414 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.43 123.65 21.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.935 1.694 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -130.58 170.65 13.99 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.576 2.351 . . . . 0.0 107.748 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -21.74 8.29 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 113.537 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -159.64 -162.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.916 3.287 . . . . 0.0 104.933 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.14 -55.09 16.48 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.861 2.065 . . . . 0.0 107.365 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.27 -96.95 0.02 OUTLIER Glycine 0 C--N 1.337 0.602 0 C-N-CA 128.251 2.834 . . . . 0.0 114.252 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -135.88 13.08 3.39 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.683 1.193 . . . . 0.0 110.859 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -52.03 -31.59 30.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.943 0.792 . . . . 0.0 110.961 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -72.19 -35.45 68.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.159 2.184 . . . . 0.0 111.745 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.43 -46.64 14.29 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.15 -30.84 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.02 94.91 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -71.65 -42.66 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.781 0.832 . . . . 0.0 109.203 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.2 tp -50.41 -62.15 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.133 1.373 . . . . 0.0 111.848 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.46 -38.62 80.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.115 0.566 . . . . 0.0 110.688 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.76 64.36 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.615 0.766 . . . . 0.0 109.727 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.05 -24.4 67.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.669 0.788 . . . . 0.0 111.589 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -77.2 -21.79 53.36 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.783 0.719 . . . . 0.0 110.844 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.56 6.52 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 117.154 -1.914 . . . . 0.0 114.086 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.7 m-85 -70.01 152.1 44.8 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.616 2.208 . . . . 0.0 108.703 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -48.98 -65.81 0.5 Allowed 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.188 1.795 . . . . 0.0 113.184 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -155.74 174.75 14.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.911 1.284 . . . . 0.0 108.948 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.43 146.46 18.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -135.41 128.87 32.36 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.812 0.845 . . . . 0.0 110.394 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.81 118.39 30.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.36 115.74 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 121.286 -0.884 . . . . 0.0 109.029 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -68.23 150.1 48.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.8 11.59 8.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.625 1.57 . . . . 0.0 113.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.66 -136.84 2.71 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 124.964 1.269 . . . . 0.0 112.781 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -101.2 -26.61 13.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -100.12 -10.84 21.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.796 2.438 . . . . 0.0 115.281 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.9 170.39 8.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.999 1.272 . . . . 0.0 111.824 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.41 -29.33 23.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 124.022 3.148 . . . . 0.0 114.556 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.28 25.97 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.443 1.497 . . . . 0.0 110.616 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -173.59 3.88 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.401 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 17.6 t-105 -41.66 -56.51 2.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.15 -52.81 64.01 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 123.492 0.717 . . . . 0.0 109.56 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.64 22.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.951 1.301 . . . . 0.0 112.791 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.3 m -120.13 10.26 11.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.055 1.742 . . . . 0.0 110.957 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.85 24.96 9.65 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.221 0.919 . . . . 0.0 110.397 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 57.2 mt -97.89 140.71 22.1 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 31.4 Cg_exo -58.86 140.06 93.55 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 125.07 3.847 . . . . 0.0 110.691 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -148.38 135.51 20.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.019 0.927 . . . . 0.0 112.204 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 40' ' ' ASN . 5.2 mt -85.05 96.92 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.818 2.447 . . . . 0.0 108.108 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.73 155.93 68.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 O-C-N 121.484 -0.76 . . . . 0.0 112.719 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -80.13 165.16 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.307 2.671 . . . . 0.0 107.083 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -71.11 120.96 17.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -67.48 -2.71 6.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 p -66.19 -67.27 0.46 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.6 t -60.2 -16.93 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.51 119.27 5.09 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.94 160.05 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.296 2.048 . . . . 0.0 110.435 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 135.07 54.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 m -158.02 172.13 18.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.827 1.651 . . . . 0.0 108.566 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 125.82 1.676 . . . . 0.0 110.228 179.535 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -148.13 170.71 17.22 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.079 2.152 . . . . 0.0 107.892 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.51 118.9 3.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.949 0.795 . . . . 0.0 110.82 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.64 128.25 2.97 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 125.341 1.448 . . . . 0.0 109.891 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -64.47 108.45 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -136.05 162.8 31.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.65 0.78 . . . . 0.0 110.156 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.9 -112.12 0.26 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 163.57 36.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.916 1.358 . . . . 0.0 112.076 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.95 98.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -53.22 -55.63 22.84 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.216 1.007 . . . . 0.0 110.202 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -62.06 -45.3 94.14 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.699 0.624 . . . . 0.0 111.832 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.47 -41.75 85.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.62 -48.18 82.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.867 0.758 . . . . 0.0 109.605 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -60.6 -43.37 97.49 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.199 0.6 . . . . 0.0 111.025 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -39.04 89.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.245 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.0 mt -64.74 -20.4 66.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.895 1.225 . . . . 0.0 110.663 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 -12.46 64.56 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.327 0.965 . . . . 0.0 112.212 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p -117.82 -2.45 11.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.628 1.571 . . . . 0.0 112.243 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -125.12 109.11 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.147 1.379 . . . . 0.0 107.567 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.16 -29.97 68.09 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -84.46 -26.86 27.9 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.717 -0.615 . . . . 0.0 111.977 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 137.98 58.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -141.02 121.98 14.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.857 1.263 . . . . 0.0 109.627 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -55.11 129.79 39.46 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.013 0.925 . . . . 0.0 109.192 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp -109.73 99.49 8.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.929 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.79 112.69 19.17 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.84 7.15 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -64.88 172.12 3.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 110.815 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 144.36 30.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -44.48 -39.87 5.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.027 2.131 . . . . 0.0 111.902 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.33 77.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.929 -0.557 . . . . 0.0 111.557 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.58 -37.2 75.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.393 0.997 . . . . 0.0 110.629 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -62.05 -7.69 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.935 -1.103 . . . . 0.0 112.887 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -123.41 -14.82 7.31 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.543 1.937 . . . . 0.0 111.115 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.93 -45.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.956 1.303 . . . . 0.0 110.814 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.19 -18.56 7.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 124.938 1.295 . . . . 0.0 110.472 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.25 -156.51 21.27 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.446 -0.784 . . . . 0.0 111.808 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -145.8 167.58 13.89 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 121.648 -0.913 . . . . 0.0 112.251 -178.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 83.1 Cg_endo -71.16 158.3 55.22 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.217 1.278 . . . . 0.0 110.309 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB3' ' CD1' ' A' ' 123' ' ' ILE . 43.7 p-10 -125.0 56.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.946 1.698 . . . . 0.0 112.965 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.6 pt -71.67 10.54 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.415 1.086 . . . . 0.0 111.651 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -42.63 69.55 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.133 1.373 . . . . 0.0 111.074 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -52.58 -46.05 59.17 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 mt -61.91 -23.71 66.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 112.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.32 38.87 3.63 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -136.45 168.54 19.27 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 117.773 0.786 . . . . 0.0 111.989 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -138.84 127.56 23.42 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 157.45 37.73 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -116.67 99.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 p -79.02 113.14 16.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.4 m -142.02 109.62 5.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.18 116.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.822 0.283 . . . . 0.0 110.67 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.95 138.95 36.1 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -150.64 127.69 11.15 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.65 -19.14 34.0 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.186 1.374 . . . . 0.0 113.96 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.18 -17.28 60.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.866 1.833 . . . . 0.0 110.938 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -133.12 59.91 1.72 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.686 0.794 . . . . 0.0 110.37 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.05 -54.6 53.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 120.699 -1.251 . . . . 0.0 108.533 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.82 -41.16 8.39 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 121.664 1.63 . . . . 0.0 109.468 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.91 59.17 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.287 0.946 . . . . 0.0 111.695 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -71.49 -60.18 2.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.9 mt -47.29 -46.58 25.01 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.335 1.854 . . . . 0.0 111.639 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -59.43 -33.3 71.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.485 0.714 . . . . 0.0 110.907 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -69.17 -23.99 64.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.064 1.302 . . . . 0.0 111.115 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.74 -34.73 30.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -57.79 -36.62 72.43 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.524 -0.735 . . . . 0.0 112.774 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.64 -5.76 44.87 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -117.14 -33.11 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.987 0.812 . . . . 0.0 112.909 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.2 m-85 -93.5 106.16 18.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.533 1.133 . . . . 0.0 111.139 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -56.82 -51.09 70.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.626 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.34 86.22 50.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.081 0.952 . . . . 0.0 109.048 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.08 -18.81 60.22 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.807 1.671 . . . . 0.0 113.808 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.4 -16.82 16.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -123.25 -1.84 8.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.603 1.561 . . . . 0.0 112.078 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 69' ' ' PHE . 21.1 m -93.22 132.66 37.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 111.193 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -102.25 149.91 23.83 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.92 91.79 3.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.064 1.346 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 30.8 m-85 -74.34 101.52 4.09 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 102.961 -2.977 . . . . 0.0 102.961 177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.89 130.23 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.759 1.223 . . . . 0.0 112.671 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.23 107.88 11.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.513 1.525 . . . . 0.0 109.361 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.25 173.59 6.25 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.03 -58.73 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.615 -1.303 . . . . 0.0 109.311 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.78 -153.05 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.63 -36.68 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.247 0.476 . . . . 0.0 109.872 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.24 -118.67 0.19 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 128.572 2.987 . . . . 0.0 115.566 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -101.12 -3.1 29.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -41.55 -55.97 2.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.299 1.839 . . . . 0.0 115.102 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -26.79 66.32 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -49.81 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.24 -35.06 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.489 1.115 . . . . 0.0 109.222 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.3 66.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.392 1.077 . . . . 0.0 111.355 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -92.61 -35.38 13.57 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.775 0.716 . . . . 0.0 110.026 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.0 -59.22 4.61 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.649 0.738 . . . . 0.0 109.895 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.03 -38.81 78.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.14 0.976 . . . . 0.0 112.107 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.02 -53.75 51.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.129 1.372 . . . . 0.0 109.804 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.01 -28.62 67.87 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 110.54 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -76.97 -24.31 52.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.892 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.15 -0.8 2.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.906 -1.497 . . . . 0.0 115.695 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -73.1 150.62 42.11 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 120.198 1.999 . . . . 0.0 107.303 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 1.6 tpmt? -59.13 -52.83 64.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -165.49 176.41 8.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 107.903 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.9 163.39 40.12 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 43.9 m-85 -146.92 114.75 6.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.354 1.062 . . . . 0.0 109.144 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.11 113.89 15.34 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.497 1.119 . . . . 0.0 108.798 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.79 101.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -62.69 150.52 40.81 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 71.58 6.77 5.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.222 1.809 . . . . 0.0 110.934 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.35 -130.21 14.51 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.058 1.299 . . . . 0.0 110.51 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.66 -16.7 7.13 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.22 -25.57 21.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.504 1.047 . . . . 0.0 112.99 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.51 170.23 1.34 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 128.851 3.119 . . . . 0.0 116.598 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.82 -22.36 36.78 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 124.064 3.176 . . . . 0.0 112.774 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.255 12.7 tpt180 -124.85 14.13 8.57 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.741 2.017 . . . . 0.0 109.56 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.82 -177.94 20.62 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.45 -1.406 . . . . 0.0 111.382 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -48.88 -53.27 20.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 113.405 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.02 -51.12 70.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.848 0.459 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.6 32.14 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.737 2.015 . . . . 0.0 112.303 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.8 m -126.5 12.2 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.007 1.723 . . . . 0.0 109.836 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 t 62.0 28.51 17.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.867 0.758 . . . . 0.0 110.437 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.81 138.63 19.69 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HB2' HD22 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -70.75 157.23 59.05 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.031 1.821 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -158.39 151.29 22.5 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 108.772 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 40' ' ' ASN . 2.5 mt -98.08 88.57 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.73 153.94 85.27 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.0 173.42 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.476 2.118 . . . . 0.0 108.509 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -59.25 -29.4 67.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -76.84 115.3 16.5 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.81 1.244 . . . . 0.0 111.135 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.52 133.54 34.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.8 t -165.62 141.58 5.2 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.709 1.203 . . . . 0.0 108.399 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.49 120.46 1.01 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.47 169.63 13.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.86 2.373 . . . . 0.0 112.209 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.9 m -76.98 96.36 4.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.94 144.14 29.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 106.331 -2.708 . . . . 0.0 106.331 -178.827 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.565 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -142.64 127.74 18.55 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 100.79 2.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.574 1.079 . . . . 0.0 109.564 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.74 -131.59 43.57 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -141.65 81.1 1.75 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p -59.94 128.65 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.026 -1.046 . . . . 0.0 108.502 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.28 109.38 0.41 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -37.47 149.89 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.446 2.298 . . . . 0.0 112.848 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.6 47.58 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.581 . . . . 0.0 111.623 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -60.71 -51.75 68.06 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 110.191 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -55.47 -46.57 76.83 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.758 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.85 87.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.267 0.627 . . . . 0.0 109.611 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.99 -51.34 70.49 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.656 0.782 . . . . 0.0 109.991 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.3 m -61.62 -41.86 98.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.888 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 18' ' ' THR . 27.7 mmtt -56.97 -48.74 77.68 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.502 1.121 . . . . 0.0 109.978 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.86 -19.67 60.47 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.035 0.534 . . . . 0.0 111.656 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.03 -7.06 61.37 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.501 2.477 . . . . 0.0 114.418 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 15' ' ' LYS . 11.2 t -121.3 -8.91 9.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.08 1.752 . . . . 0.0 109.351 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.81 178.43 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.884 0.874 . . . . 0.0 109.494 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 38.1 t70 -128.12 -49.16 1.33 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.333 0.969 . . . . 0.0 111.666 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -71.51 -2.84 18.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.695 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 121.83 23.67 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.555 2.342 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -136.38 149.22 48.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.49 132.08 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.663 1.185 . . . . 0.0 110.107 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 tp -113.38 111.12 21.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.026 1.33 . . . . 0.0 109.829 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.08 116.36 28.84 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.8 pt -99.4 9.06 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -65.36 163.65 15.19 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.728 1.611 . . . . 0.0 113.619 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.49 139.62 44.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -45.94 -41.84 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.792 1.237 . . . . 0.0 112.459 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.1 67.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.75 0.82 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -59.82 -43.69 94.41 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.435 0.562 . . . . 0.0 110.502 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -56.91 -21.94 33.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.004 0.82 . . . . 0.0 112.823 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -84.12 -26.83 28.61 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.024 0.929 . . . . 0.0 109.825 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -91.29 -59.3 2.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.457 1.503 . . . . 0.0 112.816 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.6 -34.71 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.836 1.254 . . . . 0.0 114.148 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -144.93 16.44 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.9 p -154.15 156.01 31.5 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 119.374 1.587 . . . . 0.0 112.889 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.51 135.93 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.936 2.424 . . . . 0.0 111.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.451 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 1.6 p30 -103.41 80.12 1.78 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.851 2.861 . . . . 0.0 107.893 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 pt -77.75 2.61 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.493 -1.379 . . . . 0.0 111.668 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -47.79 -31.84 5.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.495 2.718 . . . . 0.0 115.729 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.09 77.32 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt -85.05 -38.36 19.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.69 0.68 Allowed Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.696 1.141 . . . . 0.0 111.047 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 20' ' ' ASP . 41.6 mmtm -145.51 178.86 7.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.091 1.756 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -133.66 165.49 24.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.974 0.892 . . . . 0.0 110.839 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.49 163.74 15.62 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 108.843 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -138.79 128.37 31.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.153 1.381 . . . . 0.0 107.693 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -99.22 121.94 41.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.398 1.079 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.9 m -148.65 106.56 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.99 110.17 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -76.14 162.95 27.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -166.98 136.45 2.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.069 2.148 . . . . 0.0 105.277 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.2 66.7 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.472 0.558 . . . . 0.0 112.829 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.93 -50.28 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.15 24.48 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -43.76 -52.15 15.22 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 120.244 1.384 . . . . 0.0 110.09 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.41 -44.95 12.87 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.37 2.047 . . . . 0.0 111.786 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.95 83.69 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.722 1.153 . . . . 0.0 110.906 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.07 -53.06 51.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.527 1.931 . . . . 0.0 108.394 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.92 -47.47 64.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.228 1.011 . . . . 0.0 111.177 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -51.92 -47.42 64.66 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.95 -29.43 12.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.465 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -50.35 6.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m -55.93 -32.73 64.06 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.418 1.008 . . . . 0.0 112.198 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.25 -5.02 57.31 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.566 0.746 . . . . 0.0 112.961 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -41.48 3.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.524 1.13 . . . . 0.0 111.578 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.95 179.57 7.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.845 1.258 . . . . 0.0 108.716 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -127.6 -24.36 3.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.415 1.086 . . . . 0.0 113.153 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.75 83.09 8.31 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -56.19 -38.1 95.51 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.267 1.312 . . . . 0.0 110.229 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.45 -15.9 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.503 1.921 . . . . 0.0 114.425 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -124.03 -16.13 6.63 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.784 1.233 . . . . 0.0 111.55 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.1 m -77.98 137.2 38.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.049 0.84 . . . . 0.0 110.656 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -110.25 125.45 53.12 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.24 100.51 10.1 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.431 1.092 . . . . 0.0 112.408 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CE2' ' CD1' ' A' ' 103' ' ' TYR . 40.6 m-85 -82.54 96.7 8.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -73.99 124.49 31.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.095 1.358 . . . . 0.0 109.565 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -121.77 125.44 46.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 109.498 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -133.41 172.42 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.808 0.843 . . . . 0.0 112.572 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -46.52 -54.67 8.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.65 1.58 . . . . 0.0 108.926 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -136.82 -155.97 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.04 2.936 . . . . 0.0 104.716 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -52.85 -54.23 37.4 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.765 1.226 . . . . 0.0 109.722 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.36 -98.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.448 1.975 . . . . 0.0 111.459 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.66 16.47 2.71 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.293 2.237 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -45.04 -45.23 10.72 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.968 1.258 . . . . 0.0 113.41 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -73.38 -41.8 62.92 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.202 0.91 . . . . 0.0 111.24 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.42 -46.67 88.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.7 t -66.73 -34.51 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.13 82.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.036 0.835 . . . . 0.0 109.389 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -73.11 -48.17 37.93 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.9 tp -50.16 -58.97 4.42 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.122 1.769 . . . . 0.0 113.837 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.91 -38.39 81.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 122.15 -0.343 . . . . 0.0 110.126 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.4 77.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.36 -26.68 67.98 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.374 1.469 . . . . 0.0 111.349 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -84.55 -21.65 30.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.655 0.662 . . . . 0.0 111.968 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.66 1.98 2.04 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.046 -1.975 . . . . 0.0 115.978 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -73.34 150.27 41.98 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.78 2.29 . . . . 0.0 109.633 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -55.89 -58.41 8.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.582 0.753 . . . . 0.0 111.129 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.8 m -159.3 166.18 31.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 107.465 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.37 12.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CD1' ' CE2' ' A' ' 78' ' ' TYR . 55.3 m-85 -100.26 151.23 21.71 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.23 111.14 19.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.32 91.37 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 113.96 10.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.25 34.0 m-20 115.32 4.84 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 133.079 4.552 . . . . 0.0 110.553 179.994 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.39 -134.49 41.92 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.658 -1.276 . . . . 0.0 114.866 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.98 -44.77 5.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -87.72 -22.71 24.45 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -52.98 170.88 0.59 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.443 1.973 . . . . 0.0 115.012 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -57.0 -27.55 74.07 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 124.532 3.488 . . . . 0.0 115.619 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -120.64 9.67 10.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.002 2.121 . . . . 0.0 109.03 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 168.98 20.83 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -47.19 -62.62 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 113.632 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.37 -52.83 63.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.795 1.238 . . . . 0.0 110.459 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.36 13.98 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.172 2.189 . . . . 0.0 113.437 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.4 m -129.47 16.56 5.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.644 1.578 . . . . 0.0 112.0 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.7 m 63.59 18.97 11.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.084 1.754 . . . . 0.0 113.661 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.3 mt -76.7 154.74 83.45 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.61 162.62 40.82 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.165 1.243 . . . . 0.0 109.969 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -167.38 126.51 1.36 Allowed 'General case' 0 C--O 1.238 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 113.059 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -73.49 93.19 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.977 2.111 . . . . 0.0 109.565 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.55 151.69 50.91 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.56 -165.78 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.14 2.56 . . . . 0.0 107.366 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 135.23 29.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -43.88 103.33 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.602 1.561 . . . . 0.0 109.61 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.8 m -92.16 129.89 38.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.7 p -164.21 178.29 7.69 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.672 1.189 . . . . 0.0 109.299 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 163.61 -102.38 0.2 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-O 117.703 -1.61 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.98 -19.9 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.675 2.916 . . . . 0.0 115.836 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 p -133.06 157.51 45.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.853 1.66 . . . . 0.0 112.132 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.64 -162.5 1.53 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.955 2.102 . . . . 0.0 108.159 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 179.344 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -147.64 160.36 42.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.557 1.179 . . . . 0.0 111.231 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 p -169.88 115.35 0.53 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.63 1.972 . . . . 0.0 108.363 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.32 136.58 37.13 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 t -77.91 88.56 4.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.372 1.086 . . . . 0.0 109.196 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -61.0 136.1 57.99 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.08 106.88 0.49 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -49.68 148.7 2.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.515 1.158 . . . . 0.0 109.023 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.86 48.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -67.8 -48.03 67.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.288 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -63.11 -45.14 93.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.856 0.753 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.12 81.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.47 -41.07 98.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.092 0.86 . . . . 0.0 111.581 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -60.35 -54.78 41.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -49.6 -53.01 26.36 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.327 1.051 . . . . 0.0 111.719 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.9 mt -57.55 -23.2 49.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 113.202 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.87 -5.79 60.93 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.951 1.262 . . . . 0.0 112.676 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -124.62 -1.86 7.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.495 1.148 . . . . 0.0 111.227 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -131.38 115.83 16.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -69.18 -47.48 64.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.842 1.257 . . . . 0.0 111.703 -178.488 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 75' ' ' THR . 22.1 m120 -72.56 -6.9 47.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.582 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -76.02 118.6 18.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.56 131.91 46.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.816 0.817 . . . . 0.0 110.944 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -65.28 127.52 32.09 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.465 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' LEU . 47.2 tp -109.36 103.92 12.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.854 2.062 . . . . 0.0 109.525 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.96 108.3 16.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.245 1.018 . . . . 0.0 108.273 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -102.36 0.09 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 70.6 mtm-85 -61.44 168.55 2.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.374 1.07 . . . . 0.0 113.632 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.45 136.81 37.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.413 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -38.25 -40.35 0.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.664 2.786 . . . . 0.0 114.322 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.02 76.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.869 0.759 . . . . 0.0 112.571 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.18 80.07 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.446 0.566 . . . . 0.0 111.024 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -65.67 -6.31 11.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.592 1.157 . . . . 0.0 111.824 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.68 -29.42 7.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.556 1.943 . . . . 0.0 109.486 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -94.67 -59.42 1.93 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.88 0.872 . . . . 0.0 112.824 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -26.33 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.696 1.599 . . . . 0.0 112.947 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.82 -153.38 19.17 Favored Glycine 0 C--N 1.335 0.487 0 O-C-N 121.42 -0.8 . . . . 0.0 112.836 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -143.3 162.0 44.84 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.49 178.39 6.23 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.072 1.181 . . . . 0.0 111.185 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -145.17 145.75 31.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.57 178.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.69 13.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.413 1.885 . . . . 0.0 110.619 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -59.06 -27.54 65.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.106 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.64 94.58 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.3 mt -70.16 -28.42 65.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 0.0 109.785 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.86 19.29 7.39 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 127.694 2.569 . . . . 0.0 110.817 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 20' ' ' ASP . 46.1 mmtm -130.24 -178.57 4.8 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 150.49 34.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.612 1.165 . . . . 0.0 108.855 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 179.96 7.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.745 0.818 . . . . 0.0 110.697 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.85 133.09 44.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -113.7 121.05 42.94 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.008 1.276 . . . . 0.0 111.273 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -146.69 108.1 4.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 t -57.98 119.91 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -75.92 124.45 27.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -131.12 116.72 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.04 1.736 . . . . 0.0 107.197 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.01 -27.43 67.12 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 118.464 0.575 . . . . 0.0 112.652 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -74.1 -15.42 61.05 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.625 0.712 . . . . 0.0 110.6 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.74 32.32 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.468 1.907 . . . . 0.0 113.584 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -43.06 -56.69 6.03 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 121.452 1.933 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -63.7 -37.05 48.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.724 2.282 . . . . 0.0 112.341 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.44 74.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.319 1.437 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -82.11 -56.7 3.77 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.09 -44.59 61.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.042 1.737 . . . . 0.0 112.769 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -57.36 -36.88 71.76 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.801 0.728 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -61.82 -20.62 63.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.921 0.889 . . . . 0.0 111.356 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.8 -43.28 8.3 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.6 t -52.43 -34.62 49.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.991 1.716 . . . . 0.0 111.541 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.99 -6.03 53.17 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.53 -37.37 4.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.785 0.721 . . . . 0.0 110.899 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 75' ' ' THR . 72.9 m-85 -91.88 103.88 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.901 0.881 . . . . 0.0 109.627 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -18.33 60.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.338 0.517 . . . . 0.0 111.68 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 68.24 79.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.642 1.177 . . . . 0.0 109.532 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -32.39 93.21 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.499 2.133 . . . . 0.0 111.63 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.11 -19.9 8.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.394 1.878 . . . . 0.0 115.934 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -124.87 8.48 8.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.841 1.256 . . . . 0.0 110.957 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.611 HG21 ' CD1' ' A' ' 69' ' ' PHE . 63.5 m -104.42 111.83 24.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.712 1.605 . . . . 0.0 111.323 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.5 m -83.67 129.32 34.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.85 102.61 14.43 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.478 0.711 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.499 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 49.4 m-85 -84.43 92.56 8.09 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.18 127.17 31.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.68 1.592 . . . . 0.0 110.849 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -127.2 130.98 50.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.647 1.579 . . . . 0.0 109.128 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 49.1 t0 -137.09 -170.54 2.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.078 2.151 . . . . 0.0 107.703 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -62.51 -48.5 79.28 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.03 -1.044 . . . . 0.0 108.676 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -140.97 -172.77 3.55 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.999 2.519 . . . . 0.0 108.886 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -48.89 -30.02 5.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.686 1.994 . . . . 0.0 113.121 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.33 -108.14 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 C-N-CA 130.208 3.766 . . . . 0.0 115.717 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -110.73 0.92 17.57 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 127.209 2.203 . . . . 0.0 108.816 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -51.48 -47.04 63.33 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 121.188 1.813 . . . . 0.0 109.755 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -64.47 -23.99 67.47 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 tp -87.32 -43.23 12.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.127 0.971 . . . . 0.0 110.97 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.98 -30.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.18 83.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.04 -43.24 71.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 125.794 1.637 . . . . 0.0 111.131 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.41 -56.16 21.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.915 0.886 . . . . 0.0 112.175 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.22 -35.32 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.14 95.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.058 0.543 . . . . 0.0 109.893 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.16 -37.97 84.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.579 0.752 . . . . 0.0 109.709 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -61.28 -50.58 72.44 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.18 -3.1 0.29 Allowed Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.976 -1.458 . . . . 0.0 115.377 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -58.79 153.2 17.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.632 1.716 . . . . 0.0 109.107 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -46.94 -70.13 0.11 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.489 1.116 . . . . 0.0 112.523 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 m -154.79 177.38 11.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.443 2.297 . . . . 0.0 105.826 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.06 136.55 8.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.15 -0.969 . . . . 0.0 108.651 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -113.33 154.52 26.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.703 1.201 . . . . 0.0 108.339 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.49 114.12 23.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.264 2.4 mp -66.15 106.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.73 128.02 34.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.22 9.88 4.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.885 2.874 . . . . 0.0 111.76 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.03 -111.8 0.51 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.196 1.855 . . . . 0.0 110.839 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.75 -9.12 3.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.516 1.126 . . . . 0.0 112.027 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.82 -1.54 27.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.2 41.64 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.31 -39.92 84.84 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.527 3.485 . . . . 0.0 114.746 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 21.55 9.63 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.862 0.865 . . . . 0.0 110.999 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.4 171.71 4.01 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -40.91 -46.3 2.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 113.52 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.8 mt -65.76 -57.2 8.55 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.374 0.988 . . . . 0.0 110.627 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -66.81 -4.49 9.33 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.712 2.005 . . . . 0.0 114.303 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 p -97.2 3.9 51.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 t 77.24 11.16 2.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.634 1.973 . . . . 0.0 111.859 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.1 152.88 79.72 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.012 0.824 . . . . 0.0 110.459 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.72 142.96 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.187 1.925 . . . . 0.0 110.981 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -145.06 142.2 29.52 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.502 -0.749 . . . . 0.0 110.313 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.0 mt -92.59 93.01 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.851 1.26 . . . . 0.0 109.121 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.85 148.64 72.73 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.639 0.775 . . . . 0.0 109.103 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.91 -155.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.284 3.323 . . . . 0.0 107.118 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -118.43 56.05 0.89 Allowed 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.518 -1.364 . . . . 0.0 109.842 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 129' ' ' SER . 1.2 tmtp? -125.12 146.95 49.24 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.784 1.634 . . . . 0.0 109.726 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.8 m -156.82 121.53 4.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -163.05 145.29 10.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.559 1.544 . . . . 0.0 107.805 178.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.22 149.5 45.82 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.63 176.44 9.88 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.875 3.05 . . . . 0.0 111.985 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.2 m -135.63 130.39 34.29 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.675 2.39 . . . . 0.0 107.132 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -61.26 141.43 57.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.843 1.257 . . . . 0.0 111.818 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.593 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.668 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -71.43 167.11 20.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.399 2.28 . . . . 0.0 111.171 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 2.46 26.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.727 0.811 . . . . 0.0 110.0 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.06 151.86 19.25 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.59 0.632 . . . . 0.0 113.593 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -84.02 100.15 10.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.197 2.199 . . . . 0.0 108.778 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 p -130.97 160.21 35.22 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.525 0.73 . . . . 0.0 111.416 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.9 -98.32 0.11 Allowed Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.6 m -157.26 160.08 38.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.104 1.452 . . . . 0.0 112.446 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.96 77.63 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.858 -1.068 . . . . 0.0 112.385 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -55.03 -51.5 66.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.911 1.232 . . . . 0.0 109.832 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -52.02 -54.36 30.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.598 0.759 . . . . 0.0 110.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.23 82.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 112.621 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.24 -45.72 75.89 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -59.89 -41.47 91.66 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -60.79 -44.2 97.12 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.631 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.81 -44.83 78.24 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.355 1.434 . . . . 0.0 107.708 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.0 -6.86 33.81 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.535 1.541 . . . . 0.0 115.952 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 t -129.59 -2.82 4.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.659 1.73 . . . . 0.0 111.655 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -113.97 94.09 4.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.805 1.642 . . . . 0.0 106.82 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.52 -27.03 1.59 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.523 1.929 . . . . 0.0 115.862 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -109.9 5.42 22.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.239 0.927 . . . . 0.0 113.11 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.27 148.56 39.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.008 0.822 . . . . 0.0 111.618 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -142.9 158.88 43.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.235 0.614 . . . . 0.0 110.277 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -102.08 119.72 39.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.362 1.465 . . . . 0.0 108.006 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 109.33 20.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.492 1.917 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 121.16 27.43 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.148 2.179 . . . . 0.0 107.625 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 81' ' ' ASP . 5.8 pt -120.44 4.66 6.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -66.43 170.45 6.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 121.798 2.09 . . . . 0.0 108.968 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.73 150.11 48.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -52.42 -32.8 40.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 111.701 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.94 70.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.179 0.899 . . . . 0.0 113.222 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.82 -38.34 88.64 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -63.25 -10.4 15.63 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.573 -1.954 . . . . 0.0 114.803 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -21.05 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.337 1.855 . . . . 0.0 109.43 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.06 -79.32 0.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.853 2.061 . . . . 0.0 109.265 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.85 -30.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.267 1.427 . . . . 0.0 112.731 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 125' ' ' PRO . . . 94.68 -134.22 11.9 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 p -151.11 158.17 34.83 Favored Pre-proline 0 N--CA 1.448 -0.573 0 O-C-N 122.654 -0.321 . . . . 0.0 111.175 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HG3' HD22 ' A' ' 80' ' ' LEU . 88.2 Cg_endo -71.74 173.81 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 N-CA-C 107.321 -1.838 . . . . 0.0 107.321 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.61 HD21 ' HB2' ' A' ' 121' ' ' PRO . 1.3 p30 -141.31 149.09 40.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.09 9.31 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.464 1.126 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -58.3 -32.72 68.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.392 1.477 . . . . 0.0 111.586 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -48.1 -42.79 24.28 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 124.804 1.315 . . . . 0.0 110.321 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 mt -77.1 -75.01 0.22 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.51 44.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -141.09 -176.11 4.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.922 1.689 . . . . 0.0 109.014 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.23 136.93 25.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.862 2.065 . . . . 0.0 107.136 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -175.79 2.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.977 0.911 . . . . 0.0 111.732 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.14 133.95 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.4 p -120.05 108.47 14.32 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.982 0.913 . . . . 0.0 113.455 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -143.46 108.48 4.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -57.47 122.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 118.149 0.431 . . . . 0.0 110.226 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -74.18 151.09 40.07 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -156.45 116.16 3.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.17 -22.15 57.72 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 117.902 0.319 . . . . 0.0 112.726 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 58.1 mt-10 -76.66 -15.22 59.86 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.163 0.981 . . . . 0.0 111.591 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -128.13 33.75 4.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.073 1.349 . . . . 0.0 113.784 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.39 -54.37 7.99 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.765 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.92 -47.26 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.563 2.175 . . . . 0.0 112.362 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.42 -24.88 71.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.849 -0.417 . . . . 0.0 112.593 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.76 -39.82 17.99 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 118.159 0.979 . . . . 0.0 108.602 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.6 -47.97 79.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.89 0.876 . . . . 0.0 111.194 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -52.94 -37.74 61.3 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.034 0.534 . . . . 0.0 111.623 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.86 -29.39 68.26 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.474 -0.766 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.63 -50.61 6.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 t -55.0 -26.6 38.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.206 1.802 . . . . 0.0 112.631 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.67 -18.3 33.57 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.231 -0.918 . . . . 0.0 111.64 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -51.61 3.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.462 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.32 98.8 4.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -56.97 -33.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.176 0.99 . . . . 0.0 113.469 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -131.68 80.84 65.34 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 39.5 Cg_endo -67.11 -26.42 42.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.814 2.343 . . . . 0.0 113.101 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -54.54 -18.62 4.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.161 1.785 . . . . 0.0 114.165 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -132.84 7.66 4.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 112.694 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -105.25 109.15 21.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.454 1.502 . . . . 0.0 109.895 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.7 m -80.84 137.98 36.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.519 0.728 . . . . 0.0 109.997 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.2 mt -113.54 99.62 7.88 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 112.22 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 52.7 m-85 -76.58 112.52 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.5 141.87 14.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.147 1.379 . . . . 0.0 110.478 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD22 ' HG3' ' A' ' 39' ' ' PRO . 12.7 tp -137.42 133.48 34.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.555 ' CG ' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -134.33 175.58 9.38 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -58.28 -55.53 33.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.59 -1.319 . . . . 0.0 110.682 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -130.26 -152.52 0.52 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.258 3.423 . . . . 0.0 105.503 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.3 -6.09 2.92 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 10.38 -94.18 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 1 C-N-CA 131.872 4.558 . . . . 0.0 117.5 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.37 4.62 1.21 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.287 2.235 . . . . 0.0 112.161 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' HG21 ' A' ' 79' ' ' ILE . 1.7 m -29.31 -62.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.404 2.682 . . . . 0.0 114.463 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.04 -45.81 82.88 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.254 2.222 . . . . 0.0 112.916 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -48.24 79.23 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.695 1.198 . . . . 0.0 108.71 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.0 -34.6 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -64.11 -45.72 87.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.983 0.81 . . . . 0.0 109.124 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.4 -42.38 87.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -53.13 -58.79 5.84 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.993 1.317 . . . . 0.0 111.685 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.11 -38.0 81.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 121.873 -0.517 . . . . 0.0 110.555 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.19 93.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.701 0.626 . . . . 0.0 111.057 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.59 -45.21 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.59 0.756 . . . . 0.0 110.236 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -55.26 -37.91 67.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.753 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -9.51 0.26 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.99 -0.895 . . . . 0.0 115.205 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 51.9 m-85 -67.57 142.04 56.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.444 1.622 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -41.14 -57.52 2.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.296 2.638 . . . . 0.0 112.79 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.0 t -166.99 173.59 9.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.44 149.61 27.94 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 44.9 m-85 -133.26 122.01 23.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.7 98.4 11.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 108.871 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -64.12 120.11 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -72.21 165.39 24.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.372 0.669 . . . . 0.0 109.82 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.3 16.07 10.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.244 1.818 . . . . 0.0 112.942 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.13 -123.97 32.85 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.36 -24.76 3.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.737 2.415 . . . . 0.0 109.472 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.43 -27.63 25.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.891 1.676 . . . . 0.0 113.524 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.48 178.9 41.14 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.214 0.911 . . . . 0.0 114.652 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.53 -51.12 11.2 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.411 3.408 . . . . 0.0 113.839 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 113' ' ' ARG . 34.0 mmt180 -88.66 7.26 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.688 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.78 153.46 47.27 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -34.13 -64.06 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 129.512 3.125 . . . . 0.0 115.711 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -56.66 -53.94 51.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.03 0.377 . . . . 0.0 110.497 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -15.33 62.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.91 2.084 . . . . 0.0 113.031 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 t -88.51 8.13 29.62 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.571 1.548 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.6 t 64.77 20.75 12.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.867 2.467 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.57 158.51 59.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 123.592 0.757 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.61 ' HB2' HD21 ' A' ' 40' ' ' ASN . 57.3 Cg_endo -77.62 152.88 29.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.305 2.003 . . . . 0.0 110.613 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -151.08 141.66 22.61 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 120.704 -1.247 . . . . 0.0 111.191 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 40' ' ' ASN . 2.9 mt -81.38 80.99 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.915 1.286 . . . . 0.0 109.908 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -78.98 122.36 84.44 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 37' ' ' GLY . 83.5 Cg_endo -69.9 174.43 9.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -67.5 113.21 5.16 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -121.53 179.86 4.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.038 1.335 . . . . 0.0 109.468 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.7 t -87.86 179.78 6.4 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 p -128.1 168.41 15.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.726 -1.234 . . . . 0.0 109.59 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.95 142.99 11.29 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.29 165.66 25.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.496 2.13 . . . . 0.0 111.579 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.92 137.08 16.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -143.87 179.66 7.03 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.724 0.774 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.449 0 N-CA-C 106.981 -2.447 . . . . 0.0 106.981 179.421 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.405 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m -138.52 -42.24 0.5 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.049 0.94 . . . . 0.0 111.195 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -80.6 89.66 5.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.267 1.394 . . . . 0.0 108.335 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.02 130.96 3.38 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 106.462 -2.655 . . . . 0.0 106.462 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m -65.94 57.67 0.03 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.787 2.435 . . . . 0.0 115.631 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.0 p -75.58 162.39 28.32 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.92 -110.93 0.28 Allowed Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.3 m -147.31 160.23 42.75 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.374 1.07 . . . . 0.0 111.064 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.48 33.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.462 1.905 . . . . 0.0 110.369 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -53.72 -49.87 67.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.398 0.544 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -57.03 -50.47 72.65 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.824 0.284 . . . . 0.0 111.493 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.81 77.09 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.927 0.491 . . . . 0.0 111.147 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 120' ' ' LEU . 44.6 t80 -63.9 -48.3 77.15 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.8 m -58.16 -42.27 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.203 0.601 . . . . 0.0 109.954 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -62.31 -34.31 76.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.578 -1.201 . . . . 0.0 111.844 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.27 -43.0 99.59 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.09 -0.48 15.29 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.839 1.685 . . . . 0.0 113.142 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -19.88 7.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.99 2.516 . . . . 0.0 111.279 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -127.61 112.49 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.117 -1.614 . . . . 0.0 111.612 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -40.43 94.06 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.903 0.881 . . . . 0.0 110.812 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.65 -12.72 60.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.282 0.633 . . . . 0.0 110.788 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.407 ' HA ' ' HB ' ' A' ' 76' ' ' THR . . . -77.83 143.03 38.18 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.61 155.6 47.35 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.321 1.048 . . . . 0.0 108.467 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.6 134.56 47.56 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -127.1 108.43 10.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.085 1.754 . . . . 0.0 111.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.33 116.89 21.39 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 pt -104.81 6.0 10.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -67.53 161.3 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.907 0.776 . . . . 0.0 110.053 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 144.5 55.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -54.15 -25.45 22.47 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.629 1.972 . . . . 0.0 110.951 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.98 92.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.07 -1.019 . . . . 0.0 109.93 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.03 -28.59 70.2 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.98 -17.18 61.82 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.759 -1.838 . . . . 0.0 111.604 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -105.49 -18.47 14.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.306 1.442 . . . . 0.0 110.332 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -100.71 -23.94 14.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.53 -26.33 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.758 1.163 . . . . 0.0 111.807 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.83 -137.79 13.47 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.72 158.0 31.64 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 118.553 1.176 . . . . 0.0 108.741 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.47 174.53 12.55 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.381 -1.815 . . . . 0.0 107.381 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.35 151.12 48.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.325 177.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -139.96 8.58 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.33 1.852 . . . . 0.0 110.472 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.92 -30.33 65.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.967 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.15 -37.33 94.33 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 mt -68.45 -33.96 75.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.4 19.42 4.62 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.254 1.883 . . . . 0.0 114.04 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -125.35 177.86 5.92 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.281 1.033 . . . . 0.0 111.661 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -131.15 159.18 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.752 1.621 . . . . 0.0 108.48 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.61 177.71 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.716 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.39 137.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.344 -2.835 . . . . 0.0 103.344 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -118.31 106.26 12.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.608 1.563 . . . . 0.0 107.883 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 m -143.96 98.31 3.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.01 122.26 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -77.38 145.02 37.51 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -146.74 114.15 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.82 1.248 . . . . 0.0 109.742 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.4 -21.82 9.49 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 121.11 -0.994 . . . . 0.0 114.104 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.88 -22.95 64.16 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.131 0.966 . . . . 0.0 111.62 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -144.53 62.79 1.32 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.42 1.105 . . . . 0.0 111.397 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.92 -56.4 23.79 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.605 1.162 . . . . 0.0 110.697 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.88 -38.76 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.897 1.731 . . . . 0.0 112.157 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.61 88.91 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -64.47 -47.03 80.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.329 1.052 . . . . 0.0 109.744 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mt -54.49 -42.23 70.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.101 0.96 . . . . 0.0 112.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -59.25 -32.42 69.97 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.842 -0.536 . . . . 0.0 111.743 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -62.85 -25.41 68.26 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -44.88 9.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -57.41 -28.01 62.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.698 1.199 . . . . 0.0 112.486 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.77 -12.23 59.96 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.766 -0.584 . . . . 0.0 111.627 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -112.84 -49.25 2.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.649 0.779 . . . . 0.0 109.699 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 51.3 m-85 -80.87 99.14 8.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -57.77 -44.69 86.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 81.42 33.87 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -26.2 44.17 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.62 2.214 . . . . 0.0 113.789 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -59.42 -14.65 13.03 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -116.68 -16.47 10.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.655 1.582 . . . . 0.0 110.114 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -77.23 132.97 38.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.072 1.349 . . . . 0.0 111.507 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.407 ' HB ' ' HA ' ' A' ' 22' ' ' ALA . 25.9 m -103.67 138.15 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.09 101.93 8.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -78.87 103.42 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.63 123.89 38.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 tp -120.23 125.04 47.14 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.704 1.201 . . . . 0.0 109.061 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -127.94 172.92 10.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.856 1.662 . . . . 0.0 106.877 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -65.71 -36.44 83.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.561 -1.337 . . . . 0.0 111.986 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -138.76 -173.98 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.572 1.949 . . . . 0.0 107.017 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.64 -26.81 2.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.709 2.404 . . . . 0.0 114.548 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.55 -113.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 130.197 3.761 . . . . 0.0 116.552 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -116.54 0.49 12.71 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.057 1.743 . . . . 0.0 113.645 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -30.65 -54.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 130.085 3.354 . . . . 0.0 115.714 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.64 -42.28 82.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.724 0.81 . . . . 0.0 110.346 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -42.99 96.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.1 -37.45 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.349 1.46 . . . . 0.0 108.496 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.48 98.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.46 -43.6 76.65 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -52.43 -57.47 9.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.832 1.196 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.5 m -63.7 -39.28 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.135 -0.353 . . . . 0.0 111.033 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.48 -52.53 64.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.598 0.759 . . . . 0.0 110.161 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.8 -44.47 93.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.557 1.543 . . . . 0.0 108.572 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -57.07 -45.07 83.56 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.126 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.21 -13.55 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-O 117.269 -1.85 . . . . 0.0 114.943 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.51 146.5 40.22 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.861 2.33 . . . . 0.0 110.705 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -60.55 3.23 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.193 1.397 . . . . 0.0 113.367 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.5 t -149.7 169.89 19.98 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.11 141.25 15.03 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -128.19 143.94 51.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.936 1.694 . . . . 0.0 106.673 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.92 118.28 36.13 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.6 95.89 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.67 142.54 39.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 76.55 2.29 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.261 2.225 . . . . 0.0 111.673 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.92 -126.22 35.07 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.879 -1.138 . . . . 0.0 113.783 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.48 4.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.122 1.369 . . . . 0.0 112.211 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -93.99 -12.81 27.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.396 1.478 . . . . 0.0 114.533 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.01 169.28 13.29 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.878 1.217 . . . . 0.0 111.471 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 -25.46 24.97 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.951 3.101 . . . . 0.0 115.671 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -134.11 27.53 3.84 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.22 1.808 . . . . 0.0 110.053 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.65 174.16 39.66 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -40.43 -53.11 2.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -63.21 -51.2 67.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.34 0.518 . . . . 0.0 109.659 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -77.47 27.82 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.478 1.111 . . . . 0.0 111.453 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.0 m -128.38 7.4 5.87 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.063 1.745 . . . . 0.0 111.524 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.9 m 57.83 53.66 6.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.039 1.335 . . . . 0.0 110.08 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 13' ' ' TYR . 90.5 mt -122.11 144.28 41.06 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.6 144.11 99.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.286 2.658 . . . . 0.0 112.285 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -147.2 156.05 42.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.87 0.868 . . . . 0.0 112.161 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.5 mt -105.66 89.95 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 110.132 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -74.67 156.4 86.72 Favored Pre-proline 0 C--O 1.239 0.519 0 O-C-N 121.776 -0.577 . . . . 0.0 109.587 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.61 178.4 7.6 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.54 2.827 . . . . 0.0 109.042 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -66.91 -34.62 78.18 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 128.8 37.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.495 0.718 . . . . 0.0 109.41 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 t -151.46 173.74 14.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 p -161.5 142.29 11.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.037 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.69 -171.99 8.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 123.82 0.7 . . . . 0.0 111.628 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.15 59.85 7.56 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.803 3.002 . . . . 0.0 108.487 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -63.65 132.72 51.99 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.536 -0.727 . . . . 0.0 110.377 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 m -83.6 -178.81 7.15 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 110.885 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 179.344 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -137.12 150.02 47.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.13 1.372 . . . . 0.0 107.363 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -66.89 97.89 0.51 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.554 1.541 . . . . 0.0 108.309 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 41.07 -117.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.198 1.856 . . . . 0.0 108.598 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -157.61 142.3 16.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 p -149.71 179.24 8.16 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 123.933 0.893 . . . . 0.0 109.353 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 -86.43 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -178.03 167.32 2.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.642 1.977 . . . . 0.0 109.16 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.46 -52.69 60.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.929 0.892 . . . . 0.0 110.083 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -55.41 -52.04 64.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.901 0.48 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.55 -51.53 66.76 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -55.96 -47.22 78.01 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -53.09 -52.23 59.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.606 0.763 . . . . 0.0 112.032 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 m -69.01 -36.06 77.36 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.557 -0.714 . . . . 0.0 111.441 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.39 -39.98 89.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.5 HD23 ' HB1' ' A' ' 22' ' ' ALA . 73.6 mt -63.9 -38.82 92.5 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.51 0.53 33.59 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 127.084 2.278 . . . . 0.0 114.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.48 -20.88 3.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.522 1.161 . . . . 0.0 111.043 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -117.16 102.98 9.75 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.562 -0.711 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.47 -26.24 60.94 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.42 -13.18 61.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.441 1.096 . . . . 0.0 111.252 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -90.74 146.63 23.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.914 -1.117 . . . . 0.0 111.524 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.56 30.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 tt -103.93 143.73 32.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.665 0.786 . . . . 0.0 108.903 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -131.37 98.44 4.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.917 1.687 . . . . 0.0 108.868 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -78.47 113.81 16.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.9 pt -103.79 13.38 7.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -73.74 166.33 23.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 134.36 50.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -54.63 -27.01 36.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.72 1.208 . . . . 0.0 112.39 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.26 88.35 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.997 -1.064 . . . . 0.0 110.128 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -71.41 -27.05 63.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.105 0.866 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -59.3 -28.5 66.84 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.593 0.633 . . . . 0.0 109.377 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -85.58 -38.9 17.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.862 0.865 . . . . 0.0 110.086 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -68.77 -50.11 53.14 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.81 -12.33 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.02 -152.18 20.01 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.141 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 p -143.71 161.36 46.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.562 1.181 . . . . 0.0 112.956 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.4 157.73 58.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.989 1.793 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.453 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 4.7 p30 -125.19 87.5 2.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.968 2.107 . . . . 0.0 112.493 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.3 5.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 119.313 -2.117 . . . . 0.0 111.043 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -24.53 61.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.234 1.814 . . . . 0.0 112.867 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.9 -27.08 61.53 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.61 -50.76 6.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 1.59 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.682 1.61 . . . . 0.0 112.668 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.25 -179.9 5.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.15 . . . . 0.0 109.55 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -141.28 133.88 28.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.68 1.592 . . . . 0.0 107.192 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.32 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.628 0.728 . . . . 0.0 111.754 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -127.95 138.3 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -115.72 110.33 18.96 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.439 1.096 . . . . 0.0 109.842 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.41 103.12 4.21 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.773 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.11 124.53 12.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 119.985 1.266 . . . . 0.0 109.417 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -79.75 122.49 26.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.68 121.58 25.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.21 -15.37 37.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.124 -0.82 . . . . 0.0 114.087 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.44 -17.8 60.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.68 1.24 . . . . 0.0 110.478 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -131.49 66.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.275 1.03 . . . . 0.0 109.976 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -57.54 -58.68 16.58 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 120.195 -1.566 . . . . 0.0 108.46 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -34.61 8.18 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.867 1.712 . . . . 0.0 110.241 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.82 -28.55 63.36 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -80.86 -55.93 4.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -48.74 -50.31 34.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.424 1.89 . . . . 0.0 112.824 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -32.99 63.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -63.35 -28.16 69.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.892 0.877 . . . . 0.0 110.189 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -45.91 10.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 t -53.93 -33.52 56.99 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.268 1.427 . . . . 0.0 112.095 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -6.18 52.11 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.66 -39.4 3.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.623 0.769 . . . . 0.0 112.851 -178.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CD1' HG21 ' A' ' 75' ' ' THR . 47.7 m-85 -80.12 119.86 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -33.53 72.48 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.548 0.53 . . . . 0.0 112.097 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -145.67 96.24 4.8 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 124.467 1.107 . . . . 0.0 108.223 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.84 -34.53 91.22 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.699 1.6 . . . . 0.0 111.906 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.28 -12.81 32.09 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.25 6.9 p30 -122.5 25.5 8.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.941 1.296 . . . . 0.0 109.29 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' PHE . 25.4 m -130.84 120.16 23.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.258 1.023 . . . . 0.0 110.696 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.6 m -93.18 137.05 32.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.6 mt -115.91 96.21 5.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.227 1.011 . . . . 0.0 112.148 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.463 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 13.9 m-85 -78.21 121.07 23.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.434 HG12 ' H ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -74.2 154.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.98 1.312 . . . . 0.0 112.668 -179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 80' ' ' LEU . 12.4 tp -155.31 105.05 2.46 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 176.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.94 171.88 8.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.851 1.66 . . . . 0.0 106.823 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.66 -58.16 3.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.059 1.343 . . . . 0.0 112.304 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -137.74 -152.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.725 2.41 . . . . 0.0 105.544 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.76 -45.4 9.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.995 2.118 . . . . 0.0 112.253 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.17 -104.09 0.06 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.829 2.157 . . . . 0.0 113.834 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -143.74 11.81 1.65 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.055 1.742 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -39.77 -48.04 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.475 1.91 . . . . 0.0 114.601 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.93 -49.45 77.77 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.835 0.854 . . . . 0.0 110.518 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.18 89.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.24 -33.67 62.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.31 93.93 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.254 0.934 . . . . 0.0 109.66 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -74.28 -38.95 63.26 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.998 0.817 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.4 tp -51.55 -60.09 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.046 1.338 . . . . 0.0 111.808 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.58 -37.47 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 122.603 0.361 . . . . 0.0 111.388 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.6 70.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.15 -41.42 88.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -66.69 -25.68 66.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.03 -4.5 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 117.712 -1.605 . . . . 0.0 115.717 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.24 146.55 48.93 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 120.458 2.129 . . . . 0.0 108.137 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -45.36 -64.03 0.81 Allowed 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.726 1.211 . . . . 0.0 111.523 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.0 m -157.39 179.27 9.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.838 1.655 . . . . 0.0 107.599 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.59 142.31 12.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.494 1.518 . . . . 0.0 106.95 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.442 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -128.6 129.45 45.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.865 1.266 . . . . 0.0 108.78 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.64 139.88 30.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.65 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 126.417 1.887 . . . . 0.0 107.793 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -59.66 151.98 23.58 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.81 0.844 . . . . 0.0 109.445 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 66.83 10.17 7.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.42 1.488 . . . . 0.0 112.742 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.89 -116.54 3.39 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.925 2.202 . . . . 0.0 113.284 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 -43.57 3.26 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.653 0.781 . . . . 0.0 112.774 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.71 -10.74 41.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.74 176.01 9.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.028 1.286 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.44 -19.31 67.72 Favored 'Trans proline' 0 N--CA 1.471 0.147 0 C-N-CA 123.919 3.079 . . . . 0.0 112.982 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -119.54 -3.97 10.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.345 2.258 . . . . 0.0 109.327 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.45 159.26 25.81 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -25.9 -62.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.462 2.305 . . . . 0.0 114.164 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.51 -62.68 1.52 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.176 1.39 . . . . 0.0 110.77 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.66 -10.01 16.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.423 1.089 . . . . 0.0 113.263 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.82 15.31 7.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 0.0 109.113 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 m 68.85 15.56 8.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.349 2.66 . . . . 0.0 112.62 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.69 153.01 52.44 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 119.144 0.884 . . . . 0.0 110.252 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.64 169.75 21.85 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.2 1.934 . . . . 0.0 109.536 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -165.19 130.09 2.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 119.946 -1.721 . . . . 0.0 109.555 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -72.26 97.21 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.658 1.983 . . . . 0.0 109.439 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -93.91 149.52 37.1 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 121.058 -1.026 . . . . 0.0 112.388 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.06 179.97 5.58 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.046 3.164 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.06 117.65 4.57 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.59 155.15 12.89 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.7 m -125.13 -68.77 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.4 p -75.25 -179.82 4.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.584 0.754 . . . . 0.0 110.94 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.66 167.31 15.03 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.68 1.61 . . . . 0.0 109.472 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.18 150.85 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.027 1.818 . . . . 0.0 109.883 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t 47.12 42.84 13.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.641 1.176 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.6 t -149.47 78.35 1.37 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 109.356 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 C-N-CA 125.232 1.396 . . . . 0.0 110.513 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 121.328 0.585 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.24 -117.6 0.61 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.348 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 m -122.2 148.4 45.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.523 1.529 . . . . 0.0 111.002 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.57 -42.87 75.32 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.315 1.046 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.36 -41.32 79.88 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.732 0.813 . . . . 0.0 111.482 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -61.45 -42.8 99.33 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.07 82.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.343 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.56 -40.17 90.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.036 1.289 . . . . 0.0 110.251 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.2 m -62.98 -54.02 44.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -57.17 -43.09 82.26 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.619 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.98 -20.5 58.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.966 1.257 . . . . 0.0 111.423 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.2 -9.33 62.11 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.219 1.866 . . . . 0.0 112.653 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -122.96 -18.18 6.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.064 1.432 . . . . 0.0 110.913 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -97.21 103.73 15.69 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.59 -24.48 67.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.904 0.881 . . . . 0.0 109.905 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -94.24 -0.19 55.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.164 1.785 . . . . 0.0 112.912 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.91 148.39 29.89 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.246 0.93 . . . . 0.0 111.646 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -148.11 154.68 40.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.02 1.728 . . . . 0.0 108.321 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.04 131.09 52.99 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.067 1.747 . . . . 0.0 108.022 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.0 tp -122.68 114.97 21.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.849 1.66 . . . . 0.0 109.284 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.6 m-20 -84.67 104.19 14.43 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 126.292 1.837 . . . . 0.0 109.445 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.66 2.96 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 122.224 -0.298 . . . . 0.0 110.71 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.473 HH21 ' CG ' ' A' ' 26' ' ' ASP . 39.9 mtm180 -57.06 165.01 1.41 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.49 1.516 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.53 141.74 32.38 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.9 m -49.16 -33.66 12.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.351 1.46 . . . . 0.0 111.194 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.52 78.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.235 0.925 . . . . 0.0 110.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 36' ' ' VAL . 66.3 m-20 -63.69 -39.42 94.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -58.9 -20.72 54.15 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.276 -1.515 . . . . 0.0 114.574 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -96.03 -23.47 16.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.955 0.502 . . . . 0.0 111.586 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.35 -70.26 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.897 1.679 . . . . 0.0 110.941 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 32' ' ' ASP . 9.6 p -77.36 -31.92 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.425 1.09 . . . . 0.0 111.708 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.3 -138.32 13.92 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -147.48 162.63 31.38 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 120.619 -1.518 . . . . 0.0 109.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.55 163.28 37.44 Favored 'Trans proline' 0 N--CA 1.435 -1.937 0 CA-C-O 124.618 1.841 . . . . 0.0 110.141 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.612 ' HB2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -126.19 92.26 3.54 Favored 'General case' 0 N--CA 1.419 -2.003 1 C-N-CA 132.346 4.258 . . . . 0.0 105.295 -179.212 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 pt -115.43 -19.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.195 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -43.24 -26.54 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.567 -1.682 . . . . 0.0 115.475 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.4 37.36 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 119.991 1.269 . . . . 0.0 110.303 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.46 -71.5 0.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.32 32.2 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 CA-C-O 118.815 -0.992 . . . . 0.0 115.194 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -126.77 177.73 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.053 1.926 . . . . 0.0 110.39 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.86 133.7 43.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.413 1.085 . . . . 0.0 110.076 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.26 167.39 18.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.374 -0.828 . . . . 0.0 110.387 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.1 t -134.34 134.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -115.14 115.84 27.41 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.564 1.146 . . . . 0.0 109.355 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.5 107.86 4.41 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.73 111.44 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 119.776 1.171 . . . . 0.0 110.182 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -74.29 154.86 38.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.592 0.71 . . . . 0.0 109.34 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -165.3 134.78 3.5 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.91 -34.79 80.06 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -66.99 -24.87 66.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.414 1.107 . . . . 0.0 111.115 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -105.32 15.35 27.45 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.582 1.553 . . . . 0.0 114.169 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -39.43 -60.0 1.41 Allowed Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 121.459 1.936 . . . . 0.0 112.328 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.82 -47.64 6.6 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.554 2.836 . . . . 0.0 112.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.75 -22.85 68.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.847 0.737 . . . . 0.0 113.293 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -82.89 -50.17 8.89 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.097 1.759 . . . . 0.0 107.481 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.53 -47.58 66.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.495 1.518 . . . . 0.0 112.882 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -52.38 -43.44 64.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -58.16 -22.2 50.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.741 1.216 . . . . 0.0 113.794 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.41 -52.79 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.8 t -55.68 -30.0 60.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.951 0.9 . . . . 0.0 110.106 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.74 -4.58 59.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -36.67 4.54 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 119.497 1.044 . . . . 0.0 111.342 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.49 120.2 29.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.167 1.387 . . . . 0.0 107.503 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -58.79 -54.11 50.79 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.293 0.497 . . . . 0.0 111.124 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -116.87 83.78 14.91 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.526 1.13 . . . . 0.0 110.012 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 11.0 Cg_endo -56.6 -40.75 82.25 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.163 1.909 . . . . 0.0 110.253 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.32 -0.78 1.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 -11.92 4.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.135 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 138.19 31.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.718 1.207 . . . . 0.0 110.979 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -100.82 123.46 45.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.64 97.16 6.76 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.018 1.327 . . . . 0.0 110.975 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 41.8 m-85 -73.42 120.04 18.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.9 OUTLIER -76.42 156.86 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.278 1.431 . . . . 0.0 109.992 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.4 tt -156.35 110.57 2.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -123.76 169.21 11.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -54.89 -39.07 68.36 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.718 -1.238 . . . . 0.0 109.736 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -141.77 -140.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.658 1.983 . . . . 0.0 108.989 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -64.95 -62.29 1.65 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.643 1.577 . . . . 0.0 108.2 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.89 -86.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 127.739 2.59 . . . . 0.0 113.675 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.46 9.44 2.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.584 ' HA ' HG21 ' A' ' 79' ' ' ILE . 19.3 m -42.69 -53.6 4.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.829 1.652 . . . . 0.0 114.182 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -39.23 78.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.24 1.382 . . . . 0.0 112.249 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -50.59 72.81 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.9 -30.42 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 109.94 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.13 89.15 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -78.84 -35.62 43.67 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.04 -57.22 9.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 112.194 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.04 -41.07 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.63 77.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.038 0.935 . . . . 0.0 110.024 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.99 -38.5 91.4 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.211 1.004 . . . . 0.0 109.445 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.96 -49.35 76.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -8.07 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-O 118.132 -1.371 . . . . 0.0 113.269 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 31.9 m-85 -61.1 156.33 18.36 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.123 1.961 . . . . 0.0 109.93 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -59.22 -68.48 0.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 m -158.76 171.28 20.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.155 0.982 . . . . 0.0 109.068 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.72 164.24 36.61 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 32.9 m-85 -135.0 125.45 26.59 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.87 109.58 20.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.36 92.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.02 133.5 14.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.98 2.112 . . . . 0.0 107.015 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 89.85 -5.07 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.636 3.174 . . . . 0.0 112.375 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 65.44 -164.54 37.51 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -88.89 -14.09 37.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.656 -1.164 . . . . 0.0 114.047 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.23 -2.63 14.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.362 0.983 . . . . 0.0 113.61 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.4 176.29 19.1 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.131 -0.981 . . . . 0.0 113.304 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.22 -25.48 56.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.316 3.344 . . . . 0.0 115.248 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -134.8 28.5 3.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.762 2.025 . . . . 0.0 110.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.19 -171.76 5.21 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.483 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 36.4 t-105 -47.2 -55.17 9.04 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.646 0.778 . . . . 0.0 112.613 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.14 -50.77 71.83 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.044 0.937 . . . . 0.0 110.29 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.11 24.96 0.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.802 1.241 . . . . 0.0 113.468 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.3 m -129.37 12.26 5.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.599 1.96 . . . . 0.0 110.823 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.46 18.29 11.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.398 1.479 . . . . 0.0 112.976 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.44 149.96 62.49 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.62 154.68 49.78 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.35 2.033 . . . . 0.0 109.856 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -155.15 157.33 37.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.263 0.483 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' ' 40' ' ' ASN . 3.4 mt -107.83 88.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.184 1.394 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.42 156.22 91.81 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.984 0.913 . . . . 0.0 109.365 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 C-N-CA 124.147 3.232 . . . . 0.0 109.124 178.506 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 C--O 1.241 0.655 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.6 -120.77 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 118.64 -1.743 . . . . 0.0 115.438 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.02 146.05 52.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.018 1.327 . . . . 0.0 109.991 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.43 ' HB3' ' OG ' ' A' ' 118' ' ' SER . . . -53.9 -50.41 66.41 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.135 1.774 . . . . 0.0 107.864 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -55.71 -49.58 72.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.634 0.652 . . . . 0.0 111.823 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -55.49 -43.99 76.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.145 0.43 . . . . 0.0 111.086 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.06 -34.19 72.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.258 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.49 -49.13 67.61 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.762 1.619 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -54.43 -45.2 72.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.579 0.751 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 18' ' ' THR . 51.4 mmtt -58.25 -36.26 72.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.604 -1.188 . . . . 0.0 112.275 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.08 -25.68 65.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.72 1.6 . . . . 0.0 111.736 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -40.18 6.36 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 15' ' ' LYS . 1.1 t -78.67 -4.28 48.24 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.751 0.776 . . . . 0.0 110.941 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -126.51 -168.72 1.9 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.565 0.746 . . . . 0.0 109.12 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -141.66 -43.23 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.882 2.473 . . . . 0.0 106.554 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.37 63.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.476 0.71 . . . . 0.0 111.44 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.85 124.03 27.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -134.33 138.02 44.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.6 tm? -84.5 133.5 34.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.413 1.085 . . . . 0.0 108.552 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 24' ' ' LEU . 21.3 tp -126.58 112.47 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.593 1.557 . . . . 0.0 109.407 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -89.09 117.96 28.46 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.585 2.354 . . . . 0.0 109.15 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.1 pt -108.98 14.2 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -76.55 164.87 25.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 135.15 55.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 m -51.6 -32.54 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.849 1.26 . . . . 0.0 111.724 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.3 77.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.637 1.108 . . . . 0.0 111.622 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -62.62 -28.99 70.28 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.74 0.7 . . . . 0.0 109.804 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -62.43 -13.67 32.42 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.873 -1.142 . . . . 0.0 111.313 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -107.78 -35.87 6.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.385 1.074 . . . . 0.0 110.467 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -85.61 -28.8 24.56 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.74 -22.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.424 1.011 . . . . 0.0 110.346 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.06 -159.6 17.2 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 121.64 -0.662 . . . . 0.0 112.722 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -140.01 161.39 56.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.611 0.764 . . . . 0.0 111.285 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.09 155.69 47.34 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.73 1.62 . . . . 0.0 110.51 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.635 HD21 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -127.39 86.86 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.494 1.918 . . . . 0.0 108.934 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 pt -85.18 6.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.962 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -51.92 -34.65 42.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.459 1.503 . . . . 0.0 112.257 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.57 -6.97 9.46 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.796 1.634 . . . . 0.0 114.173 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 mt -105.15 -23.33 12.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.571 1.548 . . . . 0.0 109.086 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.41 5.73 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 127.939 2.685 . . . . 0.0 109.883 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -124.37 168.5 12.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.849 0.824 . . . . 0.0 110.831 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 48' ' ' ALA . 6.7 tptt -135.84 120.16 17.93 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.613 1.165 . . . . 0.0 108.296 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . -66.75 174.77 2.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.84 0.829 . . . . 0.0 112.387 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.46 149.83 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.131 -2.914 . . . . 0.0 103.131 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -133.95 113.74 12.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.085 1.354 . . . . 0.0 111.315 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.9 m -158.26 113.75 2.68 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.78 121.32 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 112.773 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.89 156.4 32.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.1 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -166.88 161.27 15.12 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 129.33 3.052 . . . . 0.0 106.141 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.32 62.22 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.558 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.7 -42.57 77.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.352 1.061 . . . . 0.0 110.223 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.32 38.82 2.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.661 1.984 . . . . 0.0 112.841 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -46.83 -50.55 43.5 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 120.737 1.608 . . . . 0.0 109.882 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.9 -40.01 13.16 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.727 1.618 . . . . 0.0 111.959 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.88 -53.19 46.12 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 125.394 1.473 . . . . 0.0 109.644 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -55.93 -50.35 70.97 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.202 2.201 . . . . 0.0 108.307 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -56.85 -46.89 81.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.184 0.593 . . . . 0.0 109.902 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -58.21 -42.88 87.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.097 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -56.94 -24.08 50.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.466 1.03 . . . . 0.0 111.984 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mt -96.26 -46.9 6.24 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.57 1.148 . . . . 0.0 108.894 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -64.02 -11.9 33.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.51 0.595 . . . . 0.0 112.139 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.79 -3.86 51.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.251 0.478 . . . . 0.0 110.297 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 -32.68 5.88 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.5 1.92 . . . . 0.0 112.425 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.41 127.46 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.635 1.174 . . . . 0.0 111.503 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.29 -41.36 66.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -135.99 89.61 20.27 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 119.677 1.126 . . . . 0.0 111.027 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.58 -31.42 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.702 1.601 . . . . 0.0 112.414 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.1 -10.86 6.93 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.075 0.95 . . . . 0.0 112.706 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -130.84 23.61 4.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.434 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.8 m -134.06 120.93 20.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.84 1.2 . . . . 0.0 110.603 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -83.7 132.26 34.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.288 1.435 . . . . 0.0 110.605 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 99' ' ' PHE . 51.7 mt -108.19 103.47 12.67 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.001 0.92 . . . . 0.0 112.154 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 65.7 m-85 -82.86 100.68 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.1 134.2 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.951 0.901 . . . . 0.0 110.127 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.79 135.94 38.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.063 0.945 . . . . 0.0 109.141 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -130.4 176.19 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 128.693 2.797 . . . . 0.0 108.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.69 -35.61 78.5 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.546 -1.347 . . . . 0.0 109.628 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.58 -151.64 0.39 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.598 1.959 . . . . 0.0 106.808 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.51 -45.68 89.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.61 -108.93 0.22 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 128.2 2.81 . . . . 0.0 114.66 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -118.6 2.15 11.72 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.596 1.159 . . . . 0.0 112.829 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 m -35.29 -57.14 0.6 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.978 2.111 . . . . 0.0 114.717 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.59 -38.07 89.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -31.44 63.19 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.601 0.715 . . . . 0.0 110.074 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.75 -31.29 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.15 93.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.386 0.674 . . . . 0.0 109.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.59 -44.61 73.98 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.91 0.484 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.57 -57.24 10.62 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.298 1.039 . . . . 0.0 112.648 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.21 -40.28 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.54 68.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.72 0.808 . . . . 0.0 109.902 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.36 -23.34 67.26 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.804 0.842 . . . . 0.0 112.623 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -82.01 -19.52 40.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.42 -4.18 5.88 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-O 117.406 -1.775 . . . . 0.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 77' ' ' LEU . 35.2 m-85 -65.38 140.75 58.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 120.61 2.205 . . . . 0.0 108.224 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -47.77 -61.01 2.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -157.29 166.57 32.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.28 151.39 31.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.425 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 24.8 m-85 -141.19 135.5 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 107.748 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.34 118.95 38.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.707 2.003 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.07 110.66 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -66.89 149.07 51.12 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 66.76 8.96 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.312 1.845 . . . . 0.0 113.833 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.71 -104.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.813 0 C-N-CA 127.057 2.265 . . . . 0.0 114.244 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.6 -45.5 0.67 Allowed 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.901 1.28 . . . . 0.0 111.948 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.0 -2.02 31.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.735 0.647 . . . . 0.0 112.089 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.33 174.53 53.46 Favored Glycine 0 CA--C 1.54 1.648 0 O-C-N 121.035 -1.04 . . . . 0.0 112.059 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.36 -23.69 75.36 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.559 3.506 . . . . 0.0 115.542 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -131.79 14.84 4.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.51 1.124 . . . . 0.0 110.57 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.4 165.91 30.99 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -27.7 -56.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.198 2.599 . . . . 0.0 114.697 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.71 -63.19 1.28 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.117 0.967 . . . . 0.0 109.159 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -69.07 7.21 0.75 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.741 1.616 . . . . 0.0 112.718 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 22.7 t -100.53 6.87 44.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.32 1.448 . . . . 0.0 109.877 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t 66.78 49.22 1.25 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.147 1.34 . . . . 0.0 108.657 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.7 mt -128.67 155.57 78.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 125.084 1.354 . . . . 0.0 109.123 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' C ' HD21 ' A' ' 40' ' ' ASN . 58.4 Cg_endo -76.62 168.72 23.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.645 2.23 . . . . 0.0 110.989 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.635 ' N ' HD21 ' A' ' 40' ' ' ASN . 34.0 t-105 -171.83 126.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.182 -1.574 . . . . 0.0 110.816 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.426 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.8 mt -68.66 88.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.324 1.85 . . . . 0.0 110.716 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.24 155.11 69.65 Favored Pre-proline 0 C--O 1.24 0.603 0 O-C-N 121.103 -0.998 . . . . 0.0 110.309 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 0 CA--C 1.535 0.525 0 C-N-CA 124.51 3.473 . . . . 0.0 110.72 179.111 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.239 0.501 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.4 -101.65 0.23 Allowed Glycine 0 C--N 1.338 0.67 0 O-C-N 121.491 -0.755 . . . . 0.0 111.941 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.3 m -160.11 164.94 32.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.054 2.542 . . . . 0.0 106.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.5 95.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.654 -0.654 . . . . 0.0 112.554 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -55.26 -48.81 73.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.006 0.821 . . . . 0.0 110.684 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -55.59 -50.1 71.01 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.379 0.671 . . . . 0.0 109.419 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.75 81.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.101 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.4 t80 -59.42 -43.37 93.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.777 1.171 . . . . 0.0 110.561 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.6 m -58.91 -45.02 91.3 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.235 -0.915 . . . . 0.0 109.425 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -65.04 -42.16 94.55 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.946 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 13' ' ' TYR . 53.3 mt -57.28 -41.88 80.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.108 0.867 . . . . 0.0 109.548 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 44' ' ' LEU . . . -72.67 -14.31 77.92 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-O 118.186 -1.341 . . . . 0.0 115.32 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 t -115.25 -13.12 11.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.05 1.425 . . . . 0.0 112.02 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -113.3 99.78 8.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.84 -25.86 43.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.572 1.149 . . . . 0.0 112.9 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -89.37 -3.96 58.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.543 0.737 . . . . 0.0 112.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.05 149.84 24.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.528 1.058 . . . . 0.0 110.092 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -145.96 174.09 11.57 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.39 144.42 40.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.436 0.695 . . . . 0.0 110.144 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 tp -121.35 108.73 14.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.666 2.387 . . . . 0.0 112.541 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -86.5 109.82 19.34 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.476 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.07 2.25 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -42.19 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.72 130.02 3.68 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -44.59 -34.33 2.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.906 2.082 . . . . 0.0 114.726 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.78 -34.29 45.68 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 120.359 1.436 . . . . 0.0 110.781 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.08 -29.33 69.68 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.34 -20.69 65.73 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 119.628 -1.92 . . . . 0.0 112.168 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -91.92 -19.93 21.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.573 1.549 . . . . 0.0 109.474 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.5 -62.86 1.18 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.16 1.384 . . . . 0.0 112.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.02 -38.53 12.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 123.964 0.906 . . . . 0.0 111.136 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.69 -151.76 17.27 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 118.886 0.766 . . . . 0.0 113.618 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.56 154.6 60.04 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.801 1.64 . . . . 0.0 108.036 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.75 172.65 14.77 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 121.551 1.501 . . . . 0.0 109.774 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.19 113.15 12.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.624 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.4 pt -103.27 14.47 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.631 1.205 . . . . 0.0 110.933 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.02 -17.29 51.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.548 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.65 -6.82 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 120.276 1.398 . . . . 0.0 111.335 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 ' HA2' ' A' ' 17' ' ' GLY . 52.3 mt -112.5 -22.72 10.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.703 2.801 . . . . 0.0 109.376 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.93 25.66 14.29 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.614 2.054 . . . . 0.0 109.667 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -116.63 178.92 4.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.512 1.925 . . . . 0.0 111.695 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.98 138.77 17.95 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.08 170.81 16.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.2 1.0 . . . . 0.0 112.421 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.0 133.75 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.956 2.102 . . . . 0.0 106.159 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -106.63 122.62 46.7 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.983 0.913 . . . . 0.0 111.611 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.502 ' CG2' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -152.13 102.96 2.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.866 1.266 . . . . 0.0 109.503 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.71 127.36 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 120.321 -1.487 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -81.37 151.81 27.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -157.84 131.29 7.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.475 1.11 . . . . 0.0 108.563 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.84 66.56 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -86.67 -0.5 56.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.801 1.3 . . . . 0.0 111.833 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.62 25.58 5.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.64 0.776 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -48.36 -57.14 11.44 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.676 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.28 -41.05 13.32 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.346 1.364 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -22.53 63.8 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.693 0.663 . . . . 0.0 113.78 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -83.29 -47.23 11.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.439 1.496 . . . . 0.0 107.585 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 mt -55.78 -46.83 77.85 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.214 1.405 . . . . 0.0 110.801 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -45.24 66.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.685 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HE3' ' CG2' ' A' ' 51' ' ' THR . 40.9 mtmt -62.32 -20.03 63.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.67 -46.24 6.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 t -60.74 -21.25 62.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.23 -2.79 56.28 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 -27.79 7.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.979 0.911 . . . . 0.0 112.308 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.8 114.18 25.8 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 108.268 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -66.21 -31.82 72.88 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.49 1.116 . . . . 0.0 111.287 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.49 77.48 34.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 17.3 Cg_endo -58.15 -40.75 74.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.091 1.861 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.97 -6.11 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -125.94 -4.04 6.98 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.782 0.719 . . . . 0.0 111.463 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.4 m -96.39 124.37 40.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 110.488 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.8 m -89.68 132.87 34.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.66 98.73 7.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 29.6 m-85 -78.33 113.99 16.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.127 -0.94 . . . . 0.0 108.478 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -81.93 134.55 26.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 120.228 1.376 . . . . 0.0 111.722 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 tp -129.88 113.29 14.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.35 1.46 . . . . 0.0 109.254 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -119.36 -177.27 3.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.691 1.596 . . . . 0.0 108.682 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -61.23 -54.48 43.67 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.356 -0.84 . . . . 0.0 110.121 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -139.1 -168.9 2.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.871 2.869 . . . . 0.0 106.34 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.68 -58.51 0.5 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.898 2.479 . . . . 0.0 112.689 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.02 -109.03 0.57 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.639 1.59 . . . . 0.0 114.835 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -134.55 10.04 3.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.194 2.198 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.7 m -44.13 -42.1 6.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.692 1.597 . . . . 0.0 113.157 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -64.01 -44.23 93.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.501 0.72 . . . . 0.0 111.284 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.61 -45.45 86.85 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.72 -28.6 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.094 0.958 . . . . 0.0 109.471 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.32 -44.8 82.37 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.916 0.78 . . . . 0.0 110.218 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.15 -39.35 60.45 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.1 -56.65 5.33 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.351 1.46 . . . . 0.0 111.798 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.56 -39.43 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.608 0.763 . . . . 0.0 111.19 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.57 -52.85 63.72 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.63 0.772 . . . . 0.0 109.093 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.84 -20.18 65.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.053 1.741 . . . . 0.0 111.656 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.58 -15.43 32.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.178 1.391 . . . . 0.0 114.025 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.14 -0.76 5.31 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.016 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 36.2 m-85 -81.74 156.35 25.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.9 1.85 . . . . 0.0 109.196 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -54.54 -69.45 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.077 0.951 . . . . 0.0 112.128 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.3 m -161.31 177.93 9.69 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.694 2.398 . . . . 0.0 107.008 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.15 163.93 39.01 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 126.103 1.761 . . . . 0.0 107.253 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 28.5 m-85 -136.21 145.45 45.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 107.891 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.15 118.43 35.33 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.846 1.259 . . . . 0.0 108.713 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.13 113.16 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -63.12 143.46 57.77 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 70.69 2.82 4.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.304 1.442 . . . . 0.0 112.983 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.69 -110.64 0.86 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 126.922 2.201 . . . . 0.0 114.639 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -122.44 -21.99 5.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.069 1.348 . . . . 0.0 114.36 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -110.01 -10.56 14.7 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.03 -173.47 47.62 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 119.579 1.081 . . . . 0.0 114.145 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.46 -36.32 93.92 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.116 3.211 . . . . 0.0 114.281 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 78.7 mmt-85 -111.32 11.1 21.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.491 1.116 . . . . 0.0 110.769 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.68 156.77 46.09 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.4 t-105 -36.22 -54.54 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 114.538 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.29 -39.4 86.78 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -86.99 -8.56 57.08 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.013 0.925 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.8 t -82.63 6.59 17.29 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.264 1.026 . . . . 0.0 111.028 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m 54.72 57.08 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.993 1.717 . . . . 0.0 108.558 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 98.0 mt -121.67 154.58 60.2 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 126.844 2.058 . . . . 0.0 105.919 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.89 166.1 29.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.9 1.734 . . . . 0.0 110.159 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -159.94 143.09 13.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.847 1.203 . . . . 0.0 111.928 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 mt -95.2 98.07 7.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 0.0 110.173 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.33 141.13 42.33 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.544 0.993 0 C-N-CA 122.538 2.159 . . . . 0.0 106.584 176.845 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 C--O 1.238 0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.77 98.38 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -51.85 158.61 0.98 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.0 110.434 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.67 -49.77 46.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.684 0.674 . . . . 0.0 111.701 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -58.37 -48.36 80.85 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.759 -0.588 . . . . 0.0 110.785 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -52.73 63.86 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 78' ' ' TYR . . . -53.77 -51.24 64.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.53 1.132 . . . . 0.0 110.3 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.0 -41.86 93.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.209 0.603 . . . . 0.0 111.698 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -61.77 -51.63 67.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -62.93 -36.12 82.36 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.769 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.98 -30.59 69.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.088 1.313 . . . . 0.0 108.195 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.48 -24.84 74.09 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 125.266 1.413 . . . . 0.0 113.94 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -100.57 -24.16 14.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.301 1.551 . . . . 0.0 109.923 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.34 170.24 15.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.493 0.588 . . . . 0.0 110.329 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -119.36 -32.76 4.28 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.083 0.953 . . . . 0.0 111.475 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -101.83 -11.76 18.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.45 -0.781 . . . . 0.0 112.832 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.22 58.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.612 0.642 . . . . 0.0 112.466 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -140.02 166.55 24.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.93 125.16 42.7 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.628 1.571 . . . . 0.0 107.419 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.5 97.6 7.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.771 1.628 . . . . 0.0 108.574 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.87 106.2 8.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.1 1.41 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 122.953 0.501 . . . . 0.0 111.738 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -59.19 168.04 1.55 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 126.91 2.084 . . . . 0.0 112.393 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.35 135.97 35.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 m -41.71 -41.22 2.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.187 2.195 . . . . 0.0 114.249 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.34 92.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.621 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -58.86 -29.08 66.7 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.0 -19.27 51.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.091 0.859 . . . . 0.0 109.23 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -104.33 -33.69 8.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.779 2.432 . . . . 0.0 111.916 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -77.91 -44.01 28.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.232 1.013 . . . . 0.0 111.618 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.68 -25.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.492 1.117 . . . . 0.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.52 -163.27 13.55 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.199 0.909 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -143.06 162.97 40.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 122.958 0.503 . . . . 0.0 111.121 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.72 146.46 33.94 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.545 1.497 . . . . 0.0 112.94 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -108.69 76.25 1.01 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.812 2.445 . . . . 0.0 109.659 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 pt -85.57 5.23 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.651 0.739 . . . . 0.0 110.817 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -53.09 -34.51 56.93 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.889 1.676 . . . . 0.0 114.368 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.63 -30.65 69.22 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.061 1.3 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.62 -21.01 49.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.745 0.818 . . . . 0.0 110.129 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 38.18 5.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -126.56 171.03 11.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.822 1.249 . . . . 0.0 111.029 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -143.86 137.73 28.14 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.899 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.14 167.08 22.51 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.2 94.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -62.32 119.87 9.9 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 m -152.26 95.64 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.966 1.307 . . . . 0.0 108.884 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -61.78 122.76 13.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -75.64 154.23 36.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.693 0.397 . . . . 0.0 109.984 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -148.98 127.27 12.16 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.92 -13.3 82.64 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.57 -41.31 10.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.55 1.175 . . . . 0.0 108.15 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.71 29.03 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.744 1.618 . . . . 0.0 111.852 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -43.2 -53.84 10.3 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 120.971 -1.081 . . . . 0.0 111.137 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.09 -49.66 4.64 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.997 1.798 . . . . 0.0 112.136 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -29.47 71.92 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.763 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -69.56 -48.36 60.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.062 1.745 . . . . 0.0 108.657 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.4 -41.59 66.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.321 1.049 . . . . 0.0 111.854 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -59.12 -33.18 70.57 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.572 -0.705 . . . . 0.0 111.741 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -60.03 -16.46 31.15 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.663 0.785 . . . . 0.0 111.92 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.3 -37.58 8.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.349 1.46 . . . . 0.0 109.731 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -25.18 65.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.637 1.562 . . . . 0.0 111.498 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.67 -6.04 41.61 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.585 -0.697 . . . . 0.0 112.03 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 -49.69 2.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.209 1.003 . . . . 0.0 108.455 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.9 m-85 -77.83 103.7 7.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 108.964 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.66 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.756 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -134.45 69.93 72.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.635 1.974 . . . . 0.0 112.861 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 -24.15 64.48 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.989 3.793 . . . . 0.0 111.919 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -53.87 -18.43 3.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 130.792 3.637 . . . . 0.0 113.057 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -134.31 -4.51 2.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.564 1.546 . . . . 0.0 111.689 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 69' ' ' PHE . 22.3 m -76.03 121.79 23.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.607 1.094 . . . . 0.0 110.834 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -89.58 122.77 33.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.433 ' CD1' ' HB1' ' A' ' 12' ' ' ALA . 72.2 m-85 -79.16 105.47 10.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 mt -83.56 129.15 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 119.235 0.925 . . . . 0.0 110.959 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -125.56 125.8 43.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.562 1.145 . . . . 0.0 108.319 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -128.17 177.36 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.961 2.105 . . . . 0.0 107.537 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -58.87 -52.59 65.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.692 -1.255 . . . . 0.0 109.378 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.31 178.77 7.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.691 3.196 . . . . 0.0 104.848 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -24.45 -57.33 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 130.399 3.48 . . . . 0.0 112.979 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.94 -104.33 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.906 2.193 . . . . 0.0 115.499 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -125.13 14.0 8.39 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.899 1.28 . . . . 0.0 112.82 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -51.96 -39.11 58.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.957 1.708 . . . . 0.0 112.068 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.55 -43.59 69.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.194 0.907 . . . . 0.0 110.362 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.27 -49.58 77.03 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.705 0.802 . . . . 0.0 109.733 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.97 -33.91 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.113 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.95 95.58 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.232 0.924 . . . . 0.0 109.34 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -69.02 -47.48 65.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.4 -62.05 1.69 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.941 1.696 . . . . 0.0 113.96 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 m -63.04 -39.02 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 122.584 0.354 . . . . 0.0 111.382 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.89 70.94 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.938 0.774 . . . . 0.0 110.196 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.26 -42.62 99.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.599 0.562 . . . . 0.0 109.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.86 -45.25 95.28 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 -14.97 0.06 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.313 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -71.93 156.04 39.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.217 1.509 . . . . 0.0 108.234 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -58.57 -66.86 0.42 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.879 0.871 . . . . 0.0 111.557 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -159.0 170.6 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.915 1.286 . . . . 0.0 107.584 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.33 163.75 35.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.432 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 42.9 m-85 -133.94 123.37 24.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.79 104.78 15.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.058 0.943 . . . . 0.0 108.856 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.52 109.44 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -59.99 146.45 42.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.43 2.44 1.57 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.503 1.521 . . . . 0.0 114.797 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.31 -111.71 2.21 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.733 1.159 . . . . 0.0 112.297 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.25 -28.52 2.34 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.53 -19.14 26.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.64 163.74 50.11 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 121.042 -1.036 . . . . 0.0 111.492 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.63 -24.96 47.85 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.575 3.517 . . . . 0.0 115.415 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 0.62 24.24 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.048 1.339 . . . . 0.0 110.815 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.92 163.56 54.91 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.663 1.125 . . . . 0.0 111.403 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -29.84 -66.59 0.09 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.57 2.348 . . . . 0.0 115.293 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.1 mt -50.64 -60.93 2.53 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.923 1.289 . . . . 0.0 110.735 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -69.12 -7.45 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.563 1.545 . . . . 0.0 113.806 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.0 t -88.75 8.14 30.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.551 -1.343 . . . . 0.0 111.203 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 t 69.13 47.32 0.74 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.19 157.28 58.73 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.088 1.355 . . . . 0.0 109.22 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.494 ' C ' HD21 ' A' ' 40' ' ' ASN . 30.0 Cg_endo -78.08 165.76 25.65 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.404 2.736 . . . . 0.0 109.479 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -168.37 133.75 1.78 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.804 -1.185 . . . . 0.0 112.463 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.501 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 2.3 mt -74.92 86.94 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.992 1.317 . . . . 0.0 110.439 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 150.52 75.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.679 -0.638 . . . . 0.0 110.535 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo . . . . . 0 CA--C 1.537 0.672 1 C-N-CA 125.313 4.009 . . . . 0.0 109.922 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.239 0.539 0 CA-C-O 121.307 0.575 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.55 -114.71 0.3 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -178.0 169.78 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 131.157 3.783 . . . . 0.0 106.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.69 -51.36 70.27 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.528 0.731 . . . . 0.0 112.451 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -52.31 -53.83 39.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.343 0.52 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -53.7 -51.07 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.935 0.494 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.88 94.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.047 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -56.94 -44.23 82.28 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.783 1.174 . . . . 0.0 110.293 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -63.28 -53.36 54.16 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -56.65 -43.06 79.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.481 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.85 -40.95 85.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.981 2.113 . . . . 0.0 107.937 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.9 -20.42 79.47 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.717 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -106.94 -10.36 16.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.606 1.703 . . . . 0.0 112.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.23 135.27 34.59 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -32.99 37.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -97.61 -13.43 21.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 149.43 26.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -150.0 164.45 35.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 108.309 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -106.04 133.4 50.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.593 1.557 . . . . 0.0 108.299 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.0 tp -122.26 104.8 9.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.903 1.681 . . . . 0.0 110.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.61 111.98 12.68 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.182 1.793 . . . . 0.0 106.978 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.89 3.33 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 118.698 0.681 . . . . 0.0 112.093 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -62.54 167.04 4.66 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.493 1.917 . . . . 0.0 112.58 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.34 133.71 37.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 108.519 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.437 ' HA ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -43.03 -29.27 0.33 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.151 2.58 . . . . 0.0 115.609 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.95 63.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.596 -1.315 . . . . 0.0 110.528 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.52 -27.74 69.47 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.756 -1.215 . . . . 0.0 112.358 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 81.2 m-85 -62.55 -21.07 65.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.886 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -91.75 -35.2 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.802 2.041 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.05 -58.15 3.44 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.935 1.694 . . . . 0.0 112.99 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.68 -19.3 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.99 -159.95 22.23 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.611 1.096 . . . . 0.0 111.808 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 39' ' ' PRO . 39.0 p -142.03 161.6 50.2 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.88 -0.776 . . . . 0.0 112.088 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 38' ' ' SER . 94.2 Cg_endo -71.67 158.15 54.09 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.03 1.153 . . . . 0.0 111.094 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -125.19 74.75 1.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.15 1.78 . . . . 0.0 109.583 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.2 pt -74.97 2.87 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 121.763 -0.585 . . . . 0.0 109.545 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.95 -31.61 65.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.467 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.28 75.81 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.0 -35.9 69.6 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.896 1.279 . . . . 0.0 110.669 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.0 21.62 1.88 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.775 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -123.01 178.57 5.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.383 1.591 . . . . 0.0 111.204 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -137.86 131.55 31.2 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.474 -0.766 . . . . 0.0 110.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.38 168.11 16.73 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.769 0.795 . . . . 0.0 111.125 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.7 138.03 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 127.645 2.378 . . . . 0.0 104.646 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.4 p -117.91 124.37 48.1 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -152.55 102.9 2.76 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -54.61 117.74 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.793 0.837 . . . . 0.0 111.859 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -79.63 134.67 36.45 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.52 119.78 6.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -51.46 -20.65 5.53 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -71.12 -16.65 62.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.538 1.169 . . . . 0.0 112.569 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -133.4 29.31 3.96 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 117.317 -1.325 . . . . 0.0 114.335 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -38.79 -56.14 2.47 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 121.482 1.946 . . . . 0.0 111.532 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.87 -40.82 33.12 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.421 2.747 . . . . 0.0 111.451 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.53 58.64 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.112 1.815 . . . . 0.0 109.844 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.62 -54.24 46.57 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.555 1.942 . . . . 0.0 106.633 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.28 -45.75 62.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.974 0.909 . . . . 0.0 110.112 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.92 -37.45 87.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.042 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -61.12 -31.54 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.052 1.296 . . . . 0.0 108.484 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -43.32 18.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.044 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.31 64.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.188 1.358 . . . . 0.0 112.443 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.24 -9.8 59.71 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.687 1.13 . . . . 0.0 110.968 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -109.04 -43.11 4.26 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.037 1.335 . . . . 0.0 110.363 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 66.6 m-85 -90.72 102.95 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -57.72 -33.26 68.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.478 0.311 . . . . 0.0 111.395 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -131.93 86.41 47.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 123.719 0.808 . . . . 0.0 110.992 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 26.3 Cg_endo -66.72 -33.43 34.88 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.395 2.063 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.22 -23.52 14.96 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.4 1.48 . . . . 0.0 114.623 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -117.28 -6.42 11.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.087 1.312 . . . . 0.0 110.661 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.4 m -94.07 121.6 35.73 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 112.889 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -91.47 131.86 36.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.41 1.084 . . . . 0.0 108.681 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.35 97.35 5.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 111.153 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.91 119.4 19.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.715 0.806 . . . . 0.0 109.084 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 79' ' ' ILE . 1.1 mp -75.56 133.9 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 111.508 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.81 121.83 27.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.45 167.0 16.18 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 108.398 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -61.02 -39.55 90.18 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.988 -1.07 . . . . 0.0 109.411 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -131.92 -136.51 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.635 1.974 . . . . 0.0 106.919 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.93 -55.64 4.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.019 1.328 . . . . 0.0 108.723 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.66 -95.1 0.1 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.811 1.672 . . . . 0.0 113.203 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -145.82 10.79 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 128.097 2.559 . . . . 0.0 110.907 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.2 m -48.54 -40.56 27.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.248 1.419 . . . . 0.0 111.587 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.3 -30.49 71.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.702 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 89' ' ' LEU . 2.5 tm? -83.47 -41.52 17.94 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.06 -34.75 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.9 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.983 1.313 . . . . 0.0 111.239 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -86.68 -44.28 11.95 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 108.979 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -48.79 -61.37 2.08 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 126.718 2.007 . . . . 0.0 112.771 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.14 -37.39 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.571 0.348 . . . . 0.0 111.744 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -53.47 54.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.853 0.721 . . . . 0.0 109.666 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.47 -20.47 65.61 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.483 1.113 . . . . 0.0 112.195 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -84.53 -35.34 22.93 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 111.58 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.42 -8.11 0.46 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.35 -1.805 . . . . 0.0 115.155 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 34.9 m-85 -71.69 153.48 42.02 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 120.425 2.112 . . . . 0.0 109.484 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -56.62 -56.67 18.44 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 m -162.14 171.7 17.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -165.21 115.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.67 140.66 32.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.69 114.32 26.77 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.23 100.55 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -63.21 151.28 40.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 75.37 -1.58 3.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.945 2.098 . . . . 0.0 112.971 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.52 -140.24 48.06 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 119.703 1.138 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.62 -35.46 6.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.837 0.855 . . . . 0.0 111.188 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.2 -15.23 47.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.71 1.204 . . . . 0.0 113.358 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.7 166.32 27.25 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.64 -30.41 90.42 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.466 2.777 . . . . 0.0 113.454 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 20.8 tpt180 -110.63 14.26 22.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.354 1.862 . . . . 0.0 110.179 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.17 170.84 51.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -45.29 -58.68 3.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.6 mt -59.89 -38.22 81.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.557 0.343 . . . . 0.0 110.935 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -88.9 19.84 3.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 111.467 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.4 m -121.42 12.21 10.82 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.526 -1.359 . . . . 0.0 112.289 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.0 m 56.57 55.8 6.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.343 1.057 . . . . 0.0 108.503 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -121.74 150.93 56.55 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' C ' HD21 ' A' ' 40' ' ' ASN . 44.1 Cg_endo -70.31 158.9 54.81 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.634 1.556 . . . . 0.0 109.322 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.501 ' N ' HD21 ' A' ' 40' ' ' ASN . 37.8 t-105 -167.84 132.2 1.77 Allowed 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.388 -1.445 . . . . 0.0 110.749 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.48 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 8.8 mt -71.06 90.77 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.205 1.402 . . . . 0.0 108.443 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.63 151.01 60.92 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 CA--C 1.539 0.746 0 C-N-CA 124.605 3.536 . . . . 0.0 107.712 178.387 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.03 -90.05 0.08 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.591 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.7 t -166.63 167.56 15.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.024 0.929 . . . . 0.0 109.855 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.85 -34.18 75.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -71.19 -49.95 38.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.69 -50.88 62.44 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.169 0.588 . . . . 0.0 110.271 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.82 74.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.067 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.96 -39.68 78.72 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.253 1.388 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -68.79 -46.53 68.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.693 0.797 . . . . 0.0 109.102 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.01 -39.16 93.91 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.032 -1.668 . . . . 0.0 110.97 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.08 -23.53 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.954 1.702 . . . . 0.0 109.551 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.94 -22.92 36.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 -13.1 24.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.588 1.194 . . . . 0.0 110.458 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -114.74 112.35 22.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.911 1.232 . . . . 0.0 110.718 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.55 -36.08 82.6 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.722 1.209 . . . . 0.0 112.653 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -84.18 -17.21 40.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.575 -0.703 . . . . 0.0 112.349 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.0 153.81 32.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.309 0.959 . . . . 0.0 112.513 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -150.25 162.26 40.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.201 1.401 . . . . 0.0 109.388 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.42 154.22 19.0 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 tp -134.41 103.87 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.207 1.403 . . . . 0.0 109.837 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.41 96.63 5.4 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.036 1.334 . . . . 0.0 108.629 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -87.82 -1.33 8.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.6 mtm-85 -69.46 162.57 27.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.969 0.804 . . . . 0.0 109.978 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.73 133.97 51.26 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.34 -22.11 1.03 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.632 1.973 . . . . 0.0 112.38 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.92 88.9 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.285 -1.509 . . . . 0.0 110.16 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -55.15 -40.75 70.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.495 1.518 . . . . 0.0 111.267 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -53.66 -30.13 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.394 1.077 . . . . 0.0 112.066 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -97.3 -20.89 17.56 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 126.549 1.94 . . . . 0.0 112.726 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -101.11 -60.37 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.49 -31.61 4.23 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.758 1.623 . . . . 0.0 111.559 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.35 -163.34 12.26 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.78 158.55 49.29 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.79 157.8 54.49 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.141 1.894 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.531 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -122.39 83.68 2.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.897 2.479 . . . . 0.0 111.961 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -79.58 -0.68 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.394 -1.441 . . . . 0.0 109.747 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -46.12 -40.7 11.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.429 2.692 . . . . 0.0 113.188 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.05 77.07 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.422 -0.654 . . . . 0.0 113.044 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.4 mt -77.57 -40.85 40.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.56 1.03 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.909 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -126.02 -179.1 4.54 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.094 1.447 . . . . 0.0 111.927 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -133.23 144.11 49.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.177 1.391 . . . . 0.0 109.15 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 167.18 14.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 111.98 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -140.54 93.59 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -76.87 102.74 6.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.879 2.072 . . . . 0.0 112.393 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -141.54 98.82 3.43 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.53 125.89 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.221 0.919 . . . . 0.0 110.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -76.02 152.35 36.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.857 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -155.77 116.5 3.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.55 -24.11 61.44 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.539 -0.59 . . . . 0.0 112.192 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.89 -7.01 59.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.035 1.417 . . . . 0.0 110.159 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -126.22 28.95 5.92 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.333 1.453 . . . . 0.0 112.577 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -45.57 -52.38 23.67 Favored Pre-proline 0 N--CA 1.474 0.765 0 O-C-N 120.553 -1.342 . . . . 0.0 112.138 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.78 -44.61 16.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.446 2.097 . . . . 0.0 112.434 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.26 -44.07 96.76 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.71 -54.16 46.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.981 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.93 -43.72 66.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.991 1.716 . . . . 0.0 111.504 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -54.79 -50.56 68.21 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 109.544 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.29 -29.15 57.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -80.6 -51.79 8.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 t -56.36 -23.32 36.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.333 1.453 . . . . 0.0 110.624 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.84 -2.87 43.15 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 -42.52 3.13 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.39 114.4 21.86 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -30.37 71.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.35 70.14 82.22 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.092 1.757 . . . . 0.0 109.312 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 18.8 Cg_endo -57.88 -43.11 52.01 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.381 2.054 . . . . 0.0 111.972 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -62.65 -3.53 1.55 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.301 1.441 . . . . 0.0 113.617 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -127.36 -18.04 4.56 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 111.586 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -90.93 104.76 17.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.401 1.48 . . . . 0.0 111.39 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.2 m -71.72 137.73 47.97 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.852 -1.155 . . . . 0.0 109.679 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -102.72 99.99 10.0 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.202 1.401 . . . . 0.0 113.839 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.98 99.78 8.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mt -79.41 133.58 29.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 123.922 0.889 . . . . 0.0 109.622 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.66 121.22 26.56 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.762 0.825 . . . . 0.0 112.391 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.77 172.3 7.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.069 2.548 . . . . 0.0 107.62 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.25 84.53 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 119.888 -1.757 . . . . 0.0 112.599 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -146.39 -173.22 4.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 130.094 3.358 . . . . 0.0 104.099 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.32 -55.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.641 2.776 . . . . 0.0 113.397 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.96 -101.51 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 128.288 2.851 . . . . 0.0 115.582 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -144.04 -0.21 1.03 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.17 1.388 . . . . 0.0 113.336 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 p -44.62 -44.71 9.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.741 1.155 . . . . 0.0 113.667 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -60.05 -40.34 89.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.782 0.719 . . . . 0.0 112.597 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -71.59 -49.69 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.939 1.696 . . . . 0.0 108.911 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.53 -33.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.231 1.013 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.9 70.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.408 0.549 . . . . 0.0 111.94 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.65 -42.76 13.17 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.363 0.983 . . . . 0.0 108.405 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.8 tp -49.95 -59.34 3.96 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.938 1.695 . . . . 0.0 112.332 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.3 -37.64 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.975 -0.453 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.68 68.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.384 0.674 . . . . 0.0 109.532 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.07 -28.93 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.55 0.74 . . . . 0.0 110.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.82 -33.63 70.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.541 0.61 . . . . 0.0 110.039 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.7 -13.52 0.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.242 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 66.6 m-85 -60.24 146.48 43.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.219 1.509 . . . . 0.0 111.094 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -47.3 -60.19 2.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.701 2.001 . . . . 0.0 112.929 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -167.09 174.75 8.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 126.768 2.027 . . . . 0.0 105.686 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 152.98 36.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -135.62 111.22 9.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.415 0.686 . . . . 0.0 111.26 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.84 133.78 38.1 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 103.24 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -58.09 137.55 56.82 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 36.3 m-20 71.48 15.62 6.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.24 2.216 . . . . 0.0 112.933 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.72 -144.06 7.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.132 1.348 . . . . 0.0 114.913 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.67 -26.51 15.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.52 -1.45 12.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.98 -178.68 8.53 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.75 1.159 . . . . 0.0 114.078 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -29.92 43.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.333 3.355 . . . . 0.0 114.378 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -132.12 12.45 4.68 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.26 1.424 . . . . 0.0 110.296 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.85 174.35 3.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -31.56 -60.87 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.187 1.795 . . . . 0.0 114.327 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.18 -50.93 71.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.507 0.723 . . . . 0.0 111.049 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.92 3.3 5.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.067 1.747 . . . . 0.0 113.772 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.96 13.85 28.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 111.316 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 60.01 46.0 11.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.627 1.171 . . . . 0.0 110.306 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.09 151.18 45.39 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.531 ' C ' HD21 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -73.44 163.96 36.32 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.928 1.752 . . . . 0.0 110.221 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -161.65 128.13 3.81 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.66 -1.275 . . . . 0.0 111.792 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 1.8 mt -73.39 87.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.466 1.906 . . . . 0.0 111.489 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.46 146.0 46.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.864 0.865 . . . . 0.0 110.387 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo . . . . . 0 N--CA 1.45 -1.069 0 C-N-CA 122.649 2.233 . . . . 0.0 108.468 177.59 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p . . . . . 0 C--O 1.238 0.487 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.93 -112.56 0.43 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.454 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 m -152.35 150.33 29.6 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.574 1.55 . . . . 0.0 107.319 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.89 66.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.753 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -51.87 -43.71 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.068 -1.645 . . . . 0.0 113.182 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -53.28 54.76 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -57.11 -37.27 71.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.444 0.465 . . . . 0.0 111.148 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.47 -51.57 42.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.805 1.242 . . . . 0.0 109.087 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -56.57 -40.84 75.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.521 0.601 . . . . 0.0 109.978 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -60.42 -44.18 96.02 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.36 -27.61 64.35 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.192 1.36 . . . . 0.0 109.576 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 -2.13 82.61 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.87 1.7 . . . . 0.0 114.171 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -0.21 6.59 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.832 2.053 . . . . 0.0 109.1 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -138.56 98.5 3.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.276 1.43 . . . . 0.0 110.064 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -62.46 -36.54 82.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.663 1.22 . . . . 0.0 110.297 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.76 -7.78 17.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.803 0.841 . . . . 0.0 111.62 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.32 150.17 21.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 120.364 1.438 . . . . 0.0 110.969 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -139.17 161.45 37.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.489 1.516 . . . . 0.0 109.691 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.9 tm? -106.01 128.82 54.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 24' ' ' LEU . 16.2 tp -118.36 102.3 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.221 1.809 . . . . 0.0 112.65 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.31 116.93 19.08 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.2 4.09 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -62.77 172.98 1.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.06 2.144 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.71 139.41 34.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -45.04 -35.99 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.308 1.843 . . . . 0.0 114.266 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.231 0.923 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.26 -35.33 64.89 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.343 1.057 . . . . 0.0 110.761 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.24 -23.69 64.27 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.378 -0.826 . . . . 0.0 112.253 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mtp85 -104.67 -15.79 15.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.936 1.294 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -89.88 -58.2 2.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.136 1.374 . . . . 0.0 111.007 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.87 -26.53 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.594 0.758 . . . . 0.0 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.03 -162.14 12.45 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 121.609 -0.682 . . . . 0.0 112.764 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -139.36 152.5 69.4 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 123.008 0.523 . . . . 0.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.6 139.63 25.65 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.186 1.924 . . . . 0.0 109.693 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.661 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -110.23 82.22 1.56 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.571 2.749 . . . . 0.0 106.982 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 pt -71.99 1.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 119.953 -1.717 . . . . 0.0 110.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -22.44 51.77 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.091 1.757 . . . . 0.0 112.099 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.79 -40.74 72.98 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.8 mt -75.92 -52.17 10.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.45 -9.37 1.24 Allowed Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.106 1.336 . . . . 0.0 115.519 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -91.5 -169.85 2.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.85 1.325 . . . . 0.0 113.073 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -144.42 139.15 28.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.525 1.13 . . . . 0.0 109.725 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.52 170.47 16.34 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.007 0.908 . . . . 0.0 112.265 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.3 138.42 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -120.3 132.01 55.13 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.748 0.419 . . . . 0.0 109.97 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.3 m -152.44 100.07 2.54 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.47 112.43 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.507 0.723 . . . . 0.0 110.262 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -83.56 148.97 26.88 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -156.54 131.27 8.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.46 2.704 . . . . 0.0 105.557 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.15 -23.27 52.07 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.321 0.962 . . . . 0.0 112.965 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.3 -22.57 63.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.756 1.223 . . . . 0.0 112.019 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -135.69 44.81 2.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -45.09 -56.05 9.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.538 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.18 -40.8 24.45 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.528 2.152 . . . . 0.0 111.317 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.78 61.01 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 124.2 0.905 . . . . 0.0 112.54 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.03 -53.7 4.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.84 -48.88 41.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.127 1.771 . . . . 0.0 111.899 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -54.52 -36.26 64.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 112.715 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.66 -22.49 66.5 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.276 1.03 . . . . 0.0 112.027 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.73 -44.99 8.25 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -52.19 -35.0 47.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.904 2.082 . . . . 0.0 111.459 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.67 -5.5 57.06 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.08 -32.85 4.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.969 0.804 . . . . 0.0 113.122 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 38.3 m-85 -91.02 121.07 32.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -51.89 42.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 110.485 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -113.66 81.91 5.97 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.877 0.871 . . . . 0.0 109.936 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 9.9 Cg_endo -53.54 -36.19 79.47 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.51 2.14 . . . . 0.0 111.391 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.63 -11.58 26.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.089 2.155 . . . . 0.0 111.361 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -130.14 26.9 5.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.872 2.069 . . . . 0.0 110.258 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -137.38 112.92 9.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.721 0.691 . . . . 0.0 109.934 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.9 m -83.34 141.32 31.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.266 0.627 . . . . 0.0 111.572 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -115.33 95.97 5.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.739 2.016 . . . . 0.0 114.843 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 39.8 m-85 -78.63 102.5 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.06 136.72 23.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 123.717 0.807 . . . . 0.0 109.036 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.56 126.02 39.46 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.651 0.781 . . . . 0.0 111.107 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -127.89 166.91 17.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.255 2.622 . . . . 0.0 107.695 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -63.45 -41.67 98.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.563 -1.336 . . . . 0.0 113.733 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -144.97 179.27 7.45 Favored 'General case' 0 C--N 1.322 -0.626 1 C-N-CA 132.828 4.451 . . . . 0.0 103.545 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -34.35 -32.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.958 2.903 . . . . 0.0 117.097 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 24.3 -88.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 130.066 3.698 . . . . 0.0 116.631 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -144.35 0.56 1.03 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.892 1.277 . . . . 0.0 113.314 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.3 p -41.16 -48.6 3.45 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.31 -41.83 84.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.626 1.103 . . . . 0.0 112.105 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.06 -46.2 85.43 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.71 -35.86 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.27 71.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.734 -0.651 . . . . 0.0 110.052 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -46.62 15.97 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.496 1.044 . . . . 0.0 108.913 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.1 tp -46.52 -61.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.77 -42.49 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.168 -0.333 . . . . 0.0 110.3 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.74 88.02 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.608 0.763 . . . . 0.0 110.956 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.16 -43.37 91.97 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.336 0.654 . . . . 0.0 109.332 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -55.78 -39.05 70.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.167 0.44 . . . . 0.0 111.077 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.27 4.4 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.497 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 72' ' ' PRO . 41.4 m-85 -74.58 152.37 39.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.906 1.853 . . . . 0.0 109.558 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -50.82 -70.15 0.09 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.468 2.707 . . . . 0.0 112.95 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -155.8 164.2 38.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.515 1.526 . . . . 0.0 107.85 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.68 17.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -126.14 150.24 48.4 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.179 1.792 . . . . 0.0 108.024 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.68 118.92 36.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -72.1 109.87 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.29 151.43 46.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 63.05 19.33 11.58 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.131 1.373 . . . . 0.0 111.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 34.73 -114.75 0.15 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 129.004 3.192 . . . . 0.0 114.088 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.76 -12.67 4.79 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.874 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.26 -14.91 16.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.587 1.539 . . . . 0.0 110.727 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.78 35.22 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 118.95 0.795 . . . . 0.0 112.567 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.47 -16.89 48.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.647 2.898 . . . . 0.0 113.261 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -119.35 2.6 11.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.476 2.311 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.23 177.13 25.41 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.786 0.721 . . . . 0.0 112.454 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -41.38 -61.5 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.421 1.888 . . . . 0.0 113.029 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.0 mt -57.58 -36.63 71.95 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.005 1.322 . . . . 0.0 113.587 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -96.08 10.79 36.44 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.893 1.277 . . . . 0.0 111.726 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.2 t -113.73 24.41 12.16 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.499 -1.375 . . . . 0.0 111.614 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 m 63.06 22.87 13.67 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.367 1.867 . . . . 0.0 113.609 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.3 mt -92.37 160.19 35.5 Favored Pre-proline 0 C--N 1.334 -0.091 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.661 ' C ' HD21 ' A' ' 40' ' ' ASN . 71.6 Cg_endo -80.71 166.1 19.7 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.082 1.855 . . . . 0.0 108.922 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.422 ' N ' HD21 ' A' ' 40' ' ' ASN . 48.1 t-105 -167.49 134.27 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.528 -1.982 . . . . 0.0 112.653 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.1 mt -77.07 88.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.645 1.578 . . . . 0.0 108.809 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.85 144.55 48.31 Favored Pre-proline 0 C--O 1.245 0.863 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 123.669 2.913 . . . . 0.0 109.32 179.19 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 121.753 0.787 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.73 -125.84 1.32 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m -138.89 160.53 39.5 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.798 1.239 . . . . 0.0 111.641 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.62 -54.71 13.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.871 2.468 . . . . 0.0 114.339 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -60.36 -39.87 88.74 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.839 1.654 . . . . 0.0 112.837 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -47.92 84.21 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.22 96.6 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.191 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CG ' HD22 ' A' ' 120' ' ' LEU . 71.8 t80 -61.85 -40.36 95.06 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.091 0.86 . . . . 0.0 109.95 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 m -61.97 -50.91 70.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -57.0 -47.65 80.34 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.26 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mt -52.29 -32.56 38.16 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.008 1.723 . . . . 0.0 113.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.14 -14.06 70.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.762 0.71 . . . . 0.0 112.934 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.3 -24.23 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 110.458 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -100.99 99.63 10.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.613 1.565 . . . . 0.0 108.371 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.48 -50.51 59.71 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.371 -0.831 . . . . 0.0 112.551 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -2.47 17.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.974 1.31 . . . . 0.0 113.856 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -78.18 128.39 33.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.932 0.787 . . . . 0.0 109.105 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -138.81 139.0 38.07 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -76.13 128.87 35.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 108.618 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.0 tp -117.23 109.63 17.11 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.687 1.595 . . . . 0.0 111.269 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 98.77 5.51 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.141 1.376 . . . . 0.0 108.412 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -86.63 -3.83 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 118.926 0.784 . . . . 0.0 111.235 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -63.52 163.68 10.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 125.902 1.681 . . . . 0.0 111.431 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.87 148.39 27.73 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.097 1.427 . . . . 0.0 108.984 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -42.41 -43.19 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 129.72 3.208 . . . . 0.0 111.529 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.69 -40.4 65.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.878 1.271 . . . . 0.0 112.914 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.5 m-20 -64.16 -35.22 80.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 38' ' ' SER . 13.9 m-85 -61.06 -27.62 68.48 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.098 -1.626 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -89.1 -23.93 22.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.563 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.11 -35.71 7.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.8 p -117.9 -13.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.532 1.133 . . . . 0.0 112.948 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.4 -163.01 29.8 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . 2.5 p -135.74 157.17 76.7 Favored Pre-proline 0 CA--C 1.511 -0.528 0 O-C-N 122.354 -0.498 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.88 172.33 16.09 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.382 1.388 . . . . 0.0 109.454 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.53 ' HB3' HG13 ' A' ' 123' ' ' ILE . 6.4 p30 -146.36 167.56 23.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 46' ' ' LYS . 5.1 pt -145.0 20.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 127.475 2.31 . . . . 0.0 107.618 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.57 64.37 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.076 2.15 . . . . 0.0 114.142 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -33.73 78.92 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.66 -23.44 36.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 109.347 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 23.1 24.13 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 125.198 1.38 . . . . 0.0 111.327 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' HD12 ' A' ' 41' ' ' ILE . 32.0 mmtp -106.04 173.08 6.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.356 1.862 . . . . 0.0 107.807 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -143.23 124.98 14.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.252 1.387 . . . . 0.0 109.625 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.03 171.02 7.36 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.09 136.15 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.753 1.621 . . . . 0.0 106.666 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 p -103.04 110.38 22.28 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.035 1.734 . . . . 0.0 110.884 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -149.97 98.32 2.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.69 117.74 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 122.229 -0.294 . . . . 0.0 110.847 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -81.29 142.91 32.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -154.2 140.7 18.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.45 -13.9 74.35 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.177 -1.346 . . . . 0.0 115.124 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -79.67 -15.95 56.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.509 1.654 . . . . 0.0 111.642 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -138.52 43.5 2.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.357 1.435 . . . . 0.0 111.189 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -45.05 -53.58 16.05 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.869 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.63 -39.28 36.03 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.844 1.696 . . . . 0.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.86 -14.67 73.26 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.273 -0.892 . . . . 0.0 112.671 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.9 -52.21 5.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -50.82 -48.38 59.76 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.794 1.638 . . . . 0.0 111.801 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.85 -36.15 69.68 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -58.74 -26.32 63.86 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.095 0.558 . . . . 0.0 110.648 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.51 -49.43 7.2 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.43 -30.63 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.07 0.85 . . . . 0.0 113.115 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.53 -23.39 62.63 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.819 -1.176 . . . . 0.0 110.249 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -41.34 8.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.635 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD1' HG21 ' A' ' 75' ' ' THR . 65.8 m-85 -85.68 99.42 11.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.464 1.106 . . . . 0.0 108.855 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -19.43 47.78 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.23 78.88 27.28 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.209 1.404 . . . . 0.0 107.548 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.55 -39.04 57.97 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.679 1.586 . . . . 0.0 111.05 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.53 -22.01 2.88 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 127.068 2.147 . . . . 0.0 114.981 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -120.94 -9.08 9.3 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.097 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 69' ' ' PHE . 90.1 m -82.76 136.54 34.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.646 1.178 . . . . 0.0 109.156 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -111.1 125.37 53.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.9 mt -98.53 96.43 7.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.997 1.319 . . . . 0.0 112.526 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.44 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 13.8 m-85 -80.07 106.76 12.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.505 HG21 ' HA ' ' A' ' 87' ' ' SER . 1.2 mm -67.36 145.37 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.33 1.052 . . . . 0.0 112.725 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.29 112.88 7.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -119.09 164.52 15.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.65 1.18 . . . . 0.0 108.511 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -53.5 -41.81 66.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.38 1.072 . . . . 0.0 109.736 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.98 -143.98 0.21 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.785 2.034 . . . . 0.0 106.943 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -75.57 -36.3 60.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.568 1.547 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.9 -103.67 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 130.432 3.872 . . . . 0.0 116.032 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.32 9.26 10.35 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.044 0.937 . . . . 0.0 113.352 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 79' ' ' ILE . 13.7 m -46.71 -52.02 14.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.48 -33.26 75.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.033 0.933 . . . . 0.0 111.699 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.15 -52.0 13.84 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.631 0.772 . . . . 0.0 109.77 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.57 -31.07 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.494 1.117 . . . . 0.0 110.277 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.38 93.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.879 0.763 . . . . 0.0 108.951 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -73.2 -36.58 66.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.34 -59.0 5.13 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.9 0.88 . . . . 0.0 111.309 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.8 m -62.64 -39.26 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 121.909 -0.494 . . . . 0.0 111.072 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.55 -50.22 72.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.964 0.906 . . . . 0.0 111.436 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.29 -28.81 68.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.481 1.112 . . . . 0.0 110.623 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.78 -54.57 13.06 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.89 2.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 CA-C-O 118.196 -1.335 . . . . 0.0 115.67 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.54 157.16 34.3 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 120.04 1.92 . . . . 0.0 106.755 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -53.36 -63.66 1.08 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.193 0.597 . . . . 0.0 110.235 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.7 t -161.53 -179.8 7.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.317 1.847 . . . . 0.0 106.09 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.47 20.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -118.16 123.8 46.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.5 101.66 14.32 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.32 116.89 13.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -72.46 156.52 38.96 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.82 8.91 5.54 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.114 1.766 . . . . 0.0 115.101 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.27 -127.46 21.45 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.61 -35.88 4.1 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.478 0.711 . . . . 0.0 109.565 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.28 -17.19 61.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.195 2.198 . . . . 0.0 114.28 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.1 172.46 46.98 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.18 0.9 . . . . 0.0 114.481 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.8 -30.71 58.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 125.172 3.915 . . . . 0.0 115.768 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.253 0.0 OUTLIER -131.49 20.7 4.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.025 1.33 . . . . 0.0 109.178 177.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.99 166.62 40.29 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -34.28 -50.94 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.65 -50.7 72.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.23 0.923 . . . . 0.0 110.058 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.79 -0.38 34.21 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.029 2.132 . . . . 0.0 113.403 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -91.77 6.53 45.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.666 1.986 . . . . 0.0 111.629 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t 60.7 46.09 9.48 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 13' ' ' TYR . 88.3 mt -123.34 145.26 46.04 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.016 0.926 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.81 147.05 84.98 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.291 2.661 . . . . 0.0 110.211 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -148.49 139.57 23.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.596 1.559 . . . . 0.0 110.825 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 40' ' ' ASN . 3.6 mt -78.9 91.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.486 1.114 . . . . 0.0 109.669 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.6 153.86 95.32 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.379 -0.826 . . . . 0.0 110.74 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo . . . . . 0 CA--C 1.537 0.649 1 C-N-CA 125.32 4.014 . . . . 0.0 110.198 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.237 0.408 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.01 -106.02 0.22 Allowed Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.375 -0.828 . . . . 0.0 115.079 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -153.67 154.11 33.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 118.298 1.049 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.62 91.75 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -65.47 -49.28 69.69 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.042 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.92 -44.96 91.35 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -59.03 -41.11 87.0 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.238 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.44 -41.93 96.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.815 0.734 . . . . 0.0 109.835 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -60.92 -46.47 90.55 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.33 -48.37 82.03 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.995 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.2 mt -56.75 -22.03 32.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.515 1.507 . . . . 0.0 113.115 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.61 -7.06 60.53 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.391 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t -126.08 -10.16 6.51 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.779 1.289 . . . . 0.0 110.223 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.07 95.23 5.45 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -12.85 12.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -106.4 -7.52 17.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.279 1.432 . . . . 0.0 111.129 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.16 148.86 41.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.24 152.32 36.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.043 1.737 . . . . 0.0 108.705 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -94.82 151.55 19.15 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 tp -140.13 101.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.368 1.467 . . . . 0.0 111.14 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.17 110.25 18.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.937 2.495 . . . . 0.0 107.378 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -103.68 3.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -61.83 167.32 3.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.22 141.12 43.6 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 m -46.81 -34.02 4.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.184 2.193 . . . . 0.0 112.478 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.61 76.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 119.259 0.936 . . . . 0.0 111.643 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.87 -36.48 84.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 79.4 m-85 -65.56 -6.04 9.8 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.855 -1.153 . . . . 0.0 111.997 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -112.93 -10.49 13.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.914 1.234 . . . . 0.0 111.643 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -115.6 -43.66 3.02 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.63 -16.81 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.904 1.281 . . . . 0.0 113.789 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.32 -153.81 20.3 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 121.219 -0.925 . . . . 0.0 112.297 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 p -143.48 158.09 58.03 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 111.129 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.85 172.17 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 N-CA-C 109.269 -1.089 . . . . 0.0 109.269 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 148.94 35.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.543 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.0 pt -140.85 15.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.287 1.835 . . . . 0.0 110.088 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -56.09 -31.05 62.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.573 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.35 -22.53 71.21 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 120.457 1.48 . . . . 0.0 110.735 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.31 -17.25 37.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.845 1.258 . . . . 0.0 110.274 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.25 33.65 7.12 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.166 1.365 . . . . 0.0 109.889 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -136.25 175.08 9.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.158 1.383 . . . . 0.0 109.578 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -140.81 160.15 40.67 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.82 0.736 . . . . 0.0 110.405 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.5 163.79 20.24 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.82 88.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 7.7 p -58.02 108.71 0.62 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.51 0.724 . . . . 0.0 109.287 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -136.55 89.41 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.58 112.02 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 124.091 0.956 . . . . 0.0 108.493 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.53 149.1 30.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -159.73 145.63 15.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.347 2.259 . . . . 0.0 107.775 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.86 -26.73 61.91 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.22 -5.41 18.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.046 2.138 . . . . 0.0 113.965 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.44 31.97 0.73 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.527 0.731 . . . . 0.0 109.797 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -38.32 -57.01 1.94 Allowed Pre-proline 0 N--CA 1.475 0.824 0 CA-C-O 117.806 -1.092 . . . . 0.0 111.846 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.99 -48.16 9.05 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.493 2.795 . . . . 0.0 111.991 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.94 -50.15 62.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.3 -53.95 49.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.095 1.758 . . . . 0.0 108.427 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.44 -48.0 69.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.859 1.264 . . . . 0.0 111.672 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -55.95 -35.56 66.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.796 0.839 . . . . 0.0 110.007 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -60.72 -29.2 69.21 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.709 1.14 . . . . 0.0 111.226 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 -46.44 13.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -54.36 -34.05 60.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.956 1.302 . . . . 0.0 111.624 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.75 -8.03 58.35 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.065 -1.022 . . . . 0.0 113.222 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -46.83 2.99 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.328 0.967 . . . . 0.0 112.417 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.78 120.84 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -29.44 64.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -129.0 68.65 80.12 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 126.842 2.057 . . . . 0.0 110.026 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.18 -41.34 79.52 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.2 -15.35 14.54 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.45 -14.09 10.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -86.72 124.21 32.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.226 1.376 . . . . 0.0 111.403 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.7 m -88.47 134.61 33.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.84 96.87 6.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.282 0.946 . . . . 0.0 109.239 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.489 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 42.2 m-85 -75.19 113.98 13.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.615 1.966 . . . . 0.0 109.006 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.66 144.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.185 1.357 . . . . 0.0 111.836 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.64 83.69 1.91 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.346 0.658 . . . . 0.0 110.639 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.98 176.5 7.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -53.29 -50.99 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.903 1.281 . . . . 0.0 110.342 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.58 -141.2 0.21 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.58 -40.54 88.99 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 40.94 -127.52 3.24 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.297 1.903 . . . . 0.0 113.741 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.23 3.8 35.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.271 1.028 . . . . 0.0 113.211 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.1 m -40.69 -61.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.103 2.261 . . . . 0.0 117.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -53.28 -37.73 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.167 0.987 . . . . 0.0 111.886 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.01 -46.99 61.27 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.85 -28.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.023 -1.048 . . . . 0.0 109.793 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.53 -36.03 78.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.972 0.805 . . . . 0.0 109.676 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.34 -41.36 28.08 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.449 -0.782 . . . . 0.0 109.665 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.6 tp -49.82 -60.82 2.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.056 2.143 . . . . 0.0 113.393 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.36 -40.96 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.037 0.535 . . . . 0.0 110.758 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -48.88 78.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.082 0.553 . . . . 0.0 109.85 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.17 -28.32 69.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -74.41 -43.32 56.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.292 0.496 . . . . 0.0 110.743 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.08 -5.74 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 CA-C-O 117.508 -1.718 . . . . 0.0 113.631 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.33 160.37 27.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 120.297 2.049 . . . . 0.0 110.396 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.62 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -59.04 -69.77 0.18 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.25 0.62 . . . . 0.0 112.038 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -155.0 -178.22 7.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.429 1.892 . . . . 0.0 108.809 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.9 154.37 27.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.47 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -142.77 111.99 6.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 128.387 2.675 . . . . 0.0 108.737 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.15 119.73 23.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.038 0.935 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.3 108.82 4.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.32 151.31 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 73.34 0.32 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.925 1.69 . . . . 0.0 111.86 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.59 -122.09 14.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.805 1.193 . . . . 0.0 110.997 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.67 -24.41 4.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.442 1.497 . . . . 0.0 111.465 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.11 -11.91 23.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.647 1.579 . . . . 0.0 114.38 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.53 174.3 39.0 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.818 0.736 . . . . 0.0 112.349 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.27 -28.14 86.26 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.543 2.829 . . . . 0.0 113.387 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -117.44 1.06 12.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 110.613 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.05 160.12 1.72 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.173 -0.954 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -25.94 -62.52 0.07 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.163 2.185 . . . . 0.0 115.622 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.18 -60.17 3.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.323 1.049 . . . . 0.0 109.265 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.05 -2.78 2.15 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.94 1.696 . . . . 0.0 113.022 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.35 12.82 31.78 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.249 -1.532 . . . . 0.0 109.555 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.1 t 66.38 12.55 8.72 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.327 1.851 . . . . 0.0 112.103 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.59 157.34 72.44 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.787 0.835 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.74 147.2 21.64 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.101 1.867 . . . . 0.0 110.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -144.25 144.14 31.37 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.97 87.13 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.205 1.002 . . . . 0.0 108.857 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.59 147.31 78.25 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.457 -0.626 0 C-N-CA 124.073 3.182 . . . . 0.0 112.505 -179.69 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.342 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.04 100.92 0.25 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.53 146.21 0.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.563 1.545 . . . . 0.0 110.821 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -38.78 -54.43 1.6 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -58.07 -49.78 75.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.021 1.282 . . . . 0.0 111.081 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -51.79 66.61 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.959 0.904 . . . . 0.0 109.176 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.99 73.11 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.868 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.66 -49.34 77.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.38 0.991 . . . . 0.0 109.39 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -62.3 -41.42 98.5 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.69 -0.631 . . . . 0.0 109.881 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.36 -41.51 97.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.209 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.39 -27.87 69.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 111.361 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 -21.99 45.03 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.901 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -98.35 -18.11 18.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.642 1.221 . . . . 0.0 110.903 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 11.2 t70 -101.6 110.37 22.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -38.41 -53.97 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.28 2.232 . . . . 0.0 114.98 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -101.37 13.61 34.51 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -67.88 124.67 23.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.936 -1.102 . . . . 0.0 111.507 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -128.84 144.55 51.2 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.064 0.945 . . . . 0.0 109.731 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.83 144.24 28.56 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.8 tp -127.08 107.2 9.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.658 1.583 . . . . 0.0 109.206 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -80.34 132.75 35.84 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.6 pt -119.67 13.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.827 0.74 . . . . 0.0 111.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -74.89 170.53 15.75 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.838 1.199 . . . . 0.0 110.08 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.5 142.23 44.83 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.62 -41.97 23.15 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.541 2.336 . . . . 0.0 112.68 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.13 73.81 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.53 -0.731 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -66.8 -27.42 67.56 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.572 0.749 . . . . 0.0 111.257 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -64.42 -16.62 62.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.159 -1.588 . . . . 0.0 110.452 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -104.89 -22.04 13.22 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.38 1.472 . . . . 0.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.75 -52.77 4.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.207 1.003 . . . . 0.0 112.22 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.8 -29.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.042 1.737 . . . . 0.0 112.259 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.84 -151.75 17.7 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.276 0.944 . . . . 0.0 112.12 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -147.49 156.16 45.61 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.903 0.881 . . . . 0.0 109.839 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.96 176.28 10.33 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.85 1.7 . . . . 0.0 109.75 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.2 142.96 37.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.923 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.95 12.16 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.734 2.014 . . . . 0.0 111.305 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -37.45 67.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 117.638 -1.172 . . . . 0.0 113.524 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.61 -35.33 85.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.61 -16.24 61.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.209 0.604 . . . . 0.0 110.57 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 45.66 5.89 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 106.606 -2.598 . . . . 0.0 106.606 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -135.47 168.1 19.84 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.608 0.763 . . . . 0.0 110.736 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -145.18 122.42 11.53 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.224 -0.922 . . . . 0.0 110.359 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.78 172.6 10.48 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.784 1.278 . . . . 0.0 112.265 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.89 146.64 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 m -129.13 117.81 21.43 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.926 -1.109 . . . . 0.0 111.38 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -147.73 115.77 6.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.399 1.08 . . . . 0.0 110.356 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.92 129.16 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 120.004 1.275 . . . . 0.0 109.221 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.03 166.83 22.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.23 125.63 0.91 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.78 -20.56 57.13 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.148 0.885 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -84.22 -11.7 56.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.579 1.189 . . . . 0.0 111.621 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -127.47 36.98 4.31 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.522 1.129 . . . . 0.0 111.375 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -48.12 -57.67 9.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.101 1.318 . . . . 0.0 111.847 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.46 -37.67 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.644 2.229 . . . . 0.0 110.623 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.5 -23.55 66.89 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.509 0.576 . . . . 0.0 112.958 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -87.4 -41.5 13.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.279 1.432 . . . . 0.0 107.28 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.74 -46.67 88.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.784 1.234 . . . . 0.0 112.067 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -54.68 -33.7 61.24 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.048 0.539 . . . . 0.0 111.257 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -60.04 -27.33 66.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.856 0.863 . . . . 0.0 110.99 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.12 -43.19 9.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -31.04 66.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.535 -0.728 . . . . 0.0 112.322 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 -7.23 52.14 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.063 -1.023 . . . . 0.0 112.405 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.76 -48.19 2.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.564 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 69.7 m-85 -77.79 107.56 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.733 1.213 . . . . 0.0 109.499 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -72.68 -17.49 61.63 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.483 0.713 . . . . 0.0 112.106 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -148.04 77.31 10.11 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 126.234 1.814 . . . . 0.0 109.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.25 -29.51 73.29 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.752 2.301 . . . . 0.0 110.645 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -53.85 -18.61 3.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.152 2.181 . . . . 0.0 113.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -125.93 3.98 7.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 0.0 112.39 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 m -109.38 121.77 45.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.382 1.473 . . . . 0.0 112.143 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.0 m -91.0 130.92 36.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.69 0.796 . . . . 0.0 110.169 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.53 105.99 15.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.62 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 23.7 m-85 -85.67 110.53 19.36 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.37 134.38 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.012 1.325 . . . . 0.0 111.425 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.54 128.9 30.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.469 1.108 . . . . 0.0 109.337 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -130.7 174.78 9.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.908 1.683 . . . . 0.0 108.369 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -52.84 -52.15 58.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.746 1.218 . . . . 0.0 109.382 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -144.53 174.93 10.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.275 3.83 . . . . 0.0 105.164 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -17.81 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 128.85 2.86 . . . . 0.0 112.508 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.04 -103.22 0.12 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 126.204 1.859 . . . . 0.0 110.39 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -128.9 9.54 5.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.807 1.243 . . . . 0.0 112.38 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -39.01 -51.97 1.81 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.315 1.846 . . . . 0.0 113.791 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.63 -45.95 87.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -39.61 93.95 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.756 0.422 . . . . 0.0 110.938 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.33 -25.58 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.949 -0.469 . . . . 0.0 109.74 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.43 65.25 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.536 -0.727 . . . . 0.0 111.158 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.04 -36.59 61.85 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.007 -0.433 . . . . 0.0 110.87 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.41 -56.79 13.91 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.774 1.229 . . . . 0.0 112.227 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.25 -39.4 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.316 0.647 . . . . 0.0 111.425 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.55 73.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.01 -25.24 65.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.545 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -80.21 -23.79 40.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.43 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.11 1.84 3.15 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 119.956 1.253 . . . . 0.0 115.546 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -76.67 153.59 35.03 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.756 1.778 . . . . 0.0 110.099 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -51.21 -65.88 0.48 Allowed 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 126.785 2.034 . . . . 0.0 112.466 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 m -157.47 171.96 19.42 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.312 1.845 . . . . 0.0 108.29 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.51 140.16 14.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.45 142.85 49.63 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 108.618 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.7 113.56 26.91 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.2 108.12 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 0.0 110.036 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -71.17 141.77 50.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 72.82 22.46 3.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.746 2.818 . . . . 0.0 109.764 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 27.82 -113.02 0.03 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.002 2.239 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -119.18 -54.93 2.18 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.864 1.266 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.44 8.75 4.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.314 1.846 . . . . 0.0 114.045 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.06 173.52 55.34 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.066 -1.021 . . . . 0.0 112.475 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.42 -34.98 98.85 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.714 2.943 . . . . 0.0 111.674 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -129.88 22.14 5.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.114 0.966 . . . . 0.0 110.192 177.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.24 168.36 16.04 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -29.45 -53.61 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.27 -59.26 5.69 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.227 0.922 . . . . 0.0 109.302 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.03 3.53 4.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.195 1.798 . . . . 0.0 112.269 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 t -95.43 11.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.717 2.007 . . . . 0.0 111.539 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 27.86 15.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.352 1.061 . . . . 0.0 111.659 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.1 mt -107.99 153.77 41.52 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.119 0.968 . . . . 0.0 109.507 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.47 154.4 27.7 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.199 1.933 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -147.69 144.35 28.27 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 111.477 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.21 88.73 2.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 126.016 1.726 . . . . 0.0 108.83 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -77.25 153.54 82.11 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.423 0.689 . . . . 0.0 111.715 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 123.965 3.11 . . . . 0.0 108.501 177.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.447 -0.603 0 CA-C-O 122.289 1.042 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.34 -115.18 0.41 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -160.06 169.99 22.23 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.855 -1.38 . . . . 0.0 109.329 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.23 -46.03 92.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -49.74 -52.06 34.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 111.099 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -54.97 -59.78 4.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.222 1.009 . . . . 0.0 110.08 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.84 -41.13 67.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.084 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.19 -48.01 79.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.556 1.071 . . . . 0.0 112.91 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.0 m -68.2 -41.37 81.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 18' ' ' THR . 20.5 mmtp -60.74 -31.69 70.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.969 0.804 . . . . 0.0 111.975 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.21 -17.01 60.44 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.391 1.876 . . . . 0.0 110.841 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.1 -52.49 2.21 Favored Glycine 0 CA--C 1.506 -0.494 0 C-N-CA 126.006 1.765 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -64.22 -15.31 59.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.609 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -119.17 128.36 54.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 108.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.43 -39.69 38.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.633 0.651 . . . . 0.0 112.466 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.11 -14.08 60.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.95 1.3 . . . . 0.0 112.423 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -68.86 131.54 45.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.244 1.418 . . . . 0.0 110.388 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -138.86 142.69 38.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.413 0.625 . . . . 0.0 111.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.3 tm? -76.88 131.26 38.5 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HD12 ' A' ' 77' ' ' LEU . 40.0 tp -112.13 95.89 5.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.15 2.18 . . . . 0.0 107.552 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -75.63 109.48 9.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.95 0.38 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 HD22 ' A' ' 80' ' ' LEU . 46.8 mtm-85 -69.46 162.8 26.68 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.071 0.85 . . . . 0.0 110.485 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.09 136.66 56.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -52.34 -23.22 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 111.406 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.66 79.55 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.531 -1.356 . . . . 0.0 110.701 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.54 -33.84 76.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.006 1.722 . . . . 0.0 109.972 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.42 -18.9 53.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -95.59 -37.14 10.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.053 1.741 . . . . 0.0 109.984 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -81.29 -50.52 9.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.9 -23.33 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 113.85 -177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.13 -157.97 22.23 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 p -139.21 160.82 60.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.56 176.53 7.26 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.165 1.91 . . . . 0.0 109.009 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.471 ' HB3' HG13 ' A' ' 123' ' ' ILE 0.261 8.5 p30 -141.61 114.09 8.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 122.069 0.938 . . . . 0.0 111.973 177.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -85.57 8.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 122.188 0.994 . . . . 0.0 109.255 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -55.44 -28.07 52.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.817 1.647 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.42 -48.81 47.45 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.91 -46.65 62.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.646 1.178 . . . . 0.0 108.448 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.08 40.62 0.69 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.73 1.633 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.14 -176.38 3.11 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.1 0.96 . . . . 0.0 111.437 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.62 116.72 10.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.356 0.98 . . . . 0.0 110.992 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.65 152.25 39.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.592 0.757 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -108.85 91.15 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 110.314 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -57.96 102.43 0.1 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 127.171 2.188 . . . . 0.0 110.298 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -143.09 97.41 3.09 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.633 0.773 . . . . 0.0 109.757 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.15 119.82 3.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.348 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -74.94 154.52 38.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -156.09 118.7 4.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -22.93 68.06 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.115 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -82.5 -6.12 59.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.615 1.207 . . . . 0.0 110.952 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.37 39.61 2.67 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.032 0.833 . . . . 0.0 110.553 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -43.02 -60.83 2.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 120.762 -1.211 . . . . 0.0 113.622 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -67.2 -43.47 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.585 2.857 . . . . 0.0 111.42 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.03 -47.34 81.0 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.42 -50.62 72.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.533 1.533 . . . . 0.0 108.026 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.4 -39.59 70.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.465 0.706 . . . . 0.0 111.049 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -37.46 78.72 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.779 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.54 -24.17 44.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.432 1.093 . . . . 0.0 111.894 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.08 -44.09 7.47 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t -54.28 -33.01 57.73 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.654 1.182 . . . . 0.0 111.498 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.92 -2.92 39.18 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -121.32 -40.23 2.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.967 0.803 . . . . 0.0 112.564 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CD1' HG21 ' A' ' 75' ' ' THR . 64.1 m-85 -79.94 111.99 16.8 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -18.58 62.22 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.069 0.548 . . . . 0.0 111.315 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 78.26 11.06 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 125.815 1.646 . . . . 0.0 108.44 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.29 -32.97 97.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.47 2.113 . . . . 0.0 110.961 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -57.97 -18.75 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.354 3.062 . . . . 0.0 113.089 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.61 -4.71 9.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.918 . . . . 0.0 111.419 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 69' ' ' PHE . 29.2 m -95.16 113.92 25.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 0.0 112.296 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.6 m -86.75 129.16 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -100.42 99.14 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.532 1.533 . . . . 0.0 111.768 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 37.5 m-85 -84.34 98.6 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -68.0 157.58 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.559 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.542 HD22 HH11 ' A' ' 28' ' ' ARG . 6.7 tt -152.47 112.06 3.93 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.773 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.79 173.3 6.44 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -31.05 70.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.93 -1.731 . . . . 0.0 111.409 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -138.6 -152.71 0.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.034 2.134 . . . . 0.0 106.48 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.11 -18.33 62.53 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.896 2.079 . . . . 0.0 113.58 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.96 -97.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.798 3.571 . . . . 0.0 115.913 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -129.62 6.89 5.22 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.363 1.865 . . . . 0.0 110.957 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -42.91 -47.4 5.64 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.26 1.824 . . . . 0.0 113.487 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.5 -43.64 84.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.424 1.09 . . . . 0.0 111.26 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.46 -49.05 58.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.342 1.057 . . . . 0.0 109.49 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.09 -31.56 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.563 0.745 . . . . 0.0 109.142 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.62 87.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.857 0.753 . . . . 0.0 110.162 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.87 74.26 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -50.39 -57.52 7.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.884 1.674 . . . . 0.0 112.557 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.91 -40.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.12 78.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.068 0.547 . . . . 0.0 109.808 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.15 -38.31 90.61 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.81 -23.38 67.22 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 117.66 -1.162 . . . . 0.0 113.265 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.98 1.32 4.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 117.871 -1.516 . . . . 0.0 113.46 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -76.11 157.67 32.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.15 1.475 . . . . 0.0 108.473 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -49.79 -71.07 0.07 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 127.445 2.298 . . . . 0.0 110.087 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 m -163.62 -178.86 6.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 126.674 1.99 . . . . 0.0 106.857 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.8 164.64 38.29 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -136.99 142.88 42.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.26 110.3 22.3 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 124.734 1.271 . . . . 0.0 107.784 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.95 106.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -68.63 144.01 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 82.24 -2.09 1.45 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.598 1.959 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.14 -102.61 0.07 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 126.449 1.976 . . . . 0.0 114.532 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.31 -43.52 2.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.674 1.59 . . . . 0.0 110.656 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.88 -28.79 39.87 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.0 171.82 41.58 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 121.151 1.796 . . . . 0.0 111.811 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.54 -15.37 35.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.798 3.665 . . . . 0.0 116.052 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 48.7 mmt-85 -115.78 5.64 14.2 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 111.112 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.45 163.23 54.78 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -46.52 -45.28 18.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -66.93 -39.89 87.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.247 0.476 . . . . 0.0 111.038 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -87.67 23.26 2.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.8 1.64 . . . . 0.0 111.433 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 t -120.51 6.56 10.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.445 1.098 . . . . 0.0 112.819 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 56.86 48.5 15.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.991 0.917 . . . . 0.0 109.363 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.1 mt -116.53 160.74 35.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.81 145.01 17.65 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.123 1.882 . . . . 0.0 110.149 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -144.0 132.2 21.86 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.987 -1.071 . . . . 0.0 110.833 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 40' ' ' ASN . 6.6 mt -75.27 90.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.567 1.547 . . . . 0.0 110.082 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -83.49 143.9 45.19 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.809 -1.182 . . . . 0.0 110.94 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 125.03 3.82 . . . . 0.0 109.488 179.031 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.3 p . . . . . 0 C--O 1.239 0.545 0 CA-C-O 122.128 0.966 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.57 -116.82 0.5 Allowed Glycine 0 N--CA 1.445 -0.748 0 O-C-N 121.545 -0.722 . . . . 0.0 111.752 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -142.45 157.3 44.9 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.877 0.871 . . . . 0.0 112.439 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.45 90.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.374 1.469 . . . . 0.0 113.46 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.53 -52.66 64.7 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.841 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.82 -42.95 85.0 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.182 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.27 75.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.583 0.628 . . . . 0.0 111.283 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.23 -47.55 79.26 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -60.73 -40.67 93.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.308 0.243 . . . . 0.0 110.494 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.5 mmpt? -58.94 -43.77 91.26 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.446 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.26 -23.95 62.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.289 1.404 . . . . 0.0 111.121 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.06 4.38 62.75 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.435 1.493 . . . . 0.0 112.505 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.12 -4.72 3.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.121 1.768 . . . . 0.0 110.778 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -124.53 106.12 9.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.1 -18.19 2.0 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -122.57 5.48 9.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.397 0.999 . . . . 0.0 113.155 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.67 50.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.635 1.107 . . . . 0.0 108.442 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -140.27 152.86 46.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.338 1.055 . . . . 0.0 109.415 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.52 118.85 37.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.24 107.36 16.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.654 1.581 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.64 123.0 31.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.56 -0.85 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -33.78 -109.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.901 3.68 . . . . 0.0 115.39 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.64 134.27 5.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -45.74 -43.39 12.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.78 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.52 80.92 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.3 0.955 . . . . 0.0 109.809 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.98 -40.56 67.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.515 1.126 . . . . 0.0 110.635 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -60.99 -15.85 36.41 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.025 1.739 . . . . 0.0 112.913 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -107.91 -13.02 15.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.746 1.618 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -102.14 -47.06 4.65 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.717 1.207 . . . . 0.0 110.489 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 -24.93 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.808 1.243 . . . . 0.0 113.468 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.45 -148.16 18.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 119.145 0.884 . . . . 0.0 113.807 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -146.28 162.63 33.98 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.66 128.41 10.95 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.68 2.253 . . . . 0.0 110.044 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.514 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -86.29 73.89 10.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.494 -1.684 . . . . 0.0 109.64 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.4 pt -78.66 -4.37 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.556 -1.34 . . . . 0.0 110.597 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -50.03 -37.62 33.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.65 2.38 . . . . 0.0 112.474 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.95 -40.44 72.91 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 124.206 0.941 . . . . 0.0 111.465 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.87 -50.52 28.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.84 25.56 0.14 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.727 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -133.33 -175.12 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.12 1.46 . . . . 0.0 109.971 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -144.52 131.65 20.55 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.138 2.175 . . . . 0.0 105.879 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.23 164.89 14.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.679 0.672 . . . . 0.0 111.565 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.47 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.198 1.799 . . . . 0.0 107.252 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.7 p -63.84 108.7 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.062 1.345 . . . . 0.0 111.206 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.434 HG23 ' HE3' ' A' ' 64' ' ' LYS . 2.1 m -142.38 94.09 2.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.1 116.25 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -76.75 150.44 36.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -155.33 134.97 12.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 128.361 2.664 . . . . 0.0 104.516 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.17 -13.22 81.38 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 113.987 0.355 . . . . 0.0 113.987 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.33 -43.83 39.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.023 0.911 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.32 51.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 109.78 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -52.03 -54.8 37.01 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.27 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.55 -42.11 7.57 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.877 1.349 . . . . 0.0 109.802 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.03 -19.77 46.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.41 1.481 . . . . 0.0 113.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -89.76 -54.23 4.15 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.242 1.817 . . . . 0.0 106.664 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -54.09 -46.87 72.18 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.502 1.921 . . . . 0.0 111.082 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -41.34 66.07 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.597 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 51' ' ' THR . 51.3 mtmt -60.61 -34.49 74.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.528 1.058 . . . . 0.0 110.948 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -48.01 25.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -61.21 -9.29 4.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.914 2.086 . . . . 0.0 115.323 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.11 -13.36 15.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.223 0.919 . . . . 0.0 109.337 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -98.97 -47.1 5.38 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 56.0 m-85 -86.38 159.91 19.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.367 1.467 . . . . 0.0 109.529 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -2.38 1.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.274 2.63 . . . . 0.0 112.362 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -136.11 52.54 6.59 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 128.76 2.824 . . . . 0.0 112.384 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.95 -36.54 17.54 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.532 2.821 . . . . 0.0 112.7 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -55.64 -18.11 7.13 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.652 2.381 . . . . 0.0 113.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -125.02 -1.38 7.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.215 1.006 . . . . 0.0 112.736 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -100.69 136.22 40.9 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.166 1.387 . . . . 0.0 112.411 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.2 m -102.59 128.02 49.43 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.57 97.78 7.94 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.131 0.972 . . . . 0.0 111.708 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 39.0 m-85 -74.87 126.78 31.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.01 126.7 57.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 121.002 1.728 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.8 tt -120.94 114.58 21.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.97 1.708 . . . . 0.0 109.046 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -119.47 170.41 9.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.668 1.987 . . . . 0.0 107.22 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.211 -1.555 . . . . 0.0 111.648 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.83 -154.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.912 2.485 . . . . 0.0 106.996 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -59.42 -53.44 58.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.605 1.162 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.6 -112.86 0.62 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.521 2.486 . . . . 0.0 114.716 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -112.27 3.72 17.29 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.741 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.1 m -40.02 -51.33 2.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.791 1.636 . . . . 0.0 113.686 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.58 -38.5 91.23 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.311 0.96 . . . . 0.0 112.175 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.63 -48.21 70.16 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -60.59 -23.11 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.661 0.785 . . . . 0.0 110.043 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.31 -31.33 48.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.013 0.525 . . . . 0.0 109.928 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -85.59 -33.62 21.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.592 1.087 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.0 tp -50.79 -56.83 10.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.348 2.259 . . . . 0.0 111.325 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.96 -35.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 0.0 111.777 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.84 -17.67 62.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 111.935 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -91.34 -24.04 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.776 1.23 . . . . 0.0 113.851 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.28 -6.19 4.28 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.74 -1.033 . . . . 0.0 114.45 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -69.74 147.63 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.573 1.687 . . . . 0.0 109.021 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.01 -66.92 0.3 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 113.318 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -152.57 170.81 19.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 108.817 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.18 128.44 9.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.461 -0.774 . . . . 0.0 109.797 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.401 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 31.6 m-85 -109.92 120.85 43.78 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.95 1.3 . . . . 0.0 110.9 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.75 113.88 22.96 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.43 115.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -71.04 161.59 30.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.55 12.16 8.6 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 129.354 3.062 . . . . 0.0 113.822 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.22 -138.55 27.14 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.707 1.171 . . . . 0.0 112.701 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.446 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -115.68 5.49 14.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 110.529 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.91 -3.28 3.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.41 172.78 49.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.595 1.089 . . . . 0.0 112.465 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.62 -25.2 73.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.891 3.061 . . . . 0.0 114.392 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 13.08 15.88 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.354 1.862 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.31 176.51 26.99 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.953 -1.092 . . . . 0.0 111.619 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -47.05 -61.8 1.71 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 113.186 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.26 -53.31 59.76 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.54 -14.57 43.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.813 1.645 . . . . 0.0 112.79 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -91.62 13.79 16.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.568 1.547 . . . . 0.0 110.442 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.9 m 63.15 23.15 13.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.649 2.38 . . . . 0.0 113.498 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.75 153.2 64.17 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.514 ' C ' HD21 ' A' ' 40' ' ' ASN . 37.8 Cg_endo -74.24 160.9 41.61 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.805 1.67 . . . . 0.0 110.175 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -163.08 135.76 5.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.864 1.211 . . . . 0.0 112.12 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.472 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 4.0 mt -76.13 95.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.697 1.999 . . . . 0.0 109.973 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -96.69 139.89 21.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 120.962 -1.086 . . . . 0.0 108.352 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo . . . . . 0 CA--C 1.54 0.794 0 C-N-CA 123.798 2.998 . . . . 0.0 110.721 178.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.3 p . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 122.284 1.04 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.46 -103.51 0.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 m -156.29 163.92 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.414 1.086 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.51 44.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.618 1.967 . . . . 0.0 111.962 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -55.1 -50.55 68.91 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.216 0.916 . . . . 0.0 110.853 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -51.56 67.49 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.951 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.23 77.33 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -73.24 -41.76 63.34 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.102 -0.999 . . . . 0.0 108.999 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -57.92 -45.92 85.8 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -51.69 -51.62 54.57 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.039 1.735 . . . . 0.0 110.644 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.23 -21.16 13.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.97 1.259 . . . . 0.0 113.094 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.6 -5.97 57.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.891 1.223 . . . . 0.0 112.824 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -123.38 -1.13 8.66 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.656 1.582 . . . . 0.0 110.565 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -127.33 102.25 6.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.052 -1.03 . . . . 0.0 110.722 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -93.3 32.4 1.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.71 0.804 . . . . 0.0 110.077 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -110.11 137.47 47.82 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 123.63 0.772 . . . . 0.0 109.164 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -144.58 136.0 25.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.832 0.853 . . . . 0.0 109.772 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.2 tm? -84.68 133.95 34.37 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 77' ' ' LEU . 15.6 tp -123.86 104.44 8.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.589 1.956 . . . . 0.0 109.264 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -80.95 122.95 27.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.7 pt -105.62 1.84 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -66.09 171.67 4.41 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.15 1.38 . . . . 0.0 111.294 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.5 146.85 28.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.61 1.195 . . . . 0.0 109.472 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -43.03 -45.15 5.07 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 129.831 3.253 . . . . 0.0 113.682 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -35.61 79.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -32.35 73.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -67.21 -14.01 62.51 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.067 -1.646 . . . . 0.0 111.034 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -100.74 -14.38 18.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.008 2.123 . . . . 0.0 109.266 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -103.19 -65.41 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.971 1.708 . . . . 0.0 110.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -86.65 -36.44 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.934 1.294 . . . . 0.0 111.636 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.42 -155.3 16.17 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 118.977 0.808 . . . . 0.0 113.395 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 p -133.96 148.95 70.26 Favored Pre-proline 0 CA--C 1.518 -0.266 0 C-N-CA 124.756 1.223 . . . . 0.0 110.1 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.56 169.2 22.3 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 129.96 45.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.148 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.8 pt -124.33 7.08 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 125.917 1.687 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -58.77 -31.02 67.98 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 125.066 1.346 . . . . 0.0 110.77 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.33 -51.09 32.76 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.89 -50.72 61.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.872 0.836 . . . . 0.0 110.074 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.2 39.01 0.14 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.664 1.126 . . . . 0.0 111.385 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.31 -179.56 5.43 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.566 1.183 . . . . 0.0 110.935 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -143.77 115.11 8.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.967 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 150.53 22.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 118.537 0.608 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.26 125.95 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 p -103.15 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.153 0.981 . . . . 0.0 109.752 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 m -138.05 98.85 3.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.6 114.4 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.355 1.062 . . . . 0.0 109.593 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -80.79 150.0 29.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.917 0.865 . . . . 0.0 110.131 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -157.57 119.77 3.79 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.751 2.42 . . . . 0.0 105.131 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -22.6 59.43 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.15 -11.9 52.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.165 1.386 . . . . 0.0 110.453 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -146.26 46.67 1.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.069 -1.019 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 48.5 mttp -46.0 -49.02 41.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.99 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 55.4 Cg_endo -64.14 -49.7 3.52 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.674 1.583 . . . . 0.0 111.306 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.33 78.75 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.579 1.081 . . . . 0.0 110.825 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.12 -58.7 7.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.909 1.284 . . . . 0.0 107.871 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 mt -51.25 -47.34 62.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.657 1.583 . . . . 0.0 110.694 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -57.21 -37.64 72.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.227 1.411 . . . . 0.0 110.253 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -62.32 -26.38 68.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.541 1.519 . . . . 0.0 110.895 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -47.14 11.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -54.67 -37.96 66.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.709 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.51 -0.98 35.54 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.83 -38.69 3.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.098 0.863 . . . . 0.0 111.288 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CD1' HG21 ' A' ' 75' ' ' THR . 62.8 m-85 -89.92 113.56 25.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -25.35 67.97 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.954 -0.546 . . . . 0.0 111.822 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -138.11 78.82 33.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.924 1.29 . . . . 0.0 111.165 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.05 -37.25 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.521 2.814 . . . . 0.0 113.107 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -12.98 7.15 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.879 1.272 . . . . 0.0 112.892 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.12 28.04 5.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 109.596 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 69' ' ' PHE . 70.6 m -125.75 120.82 31.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.4 m -100.79 122.03 42.7 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.476 1.11 . . . . 0.0 108.09 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 25' ' ' LEU . 1.3 mm? -97.61 106.78 19.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 21.4 m-85 -83.37 97.19 8.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mt -73.07 132.22 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 109.462 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.2 tt -131.21 131.4 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.066 1.347 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -134.48 175.43 9.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.797 2.439 . . . . 0.0 109.233 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -44.06 80.44 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.579 -1.326 . . . . 0.0 109.493 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -136.25 -148.82 0.3 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.64 -36.18 82.97 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.73 -1.231 . . . . 0.0 109.187 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.28 -99.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 127.247 2.356 . . . . 0.0 111.274 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -139.16 12.97 2.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 108.787 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -43.32 -57.07 3.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.049 1.74 . . . . 0.0 114.107 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -65.67 -30.67 71.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.252 0.933 . . . . 0.0 112.116 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -48.34 67.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.95 1.357 . . . . 0.0 108.966 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.58 -32.06 52.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.068 1.747 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.72 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.407 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -79.19 -48.8 13.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.703 1.138 . . . . 0.0 108.416 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.5 tp -42.21 -64.98 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.525 1.53 . . . . 0.0 114.056 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.8 m -62.92 -40.3 88.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.965 0.906 . . . . 0.0 112.018 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.62 45.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.848 0.718 . . . . 0.0 109.489 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 -27.11 68.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.07 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.59 -34.68 72.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.428 0.558 . . . . 0.0 111.839 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.52 -9.2 0.48 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.982 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.21 155.6 38.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.823 1.811 . . . . 0.0 110.806 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -66.59 0.36 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.518 0.727 . . . . 0.0 109.97 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -158.03 -179.46 8.15 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.505 1.922 . . . . 0.0 107.246 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.54 130.74 6.84 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -102.24 163.81 12.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.82 119.68 11.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.64 116.46 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.567 0.699 . . . . 0.0 111.26 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -66.32 148.4 51.91 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.621 ' H ' ' HE2' ' A' ' 106' ' ' LYS . 4.2 m-20 68.09 -0.55 2.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.975 1.71 . . . . 0.0 111.426 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.75 -134.08 39.65 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.651 . . . . 0.0 111.723 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.406 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -94.07 -56.74 2.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.612 1.965 . . . . 0.0 111.827 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.39 -12.77 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.59 169.6 33.29 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 120.733 1.606 . . . . 0.0 113.048 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.6 -46.67 31.74 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.344 2.696 . . . . 0.0 113.306 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -98.76 21.41 11.47 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.542 1.519 . . . . 0.0 110.006 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.41 175.91 19.85 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.402 1.001 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -45.77 -67.29 0.3 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.431 1.892 . . . . 0.0 114.448 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.69 -45.55 63.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.921 0.888 . . . . 0.0 111.225 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -71.8 -8.14 52.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.245 1.418 . . . . 0.0 113.819 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -103.29 19.65 19.25 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.924 1.69 . . . . 0.0 112.745 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.8 t 61.53 32.03 18.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.858 0.863 . . . . 0.0 110.848 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.44 146.7 32.23 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.46 144.42 16.0 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.472 2.115 . . . . 0.0 111.196 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -142.27 156.35 45.28 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.355 -0.841 . . . . 0.0 110.441 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.3 90.3 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.491 1.117 . . . . 0.0 110.292 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -70.69 155.21 93.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.75 -0.594 . . . . 0.0 109.697 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.435 2.756 . . . . 0.0 110.164 178.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.5 p . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.267 0.556 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.07 -111.31 0.25 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.92 163.13 32.25 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.988 1.315 . . . . 0.0 112.135 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.17 79.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.646 1.578 . . . . 0.0 106.901 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.32 -50.65 72.79 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.194 -0.316 . . . . 0.0 111.351 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.3 -43.63 98.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.662 0.665 . . . . 0.0 111.04 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.5 66.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -72.71 -56.3 5.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.5 1.045 . . . . 0.0 109.054 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -51.16 -45.75 61.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.021 0.928 . . . . 0.0 110.983 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -57.15 -20.51 26.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.1 -29.27 31.83 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 119.598 1.09 . . . . 0.0 108.852 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.32 -35.04 12.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.062 1.315 . . . . 0.0 111.663 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -74.48 -14.53 60.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.02 0.91 . . . . 0.0 110.653 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.22 175.61 7.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.579 0.627 . . . . 0.0 111.793 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -112.72 -43.37 3.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.59 1.156 . . . . 0.0 111.372 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.99 -3.62 52.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.789 0.835 . . . . 0.0 111.781 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.63 119.58 21.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -132.39 145.74 51.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.259 0.481 . . . . 0.0 110.077 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.31 143.65 29.38 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.5 tp -122.42 109.39 14.32 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.734 1.614 . . . . 0.0 111.178 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.96 89.88 7.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.126 1.37 . . . . 0.0 109.221 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -83.12 -0.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 119.872 -1.768 . . . . 0.0 113.828 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -59.32 164.27 3.38 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 126.329 1.852 . . . . 0.0 111.818 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.32 147.97 32.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m -58.23 -20.72 44.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.704 1.602 . . . . 0.0 109.676 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -43.6 90.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.964 -1.085 . . . . 0.0 108.102 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -61.67 -28.64 69.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 110.777 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.73 -17.91 38.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.323 0.965 . . . . 0.0 110.805 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -110.12 -36.97 5.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.418 1.487 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.21 -27.64 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.86 -19.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.9 -152.61 17.76 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.311 -0.868 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 p -147.7 158.31 43.06 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 124.175 0.99 . . . . 0.0 111.527 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -78.66 155.42 27.48 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.696 1.597 . . . . 0.0 111.18 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.553 ' HB3' HG13 ' A' ' 123' ' ' ILE . 1.2 p30 -127.74 87.7 2.66 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.396 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 pt -72.95 5.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.589 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -55.18 -34.72 64.09 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 110.543 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.16 -34.73 32.68 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.011 0.815 . . . . 0.0 111.729 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.58 -32.36 17.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.009 0.905 . . . . 0.0 111.034 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.57 29.2 1.09 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.897 1.237 . . . . 0.0 114.463 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -135.74 -178.79 5.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.234 1.017 . . . . 0.0 110.116 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.24 131.76 28.7 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.485 1.114 . . . . 0.0 109.636 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.2 163.07 27.42 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.69 130.19 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -96.77 94.72 7.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.039 2.135 . . . . 0.0 113.733 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -127.7 90.81 3.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.68 1.592 . . . . 0.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -49.97 116.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 121.476 -0.765 . . . . 0.0 110.966 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -82.52 153.57 25.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -156.33 130.1 8.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.01 -23.58 59.54 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.026 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -86.54 -8.88 57.17 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.674 1.19 . . . . 0.0 112.194 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -123.13 26.55 7.99 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.307 1.443 . . . . 0.0 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -42.7 -58.39 3.85 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.745 1.157 . . . . 0.0 111.913 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.65 -42.54 12.01 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.128 2.552 . . . . 0.0 112.101 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.28 -52.46 49.55 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -55.56 -49.03 73.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.491 1.517 . . . . 0.0 107.862 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.6 mt -53.89 -50.21 66.84 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.769 0.828 . . . . 0.0 109.773 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -43.44 84.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.299 1.04 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -58.49 -23.99 59.29 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.133 1.333 . . . . 0.0 112.685 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 62' ' ' LEU . 5.4 mt -93.36 -50.55 5.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.709 1.604 . . . . 0.0 108.003 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.0 t -56.92 -23.25 43.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 109.398 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.2 -8.07 52.04 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -38.38 6.66 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.69 1.196 . . . . 0.0 109.663 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -83.07 177.44 8.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.072 1.349 . . . . 0.0 108.407 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -33.9 3.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.295 1.038 . . . . 0.0 112.334 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -144.57 86.3 8.11 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.99 0.916 . . . . 0.0 110.588 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 10.7 Cg_endo -55.23 -32.61 81.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.948 2.432 . . . . 0.0 112.865 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.66 -8.0 1.8 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -123.22 -6.73 8.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.777 -1.106 . . . . 0.0 112.97 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -101.26 130.06 47.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -98.63 130.45 45.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.328 1.051 . . . . 0.0 109.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.36 103.16 12.64 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.646 1.178 . . . . 0.0 112.19 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.91 102.31 13.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.07 139.65 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.916 1.286 . . . . 0.0 113.414 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.43 123.65 21.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.935 1.694 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -130.58 170.65 13.99 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.576 2.351 . . . . 0.0 107.748 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -21.74 8.29 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 113.537 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -159.64 -162.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.916 3.287 . . . . 0.0 104.933 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.14 -55.09 16.48 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.861 2.065 . . . . 0.0 107.365 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.27 -96.95 0.02 OUTLIER Glycine 0 C--N 1.337 0.602 0 C-N-CA 128.251 2.834 . . . . 0.0 114.252 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -135.88 13.08 3.39 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.683 1.193 . . . . 0.0 110.859 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -52.03 -31.59 30.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.943 0.792 . . . . 0.0 110.961 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -72.19 -35.45 68.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.159 2.184 . . . . 0.0 111.745 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.43 -46.64 14.29 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.15 -30.84 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.02 94.91 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -71.65 -42.66 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.781 0.832 . . . . 0.0 109.203 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.2 tp -50.41 -62.15 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.133 1.373 . . . . 0.0 111.848 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.46 -38.62 80.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.115 0.566 . . . . 0.0 110.688 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.76 64.36 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.615 0.766 . . . . 0.0 109.727 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.05 -24.4 67.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.669 0.788 . . . . 0.0 111.589 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -77.2 -21.79 53.36 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.783 0.719 . . . . 0.0 110.844 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.56 6.52 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 117.154 -1.914 . . . . 0.0 114.086 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.7 m-85 -70.01 152.1 44.8 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.616 2.208 . . . . 0.0 108.703 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -48.98 -65.81 0.5 Allowed 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.188 1.795 . . . . 0.0 113.184 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -155.74 174.75 14.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.911 1.284 . . . . 0.0 108.948 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.43 146.46 18.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -135.41 128.87 32.36 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.812 0.845 . . . . 0.0 110.394 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.81 118.39 30.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.36 115.74 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 121.286 -0.884 . . . . 0.0 109.029 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -68.23 150.1 48.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.8 11.59 8.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.625 1.57 . . . . 0.0 113.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.66 -136.84 2.71 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 124.964 1.269 . . . . 0.0 112.781 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -101.2 -26.61 13.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -100.12 -10.84 21.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.796 2.438 . . . . 0.0 115.281 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.9 170.39 8.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.999 1.272 . . . . 0.0 111.824 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.41 -29.33 23.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 124.022 3.148 . . . . 0.0 114.556 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.28 25.97 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.443 1.497 . . . . 0.0 110.616 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -173.59 3.88 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.401 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 17.6 t-105 -41.66 -56.51 2.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.15 -52.81 64.01 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 123.492 0.717 . . . . 0.0 109.56 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.64 22.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.951 1.301 . . . . 0.0 112.791 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.3 m -120.13 10.26 11.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.055 1.742 . . . . 0.0 110.957 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.85 24.96 9.65 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.221 0.919 . . . . 0.0 110.397 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 57.2 mt -97.89 140.71 22.1 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 31.4 Cg_exo -58.86 140.06 93.55 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 125.07 3.847 . . . . 0.0 110.691 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -148.38 135.51 20.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.019 0.927 . . . . 0.0 112.204 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 40' ' ' ASN . 5.2 mt -85.05 96.92 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.818 2.447 . . . . 0.0 108.108 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.73 155.93 68.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 O-C-N 121.484 -0.76 . . . . 0.0 112.719 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.453 -0.857 0 C-N-CA 123.307 2.671 . . . . 0.0 107.083 177.348 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.237 0.416 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.9 -112.12 0.26 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 163.57 36.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.916 1.358 . . . . 0.0 112.076 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.95 98.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -53.22 -55.63 22.84 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.216 1.007 . . . . 0.0 110.202 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -62.06 -45.3 94.14 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.699 0.624 . . . . 0.0 111.832 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.47 -41.75 85.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.62 -48.18 82.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.867 0.758 . . . . 0.0 109.605 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -60.6 -43.37 97.49 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.199 0.6 . . . . 0.0 111.025 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -39.04 89.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.245 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.0 mt -64.74 -20.4 66.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.895 1.225 . . . . 0.0 110.663 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 -12.46 64.56 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.327 0.965 . . . . 0.0 112.212 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p -117.82 -2.45 11.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.628 1.571 . . . . 0.0 112.243 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -125.12 109.11 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.147 1.379 . . . . 0.0 107.567 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.16 -29.97 68.09 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -84.46 -26.86 27.9 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.717 -0.615 . . . . 0.0 111.977 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 137.98 58.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -141.02 121.98 14.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.857 1.263 . . . . 0.0 109.627 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -55.11 129.79 39.46 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.013 0.925 . . . . 0.0 109.192 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp -109.73 99.49 8.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.929 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.79 112.69 19.17 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.84 7.15 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -64.88 172.12 3.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 110.815 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 144.36 30.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -44.48 -39.87 5.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.027 2.131 . . . . 0.0 111.902 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.33 77.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.929 -0.557 . . . . 0.0 111.557 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.58 -37.2 75.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.393 0.997 . . . . 0.0 110.629 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -62.05 -7.69 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.935 -1.103 . . . . 0.0 112.887 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -123.41 -14.82 7.31 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.543 1.937 . . . . 0.0 111.115 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.93 -45.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.956 1.303 . . . . 0.0 110.814 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.19 -18.56 7.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 124.938 1.295 . . . . 0.0 110.472 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.25 -156.51 21.27 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.446 -0.784 . . . . 0.0 111.808 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -145.8 167.58 13.89 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 121.648 -0.913 . . . . 0.0 112.251 -178.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 83.1 Cg_endo -71.16 158.3 55.22 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.217 1.278 . . . . 0.0 110.309 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB3' ' CD1' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -125.0 56.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.946 1.698 . . . . 0.0 112.965 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.6 pt -71.67 10.54 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.415 1.086 . . . . 0.0 111.651 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -42.63 69.55 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.133 1.373 . . . . 0.0 111.074 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -52.58 -46.05 59.17 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 mt -61.91 -23.71 66.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 112.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.32 38.87 3.63 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -136.45 168.54 19.27 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 117.773 0.786 . . . . 0.0 111.989 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -138.84 127.56 23.42 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 157.45 37.73 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -116.67 99.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 p -79.02 113.14 16.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.4 m -142.02 109.62 5.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.18 116.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.822 0.283 . . . . 0.0 110.67 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.95 138.95 36.1 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -150.64 127.69 11.15 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.65 -19.14 34.0 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.186 1.374 . . . . 0.0 113.96 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.18 -17.28 60.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.866 1.833 . . . . 0.0 110.938 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -133.12 59.91 1.72 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.686 0.794 . . . . 0.0 110.37 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.05 -54.6 53.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 120.699 -1.251 . . . . 0.0 108.533 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.82 -41.16 8.39 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 121.664 1.63 . . . . 0.0 109.468 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.91 59.17 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.287 0.946 . . . . 0.0 111.695 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -71.49 -60.18 2.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.9 mt -47.29 -46.58 25.01 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.335 1.854 . . . . 0.0 111.639 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -59.43 -33.3 71.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.485 0.714 . . . . 0.0 110.907 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -69.17 -23.99 64.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.064 1.302 . . . . 0.0 111.115 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.74 -34.73 30.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -57.79 -36.62 72.43 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.524 -0.735 . . . . 0.0 112.774 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.64 -5.76 44.87 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -117.14 -33.11 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.987 0.812 . . . . 0.0 112.909 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.2 m-85 -93.5 106.16 18.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.533 1.133 . . . . 0.0 111.139 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -56.82 -51.09 70.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.626 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.34 86.22 50.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.081 0.952 . . . . 0.0 109.048 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.08 -18.81 60.22 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.807 1.671 . . . . 0.0 113.808 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.4 -16.82 16.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -123.25 -1.84 8.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.603 1.561 . . . . 0.0 112.078 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 69' ' ' PHE . 21.1 m -93.22 132.66 37.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 111.193 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -102.25 149.91 23.83 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.92 91.79 3.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.064 1.346 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 30.8 m-85 -74.34 101.52 4.09 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 102.961 -2.977 . . . . 0.0 102.961 177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.89 130.23 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.759 1.223 . . . . 0.0 112.671 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.23 107.88 11.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.513 1.525 . . . . 0.0 109.361 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.25 173.59 6.25 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.03 -58.73 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.615 -1.303 . . . . 0.0 109.311 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.78 -153.05 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.63 -36.68 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.247 0.476 . . . . 0.0 109.872 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.24 -118.67 0.19 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 128.572 2.987 . . . . 0.0 115.566 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -101.12 -3.1 29.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -41.55 -55.97 2.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.299 1.839 . . . . 0.0 115.102 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -26.79 66.32 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -49.81 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.24 -35.06 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.489 1.115 . . . . 0.0 109.222 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.3 66.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.392 1.077 . . . . 0.0 111.355 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -92.61 -35.38 13.57 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.775 0.716 . . . . 0.0 110.026 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.0 -59.22 4.61 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.649 0.738 . . . . 0.0 109.895 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.03 -38.81 78.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.14 0.976 . . . . 0.0 112.107 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.02 -53.75 51.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.129 1.372 . . . . 0.0 109.804 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.01 -28.62 67.87 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 110.54 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -76.97 -24.31 52.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.892 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.15 -0.8 2.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.906 -1.497 . . . . 0.0 115.695 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -73.1 150.62 42.11 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 120.198 1.999 . . . . 0.0 107.303 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.6 tpmt? -59.13 -52.83 64.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -165.49 176.41 8.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 107.903 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.9 163.39 40.12 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 43.9 m-85 -146.92 114.75 6.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.354 1.062 . . . . 0.0 109.144 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.11 113.89 15.34 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.497 1.119 . . . . 0.0 108.798 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.79 101.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -62.69 150.52 40.81 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 71.58 6.77 5.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.222 1.809 . . . . 0.0 110.934 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.35 -130.21 14.51 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.058 1.299 . . . . 0.0 110.51 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.66 -16.7 7.13 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.22 -25.57 21.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.504 1.047 . . . . 0.0 112.99 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.51 170.23 1.34 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 128.851 3.119 . . . . 0.0 116.598 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.82 -22.36 36.78 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 124.064 3.176 . . . . 0.0 112.774 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.255 12.7 tpt180 -124.85 14.13 8.57 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.741 2.017 . . . . 0.0 109.56 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.82 -177.94 20.62 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.45 -1.406 . . . . 0.0 111.382 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -48.88 -53.27 20.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 113.405 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.02 -51.12 70.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.848 0.459 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.6 32.14 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.737 2.015 . . . . 0.0 112.303 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.8 m -126.5 12.2 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.007 1.723 . . . . 0.0 109.836 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 t 62.0 28.51 17.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.867 0.758 . . . . 0.0 110.437 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.81 138.63 19.69 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.422 ' HB2' HD21 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -70.75 157.23 59.05 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.031 1.821 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -158.39 151.29 22.5 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 108.772 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 40' ' ' ASN . 2.5 mt -98.08 88.57 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.73 153.94 85.27 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 C-N-CA 122.476 2.118 . . . . 0.0 108.509 178.083 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.28 109.38 0.41 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -37.47 149.89 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.446 2.298 . . . . 0.0 112.848 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.6 47.58 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.581 . . . . 0.0 111.623 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -60.71 -51.75 68.06 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 110.191 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -55.47 -46.57 76.83 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.758 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.85 87.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.267 0.627 . . . . 0.0 109.611 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.99 -51.34 70.49 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.656 0.782 . . . . 0.0 109.991 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.3 m -61.62 -41.86 98.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.888 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 18' ' ' THR . 27.7 mmtt -56.97 -48.74 77.68 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.502 1.121 . . . . 0.0 109.978 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.86 -19.67 60.47 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.035 0.534 . . . . 0.0 111.656 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.03 -7.06 61.37 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.501 2.477 . . . . 0.0 114.418 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 15' ' ' LYS . 11.2 t -121.3 -8.91 9.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.08 1.752 . . . . 0.0 109.351 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.81 178.43 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.884 0.874 . . . . 0.0 109.494 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 38.1 t70 -128.12 -49.16 1.33 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.333 0.969 . . . . 0.0 111.666 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -71.51 -2.84 18.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.695 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 121.83 23.67 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.555 2.342 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -136.38 149.22 48.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.49 132.08 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.663 1.185 . . . . 0.0 110.107 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 tp -113.38 111.12 21.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.026 1.33 . . . . 0.0 109.829 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.08 116.36 28.84 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.8 pt -99.4 9.06 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -65.36 163.65 15.19 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.728 1.611 . . . . 0.0 113.619 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.49 139.62 44.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -45.94 -41.84 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.792 1.237 . . . . 0.0 112.459 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.1 67.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.75 0.82 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -59.82 -43.69 94.41 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.435 0.562 . . . . 0.0 110.502 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -56.91 -21.94 33.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.004 0.82 . . . . 0.0 112.823 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -84.12 -26.83 28.61 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.024 0.929 . . . . 0.0 109.825 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -91.29 -59.3 2.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.457 1.503 . . . . 0.0 112.816 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.6 -34.71 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.836 1.254 . . . . 0.0 114.148 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -144.93 16.44 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.9 p -154.15 156.01 31.5 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 119.374 1.587 . . . . 0.0 112.889 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.51 135.93 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.936 2.424 . . . . 0.0 111.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.651 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -103.41 80.12 1.78 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.851 2.861 . . . . 0.0 107.893 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 pt -77.75 2.61 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.493 -1.379 . . . . 0.0 111.668 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -47.79 -31.84 5.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.495 2.718 . . . . 0.0 115.729 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.09 77.32 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt -85.05 -38.36 19.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.69 0.68 Allowed Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.696 1.141 . . . . 0.0 111.047 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 20' ' ' ASP . 41.6 mmtm -145.51 178.86 7.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.091 1.756 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -133.66 165.49 24.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.974 0.892 . . . . 0.0 110.839 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.49 163.74 15.62 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 108.843 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -138.79 128.37 31.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.153 1.381 . . . . 0.0 107.693 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -99.22 121.94 41.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.398 1.079 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.9 m -148.65 106.56 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.99 110.17 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -76.14 162.95 27.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -166.98 136.45 2.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.069 2.148 . . . . 0.0 105.277 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.2 66.7 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.472 0.558 . . . . 0.0 112.829 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.93 -50.28 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.15 24.48 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -43.76 -52.15 15.22 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 120.244 1.384 . . . . 0.0 110.09 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.41 -44.95 12.87 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.37 2.047 . . . . 0.0 111.786 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.95 83.69 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.722 1.153 . . . . 0.0 110.906 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.07 -53.06 51.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.527 1.931 . . . . 0.0 108.394 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.92 -47.47 64.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.228 1.011 . . . . 0.0 111.177 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -51.92 -47.42 64.66 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.95 -29.43 12.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.465 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -50.35 6.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m -55.93 -32.73 64.06 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.418 1.008 . . . . 0.0 112.198 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.25 -5.02 57.31 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.566 0.746 . . . . 0.0 112.961 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -41.48 3.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.524 1.13 . . . . 0.0 111.578 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.95 179.57 7.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.845 1.258 . . . . 0.0 108.716 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -127.6 -24.36 3.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.415 1.086 . . . . 0.0 113.153 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.75 83.09 8.31 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -56.19 -38.1 95.51 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.267 1.312 . . . . 0.0 110.229 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.45 -15.9 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.503 1.921 . . . . 0.0 114.425 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -124.03 -16.13 6.63 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.784 1.233 . . . . 0.0 111.55 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.1 m -77.98 137.2 38.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.049 0.84 . . . . 0.0 110.656 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -110.25 125.45 53.12 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.24 100.51 10.1 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.431 1.092 . . . . 0.0 112.408 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CE2' ' CD1' ' A' ' 103' ' ' TYR . 40.6 m-85 -82.54 96.7 8.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -73.99 124.49 31.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.095 1.358 . . . . 0.0 109.565 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -121.77 125.44 46.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 109.498 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -133.41 172.42 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.808 0.843 . . . . 0.0 112.572 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -46.52 -54.67 8.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.65 1.58 . . . . 0.0 108.926 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -136.82 -155.97 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.04 2.936 . . . . 0.0 104.716 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -52.85 -54.23 37.4 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.765 1.226 . . . . 0.0 109.722 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.36 -98.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.448 1.975 . . . . 0.0 111.459 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.66 16.47 2.71 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.293 2.237 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -45.04 -45.23 10.72 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.968 1.258 . . . . 0.0 113.41 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -73.38 -41.8 62.92 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.202 0.91 . . . . 0.0 111.24 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.42 -46.67 88.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.7 t -66.73 -34.51 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.13 82.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.036 0.835 . . . . 0.0 109.389 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -73.11 -48.17 37.93 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.9 tp -50.16 -58.97 4.42 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.122 1.769 . . . . 0.0 113.837 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.91 -38.39 81.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 122.15 -0.343 . . . . 0.0 110.126 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.4 77.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.36 -26.68 67.98 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.374 1.469 . . . . 0.0 111.349 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -84.55 -21.65 30.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.655 0.662 . . . . 0.0 111.968 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.66 1.98 2.04 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.046 -1.975 . . . . 0.0 115.978 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -73.34 150.27 41.98 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.78 2.29 . . . . 0.0 109.633 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -55.89 -58.41 8.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.582 0.753 . . . . 0.0 111.129 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.8 m -159.3 166.18 31.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 107.465 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.37 12.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CD1' ' CE2' ' A' ' 78' ' ' TYR . 55.3 m-85 -100.26 151.23 21.71 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.23 111.14 19.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.32 91.37 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 113.96 10.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.25 34.0 m-20 115.32 4.84 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 133.079 4.552 . . . . 0.0 110.553 179.994 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.39 -134.49 41.92 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.658 -1.276 . . . . 0.0 114.866 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.98 -44.77 5.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -87.72 -22.71 24.45 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -52.98 170.88 0.59 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.443 1.973 . . . . 0.0 115.012 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -57.0 -27.55 74.07 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 124.532 3.488 . . . . 0.0 115.619 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -120.64 9.67 10.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.002 2.121 . . . . 0.0 109.03 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 168.98 20.83 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -47.19 -62.62 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 113.632 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.37 -52.83 63.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.795 1.238 . . . . 0.0 110.459 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.36 13.98 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.172 2.189 . . . . 0.0 113.437 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.4 m -129.47 16.56 5.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.644 1.578 . . . . 0.0 112.0 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.7 m 63.59 18.97 11.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.084 1.754 . . . . 0.0 113.661 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.3 mt -76.7 154.74 83.45 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.651 ' C ' HD21 ' A' ' 40' ' ' ASN . 98.3 Cg_endo -72.61 162.62 40.82 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.165 1.243 . . . . 0.0 109.969 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -167.38 126.51 1.36 Allowed 'General case' 0 C--O 1.238 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 113.059 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -73.49 93.19 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.977 2.111 . . . . 0.0 109.565 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.55 151.69 50.91 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 CA--C 1.546 1.105 0 C-N-CA 123.14 2.56 . . . . 0.0 107.366 177.458 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--O 1.241 0.606 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.08 106.88 0.49 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -49.68 148.7 2.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.515 1.158 . . . . 0.0 109.023 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.86 48.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -67.8 -48.03 67.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.288 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -63.11 -45.14 93.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.856 0.753 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.12 81.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.47 -41.07 98.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.092 0.86 . . . . 0.0 111.581 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -60.35 -54.78 41.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -49.6 -53.01 26.36 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.327 1.051 . . . . 0.0 111.719 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.9 mt -57.55 -23.2 49.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 113.202 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.87 -5.79 60.93 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.951 1.262 . . . . 0.0 112.676 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -124.62 -1.86 7.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.495 1.148 . . . . 0.0 111.227 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -131.38 115.83 16.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -69.18 -47.48 64.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.842 1.257 . . . . 0.0 111.703 -178.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 75' ' ' THR . 22.1 m120 -72.56 -6.9 47.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.582 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -76.02 118.6 18.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.56 131.91 46.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.816 0.817 . . . . 0.0 110.944 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -65.28 127.52 32.09 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.465 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' LEU . 47.2 tp -109.36 103.92 12.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.854 2.062 . . . . 0.0 109.525 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.96 108.3 16.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.245 1.018 . . . . 0.0 108.273 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -102.36 0.09 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 70.6 mtm-85 -61.44 168.55 2.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.374 1.07 . . . . 0.0 113.632 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.45 136.81 37.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.413 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -38.25 -40.35 0.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.664 2.786 . . . . 0.0 114.322 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.02 76.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.869 0.759 . . . . 0.0 112.571 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.18 80.07 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.446 0.566 . . . . 0.0 111.024 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -65.67 -6.31 11.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.592 1.157 . . . . 0.0 111.824 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.68 -29.42 7.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.556 1.943 . . . . 0.0 109.486 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -94.67 -59.42 1.93 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.88 0.872 . . . . 0.0 112.824 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -26.33 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.696 1.599 . . . . 0.0 112.947 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.82 -153.38 19.17 Favored Glycine 0 C--N 1.335 0.487 0 O-C-N 121.42 -0.8 . . . . 0.0 112.836 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -143.3 162.0 44.84 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.49 178.39 6.23 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.072 1.181 . . . . 0.0 111.185 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -145.17 145.75 31.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.57 178.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.69 13.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.413 1.885 . . . . 0.0 110.619 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -59.06 -27.54 65.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.106 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.64 94.58 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.3 mt -70.16 -28.42 65.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 0.0 109.785 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.86 19.29 7.39 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 127.694 2.569 . . . . 0.0 110.817 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 20' ' ' ASP . 46.1 mmtm -130.24 -178.57 4.8 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 150.49 34.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.612 1.165 . . . . 0.0 108.855 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 179.96 7.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.745 0.818 . . . . 0.0 110.697 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.85 133.09 44.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -113.7 121.05 42.94 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.008 1.276 . . . . 0.0 111.273 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -146.69 108.1 4.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 t -57.98 119.91 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -75.92 124.45 27.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -131.12 116.72 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.04 1.736 . . . . 0.0 107.197 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.01 -27.43 67.12 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 118.464 0.575 . . . . 0.0 112.652 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -74.1 -15.42 61.05 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.625 0.712 . . . . 0.0 110.6 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.74 32.32 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.468 1.907 . . . . 0.0 113.584 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -43.06 -56.69 6.03 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 121.452 1.933 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -63.7 -37.05 48.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.724 2.282 . . . . 0.0 112.341 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.44 74.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.319 1.437 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -82.11 -56.7 3.77 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.09 -44.59 61.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.042 1.737 . . . . 0.0 112.769 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -57.36 -36.88 71.76 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.801 0.728 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -61.82 -20.62 63.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.921 0.889 . . . . 0.0 111.356 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.8 -43.28 8.3 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.6 t -52.43 -34.62 49.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.991 1.716 . . . . 0.0 111.541 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.99 -6.03 53.17 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.53 -37.37 4.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.785 0.721 . . . . 0.0 110.899 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 75' ' ' THR . 72.9 m-85 -91.88 103.88 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.901 0.881 . . . . 0.0 109.627 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -18.33 60.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.338 0.517 . . . . 0.0 111.68 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 68.24 79.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.642 1.177 . . . . 0.0 109.532 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -32.39 93.21 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.499 2.133 . . . . 0.0 111.63 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.11 -19.9 8.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.394 1.878 . . . . 0.0 115.934 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -124.87 8.48 8.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.841 1.256 . . . . 0.0 110.957 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.611 HG21 ' CD1' ' A' ' 69' ' ' PHE . 63.5 m -104.42 111.83 24.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.712 1.605 . . . . 0.0 111.323 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.5 m -83.67 129.32 34.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.85 102.61 14.43 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.478 0.711 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.499 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 49.4 m-85 -84.43 92.56 8.09 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.18 127.17 31.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.68 1.592 . . . . 0.0 110.849 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -127.2 130.98 50.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.647 1.579 . . . . 0.0 109.128 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 49.1 t0 -137.09 -170.54 2.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.078 2.151 . . . . 0.0 107.703 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -62.51 -48.5 79.28 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.03 -1.044 . . . . 0.0 108.676 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -140.97 -172.77 3.55 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.999 2.519 . . . . 0.0 108.886 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -48.89 -30.02 5.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.686 1.994 . . . . 0.0 113.121 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.33 -108.14 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 C-N-CA 130.208 3.766 . . . . 0.0 115.717 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -110.73 0.92 17.57 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 127.209 2.203 . . . . 0.0 108.816 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -51.48 -47.04 63.33 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 121.188 1.813 . . . . 0.0 109.755 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -64.47 -23.99 67.47 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 tp -87.32 -43.23 12.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.127 0.971 . . . . 0.0 110.97 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.98 -30.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.18 83.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.04 -43.24 71.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 125.794 1.637 . . . . 0.0 111.131 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.41 -56.16 21.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.915 0.886 . . . . 0.0 112.175 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.22 -35.32 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.14 95.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.058 0.543 . . . . 0.0 109.893 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.16 -37.97 84.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.579 0.752 . . . . 0.0 109.709 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -61.28 -50.58 72.44 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.18 -3.1 0.29 Allowed Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.976 -1.458 . . . . 0.0 115.377 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -58.79 153.2 17.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.632 1.716 . . . . 0.0 109.107 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -46.94 -70.13 0.11 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.489 1.116 . . . . 0.0 112.523 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 m -154.79 177.38 11.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.443 2.297 . . . . 0.0 105.826 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.06 136.55 8.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.15 -0.969 . . . . 0.0 108.651 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -113.33 154.52 26.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.703 1.201 . . . . 0.0 108.339 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.49 114.12 23.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.264 2.4 mp -66.15 106.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.73 128.02 34.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.22 9.88 4.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.885 2.874 . . . . 0.0 111.76 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.03 -111.8 0.51 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.196 1.855 . . . . 0.0 110.839 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.75 -9.12 3.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.516 1.126 . . . . 0.0 112.027 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.82 -1.54 27.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.2 41.64 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.31 -39.92 84.84 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.527 3.485 . . . . 0.0 114.746 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 21.55 9.63 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.862 0.865 . . . . 0.0 110.999 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.4 171.71 4.01 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -40.91 -46.3 2.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 113.52 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.8 mt -65.76 -57.2 8.55 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.374 0.988 . . . . 0.0 110.627 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -66.81 -4.49 9.33 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.712 2.005 . . . . 0.0 114.303 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 p -97.2 3.9 51.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 t 77.24 11.16 2.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.634 1.973 . . . . 0.0 111.859 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.1 152.88 79.72 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.012 0.824 . . . . 0.0 110.459 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.72 142.96 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.187 1.925 . . . . 0.0 110.981 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -145.06 142.2 29.52 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.502 -0.749 . . . . 0.0 110.313 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.0 mt -92.59 93.01 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.851 1.26 . . . . 0.0 109.121 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.85 148.64 72.73 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.639 0.775 . . . . 0.0 109.103 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 CA--C 1.545 1.035 0 C-N-CA 124.284 3.323 . . . . 0.0 107.118 177.483 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.77 0.319 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.9 -98.32 0.11 Allowed Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.6 m -157.26 160.08 38.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.104 1.452 . . . . 0.0 112.446 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.96 77.63 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.858 -1.068 . . . . 0.0 112.385 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -55.03 -51.5 66.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.911 1.232 . . . . 0.0 109.832 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -52.02 -54.36 30.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.598 0.759 . . . . 0.0 110.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.23 82.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 112.621 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.24 -45.72 75.89 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -59.89 -41.47 91.66 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -60.79 -44.2 97.12 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.631 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.81 -44.83 78.24 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.355 1.434 . . . . 0.0 107.708 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.0 -6.86 33.81 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.535 1.541 . . . . 0.0 115.952 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 t -129.59 -2.82 4.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.659 1.73 . . . . 0.0 111.655 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -113.97 94.09 4.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.805 1.642 . . . . 0.0 106.82 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.52 -27.03 1.59 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.523 1.929 . . . . 0.0 115.862 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -109.9 5.42 22.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.239 0.927 . . . . 0.0 113.11 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.27 148.56 39.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.008 0.822 . . . . 0.0 111.618 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -142.9 158.88 43.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.235 0.614 . . . . 0.0 110.277 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -102.08 119.72 39.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.362 1.465 . . . . 0.0 108.006 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 109.33 20.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.492 1.917 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 121.16 27.43 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.148 2.179 . . . . 0.0 107.625 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 81' ' ' ASP . 5.8 pt -120.44 4.66 6.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -66.43 170.45 6.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 121.798 2.09 . . . . 0.0 108.968 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.73 150.11 48.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -52.42 -32.8 40.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 111.701 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.94 70.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.179 0.899 . . . . 0.0 113.222 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.82 -38.34 88.64 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -63.25 -10.4 15.63 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.573 -1.954 . . . . 0.0 114.803 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -21.05 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.337 1.855 . . . . 0.0 109.43 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.06 -79.32 0.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.853 2.061 . . . . 0.0 109.265 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.85 -30.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.267 1.427 . . . . 0.0 112.731 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 125' ' ' PRO . . . 94.68 -134.22 11.9 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 p -151.11 158.17 34.83 Favored Pre-proline 0 N--CA 1.448 -0.573 0 O-C-N 122.654 -0.321 . . . . 0.0 111.175 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HG3' HD22 ' A' ' 80' ' ' LEU . 88.2 Cg_endo -71.74 173.81 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 N-CA-C 107.321 -1.838 . . . . 0.0 107.321 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.61 HD21 ' HB2' ' A' ' 121' ' ' PRO . 1.3 p30 -141.31 149.09 40.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.09 9.31 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.464 1.126 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -58.3 -32.72 68.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.392 1.477 . . . . 0.0 111.586 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -48.1 -42.79 24.28 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 124.804 1.315 . . . . 0.0 110.321 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 mt -77.1 -75.01 0.22 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.51 44.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -141.09 -176.11 4.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.922 1.689 . . . . 0.0 109.014 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.23 136.93 25.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.862 2.065 . . . . 0.0 107.136 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -175.79 2.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.977 0.911 . . . . 0.0 111.732 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.14 133.95 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.4 p -120.05 108.47 14.32 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.982 0.913 . . . . 0.0 113.455 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -143.46 108.48 4.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -57.47 122.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 118.149 0.431 . . . . 0.0 110.226 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -74.18 151.09 40.07 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -156.45 116.16 3.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.17 -22.15 57.72 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 117.902 0.319 . . . . 0.0 112.726 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 58.1 mt-10 -76.66 -15.22 59.86 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.163 0.981 . . . . 0.0 111.591 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -128.13 33.75 4.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.073 1.349 . . . . 0.0 113.784 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.39 -54.37 7.99 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.765 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.92 -47.26 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.563 2.175 . . . . 0.0 112.362 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.42 -24.88 71.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.849 -0.417 . . . . 0.0 112.593 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.76 -39.82 17.99 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 118.159 0.979 . . . . 0.0 108.602 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.6 -47.97 79.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.89 0.876 . . . . 0.0 111.194 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -52.94 -37.74 61.3 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.034 0.534 . . . . 0.0 111.623 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.86 -29.39 68.26 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.474 -0.766 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.63 -50.61 6.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 t -55.0 -26.6 38.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.206 1.802 . . . . 0.0 112.631 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.67 -18.3 33.57 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.231 -0.918 . . . . 0.0 111.64 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -51.61 3.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.462 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.32 98.8 4.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -56.97 -33.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.176 0.99 . . . . 0.0 113.469 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -131.68 80.84 65.34 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 39.5 Cg_endo -67.11 -26.42 42.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.814 2.343 . . . . 0.0 113.101 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -54.54 -18.62 4.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.161 1.785 . . . . 0.0 114.165 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -132.84 7.66 4.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 112.694 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -105.25 109.15 21.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.454 1.502 . . . . 0.0 109.895 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.7 m -80.84 137.98 36.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.519 0.728 . . . . 0.0 109.997 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.2 mt -113.54 99.62 7.88 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 112.22 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 52.7 m-85 -76.58 112.52 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.5 141.87 14.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.147 1.379 . . . . 0.0 110.478 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.421 HD22 ' HG3' ' A' ' 39' ' ' PRO . 12.7 tp -137.42 133.48 34.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.555 ' CG ' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -134.33 175.58 9.38 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -58.28 -55.53 33.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.59 -1.319 . . . . 0.0 110.682 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -130.26 -152.52 0.52 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.258 3.423 . . . . 0.0 105.503 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.3 -6.09 2.92 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 10.38 -94.18 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 1 C-N-CA 131.872 4.558 . . . . 0.0 117.5 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.37 4.62 1.21 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.287 2.235 . . . . 0.0 112.161 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' HG21 ' A' ' 79' ' ' ILE . 1.7 m -29.31 -62.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.404 2.682 . . . . 0.0 114.463 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.04 -45.81 82.88 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.254 2.222 . . . . 0.0 112.916 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -48.24 79.23 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.695 1.198 . . . . 0.0 108.71 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.0 -34.6 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -64.11 -45.72 87.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.983 0.81 . . . . 0.0 109.124 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.4 -42.38 87.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -53.13 -58.79 5.84 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.993 1.317 . . . . 0.0 111.685 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.11 -38.0 81.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 121.873 -0.517 . . . . 0.0 110.555 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.19 93.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.701 0.626 . . . . 0.0 111.057 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.59 -45.21 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.59 0.756 . . . . 0.0 110.236 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -55.26 -37.91 67.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.753 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -9.51 0.26 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.99 -0.895 . . . . 0.0 115.205 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 51.9 m-85 -67.57 142.04 56.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.444 1.622 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -41.14 -57.52 2.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.296 2.638 . . . . 0.0 112.79 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.0 t -166.99 173.59 9.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.44 149.61 27.94 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 44.9 m-85 -133.26 122.01 23.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.7 98.4 11.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 108.871 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -64.12 120.11 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -72.21 165.39 24.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.372 0.669 . . . . 0.0 109.82 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.3 16.07 10.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.244 1.818 . . . . 0.0 112.942 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.13 -123.97 32.85 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.36 -24.76 3.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.737 2.415 . . . . 0.0 109.472 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.43 -27.63 25.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.891 1.676 . . . . 0.0 113.524 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.48 178.9 41.14 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.214 0.911 . . . . 0.0 114.652 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.53 -51.12 11.2 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.411 3.408 . . . . 0.0 113.839 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 113' ' ' ARG . 34.0 mmt180 -88.66 7.26 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.688 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.78 153.46 47.27 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -34.13 -64.06 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 129.512 3.125 . . . . 0.0 115.711 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -56.66 -53.94 51.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.03 0.377 . . . . 0.0 110.497 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.23 -15.33 62.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.91 2.084 . . . . 0.0 113.031 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 t -88.51 8.13 29.62 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.571 1.548 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.6 t 64.77 20.75 12.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.867 2.467 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.57 158.51 59.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 123.592 0.757 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.61 ' HB2' HD21 ' A' ' 40' ' ' ASN . 57.3 Cg_endo -77.62 152.88 29.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.305 2.003 . . . . 0.0 110.613 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -151.08 141.66 22.61 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 120.704 -1.247 . . . . 0.0 111.191 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 40' ' ' ASN . 2.9 mt -81.38 80.99 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.915 1.286 . . . . 0.0 109.908 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -78.98 122.36 84.44 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 37' ' ' GLY . 83.5 Cg_endo . . . . . 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.0 110.002 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.0 p . . . . . 0 C--O 1.24 0.589 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.92 -110.93 0.28 Allowed Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.3 m -147.31 160.23 42.75 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.374 1.07 . . . . 0.0 111.064 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.48 33.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.462 1.905 . . . . 0.0 110.369 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -53.72 -49.87 67.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.398 0.544 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -57.03 -50.47 72.65 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.824 0.284 . . . . 0.0 111.493 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.81 77.09 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.927 0.491 . . . . 0.0 111.147 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 120' ' ' LEU . 44.6 t80 -63.9 -48.3 77.15 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.8 m -58.16 -42.27 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.203 0.601 . . . . 0.0 109.954 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -62.31 -34.31 76.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.578 -1.201 . . . . 0.0 111.844 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.27 -43.0 99.59 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.09 -0.48 15.29 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.839 1.685 . . . . 0.0 113.142 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -19.88 7.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.99 2.516 . . . . 0.0 111.279 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -127.61 112.49 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.117 -1.614 . . . . 0.0 111.612 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -40.43 94.06 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.903 0.881 . . . . 0.0 110.812 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.65 -12.72 60.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.282 0.633 . . . . 0.0 110.788 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.407 ' HA ' ' HB ' ' A' ' 76' ' ' THR . . . -77.83 143.03 38.18 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.61 155.6 47.35 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.321 1.048 . . . . 0.0 108.467 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.6 134.56 47.56 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -127.1 108.43 10.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.085 1.754 . . . . 0.0 111.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.33 116.89 21.39 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 pt -104.81 6.0 10.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -67.53 161.3 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.907 0.776 . . . . 0.0 110.053 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 144.5 55.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -54.15 -25.45 22.47 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.629 1.972 . . . . 0.0 110.951 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.98 92.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.07 -1.019 . . . . 0.0 109.93 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.03 -28.59 70.2 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.98 -17.18 61.82 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.759 -1.838 . . . . 0.0 111.604 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -105.49 -18.47 14.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.306 1.442 . . . . 0.0 110.332 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -100.71 -23.94 14.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.53 -26.33 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.758 1.163 . . . . 0.0 111.807 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.83 -137.79 13.47 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.72 158.0 31.64 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 118.553 1.176 . . . . 0.0 108.741 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.47 174.53 12.55 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.381 -1.815 . . . . 0.0 107.381 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.35 151.12 48.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.325 177.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -139.96 8.58 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.33 1.852 . . . . 0.0 110.472 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.92 -30.33 65.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.967 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.15 -37.33 94.33 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 mt -68.45 -33.96 75.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.4 19.42 4.62 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.254 1.883 . . . . 0.0 114.04 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -125.35 177.86 5.92 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.281 1.033 . . . . 0.0 111.661 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -131.15 159.18 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.752 1.621 . . . . 0.0 108.48 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.61 177.71 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.716 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.39 137.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.344 -2.835 . . . . 0.0 103.344 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -118.31 106.26 12.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.608 1.563 . . . . 0.0 107.883 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 m -143.96 98.31 3.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.01 122.26 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -77.38 145.02 37.51 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -146.74 114.15 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.82 1.248 . . . . 0.0 109.742 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.4 -21.82 9.49 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 121.11 -0.994 . . . . 0.0 114.104 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.88 -22.95 64.16 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.131 0.966 . . . . 0.0 111.62 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -144.53 62.79 1.32 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.42 1.105 . . . . 0.0 111.397 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.92 -56.4 23.79 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.605 1.162 . . . . 0.0 110.697 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.88 -38.76 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.897 1.731 . . . . 0.0 112.157 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.61 88.91 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -64.47 -47.03 80.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.329 1.052 . . . . 0.0 109.744 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mt -54.49 -42.23 70.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.101 0.96 . . . . 0.0 112.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -59.25 -32.42 69.97 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.842 -0.536 . . . . 0.0 111.743 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -62.85 -25.41 68.26 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -44.88 9.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -57.41 -28.01 62.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.698 1.199 . . . . 0.0 112.486 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.77 -12.23 59.96 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.766 -0.584 . . . . 0.0 111.627 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -112.84 -49.25 2.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.649 0.779 . . . . 0.0 109.699 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 51.3 m-85 -80.87 99.14 8.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -57.77 -44.69 86.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 81.42 33.87 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -26.2 44.17 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.62 2.214 . . . . 0.0 113.789 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -59.42 -14.65 13.03 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -116.68 -16.47 10.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.655 1.582 . . . . 0.0 110.114 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -77.23 132.97 38.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.072 1.349 . . . . 0.0 111.507 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.407 ' HB ' ' HA ' ' A' ' 22' ' ' ALA . 25.9 m -103.67 138.15 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.09 101.93 8.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -78.87 103.42 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.63 123.89 38.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 tp -120.23 125.04 47.14 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.704 1.201 . . . . 0.0 109.061 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -127.94 172.92 10.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.856 1.662 . . . . 0.0 106.877 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -65.71 -36.44 83.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.561 -1.337 . . . . 0.0 111.986 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -138.76 -173.98 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.572 1.949 . . . . 0.0 107.017 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.64 -26.81 2.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.709 2.404 . . . . 0.0 114.548 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.55 -113.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 130.197 3.761 . . . . 0.0 116.552 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -116.54 0.49 12.71 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.057 1.743 . . . . 0.0 113.645 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -30.65 -54.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 130.085 3.354 . . . . 0.0 115.714 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.64 -42.28 82.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.724 0.81 . . . . 0.0 110.346 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -42.99 96.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.1 -37.45 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.349 1.46 . . . . 0.0 108.496 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.48 98.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.46 -43.6 76.65 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -52.43 -57.47 9.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.832 1.196 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.5 m -63.7 -39.28 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.135 -0.353 . . . . 0.0 111.033 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.48 -52.53 64.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.598 0.759 . . . . 0.0 110.161 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.8 -44.47 93.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.557 1.543 . . . . 0.0 108.572 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -57.07 -45.07 83.56 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.126 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.21 -13.55 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-O 117.269 -1.85 . . . . 0.0 114.943 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.51 146.5 40.22 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.861 2.33 . . . . 0.0 110.705 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -60.55 3.23 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.193 1.397 . . . . 0.0 113.367 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.5 t -149.7 169.89 19.98 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.11 141.25 15.03 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -128.19 143.94 51.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.936 1.694 . . . . 0.0 106.673 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.92 118.28 36.13 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.6 95.89 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.67 142.54 39.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 76.55 2.29 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.261 2.225 . . . . 0.0 111.673 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.92 -126.22 35.07 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.879 -1.138 . . . . 0.0 113.783 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.48 4.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.122 1.369 . . . . 0.0 112.211 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -93.99 -12.81 27.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.396 1.478 . . . . 0.0 114.533 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.01 169.28 13.29 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.878 1.217 . . . . 0.0 111.471 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 -25.46 24.97 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.951 3.101 . . . . 0.0 115.671 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -134.11 27.53 3.84 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.22 1.808 . . . . 0.0 110.053 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.65 174.16 39.66 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -40.43 -53.11 2.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -63.21 -51.2 67.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.34 0.518 . . . . 0.0 109.659 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -77.47 27.82 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.478 1.111 . . . . 0.0 111.453 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.0 m -128.38 7.4 5.87 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.063 1.745 . . . . 0.0 111.524 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.9 m 57.83 53.66 6.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.039 1.335 . . . . 0.0 110.08 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 13' ' ' TYR . 90.5 mt -122.11 144.28 41.06 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.6 144.11 99.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.286 2.658 . . . . 0.0 112.285 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -147.2 156.05 42.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.87 0.868 . . . . 0.0 112.161 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.5 mt -105.66 89.95 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 110.132 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -74.67 156.4 86.72 Favored Pre-proline 0 C--O 1.239 0.519 0 O-C-N 121.776 -0.577 . . . . 0.0 109.587 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 CA--C 1.54 0.809 0 C-N-CA 123.54 2.827 . . . . 0.0 109.042 178.18 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.441 -0.902 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 -86.43 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -178.03 167.32 2.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.642 1.977 . . . . 0.0 109.16 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.46 -52.69 60.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.929 0.892 . . . . 0.0 110.083 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -55.41 -52.04 64.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.901 0.48 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.55 -51.53 66.76 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -55.96 -47.22 78.01 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -53.09 -52.23 59.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.606 0.763 . . . . 0.0 112.032 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 m -69.01 -36.06 77.36 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.557 -0.714 . . . . 0.0 111.441 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.39 -39.98 89.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.5 HD23 ' HB1' ' A' ' 22' ' ' ALA . 73.6 mt -63.9 -38.82 92.5 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.51 0.53 33.59 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 127.084 2.278 . . . . 0.0 114.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.48 -20.88 3.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.522 1.161 . . . . 0.0 111.043 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -117.16 102.98 9.75 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.562 -0.711 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.47 -26.24 60.94 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.42 -13.18 61.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.441 1.096 . . . . 0.0 111.252 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -90.74 146.63 23.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.914 -1.117 . . . . 0.0 111.524 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.56 30.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 tt -103.93 143.73 32.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.665 0.786 . . . . 0.0 108.903 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -131.37 98.44 4.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.917 1.687 . . . . 0.0 108.868 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -78.47 113.81 16.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.9 pt -103.79 13.38 7.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -73.74 166.33 23.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 134.36 50.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -54.63 -27.01 36.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.72 1.208 . . . . 0.0 112.39 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.26 88.35 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.997 -1.064 . . . . 0.0 110.128 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -71.41 -27.05 63.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.105 0.866 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -59.3 -28.5 66.84 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.593 0.633 . . . . 0.0 109.377 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -85.58 -38.9 17.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.862 0.865 . . . . 0.0 110.086 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -68.77 -50.11 53.14 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.81 -12.33 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.02 -152.18 20.01 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.141 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 p -143.71 161.36 46.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.562 1.181 . . . . 0.0 112.956 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.4 157.73 58.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.989 1.793 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.559 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -125.19 87.5 2.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.968 2.107 . . . . 0.0 112.493 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.3 5.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 119.313 -2.117 . . . . 0.0 111.043 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -24.53 61.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.234 1.814 . . . . 0.0 112.867 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.9 -27.08 61.53 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.61 -50.76 6.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 1.59 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.682 1.61 . . . . 0.0 112.668 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.25 -179.9 5.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.15 . . . . 0.0 109.55 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -141.28 133.88 28.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.68 1.592 . . . . 0.0 107.192 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.32 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.628 0.728 . . . . 0.0 111.754 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -127.95 138.3 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -115.72 110.33 18.96 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.439 1.096 . . . . 0.0 109.842 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.41 103.12 4.21 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.773 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.11 124.53 12.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 119.985 1.266 . . . . 0.0 109.417 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -79.75 122.49 26.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.68 121.58 25.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.21 -15.37 37.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.124 -0.82 . . . . 0.0 114.087 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.44 -17.8 60.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.68 1.24 . . . . 0.0 110.478 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -131.49 66.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.275 1.03 . . . . 0.0 109.976 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -57.54 -58.68 16.58 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 120.195 -1.566 . . . . 0.0 108.46 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -34.61 8.18 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.867 1.712 . . . . 0.0 110.241 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.82 -28.55 63.36 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -80.86 -55.93 4.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -48.74 -50.31 34.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.424 1.89 . . . . 0.0 112.824 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -32.99 63.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -63.35 -28.16 69.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.892 0.877 . . . . 0.0 110.189 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -45.91 10.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 t -53.93 -33.52 56.99 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.268 1.427 . . . . 0.0 112.095 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -6.18 52.11 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.66 -39.4 3.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.623 0.769 . . . . 0.0 112.851 -178.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CD1' HG21 ' A' ' 75' ' ' THR . 47.7 m-85 -80.12 119.86 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -33.53 72.48 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.548 0.53 . . . . 0.0 112.097 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -145.67 96.24 4.8 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 124.467 1.107 . . . . 0.0 108.223 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.84 -34.53 91.22 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.699 1.6 . . . . 0.0 111.906 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.28 -12.81 32.09 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.25 6.9 p30 -122.5 25.5 8.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.941 1.296 . . . . 0.0 109.29 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' PHE . 25.4 m -130.84 120.16 23.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.258 1.023 . . . . 0.0 110.696 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.6 m -93.18 137.05 32.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.6 mt -115.91 96.21 5.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.227 1.011 . . . . 0.0 112.148 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 13.9 m-85 -78.21 121.07 23.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.434 HG12 ' H ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -74.2 154.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.98 1.312 . . . . 0.0 112.668 -179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 80' ' ' LEU . 12.4 tp -155.31 105.05 2.46 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 176.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.94 171.88 8.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.851 1.66 . . . . 0.0 106.823 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.66 -58.16 3.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.059 1.343 . . . . 0.0 112.304 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -137.74 -152.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.725 2.41 . . . . 0.0 105.544 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.76 -45.4 9.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.995 2.118 . . . . 0.0 112.253 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.17 -104.09 0.06 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.829 2.157 . . . . 0.0 113.834 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -143.74 11.81 1.65 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.055 1.742 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -39.77 -48.04 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.475 1.91 . . . . 0.0 114.601 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.93 -49.45 77.77 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.835 0.854 . . . . 0.0 110.518 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.18 89.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.24 -33.67 62.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.31 93.93 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.254 0.934 . . . . 0.0 109.66 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -74.28 -38.95 63.26 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.998 0.817 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.4 tp -51.55 -60.09 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.046 1.338 . . . . 0.0 111.808 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.58 -37.47 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 122.603 0.361 . . . . 0.0 111.388 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.6 70.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.15 -41.42 88.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -66.69 -25.68 66.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.03 -4.5 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 117.712 -1.605 . . . . 0.0 115.717 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.24 146.55 48.93 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 120.458 2.129 . . . . 0.0 108.137 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -45.36 -64.03 0.81 Allowed 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.726 1.211 . . . . 0.0 111.523 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.0 m -157.39 179.27 9.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.838 1.655 . . . . 0.0 107.599 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.59 142.31 12.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.494 1.518 . . . . 0.0 106.95 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.442 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -128.6 129.45 45.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.865 1.266 . . . . 0.0 108.78 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.64 139.88 30.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.65 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 126.417 1.887 . . . . 0.0 107.793 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -59.66 151.98 23.58 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.81 0.844 . . . . 0.0 109.445 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 66.83 10.17 7.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.42 1.488 . . . . 0.0 112.742 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.89 -116.54 3.39 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.925 2.202 . . . . 0.0 113.284 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 -43.57 3.26 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.653 0.781 . . . . 0.0 112.774 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.71 -10.74 41.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.74 176.01 9.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.028 1.286 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.44 -19.31 67.72 Favored 'Trans proline' 0 N--CA 1.471 0.147 0 C-N-CA 123.919 3.079 . . . . 0.0 112.982 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -119.54 -3.97 10.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.345 2.258 . . . . 0.0 109.327 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.45 159.26 25.81 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -25.9 -62.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.462 2.305 . . . . 0.0 114.164 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.51 -62.68 1.52 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.176 1.39 . . . . 0.0 110.77 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.66 -10.01 16.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.423 1.089 . . . . 0.0 113.263 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.82 15.31 7.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 0.0 109.113 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 m 68.85 15.56 8.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.349 2.66 . . . . 0.0 112.62 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.69 153.01 52.44 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 119.144 0.884 . . . . 0.0 110.252 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' C ' HD21 ' A' ' 40' ' ' ASN . 33.7 Cg_endo -74.64 169.75 21.85 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.2 1.934 . . . . 0.0 109.536 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -165.19 130.09 2.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 119.946 -1.721 . . . . 0.0 109.555 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -72.26 97.21 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.658 1.983 . . . . 0.0 109.439 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -93.91 149.52 37.1 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 121.058 -1.026 . . . . 0.0 112.388 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo . . . . . 0 N--CA 1.453 -0.886 0 C-N-CA 124.046 3.164 . . . . 0.0 109.156 178.751 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.808 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 m -60.93 137.61 58.21 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 117.921 0.86 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 p -128.83 -70.32 0.68 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.678 1.191 . . . . 0.0 109.975 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.62 117.15 8.51 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 125.276 1.417 . . . . 0.0 110.21 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.4 m -57.5 115.24 2.63 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 p -147.01 178.45 8.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.693 -0.629 . . . . 0.0 111.536 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.24 -117.6 0.61 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.348 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 m -122.2 148.4 45.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.523 1.529 . . . . 0.0 111.002 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.57 -42.87 75.32 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.315 1.046 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.36 -41.32 79.88 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.732 0.813 . . . . 0.0 111.482 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -61.45 -42.8 99.33 Favored 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.07 82.74 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.343 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -60.56 -40.17 90.68 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.036 1.289 . . . . 0.0 110.251 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.2 m -62.98 -54.02 44.93 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -57.17 -43.09 82.26 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.619 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.98 -20.5 58.0 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.966 1.257 . . . . 0.0 111.423 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.2 -9.33 62.11 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.219 1.866 . . . . 0.0 112.653 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -122.96 -18.18 6.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.064 1.432 . . . . 0.0 110.913 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -97.21 103.73 15.69 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.59 -24.48 67.58 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.904 0.881 . . . . 0.0 109.905 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -94.24 -0.19 55.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.164 1.785 . . . . 0.0 112.912 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.91 148.39 29.89 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.246 0.93 . . . . 0.0 111.646 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -148.11 154.68 40.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.02 1.728 . . . . 0.0 108.321 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.04 131.09 52.99 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.067 1.747 . . . . 0.0 108.022 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.0 tp -122.68 114.97 21.31 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.849 1.66 . . . . 0.0 109.284 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.6 m-20 -84.67 104.19 14.43 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 126.292 1.837 . . . . 0.0 109.445 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -90.66 2.96 7.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 122.224 -0.298 . . . . 0.0 110.71 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 HH21 ' CG ' ' A' ' 26' ' ' ASP . 39.9 mtm180 -57.06 165.01 1.41 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.49 1.516 . . . . 0.0 110.966 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.53 141.74 32.38 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.9 m -49.16 -33.66 12.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.351 1.46 . . . . 0.0 111.194 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.52 78.49 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.235 0.925 . . . . 0.0 110.279 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 36' ' ' VAL . 66.3 m-20 -63.69 -39.42 94.27 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -58.9 -20.72 54.15 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.276 -1.515 . . . . 0.0 114.574 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.7 mtm180 -96.03 -23.47 16.8 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.955 0.502 . . . . 0.0 111.586 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -90.35 -70.26 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.897 1.679 . . . . 0.0 110.941 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 32' ' ' ASP . 9.6 p -77.36 -31.92 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.425 1.09 . . . . 0.0 111.708 -178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.3 -138.32 13.92 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -147.48 162.63 31.38 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 120.619 -1.518 . . . . 0.0 109.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.55 163.28 37.44 Favored 'Trans proline' 0 N--CA 1.435 -1.937 0 CA-C-O 124.618 1.841 . . . . 0.0 110.141 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.612 ' HB2' HG13 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -126.19 92.26 3.54 Favored 'General case' 0 N--CA 1.419 -2.003 1 C-N-CA 132.346 4.258 . . . . 0.0 105.295 -179.212 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.8 pt -115.43 -19.73 6.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.195 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -43.24 -26.54 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 116.567 -1.682 . . . . 0.0 115.475 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.4 37.36 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 119.991 1.269 . . . . 0.0 110.303 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.46 -71.5 0.5 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.32 32.2 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 CA-C-O 118.815 -0.992 . . . . 0.0 115.194 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -126.77 177.73 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.053 1.926 . . . . 0.0 110.39 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.86 133.7 43.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.413 1.085 . . . . 0.0 110.076 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.26 167.39 18.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.374 -0.828 . . . . 0.0 110.387 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.1 t -134.34 134.59 54.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -115.14 115.84 27.41 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.564 1.146 . . . . 0.0 109.355 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.5 107.86 4.41 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 t -65.73 111.44 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 119.776 1.171 . . . . 0.0 110.182 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -74.29 154.86 38.76 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.592 0.71 . . . . 0.0 109.34 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -165.3 134.78 3.5 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.91 -34.79 80.06 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -66.99 -24.87 66.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.414 1.107 . . . . 0.0 111.115 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -105.32 15.35 27.45 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.582 1.553 . . . . 0.0 114.169 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -39.43 -60.0 1.41 Allowed Pre-proline 0 N--CA 1.482 1.144 0 CA-C-N 121.459 1.936 . . . . 0.0 112.328 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.82 -47.64 6.6 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.554 2.836 . . . . 0.0 112.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.75 -22.85 68.6 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 123.847 0.737 . . . . 0.0 113.293 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -82.89 -50.17 8.89 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.097 1.759 . . . . 0.0 107.481 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.2 mt -52.53 -47.58 66.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.495 1.518 . . . . 0.0 112.882 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -52.38 -43.44 64.72 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -58.16 -22.2 50.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.741 1.216 . . . . 0.0 113.794 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.41 -52.79 5.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.8 t -55.68 -30.0 60.32 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.951 0.9 . . . . 0.0 110.106 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.74 -4.58 59.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.47 -36.67 4.54 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 119.497 1.044 . . . . 0.0 111.342 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.49 120.2 29.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.167 1.387 . . . . 0.0 107.503 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -58.79 -54.11 50.79 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.293 0.497 . . . . 0.0 111.124 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -116.87 83.78 14.91 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.526 1.13 . . . . 0.0 110.012 -178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 11.0 Cg_endo -56.6 -40.75 82.25 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.163 1.909 . . . . 0.0 110.253 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -64.32 -0.78 1.38 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.69 -11.92 4.9 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.119 1.368 . . . . 0.0 110.135 178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.9 m -90.29 138.19 31.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.718 1.207 . . . . 0.0 110.979 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.5 m -100.82 123.46 45.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.64 97.16 6.76 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.018 1.327 . . . . 0.0 110.975 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 41.8 m-85 -73.42 120.04 18.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.584 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.9 OUTLIER -76.42 156.86 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.278 1.431 . . . . 0.0 109.992 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.4 tt -156.35 110.57 2.77 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -123.76 169.21 11.75 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -54.89 -39.07 68.36 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.718 -1.238 . . . . 0.0 109.736 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -141.77 -140.84 0.13 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.658 1.983 . . . . 0.0 108.989 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -64.95 -62.29 1.65 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.643 1.577 . . . . 0.0 108.2 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.89 -86.87 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 127.739 2.59 . . . . 0.0 113.675 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -140.46 9.44 2.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.992 0.917 . . . . 0.0 111.422 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.584 ' HA ' HG21 ' A' ' 79' ' ' ILE . 19.3 m -42.69 -53.6 4.43 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.829 1.652 . . . . 0.0 114.182 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -39.23 78.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.24 1.382 . . . . 0.0 112.249 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.84 -50.59 72.81 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.9 -30.42 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.547 1.139 . . . . 0.0 109.94 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.13 89.15 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -78.84 -35.62 43.67 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.2 tp -51.04 -57.22 9.22 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.295 1.438 . . . . 0.0 112.194 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -63.04 -41.07 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.406 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.63 77.07 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.038 0.935 . . . . 0.0 110.024 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.99 -38.5 91.4 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.211 1.004 . . . . 0.0 109.445 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.96 -49.35 76.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -8.07 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-O 118.132 -1.371 . . . . 0.0 113.269 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 31.9 m-85 -61.1 156.33 18.36 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 120.123 1.961 . . . . 0.0 109.93 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -59.22 -68.48 0.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.5 m -158.76 171.28 20.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.155 0.982 . . . . 0.0 109.068 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.72 164.24 36.61 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.4 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 32.9 m-85 -135.0 125.45 26.59 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.87 109.58 20.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.36 92.28 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.02 133.5 14.72 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.98 2.112 . . . . 0.0 107.015 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 89.85 -5.07 0.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 129.636 3.174 . . . . 0.0 112.375 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 65.44 -164.54 37.51 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -88.89 -14.09 37.6 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 117.656 -1.164 . . . . 0.0 114.047 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.23 -2.63 14.03 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.362 0.983 . . . . 0.0 113.61 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.4 176.29 19.1 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.131 -0.981 . . . . 0.0 113.304 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.22 -25.48 56.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.316 3.344 . . . . 0.0 115.248 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -134.8 28.5 3.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.762 2.025 . . . . 0.0 110.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.19 -171.76 5.21 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.483 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 36.4 t-105 -47.2 -55.17 9.04 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.646 0.778 . . . . 0.0 112.613 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.14 -50.77 71.83 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.044 0.937 . . . . 0.0 110.29 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -75.11 24.96 0.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.802 1.241 . . . . 0.0 113.468 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.3 m -129.37 12.26 5.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.599 1.96 . . . . 0.0 110.823 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.46 18.29 11.27 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.398 1.479 . . . . 0.0 112.976 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.4 mt -82.44 149.96 62.49 Favored Pre-proline 0 N--CA 1.451 -0.42 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.62 154.68 49.78 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.35 2.033 . . . . 0.0 109.856 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.6 t-105 -155.15 157.33 37.25 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.263 0.483 . . . . 0.0 110.385 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.612 HG13 ' HB2' ' A' ' 40' ' ' ASN . 3.4 mt -107.83 88.03 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.184 1.394 . . . . 0.0 110.45 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.42 156.22 91.81 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.984 0.913 . . . . 0.0 109.365 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.75 -173.58 1.9 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.147 3.232 . . . . 0.0 109.124 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -68.82 103.53 1.8 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.768 0.794 . . . . 0.0 109.091 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -78.12 162.47 26.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.2 m -130.25 149.89 51.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.8 m -72.5 110.33 6.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.06 105.44 0.25 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.53 165.19 31.0 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.634 2.223 . . . . 0.0 109.622 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.8 p -147.35 -1.56 0.63 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.5 t -80.1 -173.47 3.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 123.077 1.418 . . . . 0.0 109.704 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 1 C-N-CA 132.001 4.62 . . . . 0.0 104.544 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.698 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.41 31.16 1.22 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 108.68 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -67.14 -26.44 66.67 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.439 1.496 . . . . 0.0 111.716 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.1 170.58 53.15 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.2 t -117.63 100.53 7.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.9 p -133.35 166.01 23.5 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 109.617 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.6 -120.77 0.57 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 118.64 -1.743 . . . . 0.0 115.438 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.02 146.05 52.25 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.018 1.327 . . . . 0.0 109.991 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.43 ' HB3' ' OG ' ' A' ' 118' ' ' SER . . . -53.9 -50.41 66.41 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.135 1.774 . . . . 0.0 107.864 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -55.71 -49.58 72.63 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.634 0.652 . . . . 0.0 111.823 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -55.49 -43.99 76.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.145 0.43 . . . . 0.0 111.086 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.06 -34.19 72.9 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.258 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -66.49 -49.13 67.61 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.762 1.619 . . . . 0.0 109.064 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -54.43 -45.2 72.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.579 0.751 . . . . 0.0 109.093 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 18' ' ' THR . 51.4 mmtt -58.25 -36.26 72.96 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.604 -1.188 . . . . 0.0 112.275 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.08 -25.68 65.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.72 1.6 . . . . 0.0 111.736 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.77 -40.18 6.36 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 15' ' ' LYS . 1.1 t -78.67 -4.28 48.24 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.751 0.776 . . . . 0.0 110.941 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -126.51 -168.72 1.9 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.565 0.746 . . . . 0.0 109.12 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -141.66 -43.23 0.36 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.882 2.473 . . . . 0.0 106.554 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -16.37 63.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.476 0.71 . . . . 0.0 111.44 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.85 124.03 27.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -134.33 138.02 44.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.789 0.836 . . . . 0.0 110.218 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.6 tm? -84.5 133.5 34.46 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.413 1.085 . . . . 0.0 108.552 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 24' ' ' LEU . 21.3 tp -126.58 112.47 15.55 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.593 1.557 . . . . 0.0 109.407 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -89.09 117.96 28.46 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.585 2.354 . . . . 0.0 109.15 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.1 pt -108.98 14.2 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -76.55 164.87 25.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 135.15 55.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 60.7 m -51.6 -32.54 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.849 1.26 . . . . 0.0 111.724 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.46 -36.3 77.92 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.637 1.108 . . . . 0.0 111.622 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -62.62 -28.99 70.28 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.74 0.7 . . . . 0.0 109.804 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -62.43 -13.67 32.42 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 120.873 -1.142 . . . . 0.0 111.313 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.4 mtm180 -107.78 -35.87 6.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.385 1.074 . . . . 0.0 110.467 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -85.61 -28.8 24.56 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.74 -22.57 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 119.424 1.011 . . . . 0.0 110.346 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.06 -159.6 17.2 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 121.64 -0.662 . . . . 0.0 112.722 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -140.01 161.39 56.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 123.611 0.764 . . . . 0.0 111.285 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.09 155.69 47.34 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.73 1.62 . . . . 0.0 110.51 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.635 HD21 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -127.39 86.86 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.494 1.918 . . . . 0.0 108.934 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 pt -85.18 6.6 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.323 -0.861 . . . . 0.0 109.962 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -51.92 -34.65 42.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.459 1.503 . . . . 0.0 112.257 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.57 -6.97 9.46 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 120.796 1.634 . . . . 0.0 114.173 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.8 mt -105.15 -23.33 12.93 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.571 1.548 . . . . 0.0 109.086 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 103.26 29.41 5.73 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 127.939 2.685 . . . . 0.0 109.883 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -124.37 168.5 12.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.849 0.824 . . . . 0.0 110.831 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 48' ' ' ALA . 6.7 tptt -135.84 120.16 17.93 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.613 1.165 . . . . 0.0 108.296 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' HE3' ' A' ' 47' ' ' LYS . . . -66.75 174.77 2.72 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.84 0.829 . . . . 0.0 112.387 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -119.46 149.83 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.131 -2.914 . . . . 0.0 103.131 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 p -133.95 113.74 12.51 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.085 1.354 . . . . 0.0 111.315 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.9 m -158.26 113.75 2.68 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.78 121.32 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 122.03 0.919 . . . . 0.0 112.773 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.89 156.4 32.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.1 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -166.88 161.27 15.12 Favored 'General case' 0 N--CA 1.437 -1.117 0 C-N-CA 129.33 3.052 . . . . 0.0 106.141 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.95 -12.32 62.22 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.558 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -68.7 -42.57 77.57 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.352 1.061 . . . . 0.0 110.223 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -114.32 38.82 2.93 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.661 1.984 . . . . 0.0 112.841 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -46.83 -50.55 43.5 Favored Pre-proline 0 CA--C 1.546 0.82 0 CA-C-N 120.737 1.608 . . . . 0.0 109.882 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.9 -40.01 13.16 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.727 1.618 . . . . 0.0 111.959 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.88 -53.19 46.12 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 125.394 1.473 . . . . 0.0 109.644 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -55.93 -50.35 70.97 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.202 2.201 . . . . 0.0 108.307 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -56.85 -46.89 81.45 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.184 0.593 . . . . 0.0 109.902 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -58.21 -42.88 87.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.097 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -56.94 -24.08 50.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.466 1.03 . . . . 0.0 111.984 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mt -96.26 -46.9 6.24 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.57 1.148 . . . . 0.0 108.894 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -64.02 -11.9 33.43 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.51 0.595 . . . . 0.0 112.139 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 pp -93.79 -3.86 51.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.251 0.478 . . . . 0.0 110.297 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 -32.68 5.88 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.5 1.92 . . . . 0.0 112.425 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.41 127.46 48.05 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.635 1.174 . . . . 0.0 111.503 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.29 -41.36 66.75 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -135.99 89.61 20.27 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 119.677 1.126 . . . . 0.0 111.027 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.58 -31.42 26.75 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.702 1.601 . . . . 0.0 112.414 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -61.1 -10.86 6.93 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.075 0.95 . . . . 0.0 112.706 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -130.84 23.61 4.99 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.434 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.8 m -134.06 120.93 20.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.84 1.2 . . . . 0.0 110.603 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 m -83.7 132.26 34.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.288 1.435 . . . . 0.0 110.605 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 99' ' ' PHE . 51.7 mt -108.19 103.47 12.67 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.001 0.92 . . . . 0.0 112.154 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 65.7 m-85 -82.86 100.68 10.5 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.1 134.2 28.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 123.951 0.901 . . . . 0.0 110.127 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.79 135.94 38.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.063 0.945 . . . . 0.0 109.141 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -130.4 176.19 8.35 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 128.693 2.797 . . . . 0.0 108.161 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -61.69 -35.61 78.5 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.546 -1.347 . . . . 0.0 109.628 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -138.58 -151.64 0.39 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.598 1.959 . . . . 0.0 106.808 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -63.51 -45.68 89.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.61 -108.93 0.22 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 128.2 2.81 . . . . 0.0 114.66 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -118.6 2.15 11.72 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.596 1.159 . . . . 0.0 112.829 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.8 m -35.29 -57.14 0.6 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.978 2.111 . . . . 0.0 114.717 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -63.59 -38.07 89.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.85 -31.44 63.19 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.601 0.715 . . . . 0.0 110.074 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.75 -31.29 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.15 93.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.386 0.674 . . . . 0.0 109.545 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.59 -44.61 73.98 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 122.91 0.484 . . . . 0.0 110.39 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.8 tp -52.57 -57.24 10.62 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.298 1.039 . . . . 0.0 112.648 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -62.21 -40.28 87.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.29 -51.54 68.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.72 0.808 . . . . 0.0 109.902 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -64.36 -23.34 67.26 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.804 0.842 . . . . 0.0 112.623 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -82.01 -19.52 40.28 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 121.567 -0.708 . . . . 0.0 111.136 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.42 -4.18 5.88 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-O 117.406 -1.775 . . . . 0.0 113.4 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CE2' HD11 ' A' ' 77' ' ' LEU . 35.2 m-85 -65.38 140.75 58.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 120.61 2.205 . . . . 0.0 108.224 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.3 tptt -47.77 -61.01 2.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.806 2.042 . . . . 0.0 114.142 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -157.29 166.57 32.77 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.28 151.39 31.74 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.425 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 24.8 m-85 -141.19 135.5 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.743 1.617 . . . . 0.0 107.748 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.34 118.95 38.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.707 2.003 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mp -77.07 110.66 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -66.89 149.07 51.12 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 66.76 8.96 6.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.312 1.845 . . . . 0.0 113.833 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.71 -104.25 0.07 OUTLIER Glycine 0 C--N 1.341 0.813 0 C-N-CA 127.057 2.265 . . . . 0.0 114.244 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.6 -45.5 0.67 Allowed 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.901 1.28 . . . . 0.0 111.948 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.0 -2.02 31.8 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 123.735 0.647 . . . . 0.0 112.089 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.33 174.53 53.46 Favored Glycine 0 CA--C 1.54 1.648 0 O-C-N 121.035 -1.04 . . . . 0.0 112.059 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.36 -23.69 75.36 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 124.559 3.506 . . . . 0.0 115.542 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -131.79 14.84 4.84 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.51 1.124 . . . . 0.0 110.57 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.4 165.91 30.99 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -27.7 -56.98 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 128.198 2.599 . . . . 0.0 114.697 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 mt -56.71 -63.19 1.28 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.117 0.967 . . . . 0.0 109.159 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -69.07 7.21 0.75 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.741 1.616 . . . . 0.0 112.718 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 22.7 t -100.53 6.87 44.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.32 1.448 . . . . 0.0 109.877 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.4 t 66.78 49.22 1.25 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.147 1.34 . . . . 0.0 108.657 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.7 mt -128.67 155.57 78.88 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 125.084 1.354 . . . . 0.0 109.123 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' C ' HD21 ' A' ' 40' ' ' ASN . 58.4 Cg_endo -76.62 168.72 23.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.645 2.23 . . . . 0.0 110.989 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.635 ' N ' HD21 ' A' ' 40' ' ' ASN . 34.0 t-105 -171.83 126.19 0.59 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.182 -1.574 . . . . 0.0 110.816 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.426 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 5.8 mt -68.66 88.63 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.324 1.85 . . . . 0.0 110.716 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.24 155.11 69.65 Favored Pre-proline 0 C--O 1.24 0.603 0 O-C-N 121.103 -0.998 . . . . 0.0 110.309 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.72 -175.2 2.34 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 124.51 3.473 . . . . 0.0 110.72 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -76.22 90.09 3.13 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -60.23 149.8 32.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.058 0.844 . . . . 0.0 109.131 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.6 t -127.42 177.5 6.7 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.517 1.127 . . . . 0.0 109.641 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -66.85 171.28 5.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.021 1.328 . . . . 0.0 109.563 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.13 73.29 1.13 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.58 177.84 6.36 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.449 2.099 . . . . 0.0 110.62 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.8 p -125.86 161.03 28.35 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.185 1.394 . . . . 0.0 108.598 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.9 p -66.57 169.19 8.0 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.371 0.668 . . . . 0.0 111.564 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.745 -1.03 . . . . 0.0 111.296 179.524 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -122.1 -55.57 1.87 Allowed 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.046 0.938 . . . . 0.0 109.218 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m 57.75 30.57 19.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.388 0.54 . . . . 0.0 111.544 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.91 73.89 0.02 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.656 1.598 . . . . 0.0 109.771 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.2 t -84.27 86.38 7.25 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.281 -1.129 . . . . 0.0 109.769 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.7 p -113.47 151.77 31.01 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.1 0.56 . . . . 0.0 111.533 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.4 -101.65 0.23 Allowed Glycine 0 C--N 1.338 0.67 0 O-C-N 121.491 -0.755 . . . . 0.0 111.941 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.3 m -160.11 164.94 32.62 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.054 2.542 . . . . 0.0 106.936 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.26 -44.5 95.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.654 -0.654 . . . . 0.0 112.554 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttp -55.26 -48.81 73.44 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.006 0.821 . . . . 0.0 110.684 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -55.59 -50.1 71.01 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.379 0.671 . . . . 0.0 109.419 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.65 -47.75 81.39 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.101 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 16' ' ' LEU . 2.4 t80 -59.42 -43.37 93.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.777 1.171 . . . . 0.0 110.561 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.6 m -58.91 -45.02 91.3 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.235 -0.915 . . . . 0.0 109.425 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -65.04 -42.16 94.55 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-O 118.274 -0.87 . . . . 0.0 109.946 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 13' ' ' TYR . 53.3 mt -57.28 -41.88 80.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 119.108 0.867 . . . . 0.0 109.548 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA2' HD22 ' A' ' 44' ' ' LEU . . . -72.67 -14.31 77.92 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-O 118.186 -1.341 . . . . 0.0 115.32 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 t -115.25 -13.12 11.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.05 1.425 . . . . 0.0 112.02 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -113.3 99.78 8.06 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -55.84 -25.86 43.94 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.572 1.149 . . . . 0.0 112.9 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -89.37 -3.96 58.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.543 0.737 . . . . 0.0 112.758 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.05 149.84 24.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.528 1.058 . . . . 0.0 110.092 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -145.96 174.09 11.57 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -111.39 144.42 40.61 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.436 0.695 . . . . 0.0 110.144 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 tp -121.35 108.73 14.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 127.666 2.387 . . . . 0.0 112.541 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -86.5 109.82 19.34 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.476 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.4 pt -102.07 2.25 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -42.19 -102.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.72 130.02 3.68 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -44.59 -34.33 2.11 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.906 2.082 . . . . 0.0 114.726 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.78 -34.29 45.68 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 120.359 1.436 . . . . 0.0 110.781 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.08 -29.33 69.68 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -63.34 -20.69 65.73 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 119.628 -1.92 . . . . 0.0 112.168 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -91.92 -19.93 21.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.573 1.549 . . . . 0.0 109.474 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.5 -62.86 1.18 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.16 1.384 . . . . 0.0 112.074 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.02 -38.53 12.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 123.964 0.906 . . . . 0.0 111.136 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.69 -151.76 17.27 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 118.886 0.766 . . . . 0.0 113.618 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.56 154.6 60.04 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.801 1.64 . . . . 0.0 108.036 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.75 172.65 14.77 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 121.551 1.501 . . . . 0.0 109.774 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -132.19 113.15 12.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.624 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.4 pt -103.27 14.47 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 122.631 1.205 . . . . 0.0 110.933 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.02 -17.29 51.42 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.548 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.65 -6.82 37.83 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-N 120.276 1.398 . . . . 0.0 111.335 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD22 ' HA2' ' A' ' 17' ' ' GLY . 52.3 mt -112.5 -22.72 10.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.703 2.801 . . . . 0.0 109.376 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.93 25.66 14.29 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 126.614 2.054 . . . . 0.0 109.667 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -116.63 178.92 4.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.512 1.925 . . . . 0.0 111.695 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.98 138.77 17.95 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.08 170.81 16.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.2 1.0 . . . . 0.0 112.421 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.0 133.75 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 126.956 2.102 . . . . 0.0 106.159 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.3 m -106.63 122.62 46.7 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.983 0.913 . . . . 0.0 111.611 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.502 ' CG2' ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -152.13 102.96 2.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.866 1.266 . . . . 0.0 109.503 -178.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.71 127.36 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 120.321 -1.487 . . . . 0.0 109.86 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -81.37 151.81 27.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -157.84 131.29 7.75 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.475 1.11 . . . . 0.0 108.563 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.84 66.56 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -86.67 -0.5 56.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.801 1.3 . . . . 0.0 111.833 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.62 25.58 5.37 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.64 0.776 . . . . 0.0 110.503 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -48.36 -57.14 11.44 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.844 -1.074 . . . . 0.0 109.676 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.28 -41.05 13.32 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 121.346 1.364 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -22.53 63.8 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 123.693 0.663 . . . . 0.0 113.78 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -83.29 -47.23 11.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.439 1.496 . . . . 0.0 107.585 177.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.2 mt -55.78 -46.83 77.85 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.214 1.405 . . . . 0.0 110.801 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -45.24 66.58 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 118.961 -0.543 . . . . 0.0 111.685 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.502 ' HE3' ' CG2' ' A' ' 51' ' ' THR . 40.9 mtmt -62.32 -20.03 63.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mt -95.67 -46.24 6.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.5 t -60.74 -21.25 62.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -92.23 -2.79 56.28 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 -27.79 7.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.979 0.911 . . . . 0.0 112.308 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.8 114.18 25.8 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.256 1.422 . . . . 0.0 108.268 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -66.21 -31.82 72.88 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.49 1.116 . . . . 0.0 111.287 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -138.49 77.48 34.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 17.3 Cg_endo -58.15 -40.75 74.01 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.091 1.861 . . . . 0.0 112.919 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -61.97 -6.11 2.63 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -125.94 -4.04 6.98 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.782 0.719 . . . . 0.0 111.463 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.4 m -96.39 124.37 40.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.781 1.232 . . . . 0.0 110.488 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.8 m -89.68 132.87 34.94 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.66 98.73 7.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 29.6 m-85 -78.33 113.99 16.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.127 -0.94 . . . . 0.0 108.478 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -81.93 134.55 26.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 120.228 1.376 . . . . 0.0 111.722 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.9 tp -129.88 113.29 14.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.35 1.46 . . . . 0.0 109.254 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -119.36 -177.27 3.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.691 1.596 . . . . 0.0 108.682 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -61.23 -54.48 43.67 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.356 -0.84 . . . . 0.0 110.121 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -139.1 -168.9 2.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.871 2.869 . . . . 0.0 106.34 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.68 -58.51 0.5 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.898 2.479 . . . . 0.0 112.689 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.02 -109.03 0.57 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.639 1.59 . . . . 0.0 114.835 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -134.55 10.04 3.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.194 2.198 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.7 m -44.13 -42.1 6.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.692 1.597 . . . . 0.0 113.157 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -64.01 -44.23 93.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.501 0.72 . . . . 0.0 111.284 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.61 -45.45 86.85 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.72 -28.6 44.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.094 0.958 . . . . 0.0 109.471 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.32 -44.8 82.37 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.916 0.78 . . . . 0.0 110.218 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -75.15 -39.35 60.45 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.1 -56.65 5.33 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.351 1.46 . . . . 0.0 111.798 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.56 -39.43 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.608 0.763 . . . . 0.0 111.19 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.57 -52.85 63.72 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.63 0.772 . . . . 0.0 109.093 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.84 -20.18 65.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.053 1.741 . . . . 0.0 111.656 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -89.58 -15.43 32.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.178 1.391 . . . . 0.0 114.025 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.14 -0.76 5.31 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-O 117.364 -1.798 . . . . 0.0 114.016 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 36.2 m-85 -81.74 156.35 25.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.9 1.85 . . . . 0.0 109.196 178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -54.54 -69.45 0.13 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.077 0.951 . . . . 0.0 112.128 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.3 m -161.31 177.93 9.69 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.694 2.398 . . . . 0.0 107.008 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.15 163.93 39.01 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 126.103 1.761 . . . . 0.0 107.253 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.515 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 28.5 m-85 -136.21 145.45 45.71 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.065 1.746 . . . . 0.0 107.891 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.15 118.43 35.33 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.846 1.259 . . . . 0.0 108.713 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.13 113.16 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -63.12 143.46 57.77 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 70.69 2.82 4.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.304 1.442 . . . . 0.0 112.983 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.69 -110.64 0.86 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 126.922 2.201 . . . . 0.0 114.639 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -122.44 -21.99 5.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.069 1.348 . . . . 0.0 114.36 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -110.01 -10.56 14.7 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.03 -173.47 47.62 Favored Glycine 0 CA--C 1.54 1.597 0 CA-C-N 119.579 1.081 . . . . 0.0 114.145 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.46 -36.32 93.92 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.116 3.211 . . . . 0.0 114.281 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.45 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 78.7 mmt-85 -111.32 11.1 21.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.491 1.116 . . . . 0.0 110.769 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.68 156.77 46.09 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 8.4 t-105 -36.22 -54.54 0.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.931 1.692 . . . . 0.0 114.538 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.29 -39.4 86.78 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -86.99 -8.56 57.08 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.013 0.925 . . . . 0.0 112.999 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 31.8 t -82.63 6.59 17.29 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.264 1.026 . . . . 0.0 111.028 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.2 m 54.72 57.08 6.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.993 1.717 . . . . 0.0 108.558 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 98.0 mt -121.67 154.58 60.2 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 126.844 2.058 . . . . 0.0 105.919 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.89 166.1 29.99 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.9 1.734 . . . . 0.0 110.159 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -159.94 143.09 13.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.847 1.203 . . . . 0.0 111.928 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 7.7 mt -95.2 98.07 7.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 123.208 0.603 . . . . 0.0 110.173 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.33 141.13 42.33 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.6 158.34 50.97 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.538 2.159 . . . . 0.0 106.584 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -75.15 35.44 0.11 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.462 -1.399 . . . . 0.0 113.065 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.41 -15.25 50.46 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 82.4 p -68.33 162.15 25.86 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 121.467 1.94 . . . . 0.0 110.168 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.6 m -148.9 117.82 6.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.843 2.057 . . . . 0.0 105.477 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.57 166.45 40.12 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.345 0.974 . . . . 0.0 111.61 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.29 -50.95 0.07 OUTLIER 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.963 2.442 . . . . 0.0 113.059 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.2 m -53.94 113.61 1.28 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.854 2.062 . . . . 0.0 112.088 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.5 m -68.24 -14.91 63.33 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.529 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -67.53 172.21 5.32 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.306 0.553 . . . . 0.0 110.992 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 m -84.7 40.35 0.79 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.119 0.968 . . . . 0.0 108.827 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.64 -170.46 23.06 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.45 1.976 . . . . 0.0 112.657 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.0 m -63.13 93.35 0.06 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.802 2.441 . . . . 0.0 114.876 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.9 p -75.25 159.56 31.39 Favored 'General case' 0 C--O 1.238 0.488 0 O-C-N 120.887 -1.133 . . . . 0.0 108.889 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.77 98.38 0.11 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -51.85 158.61 0.98 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.07 1.348 . . . . 0.0 110.434 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.67 -49.77 46.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.684 0.674 . . . . 0.0 111.701 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -58.37 -48.36 80.85 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.759 -0.588 . . . . 0.0 110.785 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -52.73 63.86 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 78' ' ' TYR . . . -53.77 -51.24 64.05 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.53 1.132 . . . . 0.0 110.3 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -60.0 -41.86 93.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.209 0.603 . . . . 0.0 111.698 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -61.77 -51.63 67.55 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -62.93 -36.12 82.36 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.769 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -59.98 -30.59 69.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.088 1.313 . . . . 0.0 108.195 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.48 -24.84 74.09 Favored Glycine 0 C--N 1.341 0.854 0 C-N-CA 125.266 1.413 . . . . 0.0 113.94 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -100.57 -24.16 14.52 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.301 1.551 . . . . 0.0 109.923 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.34 170.24 15.57 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.493 0.588 . . . . 0.0 110.329 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -119.36 -32.76 4.28 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.083 0.953 . . . . 0.0 111.475 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -101.83 -11.76 18.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.45 -0.781 . . . . 0.0 112.832 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.22 58.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.612 0.642 . . . . 0.0 112.466 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -140.02 166.55 24.34 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.93 125.16 42.7 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.628 1.571 . . . . 0.0 107.419 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 tp -108.5 97.6 7.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.771 1.628 . . . . 0.0 108.574 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.87 106.2 8.4 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -93.1 1.41 9.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 122.953 0.501 . . . . 0.0 111.738 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -59.19 168.04 1.55 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 126.91 2.084 . . . . 0.0 112.393 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.35 135.97 35.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 m -41.71 -41.22 2.22 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 127.187 2.195 . . . . 0.0 114.249 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.34 92.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.621 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -58.86 -29.08 66.7 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.0 -19.27 51.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.091 0.859 . . . . 0.0 109.23 177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -104.33 -33.69 8.56 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.779 2.432 . . . . 0.0 111.916 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -77.91 -44.01 28.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.232 1.013 . . . . 0.0 111.618 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -111.68 -25.71 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 124.492 1.117 . . . . 0.0 111.903 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.52 -163.27 13.55 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.199 0.909 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -143.06 162.97 40.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 122.958 0.503 . . . . 0.0 111.121 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -74.72 146.46 33.94 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.545 1.497 . . . . 0.0 112.94 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HB3' ' CG1' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -108.69 76.25 1.01 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 127.812 2.445 . . . . 0.0 109.659 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 pt -85.57 5.23 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.651 0.739 . . . . 0.0 110.817 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -53.09 -34.51 56.93 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.889 1.676 . . . . 0.0 114.368 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.63 -30.65 69.22 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.061 1.3 . . . . 0.0 110.971 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 36.5 mt -78.62 -21.01 49.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.745 0.818 . . . . 0.0 110.129 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.4 38.18 5.99 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -126.56 171.03 11.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.822 1.249 . . . . 0.0 111.029 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -143.86 137.73 28.14 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.899 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.14 167.08 22.51 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.2 94.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 t -62.32 119.87 9.9 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 m -152.26 95.64 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.966 1.307 . . . . 0.0 108.884 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 t -61.78 122.76 13.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -75.64 154.23 36.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.693 0.397 . . . . 0.0 109.984 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -148.98 127.27 12.16 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.92 -13.3 82.64 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 115.452 0.941 . . . . 0.0 115.452 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -91.57 -41.31 10.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.55 1.175 . . . . 0.0 108.15 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -91.71 29.03 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.744 1.618 . . . . 0.0 111.852 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -43.2 -53.84 10.3 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 120.971 -1.081 . . . . 0.0 111.137 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.09 -49.66 4.64 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.997 1.798 . . . . 0.0 112.136 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.56 -29.47 71.92 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.763 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -69.56 -48.36 60.55 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.062 1.745 . . . . 0.0 108.657 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -53.4 -41.59 66.12 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.321 1.049 . . . . 0.0 111.854 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -59.12 -33.18 70.57 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.572 -0.705 . . . . 0.0 111.741 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -60.03 -16.46 31.15 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.663 0.785 . . . . 0.0 111.92 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.3 -37.58 8.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.349 1.46 . . . . 0.0 109.731 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -25.18 65.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.637 1.562 . . . . 0.0 111.498 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -72.67 -6.04 41.61 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 121.585 -0.697 . . . . 0.0 112.03 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.48 -49.69 2.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.209 1.003 . . . . 0.0 108.455 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.9 m-85 -77.83 103.7 7.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 108.964 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.66 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.756 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -134.45 69.93 72.76 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.635 1.974 . . . . 0.0 112.861 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 -24.15 64.48 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 124.989 3.793 . . . . 0.0 111.919 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -53.87 -18.43 3.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 130.792 3.637 . . . . 0.0 113.057 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -134.31 -4.51 2.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.564 1.546 . . . . 0.0 111.689 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.491 HG21 ' CD1' ' A' ' 69' ' ' PHE . 22.3 m -76.03 121.79 23.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.607 1.094 . . . . 0.0 110.834 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -89.58 122.77 33.05 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.74 100.23 10.24 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.433 ' CD1' ' HB1' ' A' ' 12' ' ' ALA . 72.2 m-85 -79.16 105.47 10.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 mt -83.56 129.15 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 119.235 0.925 . . . . 0.0 110.959 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.1 tp -125.56 125.8 43.78 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.562 1.145 . . . . 0.0 108.319 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -128.17 177.36 6.97 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.961 2.105 . . . . 0.0 107.537 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -58.87 -52.59 65.07 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.692 -1.255 . . . . 0.0 109.378 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -141.31 178.77 7.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 129.691 3.196 . . . . 0.0 104.848 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -24.45 -57.33 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 130.399 3.48 . . . . 0.0 112.979 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.94 -104.33 0.04 OUTLIER Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.906 2.193 . . . . 0.0 115.499 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -125.13 14.0 8.39 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.899 1.28 . . . . 0.0 112.82 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -51.96 -39.11 58.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 120.957 1.708 . . . . 0.0 112.068 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.55 -43.59 69.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.194 0.907 . . . . 0.0 110.362 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.27 -49.58 77.03 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.705 0.802 . . . . 0.0 109.733 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.97 -33.91 65.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.113 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.95 95.58 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.232 0.924 . . . . 0.0 109.34 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -69.02 -47.48 65.36 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -48.4 -62.05 1.69 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.941 1.696 . . . . 0.0 113.96 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.7 m -63.04 -39.02 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 122.584 0.354 . . . . 0.0 111.382 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.45 -50.89 70.94 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.938 0.774 . . . . 0.0 110.196 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mp -63.26 -42.62 99.17 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.599 0.562 . . . . 0.0 109.967 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -60.86 -45.25 95.28 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.23 -14.97 0.06 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.313 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -71.93 156.04 39.71 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 119.217 1.509 . . . . 0.0 108.234 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -58.57 -66.86 0.42 Allowed 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 123.879 0.871 . . . . 0.0 111.557 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.1 m -159.0 170.6 21.73 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.915 1.286 . . . . 0.0 107.584 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.33 163.75 35.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.432 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 42.9 m-85 -133.94 123.37 24.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -84.79 104.78 15.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.058 0.943 . . . . 0.0 108.856 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.52 109.44 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -59.99 146.45 42.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.43 2.44 1.57 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.503 1.521 . . . . 0.0 114.797 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.31 -111.71 2.21 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.733 1.159 . . . . 0.0 112.297 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.25 -28.52 2.34 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 112.236 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.53 -19.14 26.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.64 163.74 50.11 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 121.042 -1.036 . . . . 0.0 111.492 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.63 -24.96 47.85 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 124.575 3.517 . . . . 0.0 115.415 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 0.62 24.24 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.048 1.339 . . . . 0.0 110.815 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.92 163.56 54.91 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.663 1.125 . . . . 0.0 111.403 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -29.84 -66.59 0.09 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.57 2.348 . . . . 0.0 115.293 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.1 mt -50.64 -60.93 2.53 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.923 1.289 . . . . 0.0 110.735 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -69.12 -7.45 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.563 1.545 . . . . 0.0 113.806 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.0 t -88.75 8.14 30.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.551 -1.343 . . . . 0.0 111.203 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.9 t 69.13 47.32 0.74 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.36 1.464 . . . . 0.0 111.094 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.19 157.28 58.73 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 125.088 1.355 . . . . 0.0 109.22 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.494 ' C ' HD21 ' A' ' 40' ' ' ASN . 30.0 Cg_endo -78.08 165.76 25.65 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.404 2.736 . . . . 0.0 109.479 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 55.9 t-105 -168.37 133.75 1.78 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.804 -1.185 . . . . 0.0 112.463 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.501 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 2.3 mt -74.92 86.94 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.992 1.317 . . . . 0.0 110.439 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.93 150.52 75.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 121.679 -0.638 . . . . 0.0 110.535 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -84.46 -172.89 1.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 1 C-N-CA 125.313 4.009 . . . . 0.0 109.922 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.45 165.59 1.07 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.212 1.005 . . . . 0.0 111.048 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.63 161.69 24.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.54 1.136 . . . . 0.0 109.364 179.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.54 173.22 11.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.1 p -128.66 80.47 1.97 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.936 1.294 . . . . 0.0 110.076 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.42 -177.18 19.08 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 127.485 2.469 . . . . 0.0 107.657 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -74.71 154.85 44.25 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.197 1.932 . . . . 0.0 109.551 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.8 m -115.73 -35.45 4.51 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.389 1.076 . . . . 0.0 109.967 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.0 t -139.37 155.55 47.58 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.697 1.999 . . . . 0.0 108.834 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -179.243 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.987 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.1 m -142.97 148.38 36.73 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.645 1.578 . . . . 0.0 108.597 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 t -153.84 159.17 41.74 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.62 -102.19 0.13 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.379 1.466 . . . . 0.0 110.558 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.1 m -151.98 55.65 0.83 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.504 1.522 . . . . 0.0 108.381 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.1 p -65.55 158.16 27.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.142 0.977 . . . . 0.0 110.915 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.55 -114.71 0.3 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -178.0 169.78 1.93 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 131.157 3.783 . . . . 0.0 106.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.69 -51.36 70.27 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.528 0.731 . . . . 0.0 112.451 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -52.31 -53.83 39.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.343 0.52 . . . . 0.0 111.012 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -53.7 -51.07 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.935 0.494 . . . . 0.0 110.851 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.96 -43.88 94.78 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.047 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -56.94 -44.23 82.28 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.783 1.174 . . . . 0.0 110.293 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -63.28 -53.36 54.16 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mmtm -56.65 -43.06 79.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.481 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.85 -40.95 85.77 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.981 2.113 . . . . 0.0 107.937 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.9 -20.42 79.47 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.717 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.1 p -106.94 -10.36 16.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.606 1.703 . . . . 0.0 112.111 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.23 135.27 34.59 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.35 -32.99 37.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -97.61 -13.43 21.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.67 149.43 26.04 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -150.0 164.45 35.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.682 1.593 . . . . 0.0 108.309 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -106.04 133.4 50.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.593 1.557 . . . . 0.0 108.299 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.0 tp -122.26 104.8 9.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.903 1.681 . . . . 0.0 110.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.61 111.98 12.68 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.182 1.793 . . . . 0.0 106.978 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.1 pt -93.89 3.33 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 118.698 0.681 . . . . 0.0 112.093 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -62.54 167.04 4.66 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 126.493 1.917 . . . . 0.0 112.58 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.34 133.71 37.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.908 1.283 . . . . 0.0 108.519 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.437 ' HA ' ' CD1' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -43.03 -29.27 0.33 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.151 2.58 . . . . 0.0 115.609 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.95 63.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.596 -1.315 . . . . 0.0 110.528 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.52 -27.74 69.47 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.756 -1.215 . . . . 0.0 112.358 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 30' ' ' THR . 81.2 m-85 -62.55 -21.07 65.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.116 -0.99 . . . . 0.0 109.886 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.4 mmm-85 -91.75 -35.2 14.28 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.802 2.041 . . . . 0.0 110.341 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -77.05 -58.15 3.44 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.935 1.694 . . . . 0.0 112.99 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.68 -19.3 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.99 -159.95 22.23 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 119.611 1.096 . . . . 0.0 111.808 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 39' ' ' PRO . 39.0 p -142.03 161.6 50.2 Favored Pre-proline 0 CA--C 1.532 0.252 0 O-C-N 121.88 -0.776 . . . . 0.0 112.088 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 38' ' ' SER . 94.2 Cg_endo -71.67 158.15 54.09 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.03 1.153 . . . . 0.0 111.094 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 122' ' ' TRP . 0.1 OUTLIER -125.19 74.75 1.4 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.15 1.78 . . . . 0.0 109.583 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.2 pt -74.97 2.87 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 121.763 -0.585 . . . . 0.0 109.545 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -56.95 -31.61 65.15 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.467 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.28 75.81 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.0 -35.9 69.6 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.896 1.279 . . . . 0.0 110.669 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.0 21.62 1.88 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.775 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -123.01 178.57 5.01 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.383 1.591 . . . . 0.0 111.204 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -137.86 131.55 31.2 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.474 -0.766 . . . . 0.0 110.221 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.38 168.11 16.73 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.769 0.795 . . . . 0.0 111.125 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.0 t -137.7 138.03 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 127.645 2.378 . . . . 0.0 104.646 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.4 p -117.91 124.37 48.1 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -152.55 102.9 2.76 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -54.61 117.74 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.793 0.837 . . . . 0.0 111.859 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -79.63 134.67 36.45 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -150.52 119.78 6.81 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -51.46 -20.65 5.53 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 114.94 0.736 . . . . 0.0 114.94 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -71.12 -16.65 62.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.538 1.169 . . . . 0.0 112.569 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 p30 -133.4 29.31 3.96 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 117.317 -1.325 . . . . 0.0 114.335 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -38.79 -56.14 2.47 Favored Pre-proline 0 N--CA 1.476 0.827 0 CA-C-N 121.482 1.946 . . . . 0.0 111.532 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -62.87 -40.82 33.12 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.421 2.747 . . . . 0.0 111.451 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.2 -51.53 58.64 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 126.112 1.815 . . . . 0.0 109.844 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -55.62 -54.24 46.57 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 126.555 1.942 . . . . 0.0 106.633 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 mt -51.28 -45.75 62.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.974 0.909 . . . . 0.0 110.112 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.92 -37.45 87.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.042 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -61.12 -31.54 71.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.052 1.296 . . . . 0.0 108.484 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -43.32 18.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.044 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -25.31 64.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.188 1.358 . . . . 0.0 112.443 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.24 -9.8 59.71 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.687 1.13 . . . . 0.0 110.968 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -109.04 -43.11 4.26 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.037 1.335 . . . . 0.0 110.363 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 66.6 m-85 -90.72 102.95 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -57.72 -33.26 68.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.478 0.311 . . . . 0.0 111.395 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -131.93 86.41 47.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 C-N-CA 123.719 0.808 . . . . 0.0 110.992 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 26.3 Cg_endo -66.72 -33.43 34.88 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.395 2.063 . . . . 0.0 112.086 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -54.22 -23.52 14.96 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 125.4 1.48 . . . . 0.0 114.623 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -117.28 -6.42 11.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.087 1.312 . . . . 0.0 110.661 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.4 m -94.07 121.6 35.73 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.287 1.435 . . . . 0.0 112.889 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.3 m -91.47 131.86 36.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.41 1.084 . . . . 0.0 108.681 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.35 97.35 5.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 111.153 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -74.91 119.4 19.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.715 0.806 . . . . 0.0 109.084 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 79' ' ' ILE . 1.1 mp -75.56 133.9 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 124.205 1.002 . . . . 0.0 111.508 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.81 121.83 27.56 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -126.45 167.0 16.18 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.728 2.011 . . . . 0.0 108.398 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -61.02 -39.55 90.18 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.988 -1.07 . . . . 0.0 109.411 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -131.92 -136.51 0.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.635 1.974 . . . . 0.0 106.919 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.93 -55.64 4.12 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.019 1.328 . . . . 0.0 108.723 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.66 -95.1 0.1 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.811 1.672 . . . . 0.0 113.203 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -145.82 10.79 1.21 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 128.097 2.559 . . . . 0.0 110.907 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.2 m -48.54 -40.56 27.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 125.248 1.419 . . . . 0.0 111.587 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.3 -30.49 71.54 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.702 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 89' ' ' LEU . 2.5 tm? -83.47 -41.52 17.94 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.2 t -57.06 -34.75 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.9 71.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.983 1.313 . . . . 0.0 111.239 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -86.68 -44.28 11.95 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.4 1.08 . . . . 0.0 108.979 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 tp -48.79 -61.37 2.08 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 126.718 2.007 . . . . 0.0 112.771 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.3 m -64.14 -37.39 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.571 0.348 . . . . 0.0 111.744 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -53.47 54.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.853 0.721 . . . . 0.0 109.666 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.47 -20.47 65.61 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.483 1.113 . . . . 0.0 112.195 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -84.53 -35.34 22.93 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.842 0.857 . . . . 0.0 111.58 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.42 -8.11 0.46 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.35 -1.805 . . . . 0.0 115.155 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 34.9 m-85 -71.69 153.48 42.02 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 120.425 2.112 . . . . 0.0 109.484 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -56.62 -56.67 18.44 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.4 m -162.14 171.7 17.01 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -165.21 115.89 1.11 Allowed 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -98.67 140.66 32.55 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.69 114.32 26.77 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -76.23 100.55 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -63.21 151.28 40.85 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 75.37 -1.58 3.01 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.945 2.098 . . . . 0.0 112.971 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.52 -140.24 48.06 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-N 119.703 1.138 . . . . 0.0 111.154 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.62 -35.46 6.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.837 0.855 . . . . 0.0 111.188 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.2 -15.23 47.73 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.71 1.204 . . . . 0.0 113.358 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.7 166.32 27.25 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.64 -30.41 90.42 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.466 2.777 . . . . 0.0 113.454 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 20.8 tpt180 -110.63 14.26 22.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.354 1.862 . . . . 0.0 110.179 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.17 170.84 51.75 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -45.29 -58.68 3.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.626 1.57 . . . . 0.0 114.865 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 47.6 mt -59.89 -38.22 81.65 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.557 0.343 . . . . 0.0 110.935 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -88.9 19.84 3.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.318 1.447 . . . . 0.0 111.467 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 45.4 m -121.42 12.21 10.82 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.526 -1.359 . . . . 0.0 112.289 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.0 m 56.57 55.8 6.13 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.343 1.057 . . . . 0.0 108.503 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -121.74 150.93 56.55 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' C ' HD21 ' A' ' 40' ' ' ASN . 44.1 Cg_endo -70.31 158.9 54.81 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.634 1.556 . . . . 0.0 109.322 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.501 ' N ' HD21 ' A' ' 40' ' ' ASN . 37.8 t-105 -167.84 132.2 1.77 Allowed 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 120.388 -1.445 . . . . 0.0 110.749 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.48 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 8.8 mt -71.06 90.77 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.205 1.402 . . . . 0.0 108.443 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.63 151.01 60.92 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.18 -159.34 0.1 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.605 3.536 . . . . 0.0 107.712 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -124.04 97.97 5.58 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -130.72 156.77 44.37 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 127.105 2.162 . . . . 0.0 106.559 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 p -121.53 65.6 0.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.74 171.23 11.96 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.478 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -148.75 -157.04 7.39 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.589 1.09 . . . . 0.0 110.965 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.5 163.74 33.63 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.959 1.773 . . . . 0.0 111.808 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.3 m -122.8 178.85 4.85 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.414 1.885 . . . . 0.0 106.654 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.4 p -142.14 101.68 3.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.826 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.797 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 m -68.21 163.56 22.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.558 1.179 . . . . 0.0 108.614 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 t -151.78 152.96 33.37 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.4 158.59 37.88 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.01 147.78 30.04 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.144 1.472 . . . . 0.0 109.829 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.08 173.0 13.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.638 1.975 . . . . 0.0 107.16 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.03 -90.05 0.08 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 119.562 -1.304 . . . . 0.0 113.591 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.7 t -166.63 167.56 15.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.024 0.929 . . . . 0.0 109.855 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.85 -34.18 75.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -71.19 -49.95 38.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.69 -50.88 62.44 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.169 0.588 . . . . 0.0 110.271 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -49.82 74.75 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.067 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -57.96 -39.68 78.72 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.253 1.388 . . . . 0.0 110.658 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m -68.79 -46.53 68.48 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.693 0.797 . . . . 0.0 109.102 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -63.01 -39.16 93.91 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.032 -1.668 . . . . 0.0 110.97 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.08 -23.53 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.954 1.702 . . . . 0.0 109.551 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.94 -22.92 36.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 -13.1 24.43 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.588 1.194 . . . . 0.0 110.458 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -114.74 112.35 22.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.911 1.232 . . . . 0.0 110.718 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.55 -36.08 82.6 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.722 1.209 . . . . 0.0 112.653 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -84.18 -17.21 40.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 121.575 -0.703 . . . . 0.0 112.349 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.0 153.81 32.65 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.309 0.959 . . . . 0.0 112.513 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 -150.25 162.26 40.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.201 1.401 . . . . 0.0 109.388 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tt -101.42 154.22 19.0 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.0 tp -134.41 103.87 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.207 1.403 . . . . 0.0 109.837 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.41 96.63 5.4 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.036 1.334 . . . . 0.0 108.629 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -87.82 -1.33 8.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.6 mtm-85 -69.46 162.57 27.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.969 0.804 . . . . 0.0 109.978 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.73 133.97 51.26 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.34 -22.11 1.03 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.632 1.973 . . . . 0.0 112.38 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.92 88.9 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.285 -1.509 . . . . 0.0 110.16 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -55.15 -40.75 70.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.495 1.518 . . . . 0.0 111.267 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -53.66 -30.13 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.394 1.077 . . . . 0.0 112.066 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.0 mtt180 -97.3 -20.89 17.56 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 126.549 1.94 . . . . 0.0 112.726 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -101.11 -60.37 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.49 -31.61 4.23 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.758 1.623 . . . . 0.0 111.559 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.35 -163.34 12.26 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.78 158.55 49.29 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -71.79 157.8 54.49 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.141 1.894 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.531 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -122.39 83.68 2.15 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.897 2.479 . . . . 0.0 111.961 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 pt -79.58 -0.68 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 120.394 -1.441 . . . . 0.0 109.747 177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -46.12 -40.7 11.38 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 128.429 2.692 . . . . 0.0 113.188 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.05 77.07 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 119.422 -0.654 . . . . 0.0 113.044 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.4 mt -77.57 -40.85 40.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 129.24 24.56 1.03 Allowed Glycine 0 C--N 1.338 0.644 0 CA-C-O 119.111 -0.827 . . . . 0.0 113.909 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -126.02 -179.1 4.54 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.094 1.447 . . . . 0.0 111.927 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -133.23 144.11 49.57 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.177 1.391 . . . . 0.0 109.15 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 167.18 14.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 111.98 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.6 t -140.54 93.59 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -76.87 102.74 6.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.879 2.072 . . . . 0.0 112.393 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -141.54 98.82 3.43 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.8 p -66.53 125.89 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.221 0.919 . . . . 0.0 110.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -76.02 152.35 36.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.897 0.856 . . . . 0.0 110.857 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -155.77 116.5 3.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.55 -24.11 61.44 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.539 -0.59 . . . . 0.0 112.192 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -82.89 -7.01 59.7 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.035 1.417 . . . . 0.0 110.159 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -126.22 28.95 5.92 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.333 1.453 . . . . 0.0 112.577 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -45.57 -52.38 23.67 Favored Pre-proline 0 N--CA 1.474 0.765 0 O-C-N 120.553 -1.342 . . . . 0.0 112.138 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -62.78 -44.61 16.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.446 2.097 . . . . 0.0 112.434 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.26 -44.07 96.76 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.71 -54.16 46.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.023 1.329 . . . . 0.0 107.981 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.93 -43.72 66.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.991 1.716 . . . . 0.0 111.504 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -54.79 -50.56 68.21 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 109.544 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.29 -29.15 57.64 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 mt -80.6 -51.79 8.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.222 -0.924 . . . . 0.0 109.099 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 t -56.36 -23.32 36.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.333 1.453 . . . . 0.0 110.624 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.84 -2.87 43.15 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.51 -42.52 3.13 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -84.39 114.4 21.86 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -30.37 71.11 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -130.35 70.14 82.22 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.092 1.757 . . . . 0.0 109.312 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.493 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 18.8 Cg_endo -57.88 -43.11 52.01 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.381 2.054 . . . . 0.0 111.972 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -62.65 -3.53 1.55 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.301 1.441 . . . . 0.0 113.617 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -127.36 -18.04 4.56 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 111.586 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -90.93 104.76 17.31 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.401 1.48 . . . . 0.0 111.39 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.2 m -71.72 137.73 47.97 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.852 -1.155 . . . . 0.0 109.679 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.2 mt -102.72 99.99 10.0 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.202 1.401 . . . . 0.0 113.839 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -80.98 99.78 8.6 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 mt -79.41 133.58 29.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 123.922 0.889 . . . . 0.0 109.622 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -129.66 121.22 26.56 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.762 0.825 . . . . 0.0 112.391 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.77 172.3 7.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.069 2.548 . . . . 0.0 107.62 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -38.25 84.53 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 119.888 -1.757 . . . . 0.0 112.599 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -146.39 -173.22 4.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 130.094 3.358 . . . . 0.0 104.099 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -23.32 -55.5 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 128.641 2.776 . . . . 0.0 113.397 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.96 -101.51 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 128.288 2.851 . . . . 0.0 115.582 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -144.04 -0.21 1.03 Allowed 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 125.17 1.388 . . . . 0.0 113.336 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 p -44.62 -44.71 9.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.741 1.155 . . . . 0.0 113.667 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -60.05 -40.34 89.07 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.782 0.719 . . . . 0.0 112.597 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -71.59 -49.69 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.939 1.696 . . . . 0.0 108.911 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.53 -33.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.231 1.013 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.36 -29.9 70.19 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.408 0.549 . . . . 0.0 111.94 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -86.65 -42.76 13.17 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.363 0.983 . . . . 0.0 108.405 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.8 tp -49.95 -59.34 3.96 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.938 1.695 . . . . 0.0 112.332 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.3 -37.64 80.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.975 -0.453 . . . . 0.0 111.085 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.62 -51.68 68.76 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.384 0.674 . . . . 0.0 109.532 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.07 -28.93 69.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.55 0.74 . . . . 0.0 110.982 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -70.82 -33.63 70.9 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.541 0.61 . . . . 0.0 110.039 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.7 -13.52 0.89 Allowed Glycine 0 N--CA 1.448 -0.51 0 CA-C-O 117.853 -1.526 . . . . 0.0 113.242 178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 66.6 m-85 -60.24 146.48 43.55 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.219 1.509 . . . . 0.0 111.094 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -47.3 -60.19 2.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.701 2.001 . . . . 0.0 112.929 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 p -167.09 174.75 8.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 126.768 2.027 . . . . 0.0 105.686 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 152.98 36.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -135.62 111.22 9.24 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.415 0.686 . . . . 0.0 111.26 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.84 133.78 38.1 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.11 103.24 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -58.09 137.55 56.82 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 36.3 m-20 71.48 15.62 6.12 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.24 2.216 . . . . 0.0 112.933 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.72 -144.06 7.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.132 1.348 . . . . 0.0 114.913 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.67 -26.51 15.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.52 -1.45 12.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.98 -178.68 8.53 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-N 119.75 1.159 . . . . 0.0 114.078 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.6 -29.92 43.0 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.333 3.355 . . . . 0.0 114.378 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -132.12 12.45 4.68 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.26 1.424 . . . . 0.0 110.296 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.85 174.35 3.21 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -31.56 -60.87 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.187 1.795 . . . . 0.0 114.327 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.18 -50.93 71.8 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.507 0.723 . . . . 0.0 111.049 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -72.92 3.3 5.46 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.067 1.747 . . . . 0.0 113.772 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.96 13.85 28.75 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.872 1.669 . . . . 0.0 111.316 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 60.01 46.0 11.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.627 1.171 . . . . 0.0 110.306 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.7 mt -115.09 151.18 45.39 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.531 ' C ' HD21 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -73.44 163.96 36.32 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.928 1.752 . . . . 0.0 110.221 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -161.65 128.13 3.81 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.66 -1.275 . . . . 0.0 111.792 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.459 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 1.8 mt -73.39 87.01 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 126.466 1.906 . . . . 0.0 111.489 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.46 146.0 46.33 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.864 0.865 . . . . 0.0 110.387 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.27 163.32 27.7 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.649 2.233 . . . . 0.0 108.468 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -75.37 76.53 2.45 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.501 -0.75 . . . . 0.0 109.636 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -149.23 104.68 3.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.7 m -64.03 149.07 48.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.577 0.751 . . . . 0.0 110.332 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -125.77 166.7 16.33 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.118 0.967 . . . . 0.0 109.989 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.19 78.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.87 174.36 12.03 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.123 2.549 . . . . 0.0 112.281 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.8 p -150.62 25.32 0.77 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.653 1.181 . . . . 0.0 111.334 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.4 p -109.16 83.63 1.79 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.481 1.913 . . . . 0.0 109.249 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.442 0 CA-C-O 117.335 -1.814 . . . . 0.0 109.002 -179.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.579 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.9 m -98.72 -0.72 42.21 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.932 2.197 . . . . 0.0 116.932 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -154.76 1.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 120.616 1.553 . . . . 0.0 114.077 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.79 175.59 41.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.6 m -147.88 125.05 11.45 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.2 p -128.11 -173.68 3.01 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.93 -112.56 0.43 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.454 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.8 m -152.35 150.33 29.6 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.574 1.55 . . . . 0.0 107.319 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.89 66.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.753 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -51.87 -43.71 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.068 -1.645 . . . . 0.0 113.182 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.43 -53.28 54.76 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -57.11 -37.27 71.72 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 123.444 0.465 . . . . 0.0 111.148 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -68.47 -51.57 42.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.805 1.242 . . . . 0.0 109.087 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.0 m -56.57 -40.84 75.88 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.521 0.601 . . . . 0.0 109.978 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -60.42 -44.18 96.02 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.31 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.36 -27.61 64.35 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.192 1.36 . . . . 0.0 109.576 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 -2.13 82.61 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.87 1.7 . . . . 0.0 114.171 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.94 -0.21 6.59 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.832 2.053 . . . . 0.0 109.1 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -138.56 98.5 3.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.276 1.43 . . . . 0.0 110.064 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -62.46 -36.54 82.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 122.663 1.22 . . . . 0.0 110.297 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.76 -7.78 17.69 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 123.803 0.841 . . . . 0.0 111.62 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.32 150.17 21.42 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 120.364 1.438 . . . . 0.0 110.969 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -139.17 161.45 37.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.489 1.516 . . . . 0.0 109.691 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.9 tm? -106.01 128.82 54.09 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 24' ' ' LEU . 16.2 tp -118.36 102.3 8.84 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.221 1.809 . . . . 0.0 112.65 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.31 116.93 19.08 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -105.2 4.09 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -62.77 172.98 1.44 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.06 2.144 . . . . 0.0 112.639 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.71 139.41 34.91 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -45.04 -35.99 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.308 1.843 . . . . 0.0 114.266 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.231 0.923 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.26 -35.33 64.89 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.343 1.057 . . . . 0.0 110.761 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.24 -23.69 64.27 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.378 -0.826 . . . . 0.0 112.253 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.8 mtp85 -104.67 -15.79 15.17 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.936 1.294 . . . . 0.0 110.83 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -89.88 -58.2 2.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.136 1.374 . . . . 0.0 111.007 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.3 p -97.87 -26.53 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.594 0.758 . . . . 0.0 110.444 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.03 -162.14 12.45 Favored Glycine 0 C--N 1.338 0.683 0 O-C-N 121.609 -0.682 . . . . 0.0 112.764 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 p -139.36 152.5 69.4 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 123.008 0.523 . . . . 0.0 112.312 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.6 139.63 25.65 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.186 1.924 . . . . 0.0 109.693 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.661 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -110.23 82.22 1.56 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.571 2.749 . . . . 0.0 106.982 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 pt -71.99 1.71 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 119.953 -1.717 . . . . 0.0 110.843 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -22.44 51.77 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 126.091 1.757 . . . . 0.0 112.099 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.79 -40.74 72.98 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 107.908 -2.077 . . . . 0.0 107.908 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.8 mt -75.92 -52.17 10.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.45 -9.37 1.24 Allowed Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.106 1.336 . . . . 0.0 115.519 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -91.5 -169.85 2.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.85 1.325 . . . . 0.0 113.073 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -144.42 139.15 28.2 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.525 1.13 . . . . 0.0 109.725 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.52 170.47 16.34 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.007 0.908 . . . . 0.0 112.265 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.4 t -131.3 138.42 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.2 p -120.3 132.01 55.13 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 122.748 0.419 . . . . 0.0 109.97 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.3 m -152.44 100.07 2.54 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 t -57.47 112.43 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 123.507 0.723 . . . . 0.0 110.262 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -83.56 148.97 26.88 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -156.54 131.27 8.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.46 2.704 . . . . 0.0 105.557 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.15 -23.27 52.07 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.321 0.962 . . . . 0.0 112.965 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -69.3 -22.57 63.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.756 1.223 . . . . 0.0 112.019 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -135.69 44.81 2.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -45.09 -56.05 9.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.538 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.18 -40.8 24.45 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.528 2.152 . . . . 0.0 111.317 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.78 61.01 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 124.2 0.905 . . . . 0.0 112.54 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.03 -53.7 4.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -48.84 -48.88 41.38 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.127 1.771 . . . . 0.0 111.899 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -54.52 -36.26 64.06 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.482 0.713 . . . . 0.0 112.715 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -62.66 -22.49 66.5 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.276 1.03 . . . . 0.0 112.027 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.73 -44.99 8.25 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -52.19 -35.0 47.86 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.904 2.082 . . . . 0.0 111.459 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -80.67 -5.5 57.06 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.517 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.08 -32.85 4.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.969 0.804 . . . . 0.0 113.122 -178.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.517 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 38.3 m-85 -91.02 121.07 32.52 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -51.89 42.09 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.469 0.577 . . . . 0.0 110.485 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -113.66 81.91 5.97 Favored Pre-proline 0 N--CA 1.451 -0.387 0 C-N-CA 123.877 0.871 . . . . 0.0 109.936 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 9.9 Cg_endo -53.54 -36.19 79.47 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.51 2.14 . . . . 0.0 111.391 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -63.63 -11.58 26.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.089 2.155 . . . . 0.0 111.361 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -130.14 26.9 5.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.872 2.069 . . . . 0.0 110.258 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -137.38 112.92 9.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.721 0.691 . . . . 0.0 109.934 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.9 m -83.34 141.32 31.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.266 0.627 . . . . 0.0 111.572 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.9 mt -115.33 95.97 5.43 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.739 2.016 . . . . 0.0 114.843 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 39.8 m-85 -78.63 102.5 8.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.06 136.72 23.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 123.717 0.807 . . . . 0.0 109.036 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 tp -128.56 126.02 39.46 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.651 0.781 . . . . 0.0 111.107 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -127.89 166.91 17.39 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.255 2.622 . . . . 0.0 107.695 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -63.45 -41.67 98.63 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.563 -1.336 . . . . 0.0 113.733 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -144.97 179.27 7.45 Favored 'General case' 0 C--N 1.322 -0.626 1 C-N-CA 132.828 4.451 . . . . 0.0 103.545 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -34.35 -32.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 128.958 2.903 . . . . 0.0 117.097 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 24.3 -88.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 130.066 3.698 . . . . 0.0 116.631 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -144.35 0.56 1.03 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.892 1.277 . . . . 0.0 113.314 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.3 p -41.16 -48.6 3.45 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.31 -41.83 84.66 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.626 1.103 . . . . 0.0 112.105 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.06 -46.2 85.43 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 83.6 t -60.71 -35.86 66.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.27 71.45 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.734 -0.651 . . . . 0.0 110.052 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -46.62 15.97 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.496 1.044 . . . . 0.0 108.913 177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.1 tp -46.52 -61.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.77 -42.49 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 122.168 -0.333 . . . . 0.0 110.3 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.74 88.02 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.608 0.763 . . . . 0.0 110.956 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.16 -43.37 91.97 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.336 0.654 . . . . 0.0 109.332 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -55.78 -39.05 70.71 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.167 0.44 . . . . 0.0 111.077 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.27 4.4 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.497 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 72' ' ' PRO . 41.4 m-85 -74.58 152.37 39.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.906 1.853 . . . . 0.0 109.558 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -50.82 -70.15 0.09 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 128.468 2.707 . . . . 0.0 112.95 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.1 m -155.8 164.2 38.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.515 1.526 . . . . 0.0 107.85 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.68 17.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -126.14 150.24 48.4 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.179 1.792 . . . . 0.0 108.024 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -111.68 118.92 36.97 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -72.1 109.87 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.29 151.43 46.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 63.05 19.33 11.58 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.131 1.373 . . . . 0.0 111.176 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 34.73 -114.75 0.15 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 129.004 3.192 . . . . 0.0 114.088 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.76 -12.67 4.79 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 117.454 -1.26 . . . . 0.0 112.874 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -103.26 -14.91 16.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.587 1.539 . . . . 0.0 110.727 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.78 35.22 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 118.95 0.795 . . . . 0.0 112.567 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.47 -16.89 48.45 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.647 2.898 . . . . 0.0 113.261 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -119.35 2.6 11.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.476 2.311 . . . . 0.0 110.754 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.23 177.13 25.41 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.786 0.721 . . . . 0.0 112.454 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -41.38 -61.5 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.421 1.888 . . . . 0.0 113.029 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 97.0 mt -57.58 -36.63 71.95 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 125.005 1.322 . . . . 0.0 113.587 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -96.08 10.79 36.44 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.893 1.277 . . . . 0.0 111.726 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.2 t -113.73 24.41 12.16 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.499 -1.375 . . . . 0.0 111.614 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 m 63.06 22.87 13.67 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.367 1.867 . . . . 0.0 113.609 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.3 mt -92.37 160.19 35.5 Favored Pre-proline 0 C--N 1.334 -0.091 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.556 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.661 ' C ' HD21 ' A' ' 40' ' ' ASN . 71.6 Cg_endo -80.71 166.1 19.7 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.082 1.855 . . . . 0.0 108.922 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.422 ' N ' HD21 ' A' ' 40' ' ' ASN . 48.1 t-105 -167.49 134.27 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 119.528 -1.982 . . . . 0.0 112.653 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.469 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.1 mt -77.07 88.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.645 1.578 . . . . 0.0 108.809 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -82.85 144.55 48.31 Favored Pre-proline 0 C--O 1.245 0.863 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.81 177.65 8.24 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.669 2.913 . . . . 0.0 109.32 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -72.19 -8.74 56.4 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.09 -1.006 . . . . 0.0 111.787 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HE3' ' H ' ' A' ' 128' ' ' THR . 0.0 OUTLIER -66.95 171.77 5.11 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.403 1.001 . . . . 0.0 110.065 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.539 ' H ' ' HE3' ' A' ' 127' ' ' LYS . 3.5 p -147.14 -77.57 0.17 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 128.391 2.676 . . . . 0.0 104.45 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 t -54.0 148.42 10.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.469 1.908 . . . . 0.0 110.534 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 138.22 -79.04 0.3 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 105.703 -2.959 . . . . 0.0 105.703 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 168.79 23.11 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.014 2.476 . . . . 0.0 111.274 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 78.3 p -148.66 -72.68 0.19 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.192 1.397 . . . . 0.0 109.203 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 m -143.21 142.58 31.46 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.38 1.072 . . . . 0.0 108.687 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.873 -2.071 . . . . 0.0 108.385 -179.308 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.493 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 114.16 13.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.741 0.77 . . . . 0.0 110.654 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -73.81 100.27 3.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.53 -174.5 50.42 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.412 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 4.8 m -66.11 126.86 29.96 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 121.896 -0.767 . . . . 0.0 109.05 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.6 m -150.69 170.18 19.81 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 121.035 -1.04 . . . . 0.0 111.421 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.73 -125.84 1.32 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.5 m -138.89 160.53 39.5 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.798 1.239 . . . . 0.0 111.641 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.62 -54.71 13.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.871 2.468 . . . . 0.0 114.339 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -60.36 -39.87 88.74 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.839 1.654 . . . . 0.0 112.837 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -47.92 84.21 Favored 'General case' 0 C--O 1.228 -0.07 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.22 96.6 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.191 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.462 ' CG ' HD22 ' A' ' 120' ' ' LEU . 71.8 t80 -61.85 -40.36 95.06 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 119.091 0.86 . . . . 0.0 109.95 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.4 m -61.97 -50.91 70.21 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -57.0 -47.65 80.34 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.26 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mt -52.29 -32.56 38.16 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.008 1.723 . . . . 0.0 113.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.14 -14.06 70.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.762 0.71 . . . . 0.0 112.934 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.3 -24.23 11.95 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.841 1.656 . . . . 0.0 110.458 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -100.99 99.63 10.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.613 1.565 . . . . 0.0 108.371 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -51.48 -50.51 59.71 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.371 -0.831 . . . . 0.0 112.551 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -2.47 17.92 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.974 1.31 . . . . 0.0 113.856 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -78.18 128.39 33.7 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.932 0.787 . . . . 0.0 109.105 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -138.81 139.0 38.07 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -76.13 128.87 35.84 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.174 1.39 . . . . 0.0 108.618 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 27.0 tp -117.23 109.63 17.11 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.687 1.595 . . . . 0.0 111.269 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.59 98.77 5.51 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.141 1.376 . . . . 0.0 108.412 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -86.63 -3.83 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 118.926 0.784 . . . . 0.0 111.235 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -63.52 163.68 10.65 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 125.902 1.681 . . . . 0.0 111.431 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.87 148.39 27.73 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 123.097 1.427 . . . . 0.0 108.984 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.5 m -42.41 -43.19 3.5 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 129.72 3.208 . . . . 0.0 111.529 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.69 -40.4 65.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.878 1.271 . . . . 0.0 112.914 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.5 m-20 -64.16 -35.22 80.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 38' ' ' SER . 13.9 m-85 -61.06 -27.62 68.48 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.098 -1.626 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -89.1 -23.93 22.39 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.563 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -105.11 -35.71 7.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.4 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.8 p -117.9 -13.23 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.532 1.133 . . . . 0.0 112.948 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.4 -163.01 29.8 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD2' ' A' ' 33' ' ' PHE . 2.5 p -135.74 157.17 76.7 Favored Pre-proline 0 CA--C 1.511 -0.528 0 O-C-N 122.354 -0.498 . . . . 0.0 110.732 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.88 172.33 16.09 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 121.382 1.388 . . . . 0.0 109.454 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.53 ' HB3' HG13 ' A' ' 123' ' ' ILE . 6.4 p30 -146.36 167.56 23.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 46' ' ' LYS . 5.1 pt -145.0 20.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 127.475 2.31 . . . . 0.0 107.618 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.57 64.37 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.076 2.15 . . . . 0.0 114.142 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.22 -33.73 78.92 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.66 -23.44 36.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 109.347 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 23.1 24.13 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 125.198 1.38 . . . . 0.0 111.327 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HB3' HD12 ' A' ' 41' ' ' ILE . 32.0 mmtp -106.04 173.08 6.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.356 1.862 . . . . 0.0 107.807 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -143.23 124.98 14.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 120.252 1.387 . . . . 0.0 109.625 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.03 171.02 7.36 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.477 0.711 . . . . 0.0 111.761 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.4 t -128.09 136.15 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.753 1.621 . . . . 0.0 106.666 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 p -103.04 110.38 22.28 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.035 1.734 . . . . 0.0 110.884 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.8 m -149.97 98.32 2.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -62.69 117.74 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 122.229 -0.294 . . . . 0.0 110.847 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -81.29 142.91 32.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -154.2 140.7 18.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.45 -13.9 74.35 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.177 -1.346 . . . . 0.0 115.124 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -79.67 -15.95 56.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 119.509 1.654 . . . . 0.0 111.642 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -138.52 43.5 2.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 120.357 1.435 . . . . 0.0 111.189 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -45.05 -53.58 16.05 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.869 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.63 -39.28 36.03 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.844 1.696 . . . . 0.0 111.367 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.86 -14.67 73.26 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.273 -0.892 . . . . 0.0 112.671 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -87.9 -52.21 5.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -50.82 -48.38 59.76 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.794 1.638 . . . . 0.0 111.801 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -56.85 -36.15 69.68 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -58.74 -26.32 63.86 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.095 0.558 . . . . 0.0 110.648 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.51 -49.43 7.2 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.43 -30.63 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.07 0.85 . . . . 0.0 113.115 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.53 -23.39 62.63 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.819 -1.176 . . . . 0.0 110.249 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -41.34 8.25 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 117.898 -1.049 . . . . 0.0 110.635 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' CD1' HG21 ' A' ' 75' ' ' THR . 65.8 m-85 -85.68 99.42 11.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.464 1.106 . . . . 0.0 108.855 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -19.43 47.78 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -139.23 78.88 27.28 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 125.209 1.404 . . . . 0.0 107.548 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.55 -39.04 57.97 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 121.679 1.586 . . . . 0.0 111.05 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -51.53 -22.01 2.88 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 127.068 2.147 . . . . 0.0 114.981 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -120.94 -9.08 9.3 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 117.997 -1.001 . . . . 0.0 112.097 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.569 HG21 ' CD1' ' A' ' 69' ' ' PHE . 90.1 m -82.76 136.54 34.66 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.646 1.178 . . . . 0.0 109.156 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.6 m -111.1 125.37 53.7 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 84.9 mt -98.53 96.43 7.97 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.997 1.319 . . . . 0.0 112.526 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.44 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 13.8 m-85 -80.07 106.76 12.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.505 HG21 ' HA ' ' A' ' 87' ' ' SER . 1.2 mm -67.36 145.37 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 124.33 1.052 . . . . 0.0 112.725 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.29 112.88 7.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -119.09 164.52 15.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.65 1.18 . . . . 0.0 108.511 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -53.5 -41.81 66.67 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.38 1.072 . . . . 0.0 109.736 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -134.98 -143.98 0.21 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.785 2.034 . . . . 0.0 106.943 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -75.57 -36.3 60.41 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.568 1.547 . . . . 0.0 109.339 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.9 -103.67 0.01 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 130.432 3.872 . . . . 0.0 116.032 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -121.32 9.26 10.35 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.044 0.937 . . . . 0.0 113.352 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.505 ' HA ' HG21 ' A' ' 79' ' ' ILE . 13.7 m -46.71 -52.02 14.83 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.48 -33.26 75.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.033 0.933 . . . . 0.0 111.699 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -74.15 -52.0 13.84 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.631 0.772 . . . . 0.0 109.77 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.57 -31.07 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.494 1.117 . . . . 0.0 110.277 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.64 -44.38 93.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.879 0.763 . . . . 0.0 108.951 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -73.2 -36.58 66.56 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.9 tp -53.34 -59.0 5.13 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.9 0.88 . . . . 0.0 111.309 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 17.8 m -62.64 -39.26 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 O-C-N 121.909 -0.494 . . . . 0.0 111.072 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.55 -50.22 72.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.964 0.906 . . . . 0.0 111.436 -178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.29 -28.81 68.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.481 1.112 . . . . 0.0 110.623 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -69.78 -54.57 13.06 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 167.89 2.82 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 CA-C-O 118.196 -1.335 . . . . 0.0 115.67 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -75.54 157.16 34.3 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 120.04 1.92 . . . . 0.0 106.755 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -53.36 -63.66 1.08 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.193 0.597 . . . . 0.0 110.235 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.7 t -161.53 -179.8 7.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.317 1.847 . . . . 0.0 106.09 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.47 20.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 5' ' ' SER . 27.7 m-85 -118.16 123.8 46.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.5 101.66 14.32 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.32 116.89 13.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -72.46 156.52 38.96 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.82 8.91 5.54 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.114 1.766 . . . . 0.0 115.101 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.27 -127.46 21.45 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.61 -35.88 4.1 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.478 0.711 . . . . 0.0 109.565 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.28 -17.19 61.35 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.195 2.198 . . . . 0.0 114.28 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -72.1 172.46 46.98 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.18 0.9 . . . . 0.0 114.481 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.8 -30.71 58.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 125.172 3.915 . . . . 0.0 115.768 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.253 0.0 OUTLIER -131.49 20.7 4.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.025 1.33 . . . . 0.0 109.178 177.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.99 166.62 40.29 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -34.28 -50.94 0.43 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.65 -50.7 72.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.23 0.923 . . . . 0.0 110.058 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.79 -0.38 34.21 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.029 2.132 . . . . 0.0 113.403 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 t -91.77 6.53 45.64 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.666 1.986 . . . . 0.0 111.629 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t 60.7 46.09 9.48 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.462 HD22 ' CG ' ' A' ' 13' ' ' TYR . 88.3 mt -123.34 145.26 46.04 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.016 0.926 . . . . 0.0 109.967 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -65.81 147.05 84.98 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.291 2.661 . . . . 0.0 110.211 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -148.49 139.57 23.17 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.596 1.559 . . . . 0.0 110.825 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 40' ' ' ASN . 3.6 mt -78.9 91.62 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.486 1.114 . . . . 0.0 109.669 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -69.6 153.86 95.32 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.379 -0.826 . . . . 0.0 110.74 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -86.81 -175.89 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.649 1 C-N-CA 125.32 4.014 . . . . 0.0 110.198 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -69.62 108.71 3.96 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -58.35 163.75 2.87 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.869 0.867 . . . . 0.0 111.209 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.4 p -145.31 178.69 7.9 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.63 1.572 . . . . 0.0 108.766 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.8 p -71.7 -41.48 68.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.081 0.953 . . . . 0.0 109.744 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.45 167.56 43.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.247 1.403 . . . . 0.0 109.759 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.55 175.42 11.31 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.701 2.934 . . . . 0.0 110.166 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.5 p -71.65 107.33 4.44 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 m -42.82 117.59 1.08 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.997 1.719 . . . . 0.0 111.29 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.743 0 CA-C-O 118.697 -1.057 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.4 p -109.69 1.64 19.64 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.935 1.294 . . . . 0.0 113.62 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -133.04 163.92 28.17 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.25 66.38 2.28 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 m -34.25 116.9 0.32 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.479 2.312 . . . . 0.0 111.604 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 t -133.73 -175.27 3.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.076 1.35 . . . . 0.0 108.826 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.01 -106.02 0.22 Allowed Glycine 0 CA--C 1.522 0.477 0 O-C-N 121.375 -0.828 . . . . 0.0 115.079 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -153.67 154.11 33.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 118.298 1.049 . . . . 0.0 110.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.62 91.75 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -65.47 -49.28 69.69 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.042 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.92 -44.96 91.35 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -59.03 -41.11 87.0 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.238 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.44 -41.93 96.29 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.815 0.734 . . . . 0.0 109.835 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -60.92 -46.47 90.55 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.33 -48.37 82.03 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-O 117.873 -1.061 . . . . 0.0 108.995 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.2 mt -56.75 -22.03 32.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.515 1.507 . . . . 0.0 113.115 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.61 -7.06 60.53 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.391 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 t -126.08 -10.16 6.51 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.779 1.289 . . . . 0.0 110.223 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.07 95.23 5.45 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -12.85 12.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -106.4 -7.52 17.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.279 1.432 . . . . 0.0 111.129 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.16 148.86 41.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.24 152.32 36.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.043 1.737 . . . . 0.0 108.705 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.4 tp -94.82 151.55 19.15 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 tp -140.13 101.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.368 1.467 . . . . 0.0 111.14 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.17 110.25 18.36 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 127.937 2.495 . . . . 0.0 107.378 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -103.68 3.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 116.921 2.193 . . . . 0.0 116.921 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -61.83 167.32 3.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.22 141.12 43.6 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 m -46.81 -34.02 4.95 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.184 2.193 . . . . 0.0 112.478 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.61 76.76 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 119.259 0.936 . . . . 0.0 111.643 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.87 -36.48 84.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 50' ' ' SER . 79.4 m-85 -65.56 -6.04 9.8 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.855 -1.153 . . . . 0.0 111.997 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -112.93 -10.49 13.52 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.914 1.234 . . . . 0.0 111.643 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -115.6 -43.66 3.02 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -109.63 -16.81 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.904 1.281 . . . . 0.0 113.789 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.32 -153.81 20.3 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 121.219 -0.925 . . . . 0.0 112.297 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.2 p -143.48 158.09 58.03 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 124.46 1.104 . . . . 0.0 111.129 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.85 172.17 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 N-CA-C 109.269 -1.089 . . . . 0.0 109.269 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 148.94 35.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.543 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 29.0 pt -140.85 15.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.287 1.835 . . . . 0.0 110.088 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -56.09 -31.05 62.89 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.573 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.35 -22.53 71.21 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 120.457 1.48 . . . . 0.0 110.735 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.31 -17.25 37.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.845 1.258 . . . . 0.0 110.274 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.25 33.65 7.12 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.166 1.365 . . . . 0.0 109.889 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -136.25 175.08 9.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.158 1.383 . . . . 0.0 109.578 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -140.81 160.15 40.67 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.82 0.736 . . . . 0.0 110.405 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.5 163.79 20.24 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.82 88.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.436 ' HB3' ' CE2' ' A' ' 33' ' ' PHE . 7.7 p -58.02 108.71 0.62 Allowed 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.51 0.724 . . . . 0.0 109.287 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.4 m -136.55 89.41 2.46 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.7 t -53.58 112.02 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 124.091 0.956 . . . . 0.0 108.493 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.53 149.1 30.11 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -159.73 145.63 15.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 127.347 2.259 . . . . 0.0 107.775 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.86 -26.73 61.91 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.22 -5.41 18.1 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.046 2.138 . . . . 0.0 113.965 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -149.44 31.97 0.73 Allowed 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.527 0.731 . . . . 0.0 109.797 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -38.32 -57.01 1.94 Allowed Pre-proline 0 N--CA 1.475 0.824 0 CA-C-O 117.806 -1.092 . . . . 0.0 111.846 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -61.99 -48.16 9.05 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.493 2.795 . . . . 0.0 111.991 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.94 -50.15 62.92 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -55.3 -53.95 49.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.095 1.758 . . . . 0.0 108.427 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.44 -48.0 69.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.859 1.264 . . . . 0.0 111.672 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -55.95 -35.56 66.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.796 0.839 . . . . 0.0 110.007 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -60.72 -29.2 69.21 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.709 1.14 . . . . 0.0 111.226 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 -46.44 13.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -54.36 -34.05 60.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.956 1.302 . . . . 0.0 111.624 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.75 -8.03 58.35 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 121.065 -1.022 . . . . 0.0 113.222 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.91 -46.83 2.99 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.328 0.967 . . . . 0.0 112.417 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.78 120.84 20.87 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -29.44 64.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -129.0 68.65 80.12 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 126.842 2.057 . . . . 0.0 110.026 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.18 -41.34 79.52 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -59.2 -15.35 14.54 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.45 -14.09 10.33 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -86.72 124.21 32.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 120.226 1.376 . . . . 0.0 111.403 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 52.7 m -88.47 134.61 33.8 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -111.84 96.87 6.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.282 0.946 . . . . 0.0 109.239 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.489 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 42.2 m-85 -75.19 113.98 13.17 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.615 1.966 . . . . 0.0 109.006 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.66 144.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 120.185 1.357 . . . . 0.0 111.836 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.64 83.69 1.91 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.346 0.658 . . . . 0.0 110.639 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.98 176.5 7.3 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -53.29 -50.99 63.73 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.903 1.281 . . . . 0.0 110.342 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.58 -141.2 0.21 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.58 -40.54 88.99 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.269 -0.894 . . . . 0.0 109.974 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 40.94 -127.52 3.24 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.297 1.903 . . . . 0.0 113.741 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -103.23 3.8 35.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.271 1.028 . . . . 0.0 113.211 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.1 m -40.69 -61.06 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.103 2.261 . . . . 0.0 117.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -53.28 -37.73 62.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.167 0.987 . . . . 0.0 111.886 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.01 -46.99 61.27 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.85 -28.1 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.023 -1.048 . . . . 0.0 109.793 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.53 -36.03 78.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.972 0.805 . . . . 0.0 109.676 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -79.34 -41.36 28.08 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.449 -0.782 . . . . 0.0 109.665 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.6 tp -49.82 -60.82 2.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 127.056 2.143 . . . . 0.0 113.393 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.8 m -59.36 -40.96 82.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.037 0.535 . . . . 0.0 110.758 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.61 -48.88 78.88 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.082 0.553 . . . . 0.0 109.85 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.17 -28.32 69.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 112.185 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -74.41 -43.32 56.85 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.292 0.496 . . . . 0.0 110.743 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.08 -5.74 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 CA-C-O 117.508 -1.718 . . . . 0.0 113.631 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.33 160.37 27.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 120.297 2.049 . . . . 0.0 110.396 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.62 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -59.04 -69.77 0.18 Allowed 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.25 0.62 . . . . 0.0 112.038 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.6 m -155.0 -178.22 7.08 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.429 1.892 . . . . 0.0 108.809 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.9 154.37 27.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.47 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -142.77 111.99 6.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 128.387 2.675 . . . . 0.0 108.737 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.15 119.73 23.33 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.038 0.935 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.3 108.82 4.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.32 151.31 36.96 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 73.34 0.32 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.925 1.69 . . . . 0.0 111.86 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.59 -122.09 14.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.805 1.193 . . . . 0.0 110.997 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.67 -24.41 4.52 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.442 1.497 . . . . 0.0 111.465 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -97.11 -11.91 23.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.647 1.579 . . . . 0.0 114.38 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.53 174.3 39.0 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.818 0.736 . . . . 0.0 112.349 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.27 -28.14 86.26 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.543 2.829 . . . . 0.0 113.387 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -117.44 1.06 12.31 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.833 1.253 . . . . 0.0 110.613 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -51.05 160.12 1.72 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 121.173 -0.954 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -25.94 -62.52 0.07 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.163 2.185 . . . . 0.0 115.622 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.3 mt -54.18 -60.17 3.68 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.323 1.049 . . . . 0.0 109.265 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.05 -2.78 2.15 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.94 1.696 . . . . 0.0 113.022 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.35 12.82 31.78 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.249 -1.532 . . . . 0.0 109.555 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.1 t 66.38 12.55 8.72 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.327 1.851 . . . . 0.0 112.103 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.59 157.34 72.44 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 123.787 0.835 . . . . 0.0 110.443 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.74 147.2 21.64 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.101 1.867 . . . . 0.0 110.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -144.25 144.14 31.37 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 121.399 -0.813 . . . . 0.0 109.298 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.97 87.13 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.205 1.002 . . . . 0.0 108.857 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.59 147.31 78.25 Favored Pre-proline 0 C--O 1.239 0.543 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.27 173.39 8.83 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 124.073 3.182 . . . . 0.0 112.505 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -64.68 -21.85 66.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.843 0.457 . . . . 0.0 109.801 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -53.74 155.0 3.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.965 1.306 . . . . 0.0 110.241 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 t -146.29 44.87 1.23 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.418 1.104 . . . . 0.0 109.585 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.48 70.12 1.43 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -173.69 91.78 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 108.164 -1.975 . . . . 0.0 108.164 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -81.15 -174.67 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.292 2.661 . . . . 0.0 110.266 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.5 m -80.2 66.32 5.65 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.2 m -59.23 146.34 39.58 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.187 1.395 . . . . 0.0 110.256 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 179.56 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t 48.9 36.62 8.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.256 1.028 . . . . 0.0 112.899 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 65.27 -7.73 0.29 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.064 2.146 . . . . 0.0 114.439 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.06 152.02 47.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.691 1.132 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.1 m -80.65 91.91 5.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.71 130.35 42.12 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 176.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.04 100.92 0.25 Allowed Glycine 0 C--O 1.222 -0.611 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.53 146.21 0.36 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.563 1.545 . . . . 0.0 110.821 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -38.78 -54.43 1.6 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -58.07 -49.78 75.72 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.021 1.282 . . . . 0.0 111.081 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -51.79 66.61 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.959 0.904 . . . . 0.0 109.176 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.99 73.11 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.41 -0.805 . . . . 0.0 111.868 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.66 -49.34 77.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.38 0.991 . . . . 0.0 109.39 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -62.3 -41.42 98.5 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.69 -0.631 . . . . 0.0 109.881 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -61.36 -41.51 97.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 117.69 -1.148 . . . . 0.0 110.209 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -62.39 -27.87 69.38 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.738 1.154 . . . . 0.0 111.361 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 -21.99 45.03 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.901 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 p -98.35 -18.11 18.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 118.642 1.221 . . . . 0.0 110.903 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 11.2 t70 -101.6 110.37 22.36 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -38.41 -53.97 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 127.28 2.232 . . . . 0.0 114.98 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -101.37 13.61 34.51 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.62 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -67.88 124.67 23.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.936 -1.102 . . . . 0.0 111.507 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -128.84 144.55 51.2 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.064 0.945 . . . . 0.0 109.731 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.83 144.24 28.56 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 121.623 -0.673 . . . . 0.0 110.409 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 38.8 tp -127.08 107.2 9.83 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.658 1.583 . . . . 0.0 109.206 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -80.34 132.75 35.84 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.6 pt -119.67 13.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 118.827 0.74 . . . . 0.0 111.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -74.89 170.53 15.75 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 119.838 1.199 . . . . 0.0 110.08 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.5 142.23 44.83 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.62 -41.97 23.15 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 127.541 2.336 . . . . 0.0 112.68 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -37.13 73.81 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.53 -0.731 . . . . 0.0 111.867 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -66.8 -27.42 67.56 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.572 0.749 . . . . 0.0 111.257 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -64.42 -16.62 62.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.159 -1.588 . . . . 0.0 110.452 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -104.89 -22.04 13.22 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.38 1.472 . . . . 0.0 109.672 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.75 -52.77 4.82 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.207 1.003 . . . . 0.0 112.22 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.8 -29.04 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.042 1.737 . . . . 0.0 112.259 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.84 -151.75 17.7 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.276 0.944 . . . . 0.0 112.12 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -147.49 156.16 45.61 Favored Pre-proline 0 C--N 1.331 -0.217 0 C-N-CA 123.903 0.881 . . . . 0.0 109.839 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.96 176.28 10.33 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 121.85 1.7 . . . . 0.0 109.75 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.2 142.96 37.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.923 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.95 12.16 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.734 2.014 . . . . 0.0 111.305 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -37.45 67.43 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 117.638 -1.172 . . . . 0.0 113.524 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.61 -35.33 85.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.2 mt -72.61 -16.24 61.73 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.209 0.604 . . . . 0.0 110.57 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.98 45.66 5.89 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 106.606 -2.598 . . . . 0.0 106.606 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -135.47 168.1 19.84 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.608 0.763 . . . . 0.0 110.736 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -145.18 122.42 11.53 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.224 -0.922 . . . . 0.0 110.359 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.78 172.6 10.48 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.784 1.278 . . . . 0.0 112.265 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.89 146.64 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 m -129.13 117.81 21.43 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 120.926 -1.109 . . . . 0.0 111.38 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -147.73 115.77 6.49 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.399 1.08 . . . . 0.0 110.356 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.0 p -68.92 129.16 33.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 120.004 1.275 . . . . 0.0 109.221 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -78.03 166.83 22.34 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -169.23 125.63 0.91 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.78 -20.56 57.13 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 119.148 0.885 . . . . 0.0 112.45 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -84.22 -11.7 56.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.579 1.189 . . . . 0.0 111.621 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -127.47 36.98 4.31 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.522 1.129 . . . . 0.0 111.375 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -48.12 -57.67 9.85 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 120.101 1.318 . . . . 0.0 111.847 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.46 -37.67 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.644 2.229 . . . . 0.0 110.623 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.5 -23.55 66.89 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.509 0.576 . . . . 0.0 112.958 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -87.4 -41.5 13.53 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.279 1.432 . . . . 0.0 107.28 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.74 -46.67 88.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.784 1.234 . . . . 0.0 112.067 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -54.68 -33.7 61.24 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 123.048 0.539 . . . . 0.0 111.257 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -60.04 -27.33 66.85 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.856 0.863 . . . . 0.0 110.99 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.12 -43.19 9.5 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.98 -31.04 66.53 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.535 -0.728 . . . . 0.0 112.322 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.35 -7.23 52.14 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 121.063 -1.023 . . . . 0.0 112.405 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.76 -48.19 2.68 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.564 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 69.7 m-85 -77.79 107.56 10.39 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.733 1.213 . . . . 0.0 109.499 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -72.68 -17.49 61.63 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.483 0.713 . . . . 0.0 112.106 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -148.04 77.31 10.11 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 126.234 1.814 . . . . 0.0 109.921 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.25 -29.51 73.29 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.752 2.301 . . . . 0.0 110.645 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -53.85 -18.61 3.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.152 2.181 . . . . 0.0 113.903 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -125.93 3.98 7.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.253 1.021 . . . . 0.0 112.39 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 m -109.38 121.77 45.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.382 1.473 . . . . 0.0 112.143 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.0 m -91.0 130.92 36.87 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.69 0.796 . . . . 0.0 110.169 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.0 mp -108.53 105.99 15.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.434 1.094 . . . . 0.0 111.286 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.62 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 23.7 m-85 -85.67 110.53 19.36 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.37 134.38 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.012 1.325 . . . . 0.0 111.425 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 tt -136.54 128.9 30.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.469 1.108 . . . . 0.0 109.337 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -130.7 174.78 9.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.908 1.683 . . . . 0.0 108.369 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -52.84 -52.15 58.27 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.746 1.218 . . . . 0.0 109.382 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -144.53 174.93 10.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 131.275 3.83 . . . . 0.0 105.164 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -17.81 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 128.85 2.86 . . . . 0.0 112.508 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.04 -103.22 0.12 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 126.204 1.859 . . . . 0.0 110.39 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -128.9 9.54 5.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.807 1.243 . . . . 0.0 112.38 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 m -39.01 -51.97 1.81 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.315 1.846 . . . . 0.0 113.791 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.63 -45.95 87.91 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 -39.61 93.95 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 122.756 0.422 . . . . 0.0 110.938 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -69.33 -25.58 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.949 -0.469 . . . . 0.0 109.74 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.99 -40.43 65.25 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.536 -0.727 . . . . 0.0 111.158 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.04 -36.59 61.85 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.007 -0.433 . . . . 0.0 110.87 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.41 -56.79 13.91 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.774 1.229 . . . . 0.0 112.227 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.25 -39.4 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 123.316 0.647 . . . . 0.0 111.425 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.55 73.27 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.01 -25.24 65.3 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.545 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -80.21 -23.79 40.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 117.955 -1.021 . . . . 0.0 112.43 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.11 1.84 3.15 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 119.956 1.253 . . . . 0.0 115.546 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -76.67 153.59 35.03 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.756 1.778 . . . . 0.0 110.099 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 tptt -51.21 -65.88 0.48 Allowed 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 126.785 2.034 . . . . 0.0 112.466 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.2 m -157.47 171.96 19.42 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.312 1.845 . . . . 0.0 108.29 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.51 140.16 14.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -121.45 142.85 49.63 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.71 1.204 . . . . 0.0 108.618 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.7 113.56 26.91 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 mp -69.2 108.12 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 0.0 110.036 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -71.17 141.77 50.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 72.82 22.46 3.1 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.746 2.818 . . . . 0.0 109.764 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 27.82 -113.02 0.03 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.002 2.239 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -119.18 -54.93 2.18 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.864 1.266 . . . . 0.0 111.798 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -78.44 8.75 4.68 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.314 1.846 . . . . 0.0 114.045 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.06 173.52 55.34 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.066 -1.021 . . . . 0.0 112.475 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.42 -34.98 98.85 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.714 2.943 . . . . 0.0 111.674 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -129.88 22.14 5.39 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.114 0.966 . . . . 0.0 110.192 177.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.24 168.36 16.04 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -29.45 -53.61 0.13 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.27 1.952 . . . . 0.0 116.27 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.1 mt -60.27 -59.26 5.69 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.227 0.922 . . . . 0.0 109.302 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -72.03 3.53 4.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.195 1.798 . . . . 0.0 112.269 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 27.0 t -95.43 11.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.717 2.007 . . . . 0.0 111.539 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 m 63.12 27.86 15.84 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.352 1.061 . . . . 0.0 111.659 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.1 mt -107.99 153.77 41.52 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 124.119 0.968 . . . . 0.0 109.507 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.47 154.4 27.7 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.199 1.933 . . . . 0.0 111.218 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 29.4 t-105 -147.69 144.35 28.27 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.535 -0.728 . . . . 0.0 111.477 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.21 88.73 2.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 126.016 1.726 . . . . 0.0 108.83 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -77.25 153.54 82.11 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.423 0.689 . . . . 0.0 111.715 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.29 -179.71 5.7 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.965 3.11 . . . . 0.0 108.501 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.5 110.89 6.38 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -34.86 119.82 0.48 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.826 2.05 . . . . 0.0 111.332 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 t -99.97 157.17 16.73 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 65.7 m -68.2 158.47 33.18 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.783 -0.573 . . . . 0.0 109.837 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.71 162.78 24.17 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.565 1.079 . . . . 0.0 111.904 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -87.77 162.0 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.356 3.371 . . . . 0.0 111.719 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 16.0 p -155.63 123.96 5.87 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.5 t -173.63 154.81 2.58 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.825 1.25 . . . . 0.0 109.511 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.922 0 CA-C-O 117.985 -1.453 . . . . 0.0 111.537 179.275 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m -58.55 117.45 4.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.691 1.196 . . . . 0.0 109.412 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 m -134.79 101.49 4.94 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.979 1.312 . . . . 0.0 108.269 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.63 163.57 20.59 Favored Glycine 0 CA--C 1.529 0.956 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.3 p -81.21 44.35 0.77 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.988 1.315 . . . . 0.0 111.362 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 m -74.15 161.43 30.0 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.289 1.042 . . . . 0.0 113.263 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.34 -115.18 0.41 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -160.06 169.99 22.23 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 120.855 -1.38 . . . . 0.0 109.329 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.23 -46.03 92.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -49.74 -52.06 34.34 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.933 0.893 . . . . 0.0 111.099 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -54.97 -59.78 4.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.222 1.009 . . . . 0.0 110.08 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.84 -41.13 67.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.084 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.19 -48.01 79.82 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.556 1.071 . . . . 0.0 112.91 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.0 m -68.2 -41.37 81.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 18' ' ' THR . 20.5 mmtp -60.74 -31.69 70.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.969 0.804 . . . . 0.0 111.975 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.5 mt -75.21 -17.01 60.44 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.391 1.876 . . . . 0.0 110.841 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.1 -52.49 2.21 Favored Glycine 0 CA--C 1.506 -0.494 0 C-N-CA 126.006 1.765 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -64.22 -15.31 59.73 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.609 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -119.17 128.36 54.18 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.835 1.198 . . . . 0.0 108.367 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.43 -39.69 38.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.633 0.651 . . . . 0.0 112.466 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -74.11 -14.08 60.92 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.95 1.3 . . . . 0.0 112.423 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -68.86 131.54 45.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.244 1.418 . . . . 0.0 110.388 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -138.86 142.69 38.6 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.413 0.625 . . . . 0.0 111.59 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.3 tm? -76.88 131.26 38.5 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HD12 ' A' ' 77' ' ' LEU . 40.0 tp -112.13 95.89 5.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.15 2.18 . . . . 0.0 107.552 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -75.63 109.48 9.24 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.95 0.38 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 HD22 ' A' ' 80' ' ' LEU . 46.8 mtm-85 -69.46 162.8 26.68 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.071 0.85 . . . . 0.0 110.485 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.09 136.66 56.28 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m -52.34 -23.22 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 111.406 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.66 79.55 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.531 -1.356 . . . . 0.0 110.701 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -65.54 -33.84 76.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.006 1.722 . . . . 0.0 109.972 179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -60.42 -18.9 53.97 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -95.59 -37.14 10.98 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.053 1.741 . . . . 0.0 109.984 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -81.29 -50.52 9.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.9 -23.33 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 113.85 -177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.13 -157.97 22.23 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.981 -0.847 . . . . 0.0 110.981 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.1 p -139.21 160.82 60.7 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.56 176.53 7.26 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.165 1.91 . . . . 0.0 109.009 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' HB3' HG13 ' A' ' 123' ' ' ILE 0.261 8.5 p30 -141.61 114.09 8.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 122.069 0.938 . . . . 0.0 111.973 177.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 pt -85.57 8.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 122.188 0.994 . . . . 0.0 109.255 177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 47.4 tttm -55.44 -28.07 52.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 125.817 1.647 . . . . 0.0 111.774 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.42 -48.81 47.45 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.91 -46.65 62.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.646 1.178 . . . . 0.0 108.448 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.08 40.62 0.69 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.73 1.633 . . . . 0.0 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -119.14 -176.38 3.11 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.1 0.96 . . . . 0.0 111.437 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.62 116.72 10.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.356 0.98 . . . . 0.0 110.992 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.65 152.25 39.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.592 0.757 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -108.85 91.15 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 110.314 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 m -57.96 102.43 0.1 Allowed 'General case' 0 C--O 1.238 0.469 0 C-N-CA 127.171 2.188 . . . . 0.0 110.298 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.7 m -143.09 97.41 3.09 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.633 0.773 . . . . 0.0 109.757 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.9 t -58.15 119.82 3.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.348 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -74.94 154.52 38.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -156.09 118.7 4.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.43 -22.93 68.06 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.115 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -82.5 -6.12 59.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.615 1.207 . . . . 0.0 110.952 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -136.37 39.61 2.67 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.032 0.833 . . . . 0.0 110.553 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -43.02 -60.83 2.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 120.762 -1.211 . . . . 0.0 113.622 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -67.2 -43.47 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.585 2.857 . . . . 0.0 111.42 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.03 -47.34 81.0 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -57.42 -50.62 72.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.533 1.533 . . . . 0.0 108.026 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.4 -39.59 70.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.465 0.706 . . . . 0.0 111.049 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -37.46 78.72 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 109.779 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.54 -24.17 44.96 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.432 1.093 . . . . 0.0 111.894 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.08 -44.09 7.47 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t -54.28 -33.01 57.73 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.654 1.182 . . . . 0.0 111.498 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.92 -2.92 39.18 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -121.32 -40.23 2.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.967 0.803 . . . . 0.0 112.564 -179.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.722 ' CD1' HG21 ' A' ' 75' ' ' THR . 64.1 m-85 -79.94 111.99 16.8 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -18.58 62.22 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 123.069 0.548 . . . . 0.0 111.315 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.52 78.26 11.06 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 125.815 1.646 . . . . 0.0 108.44 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.29 -32.97 97.73 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.47 2.113 . . . . 0.0 110.961 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -57.97 -18.75 25.65 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 129.354 3.062 . . . . 0.0 113.089 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.61 -4.71 9.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.996 0.918 . . . . 0.0 111.419 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 69' ' ' PHE . 29.2 m -95.16 113.92 25.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.678 1.191 . . . . 0.0 112.296 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.6 m -86.75 129.16 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD12 HD22 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -100.42 99.14 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.532 1.533 . . . . 0.0 111.768 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 37.5 m-85 -84.34 98.6 10.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -68.0 157.58 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.559 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD22 HH11 ' A' ' 28' ' ' ARG . 6.7 tt -152.47 112.06 3.93 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.2 -0.937 . . . . 0.0 109.773 178.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -112.79 173.3 6.44 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -31.05 70.23 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 119.93 -1.731 . . . . 0.0 111.409 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -138.6 -152.71 0.44 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.034 2.134 . . . . 0.0 106.48 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -71.11 -18.33 62.53 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.896 2.079 . . . . 0.0 113.58 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.96 -97.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 129.798 3.571 . . . . 0.0 115.913 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -129.62 6.89 5.22 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 126.363 1.865 . . . . 0.0 110.957 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -42.91 -47.4 5.64 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.26 1.824 . . . . 0.0 113.487 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -57.5 -43.64 84.34 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.424 1.09 . . . . 0.0 111.26 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.46 -49.05 58.53 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.342 1.057 . . . . 0.0 109.49 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.09 -31.56 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.563 0.745 . . . . 0.0 109.142 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.62 87.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.857 0.753 . . . . 0.0 110.162 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -41.87 74.26 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 44.0 tp -50.39 -57.52 7.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.884 1.674 . . . . 0.0 112.557 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 m -66.91 -40.12 85.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.13 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.16 -49.12 78.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.068 0.547 . . . . 0.0 109.808 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.15 -38.31 90.61 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.385 1.074 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.81 -23.38 67.22 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 117.66 -1.162 . . . . 0.0 113.265 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.98 1.32 4.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 117.871 -1.516 . . . . 0.0 113.46 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -76.11 157.67 32.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 119.15 1.475 . . . . 0.0 108.473 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.0 tptm -49.79 -71.07 0.07 Allowed 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 127.445 2.298 . . . . 0.0 110.087 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.1 m -163.62 -178.86 6.05 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 126.674 1.99 . . . . 0.0 106.857 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.8 164.64 38.29 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -136.99 142.88 42.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.26 110.3 22.3 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 124.734 1.271 . . . . 0.0 107.784 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.95 106.4 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -68.63 144.01 54.63 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 82.24 -2.09 1.45 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.598 1.959 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.14 -102.61 0.07 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 126.449 1.976 . . . . 0.0 114.532 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -123.31 -43.52 2.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.674 1.59 . . . . 0.0 110.656 179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -79.88 -28.79 39.87 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.0 171.82 41.58 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 121.151 1.796 . . . . 0.0 111.811 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.54 -15.37 35.95 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 124.798 3.665 . . . . 0.0 116.052 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 48.7 mmt-85 -115.78 5.64 14.2 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.065 1.346 . . . . 0.0 111.112 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.45 163.23 54.78 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 106.844 -2.502 . . . . 0.0 106.844 178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -46.52 -45.28 18.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.2 mt -66.93 -39.89 87.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.247 0.476 . . . . 0.0 111.038 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -87.67 23.26 2.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.8 1.64 . . . . 0.0 111.433 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.9 t -120.51 6.56 10.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.445 1.098 . . . . 0.0 112.819 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 56.86 48.5 15.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.991 0.917 . . . . 0.0 109.363 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.1 mt -116.53 160.74 35.07 Favored Pre-proline 0 CA--C 1.531 0.217 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.81 145.01 17.65 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.123 1.882 . . . . 0.0 110.149 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -144.0 132.2 21.86 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.987 -1.071 . . . . 0.0 110.833 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 40' ' ' ASN . 6.6 mt -75.27 90.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.567 1.547 . . . . 0.0 110.082 178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -83.49 143.9 45.19 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 120.809 -1.182 . . . . 0.0 110.94 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -81.3 -171.13 1.14 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 125.03 3.82 . . . . 0.0 109.488 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -63.96 122.07 15.63 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 120.807 -1.183 . . . . 0.0 110.897 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -73.22 156.26 38.73 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -139.52 136.99 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 119.122 0.874 . . . . 0.0 109.009 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 m -69.56 114.14 7.5 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.3 153.8 52.9 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -81.08 -168.68 0.66 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.685 2.924 . . . . 0.0 109.697 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -83.28 42.21 0.81 Allowed 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.637 -1.29 . . . . 0.0 107.9 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 m 65.91 8.7 5.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.91 1.684 . . . . 0.0 110.842 -176.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.443 2 C-N-CA 132.533 4.873 . . . . 0.0 102.785 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 p -144.32 94.4 2.56 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.959 1.704 . . . . 0.0 106.529 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.7 t -128.25 -143.81 0.28 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.13 -167.93 39.0 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.2 m -126.42 21.75 7.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.545 1.172 . . . . 0.0 113.504 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.3 p -61.0 169.88 1.79 Allowed 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.883 1.273 . . . . 0.0 112.404 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.57 -116.82 0.5 Allowed Glycine 0 N--CA 1.445 -0.748 0 O-C-N 121.545 -0.722 . . . . 0.0 111.752 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -142.45 157.3 44.9 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.877 0.871 . . . . 0.0 112.439 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.45 90.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.374 1.469 . . . . 0.0 113.46 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -58.53 -52.66 64.7 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.841 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -66.82 -42.95 85.0 Favored 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.182 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.68 -40.27 75.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.583 0.628 . . . . 0.0 111.283 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.23 -47.55 79.26 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -60.73 -40.67 93.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.308 0.243 . . . . 0.0 110.494 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.5 mmpt? -58.94 -43.77 91.26 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 117.503 -1.237 . . . . 0.0 110.446 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.26 -23.95 62.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.289 1.404 . . . . 0.0 111.121 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.06 4.38 62.75 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.435 1.493 . . . . 0.0 112.505 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.12 -4.72 3.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.121 1.768 . . . . 0.0 110.778 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -124.53 106.12 9.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.357 -1.719 . . . . 0.0 106.357 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.1 -18.19 2.0 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -122.57 5.48 9.54 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 119.397 0.999 . . . . 0.0 113.155 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.67 50.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.635 1.107 . . . . 0.0 108.442 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -140.27 152.86 46.25 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.338 1.055 . . . . 0.0 109.415 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.52 118.85 37.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.24 107.36 16.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.654 1.581 . . . . 0.0 107.211 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -86.64 123.0 31.33 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.56 -0.85 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 -33.78 -109.38 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.901 3.68 . . . . 0.0 115.39 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.64 134.27 5.2 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.4 m -45.74 -43.39 12.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.78 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.52 80.92 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.3 0.955 . . . . 0.0 109.809 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.98 -40.56 67.03 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.515 1.126 . . . . 0.0 110.635 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -60.99 -15.85 36.41 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 121.025 1.739 . . . . 0.0 112.913 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -107.91 -13.02 15.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.746 1.618 . . . . 0.0 111.753 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -102.14 -47.06 4.65 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.717 1.207 . . . . 0.0 110.489 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.5 p -104.19 -24.93 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.808 1.243 . . . . 0.0 113.468 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.45 -148.16 18.57 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 119.145 0.884 . . . . 0.0 113.807 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -146.28 162.63 33.98 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.66 128.41 10.95 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.68 2.253 . . . . 0.0 110.044 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.514 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -86.29 73.89 10.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.494 -1.684 . . . . 0.0 109.64 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.4 pt -78.66 -4.37 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.556 -1.34 . . . . 0.0 110.597 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -50.03 -37.62 33.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.65 2.38 . . . . 0.0 112.474 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.95 -40.44 72.91 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 124.206 0.941 . . . . 0.0 111.465 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.9 mt -71.87 -50.52 28.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.84 25.56 0.14 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.727 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -133.33 -175.12 3.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.12 1.46 . . . . 0.0 109.971 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -144.52 131.65 20.55 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.138 2.175 . . . . 0.0 105.879 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.23 164.89 14.87 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.679 0.672 . . . . 0.0 111.565 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.3 t -126.47 89.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 126.198 1.799 . . . . 0.0 107.252 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.7 p -63.84 108.7 1.53 Allowed 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.062 1.345 . . . . 0.0 111.206 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.434 HG23 ' HE3' ' A' ' 64' ' ' LYS . 2.1 m -142.38 94.09 2.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.1 116.25 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -76.75 150.44 36.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.45 0.643 . . . . 0.0 110.593 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -155.33 134.97 12.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 128.361 2.664 . . . . 0.0 104.516 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.17 -13.22 81.38 Favored Glycine 0 C--O 1.227 -0.322 0 N-CA-C 113.987 0.355 . . . . 0.0 113.987 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.33 -43.83 39.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.023 0.911 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.32 51.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.875 0.87 . . . . 0.0 109.78 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -52.03 -54.8 37.01 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.27 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.55 -42.11 7.57 Favored 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.877 1.349 . . . . 0.0 109.802 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.03 -19.77 46.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.41 1.481 . . . . 0.0 113.931 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -89.76 -54.23 4.15 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.242 1.817 . . . . 0.0 106.664 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -54.09 -46.87 72.18 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.502 1.921 . . . . 0.0 111.082 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -41.34 66.07 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.138 0.975 . . . . 0.0 110.597 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.434 ' HE3' HG23 ' A' ' 51' ' ' THR . 51.3 mtmt -60.61 -34.49 74.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.528 1.058 . . . . 0.0 110.948 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -48.01 25.24 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 t -61.21 -9.29 4.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.914 2.086 . . . . 0.0 115.323 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -106.11 -13.36 15.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.223 0.919 . . . . 0.0 109.337 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -98.97 -47.1 5.38 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.441 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 56.0 m-85 -86.38 159.91 19.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.367 1.467 . . . . 0.0 109.529 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -2.38 1.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.274 2.63 . . . . 0.0 112.362 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.7 p-10 -136.11 52.54 6.59 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 128.76 2.824 . . . . 0.0 112.384 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.95 -36.54 17.54 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.532 2.821 . . . . 0.0 112.7 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -55.64 -18.11 7.13 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.652 2.381 . . . . 0.0 113.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -125.02 -1.38 7.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.215 1.006 . . . . 0.0 112.736 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.5 m -100.69 136.22 40.9 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.166 1.387 . . . . 0.0 112.411 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 91.2 m -102.59 128.02 49.43 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.5 mt -102.57 97.78 7.94 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.131 0.972 . . . . 0.0 111.708 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 39.0 m-85 -74.87 126.78 31.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.01 126.7 57.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 121.002 1.728 . . . . 0.0 111.557 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 80' ' ' LEU . 5.8 tt -120.94 114.58 21.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.97 1.708 . . . . 0.0 109.046 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -119.47 170.41 9.17 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.668 1.987 . . . . 0.0 107.22 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.211 -1.555 . . . . 0.0 111.648 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.83 -154.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.912 2.485 . . . . 0.0 106.996 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -59.42 -53.44 58.12 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.605 1.162 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 43.6 -112.86 0.62 Allowed Glycine 0 C--N 1.337 0.595 0 C-N-CA 127.521 2.486 . . . . 0.0 114.716 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -112.27 3.72 17.29 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.155 1.382 . . . . 0.0 112.741 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.1 m -40.02 -51.33 2.56 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.791 1.636 . . . . 0.0 113.686 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.58 -38.5 91.23 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 119.311 0.96 . . . . 0.0 112.175 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.63 -48.21 70.16 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.8 t -60.59 -23.11 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.661 0.785 . . . . 0.0 110.043 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.31 -31.33 48.75 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.013 0.525 . . . . 0.0 109.928 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -85.59 -33.62 21.63 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.592 1.087 . . . . 0.0 109.842 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.0 tp -50.79 -56.83 10.27 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 127.348 2.259 . . . . 0.0 111.325 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -69.96 -35.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.779 0.832 . . . . 0.0 111.777 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.38 95.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.84 -17.67 62.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.953 0.901 . . . . 0.0 111.935 178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -91.34 -24.04 19.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.776 1.23 . . . . 0.0 113.851 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.28 -6.19 4.28 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 118.74 -1.033 . . . . 0.0 114.45 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -69.74 147.63 50.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 119.573 1.687 . . . . 0.0 109.021 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.01 -66.92 0.3 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.534 1.133 . . . . 0.0 113.318 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 68.8 m -152.57 170.81 19.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.093 0.957 . . . . 0.0 108.817 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.18 128.44 9.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.461 -0.774 . . . . 0.0 109.797 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.401 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 31.6 m-85 -109.92 120.85 43.78 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.95 1.3 . . . . 0.0 110.9 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.75 113.88 22.96 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.43 115.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -71.04 161.59 30.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.55 12.16 8.6 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 129.354 3.062 . . . . 0.0 113.822 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.22 -138.55 27.14 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 122.707 1.171 . . . . 0.0 112.701 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.446 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -115.68 5.49 14.27 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.949 1.3 . . . . 0.0 110.529 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.91 -3.28 3.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.41 172.78 49.24 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.595 1.089 . . . . 0.0 112.465 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.62 -25.2 73.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.891 3.061 . . . . 0.0 114.392 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.96 13.08 15.88 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.354 1.862 . . . . 0.0 109.613 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.31 176.51 26.99 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.953 -1.092 . . . . 0.0 111.619 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -47.05 -61.8 1.71 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 113.186 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt -58.26 -53.31 59.76 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.54 -14.57 43.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.813 1.645 . . . . 0.0 112.79 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -91.62 13.79 16.93 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.568 1.547 . . . . 0.0 110.442 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.9 m 63.15 23.15 13.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.649 2.38 . . . . 0.0 113.498 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.5 mt -83.75 153.2 64.17 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' C ' HD21 ' A' ' 40' ' ' ASN . 37.8 Cg_endo -74.24 160.9 41.61 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.805 1.67 . . . . 0.0 110.175 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -163.08 135.76 5.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.864 1.211 . . . . 0.0 112.12 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.472 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 4.0 mt -76.13 95.03 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 126.697 1.999 . . . . 0.0 109.973 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -96.69 139.89 21.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 O-C-N 120.962 -1.086 . . . . 0.0 108.352 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -74.23 -172.05 1.06 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.798 2.998 . . . . 0.0 110.721 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.37 139.8 54.72 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.62 -178.58 3.48 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.551 1.54 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.1 p -112.99 157.23 21.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 124.516 1.126 . . . . 0.0 108.702 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 71.8 p -68.66 173.83 4.79 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.733 . . . . 0.0 110.141 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.24 154.75 28.31 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.5 168.24 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.167 1.911 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 12.4 p -127.46 -174.91 3.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.055 1.342 . . . . 0.0 107.962 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.6 m -154.62 178.01 10.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.204 1.401 . . . . 0.0 110.68 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.247 0 C-N-CA 127.116 2.293 . . . . 0.0 107.777 179.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.614 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.54 136.69 41.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.975 2.51 . . . . 0.0 105.051 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.49 -31.8 0.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.546 2.338 . . . . 0.0 114.722 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -168.02 22.84 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 125.573 1.559 . . . . 0.0 110.436 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 m -125.26 42.37 3.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.957 1.303 . . . . 0.0 110.654 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.3 p -69.58 173.43 6.05 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 120.364 -1.46 . . . . 0.0 111.205 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.46 -103.51 0.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.9 m -156.29 163.92 38.95 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.414 1.086 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.51 44.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.618 1.967 . . . . 0.0 111.962 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -55.1 -50.55 68.91 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.216 0.916 . . . . 0.0 110.853 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -51.56 67.49 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.951 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.23 77.33 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -73.24 -41.76 63.34 Favored 'General case' 0 C--O 1.226 -0.183 0 O-C-N 121.102 -0.999 . . . . 0.0 108.999 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.7 m -57.92 -45.92 85.8 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -51.69 -51.62 54.57 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 126.039 1.735 . . . . 0.0 110.644 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.23 -21.16 13.01 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.97 1.259 . . . . 0.0 113.094 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.6 -5.97 57.55 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 119.891 1.223 . . . . 0.0 112.824 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -123.38 -1.13 8.66 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.656 1.582 . . . . 0.0 110.565 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -127.33 102.25 6.82 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.86 -26.25 67.56 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.052 -1.03 . . . . 0.0 110.722 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -93.3 32.4 1.34 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.71 0.804 . . . . 0.0 110.077 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -110.11 137.47 47.82 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 123.63 0.772 . . . . 0.0 109.164 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -144.58 136.0 25.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.832 0.853 . . . . 0.0 109.772 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.2 tm? -84.68 133.95 34.37 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 77' ' ' LEU . 15.6 tp -123.86 104.44 8.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.589 1.956 . . . . 0.0 109.264 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -80.95 122.95 27.9 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.7 pt -105.62 1.84 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.2 mtm105 -66.09 171.67 4.41 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.15 1.38 . . . . 0.0 111.294 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.5 146.85 28.14 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.61 1.195 . . . . 0.0 109.472 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -43.03 -45.15 5.07 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 129.831 3.253 . . . . 0.0 113.682 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -35.61 79.97 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.64 -32.35 73.37 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -67.21 -14.01 62.51 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 120.067 -1.646 . . . . 0.0 111.034 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -100.74 -14.38 18.08 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.008 2.123 . . . . 0.0 109.266 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -103.19 -65.41 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.971 1.708 . . . . 0.0 110.999 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -86.65 -36.44 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.934 1.294 . . . . 0.0 111.636 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.42 -155.3 16.17 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 118.977 0.808 . . . . 0.0 113.395 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 p -133.96 148.95 70.26 Favored Pre-proline 0 CA--C 1.518 -0.266 0 C-N-CA 124.756 1.223 . . . . 0.0 110.1 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.56 169.2 22.3 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 N-CA-C 108.156 -1.517 . . . . 0.0 108.156 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.53 129.96 45.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.148 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.8 pt -124.33 7.08 4.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 125.917 1.687 . . . . 0.0 109.495 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -58.77 -31.02 67.98 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 125.066 1.346 . . . . 0.0 110.77 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.33 -51.09 32.76 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.89 -50.72 61.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.872 0.836 . . . . 0.0 110.074 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.2 39.01 0.14 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.664 1.126 . . . . 0.0 111.385 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -131.31 -179.56 5.43 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.566 1.183 . . . . 0.0 110.935 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -143.77 115.11 8.01 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 108.967 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 150.53 22.3 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 118.537 0.608 . . . . 0.0 111.146 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.26 125.95 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 p -103.15 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.153 0.981 . . . . 0.0 109.752 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 m -138.05 98.85 3.73 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.6 114.4 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.355 1.062 . . . . 0.0 109.593 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -80.79 150.0 29.39 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.917 0.865 . . . . 0.0 110.131 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -157.57 119.77 3.79 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 127.751 2.42 . . . . 0.0 105.131 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.56 -22.6 59.43 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -66.15 -11.9 52.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.165 1.386 . . . . 0.0 110.453 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -146.26 46.67 1.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.069 -1.019 . . . . 0.0 111.114 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 48.5 mttp -46.0 -49.02 41.26 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.99 177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 55.4 Cg_endo -64.14 -49.7 3.52 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 121.674 1.583 . . . . 0.0 111.306 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.33 78.75 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.579 1.081 . . . . 0.0 110.825 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.12 -58.7 7.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.909 1.284 . . . . 0.0 107.871 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.4 mt -51.25 -47.34 62.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.657 1.583 . . . . 0.0 110.694 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -57.21 -37.64 72.52 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.227 1.411 . . . . 0.0 110.253 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.1 mtmm -62.32 -26.38 68.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.541 1.519 . . . . 0.0 110.895 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.18 -47.14 11.15 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.0 t -54.67 -37.96 66.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.838 0.855 . . . . 0.0 111.709 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.51 -0.98 35.54 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.83 -38.69 3.21 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 119.098 0.863 . . . . 0.0 111.288 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.485 ' CD1' HG21 ' A' ' 75' ' ' THR . 62.8 m-85 -89.92 113.56 25.21 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -25.35 67.97 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.954 -0.546 . . . . 0.0 111.822 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -138.11 78.82 33.6 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 124.924 1.29 . . . . 0.0 111.165 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -59.05 -37.25 94.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.521 2.814 . . . . 0.0 113.107 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -12.98 7.15 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.879 1.272 . . . . 0.0 112.892 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.12 28.04 5.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.656 1.582 . . . . 0.0 109.596 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 ' CD1' ' A' ' 69' ' ' PHE . 70.6 m -125.75 120.82 31.66 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 46.4 m -100.79 122.03 42.7 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.476 1.11 . . . . 0.0 108.09 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 25' ' ' LEU . 1.3 mm? -97.61 106.78 19.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.408 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 21.4 m-85 -83.37 97.19 8.8 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.2 mt -73.07 132.22 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 109.462 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 109' ' ' ALA . 6.2 tt -131.21 131.4 43.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.066 1.347 . . . . 0.0 109.223 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -134.48 175.43 9.53 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.797 2.439 . . . . 0.0 109.233 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.53 -44.06 80.44 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.579 -1.326 . . . . 0.0 109.493 177.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -136.25 -148.82 0.3 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.64 -36.18 82.97 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.73 -1.231 . . . . 0.0 109.187 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.28 -99.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.797 0 C-N-CA 127.247 2.356 . . . . 0.0 111.274 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -139.16 12.97 2.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.482 1.513 . . . . 0.0 108.787 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -43.32 -57.07 3.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.049 1.74 . . . . 0.0 114.107 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -65.67 -30.67 71.4 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.252 0.933 . . . . 0.0 112.116 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -48.34 67.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.95 1.357 . . . . 0.0 108.966 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.58 -32.06 52.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.068 1.747 . . . . 0.0 109.423 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.72 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 119.05 -0.5 . . . . 0.0 110.407 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -79.19 -48.8 13.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.703 1.138 . . . . 0.0 108.416 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.5 tp -42.21 -64.98 0.51 Allowed 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.525 1.53 . . . . 0.0 114.056 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.8 m -62.92 -40.3 88.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.965 0.906 . . . . 0.0 112.018 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 -54.62 45.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.848 0.718 . . . . 0.0 109.489 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.43 -27.11 68.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.07 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.59 -34.68 72.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.428 0.558 . . . . 0.0 111.839 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.52 -9.2 0.48 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.982 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.21 155.6 38.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 119.823 1.811 . . . . 0.0 110.806 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.46 -66.59 0.36 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.518 0.727 . . . . 0.0 109.97 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.6 m -158.03 -179.46 8.15 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.505 1.922 . . . . 0.0 107.246 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.54 130.74 6.84 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 121.631 -0.668 . . . . 0.0 109.742 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -102.24 163.81 12.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.82 119.68 11.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.7 mp -79.64 116.46 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.567 0.699 . . . . 0.0 111.26 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 107' ' ' ASP . 0.2 OUTLIER -66.32 148.4 51.91 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.621 ' H ' ' HE2' ' A' ' 106' ' ' LYS . 4.2 m-20 68.09 -0.55 2.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.975 1.71 . . . . 0.0 111.426 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.75 -134.08 39.65 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.771 0.651 . . . . 0.0 111.723 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.406 ' HB2' HD21 ' A' ' 80' ' ' LEU . . . -94.07 -56.74 2.75 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 126.612 1.965 . . . . 0.0 111.827 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -80.39 -12.77 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.59 169.6 33.29 Favored Glycine 0 CA--C 1.537 1.448 0 CA-C-N 120.733 1.606 . . . . 0.0 113.048 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.6 -46.67 31.74 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.344 2.696 . . . . 0.0 113.306 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -98.76 21.41 11.47 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.542 1.519 . . . . 0.0 110.006 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.41 175.91 19.85 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.402 1.001 . . . . 0.0 112.548 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -45.77 -67.29 0.3 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.431 1.892 . . . . 0.0 114.448 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.69 -45.55 63.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.921 0.888 . . . . 0.0 111.225 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -71.8 -8.14 52.46 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.245 1.418 . . . . 0.0 113.819 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.2 m -103.29 19.65 19.25 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 125.924 1.69 . . . . 0.0 112.745 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.8 t 61.53 32.03 18.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.858 0.863 . . . . 0.0 110.848 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.44 146.7 32.23 Favored Pre-proline 0 N--CA 1.449 -0.479 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.46 144.42 16.0 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.472 2.115 . . . . 0.0 111.196 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 t-105 -142.27 156.35 45.28 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.355 -0.841 . . . . 0.0 110.441 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.1 mt -111.3 90.3 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.491 1.117 . . . . 0.0 110.292 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -70.69 155.21 93.72 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.75 -0.594 . . . . 0.0 109.697 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.96 178.73 6.49 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.435 2.756 . . . . 0.0 110.164 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -61.18 -58.56 7.84 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.894 . . . . 0.0 109.26 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -73.84 156.71 37.46 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.4 t -137.03 161.31 36.42 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -178.78 2.33 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.347 1.059 . . . . 0.0 111.159 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.64 73.08 0.03 OUTLIER Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.82 -178.73 4.86 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.206 2.604 . . . . 0.0 110.51 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.3 t -132.15 157.36 44.46 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.43 1.492 . . . . 0.0 108.897 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.4 t -112.35 151.51 29.66 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 N-CA-C 104.099 -3.6 . . . . 0.0 104.099 -178.257 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 t -160.23 -169.77 2.6 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.7 t -56.65 -50.64 71.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.56 158.2 23.41 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 105.726 -2.95 . . . . 0.0 105.726 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 m -121.53 147.17 46.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.591 -0.946 . . . . 0.0 111.548 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.5 p -144.07 173.22 11.92 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.531 1.532 . . . . 0.0 110.351 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.07 -111.31 0.25 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.92 163.13 32.25 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.988 1.315 . . . . 0.0 112.135 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.17 79.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.646 1.578 . . . . 0.0 106.901 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -60.32 -50.65 72.79 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 122.194 -0.316 . . . . 0.0 111.351 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.3 -43.63 98.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.662 0.665 . . . . 0.0 111.04 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -22.5 66.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.773 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -72.71 -56.3 5.5 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.5 1.045 . . . . 0.0 109.054 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -51.16 -45.75 61.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.021 0.928 . . . . 0.0 110.983 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -57.15 -20.51 26.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.1 -29.27 31.83 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 119.598 1.09 . . . . 0.0 108.852 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.32 -35.04 12.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.062 1.315 . . . . 0.0 111.663 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -74.48 -14.53 60.84 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.02 0.91 . . . . 0.0 110.653 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.22 175.61 7.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.579 0.627 . . . . 0.0 111.793 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -112.72 -43.37 3.46 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.59 1.156 . . . . 0.0 111.372 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -80.99 -3.62 52.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.789 0.835 . . . . 0.0 111.781 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.63 119.58 21.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -132.39 145.74 51.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.259 0.481 . . . . 0.0 110.077 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.2 tp -84.31 143.65 29.38 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.5 tp -122.42 109.39 14.32 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.734 1.614 . . . . 0.0 111.178 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.96 89.88 7.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.126 1.37 . . . . 0.0 109.221 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 pt -83.12 -0.24 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 119.872 -1.768 . . . . 0.0 113.828 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -59.32 164.27 3.38 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 126.329 1.852 . . . . 0.0 111.818 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.32 147.97 32.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.9 m -58.23 -20.72 44.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.704 1.602 . . . . 0.0 109.676 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -43.6 90.63 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.964 -1.085 . . . . 0.0 108.102 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -61.67 -28.64 69.54 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 110.777 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -59.73 -17.91 38.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.323 0.965 . . . . 0.0 110.805 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.8 mtt180 -110.12 -36.97 5.7 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.418 1.487 . . . . 0.0 109.961 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.21 -27.64 56.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.86 -19.66 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.9 -152.61 17.76 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 121.311 -0.868 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 p -147.7 158.31 43.06 Favored Pre-proline 0 C--N 1.331 -0.231 0 C-N-CA 124.175 0.99 . . . . 0.0 111.527 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -78.66 155.42 27.48 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.696 1.597 . . . . 0.0 111.18 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.553 ' HB3' HG13 ' A' ' 123' ' ' ILE . 1.2 p30 -127.74 87.7 2.66 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.396 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 pt -72.95 5.8 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.589 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -55.18 -34.72 64.09 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 110.543 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.16 -34.73 32.68 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.011 0.815 . . . . 0.0 111.729 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt -89.58 -32.36 17.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.009 0.905 . . . . 0.0 111.034 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.57 29.2 1.09 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 124.897 1.237 . . . . 0.0 114.463 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -135.74 -178.79 5.29 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.234 1.017 . . . . 0.0 110.116 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -139.24 131.76 28.7 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.485 1.114 . . . . 0.0 109.636 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.2 163.07 27.42 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.0 t -122.69 130.19 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 p -96.77 94.72 7.43 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.039 2.135 . . . . 0.0 113.733 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 m -127.7 90.81 3.17 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.68 1.592 . . . . 0.0 109.732 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -49.97 116.46 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 121.476 -0.765 . . . . 0.0 110.966 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -82.52 153.57 25.5 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -156.33 130.1 8.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.01 -23.58 59.54 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.748 -1.029 . . . . 0.0 113.026 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -86.54 -8.88 57.17 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.674 1.19 . . . . 0.0 112.194 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -123.13 26.55 7.99 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.307 1.443 . . . . 0.0 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -42.7 -58.39 3.85 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.745 1.157 . . . . 0.0 111.913 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.65 -42.54 12.01 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.128 2.552 . . . . 0.0 112.101 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.28 -52.46 49.55 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -55.56 -49.03 73.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.491 1.517 . . . . 0.0 107.862 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.6 mt -53.89 -50.21 66.84 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.769 0.828 . . . . 0.0 109.773 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -43.44 84.21 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.299 1.04 . . . . 0.0 110.627 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -58.49 -23.99 59.29 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.133 1.333 . . . . 0.0 112.685 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 62' ' ' LEU . 5.4 mt -93.36 -50.55 5.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.709 1.604 . . . . 0.0 108.003 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.0 t -56.92 -23.25 43.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.083 0.953 . . . . 0.0 109.398 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.2 -8.07 52.04 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.89 -38.38 6.66 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.69 1.196 . . . . 0.0 109.663 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -83.07 177.44 8.59 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.072 1.349 . . . . 0.0 108.407 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -33.9 3.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.295 1.038 . . . . 0.0 112.334 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -144.57 86.3 8.11 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 123.99 0.916 . . . . 0.0 110.588 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 10.7 Cg_endo -55.23 -32.61 81.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.948 2.432 . . . . 0.0 112.865 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.66 -8.0 1.8 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -123.22 -6.73 8.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.777 -1.106 . . . . 0.0 112.97 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.9 m -101.26 130.06 47.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.7 m -98.63 130.45 45.16 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.328 1.051 . . . . 0.0 109.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.36 103.16 12.64 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.646 1.178 . . . . 0.0 112.19 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -85.91 102.31 13.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mp -78.07 139.65 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.916 1.286 . . . . 0.0 113.414 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.43 123.65 21.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.935 1.694 . . . . 0.0 110.253 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -130.58 170.65 13.99 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.576 2.351 . . . . 0.0 107.748 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.85 -21.74 8.29 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.033 -1.042 . . . . 0.0 113.537 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -159.64 -162.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 129.916 3.287 . . . . 0.0 104.933 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -50.14 -55.09 16.48 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.861 2.065 . . . . 0.0 107.365 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.27 -96.95 0.02 OUTLIER Glycine 0 C--N 1.337 0.602 0 C-N-CA 128.251 2.834 . . . . 0.0 114.252 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -135.88 13.08 3.39 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.683 1.193 . . . . 0.0 110.859 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m -52.03 -31.59 30.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.943 0.792 . . . . 0.0 110.961 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -72.19 -35.45 68.97 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.159 2.184 . . . . 0.0 111.745 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.43 -46.64 14.29 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.2 t -60.15 -30.84 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.02 94.91 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -71.65 -42.66 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.781 0.832 . . . . 0.0 109.203 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.2 tp -50.41 -62.15 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.133 1.373 . . . . 0.0 111.848 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.46 -38.62 80.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 123.115 0.566 . . . . 0.0 110.688 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.92 -52.76 64.36 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.615 0.766 . . . . 0.0 109.727 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.05 -24.4 67.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.669 0.788 . . . . 0.0 111.589 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -77.2 -21.79 53.36 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.783 0.719 . . . . 0.0 110.844 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.6 3.56 6.52 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 117.154 -1.914 . . . . 0.0 114.086 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.7 m-85 -70.01 152.1 44.8 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.616 2.208 . . . . 0.0 108.703 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -48.98 -65.81 0.5 Allowed 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 126.188 1.795 . . . . 0.0 113.184 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -155.74 174.75 14.85 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.911 1.284 . . . . 0.0 108.948 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.43 146.46 18.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -135.41 128.87 32.36 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.812 0.845 . . . . 0.0 110.394 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.81 118.39 30.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.134 1.374 . . . . 0.0 108.173 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp -77.36 115.74 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 O-C-N 121.286 -0.884 . . . . 0.0 109.029 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -68.23 150.1 48.69 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 68.8 11.59 8.39 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.625 1.57 . . . . 0.0 113.355 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.66 -136.84 2.71 Favored Glycine 0 C--N 1.346 1.111 0 C-N-CA 124.964 1.269 . . . . 0.0 112.781 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HA ' ' H ' ' A' ' 115' ' ' TRP . . . -101.2 -26.61 13.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -100.12 -10.84 21.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.796 2.438 . . . . 0.0 115.281 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.9 170.39 8.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.999 1.272 . . . . 0.0 111.824 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -50.41 -29.33 23.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 124.022 3.148 . . . . 0.0 114.556 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.28 25.97 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.443 1.497 . . . . 0.0 110.616 177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.05 -173.59 3.88 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.401 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 17.6 t-105 -41.66 -56.51 2.6 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.15 -52.81 64.01 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 123.492 0.717 . . . . 0.0 109.56 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -78.64 22.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.951 1.301 . . . . 0.0 112.791 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.3 m -120.13 10.26 11.35 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.055 1.742 . . . . 0.0 110.957 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.85 24.96 9.65 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.221 0.919 . . . . 0.0 110.397 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 57.2 mt -97.89 140.71 22.1 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -178.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 31.4 Cg_exo -58.86 140.06 93.55 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 125.07 3.847 . . . . 0.0 110.691 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -148.38 135.51 20.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.019 0.927 . . . . 0.0 112.204 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.553 HG13 ' HB3' ' A' ' 40' ' ' ASN . 5.2 mt -85.05 96.92 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.818 2.447 . . . . 0.0 108.108 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -82.73 155.93 68.04 Favored Pre-proline 0 C--N 1.321 -0.673 0 O-C-N 121.484 -0.76 . . . . 0.0 112.719 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -80.13 165.16 21.74 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.307 2.671 . . . . 0.0 107.083 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -71.11 120.96 17.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -67.48 -2.71 6.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 p -66.19 -67.27 0.46 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.6 t -60.2 -16.93 37.54 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.51 119.27 5.09 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.94 160.05 51.04 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.296 2.048 . . . . 0.0 110.435 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.2 m -65.82 135.07 54.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.1 m -158.02 172.13 18.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.827 1.651 . . . . 0.0 108.566 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 125.82 1.676 . . . . 0.0 110.228 179.535 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -148.13 170.71 17.22 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.079 2.152 . . . . 0.0 107.892 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.51 118.9 3.28 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.949 0.795 . . . . 0.0 110.82 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.64 128.25 2.97 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 125.341 1.448 . . . . 0.0 109.891 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -64.47 108.45 1.65 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 p -136.05 162.8 31.89 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.65 0.78 . . . . 0.0 110.156 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.9 -112.12 0.26 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.98 163.57 36.45 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.916 1.358 . . . . 0.0 112.076 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.95 98.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -53.22 -55.63 22.84 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.216 1.007 . . . . 0.0 110.202 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -62.06 -45.3 94.14 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 123.699 0.624 . . . . 0.0 111.832 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.47 -41.75 85.94 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.62 -48.18 82.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.867 0.758 . . . . 0.0 109.605 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.0 m -60.6 -43.37 97.49 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.199 0.6 . . . . 0.0 111.025 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -39.04 89.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.245 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.0 mt -64.74 -20.4 66.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.895 1.225 . . . . 0.0 110.663 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 -12.46 64.56 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 124.327 0.965 . . . . 0.0 112.212 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 p -117.82 -2.45 11.35 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.628 1.571 . . . . 0.0 112.243 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -125.12 109.11 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.147 1.379 . . . . 0.0 107.567 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -69.16 -29.97 68.09 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -84.46 -26.86 27.9 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.717 -0.615 . . . . 0.0 111.977 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 137.98 58.43 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.402 1.001 . . . . 0.0 111.695 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -141.02 121.98 14.54 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.857 1.263 . . . . 0.0 109.627 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -55.11 129.79 39.46 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.013 0.925 . . . . 0.0 109.192 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.7 tp -109.73 99.49 8.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.257 1.823 . . . . 0.0 108.929 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -81.79 112.69 19.17 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 pt -98.84 7.15 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -64.88 172.12 3.05 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 110.815 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.14 144.36 30.81 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.3 m -44.48 -39.87 5.13 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.027 2.131 . . . . 0.0 111.902 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.63 -44.33 77.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.929 -0.557 . . . . 0.0 111.557 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.58 -37.2 75.27 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.393 0.997 . . . . 0.0 110.629 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -62.05 -7.69 4.31 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.935 -1.103 . . . . 0.0 112.887 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -123.41 -14.82 7.31 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.543 1.937 . . . . 0.0 111.115 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -95.93 -45.41 6.95 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.956 1.303 . . . . 0.0 110.814 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.19 -18.56 7.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 C-N-CA 124.938 1.295 . . . . 0.0 110.472 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.25 -156.51 21.27 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.446 -0.784 . . . . 0.0 111.808 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 0.7 OUTLIER -145.8 167.58 13.89 Favored Pre-proline 0 C--O 1.237 0.438 0 O-C-N 121.648 -0.913 . . . . 0.0 112.251 -178.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 38' ' ' SER . 83.1 Cg_endo -71.16 158.3 55.22 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 121.217 1.278 . . . . 0.0 110.309 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' HB3' ' CD1' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -125.0 56.75 1.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.946 1.698 . . . . 0.0 112.965 -177.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.6 pt -71.67 10.54 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.415 1.086 . . . . 0.0 111.651 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.08 -42.63 69.55 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 125.133 1.373 . . . . 0.0 111.074 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -52.58 -46.05 59.17 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 mt -61.91 -23.71 66.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 112.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.32 38.87 3.63 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -136.45 168.54 19.27 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 117.773 0.786 . . . . 0.0 111.989 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -138.84 127.56 23.42 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 157.45 37.73 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -116.67 99.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 p -79.02 113.14 16.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.4 m -142.02 109.62 5.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.18 116.71 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 117.822 0.283 . . . . 0.0 110.67 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.95 138.95 36.1 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -150.64 127.69 11.15 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.65 -19.14 34.0 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.186 1.374 . . . . 0.0 113.96 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -75.18 -17.28 60.41 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.866 1.833 . . . . 0.0 110.938 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -133.12 59.91 1.72 Allowed 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.686 0.794 . . . . 0.0 110.37 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -60.05 -54.6 53.74 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 120.699 -1.251 . . . . 0.0 108.533 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.82 -41.16 8.39 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 121.664 1.63 . . . . 0.0 109.468 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.38 -30.91 59.17 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.287 0.946 . . . . 0.0 111.695 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -71.49 -60.18 2.37 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.9 mt -47.29 -46.58 25.01 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.335 1.854 . . . . 0.0 111.639 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -59.43 -33.3 71.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.485 0.714 . . . . 0.0 110.907 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -69.17 -23.99 64.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 120.064 1.302 . . . . 0.0 111.115 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.74 -34.73 30.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -57.79 -36.62 72.43 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.524 -0.735 . . . . 0.0 112.774 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.64 -5.76 44.87 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -117.14 -33.11 4.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.987 0.812 . . . . 0.0 112.909 179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.615 ' CD1' HG21 ' A' ' 75' ' ' THR . 66.2 m-85 -93.5 106.16 18.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.533 1.133 . . . . 0.0 111.139 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -56.82 -51.09 70.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.522 -1.217 . . . . 0.0 111.626 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.34 86.22 50.99 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.081 0.952 . . . . 0.0 109.048 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.08 -18.81 60.22 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 121.807 1.671 . . . . 0.0 113.808 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.4 -16.82 16.36 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.852 1.261 . . . . 0.0 114.333 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -123.25 -1.84 8.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.603 1.561 . . . . 0.0 112.078 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CD1' ' A' ' 69' ' ' PHE . 21.1 m -93.22 132.66 37.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 123.374 0.669 . . . . 0.0 111.193 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -102.25 149.91 23.83 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.92 91.79 3.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.064 1.346 . . . . 0.0 111.558 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 30.8 m-85 -74.34 101.52 4.09 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 102.961 -2.977 . . . . 0.0 102.961 177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.89 130.23 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.759 1.223 . . . . 0.0 112.671 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.6 tt -125.23 107.88 11.18 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.513 1.525 . . . . 0.0 109.361 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.25 173.59 6.25 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -52.03 -58.73 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 120.615 -1.303 . . . . 0.0 109.311 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.78 -153.05 0.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.63 -36.68 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.247 0.476 . . . . 0.0 109.872 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.24 -118.67 0.19 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 128.572 2.987 . . . . 0.0 115.566 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -101.12 -3.1 29.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -41.55 -55.97 2.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.299 1.839 . . . . 0.0 115.102 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -59.99 -26.79 66.32 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -49.81 9.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.8 t -56.24 -35.06 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.489 1.115 . . . . 0.0 109.222 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.3 66.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.392 1.077 . . . . 0.0 111.355 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -92.61 -35.38 13.57 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 118.775 0.716 . . . . 0.0 110.026 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.0 -59.22 4.61 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.649 0.738 . . . . 0.0 109.895 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.03 -38.81 78.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 124.14 0.976 . . . . 0.0 112.107 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.02 -53.75 51.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.129 1.372 . . . . 0.0 109.804 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.01 -28.62 67.87 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 110.54 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -76.97 -24.31 52.29 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.892 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.15 -0.8 2.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 117.906 -1.497 . . . . 0.0 115.695 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -73.1 150.62 42.11 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 120.198 1.999 . . . . 0.0 107.303 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.6 tpmt? -59.13 -52.83 64.02 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 m -165.49 176.41 8.22 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 107.903 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.9 163.39 40.12 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 43.9 m-85 -146.92 114.75 6.47 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.354 1.062 . . . . 0.0 109.144 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -77.11 113.89 15.34 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.497 1.119 . . . . 0.0 108.798 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.79 101.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -62.69 150.52 40.81 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 71.58 6.77 5.81 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.222 1.809 . . . . 0.0 110.934 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.35 -130.21 14.51 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.058 1.299 . . . . 0.0 110.51 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.66 -16.7 7.13 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.22 -25.57 21.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.504 1.047 . . . . 0.0 112.99 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -54.51 170.23 1.34 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 128.851 3.119 . . . . 0.0 116.598 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.82 -22.36 36.78 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 124.064 3.176 . . . . 0.0 112.774 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . 0.255 12.7 tpt180 -124.85 14.13 8.57 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.741 2.017 . . . . 0.0 109.56 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.82 -177.94 20.62 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.45 -1.406 . . . . 0.0 111.382 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -48.88 -53.27 20.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 113.405 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.02 -51.12 70.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.848 0.459 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -83.6 32.14 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.737 2.015 . . . . 0.0 112.303 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.8 m -126.5 12.2 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.007 1.723 . . . . 0.0 109.836 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.2 t 62.0 28.51 17.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.867 0.758 . . . . 0.0 110.437 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.81 138.63 19.69 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.422 ' HB2' HD21 ' A' ' 40' ' ' ASN . 27.1 Cg_endo -70.75 157.23 59.05 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.031 1.821 . . . . 0.0 110.894 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -158.39 151.29 22.5 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.113 0.965 . . . . 0.0 108.772 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 40' ' ' ASN . 2.5 mt -98.08 88.57 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -75.73 153.94 85.27 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.0 173.42 14.54 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.476 2.118 . . . . 0.0 108.509 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -59.25 -29.4 67.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -76.84 115.3 16.5 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.81 1.244 . . . . 0.0 111.135 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.52 133.54 34.45 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.8 t -165.62 141.58 5.2 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.709 1.203 . . . . 0.0 108.399 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.49 120.46 1.01 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.47 169.63 13.8 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.86 2.373 . . . . 0.0 112.209 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 45.9 m -76.98 96.36 4.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.94 144.14 29.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 106.331 -2.708 . . . . 0.0 106.331 -178.827 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.565 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -142.64 127.74 18.55 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.0 100.79 2.68 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.574 1.079 . . . . 0.0 109.564 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.74 -131.59 43.57 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -141.65 81.1 1.75 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.1 p -59.94 128.65 37.9 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.026 -1.046 . . . . 0.0 108.502 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.28 109.38 0.41 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -37.47 149.89 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.446 2.298 . . . . 0.0 112.848 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.6 47.58 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.154 0.581 . . . . 0.0 111.623 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -60.71 -51.75 68.06 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.669 0.788 . . . . 0.0 110.191 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -55.47 -46.57 76.83 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.758 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.65 -46.85 87.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.267 0.627 . . . . 0.0 109.611 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -58.99 -51.34 70.49 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.656 0.782 . . . . 0.0 109.991 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.3 m -61.62 -41.86 98.07 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.158 -0.925 . . . . 0.0 109.888 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' HG22 ' A' ' 18' ' ' THR . 27.7 mmtt -56.97 -48.74 77.68 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 124.502 1.121 . . . . 0.0 109.978 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.86 -19.67 60.47 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.035 0.534 . . . . 0.0 111.656 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.03 -7.06 61.37 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 127.501 2.477 . . . . 0.0 114.418 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 15' ' ' LYS . 11.2 t -121.3 -8.91 9.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.08 1.752 . . . . 0.0 109.351 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -112.81 178.43 4.29 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.884 0.874 . . . . 0.0 109.494 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 38.1 t70 -128.12 -49.16 1.33 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.333 0.969 . . . . 0.0 111.666 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -71.51 -2.84 18.25 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.695 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.47 121.83 23.67 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.555 2.342 . . . . 0.0 110.941 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -136.38 149.22 48.22 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.49 132.08 34.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.663 1.185 . . . . 0.0 110.107 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.5 tp -113.38 111.12 21.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.026 1.33 . . . . 0.0 109.829 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.08 116.36 28.84 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.8 pt -99.4 9.06 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -65.36 163.65 15.19 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.728 1.611 . . . . 0.0 113.619 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.49 139.62 44.0 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.4 m -45.94 -41.84 12.12 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.792 1.237 . . . . 0.0 112.459 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.98 -41.1 67.52 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.75 0.82 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -59.82 -43.69 94.41 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.435 0.562 . . . . 0.0 110.502 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -56.91 -21.94 33.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.004 0.82 . . . . 0.0 112.823 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -84.12 -26.83 28.61 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.024 0.929 . . . . 0.0 109.825 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -91.29 -59.3 2.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.457 1.503 . . . . 0.0 112.816 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.6 -34.71 13.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.836 1.254 . . . . 0.0 114.148 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.09 -144.93 16.44 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.9 p -154.15 156.01 31.5 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 119.374 1.587 . . . . 0.0 112.889 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.51 135.93 25.14 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.936 2.424 . . . . 0.0 111.908 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.651 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -103.41 80.12 1.78 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.851 2.861 . . . . 0.0 107.893 179.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.7 pt -77.75 2.61 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 O-C-N 120.493 -1.379 . . . . 0.0 111.668 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -47.79 -31.84 5.36 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.495 2.718 . . . . 0.0 115.729 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.09 77.32 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.9 mt -85.05 -38.36 19.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.57 58.69 0.68 Allowed Glycine 0 C--N 1.339 0.748 0 C-N-CA 124.696 1.141 . . . . 0.0 111.047 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 20' ' ' ASP . 41.6 mmtm -145.51 178.86 7.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.091 1.756 . . . . 0.0 108.634 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -133.66 165.49 24.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.974 0.892 . . . . 0.0 110.839 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -116.49 163.74 15.62 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 125.935 1.694 . . . . 0.0 108.843 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.3 t -138.79 128.37 31.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.153 1.381 . . . . 0.0 107.693 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -99.22 121.94 41.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.398 1.079 . . . . 0.0 111.064 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.9 m -148.65 106.56 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.99 110.17 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -76.14 162.95 27.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -166.98 136.45 2.89 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.069 2.148 . . . . 0.0 105.277 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.46 -25.2 66.7 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.472 0.558 . . . . 0.0 112.829 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.93 -50.28 15.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -85.15 24.48 1.1 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -43.76 -52.15 15.22 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 120.244 1.384 . . . . 0.0 110.09 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.41 -44.95 12.87 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.37 2.047 . . . . 0.0 111.786 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.95 83.69 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.722 1.153 . . . . 0.0 110.906 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.07 -53.06 51.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.527 1.931 . . . . 0.0 108.394 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.92 -47.47 64.63 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.228 1.011 . . . . 0.0 111.177 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -51.92 -47.42 64.66 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 118.692 -0.67 . . . . 0.0 110.834 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.95 -29.43 12.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.9 0.88 . . . . 0.0 112.465 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -50.35 6.12 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 m -55.93 -32.73 64.06 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.418 1.008 . . . . 0.0 112.198 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 pp -81.25 -5.02 57.31 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.566 0.746 . . . . 0.0 112.961 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.86 -41.48 3.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.524 1.13 . . . . 0.0 111.578 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.95 179.57 7.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.845 1.258 . . . . 0.0 108.716 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -127.6 -24.36 3.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.415 1.086 . . . . 0.0 113.153 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.75 83.09 8.31 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -56.19 -38.1 95.51 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.267 1.312 . . . . 0.0 110.229 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -54.45 -15.9 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.503 1.921 . . . . 0.0 114.425 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -124.03 -16.13 6.63 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.784 1.233 . . . . 0.0 111.55 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.1 m -77.98 137.2 38.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.049 0.84 . . . . 0.0 110.656 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 m -110.25 125.45 53.12 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mp -105.24 100.51 10.1 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.431 1.092 . . . . 0.0 112.408 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.449 ' CE2' ' CD1' ' A' ' 103' ' ' TYR . 40.6 m-85 -82.54 96.7 8.14 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mt -73.99 124.49 31.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.095 1.358 . . . . 0.0 109.565 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -121.77 125.44 46.55 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.332 1.453 . . . . 0.0 109.498 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -133.41 172.42 12.73 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.808 0.843 . . . . 0.0 112.572 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -46.52 -54.67 8.85 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.65 1.58 . . . . 0.0 108.926 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -136.82 -155.97 0.66 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 129.04 2.936 . . . . 0.0 104.716 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -52.85 -54.23 37.4 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.765 1.226 . . . . 0.0 109.722 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.36 -98.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.448 1.975 . . . . 0.0 111.459 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -138.66 16.47 2.71 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.293 2.237 . . . . 0.0 111.078 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.0 m -45.04 -45.23 10.72 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.968 1.258 . . . . 0.0 113.41 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -73.38 -41.8 62.92 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.202 0.91 . . . . 0.0 111.24 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.42 -46.67 88.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.7 t -66.73 -34.51 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.13 82.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.036 0.835 . . . . 0.0 109.389 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -73.11 -48.17 37.93 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.9 tp -50.16 -58.97 4.42 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.122 1.769 . . . . 0.0 113.837 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.7 m -62.91 -38.39 81.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 O-C-N 122.15 -0.343 . . . . 0.0 110.126 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.4 77.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.36 -26.68 67.98 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.374 1.469 . . . . 0.0 111.349 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -84.55 -21.65 30.39 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.655 0.662 . . . . 0.0 111.968 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.66 1.98 2.04 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.046 -1.975 . . . . 0.0 115.978 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -73.34 150.27 41.98 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.78 2.29 . . . . 0.0 109.633 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -55.89 -58.41 8.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.582 0.753 . . . . 0.0 111.129 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.8 m -159.3 166.18 31.81 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.107 1.363 . . . . 0.0 107.465 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.37 12.14 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CD1' ' CE2' ' A' ' 78' ' ' TYR . 55.3 m-85 -100.26 151.23 21.71 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.23 111.14 19.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.32 91.37 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 113.96 10.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.25 34.0 m-20 115.32 4.84 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 1 C-N-CA 133.079 4.552 . . . . 0.0 110.553 179.994 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.39 -134.49 41.92 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.658 -1.276 . . . . 0.0 114.866 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.98 -44.77 5.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -87.72 -22.71 24.45 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -52.98 170.88 0.59 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.443 1.973 . . . . 0.0 115.012 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -57.0 -27.55 74.07 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 124.532 3.488 . . . . 0.0 115.619 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -120.64 9.67 10.86 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.002 2.121 . . . . 0.0 109.03 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.55 168.98 20.83 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.4 t-105 -47.19 -62.62 1.33 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 113.632 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.5 mt -58.37 -52.83 63.95 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.795 1.238 . . . . 0.0 110.459 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.36 13.98 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.172 2.189 . . . . 0.0 113.437 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.4 m -129.47 16.56 5.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.644 1.578 . . . . 0.0 112.0 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.7 m 63.59 18.97 11.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.084 1.754 . . . . 0.0 113.661 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 50.3 mt -76.7 154.74 83.45 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.651 ' C ' HD21 ' A' ' 40' ' ' ASN . 98.3 Cg_endo -72.61 162.62 40.82 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.165 1.243 . . . . 0.0 109.969 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 50.7 t-105 -167.38 126.51 1.36 Allowed 'General case' 0 C--O 1.238 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 113.059 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -73.49 93.19 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.977 2.111 . . . . 0.0 109.565 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -87.55 151.69 50.91 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.56 -165.78 0.36 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 123.14 2.56 . . . . 0.0 107.366 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 135.23 29.14 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -43.88 103.33 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.602 1.561 . . . . 0.0 109.61 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.8 m -92.16 129.89 38.01 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.7 p -164.21 178.29 7.69 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.672 1.189 . . . . 0.0 109.299 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 163.61 -102.38 0.2 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-O 117.703 -1.61 . . . . 0.0 109.774 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.98 -19.9 45.39 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.675 2.916 . . . . 0.0 115.836 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.1 p -133.06 157.51 45.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 120.853 1.66 . . . . 0.0 112.132 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.64 -162.5 1.53 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.955 2.102 . . . . 0.0 108.159 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 179.344 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 p -147.64 160.36 42.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.557 1.179 . . . . 0.0 111.231 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 p -169.88 115.35 0.53 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.63 1.972 . . . . 0.0 108.363 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.32 136.58 37.13 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.4 t -77.91 88.56 4.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.372 1.086 . . . . 0.0 109.196 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 84.3 p -61.0 136.1 57.99 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.08 106.88 0.49 Allowed Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -49.68 148.7 2.82 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.515 1.158 . . . . 0.0 109.023 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.71 -36.86 48.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -67.8 -48.03 67.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.94 -0.552 . . . . 0.0 111.288 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -63.11 -45.14 93.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.856 0.753 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.12 81.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.47 -41.07 98.52 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.092 0.86 . . . . 0.0 111.581 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -60.35 -54.78 41.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -49.6 -53.01 26.36 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.327 1.051 . . . . 0.0 111.719 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 46.9 mt -57.55 -23.2 49.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.343 1.057 . . . . 0.0 113.202 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.87 -5.79 60.93 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.951 1.262 . . . . 0.0 112.676 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -124.62 -1.86 7.95 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.495 1.148 . . . . 0.0 111.227 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -131.38 115.83 16.75 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -69.18 -47.48 64.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.842 1.257 . . . . 0.0 111.703 -178.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 75' ' ' THR . 22.1 m120 -72.56 -6.9 47.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 118.716 -0.659 . . . . 0.0 111.582 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 78' ' ' TYR . . . -76.02 118.6 18.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.56 131.91 46.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.816 0.817 . . . . 0.0 110.944 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' N ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -65.28 127.52 32.09 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.896 1.278 . . . . 0.0 108.465 179.475 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 24' ' ' LEU . 47.2 tp -109.36 103.92 12.94 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.854 2.062 . . . . 0.0 109.525 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -82.96 108.3 16.18 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.245 1.018 . . . . 0.0 108.273 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -102.36 0.09 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 81' ' ' ASP . 70.6 mtm-85 -61.44 168.55 2.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.374 1.07 . . . . 0.0 113.632 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.45 136.81 37.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.413 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -38.25 -40.35 0.51 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.664 2.786 . . . . 0.0 114.322 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.14 -37.02 76.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.869 0.759 . . . . 0.0 112.571 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -37.18 80.07 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.446 0.566 . . . . 0.0 111.024 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -65.67 -6.31 11.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.592 1.157 . . . . 0.0 111.824 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.68 -29.42 7.72 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.556 1.943 . . . . 0.0 109.486 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -94.67 -59.42 1.93 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.88 0.872 . . . . 0.0 112.824 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.83 -26.33 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.696 1.599 . . . . 0.0 112.947 -177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.82 -153.38 19.17 Favored Glycine 0 C--N 1.335 0.487 0 O-C-N 121.42 -0.8 . . . . 0.0 112.836 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.4 p -143.3 162.0 44.84 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.49 178.39 6.23 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.072 1.181 . . . . 0.0 111.185 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -145.17 145.75 31.48 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.57 178.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.4 pt -138.69 13.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 126.413 1.885 . . . . 0.0 110.619 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -59.06 -27.54 65.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 117.949 -1.024 . . . . 0.0 111.106 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.64 94.58 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.3 mt -70.16 -28.42 65.31 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 0.0 109.785 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 111.86 19.29 7.39 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 127.694 2.569 . . . . 0.0 110.817 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 20' ' ' ASP . 46.1 mmtm -130.24 -178.57 4.8 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 150.49 34.82 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.612 1.165 . . . . 0.0 108.855 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 179.96 7.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.745 0.818 . . . . 0.0 110.697 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.85 133.09 44.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.9 p -113.7 121.05 42.94 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 120.008 1.276 . . . . 0.0 111.273 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.3 m -146.69 108.1 4.27 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 t -57.98 119.91 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -75.92 124.45 27.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -131.12 116.72 18.11 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.04 1.736 . . . . 0.0 107.197 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.01 -27.43 67.12 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 118.464 0.575 . . . . 0.0 112.652 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -74.1 -15.42 61.05 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.625 0.712 . . . . 0.0 110.6 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.74 32.32 5.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.468 1.907 . . . . 0.0 113.584 -176.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -43.06 -56.69 6.03 Favored Pre-proline 0 N--CA 1.481 1.083 0 CA-C-N 121.452 1.933 . . . . 0.0 111.95 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -63.7 -37.05 48.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.724 2.282 . . . . 0.0 112.341 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.44 74.35 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.319 1.437 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -82.11 -56.7 3.77 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.09 -44.59 61.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.042 1.737 . . . . 0.0 112.769 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptmm? -57.36 -36.88 71.76 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.801 0.728 . . . . 0.0 112.457 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -61.82 -20.62 63.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.921 0.889 . . . . 0.0 111.356 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.8 -43.28 8.3 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.6 t -52.43 -34.62 49.34 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.991 1.716 . . . . 0.0 111.541 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.99 -6.03 53.17 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.53 -37.37 4.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.785 0.721 . . . . 0.0 110.899 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.611 ' CD1' HG21 ' A' ' 75' ' ' THR . 72.9 m-85 -91.88 103.88 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.901 0.881 . . . . 0.0 109.627 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -18.33 60.84 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.338 0.517 . . . . 0.0 111.68 178.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.09 68.24 79.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.642 1.177 . . . . 0.0 109.532 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 -32.39 93.21 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.499 2.133 . . . . 0.0 111.63 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -55.11 -19.9 8.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.394 1.878 . . . . 0.0 115.934 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -124.87 8.48 8.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.841 1.256 . . . . 0.0 110.957 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.611 HG21 ' CD1' ' A' ' 69' ' ' PHE . 63.5 m -104.42 111.83 24.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.712 1.605 . . . . 0.0 111.323 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.5 m -83.67 129.32 34.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.0 mt -96.85 102.61 14.43 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.478 0.711 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.499 ' CE1' ' HB1' ' A' ' 22' ' ' ALA . 49.4 m-85 -84.43 92.56 8.09 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.18 127.17 31.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 125.68 1.592 . . . . 0.0 110.849 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -127.2 130.98 50.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.647 1.579 . . . . 0.0 109.128 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 49.1 t0 -137.09 -170.54 2.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.078 2.151 . . . . 0.0 107.703 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -62.51 -48.5 79.28 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.03 -1.044 . . . . 0.0 108.676 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -140.97 -172.77 3.55 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.999 2.519 . . . . 0.0 108.886 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -48.89 -30.02 5.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.686 1.994 . . . . 0.0 113.121 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.33 -108.14 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 C-N-CA 130.208 3.766 . . . . 0.0 115.717 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -110.73 0.92 17.57 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 127.209 2.203 . . . . 0.0 108.816 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -51.48 -47.04 63.33 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 121.188 1.813 . . . . 0.0 109.755 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -64.47 -23.99 67.47 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 tp -87.32 -43.23 12.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.127 0.971 . . . . 0.0 110.97 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.98 -30.4 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.18 83.45 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -70.04 -43.24 71.65 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 125.794 1.637 . . . . 0.0 111.131 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.41 -56.16 21.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.915 0.886 . . . . 0.0 112.175 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.0 m -64.22 -35.32 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.14 95.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.058 0.543 . . . . 0.0 109.893 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.16 -37.97 84.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.579 0.752 . . . . 0.0 109.709 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -61.28 -50.58 72.44 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.18 -3.1 0.29 Allowed Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.976 -1.458 . . . . 0.0 115.377 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -58.79 153.2 17.41 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 119.632 1.716 . . . . 0.0 109.107 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -46.94 -70.13 0.11 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.489 1.116 . . . . 0.0 112.523 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 m -154.79 177.38 11.33 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.443 2.297 . . . . 0.0 105.826 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.06 136.55 8.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.15 -0.969 . . . . 0.0 108.651 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -113.33 154.52 26.73 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.703 1.201 . . . . 0.0 108.339 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.49 114.12 23.76 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.264 2.4 mp -66.15 106.9 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.73 128.02 34.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 74.22 9.88 4.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 128.885 2.874 . . . . 0.0 111.76 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.03 -111.8 0.51 Allowed Glycine 0 C--N 1.34 0.78 0 C-N-CA 126.196 1.855 . . . . 0.0 110.839 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.75 -9.12 3.56 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.516 1.126 . . . . 0.0 112.027 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.82 -1.54 27.69 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.2 41.64 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -54.31 -39.92 84.84 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.527 3.485 . . . . 0.0 114.746 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 21.55 9.63 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.862 0.865 . . . . 0.0 110.999 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.4 171.71 4.01 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -40.91 -46.3 2.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.819 1.648 . . . . 0.0 113.52 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.8 mt -65.76 -57.2 8.55 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.374 0.988 . . . . 0.0 110.627 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -66.81 -4.49 9.33 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.712 2.005 . . . . 0.0 114.303 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.5 p -97.2 3.9 51.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.998 -1.064 . . . . 0.0 111.494 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.7 t 77.24 11.16 2.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.634 1.973 . . . . 0.0 111.859 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.1 152.88 79.72 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 119.012 0.824 . . . . 0.0 110.459 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.72 142.96 36.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.187 1.925 . . . . 0.0 110.981 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 57.0 t-105 -145.06 142.2 29.52 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.502 -0.749 . . . . 0.0 110.313 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.0 mt -92.59 93.01 3.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 124.851 1.26 . . . . 0.0 109.121 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.85 148.64 72.73 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.639 0.775 . . . . 0.0 109.103 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.91 -155.39 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.284 3.323 . . . . 0.0 107.118 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -118.43 56.05 0.89 Allowed 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.518 -1.364 . . . . 0.0 109.842 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 129' ' ' SER . 1.2 tmtp? -125.12 146.95 49.24 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.784 1.634 . . . . 0.0 109.726 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.8 m -156.82 121.53 4.5 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 127' ' ' LYS . 0.2 OUTLIER -163.05 145.29 10.23 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.559 1.544 . . . . 0.0 107.805 178.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.22 149.5 45.82 Favored Glycine 0 CA--C 1.535 1.327 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -78.63 176.44 9.88 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.875 3.05 . . . . 0.0 111.985 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.2 m -135.63 130.39 34.29 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.675 2.39 . . . . 0.0 107.132 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.0 p -61.26 141.43 57.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.843 1.257 . . . . 0.0 111.818 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.668 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -71.43 167.11 20.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 127.399 2.28 . . . . 0.0 111.171 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -106.56 2.46 26.12 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.727 0.811 . . . . 0.0 110.0 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.06 151.86 19.25 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 118.59 0.632 . . . . 0.0 113.593 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -84.02 100.15 10.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.197 2.199 . . . . 0.0 108.778 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 p -130.97 160.21 35.22 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.525 0.73 . . . . 0.0 111.416 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.9 -98.32 0.11 Allowed Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.6 m -157.26 160.08 38.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.104 1.452 . . . . 0.0 112.446 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.26 -48.96 77.63 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 117.858 -1.068 . . . . 0.0 112.385 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -55.03 -51.5 66.08 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.911 1.232 . . . . 0.0 109.832 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -52.02 -54.36 30.91 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.598 0.759 . . . . 0.0 110.578 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.23 82.88 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.655 0.782 . . . . 0.0 112.621 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -67.24 -45.72 75.89 Favored 'General case' 0 C--O 1.227 -0.081 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -59.89 -41.47 91.66 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -60.79 -44.2 97.12 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 117.793 -1.099 . . . . 0.0 109.631 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.81 -44.83 78.24 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.355 1.434 . . . . 0.0 107.708 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.0 -6.86 33.81 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.535 1.541 . . . . 0.0 115.952 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 t -129.59 -2.82 4.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.659 1.73 . . . . 0.0 111.655 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -113.97 94.09 4.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.805 1.642 . . . . 0.0 106.82 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -47.52 -27.03 1.59 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.523 1.929 . . . . 0.0 115.862 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -109.9 5.42 22.44 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.239 0.927 . . . . 0.0 113.11 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.27 148.56 39.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.008 0.822 . . . . 0.0 111.618 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -142.9 158.88 43.19 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.235 0.614 . . . . 0.0 110.277 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -102.08 119.72 39.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.362 1.465 . . . . 0.0 108.006 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 109.33 20.96 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.492 1.917 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 121.16 27.43 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.148 2.179 . . . . 0.0 107.625 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 81' ' ' ASP . 5.8 pt -120.44 4.66 6.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.5 mtm-85 -66.43 170.45 6.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 121.798 2.09 . . . . 0.0 108.968 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.73 150.11 48.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 m -52.42 -32.8 40.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.142 1.377 . . . . 0.0 111.701 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.89 -31.94 70.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.179 0.899 . . . . 0.0 113.222 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.82 -38.34 88.64 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -63.25 -10.4 15.63 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.573 -1.954 . . . . 0.0 114.803 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 -21.05 14.34 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.337 1.855 . . . . 0.0 109.43 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -104.06 -79.32 0.55 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.853 2.061 . . . . 0.0 109.265 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.85 -30.58 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 125.267 1.427 . . . . 0.0 112.731 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 125' ' ' PRO . . . 94.68 -134.22 11.9 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 p -151.11 158.17 34.83 Favored Pre-proline 0 N--CA 1.448 -0.573 0 O-C-N 122.654 -0.321 . . . . 0.0 111.175 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' HG3' HD22 ' A' ' 80' ' ' LEU . 88.2 Cg_endo -71.74 173.81 12.07 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 N-CA-C 107.321 -1.838 . . . . 0.0 107.321 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.61 HD21 ' HB2' ' A' ' 121' ' ' PRO . 1.3 p30 -141.31 149.09 40.78 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 pt -124.09 9.31 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 122.464 1.126 . . . . 0.0 110.416 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -58.3 -32.72 68.72 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 125.392 1.477 . . . . 0.0 111.586 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -48.1 -42.79 24.28 Favored Glycine 0 C--N 1.34 0.757 0 O-C-N 124.804 1.315 . . . . 0.0 110.321 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.0 mt -77.1 -75.01 0.22 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.51 44.19 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -141.09 -176.11 4.57 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.922 1.689 . . . . 0.0 109.014 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -145.23 136.93 25.43 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.862 2.065 . . . . 0.0 107.136 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 -175.79 2.47 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.977 0.911 . . . . 0.0 111.732 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.14 133.95 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 103.59 -2.745 . . . . 0.0 103.59 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.4 p -120.05 108.47 14.32 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.982 0.913 . . . . 0.0 113.455 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -143.46 108.48 4.96 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 p -57.47 122.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-N 118.149 0.431 . . . . 0.0 110.226 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -74.18 151.09 40.07 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -156.45 116.16 3.54 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.17 -22.15 57.72 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 117.902 0.319 . . . . 0.0 112.726 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 58.1 mt-10 -76.66 -15.22 59.86 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.163 0.981 . . . . 0.0 111.591 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -128.13 33.75 4.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.073 1.349 . . . . 0.0 113.784 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.39 -54.37 7.99 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.765 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -63.92 -47.26 7.0 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.563 2.175 . . . . 0.0 112.362 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.42 -24.88 71.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-O 119.849 -0.417 . . . . 0.0 112.593 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -84.76 -39.82 17.99 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 118.159 0.979 . . . . 0.0 108.602 177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.6 -47.97 79.29 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.89 0.876 . . . . 0.0 111.194 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -52.94 -37.74 61.3 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.034 0.534 . . . . 0.0 111.623 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -59.86 -29.39 68.26 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.474 -0.766 . . . . 0.0 112.305 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.63 -50.61 6.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.3 t -55.0 -26.6 38.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.206 1.802 . . . . 0.0 112.631 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 pp -85.67 -18.3 33.57 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.231 -0.918 . . . . 0.0 111.64 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -51.61 3.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 117.866 -1.064 . . . . 0.0 108.462 -178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.32 98.8 4.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -56.97 -33.69 67.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.176 0.99 . . . . 0.0 113.469 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -131.68 80.84 65.34 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 99' ' ' PHE . 39.5 Cg_endo -67.11 -26.42 42.8 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.814 2.343 . . . . 0.0 113.101 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -54.54 -18.62 4.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.161 1.785 . . . . 0.0 114.165 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -132.84 7.66 4.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 112.694 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -105.25 109.15 21.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.454 1.502 . . . . 0.0 109.895 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.7 m -80.84 137.98 36.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.519 0.728 . . . . 0.0 109.997 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.2 mt -113.54 99.62 7.88 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.359 1.064 . . . . 0.0 112.22 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.502 ' CD2' ' HB2' ' A' ' 103' ' ' TYR . 52.7 m-85 -76.58 112.52 13.21 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -80.5 141.87 14.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 125.147 1.379 . . . . 0.0 110.478 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD22 ' HG3' ' A' ' 39' ' ' PRO . 12.7 tp -137.42 133.48 34.78 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.555 ' CG ' HD11 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -134.33 175.58 9.38 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -58.28 -55.53 33.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.59 -1.319 . . . . 0.0 110.682 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -130.26 -152.52 0.52 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 130.258 3.423 . . . . 0.0 105.503 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -62.3 -6.09 2.92 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 10.38 -94.18 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 1 C-N-CA 131.872 4.558 . . . . 0.0 117.5 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.37 4.62 1.21 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.287 2.235 . . . . 0.0 112.161 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.439 ' HA ' HG21 ' A' ' 79' ' ' ILE . 1.7 m -29.31 -62.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.404 2.682 . . . . 0.0 114.463 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.04 -45.81 82.88 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.254 2.222 . . . . 0.0 112.916 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.17 -48.24 79.23 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.695 1.198 . . . . 0.0 108.71 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.0 -34.6 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 79' ' ' ILE . . . -64.11 -45.72 87.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.983 0.81 . . . . 0.0 109.124 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.4 -42.38 87.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -53.13 -58.79 5.84 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.993 1.317 . . . . 0.0 111.685 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.11 -38.0 81.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 O-C-N 121.873 -0.517 . . . . 0.0 110.555 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.19 93.19 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.701 0.626 . . . . 0.0 111.057 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.59 -45.21 54.57 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.59 0.756 . . . . 0.0 110.236 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -55.26 -37.91 67.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.753 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 156.68 -9.51 0.26 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.99 -0.895 . . . . 0.0 115.205 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 72' ' ' PRO . 51.9 m-85 -67.57 142.04 56.62 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.444 1.622 . . . . 0.0 108.923 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -41.14 -57.52 2.04 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.296 2.638 . . . . 0.0 112.79 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.0 t -166.99 173.59 9.15 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.44 149.61 27.94 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 44.9 m-85 -133.26 122.01 23.28 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.7 98.4 11.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.987 1.315 . . . . 0.0 108.871 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 mp -64.12 120.11 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -72.21 165.39 24.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.372 0.669 . . . . 0.0 109.82 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 65.3 16.07 10.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 126.244 1.818 . . . . 0.0 112.942 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.13 -123.97 32.85 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.36 -24.76 3.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.737 2.415 . . . . 0.0 109.472 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -85.43 -27.63 25.61 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.891 1.676 . . . . 0.0 113.524 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.48 178.9 41.14 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.214 0.911 . . . . 0.0 114.652 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.53 -51.12 11.2 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.411 3.408 . . . . 0.0 113.839 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 113' ' ' ARG . 34.0 mmt180 -88.66 7.26 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.688 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.78 153.46 47.27 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -34.13 -64.06 0.25 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 129.512 3.125 . . . . 0.0 115.711 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -56.66 -53.94 51.86 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.03 0.377 . . . . 0.0 110.497 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -65.23 -15.33 62.35 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.91 2.084 . . . . 0.0 113.031 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.2 t -88.51 8.13 29.62 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.571 1.548 . . . . 0.0 110.272 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.6 t 64.77 20.75 12.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.867 2.467 . . . . 0.0 111.799 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 64.8 mt -84.57 158.51 59.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 123.592 0.757 . . . . 0.0 109.359 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.61 ' HB2' HD21 ' A' ' 40' ' ' ASN . 57.3 Cg_endo -77.62 152.88 29.84 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.305 2.003 . . . . 0.0 110.613 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -151.08 141.66 22.61 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 120.704 -1.247 . . . . 0.0 111.191 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 40' ' ' ASN . 2.9 mt -81.38 80.99 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.915 1.286 . . . . 0.0 109.908 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -78.98 122.36 84.44 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 37' ' ' GLY . 83.5 Cg_endo -69.9 174.43 9.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.689 2.926 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -67.5 113.21 5.16 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -121.53 179.86 4.31 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.038 1.335 . . . . 0.0 109.468 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.7 t -87.86 179.78 6.4 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 p -128.1 168.41 15.41 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.726 -1.234 . . . . 0.0 109.59 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.95 142.99 11.29 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.29 165.66 25.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.496 2.13 . . . . 0.0 111.579 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.92 137.08 16.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 84.0 p -143.87 179.66 7.03 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.724 0.774 . . . . 0.0 110.768 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.449 0 N-CA-C 106.981 -2.447 . . . . 0.0 106.981 179.421 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.405 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m -138.52 -42.24 0.5 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.049 0.94 . . . . 0.0 111.195 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 p -80.6 89.66 5.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.267 1.394 . . . . 0.0 108.335 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.02 130.96 3.38 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 106.462 -2.655 . . . . 0.0 106.462 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m -65.94 57.67 0.03 OUTLIER 'General case' 0 C--O 1.24 0.599 0 C-N-CA 127.787 2.435 . . . . 0.0 115.631 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 90.0 p -75.58 162.39 28.32 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.92 -110.93 0.28 Allowed Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.3 m -147.31 160.23 42.75 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.374 1.07 . . . . 0.0 111.064 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.6 -55.48 33.92 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.462 1.905 . . . . 0.0 110.369 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -53.72 -49.87 67.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.398 0.544 . . . . 0.0 111.092 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -57.03 -50.47 72.65 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 117.824 0.284 . . . . 0.0 111.493 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.81 77.09 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.927 0.491 . . . . 0.0 111.147 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' CD2' HD22 ' A' ' 120' ' ' LEU . 44.6 t80 -63.9 -48.3 77.15 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.8 m -58.16 -42.27 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.203 0.601 . . . . 0.0 109.954 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -62.31 -34.31 76.37 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.578 -1.201 . . . . 0.0 111.844 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.27 -43.0 99.59 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.09 -0.48 15.29 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.839 1.685 . . . . 0.0 113.142 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -19.88 7.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.99 2.516 . . . . 0.0 111.279 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -127.61 112.49 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 120.117 -1.614 . . . . 0.0 111.612 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.27 -40.43 94.06 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.903 0.881 . . . . 0.0 110.812 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -73.65 -12.72 60.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.282 0.633 . . . . 0.0 110.788 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.407 ' HA ' ' HB ' ' A' ' 76' ' ' THR . . . -77.83 143.03 38.18 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -139.61 155.6 47.35 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 124.321 1.048 . . . . 0.0 108.467 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.1 tt -104.6 134.56 47.56 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.1 tp -127.1 108.43 10.91 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.085 1.754 . . . . 0.0 111.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -81.33 116.89 21.39 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 pt -104.81 6.0 10.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -67.53 161.3 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 118.907 0.776 . . . . 0.0 110.053 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.27 144.5 55.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -54.15 -25.45 22.47 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.629 1.972 . . . . 0.0 110.951 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.98 92.92 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.07 -1.019 . . . . 0.0 109.93 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.03 -28.59 70.2 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -62.98 -17.18 61.82 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.759 -1.838 . . . . 0.0 111.604 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.7 mtt-85 -105.49 -18.47 14.09 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.306 1.442 . . . . 0.0 110.332 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -100.71 -23.94 14.52 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -134.53 -26.33 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.758 1.163 . . . . 0.0 111.807 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.83 -137.79 13.47 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.72 158.0 31.64 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 118.553 1.176 . . . . 0.0 108.741 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.47 174.53 12.55 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 N-CA-C 107.381 -1.815 . . . . 0.0 107.381 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' HB2' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -137.35 151.12 48.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.325 177.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.4 pt -139.96 8.58 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.33 1.852 . . . . 0.0 110.472 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -57.92 -30.33 65.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.967 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.15 -37.33 94.33 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 mt -68.45 -33.96 75.11 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.4 19.42 4.62 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.254 1.883 . . . . 0.0 114.04 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -125.35 177.86 5.92 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.281 1.033 . . . . 0.0 111.661 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -131.15 159.18 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.752 1.621 . . . . 0.0 108.48 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.61 177.71 5.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.716 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -134.39 137.89 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.344 -2.835 . . . . 0.0 103.344 177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.7 p -118.31 106.26 12.59 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.608 1.563 . . . . 0.0 107.883 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 m -143.96 98.31 3.2 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 p -61.01 122.26 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -77.38 145.02 37.51 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -146.74 114.15 6.31 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.82 1.248 . . . . 0.0 109.742 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.4 -21.82 9.49 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 121.11 -0.994 . . . . 0.0 114.104 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.88 -22.95 64.16 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.131 0.966 . . . . 0.0 111.62 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -144.53 62.79 1.32 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 122.42 1.105 . . . . 0.0 111.397 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.92 -56.4 23.79 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.605 1.162 . . . . 0.0 110.697 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.88 -38.76 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.897 1.731 . . . . 0.0 112.157 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.19 -44.61 88.91 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -64.47 -47.03 80.51 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.329 1.052 . . . . 0.0 109.744 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.8 mt -54.49 -42.23 70.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.101 0.96 . . . . 0.0 112.231 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -59.25 -32.42 69.97 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.842 -0.536 . . . . 0.0 111.743 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -62.85 -25.41 68.26 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.652 0.781 . . . . 0.0 110.646 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -44.88 9.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -57.41 -28.01 62.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.698 1.199 . . . . 0.0 112.486 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.77 -12.23 59.96 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.766 -0.584 . . . . 0.0 111.627 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -112.84 -49.25 2.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.649 0.779 . . . . 0.0 109.699 -178.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 51.3 m-85 -80.87 99.14 8.17 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -57.77 -44.69 86.34 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 81.42 33.87 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 -26.2 44.17 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.62 2.214 . . . . 0.0 113.789 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -59.42 -14.65 13.03 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -116.68 -16.47 10.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.655 1.582 . . . . 0.0 110.114 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -77.23 132.97 38.99 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.072 1.349 . . . . 0.0 111.507 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.407 ' HB ' ' HA ' ' A' ' 22' ' ' ALA . 25.9 m -103.67 138.15 40.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.5 mt -117.09 101.93 8.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -78.87 103.42 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -82.63 123.89 38.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 tp -120.23 125.04 47.14 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.704 1.201 . . . . 0.0 109.061 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -127.94 172.92 10.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.856 1.662 . . . . 0.0 106.877 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -65.71 -36.44 83.61 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.561 -1.337 . . . . 0.0 111.986 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -138.76 -173.98 3.71 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.572 1.949 . . . . 0.0 107.017 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -48.64 -26.81 2.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.709 2.404 . . . . 0.0 114.548 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.55 -113.96 0.01 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 130.197 3.761 . . . . 0.0 116.552 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -116.54 0.49 12.71 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.057 1.743 . . . . 0.0 113.645 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -30.65 -54.45 0.2 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 130.085 3.354 . . . . 0.0 115.714 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.64 -42.28 82.53 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.724 0.81 . . . . 0.0 110.346 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -42.99 96.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.1 -37.45 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 125.349 1.46 . . . . 0.0 108.496 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.48 98.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.46 -43.6 76.65 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -52.43 -57.47 9.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.832 1.196 . . . . 0.0 112.372 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.5 m -63.7 -39.28 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 O-C-N 122.135 -0.353 . . . . 0.0 111.033 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.48 -52.53 64.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.598 0.759 . . . . 0.0 110.161 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -59.8 -44.47 93.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.557 1.543 . . . . 0.0 108.572 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -57.07 -45.07 83.56 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.126 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.21 -13.55 0.13 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-O 117.269 -1.85 . . . . 0.0 114.943 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -59.51 146.5 40.22 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.861 2.33 . . . . 0.0 110.705 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.09 -60.55 3.23 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.193 1.397 . . . . 0.0 113.367 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.5 t -149.7 169.89 19.98 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -158.11 141.25 15.03 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -128.19 143.94 51.08 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.936 1.694 . . . . 0.0 106.673 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.92 118.28 36.13 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.6 95.89 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.67 142.54 39.64 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 76.55 2.29 3.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.261 2.225 . . . . 0.0 111.673 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.92 -126.22 35.07 Favored Glycine 0 CA--C 1.527 0.831 0 O-C-N 120.879 -1.138 . . . . 0.0 113.783 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.02 -37.48 4.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.122 1.369 . . . . 0.0 112.211 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -93.99 -12.81 27.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.396 1.478 . . . . 0.0 114.533 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.01 169.28 13.29 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 119.878 1.217 . . . . 0.0 111.471 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.44 -25.46 24.97 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.951 3.101 . . . . 0.0 115.671 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -134.11 27.53 3.84 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.22 1.808 . . . . 0.0 110.053 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.65 174.16 39.66 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -40.43 -53.11 2.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 71.2 mt -63.21 -51.2 67.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.34 0.518 . . . . 0.0 109.659 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -77.47 27.82 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.478 1.111 . . . . 0.0 111.453 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 61.0 m -128.38 7.4 5.87 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.063 1.745 . . . . 0.0 111.524 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.9 m 57.83 53.66 6.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.039 1.335 . . . . 0.0 110.08 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 13' ' ' TYR . 90.5 mt -122.11 144.28 41.06 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.6 144.11 99.5 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.286 2.658 . . . . 0.0 112.285 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -147.2 156.05 42.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.87 0.868 . . . . 0.0 112.161 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.538 HD11 ' HB2' ' A' ' 40' ' ' ASN . 10.5 mt -105.66 89.95 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 110.132 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -74.67 156.4 86.72 Favored Pre-proline 0 C--O 1.239 0.519 0 O-C-N 121.776 -0.577 . . . . 0.0 109.587 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.61 178.4 7.6 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.54 2.827 . . . . 0.0 109.042 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -66.91 -34.62 78.18 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.106 -0.996 . . . . 0.0 110.172 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 128.8 37.35 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.495 0.718 . . . . 0.0 109.41 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 t -151.46 173.74 14.21 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 p -161.5 142.29 11.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.037 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.69 -171.99 8.57 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 123.82 0.7 . . . . 0.0 111.628 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.15 59.85 7.56 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.803 3.002 . . . . 0.0 108.487 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 t -63.65 132.72 51.99 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.536 -0.727 . . . . 0.0 110.377 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.2 m -83.6 -178.81 7.15 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.795 1.238 . . . . 0.0 110.885 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 179.344 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -137.12 150.02 47.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.13 1.372 . . . . 0.0 107.363 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 p -66.89 97.89 0.51 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.554 1.541 . . . . 0.0 108.309 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 41.07 -117.45 1.06 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 126.198 1.856 . . . . 0.0 108.598 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -157.61 142.3 16.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 104.329 -2.471 . . . . 0.0 104.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 p -149.71 179.24 8.16 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 123.933 0.893 . . . . 0.0 109.353 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 -86.43 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -178.03 167.32 2.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.642 1.977 . . . . 0.0 109.16 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.46 -52.69 60.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.929 0.892 . . . . 0.0 110.083 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -55.41 -52.04 64.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.901 0.48 . . . . 0.0 110.556 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -55.55 -51.53 66.76 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HB1' ' CD2' ' A' ' 78' ' ' TYR . . . -55.96 -47.22 78.01 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -53.09 -52.23 59.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.606 0.763 . . . . 0.0 112.032 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 m -69.01 -36.06 77.36 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.557 -0.714 . . . . 0.0 111.441 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -60.39 -39.98 89.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.5 HD23 ' HB1' ' A' ' 22' ' ' ALA . 73.6 mt -63.9 -38.82 92.5 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.51 0.53 33.59 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 127.084 2.278 . . . . 0.0 114.404 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.48 -20.88 3.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.522 1.161 . . . . 0.0 111.043 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -117.16 102.98 9.75 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.562 -0.711 . . . . 0.0 109.971 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -57.47 -26.24 60.94 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -72.42 -13.18 61.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.441 1.096 . . . . 0.0 111.252 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -90.74 146.63 23.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 120.914 -1.117 . . . . 0.0 111.524 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.04 165.56 30.41 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 tt -103.93 143.73 32.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.665 0.786 . . . . 0.0 108.903 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.0 tp -131.37 98.44 4.53 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.917 1.687 . . . . 0.0 108.868 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -78.47 113.81 16.82 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.9 pt -103.79 13.38 7.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -73.74 166.33 23.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.71 134.36 50.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -54.63 -27.01 36.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.72 1.208 . . . . 0.0 112.39 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.26 88.35 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 120.997 -1.064 . . . . 0.0 110.128 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -71.41 -27.05 63.04 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.105 0.866 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -59.3 -28.5 66.84 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.593 0.633 . . . . 0.0 109.377 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -85.58 -38.9 17.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.862 0.865 . . . . 0.0 110.086 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -68.77 -50.11 53.14 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.81 -12.33 11.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.07 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.02 -152.18 20.01 Favored Glycine 0 N--CA 1.462 0.415 0 CA-C-O 118.508 -1.162 . . . . 0.0 112.141 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.6 p -143.71 161.36 46.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 118.562 1.181 . . . . 0.0 112.956 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.4 157.73 58.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.989 1.793 . . . . 0.0 109.998 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.559 HD21 ' C ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -125.19 87.5 2.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.968 2.107 . . . . 0.0 112.493 -179.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.7 pt -77.3 5.47 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 119.313 -2.117 . . . . 0.0 111.043 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -24.53 61.69 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.234 1.814 . . . . 0.0 112.867 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.9 -27.08 61.53 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 mt -87.61 -50.76 6.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 1.59 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.682 1.61 . . . . 0.0 112.668 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -90.25 -179.9 5.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.15 . . . . 0.0 109.55 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -141.28 133.88 28.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.68 1.592 . . . . 0.0 107.192 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.32 175.19 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.628 0.728 . . . . 0.0 111.754 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -127.95 138.3 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.222 -2.881 . . . . 0.0 103.222 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -115.72 110.33 18.96 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.439 1.096 . . . . 0.0 109.842 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.41 103.12 4.21 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 117.9 -1.048 . . . . 0.0 108.773 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p -58.11 124.53 12.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 119.985 1.266 . . . . 0.0 109.417 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -79.75 122.49 26.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.68 121.58 25.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -60.21 -15.37 37.09 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.124 -0.82 . . . . 0.0 114.087 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.44 -17.8 60.73 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.68 1.24 . . . . 0.0 110.478 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -131.49 66.34 1.54 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.275 1.03 . . . . 0.0 109.976 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -57.54 -58.68 16.58 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 120.195 -1.566 . . . . 0.0 108.46 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.01 -34.61 8.18 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.867 1.712 . . . . 0.0 110.241 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.82 -28.55 63.36 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -80.86 -55.93 4.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -48.74 -50.31 34.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.424 1.89 . . . . 0.0 112.824 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -32.99 63.43 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -63.35 -28.16 69.81 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.892 0.877 . . . . 0.0 110.189 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -45.91 10.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.5 t -53.93 -33.52 56.99 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.268 1.427 . . . . 0.0 112.095 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.24 -6.18 52.11 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -116.66 -39.4 3.32 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.623 0.769 . . . . 0.0 112.851 -178.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.448 ' CD1' HG21 ' A' ' 75' ' ' THR . 47.7 m-85 -80.12 119.86 23.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -33.53 72.48 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.548 0.53 . . . . 0.0 112.097 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -145.67 96.24 4.8 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 124.467 1.107 . . . . 0.0 108.223 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.84 -34.53 91.22 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.699 1.6 . . . . 0.0 111.906 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -63.28 -12.81 32.09 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.25 6.9 p30 -122.5 25.5 8.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.941 1.296 . . . . 0.0 109.29 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.448 HG21 ' CD1' ' A' ' 69' ' ' PHE . 25.4 m -130.84 120.16 23.28 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.258 1.023 . . . . 0.0 110.696 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 83.6 m -93.18 137.05 32.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.6 mt -115.91 96.21 5.48 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.227 1.011 . . . . 0.0 112.148 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.463 ' CD2' ' HB1' ' A' ' 12' ' ' ALA . 13.9 m-85 -78.21 121.07 23.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.434 HG12 ' H ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -74.2 154.36 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.98 1.312 . . . . 0.0 112.668 -179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 80' ' ' LEU . 12.4 tp -155.31 105.05 2.46 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 176.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -119.94 171.88 8.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.851 1.66 . . . . 0.0 106.823 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.66 -58.16 3.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.059 1.343 . . . . 0.0 112.304 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -137.74 -152.07 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.725 2.41 . . . . 0.0 105.544 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.76 -45.4 9.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.995 2.118 . . . . 0.0 112.253 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 45.17 -104.09 0.06 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.829 2.157 . . . . 0.0 113.834 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -143.74 11.81 1.65 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.055 1.742 . . . . 0.0 111.19 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.9 m -39.77 -48.04 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.475 1.91 . . . . 0.0 114.601 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.93 -49.45 77.77 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.835 0.854 . . . . 0.0 110.518 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -46.18 89.85 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.932 0.893 . . . . 0.0 109.529 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.24 -33.67 62.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.31 93.93 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.254 0.934 . . . . 0.0 109.66 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -74.28 -38.95 63.26 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 118.998 0.817 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.4 tp -51.55 -60.09 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.046 1.338 . . . . 0.0 111.808 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -63.58 -37.47 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 122.603 0.361 . . . . 0.0 111.388 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.44 -50.6 70.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.15 -41.42 88.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -66.69 -25.68 66.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.03 -4.5 2.11 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-O 117.712 -1.605 . . . . 0.0 115.717 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -71.24 146.55 48.93 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-N 120.458 2.129 . . . . 0.0 108.137 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -45.36 -64.03 0.81 Allowed 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.726 1.211 . . . . 0.0 111.523 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 53.0 m -157.39 179.27 9.41 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.838 1.655 . . . . 0.0 107.599 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -160.59 142.31 12.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.494 1.518 . . . . 0.0 106.95 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.442 ' HB2' ' CD2' ' A' ' 78' ' ' TYR . 42.9 m-85 -128.6 129.45 45.93 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.865 1.266 . . . . 0.0 108.78 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.64 139.88 30.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 mp -104.65 108.06 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 126.417 1.887 . . . . 0.0 107.793 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -59.66 151.98 23.58 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.81 0.844 . . . . 0.0 109.445 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 66.83 10.17 7.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.42 1.488 . . . . 0.0 112.742 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.89 -116.54 3.39 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.925 2.202 . . . . 0.0 113.284 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.83 -43.57 3.26 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.653 0.781 . . . . 0.0 112.774 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.71 -10.74 41.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.74 176.01 9.38 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.028 1.286 . . . . 0.0 111.605 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.44 -19.31 67.72 Favored 'Trans proline' 0 N--CA 1.471 0.147 0 C-N-CA 123.919 3.079 . . . . 0.0 112.982 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -119.54 -3.97 10.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 127.345 2.258 . . . . 0.0 109.327 178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.45 159.26 25.81 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -25.9 -62.83 0.07 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.462 2.305 . . . . 0.0 114.164 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.51 -62.68 1.52 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.176 1.39 . . . . 0.0 110.77 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -63.66 -10.01 16.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.423 1.089 . . . . 0.0 113.263 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.82 15.31 7.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.502 1.521 . . . . 0.0 109.113 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 m 68.85 15.56 8.92 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 128.349 2.66 . . . . 0.0 112.62 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.69 153.01 52.44 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 119.144 0.884 . . . . 0.0 110.252 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' C ' HD21 ' A' ' 40' ' ' ASN . 33.7 Cg_endo -74.64 169.75 21.85 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.2 1.934 . . . . 0.0 109.536 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -165.19 130.09 2.52 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 119.946 -1.721 . . . . 0.0 109.555 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 40' ' ' ASN . 3.2 mt -72.26 97.21 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 126.658 1.983 . . . . 0.0 109.439 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -93.91 149.52 37.1 Favored Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 121.058 -1.026 . . . . 0.0 112.388 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.06 179.97 5.58 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.046 3.164 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.06 117.65 4.57 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.59 155.15 12.89 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.7 m -125.13 -68.77 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 67.4 p -75.25 -179.82 4.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.584 0.754 . . . . 0.0 110.94 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -122.66 167.31 15.03 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.68 1.61 . . . . 0.0 109.472 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.18 150.85 48.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.027 1.818 . . . . 0.0 109.883 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t 47.12 42.84 13.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.641 1.176 . . . . 0.0 110.296 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.6 t -149.47 78.35 1.37 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 109.356 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 C-N-CA 125.232 1.396 . . . . 0.0 110.513 179.933 . . . . . . . . 0 0 . 1 stop_ save_